2019Nx k¢åwãwEåwa@€ÆÑW(HTMLÅ)
iFŽ{ÅämFº³¢j
ðUw (¬ìPÊ)
[wp_¶]
110001. [Ž] Parallel Evolution of Two dmrt1-Derived Genes, dmy and dm-W, for Vertebrate Sex Determination. Ogita Y, Mawaribuchi S, Nakasako K, Tamura K, Matsuda M, Katsumura T1, Oota H, Watanabe G, Yoneda S, Takamatsu N, Ito M: iScience 2020/1; 23 (1): 100757. (º[j1: 1ðU)
[wïE€ï]
713001. [wï (Û)] (êÊu) The fine structural approach to clarify the pathophysiological mechanism of orthopedic diseases by analyzing the spinal excurved Medaka mutant, wavy (wy). Nishimaki T1, Uchida K2, Yamada M, Oda S, Oga A, Oota H, Katsumura T3, Takaso M2, Ogawa M3: The 19th Congress of the International Federation of Associations of Anatomists (2019/8/9), London, UK. (Œê rV1, àcŸY2, º[j3, »m2, ¬ì³V3: 1`Ôn, 2®O, 3ðU)
713002. [wï (Û)] (êÊu) CHANGES IN BLOOD COMPONENT AND DNA METHYLATION PATTERNS IN HEALTHY MEN EXPOSED HYPOBARIC HYPOXIA. Motoi M, Toyoshima H, Nakayama K, Kishida F, Shin S, Nishimura T, Yasukochi Y, Katsumura T1, Oota H, Maeda T, Watanuki S: 14TH INTERNATIONAL CONGRESS OF PHYSIOLOGICAL ANTHROPOLOGY 2019 (ICPA2019) (2019/9/24), Singapore. (º[j1: 1ðU)
723001. [wï (S)] (êÊu) íj«Éš¯éá³á_fIÌÆunwWÌÏ». {ä@É, LGv, Ýc@¶, Shin S, ŒºMF, ÀÍàFP, º[j1, Rêå, Ÿc÷, Ocj, ÈÑÎì (1ðU): ú{¶lÞwïæ79ñåï (2019/6/1), Ö.
723002. [wï (S)] (êÊu) _JWcðp¢œqgVï«Çs®ÉÖíéQmÌæÌTõ. º[j1, öc³ñ, ãªj, OJ[u, ¬ì³V1, Ÿc÷, |àGŸ (1ðU): ú{i»wïæ21ñåï (2019/8/7), Dy.
723003. [wï (S)] (êÊu) VK€^ÇfƵÄwy_JÌLp«Ì¢. º[j1, àcŸY2, Rc@«, Œê rV3, öc³ñ, ¬êú¿, Ÿc÷, »m2 (1ðU, 2®O, 3`Ôn): æ34ñú{®`OÈwïîbwpWï (2019/10/17-18), ¡l.
723004. [wï (S)] (êÊu) VK€]ÇfƵÄwy_JÌLp«Ì¢. º[j1, àcŸY2, Rc@«, Œê rV3, öc³ñ, ¬êú¿, Ÿc÷, »m2, ¬ì³V1 (1ðU, 2®O, 3`Ôn): æ34ñú{®`OÈwïîbwpWï (2019/10/17), ¡l.
723005. [wï (S)] (êÊu) A}SETcL}XÉš¯éñVœ^Ìâ`îÕÌTõ. ãcé¢, cBç, º[j1, ŽûNV, OF, Michael R MILLER, ²¡ñÆ (1ðU): æ67ñú{¶Ôwïåï (2020/3/7), ŒÃ®.
'18NxÈOª
[wïE€ï]
'18-723001. [wï (S)] (êÊu) LAMP@ðgpµœðUÌÉš¯éjÛÌv¬ž. OY³Ÿ1, VäYŸ1, ÊØpŸ1,2, º[j1, ¬ì³V1 (1ðU, 2Õ°ðU³ç): æ124ñú{ðUwïïESwpWï (2019/3/27), V.
ðUw (ããPÊ)
[wp_¶]
110002. [Ž] Regulation of Ca2+/calmodulin-dependent protein kinase kinase À by cAMP signaling. Takabatake S, Ohtsuka S, Sugawara T1, Hatano N, Kanayama N, Magari M, Sakagami H1, Tokumitsu H: Biochim Biophys Acta Gen Subj 2019/4; 1863 (4): 672-80 (ŽV1, ããms1: 1ðU)
110003. [Ž] Localization of phosphatidylinositol 4-phosphate 5-kinase (PIP5K) ¿, À, Á in the three major salivary glands in situ of mice and their response to À-adrenoceptor stimulation. Khrongyut S, Rawangwong A, Pidsaya A, Sakagami H1, Kondo H, Hipkaeo W: J Anat 2019/4; 234 (4): 502-14. (ããms1: ðU1)
110004. [Ž] Mice lacking EFA6C/Psd2, a guanine nucleotide exchange factor for Arf6, exhibit lower Purkinje cell synaptic density but normal cerebellar motor functions. Saegusa S1, Fukaya M2, Kakegawa W, Tanaka M3, Katsumata O, Sugawara T2, Hara Y2, Itakura M4, Okubo T5, Sato T5, Yuzaki M, Sakagami H2: PLoS One 2019/5; 14 (5): e0216960. (O}MåY1, [J¹O2, c@w3, ŽV2, Ž@FL2, Âq@œ4, åvÛŒ5, ²¡rÆ5, ããms2: 1ãw, 2ðU, 3oCIC[W€Z, 4¶», 5À®)
110005. [Ž] Data on the effects of Charcot-Marie-Tooth disease type 2N-associated AARS missense mutation (Arg329-to-His) on the cell biological properties. Imaizumi N, Takeuchi Y, Hirano H, Torii T, Seki Y, Morimoto T, Miyamoto Y, Sakagami H1, Yamauchi J: Data Brief 2019/5; 25: 104029. (ããms1: ðU1)
110006. [Ž] Aberrant Amygdala-Dependent Cued Fear Memory in Na+/Ca2+ Exchanger 1 Heterozygous Mice. Moriguchi S, Kita S, Inagaki R, Yabuki Y, Sasaki Y, Ishikawa S, Sakagami H1, Iwamoto T, Fukunaga K: Mol Neurobiol 2019/6; 56 (6): 4381-94. (ããms1: 1ðU)
[wïE€ï]
723006. [wï (S)] (êÊu) Cn_o×EÉš¯éBRAG2-Arf6VOioHðAMPAóeÌÌVivX»²ß@\. [J¹O1, ããms1 (1ðU): æ125ñú{ðUwïïESwpWï (2020/3/27), Rû.
'18NxÈOª
[wp_¶]
H25-110001. [Ž] Type 1 inositol trisphosphate receptor regulates cerebellar circuits by maintaining the spine morphology of purkinje cells in adult mice. Sugawara T1, Hisatsune C, Le TD, Hashikawa T, Hirono M, Hattori M, Nagao S, Mikoshiba K: J Neurosci 2013/7; 33 (30): 12186-96. (ŽV1: 1ðU)
H25-110002. [Ž] IP3R1 deficiency in the cerebellum/brainstem causes basal ganglia-independent dystonia by triggering tonic Purkinje cell firings in mice. Hisatsune C, Miyamoto H, Hirono M, Yamaguchi N, Sugawara T1, Ogawa N, Ebisui E, Ohshima T, Yamada M, Hensch TK, Hattori M, Mikoshiba K: Front Neural Circuits 2013/10; 7: 156. (ŽV1: 1ðU)
H29-110001. [Ž] Regulation of spinogenesis in mature Purkinje cells via mGluR/PKC-mediated phosphorylation of CaMKIIÀ. Sugawara T1, Hisatsune C, Miyamoto H, Ogawa N, Mikoshiba K: Proc Natl Acad Sci U S A 2017/6; 114 (26): E5256-65. (ŽV1: 1ðU)
'18-110001. [Ž] Hyperactivation of mTORC1 disrupts cellular homeostasis in cerebellar Purkinje cells. Sakai Y, Kassai H, Maeda T, Nakayama H, Fukaya M1, Maeda T, Nakao K, Hashimoto K, Sakagami H1, Kano M, Aiba A: Sci Rep 2019/2; 9 (1): 2799. ([J¹O1, ããms1: 1ðU)
¶w (ìãPÊ)
[@]
620001. [wp (ªS·M)] y¶«šÆ¹ÌTzæ5Í ¹Þ@5-23 IEECR̺@\, p.224-5. ²¡ºœ (¶), Ò: ¶š¹¿wï, ©qX, , 2019/11s.
620002. [wp (ªS·M)] y¶«šÆ¹ÌTzæ5Í ¹Þ@5-27 IEECRÌR[wK, p.230-1. ¡ŽGq, ²¡ºœ1 (1¶), Ò: ¶š¹¿wï, ©qX, , 2019/11s.
[wïE€ï]
723007. [wï (S)] (êÊu) }EXÌVï°|ÌxšæÑ¡o«wKL¯lŸÌTî˶IÈá. gcÊT, cê_ÀÞ, nÓ€q, ¡ŽGq, ²¡ºœ1, {{T (1¶): ú{®šwïæ90ñåãåï 2019 (2019/9/12), åã.
723008. [wï (S)] (êÊu) ZLZCCRÌR^NgER[wKÆ®oÌæ. ²¡ºœ1, ¡ŽGq, nÓ€q, cê_ÀÞ, Matthijs A Zandbergen, Johan J Bolhuis, {{T (1¶): ú{®šwïæ90ñåãåï 2019 (2019/9/14), åã.
723009. [wï (S)] (êÊu) LiNÆÂFõÉæéîá×E Acute death of tumor cells induced by quinacrine with blue light. ä¯ÔOü (¶): æ97ñú{¶wïåï (2020/3/19), åª (ãJÃ).
'18NxÈOª
[wïE€ï]
'18-713001. [wï (Û)] (êÊu) Different expression of Olig2 and O4 in cultured mouse brain cells. Hiruma H1: 9th FAOPS Congress (2019/3/30), Kobe, Japan. (ä¯ÔOü1: 1¶)
¶w (ŽPÊ)
[wp_¶]
110007. [Ž] Bidirectional in vivo structural dendritic spine plasticity revealed by two-photon glutamate uncaging in the mouse neocortex. Noguchi J, Nagaoka A, Hayama T, Ucar H, Yagishita S, Takahashi N1, Kasai H: Sci Rep 2019/9; 9 (1): 13922. (ŽÏq1: 1¶)
110008. [Ž] Involvement of inflammasome activation via elevation of uric acid level in nociception in a mouse model of muscle pain. Yoshida S, Hagiwara Y, Tsuchiya M, Shinoda M, Koide M, Hatakeyama H1, Chaweewannakorn C, Suzuki K, Yano T, Sogi Y, Itaya N, Sekiguchi T, Yabe Y, Sasaki K, Kanzaki M, Itoi E: Mol Pain 2019/1-12; 15: 1744806919858797. (©RTN1: 1¶)
110009. [Ž] Extracellular ¿-synuclein enters dopaminergic cells by modulating flotillin-1-assisted dopamine transporter endocytosis. Kobayashi J, Hasegawa T, Sugeno N, Yoshida S, Akiyama T, Fujimori K, Hatakeyama H1, Miki Y, Tomiyama A, Kawata Y, Fukuda M, Kawahata I, Yamakuni T, Ezura M, Kikuchi A, Baba T, Takeda A, Kanzaki M, Wakabayashi K, Okano H, Aoki M: FASEB J 2019/9; 33 (9): 10240-56. (©RTN1: 1¶)
110010. [Ž] Thy1 promoter activity in the Rosa26 locus in mice: lessons from Dre-rox conditional expression system. Tamura S, Yasuoka Y1, Miura H, Takahashi G, Sato M, Ohtsuka M: Exp Anim 2020/8; 69 (3): 287-94. doi: 10.1538/expanim.20-0002. Epub 2020 Feb 11. (ÀªLIq1: 1¶)
522001. [uÀ]yÁW: äX€updatezCXªåÌ_Ci~NX. ŽÏq (¶): AaEàªåãÓÈ 2020/2; 50 (2): 71-6.
522002. [uÀ]yÁW Cl-: dð¿ÌNC[z[_] Cl-Æ»Ìð. ÍŽë, ÀªLIq1 (1¶): tÆ§Í 2020/3; 88 (3): 316-21.
522003. [uÀ]yÁW Cl-: dð¿ÌNC[z[e_] WÇÌ_î²ß\@2) AhXe-MR²Éæédð¿E_î²ß. ìXûj, ÀªLIq1, òTêY (1¶): tÆ§Í 2020/3; 88 (3): 377-81.
522004. [uÀ]yÁW Cl-: dð¿ÌNC[z[e_] WÇÌ_î²ß\ 4) tWÇÔÝ×Etype-B: ÇoAjIð·Ì (Pendrin) ̲ß@\. ÀªLIq1, ÍŽë (1¶): tÆ§Í 2020/3; 88 (3): 390-5.
540001. [»ÌŒ (Ïõïñ)] AaêåãÌ«ûƶ»ó²ž, wïÉßçêéægÝÉ¢Ä`2017NxuAaãÌLAÉš¯é»ó²žÆ¡ãÌW]Éü¯œAP[gvÊæè`. ¬£jq1, À·qÃq1, RÐÆÝ1, cL}1, rcD1, ä¬mü1, bü1, n®ŽL1, Ÿc@ß1, ªcRIq1, ¬JIq1, ŽÏq1,2, ä@€1, ººL1, ¡ìéÝ1, OYV1, Xcbüq1, ö¬@K1, AØ_ñY1 (1«Aaãðpromote·éÏõï, 2¶): Aa 2019/5; 62 (5): 337-46.
[@]
621001. [wp (ÄCEÒWE»ÌŒ)] yRX^]Ÿð¶w Žæ6Åz6 t̶w, 7 _î̶w, 8Á»ín̶w, 9àªån̶w, 10 ¶B̶w, p.271-550. Äó: Ñ@rG, ŽÏq1 (1¶), G[rAEWp, , 2019/9s.
622001. [wp (|ó)]yRX^]Ÿð¶w Žæ6Åz6 t̶w, p.271-305. ÀªLIq1, cpê1 (1¶), Äó: Ñ@rG, ŽÏq1 (1¶), G[rAEWp, , 2019/9s.
622002. [wp (|ó)]yRX^]Ÿð¶w Žæ6Åz9 àªån̶w, p.439-512. ©RTN1 (1¶), Äó: Ñ@rG, ŽÏq1 (1¶), G[rAEWp, , 2019/9s.
[wïE€ï]
722001. [wï (S)] (V|WEéæ)yÀ·zMechanosensing of the enlargement of dendritic spines by presynaptic terminals in rat hippocampus. Ucar Hasan, nÓ@š, ìû@, öº@Ë, ç{Sê, ŽÏq1, ÍŒtY (1¶): æ97ñú{¶wïåï (2020/3/18), åª.
723010. [wï (S)] (êÊu) äXÀ×E§äÉš¯éMek/ErkVOiÌðÌðŸ. ¶Fq, ¬ÑŒ÷, ŸàV³°, zKà_Ð, YcõŸY, ºJ§j, ŽÏq1, AØ_ñY (1¶): æ62ñú{AawïNwpWï (2019/5/23), åä.
723011. [wï (S)] (êÊu) áHUAJAÍ, WÇIC-BÇoPendrin©çÌHCO3-ßèªåªŽöÅ é. ÀªLIq1, åFü2, ²¡Yê3, ŽÏq1, ìXûj, ÍŽë (1¶, 2¶ššn, 3ãÃq¶w): æ62ñú{twïwpï (2019/6/23), ŒÃ®.
723012. [wï (S)] (êÊu) MEK/ERKVOiÍäXÀ×EÌÊƪå\ð§ä·é. ¶Fq, ¬ÑŒ÷, ŸàV³°, zKà_Ð, YcõŸY, ºJ§j, ŽÏq1, AØ_ñY (1¶): æ31ñªqAawV|WE (2019/12/7), .
723013. [wï (S)] (êÊu) JVE (Ca) oûÛæÌh{wI_ÆtàIzû. ÍŽë, ÀªLIq1, ìXûj, ËPal, Öì@T (1¶): æ23ñú{aÔh{wïNwpWï (2020/1/24), s.
723014. [wï (S)] (êÊu) MEK/ERK VOiÉæéäXÀ×E§ä. ¶Fq, ¬ÑŒ÷, ŸàV³°, zKà_Ð, YcõŸY, ºJ§j, ŽÏq1, AØ_ñY (1¶): æ34ñú{AaE쮚wïNwpWï (2020/2/1), Qn.
723015. [wï (S)] (êÊu) ÊA×ÇÉš¯égDJNCÌ»ÆJVEA. ÀªLIq1, åFü2, ²¡Yê3, ŽÏq1, ìXûj, ÍŽë (1¶, 2¶ššn, 3ãÃq¶w): æ97ñú{¶wïåï (2020/3/19), ãJÃ.
723016. [wï (S)] (êÊu) GLUT4AÉš¢ÄCX«ÉN±éðúßöÆÙí¬EÔZ̯»ðÍ. ©RTN1, _è@W (1¶): æ97ñú{¶wïåï (2020/3/19), ãJÃ.
732001. [wï (nûïE€ï)] (µÒu) îbãw©çAawÖÌAv[`. ŽÏq (¶): ú{AawïÖbMznûïéæ Young Diabetologists Research Forum (2019/7/6), .
733001. [wï (nûïE€ï)] (êÊu) ASÌÌ×EàAVXeðêªqxÅÝéEÍ©é. ©RTN (¶): k¢åwãwæ11ñvOX|[gïc (2019/9/18), ÍŽ.
733002. [wï (nûïE€ï)] (êÊu) TASK2KO}EXÌ_îCoXÍã«AjAY¶ðºíÈ¢. ÀªLIq1, åFü2, ŽÏq1, ²¡Yê3, ìXûj, ÑJÜèq, ËPal, Öª@T, ÍŽë (1¶, 2¶ššn, 3ãÃq¶w): æ49ñú{twïwpåï (2019/10/4), .
733003. [wï (nûïE€ï)] (êÊu) ßÌ€®ðUèÔÁÄ`œª¡ÉÂȪÁÄ¢é©?`. ©RTN (¶): Ag^m€lÞç¬VXe ¢ã€ÒV|WE2019 (2019/10/31), ŒÃ®.
¶»w (äPÊ)
[wp_¶]
110011. [Ž] IÈB kinase 2 is not essential for platelet activation. Salzmann M, Bleichert S, Moser B, Mussbacher M, Haase M, Hoesel B, Schrottmaier WC, Kral-Pointner JB, Itakura M1, Schmidt K, Assinger A, Schmid JA: Blood Adv 2020/2; 4 (4): 638-43. (Âq@œ1: 1¶»)
110012. [Ž] Electron Microscopic Detection of Single Membrane Proteins by a Specific Chemical Labeling. Tabata S, Jevtic M, Kurashige N, Fuchida H, Kido M, Tani K, Zenmyo N, Uchinomiya S, Harada H, Itakura M1, Hamachi I, Shigemoto R, Ojida A: iScience 2019/12; 22: 256-68. (Âq@œ1: 1¶»)
[wïE€ï]
713002. [wï (Û)] (êÊu) Identification and functional analysis of FGFR2 binding proteins in diffuse-type gastric carcinoma. Shirakihara T1: American Association for Cancer Research Annual Meeting 2019 (2019/4/1), Atlanta, GA, USA. (ØŽôÆ1: 1¶»)
723017. [wï (S)] (êÊu) XLXݪñÌiWÉÖíéFGFóeÌ^pN¿TfR1Ì@\ðÍ. ØŽôÆ (¶»): æ28ñú{ªñ]ÚwïwpWïEï (2019/7/26), .
723018. [wï (S)] (êÊu) ÑÜñ«ÝªñÌiWÉÖíéFGFR2^pN¿ÌTõÆ@\ðÍ. ØŽôÆ (¶»): æ78ñú{àwïwpï (2019/9/26), s.
723019. [wï (S)] (êÊu) ÑÜñ«ÝªñÌiWÉÖíéFGFR2^pN¿ÌTõÆ@\ðÍ. ØŽôÆ (¶»): æêñú{àwïáèÌï (2020/2/11), ê.
731001. [wï (S)] (ÁÊu) XLXݪñ×EÉš¯éFGFóeÌ^pN¿ÌTõÆ@\ðÍ. ØŽôÆ (¶»): áè€Ò\E¢_ï@vOX|[gïc (2019/5/22), ÍŽ.
¶»w (äÝãPÊ)
[@]
610001. [wp (ªS·M)]yKetamine: From abused drug to rapid-acting antidepressantzSynaptic modulation in the effect of ketamine, p.69-87. Okada D1, Editors: Hashimoto K2, Ide S3, Ikeda K3 (2Chiba University, 3Tokyo Metropolitan Institute of Medical Science), Springer Nature Singapore Pte Ltd., Singapore, 2020 /1. (ªcå1: 1¶»)
[wïE€ï]
723020. [wï (S)] (êÊu) XgXhÉæé]àSNAP-25Ì_»ÆmA~úoÌÏ». RXD1, ÀcCê2, nÓ@ , {ª@3, äÝã€ñ1 (1¶», 2¶ššn, 3ž_): æ92ñú{¶»wïåï (2019/9/20), ¡l.
ªqâ`w
[wp_¶]
110013. [Ž] Dysregulated DNA methylation of GLA gene was associated with dysfunction of autophagy. Yanagisawa H, Hossain MA, Miyajima T, Nagao K1, Miyashita T1, Eto Y: Mol Genet Metab 2019/4; 126 (4): 460-5. (·öaE1, {ºrV1: 1ªqâ`)
110014. [Ž] MicroRNAs profiling in fibroblasts derived from patients with Gorlin syndrome. Shiohama T, Fujii K, Miyashita T1, Takatani T, Ikehara H, Uchikawa H, Motojima T, Uchida T, Shimojo N: J Hum Genet 2019/8; 64 (8): 757-65. ({ºrV1: 1ªqâ`)
210001. [Ž] (Data Report) A novel PTCH1 mutation in basal cell nevus syndrome with rare craniofacial features. Murata Y, Kurosaka H, Ohata Y, Aikawa T, Takahata S, Fujii K, Miyashita T1, Morita C, Inubushi T, Kubota T, Sakai N, Ozono K, Kogo M, Yamashiro T: Hum Genome Var 2019/4; 6: 16. ({ºrV1: 1ªqâ`)
310001. [Çáñ] A familial case of overgrowth syndrome caused by a 9q22.3 microdeletion in a mother and daughter. Yamada H, Shimuraa M, Takahashi H, Nara S, Morishima Y, Go S, Miyashita T1, Numabe H, Kawashima H: Eur J Med Genet 2020/5; 63 (5): 103872. ({ºrV1: 1ªqâ`)
[wïE€ï]
722002. [wï (S)] (V|WE) wbWzbOÙíÇÌiPS×EÆQmÒW. {ºrV (ªqâ`): æ61ñú{¬_owïwpWï (2019/6/1), ŒÃ®.
723021. [wï (S)] (êÊè) PTCH1â`qÌSžðº€GorlinÇóQ (9q22.3÷מ) Ìeqá. uº@D, RcЩè, ·Jì¢Þ, Žpé, ÞÇžT, Xõs, à@@, {ºrV1, ÀŒ, Í®u (1ªqâ`): æ122ñú{¬ÈwïwpWï (2019/4/19-21), àò.
732002. [wï (nûïE€ï)] (µÒu) wbWzbOVOi`BÌŽiÆŸ³. {ºrV (ªqâ`): šÌ
ªñwAJf~Aæ161ñWï (2020/2/26), .
'18NxÈOª
[wp_¶]
'18-522001. [uÀ]yÁW: GorlinÇóQ|¶©ç¡ÃÜÅ|zGorlinÇóQÌâ`qff. {ºrV1, Rgi1 (1ªqâ`):T§ãwÌàÝ 2019/1; 268 (2): 123-6.
òw
[wp_¶]
110015. [Ž] VEGF Receptor 1-Expressing Macrophages Recruited from Bone Marrow Enhances Angiogenesis in Endometrial Tissues. Sekiguchi K1, Ito Y2, Hattori K3, Inoue T4, Hosono K2, Honda M3, Numao A, Amano H2, Shibuya M, Unno N1, Majima M2: Sci Rep 2019/5; 9 (1): 7037. (Öûaé1, É¡`ç2, ¿q3, äãqm4, ×ìÁÞq2, {cëq3, Vìp÷2, CìMç1, n³²2: 1YÈ, 2ò, 3åw@ãÃn€È, 4Á»íà)
110016. [Ž] RAMP1 signaling in immune cells regulates inflammation-associated lymphangiogenesis. Tsuru S1, Ito Y2, Matsuda H3, Hosono K2, Inoue T4, Nakamoto S1, Kurashige C3, Mishima T5, Tsujikawa K, Okamoto H3, Majima M2: Lab Invest 2020/5; 100 (5): 738-50. (1, É¡`ç2, ŒcOü3, ×ìÁÞq2, äãqm4, {Ci1, åUdçG3, üº5, ª{_k3, n³²2: 1åw@ãÃn€È, 2ò, 3, 4Á»íà, 5SÇO)
110017. [Ž] The role of vascular endothelial growth factor receptor 1 tyrosine kinase signaling in bleomycin-induced pulmonary fibrosis. Amano H1, Mastui Y2, Ito Y1, Shibata Y, Betto T3, Eshima K4, Ogawa F, Satoh Y2, Shibuya M, Majima M1: Biomed Pharmacother 2019/9; 117: 109067. (Vìp÷1, Œä[v2, É¡`ç1, ÊácüL3, ]kñ4, ²¡Vr2, n³²1: 1ò, 2ÄzíO, 3Á»íà, 4Æu)
110018. [Ž] Thromboxane A 2 receptor signaling in endothelial cells attenuates monocrotaline-induced liver injury. Otaka F1, Ito Y2, Inoue T3, Ohkubo H4, Nishizawa N5, Kojo K6, Betto T3, Yamane S3, Narumiya S, Koizumi W3, Majima M2: Toxicol Appl Pharmacol 2019/10; 381: 114733. (åj¹1, É¡`ç2, äãqm3, åvÛ¢4, ŒàVL±5, Ãé@6, ÊácüL3, RªIq3, ¬òaOY3, n³²2: 1åw@ãÃn€È, 2ò, 3Á»íà, 4SÇO, 5êÊE¬EÌ_äXO, 6ºÁ»ÇO)
110019. [Ž] Microsomal prostaglandin E synthase-1 promotes lung metastasis via SDF-1/CXCR4-mediated recruitment of CD11b+ Gr1+ MDSCs from bone marrow. Takahashi R1, Amano H1, Ito Y1, Eshima K2, Satoh T3, Iwamura M3, Nakamura M4, Kitasato H4, Uematsu S, Raouf J, Jakobsson PJ, Akira S, Majima M1: Biomed Pharmacother 2020/1; 121: 109581. doi: 10.1016/j.biopha.2019.109581. Epub 2019 Nov 10. (Ž@º1, Vìp÷1, É¡`ç1, ]kñ2, ²¡Ð¶3, ⺳k3, º³÷4, k¢pY4, n³²1: 1ò, 2Æu, 3åAí, 4ãÃq¶w)
110020. [Ž] EP3 signaling in dendritic cells promotes liver repair by inducing IL-13-mediated macrophage differentiation in mice. Nakamoto S1, Ito Y2, Nishizawa N3, Goto T1, Kojo K4, Kumamoto Y3, Watanabe M5, Narumiya S, Majima M2: FASEB J 2020/4; 34 (4): 5610-27. doi: 10.1096/fj.201901955R. Epub 2020 Feb 28. ({Ci1, É¡`ç2, ŒàVL±3, ã¡ìç1, Ãé@4, G³Yî3, nç²¹F5, n³²2: 1åw@ãÃn€È, 2ò, 3êÊE¬EÌ_äXO, 4ºÁ»ÇO, 5k¢åwk¢€a@)
220001. [Ž] pÇV¶ð§ä·é_oyv`hCGRPÌð. É¡`ç1, 2, ×ìÁÞq1, Vìp÷1, n³²1 (1ò, 2åw@ãÃn€È): pw 2019/12; 42 (2): 72-5.
[wïE€ï]
722003. [wï (S)] (µÒu) ÇÌpÇV¶ð§ä·é_oyv`hCGRPÌð (Neuropeptide CGRP regulates inflammation by increasing lymphangiogenesis). ×ìÁÞq1, É¡`ç1, Vìp÷1, n³²1 (1ò): æ93ñú{òwïNï (2020/3/16-18), ãJÃ.
723022. [wï (S)] (êÊu) vX^OWEP3óeÌVOiðÌ÷ó×EÌÌC£iìp. {Ci1, É¡`ç2, ŒàVM±3, åj¹1, 1, ¿q4, {cëq1, Vìp÷2, n³²2 (1åw@ãÃn€È, 2ò, 3êÊE¬EÌ_äXO, 4YÈ): æ40ñú{ǥĶãwï (2019/7/16), _Ë.
723023. [wï (S)] (êÊu) üPÉš¯émPGES-1/PGE2-EP4 signalÌðÍ. Vìp÷1, ]kñ2, É¡`ç1, RÇÃj, ¬{@ü, n³²1 (1ò, 2Æu): æ40ñú{ǥĶãwï (2019/7/16), _Ë.
723024. [wï (S)] (êÊu) Ì¡upÇV¶ð§ä·éóeÌ«²ß`1 (RAMP1) Ìð. 1, É¡`ç2, ×ìÁÞq2, äãqm3, ŒcOü4, åUdçG4, {Ci1, åj¹1, ª{_k4, n³²2 (1åw@ãÃn€È, 2ò, 3Á»íà, 4): æ40ñú{ǥĶãwï (2019/7/16), _Ë.
723025. [wï (S)] (êÊu) q{àÇÉš¯épÇV¶ð§ä·éVEGFR1ÌððŸ. ¿q1, É¡`ç2, {cëq3, Öûaé1, ×ìÁÞq2, CìMç1, n³²2 (1YÈ, 2ò, 3åw@ãÃn€È): æ40ñú{ǥĶãwï (2019/7/16), _Ë.
723026. [wï (S)] (êÊu) g{LTA2óeÌVOiÌÌÞŽÂÇÇóQÉš¯éð. É¡`ç1, åj¹2, åvÛ¢3, n³²1 (1ò, 2åw@ãÃn€È, 3SÇO): æ33ñÌÞŽÇ×E€ïwpWï (2019/11/30), åã.
723027. [wï (S)] (êÊu) ÌÞŽÂÇÇóQÉš¯ég{LTA2óeÌÌðÉ墀 (Thromboxane A2 receptor signaling attenuates monocrotaline-induced liver injury by affecting endothelial cells, but not platelets). åj¹1, É¡`ç2, äãqm3, åvÛ¢4, 1, ×ìÁÞq2, ¬òaOY3, n³²2 (1åw@ãÃn€È, 2ò, 3Á»íà, 4SÇO): æ93ñú{òwïNï (2020/3/16-18), ãJÃ.
723028. [wï (S)] (êÊu) EP4VOiÍpÇV¶ðµÄDSSU±°ÌCð£i·é (EP4 signaling facilitates mucosal repair after DSS-induced colitis by enhancement of lymphangiogenesis). É¡`ç1, ×ìÁÞq1, Ãé@2, n³²1 (1ò, 2ºÁ»ÇO): æ93ñú{òwïNï (2020/3/16-18), ãJÃ.
723029. [wï (S)] (êÊu) Æu×EÌTPVOiÍ Ì¡upÇV¶ð£i·é (TP signaling in immune cells promotes lymphangiogenesis in the diaphragm during peritonitis). 1, É¡`ç2, ŒcOü3, ×ìÁÞq2, ª{_k3, n³²2 (1åw@ãÃn€È, 2ò, 3): æ93ñú{òwïNï (2020/3/16-18), ãJÃ.
723030. [wï (S)] (êÊu) RAMP1Éæé}EXq{àÇÉš¯éÇEpÇV¶£iìp (RAMP1 signaling facilitates angiogenesis and lymphangiogenesis in the endometriotic lesions in mice). {cëq1, É¡`ç2, ¿q3, ×ìÁÞq2, {Ci1, åj¹1, 1, n³²2 (1åw@ãÃn€È, 2ò, 3YÈ): æ93ñú{òwïNï (2020/3/16-18), ãJÃ.
733004. [wï (nûïE€ï)] (êÊu) ÌÞŽÂÇÇóQÉš¯ég{LTóeÌÌð. åj¹1, É¡`ç2, äãqm3, ŒàVL±4, {Ci1, 1, ¿q5, {cëq1, ×ìÁÞq2, ¬òaOY3, n³²2 (1åw@ãÃn€È, 2ò, 3Á»íà, 4êÊE¬EÌ_äXO, 5YÈ): æ140ñú{òwïÖï (2019/7/6), .
733005. [wï (nûïE€ï)] (êÊu) q{àÇÉš¯é¬ÇV¶ð§ä·é_oyv`hCGRPÌð. {cëq1, É¡`ç2, ¿q3, ×ìÁÞq2, {Ci1, åj¹1, 1, n³²2 (1åw@ãÃn€È, 2ò, 3YÈ): æ140ñú{òwïÖï (2019/7/6), .
÷¶šw
[wp_¶]
110021. [Ž] Kozupeptins, Antimalarial Agents Produced by Paracamarosporium Species: Isolation, Structural Elucidation, Total Synthesis, and Bioactivity. Hayashi Y, Fukasawa W, Hirose T1, Iwatsuki M1, Hokari R1, Ishiyama A1, Kanaida M, Nonaka K1, Tak A2, Otoguro K, Omura S1, Shiomi K1, Sunazuka T1: Org Lett 2019/4; 21 (7): 2180-84. (A£Fõ1, â³l1, ä @æ1, ÎRI1, ìê1, @@W2, åº@q1, ©aN1, »ËqŸ1: 1k¢¶œÈw€, 2÷¶š)
110022. [Ž] Saccharopolyspora rhizosphaerae sp. nov., an actinomycete isolated from rhizosphere soil in Thailand. Intra B, Euanorasetr J, Tak A1, Inahashi Y2, Mori M2, Panbangred W, Matsumoto A2: Int J Syst Evol Microbiol 2019/5; 69 (5): 1299-305. (@@W1, îŽCN2, Xüäq2, Œ{úq2: 1÷¶š, 2k¢¶œÈw€)
110023. [Ž] Nanaomycin I and J: New nanaomycins generated by mycothiol-mediated compounds from "Streptomyces rosa subsp. notoensis" OS-3966. Matsuo H1, Noguchi Y1, Tak A2, Nakanishi J, Shigemura K, Sunazuka T1, Takahashi Y1, Omura S1, Nakashima T1: J Biosci Bioeng 2019/5; 127 (5): 549-53. (ŒömF1, ìûgF1, @@W2, »ËqŸ1, Žmq1, åº@q1, ô©1: 1k¢¶œÈw€, 2÷¶š)
110024. [Ž] Therapeutic Potential of an Endolysin Derived from Kayvirus S25-3 for Staphylococcal Impetigo. Imanishi I1, Uchiyama J, Tsukui T, Hisatsune J, Ide K, Matsuzaki S, Sugai M, Nishifuji K: Viruses 2019/8; 11 (9): 769. (¡ŒsN1: 1÷¶š)
110025. [Ž] Exfoliative toxin E, a new Staphylococcus aureus virulence factor with host-specific activity. Imanishi I1, Nicolas A, Caetano AB, Castro TLP, Tartaglia NR, Mariutti R, Gudon E, Even S, Berkova N, Arni RK, Seyffert N, Azevedo V, Nishifuji K, Le Loir Y: Sci Rep 2019/11; 9 (1): 16336. (¡ŒsN1: 1÷¶š)
110026. [Ž] Fodinicola acaciae sp. nov., an Endophytic Actinomycete Isolated from the Roots of Acacia mangium Willd. and Its Genome Analysis. Thanh Pham HT, Suwannapan W, Koomsiri W, Inahashi Y1, Tak A2, Matsumoto A1, Thamchaipenet A: Microorganisms 2020/3; 8 (4): 467. (îŽCN1, @@W2, Œ{úq1: 1k¢¶œÈw€, 2÷¶š)
310002. [Çáñ] Spontaneous regression of canine papillomavirus type 2-related papillomatosis on footpads in a dog. Iyori K, Inai K, Shimakura H, Haga T, Shimoura H, Imanishi I1, Imai A, Iwasaki T: J Vet Med Sci 2019/6; 81 (6): 933-6. (¡ŒsN1: 1÷¶š)
310003. [Çáñ] Clinical and histopathological presentation and successful treatment with ciclosporin for canine sarcoidosis: a case report. Iyori K, Kinoshita M, Imai A, Imanishi I1, Shirota K: Vet Dermatol 2019/10; 30 (5): 438-e136. (¡ŒsN1: 1÷¶š)
520001. [à] Î^ÛÉæé@àŽõ. ²¡rY, Ñ@r¡1 (1÷¶š): k¢ãw 2019/12; 49 (2): 73-8.
521001. [ðà]yHelicobacterVÛí©!z2016NšæÑ2017NɳF³êœHelicobacter®ÌVÛíÌÐî|ñ_¶æè|. Ñ@r¡ (÷¶š): Helicobacter Research 2019/5; 23 (1): 74-8.
522005. [uÀ]yPracticalÁW: êœôó@, Bêœó²û,
¹ÇÌcU[o[𩲠«®õÌmF|Cgz[8] U[o[TµÉ×Û®³ñðUÁÄÝæ€ mF|Cg3. Ñ@r¡ (÷¶š): INFECTION CONTROL 2019/6; 28 (6): 580-5.
530001. [»ÌŒ (Published Erratum)] Author Correction: Exfoliative toxin E, a new Staphylococcus aureus virulence factor with host-specific activity. Imanishi I1, Nicolas A, Caetano AB, Castro TLP, Tartaglia NR, Mariutti R, Gudon E, Even S, Berkova N, Arni RK, Seyffert N, Azevedo V, Nishifuji K, Le Loir Y: Sci Rep 2020/2; 10 (1): 2460. (¡ŒsN1: 1÷¶š)
540002. [»ÌŒ (Lñ)] ÒWãL. ãû`F (÷¶š): k¢åwãwj
[Y 2019/4; 392: 16.
540003. [»ÌŒ (€ñ)]yÈw€ïâàEîÕ€ (C)uC^ÆD^{ckXÅfâ`qð`B·ét@[WÌhåF¯@\ÌðŸÆ»Ìp (€úÔ: 2016Nx`2018Nx)vz€ã\Ò: âû`F1, €ªSÒ: Ñ@r¡1, Á¡Íé, å{ŒØ, àR~œ,
ö[q (1÷¶š):uC^ÆD^{ckXÅfâ`qð`B·ét@[WhåF¯@\ÌðŸÆ»Ìpv2018NxÀÑñ 2019/5; http://kaken.nii.ac.jp/ja/report/KAKENHI-PROJECT-16K08785/16K087852018jisseki/.
540004. [»ÌŒ (€ñ)]yÈw€ïâàEîÕ€ (C)ut@[WàÝ»ÉæésÛ̱Žõ@\ÌØ (€úÔ: 2018Nx`2020Nx)vz€ã\Ò: àR~œ, €ªSÒ: ŒèÎW, Ñ@r¡1, ãû`F1, Oºmü (1÷¶š):ut@[WàÝ»ÉæésÛ̱Žõ@\ÌØv2018NxÀ{óµñ 2019/5; https://kaken.nii.ac.jp/ja/report/KAKENHI-PROJECT-18K07127/18K071272018hokoku/.
540005. [»ÌŒ (€ñ)]yÈw€ïâàEîÕ€ (C)uC^ÆD^{ckXÅfâ`qð`B·ét@[WÌhåF¯@\ÌðŸÆ»Ìp (€úÔ: 2016Nx`2018Nx)vz€ã\Ò: âû`F1, €ªSÒ: Ñ@r¡1, Á¡Íé, å{ŒØ, àR~œ,
ö[q (1÷¶š):uC^ÆD^{ckXÅfâ`qð`B·ét@[WhåF¯@\ÌðŸÆ»Ìpv2016N`2018Nx€¬Êñ 2019/6.
540006. [»ÌŒ (Lñ)] ·Ì«. ãû`F (÷¶š): k¢åwãwj
[Y 2019/9; 396: 12.
540007. [»ÌŒ (Lñ)] ãw¯â«ï€¬ðó¯Ä. @@W (÷¶š): k¢åwãwj
[Y 2019/10; 397: 8-9.
540008. [»ÌŒ (Lñ)] 2019Nx¶ÈwÈÈw€ï¬ðó¯Ä. ãû`F (÷¶š): k¢åwãwj
[Y 2019/11; 398: 10.
540009. [»ÌŒ (€ñ)]yövàc@l É¡LOàcE2018Nxövàc@lÉ¡LOàc¬àu칪}î·éÆ{Ì{ckXÇ̪quwIðÍ (€@Ö: 2018Nx)vz€ã\Ò: âû`F1, €ªSÒ: Ñ@r¡1, ü{ëè, Kcmq, OàV®Ÿ, àR~œ,
ö[q, ã¡a` (1÷¶š): 2018Nx H÷Éַ鬀²ž¬Êñ 2019/11; VOL.37: 371-5.
540010. [»ÌŒ (Lñ)] ÒWãL. ãû`F (÷¶š): k¢åwãwj
[Y 2020/1; 399: 20.
540011. [»ÌŒ (€ñ)]yövàc@l éتOLOãÈwp€àcE2018Nx²ž€¬àuNXgfBICfX (NXgWE)EfBtBVŽõÇÌ°à×ÛpðhµÈ¢VK¡Ã@ÌJ (€úÔ: 2018Nx)vz€ã\Ò: âû`F1, €¯€Ò: Ñ@r¡1, Á¡Íé, ã¡a`, àR~œ,
ö[q, âûŽ (1÷¶š):uNXgfBICfX (NXgWE)EfBtBVŽõÇÌ°à×ÛpðhµÈ¢VK¡Ã@ÌJvÆÑñ 2020/3; p.80-4.
[@]
620003. [wp (ªS·M)] y¢ÌàÈfà Part1zæ7Í çŸ³@7.3 ^çÇ, p.374-82. ¡ŒsN (÷¶š), ÄC: Îcìv, Î[, , 2020/3s.
[wïE€ï]
713004. [wï (Û)] (êÊu) Bacterial Transmission via Phlebotomy Tourniquets. Ito M, Suzuki R, Ishii K, Ikeda N, Ninomiya A, Ueno Y, Umemura Y, Shimada A, Sanada M, Hayashi S1: The 17th East Asian Conference on Infection Control and Prevention (EACIC2020) (2020/2/15), Yokohama, Japan. (Ñ@r¡1: 1÷¶š)
713005. [wï (Û)] (êÊu) Bactericidal and Sporicidal Effects of Aerosolized Hydrogen Peroxide. Hayashi S1, Sasahara T, Ito M, Morisawa Y: The 17th East Asian Conference on Infection Control and Prevention (EACIC2020) (2020/2/15), Yokohama, Japan. (Ñ@r¡1: 1÷¶š)
713006. [wï (Û)] (êÊu) Ability of Disinfectant Wipes to Remove Bacillus cereus Spores. Hayashi S1, Sasahara T, Ito M, Morisawa Y: The 17th East Asian Conference on Infection Control and Prevention (EACIC2020) (2020/2/15), Yokohama, Japan. (Ñ@r¡1: 1÷¶š)
723031. [wï (S)] (êÊu) Analysis of gut therapy microbiota and metabolite in fecal transplantation for Clostridioides difficile infection. ãû`F1, ã¡a`,
ö[q, àR~œ, öè¹l, éãNM, Ñ@r¡1, å{ŒØ, Á¡Íé (1÷¶š): æ92ñú{×Ûwïï (2019/4/23), Dy.
723032. [wï (S)] (êÊu) {ckX_oÅfÌO³_oßÅÌìp@\ÌðÍ. R{Ríq, Ûà_÷ŸY, ŒFO, üÔF, ã¡a`, Arief Waskitho, ¡c¡, ãû`F1, Œº@¡, ¬Fšñ (1÷¶š): æ92ñú{×Ûwïï (2019/4/23), Dy.
723033. [wï (S)] (êÊu) Potential improvement of prenatal Group B Streptococcus screening using phages. àR~œ, ŒäGm, ß{ìí, ãû`F1,
ã\ñY, ãûëO, ŒèÎW, ÔØGŸ2 (1÷¶š, 2k¢¶œ€): æ92ñú{×Ûwïï (2019/4/23), Dy.
723034. [wï (S)] (êÊu) LysozymeYÁ|nÉæ誣³êœMicromonosporaceaeÈÉ®·éOK19-0010̪ހ. ¡TM, @@W1, îŽCN, åº@q, Œ{úq (1÷¶š): 2019Nx (æ34ñ) ú{úüÛwïåï (2019/9/23), Dy.
723035. [wï (S)] (êÊu) MicromonosporaceaeÈúüÛÌ¢m×EÇA~m_ÌP£Æ\¢ðÍ. @@W1, îŽCN, Žmq, åº@q, Œ{úq (1÷¶š): 2019Nx (æ34ñ) ú{úüÛwïåï (2019/9/23), Dy.
723036. [wï (S)] (êÊu) °÷}œÏÊXyNgªð@ðp¢œúüÛS. avermitilisÉš¯é¶«š¿avermectinÌÛÌào. xärœ, ô©, @@W1, À¡³_, Œ{úq, Žmq, |Rtq (1÷¶š): 2019Nx (æ34ñ) ú{úüÛwïåï (2019/9/24), Dy.
723037. [wï (S)] (êÊu) AšÌªæ誣³êœStreptosporangiaceaeÈÉ®·éK14-0274̪ހ. RcSP, îŽCN, @@W1, rcãÄê, åº@q, Œ{úq (1÷¶š): 2019Nx (æ34ñ) ú{úüÛwïåï (2019/9/24), Dy.
723038. [wï (S)] (êÊu) Analysis of gut microbiome in dairy cows infected with bovine leukemia virus. Uchiyama J, Murakami H, Sato R, Mizukami K, Suzuki T, Shima A, Ishihara G, Sakaguchi Y1, Sogawa K, Sakaguchi M: æ93ñú{×Ûwïï (2020/2/19), €m. (ãû`F1: 1÷¶š)
723039. [wï (S)] (êÊu) ß_»
f¬¶Ì«ÁÅøÊÌ¢. Ñ@r¡1, ùŽSœ, É¡¹q, XàVYi (1÷¶š): æ35ñú{«ŽõwïïEwpWï (2020/2/15), ¡l.
723040. [wï (S)] (êÊu) Åìtªgp·éìÑÌ×ÛõÆÇóµÌ¢. É¡¹q, ñ{@©, ^cü, Îäaq, éØG, ãìêq, ~ºTq, cŸb, rcIq, Ñ@r¡1 (1÷¶š): æ35ñú{«ŽõwïïEwpWï (2020/2/15), ¡l.
723041. [wï (S)] (êÊu) Analysis of gut microbiota and metabolite in fecal transplantation therapy for Clostridioides difficile infection. ãû`F1, ã¡a`,
ö[q, @@W1, àR~œ, öè¹l, éãNM, Ñ@r¡1, å{ŒØ, Á¡Íé (1÷¶š): æ93ñú{×Ûwïï (2020/2/19), ŒÃ®.
723042. [wï (S)] (êÊu) Analysis of gut microbiome in dairy cows infected with bovine leukemia virus. Uchiyama J, Murakami H, Sato R, Mizukami K, Suzuki T, Shima A, Ishihara G, ãû`F1, Sogawa K, Sakaguchi M (1÷¶š): æ93ñú{×Ûwïï (2020/2/19), ŒÃ®.
723043. [wï (S)] (êÊu) (\DGÜ) g·ŠendolysinÌuhE
ÛÉηénÛìpÈçÑÉ^áo] f}EXÉš¯éÇ}§øÊ. ¡ŒsN1, àR~œ, ÃväL, vPO, äèD, ŒèÎW, äîs, Œ¡öi (1÷¶š): æ93ñú{×Ûwïï (2020/2/19), ŒÃ®.
723044. [wï (S)] (êÊu) CkÌRj[ðpµœAgs[«çÉÖAµœûoE°à×ÛpÌðÍ. Cì©, ¡ŒsN1,
ã\ñY, å÷žj, Ü\°, ºãTM, @», FªLü, ãûëO, àR~œ (1÷¶š): æ93ñú{×Ûwï (2019/2/19), ŒÃ®.
723045. [wï (S)] (êÊu) Clostridioides difficileŽõdzÒÉηé³Ö÷¶šÚAÌøÊ`qg°à÷¶špšæÑ^{[ÌðÍ`. ãû`F1, ã¡a`,
ö[q, @@W1, àR~œ, öè¹l, éãNM, Ñ@r¡1, å{ŒØ, Á¡Íé (1÷¶š): æ140Nïú{òwï (2020/3/25), s.
733006. [wï (nûïE€ï)] (êÊu) ìÑÌ×ÛõÆÇóµÌ¢. É¡¹q, ñ{@©, Îäaq, rcIq, ^cü, éØG, ãìêq, ~ºTq, cŸb, Ñ@r¡1 (1÷¶š): æ86ñ_Þ짎õÇãwï (2019/9/7), ¡l.
733007. [wï (nûïE€ï)] (êÊu) ß_»
f¬¶ÌEÛøÊÌ¢. Ñ@r¡1, É¡¹q (1÷¶š): æ86ñ_Þ짎õÇãwï (2019/9/7), ¡l.
733008. [wï (nûïE€ï)] (êÊu) 2018Nú{×ÛwïÖxC^[{Z~i[, æ7ñt@[W€ï¯åïJÃñ. ãû`F1, àR~œ (1÷¶š): æ102ñú{×ÛwïÖxï (2019/10/3), ·ì.
733009. [wï (nûïE€ï)] (êÊu) EVÉš¯éO«gECXŽõÉæé°à×ÛpÌðÍ. àR~œ, ºãTM, ²¡çêY, ]ìêK, ãû`F1, @», ÎŽºî, ãûëO (1÷¶š): æ102ñú{×ÛwïÖxï (2019/10/3), ·ì.
733010. [wï (nûïE€ï)] (êÊu) òÜÏ«ÉÖ^·éStreptococcus suis̬EÌ€. ß{ìí, àR~œ, qG, ¬ûëç, ãû`F1, c@, ŒèÎW (1÷¶š): æ102ñú{×ÛwïÖxï (2019/10/3), ·ì.
733011. [wï (nûïE€ï)] (êÊu) ìÑÌtõÆÇóµÌ¢. É¡¹q, cŸb, ~ºTq, ãìêq, éØG, ^cü, rcIq, Îäaq, ñ{@©, Ñ@r¡1 (1÷¶š): æ87ñ_Þ짎õÇãwï (2020/2/29), ¡l.
ñ¶wEMÑãw
[wp_¶]
110027. [Ž] Tick infestation and hemoparasitic infections in cattle in some selected areas of Bangladesh. Akter MTD, Alim MA, Md. MG, Haque MH, Farjana T, Hatta T1, Anisuzzaman, Tsuji N1, Mondal MMH: Jpn J Vet Parasitol 2019/6; 18 (1): 26-34. (ªcxm1, Ò@®1: 1ñ¶EMÑãw)
110028. [Ž] Characterization of an iron-inducible Haemaphysalis longicornis tick-derived promoter in an Ixodes scapularis-derived tick cell line (ISE6). Hernandez EP, Kusakisako K, Hatta T1, Tanaka T: Parasit Vectors 2019/6; 12 (1): 321. (ªcxm1: 1ñ¶EMÑãw)
110029. [Ž] Characterization of the RAGE-binding protein, Strongyloides venestatin, produced by the silkworm-baculovirus expression system. Tsubokawa D1, Lee JM, Hatta T1, Mikami F, Maruyama H, Arakawa T, Kusakabe T, Tsuji N1: Infect Genet Evol 2019/11; 75: 103964. (Øìåå1, ªcxm1, Ò@®1: 1ñ¶EMÑãw)
110030. [Ž] Snail-borne trematodiasis in cattle in Barind Tract of Bangladesh, an overlooked problem. Rahman MA, Alim MA, Hossain MM, Yasin MG, Alam MZ, Hatta T1, Anisuzzaman, Tsuji N1, Mondal MMH: Jpn J Vet Parasitol 2019/12; 18 (2): 53-64. (ªcxm1, Ò@®1: 1ñ¶EMÑãw)
110031. [Ž] Transitions in morphological forms and rapid development of the asexual schizonts of Eimeria tenella through serial passaging in chicks. Matsubayashi M, Yamaguchi H, Hatta T1, Kawahara F, Hatabu T, Iseki H, Yamagishi J, Isobe T, Teramoto I, Kaneko A, Kita K, Tsuji N1, Sasai K: Infect Genet Evol 2019/11; 75: 103993. (ªcxm1, Ò@®1: 1ñ¶EMÑãw)
540012. [»ÌŒ (w¶_¶)] oçNü«üStrongyloides venezuelensisÌhåÌàÚsÉš¯éI»YšóeÌÌð. Øc, Øìåå1, ªcxm1, Ò@®1 (1ñ¶EMÑãw): k¢ãw 2019/12; 49 (2): 111-3.
[wïE€ï]
723046. [wï (S)] (êÊu) ÁÙIÈÆuðø«N±·Áènv^CvðL·élY~ÚTrichuris murisVKì¬ÌÝ. âè@x, ¬R_ê1, œ@î, ©@ (1ñ¶EMÑãw): æ162ñú{bãwïwpWï (2019/9/11), ÂÎ.
723047. [wï (S)] (êÊu) ZzÇÉš¯é÷èî«ÇÆI»YšóeÌ (RAGE) ÆÌÖ^. ¬òèñÌ, Øìåå1, ªcxm1, Oã[q, º@, R{õF, Ò@®1 (1ñ¶EMÑãw): æ60ñú{MÑãwïåï (2019/11/9), «ê.
733012. [wï (nûïE€ï)] (êÊu) xlYG³ü̬ñ¶Éš¯éI»YšóeÌ (RAGE) Ìð. Øìåå1, ªcxm1, ¬òèñÌ, Öûqç, Oã[q, R{õF, Ò@®1 (1ñ¶EMÑãw): æ13ñ埀ï (2019/7/14), {è.
733013. [wï (nûïE€ï)] (êÊu) }\ZzÇÉæé÷èî`¬ÖÌI»YšóeÌ (RAGE) ÌÖ^. ¬òèñÌ, Øìåå1, ªcxm1, Oã[q, º@, R{õF, Ò@®1 (1ñ¶EMÑãw): æ79ñú{ñ¶wïú{xåï (2019/10/12), .
aw (º_PÊ)
[wp_¶]
110032. [Ž] Clinicopathological and prognostic significance of nuclear UGDH localization in lung adenocarcinoma. Hagiuda D, Nagashio R1, Ichinoe M2, Tsuchiya B1, Igawa S3, Naoki K3, Satoh Y4, Murakumo Y2, Saegusa M2, Sato Y1: Biomed Res 2019; 40 (1): 17-27. (·@º1, ê˹Ÿ2, y®g1, äì@3, PØF3, ²¡Vr4, º_F÷2, O}@M2, ²¡Yê1: 1ãÃq¶w, 2a, 3Äzíà, 4ÄzíO)
510001. [à] Proposal for an Organ-Specific Chronic Inflammation-Remodeling-Carcinoma Sequence. Okayasu I, Ichinoe M1, Yoshida T1: Gastrointestinal Disorders 2019/8; 1 (3): 341-57. (ê˹Ÿ1, gc@÷1: 1a)
[wïE€ï]
723048. [wï (S)] (êÊu) xGœãçàÉš¯éCD109Ì@\ðÍ. Á¡ôÆ1, µYÞsÀ, {ºH, Näõ1, º_F÷1 (1a): æ108ñú{awïï (2019/5/9), .
723049. [wï (S)] (êÊu) ¬×Exà̶šwIÁ«Éš¯éREV7»ÌÓ`. áÁR@1, º_F÷1, ê˹Ÿ1, Näõ1 (1a): æ78ñú{àwïwpï (2019/9/26-28), s.
723050. [wï (S)] (êÊu) ««FîÉš¯éREV7Ì@\ðÍ. ¯ìºF1, ê˹Ÿ1, Näõ1, º_F÷1 (1a): æ78ñú{àwïwpï (2019/9/26-28), s.
723051. [wï (S)] (êÊu) äXàÌ\ãÉš¯éCD109»ÌÓ`ÌðÍ. ÀB@õ1, Näõ2, Á¡ôÆ2, ê˹Ÿ2, º_F÷2 (1åw@ãÃn€È, 2a): æ78ñú{àwïwpï (2019/9/26-28), s.
723052. [wï (S)] (êÊu) èpÌðp¢œäXàÉš¯éBRCAnessÌðÍ. äøŽ«Ç1, Á¡ôÆ2, ÀB@õ1, Näõ2, ê˹Ÿ2, º_F÷2 (1åw@ãÃn€È, 2a): æ78ñú{àwïwpï (2019/9/26-28), s.
aw (O}PÊ)
[wp_¶]
110033. [Ž] Nodal induces apoptosis and inhibits proliferation in ovarian endometriosis-clear cell carcinoma lesions. Miura R1, Yokoi A1, Matsumoto T2, Oguri Y3, Hashimura M3, Tochimoto M1, Kajita S2, Saegusa M2: BMC Cancer 2019/4; 19 (1): 308. (OYìq1, ¡ä€1, Œ{rp2, ¬INq3, ŽºüI3, È{¹F1, cçüT2, O}@M2: 1åw@ãÃn€È, 2a, 3`Ôn)
110034. [Ž] Alterations in À-catenin, microsatellite instability, and HNF-1À levels are independently associated with ovarian endometriosis-associated tumorigenesis. Tomohiro M1, Matsumoto T2, Miura R1, Oguri Y3, Yokoi A1, Tochimoto M1, Saegusa M2: Hum Pathol 2019/7; 89: 10-23. (FL²v1, Œ{rp2, OYìq1, ¬INq3, ¡ä€1, È{¹F1, O}@M2: 1åw@ãÃn€È, 2a, `Ôn)
110035. [Ž] S100A4/non-muscle myosin II signaling regulates epithelial-mesenchymal transition and stemness in uterine carcinosarcoma. Tochimoto M1, Oguri Y2, Hashimura M2, Konno R, Matsumoto T3, Yokoi A1, Kodera Y, Saegusa M3: Lab Invest 2020/5; 100 (5): 682-95. doi: 10.1038/s41374-019-0359-x. Epub 2019 Dec 19. (È{¹F1, ¬INq2, ŽºüI2, Œ{rp3, ¡ä€1, O}@M3: 1åw@ãÃn€È, 2`Ôn, 3a)
310004. [Çáñ] Case of Calcifying Pseudoneoplasms of the Neuraxis Coexisting with Interhemispheric Lipoma and Agenesis of the Corpus Callosum: Involvement of Infiltrating Macrophages. Inukai M1, Shibahara I2, Hotta M, Miyasaka K2, Sato S2, Hide T2, Saegusa M1, Kumabe T2: World Neurosurg 2020/2; 134: 635-40.e1. (¢@~1, ÄŽêz2, {âaO2, ²¡l2, GñêY2, O}@M1, GrG2: 1a, 2]O)
[@]
610002. [wp (ªS·M)]yVitamin AzThe Role of Vitamin A-Storing Cells (Stellate Cells) in Inflammation and Tumorigenesis. Okayasu I, Fujiwara M, Yoshida T1, Editor: Zepka LQ, InTech, UK, Published: 2019/5. (gc@÷1: 1a)
[wïE€ï]
723053. [wï (S)] (êÊu) äPèîÌS100A4Éæéªñ²×E»U±@\ÌðŸ. ¢@~1, Îäáü, ŽºüI2, O}@M1 (1a, 2`Ôn): æ108ñú{awïï (2019/5/9), .
723054. [wï (S)] (êÊu) HNF1À+Ep53+EARID1A+^àÍ\ãsÇÅ é. ¡ä€1, ¬INq2, Œ{rp3, O}@M3 (1åw@ãÃn€È, 2`Ôn, 3a): æ108ñú{awïï (2019/5/9), .
723055. [wï (S)] (êÊu) ÝàÌèpÌÌpÇNPÌagDwI]¿ÍKv©? O}@M (a): æ108ñú{awïï (2019/5/9), .
723056. [wï (S)] (êÊu) q{àÇ«XEÌàßöÉš¯éÀ-Jej, HNF-1¿, yÑâ`qsÀè«ÌÝÖA«. FL²v1, Œ{rp2, OYìq, ¬INq3, O}@M2 (1åw@ãÃn€È, 2a, 3`Ôn): æ108ñú{awïï (2019/5/10), .
723057. [wï (S)] (êÊu) EBP50ÍŸ×EàÌÄE\ãsÇöqÅ é. Œ{rp1, ¡ä€2, ®ì@º, ¬`j, O}@M1 (1a, 2åw@ãÃn€È): æ108ñú{awïï (2019/5/10), .
723058. [wï (S)] (êÊu) ÷tàÌiWßöÉš¯éS100A4/p53 axisÌÊœ·ð. gc@€1, ¡ä€1, Œ{rp2, ŽºüI3, O}@M2 (1åw@ãÃn€È, 2a, 3`Ôn): æ108ñú{awïï (2019/5/11), .
723059. [wï (S)] (êÊu) isúŒ°àÌÀ-JejÆPD1/PDL1Éæéà²×Ejb``¬ÌØŸ. nç³sT1, ŽV2, ŽºüI3, ¢@~4, MŸºq4, O}@M4 (1åw@ãÃn€È, 2ãÃq¶w, 3`Ôn, 4a): æ108ñú{awïï (2019/5/11), .
723060. [wï (S)] (êÊu) ÷tàÅÍS·^ALK»ª\ãsÇöqÉÈé. ¬cSî1, Œ{rp2, ŽºüI3, ·Jìvq2, È{¹F1, O}@M2 (1åw@ãÃn€È, 2a, 3`Ôn): æ108ñú{awïï (2019/5/11), .
723061. [wï (S)] (êÊu) Ç«oCI}[J[OLFM4©çݜǫ°Ÿ³ÖAîáÌÁÙ«ÌðŸ. ¡R@d1, gc@÷2, ŽºüI3, O}@M2 (1åw@ãÃn€È, 2a, 3`Ôn): æ108ñú{awïï (2019/5/11), .
723062. [wï (S)] (êÊu) I[ujìåϫ𶶜]²««pîÌ2á. HJ¹j1, ²¡l2, {âaO2, ÄŽêz2, ¬ò°V3, GñêY2, GrG2 (1a, 2]O, 3~œ): æ37ñú{]îáawï (2019/6/1), ŒÃ®.
723063. [wï (S)] (|X^[) ]À`¬sSEbîÉCalcifying pseudoneoplasms of the neuroaxis (CAPNON) 𹵜êá. ¢@~1, {âaO2, ÄŽêz2, ²¡l2, GñêY2, O}@M1, GrG2 (1a, 2]O): æ37ñú{]îáawï (2019/6/1), ŒÃ®.
723064. [wï (S)] (êÊu) @Éš¯éKChCñl®ÉæéÁtB×EfÌžxÇ. gc@÷ (a): æ60ñú{Õ°×Ewïï (túåï) (2019/6/9), .
723065. [wï (S)] (êÊu) A multi-center retrospective study to evaluate PD-L1 protein expression, EBV positivity and MSI status in patients with advanced gastric and esophagogastric junction adenocarcinoma in Japan. gc@÷1, Ogura G, Tanabe M, Hayashi T, Ohbayashi C, Azuma M, Kunisaki C, Akazawa Y, Ozawa S, Matsumoto S, Suzuki T, Mitoro A, Fukunaga T, Shimizu A, Fujimoto G, Yao T (1a): æ57ñú{à¡ÃwïwpWï (2019/10/24), ª.
q¶w
[wp_¶]
110036. [Ž] Effects of electrical muscle stimulation in frail elderly patients during haemodialysis (DIAL): rationale and protocol for a crossover randomised controlled trial. Suzuki Y1, Kamiya K2, Tanaka S1, Hoshi K3, Watanabe T1, Harada M1, Matsuzawa R4, Shimoda T1, Yamamoto S1, Matsunaga Y, Yoneki K, Yoshida A, Matsunaga A2: BMJ Open 2019/5; 9 (5): e025389. (éØTŸ1, _JŸY2, cLí1, ¯@ÀF3, nç²FŸ1, Žc€i1, ŒòÇŸ4, ºc²å1, R{®œ1, ŒiÄF2: 1åw@ãÃn€È, 2ãÃq¶w, 3q¶, 4nr)
110037. [Ž] Triclosan-induced alteration of gut microbiome and aggravation of asthmatic airway response in aeroallergen-sensitized mice. Hirota R, Ohya Y, Yamamoto-Hanada K, Fukutomi Y, Muto G1, Ngatu NR, Nakamura T, Nakamura H: Allergy 2019/5; 74 (5): 996-9. (¡@1: 1q¶)
110038. [Ž] Effect of frequency-modulated electromagnetic therapy on increasing deep vein blood flow in the lower extremities and improving edema: a randomized, crossover, triple-blind, placebo-controlled trial. Uchida Y1, Sakamoto Y, Hoshi K2, Takahira N3: Kitasato Med J 2019/9; 49 (2): 91-8. (àcU1, ¯@ÀF2, œ®L3: 1åw@ãÃn€È, 2q¶, 3ãÃq¶w)
110039. [Ž] Recurrent sick leave and resignation rates among female cancer survivors after return to work: the Japan sickness absence and return to work (J-SAR) study. Endo M, Haruyama Y, Muto G1, Imai Y, Mitsui K, Mizoue T, Wada H, Kobashi G, Tanigawa T: BMC Public Health 2019/9; 19 (1): 1248. (¡@1: 1q¶)
110040. [Ž] Utility of Regular Management of Physical Activity and Physical Function in Hemodialysis Patients. Yamamoto S1, Matsuzawa R, Abe Y, Hoshi K2, Yoneki K, Harada M, Watanabe T1, Shimoda T1, Suzuki Y1, Matsunaga Y, Kamiya K3, Yoshida A, Matsunaga A3: Kidney Blood Press Res 2018/10; 43 (5): 1505-15. (R{®œ1, ¯@ÀF2, nç²FŸ1, ºc²å1, éØTŸ1, _JŸY3, ŒiÄF3: 1åw@ãÃn€È, 2q¶, 3ãÃq¶w)
110041. [Ž] Trajectory of Lean Body Mass Assessed Using the Modified Creatinine Index and Mortality in Hemodialysis Patients. Suzuki Y1, Matsuzawa R, Kamiya K2 Hoshi K3, Harada M, Watanabe T1, Shimoda T1, Yamamoto S1, Matsunaga Y, Yoshida A, Matsunaga A2: Am J Kidney Dis 2020/2; 75 (2): 195-203. (éØTŸ1, _JŸY2, ¯@ÀF3, nç²FŸ1, ºc²å1, R{®œ1, ŒiÄF2: 1åw@ãÃn€È, 2ãÃq¶w, 3q¶)
522006. [uÀ]yV[Y: wp€©çÌq»Îô|ú{q¶wï©çÌñŸÉü¯Äzú{q¶wïÉš¯éq»ÎôñŸÉü¯Ä: ú{q¶wïq»Îô[LOO[vÉæéÆèÜÆß. 캱q, ¡cc, rØÖq, ŒªÎq, ¡@1, âäüK, ÑJÜè±, äãÜèq, ßìµÌÔ, kì®ü, Ò^|, Ѳmq, ãcÀã, ãÊ_, RãpRŸY, âcŽü, ÉØëV, öàVTV, Á¡¹u, ¡Ram, ¬òºv, å΀ (1q¶): ú{q¶wG 2019/12; 74: 18034.
522007. [uÀ]yÁW: IoTEAI, u@íðpµœÛEãîzIoTâuVXeðpµœnæ^îÒÛÆnæïPAVXe. ·äRßq, ¡@1 (1q¶): ÛÌÈw 2020/1; 62 (1): 23-9.
522008. [uÀ]yÁW: IoTEAI, u@íðpµœÛEãîzu@íâIoTEAIðpµœYÆÛ®ÌWJ. ¡@1, ÎäÞ, _cŽG¡, åîß®Ý, ¡Ram (1q¶): ÛÌÈw 2020/1; 62 (1): 45-51.
530002. [»ÌŒ (LETTER TO THE EDITOR)] Triclosan-induced alteration of gut microbiome and aggravation of asthmatic airway response in aeroallergen-sensitized mice. Hirota R, Ohya Y, Yamamoto-Hanada K, Fukutomi Y, Muto G1, Ngatu NR, Nakamura T, Nakamura H: Allergy 2019/5; 74 (5): 996-99. (¡@1: 1q¶)
530003. [»ÌŒ (Rg)] Probable involvement of iron deficiency in the association between low blood cadmium levels and preterm births in pregnant women. Horiguchi H1: Environ Res 2019/5; 172: 615. (xûº1: 1q¶)
540013. [»ÌŒ (€ñ)] ßa³NxEü@³ÒaEð²žîbðÍ (2005 Nx`2017NxaEðf[^gp). §¹¹K, ¬ŽTq, ¯@ÀF1, LcÍG (1q¶): Ƨs@lJÒNÀS@\ 2020/3; https://www.research.johas.go.jp/bs/doc/20200319.pdf.
540014. [»ÌŒ (€ñ)]yú¶JÈJПaÕ°€Æïâàu±¥q¶îÉÖ·é€|ëÆÛî̲avz¡@ (€ã\Ò)1, Ô¢^¹, Ž{°j, Ö¡GV, ºTV, ¡Ram,Œœ@_, ¡¹÷ (1q¶): ßa³NxE€ñ 2020/3.
540015. [»ÌŒ (€ñ)]yú¶JÈJПaÕ°€ÆïâàuEÆ«XgXÈÕ²ž[ÌOêÅÌì¬ÉÖ·é€vz¡Ram (€ã\Ò), óV, ack¡, Jì@, ¡¹÷, YìÁãq, ¡@1, ¬cØDq, cõI (1q¶): ßa³NxEªS€ñ 2020/3.
540016. [»ÌŒ (€ñ)]yú¶JÈw€ïâàuªñ³ÒÌAJp±yÑEêAÉ·é€vz¡¹÷ (€ã\Ò), âV¡õ], c@È, ö×v, Ñ@aF, Œº¡, ãaNç, XûY, KŽbî, ¡@1 (1q¶): ßa³NxEªS€ñ 2020/3.
540017. [»ÌŒ (€ñ)]yú¶JÈJПaÕ°€ÆïâàuéÆEYÆÛX^btEãÃ@ÖÌAgÉæ錧xVXeJvzŒœ@_ (€ã\Ò), ¡¹÷, XûY, ¬RPq, ŽüÛ, ìºì¶, ª@hV, ¡@1 (1q¶): ßa³Nx 2020/3.
540018. [»ÌŒ (Plain language summary|ó)] ÖReXgÍE·úIÉÖÉεÄøʪ é©? (Competitions for smoking cessation. Fanshawe TR, Hartmann-Boyce J, Perera R, Lindson N). |ó: ¯@ÀF1, Äó: ŽŽNî (1q¶): Cochrane Database of Systematic Reviews 2019, Issue 2. Art. No.: CD013272. DOI:10.1002/14651858.CD013272. 2019/4; https://www.cochrane.org/ja/CD013272/jin-yan-kontesutohazhong-chang-qi-de-nijin-yan-nidui-sitexiao-guo-gaaruka.
540019. [»ÌŒ (Plain language summary|ó)] ÅàÖøʪ¢jR`ãÖÃ@Íœ©? (Different doses, durations and modes of delivery of nicotine replacement therapy for smoking cessation. Lindson N, Chepkin SC, Ye W, Fanshawe TR, Bullen C, Hartmann-Boyce J). |ó: ¯@ÀF1, Äó: ŽŽNî (1q¶): Cochrane Systematic Review - Intervention Version: https://doi.org/10.1002/14651858.CD013308. 2019/4; https://www.cochrane.org/ja/CD013308/TOBACCO_zui-mojin-yan-xiao-guo-gagao-inikotindai-ti-liao-fa-hahe-ka.
540020. [»ÌŒ (Plain language summary|ó)] ûoà (û̪ñ) ð\h·éœßÌûoÂÇÉηé¡ÃIîü (Interventions for treating oral leukoplakia to prevent oral cancer. Lodi G, Franchini R, Warnakulasuriya S, Varoni EM, Sardella A, Kerr AR, Carrassi A, MacDonald LCI, Worthington HV). |ó: ¯@ÀF1, Äó: «§ë (1q¶): Cochrane Database of Systematic Reviews 2016, Issue 7. Art. No.: CD001829. DOI: 10.1002/14651858.CD001829.pub4. 2019/8; https://www.cochrane.org/ja/CD001829/ORAL_kou-qiang-yan-kou-noganwoyu-fang-surutamenokou-qiang-bai-ban-zheng-nidui-suruzhi-liao-de-jie-ru.
540021. [»ÌŒ (Plain language summary|ó)] Œeâ{çÒÖÌîüÉæÁÄqÇàÌ^oRÌÖÌIðžç¹é©? (Family and carer smoking control programmes for reducing children's exposure to environmental tobacco smoke. Behbod B, Sharma M, Baxi R, Roseby R, Webster P). |ó: ¯@ÀF1, Äó: ŽŽNî (1q¶): Cochrane Database of Systematic Reviews 2018, Issue 1. Art. No.: CD001746. DOI: 10.1002/14651858.CD001746.pub4. 2018/8; https://www.cochrane.org/ja/CD001746/TOBACCO_liang-qin-yayang-yu-zhe-henojie-ru-niyotutezi-domonotabakonoyan-henopu-lu-wojian-raseruka.
540022. [»ÌŒ (Plain language summary|ó)] ñVð^Šé±ÆÅÖÉ·úIøʪ é©? (Incentives for smoking cessation. Notley C, Gentry S, Livingstone-Banks J, Bauld L, Perera R, Hartmann-Boyce J). |ó: ¯@ÀF1, Äó: ŽŽNî (1q¶): Cochrane Database of Systematic Reviews 2019, Issue 7. Art. No.: CD004307.DOI: 10.1002/14651858.CD004307.pub6. 2019/9; https://www.cochrane.org/ja/CD004307/TOBACCO_bao-chou-woyu-erukotodejin-yan-nichang-qi-de-xiao-guo-gaaruka.
540023. [»ÌŒ (Plain language summary|ó)] Öɬ÷µœlªÄiµÈ¢æ€É·éœßÉLøÈîüÍ é©? (Relapse prevention interventions for smoking cessation. Livingstone-Banks J, Norris E, Hartmann-Boyce J, West R, Jarvis M, Chubb E, Hajek P). |ó: ¯@ÀF1, Äó: ŽŽNî (1q¶): Cochrane Database of Systematic Reviews 2019, Issue 10. Art. No.: CD003999. DOI: 10.1002/14651858.CD003999.pub6. 2019/12; https://www.cochrane.org/ja/CD003999/TOBACCO_jin-yan-nicheng-gong-sitaren-gazai-chi-yan-sinaiyounisurutameniyou-xiao-najie-ru-haaruka.
540024. [»ÌŒ (Plain language summary|ó)] ®@ïÊÚÍÖÉLø©? (Motivational interviewing for smoking cessation. Lindson N, Thompson TP, Ferrey A, Lambert JD, Aveyard P). |ó: ¯@ÀF1, Äó: ŽŽNî (1q¶): Cochrane Database of Systematic Reviews 2019, Issue 7. Art. No.: CD006936. DOI: 10.1002/14651858.CD006936.pub4. 2019/12; https://www.cochrane.org/ja/CD006936/dong-ji-dukemian-jie-hajin-yan-niyou-xiao-ka.
540025. [»ÌŒ (Plain language summary|ó)] Öɬ÷µœlªÄiµÈ¢æ€É·éœßÉLøÈîüÍ é©? (Relapse prevention interventions for smoking cessation. Livingstone-Banks J, Norris E, Hartmann-Boyce J, West R, Jarvis M, Chubb E, Hajek P). |ó: ¯@ÀF1, Äó: ŽŽNî (1q¶): Cochrane Database of Systematic Reviews 2019, Issue 10. Art. No.: CD003999. DOI: 10.1002/14651858.CD003999.pub6. 2019/12; https://www.cochrane.org/ja/CD003999/jin-yan-nicheng-gong-sitaren-gazai-chi-yan-sinaiyounisurutameniyou-xiao-najie-ru-haaruka.
540026. [»ÌŒ (Plain language summary|ó)] næÌòÇX^btÉæéÖxÍLø©? (Community pharmacy personnel interventions for smoking cessation. Carson-Chahhoud KV, Livingstone-Banks J, Sharrad KJ, Kopsaftis Z, Brinn MP, To-A-Nan R, Bond CM). |ó: ¯@ÀF1, Äó: ŽŽNî (1q¶): Cochrane Database of Systematic Reviews 2019, Issue 10. Art. No.: CD003698.DOI: 10.1002/14651858.CD003698.pub3. 2020/2; https://www.cochrane.org/ja/CD003698/TOBACCO_di-yu-noyao-ju-sutatuhuniyorujin-yan-zhi-yuan-hayou-xiao-ka.
540027. [»ÌŒ (Plain language summary|ó)] ^®ÍÖÉεÄøʪ é©? (Exercise interventions for smoking cessation. Ussher MH, Faulkner GEJ, Angus K, Hartmann-Boyce J, Taylor AH). |ó: ¯@ÀF1, Äó: ŽŽNî (1q¶): Cochrane Database of Systematic Reviews 2019, Issue 10. Art. No.:CD002295.DOI: 10.1002/14651858.CD002295.pub6. 2020/2; https://www.cochrane.org/ja/CD002295/TOBACCO_yun-dong-hajin-yan-nidui-sitexiao-guo-gaaruka.
540028. [»ÌŒ (Plain language summary|ó)] A^CÌrfIJEZOÍ, dbJEZOÉä×ÄÖxÉøʪ é©? (Real-time video counselling for smoking cessation. Tzelepis F, Paul CL, Williams CM, Gilligan C, Regan T, Daly J, Hodder RK, Byrnes E, Byaruhanga J, McFadyen T, Wiggers J). |ó: ¯@ÀF1, Äó: ŽŽNî (1q¶): Cochrane Database of Systematic Reviews 2019, Issue 10. Art. No.: CD012659. DOI: 10.1002/14651858.CD012659.pub2. 2020/2; https://www.cochrane.org/ja/CD012659/TOBACCO_riarutaimunobideokaunseringuhadian-hua-kaunseringunibi-betejin-yan-zhi-yuan-nixiao-guo-gaaruka.
540029. [»ÌŒ (Plain language summary|ó)] lH@B·CðKvÆ·é¬lÉš¢Ä, xbh̪ÊuÌãÍA
œÊðÛÂÌÉä×ÄlHÄzíÖAxÌ\hÉøʪ é©? (Semi-recumbent position versus supine position for the prevention of ventilator-associated pneumonia in adults requiring mechanical ventilation. Wang L, Li X, Yang Z, Tang X, Yuan Q, Deng L, Sun X). ¯@ÀF1, Äó: J貟Y (1q¶): Cochrane Database of Systematic Reviews 2016, Issue 1. Art. No.:CD009946.DOI:10.1002/14651858.CD009946.pub2. 2020/2; https://www.cochrane.org/ja/CD009946/ARI_ren-gong-ji-jie-huan-qi-wobi-yao-tosurucheng-ren-nioitebetudonotou-wei-zhi-noju-shang-hashui-ping.
540030. [»ÌŒ (Plain language summary|ó)] ³ÒPAÉš¯éŽõðž³¹éœßÌãÃ]ÒÌèwq¶ðüP·éû@ (Interventions to improve hand hygiene compliance in patient care. Gould DJ, Moralejo D, Drey N, Chudleigh JH, Taljaard M). |ó: ¯@ÀF1, Äó: äºt÷ (1q¶): Cochrane Database of Systematic Reviews 2017, Issue 9. Art. No.: CD005186.DOI: 10.1002/14651858.CD005186.pub4. 2020/3; https://www.cochrane.org/ja/CD005186/EPOC_huan-zhe-keaniokerugan-ran-wojian-shao-saserutamenoyi-liao-cong-shi-zhe-noshou-zhi-wei-sheng-wogai.
540031. [»ÌŒ (Plain language summary|ó)] dbJEZOÍÖxÉøʪ é©? (Telephone counselling for smoking cessation. Matkin W, Ord??ez-Mena JM, Hartmann-Boyce J). |ó: ¯@ÀF1, Äó: ŽŽNî (1q¶): Cochrane Database of Systematic Reviews 2019, Issue 5. Art. No.: CD002850. DOI: 10.1002/14651858.CD002850.pub4. 2020/3; https://www.cochrane.org/ja/CD002850/TOBACCO_dian-hua-kaunseringuhajin-yan-zhi-yuan-nixiao-guo-gaaruka.
540032. [»ÌŒ (Plain language summary|ó)] ÖÌòšÃ@ðó¯Ä¢élÉ, XÉxðÇÁ·é±ÆÅÖ̬÷Šðã°çêé©? (Additional behavioural support as an adjunct to pharmacotherapy for smoking cessation. Hartmann-Boyce J, Hong B, Livingstone-Banks J, Wheat H, Fanshawe TR). |ó: ¯@ÀF1, Äó: ŽŽNî (1q¶): Cochrane Database of Systematic Reviews 2019, Issue 6. Art. No.: CD009670.DOI: 10.1002/14651858.CD009670.pub4. 2020/3; https://www.cochrane.org/ja/CD009670/TOBACCO_jin-yan-noyao-wu-liao-fa-woshou-keteiruren-nigeng-nizhi-yuan-wozhui-jia-surukotodejin-yan-nocheng.
[wïE€ï]
713007. [wï (Û)] (êÊu) Renal Anemia in itai-itai disease: a case series study of medical records of the patients. Horiguchi H1, Aoshima K, Oguma E: The 59th Annual Meeting of the Society of Toxicology (2020/3/18), Anaheim, CA, USA (ãJÃ). (xûº1: 1q¶)
722004. [wï (S)] (V|WE) X
ÇÀ{næÉš¯éÄJh~EÆqfZxyÑ»Ì_ÆÖÌe¿. xûº (q¶): æ46ñú{Å«wïwpNï (2019/6/27), ¿, J Toxicol Sci 2019; 44 (Suppl): S74.
722005. [wï (S)] (³çu) ¡ÃÆdÌŒ§xÉÖ·éÛIª¬|Noc (healthy company) âÐïIûÌÝèû. ¡@1, ¡¹÷ (1q¶): æ67ñú{EÆEÐQãwïwpåï (2019/11/9-10), .
722006. [wï (S)] (V|WE)yÀ·zÐQÆNe¿. @³¿, ¡@1 (1q¶): æ67ñú{EÆEÐQãwïwpåï (2019/11/9-10), .
723066. [wï (S)] (êÊu) NocÍ, fãóÃs®Æ³ÉÖ·éê¡ÃÒ53lÌfZvgðÍ. ¡@1, ÐËÈq, ¡Ram, ¡¹÷, Œœ@_, ÎäÞ, c@m, åXRI1, xûº1 (1q¶): æ92ñú{YÆq¶wï (2019/5/22-25), ŒÃ®.
723067. [wï (S)] (êÊu) îÒÌyxFmáQEåÏIFm@\áºÍÐïQÁÅüP·é©. ¡Žq, ¡@1, ß¡¥ (1q¶): æ78ñú{öOq¶wïï (2019/10/24), m.
723068. [wï (S)] (êÊu) çt§ŒËs, ïæÊTÝuóµÆNwWÌA±¡f€: 2NÔÌÇÕ²žÌªÍ. Në¥q, ·ôRßq, ¡@1, ß¡¥ (1q¶): æ78ñú{öOq¶wïï (2019/10/24), m.
723069. [wï (S)] (êÊu) lHm\ÆJAGESf[^ðp¢œFmÇÇXN\ªASYJ. ß¡¥, Ò@åm, ·ôRßq, ¡@1, ¡Rèßq, £@É, lc@N, ì£^Ñq, Ž@@V (1q¶): æ78ñú{öOq¶wïï (2019/10/24), m.
723070. [wï (S)] (êÊû)yÀ·z\h. ¡@ (q¶): æ67ñú{EÆEÐQãwïwpåï (2019/11/9-10), .
723071. [wï (S)] (êÊu) áZxIÉæébgCnD, L-ZÖÌe¿. åXRI1, ãETñ, Öª³b, Œìxv, ¬Ñq2, ¡@1, ¡Ram, pc³j, Ъ^, âV¡Nº, {{Nç, Á¡Ýq, {Ô@_, xûº1 (1q¶, 2\hãwn): æ90ñú{q¶wïwpï (2020/3/28), âè (ãJÃ), ú{q¶wGæ 2020; 75: S191.
723072. [wï (S)] (êÊu) bgÉš¯éJh~EÌtGX|G`Y¶×EÉηé}§ìp. xûº1, ¬Fxq, ÀªLIq2, åXRI1, ÍŽë, ìXûj3 (1q¶, 2¶, 3k¢åwfBJZ^[)Fæ90ñú{q¶wïwpï (2020/3/28), âè (ãJÃ), ú{q¶wGæ 2020; 75: S191.
723073. [wï (S)] (êÊu) ãÃ]ÒÌEÆ«èŒ]Ìuw|RÛ«š¿pxÞÌIe¿]¿. ¡@1, åXRI1, xûº1, ¡Ram, OcÊñ, ºTV (1q¶): æ90ñú{q¶wïwpï (2020/3/26-28), âè (ãJÃ).
723074. [wï (S)] (êÊu) xR§_Êì¬æJh~EõnæZ¯Éš¯éA×Ç@\áQÆnÆÌÖA. Âbq, xûº1 (1q¶) : æ90ñú{q¶wïwpï (2020/3/26-28), âè (ãJÃ), ú{q¶wGæ 2020; 75: S191.
732003. [wï (nûï€ï)] (V|WE) Tv|öOq¶EÐïãw̧ê©ç. ¡@ (q¶): æ49ñ_Þì§SgãwïïEwpWï (2019/9/14), ¡l.
733014. [wï (nûïE€ï)] (êÊu) dq»A[JCu¿ðp¢œC^CC^CaÌnÉ¢ÄÌÕ°I¢. xûº1, Âbq, ¬Fxq (1q¶): ^oCITCGX€ï2019 (2019/10/30), , Fund Toxicol Sci 2019; 6: 146.
'18NxÈOª
[wp_¶]
H29-110002. [Ž] Factors Affecting the Occurrence of Complications in the Early Stages After Dental Implant Placement: A Retrospective Cohort Study. Okamoto T, Hoshi K1, Fukada K, Kataoka T, Kumasaka A, Kaibuchi N, Fukuzawa S, Ando T: Implant Dent 2018/3. doi: 10.1097/ID.0000000000000753. Online ahead of print. (¯@ÀF1: 1q¶)
'18-110002. [Ž] Association between frailty and bone loss in patients undergoing maintenance hemodialysis. Yoneki K, Kitagawa J, Hoshi K1, Harada M, Watanabe T2, Shimoda T2, Matsuzawa R, Yoshida A, Matsunaga Y, Takeuchi Y3, Kamiya K, Matsunaga A4: J Bone Miner Metab 2019/1; 37 (1): 81-9. (¯@ÀF1, nç²FŸ2, ºc²å2, |àNY3, ŒiÄF4: 1q¶, 2åw@ãÃn€, 3tà, 4ãÃq¶w)
'18-110003. [Ž] Exposure to paraben and triclosan and allergic diseases in Tokyo: A pilot cross-sectional study. Mitsui-Iwama M, Yamamoto-Hanada K, Fukutomi Y, Hirota R, Muto G1, Nakamura T, Yoshikawa T, Nakamura H, Mikami M, Morioka I, Ohya Y: Asia Pac Allergy 2019/1; 9 (1): e5. (¡@1: 1q¶)
'18-511001. [ðà] For making a declaration of countermeasures against the falling birth rate from the Japanese Society for Hygiene: summary of discussion in the working group on academic research strategy against an aging society with low birth rate. Nomura, Karita K, Araki A, Nishioka E, Muto G1, Iwai-Shimada M, Nishikitani, Inoue M, Tsurugano S, Kitano N, Tsuji M, Iijima S, Ueda K, Kamijima M, Yamagata Z, Sakata K, Iki M, Yanagisawa H, Kato M, Inadera H, Kokubo Y, Yokoyama K, Koizumi A, Otsuki T: Environ Health Prev Med 2019/3; 24 (1): 14. (¡@1: 1q¶)
'18-540001. [»ÌŒ (€ñ)]yú¶JÈJПaÕ°€ÆïâàuEÆ«XgXÈÕ²ž[ÌOêÅÌì¬ÉÖ·é€vz¡Ram (€ã\Ò), óV, ack¡, Jì, ¡¹÷, YìÁãq, ¡@1, ¬cØDq, cõI (1q¶): œ¬30Nx EªS€ñ 2019/3.
'18-540002. [»ÌŒ (€ñ)]yú¶JÈw€ïâàuªñ³ÒÌAJp±yÑEêAÉ·é€vz¡¹÷ (€ã\Ò),âV¡õ], c@È, ö×v, Ñ@aF, Œº¡, ãaNç, XûY, KŽbî, ¡@1 (1q¶): œ¬30Nx EªS€ñ 2019/3.
'18-540003. [»ÌŒ (€ñ)]yú¶JÈJПaÕ°€ÆïâàuéÆEYÆÛX^btEãÃ@ÖÌAgÉæ錧xVXeÌJvzŒœ@_ (€Òã\), ¡¹÷, XûY, ¬RPq, ŽüÛ, ìºì¶ ,ª@hV, ¡@1 (1q¶): œ¬30Nx EªSñ 2019/3.
[@]
'18-620001. [wp (ªS·M)]yuLø«]¿ÉîêñfKChCvÌœßÌGrfX|[gì¬û@ 2018NxÅzp.1-65. à_¿³Æ1, àVWF1, ×ìoã1, ÐRM¶1, ²XØŽõ1, RxY1, ¯@ÀF1,2, óä~q1, yiçq1, ìRüq1, ócLq1, ŒÀTq1 (1¶£r
[Ïõï, 2q¶), Ò: §ªñ€Z^[ÐïÆN€Z^[f€ªñfKChC±Ç, §ªñ€Z^[ÐïÆN€Z^[, , 2019/3s.
[wïE€ï]
'18-723002. [wï (S)] (êÊu) ¶KµaÌóÃfɺ€AEgJÌðÍÆðôÌ]¿-YÆãÆå¡ãÌAg»îüÌøÊ. ¡@1, ÐËÈq (1q¶): æ29ñú{uwïwpï (2019/1/30-2/1), .
'18-723003. [wï (S)] (êÊu) éÆÉš¯éAJîìÒÖÌAJxÌÀÔ²ž. mȹq, ¡Ram, ÎäÞ, ¡@1 (1q¶): æ89ñú{q¶wïwpï (2019/2/1-3), ŒÃ®.
'18-723004. [wï (S)] (êÊu) dÆîìðŒ§µÄ¢é]ÆõÖÌYÆÛêåEÌx. mȹq, ¡Ram, ÎäÞ, ¡@1 (1q¶): æ89ñú{q¶wïwpï (2019/2/1-3), ŒÃ®.
'18-723005. [wï (S)] (êÊu) züRŽŽì³êœ}EXÖÌgNT^Éæé°à×ÛÌÏ»Æb§œÌ«». OcÊñ, åîKO, R{Maq, xFn, ¡@1, Nagata NIandu Roger, º@, ºTî (1q¶): æ89ñú{q¶wïwpï (2019/2/1), ŒÃ®.
öOq¶w
[wp_¶]
110042. [Ž] Effects of two types of smartphone-based stress management programmes on depressive and anxiety symptoms among hospital nurses in Vietnam: a protocol for three-arm randomised controlled trial. Imamura K, Tran TTT, Nguyen HT Kuribayashi K, Sakuraya A Nguyen AQ, Bui TM, Nguyen QT, Nguyen KT Nguyen GTH, Tran XTN, Truong TQ Zhang MWB, Minas H, Sekiya Y, ;Sasaki N, Tsutsumi A1, Kawakami N: BMJ Open 2019/4; 9 (4): e025138. (ç@Ÿ1: 1öOq¶)
110043. [Ž] Caregiver Burden and Work Productivity Among Japanese Working Family Caregivers of People with Dementia. Fujihara S1, Inoue A1, Kubota K, Yong KFR, Kondo K: Int J Behav Med 2019/4; 26 (2): 125-35. (äã²b1: 1öOq¶)
110044. [Ž] Social Support During Emergency Work and Subsequent Serious Psychological Distress: A Cross-Sectional Study Among Emergency Workers who Responded to the Fukushima Daiichi Nuclear Power Plant Accident. Mafune K, Hiro H, Inoue A1, Hino A, Shigemura J, Yamada M, Okubo T: J Occup Environ Med 2019/6; 61 (6): e240-6. (äã²b1: 1öOq¶)
110045. [Ž] Association Between Reported Long Working Hours and History of Stroke in the CONSTANCES Cohort. Fadel M, Sembajwe G, Gagliardi D, Pico F, Li J, Ozguler A, Siegrist J, Evanoff BA, Baer M, Tsutsumi A1, Iavicoli S, Leclerc A, Roquelaure Y, Descatha A: Stroke 2019/7; 50 (7): 1879-82. (ç@Ÿ1: 1öOq¶)
110046. [Ž] The effect of changes in overtime work hours on depressive symptoms among Japanese white-collar workers: A 2-year follow-up study. Hino A, Inoue A1, Mafune K, Hiro H: J Occup Health 2019/7; 61 (4): 320-7. (äã²b1: 1öOq¶)
110047. [Ž] Long working hours and depressive symptoms: moderating effects of gender, socioeconomic status, and job resources. Tsuno K1, Kawachi I1, Inoue A1,2, Nakai S1, Tanigaki T1, Nagatomi H1, Kawakami N1 (1JSTRESS Group): Int Arch Occup Environ Health 2019/7; 92 (5): 661-72. (äã²b1,2: 2öOq¶)
110048. [Ž] Association between psychosocial factors at work and health outcomes after retirement: a protocol for a systematic review and meta-analysis. Imamura K, Tsutsumi A1, Asai Y, Arima H, Ando E, Inoue A1, Inoue R, Iwanaga M, Eguchi H1, Otsuka Y, Kobayashi Y, Sakuraya A, Sasaki N, Tsuno K, Hino A, Watanabe K, Shimazu A, Kawakami N: BMJ Open 2019/8; 9 (8): e030773. (ç@Ÿ1, äã²b1, ]û@®1: 1öOq¶)
110049. [Ž] Links between organizational preparedness and employee action to seek support among a Japanese working population with chronic diseases. Eguchi H1, Tsutsumi A1, Inoue A1, Kachi Y1: J Occup Health 2019/9; 61 (5): 407-14. (]û@®1, ç@Ÿ1, äã²b1, ÂmIq1: 1öOq¶)
110050. [Ž] Organizational justice and illness reporting among Japanese employees with chronic diseases. Eguchi H1, Tsutsumi A1, Inoue A1, Kachi Y1: PLoS One 2019/10; 14 (10): e0223595. (]û@®1, ç@Ÿ1, äã²b1, ÂmIq1: 1öOq¶)
110051. [Ž] Job satisfaction and intention to remain on the job among Japanese nursing assistants. Kudo Y, Toyoda T, Terao R, Suzuki S, Tsutsumi A1: J Rural Med 2019/11; 14 (2): 181-90. (ç@Ÿ1: 1öOq¶)
110052. [Ž] Validation of the Japanese Version of the Multidimensional Measure of Family Supportive Supervisor Behaviors (FSSB-J). Eguchi H1, Kachi Y1, Koga HK, Sakka M, Tokita M, Shimazu A: Front Psychol 2019/11; 10: 2628. (]û@®1, ÂmIq1: 1öOq¶)
110053. [Ž] Validation of the Job Content Questionnaire among hospital nurses in Vietnam. Sasaki N, Imamura K, Thuy TTT, Watanabe K, Huong NT, Kuribayashi K, Sakuraya A, Thu BM, Quynh NT, Kien NT, Nga NT, Giang NTH, Tien TQ, Minas H, Zhang M, Tsutsumi A1, Kawakami N: J Occup Health 2020/1; 62 (1): e12086. (ç@Ÿ1: 1öOq¶)
110054. [Ž] Occupational stress and the risk of turnover: a large prospective cohort study of employees in Japan. Kachi Y1, Inoue A1, Eguchi H1, Kawakami N, Shimazu A, Tsutsumi A1: BMC Public Health 2020/4; 20 (1): 174. (ÂmIq1, äã²b1, ]û@®1, ç@Ÿ1: 1öOq¶)
110055. [Ž] Measuring eudemonic well-being at work: a validation study for the 24-item the University of Tokyo Occupational Mental Health (TOMH) well-being scale among Japanese workers. Watanabe K, Imamura K, Inoue A1, Otsuka Y, Shimazu A, Eguchi H1, Adachi H, Sakuraya A, Kobayashi Y, Arima H, Kawakami N: Ind Health 2020/4; 58 (2): 107-31. doi: 10.2486/indhealth.2019-0074. Epub 2019 Aug 1. (äã²b1, ]û@®1: 1öOq¶)
120001. [Ž] «œ¢ÌɯȢlÍÇÌæ€È«ûð]ñÅ¢éÌ©|çEîìÆÌÖA©çñ³KÙpÌÂ\«ðlŠé|. ŽüÛ, ÂmIq1 (1öOq¶): YÆEgDSw€ 2019; 33 (1): 51-64.
120002. [Ž] ^®p±ÒÉ©çêép±RÌÁF|JÒÉš¯é^®p±ÖÌs®ÏeAv[`ÉÖ·é€|. ]û׳, äã²b1, ŸcëK, åa@_ (1öOq¶): ú{N³çwï 2019/8; 27 (3): 256-70.
120003. [Ž] ©EÎôÉÖµÄãÃ, Û, SÌêåÆðÚw·w¶ªL·é׫m¯ÆZpüãÌœß̳ÞJ. äã²b1, ç@Ÿ1, ç®À2, çtGB2, ßl, ¬cŽK, sqÁÞq3 (1öOq¶, 2ãw³ç, 3ãÃq¶w): ©Eô€ 2019/11; 2 (1): 5-11.
220002. [Ž] ¬Ew¶ÌÛìÒðÎÛƵœuqÇàH°vÉÖ·éC^[lbg²ž. JÀã, Vm¹, çt@, Rûß, ÂmIq1, ë{Gü, ß¡®È (1öOq¶): ú{öOq¶G 2019/9; 66 (9): 593-602.
220003. [Ž] ÐQÌ^wXÆ©E\h. åÞ^k, cpOY, Oc³¡, ªØ~q, ß¡¥, 캱q, É¡Ol, åœNç, äã²b1, ç@Ÿ1 (1öOq¶): ú{öOq¶G 2020/2; 67 (2): 101-10.
510002. [à] Proposed guidelines for primary prevention for mental health at work: an update. Tsutsumi A1, Shimazu A, Yoshikawa T: Environ Occup Health Practice 2019/10; 1 (1): 2-12. (ç@Ÿ1: 1öOq¶)
520002. [à] XgX`FbN§xÌÀ{óµÆ»ÌøÊ; VXe}eBbNr
[. ç@Ÿ1, ²XØßÃ, î£@D, nÓaL, äã²b1, ¡ºKŸY, ìãl (1öOq¶): YÆãwr
[ 2019/9; 32 (2): 65-81.
522009. [uÀ]yÁW: ¡ÃÆdÌŒ§x€Ì»Ýz1. ¡ÃÆAJÌŒ§xÌœßÌÆêàOÌYÆÛX^btÆãÃ@ÖÌAgfƻ̮]¿wWÌJÉÖ·é€. ç@Ÿ (öOq¶): YÆãwW[i 2019/7; 42 (4): 5-9.
522010. [uÀ]yÁW: YÆXgX2040zlHm\ÆEêÌ^wXÎô äã²b (öOq¶): YÆXgX€ 2019/7; 26 (3): 269-70.
522011. [uÀ]y¬ÁW: ÃTðmézdÌvx|Rg[f. äã²b (öOq¶): YÆXgX€ 2019/7; 26 (3): 335-9.
522012. [uÀ]yÁW:uNi·vðlŠézÙpÆNi·Ìvö`lÌNðçéœßÉ`. ç@Ÿ (öOq¶): A€|[g 2020/1; 353: 6-9.
522013. [uÀ]yAÚ: N12No.396z ÈœÌEêgDÍuö³vÅ·©?`gDIö³ÆJÒÌN`. äã²b (öOq¶): J±ÀSq¶©Èªí 2020/1; 65 (1): 14-16.
530004. [»ÌŒ (Editorial)] Preventing overwork-related deaths and disorders-needs of continuous and multi-faceted efforts. Tsutsumi A1: J Occup Health 2019/7; 61 (4): 265-6. (ç@Ÿ1: 1öOq¶)
[@]
610003. [wp (ªS·M)]yHandbook of Socioeconomic Determinants of Occupational Health (Handbook Series in Occupational Health Science)zSocial Inequalities in Health Among Older Adults After Retirement, p.1-14. Tsutsumi A1, Editor: Theorell T, Springer, Switzerland, First Online: 2020/2. (ç@Ÿ1: 1öOq¶)
610004. [wp (ªS·M)]yHandbook of Disability, Work and Health (Handbook Series in Occupational Health Sciences (1))zReturn to Work After Stroke, p.1-16. Tsutsumi A1, Editor: Bltmann U, Siegrist J, Springer, Switzerland, First Online: 2020/2. (ç@Ÿ1: 1öOq¶)
620004. [wp (ªS·M)]yÐïE«ÆN öOq¶w 2020NÅzCHAPTER 9@ž_Ÿ³@ž_ÛÎô, p.95-100. ç@Ÿ (öOq¶), Ò: öì@m, örV, ãòoÅ®ïÐ, , 2020/1s.
620005. [wp (ªS·M)]yÐïE«ÆN öOq¶w 2020NÅzCHAPTER 10@©ECs¶ÌÌCsÒC\Í, p.101-4. ç@Ÿ (öOq¶), Ò: öì@m, örV, ãòoÅ®ïÐ, , 2020/1s.
620006. [wp (ªS·M)]ygŠé! N³çEJq¶³ç65Izæ2 ³çe[}Ò@sN³çtÌêÊ 15 XgX}lWg, p.104-9. ç@Ÿ (öOq¶), Ò: X@W¢, êÊÐc@lú{J±€ï, , 2020/2s.
620007. [wp (ªS·M)]yîb©çwÔNÇT_z13 EêÌNÇ, p.197-210. ç@Ÿ1 (1öOq¶), Ò: örV, ç@Ÿ1, ì]°, , 2020/3s.
[wïE€ï]
712001. [wï (Û)] (µÒu) Mental health service in the workplace: Japanese experience. Tsutsumi A1: 5th International Conference of Occupational Health Services (2019/9/2), Taipei, Taiwan. (ç@Ÿ1: 1öOq¶)
712002. [wï (Û)] (µÒu) Work-life Balance in the Current Japanese Context. Tsutsumi A1: 7th International congress of person centered medicine (2019/11/2), Tokyo, Japan. (ç@Ÿ1: 1öOq¶)
713008. [wï (Û)] (êÊu) Association between PTSD symptoms and stress related factors among nuclear emergency workers over a long period. Hiro H, Hino A, Mafune K, Inoue A1, Shigemura J, Yamada M, Ookubo T: 19th World Psychiatric Association World Congress of Psychiatry (2019/8/21), Lisbon, Portugal. (A@®T, úìíq, ^D_î, äã²b1, dº@~, Rcüqq, åvÛW: 1öOq¶)
721001. [wï (S)] (ÁÊu) YÆž_ÛÌÛª¬©çÝŠéGood Practice Approach. ç@Ÿ (öOq¶): æ26ñú{YÆž_Ûwï (2019/8/31), .
721002. [wï (S)] (ÁÊu) Decent work for all`±Â\ÈnæãÃÌœßÉ`. ç@Ÿ (öOq¶): æ13ñJADECOMwpåï in Yokosuka (2019/9/14), ¡{ê.
722007. [wï (S)] (µÒu) EêÉš¯égDvöÆJÒÌNÆÌÖA|CüvöðÜßœïI¢|. äã²b (öOq¶): æ30ñú{ãwïï 2019 (2019/4/28), ŒÃ®.
722008. [wï (S)] (µÒu) EêÅRCTðÀ{µÄwñŸ. ç@Ÿ (öOq¶): æ92ñú{YÆq¶wï (2019/5/23), ŒÃ®.
722009. [wï (S)] (µÒu) ÒWÏõïÌVœÈ§íÆ€«»Éü¯Ä. ç@Ÿ (öOq¶): æ92ñú{YÆq¶wï (2019/5/24), ŒÃ®.
722010. [wï (S)] (µÒu) k¢åwãwÉš¯és®ÈwEs®ãw³çÌÀH. äã²b1, ç@Ÿ1, ç®À2, çtGB2, ¬cŽK, ßl (1öOq¶, 2ãw³ç): æ26ñú{s®ãwïwpï (2019/12/6), .
723075. [wï (S)] (êÊu) j«JÒÉš¯édÌXgXvöÆ^{bNVh[ÆÌÖA: 1NÔÌOü«Rz[g€. äã²b1, ]û@®1, åË׳, Nä€i, ç@Ÿ1, cõI (1öOq¶): æ55ñú{zÂía\hwïwpWï (2019/5/12), v¯Ä.
723076. [wï (S)] (êÊu) xgiêÅJCQ (Job Content Questionnaire) ÌJÈçÑÉM«Eë̢. ²XØßÃ, ¡ºKŸY, Tran Thi Thu Thuy, Nguyen Thanh Huong, IÑêl, NJ ·©, Bui Minh Thu, Nguyen Thuy Quynh, Nguyen Trung Kien, Nguyen Thi Huong Giang, Tran Thi Ngoc Xuyen, Truong Quang Tien, Harry Minas, ç@Ÿ1, ìãl (1öOq¶): æ92ñú{YÆq¶wï (2019/5/23), ŒÃ®.
723077. [wï (S)] (êÊu) ©¡ÌEêÉš¯éOSHMSè
ÆÀSq¶wWâ®ÖÌe¿]¿ æ25ñ. nÓTW, bcÎ÷, ²XØB, Œtjq, É¡ºD, FJMñ, Ž@Mv, ç@Ÿ1, ÛR³¡, RûG÷ (1öOq¶): æ92ñú{YÆq¶wï (2019/5/23), ŒÃ®.
723078. [wï (S)] (êÊu) EêÌždx (VreB) Úxú{êÅÌM«EëØÆ®«ÊŸ_är. ÃìÞü, ßl, c±q, À¡Güq, äã²b1, IªZq, ìãl (1öOq¶): æ92ñú{YÆq¶wï (2019/5/23), ŒÃ®.
723079. [wï (S)] (êÊu) éÆOJq¶@ÖÉš¯é¡ÃÆEƶ̌§xÌiÌœßÌc[ÌJ. éêŽRq, XûY, ]û@®1, äã²b1, ç@Ÿ1 (1öOq¶): æ92ñú{YÆq¶wï (2019/5/23), ŒÃ®.
723080. [wï (S)] (êÊu) ÔOJÔÆ7ÂÌNKµÌgÝí¹ªåÏINŽÉ^Šée¿. úìíq, äã²b1, å{ê~, ìüRI, ecSÀ, ìûTã, ^D_î, A@®T (1öOq¶): æ92ñú{YÆq¶wï (2019/5/23), ŒÃ®.
723081. [wï (S)] (êÊu) XgX»èÆ£EÆÌÖA: lf[^ðp¢œ4NÔÌRz[g€. ÂmIq1, ç@Ÿ1, ]û@®1, äã²b1 (1öOq¶): æ92ñú{YÆq¶wï (2019/5/24), ŒÃ®.
723082. [wï (S)] (êÊu) éÆÉš¯égDIö³ÆJÒÌFmIžss®ÆÌÖA. äã²b1, ]û@®1, ÂmIq1, ç@Ÿ1 (1öOq¶): æ92ñú{YÆq¶wï (2019/5/24), ŒÃ®.
723083. [wï (S)] (êÊu) \¢»ÊÚ@ðp¢œŽÙ}ìÆ]ÒÌž_NÌ]¿ÉÖ·é€. A@®T, ^D_î, úìíq, äã²b1, ºcz÷, åvÛW (1öOq¶): æ92ñú{YÆq¶wï (2019/5/24), ŒÃ®.
723084. [wï (S)] (êÊu) EÆ«XgXvöªd̶Y«É^Šée¿: Oü«Rz[g€. Ñc^q, ìãl, ¡ºKŸY, nÓaL, äã²b1, ßl, gì@O, A@®T, óäTü, ¬cØDq, gìxq, ç@Ÿ1 (1öOq¶): æ92ñú{YÆq¶wï (2019/5/25), ŒÃ®.
723085. [wï (S)] (êÊu) d«xÆ·úŸaxÆÆÌÖA: 1NÔÌOü«Rz[g€. äã²b1, ç@Ÿ1, ÂmIq1, ]û@®1, ßl, ìãl (1öOq¶): æ26ñú{YÆž_Ûwï (2019/8/31), .
723086. [wï (S)] (êÊu) ÔOJÔÆž_INÆÌÖA: PêéÆÉš¯é1NÔÌcf€. äãäq1, ç@Ÿ2, äã²b2, ]û@®2, ÂmIq2, räLü3 (1åw@ãÃn€È, 2öOq¶, 3ãÃÌ¿EÀSiº): æ29ñú{YÆq¶wïSŠcï (2019/9/13), åä.
723087. [wï (S)] (êÊu) k¢åwa@Éš¯éAJxSãtÌ®Ìñ. ]û@®1, ç@Ÿ1, äã²b1, âRüq, ß¡ÜäÝ2, ÊüRI2, cç³@3,4 (1öOq¶, 2Åì, 3V¢IãÃEæ[ãÃ, 4Á»íà): æ29ñú{YÆq¶wïSŠcï (2019/9/13), åä.
723088. [wï (S)] (êÊu) JÒÌgÌ®Êüãw±ÌîüøÊ|Êd^xÆßöd^xÌá¢|. ]û׳, äã²b1, âmG, RcWœ, ŽêüI, J~q (1öOq¶): æ37ñYÆãÈåwwïï (2019/10/12), kãB.
723089. [wï (S)] (êÊu) ÔOJÔÆ7ÂÌNKµÌgÝí¹ªž_INÉ^Šée¿. úìíq, äã²b1, ^D_î, A@®T (1öOq¶): æ37ñYÆãÈåwwïï (2019/10/12), kãB.
723090. [wï (S)] (êÊu) ÄÉš¯éÆëÌÐïoÏóµÆqÇàÌ^®\ÍÆÌÖA. Ng@€, ÂmIq1, äã²b1, ]û@®1, RkÆ, ç@Ÿ1 (1öOq¶): æ26ñú{s®ãwïwpï (2019/12/7), .
723091. [wï (S)] (êÊu) JÒÌ«iÁ«ðl¶µœgÌ®Êüãw±Ìîü€: _»är±. ]û׳, äã²b1, J~q, âmG, RcWœ, ŽêüI (1öOq¶): æ26ñú{s®ãwïwpï (2019/12/7), .
723092. [wï (S)] (êÊu) êeÌñT^ÔÑJÆqÇàÌì: 16-17ÎÌvtúÌqÇàÉš¯é¢. ÂmIq1, ¢@Ê, ]û@®1, äã²b1, ºRLq, ç@Ÿ1 (1öOq¶): æ30ñú{uwïwpï (2020/2/20-22), s.
732004. [wï (nûïE€ï)] (µÒu) ú{YÆq¶wïÒWÏõïÌÛ®üÖÌÎ JAMJEãwGÒWKChCÖÌÎá. ç@Ÿ (öOq¶): 2019Nxæ2ñ J-STAGEZ~i[ (2019/10/21), .
732005. [wï (nûïE€ï)] (µÒu) EÆ«XgX€Ì±êÜÅƱê©ç. äã²b (öOq¶): æ60ñYÆž_q¶€ï (2020/2/29), kãB (ãJÃ).
733015. [wï (nûïE€ï)] (êÊu) éÆOJq¶@ÖÉš¯é¡ÃÆEƶ̌§xÌiÌœßÌc[ÌJ. XûY, éêŽRq, ]û@®1, äã²b1, ç@Ÿ1 (1öOq¶): ú{YÆq¶wï ¬éÆÀSq¶€ï æ 53ñSWï (2019/11/23), lŒ.
@ãw
[wp_¶]
110056. [Ž] Left-right difference in carboxyhemoglobin saturation in heart blood of cadavers and its significance. Irie W1, Murakami C1, Sasaki C1, Nakamaru N2, Sakamoto M2, Nagato J2, Satoh F1: Kitasato Med J 2019/9; 49 (2): 99-105. (ü]@Â1, ºãçq1, ²XØçõq1, Û®ü2, ã{q2, ·åœ2, ²¡¶q1: 1@ã, 2`Ôn)
110057. [Ž] Sudden Infant Death After Vaccination: Survey of Forensic Autopsy Files. Osawa M, Nagao R, Kakimoto Y, Kakiuchi Y, Satoh F1: Am J Forensic Med Pathol 2019/9; 40 (3): 232-7. (²¡¶q1: 1@ã)
110058. [Ž] Emergence and Characterization of Acute Coronary Syndrome in Adults After Confirmed or Missed History of Kawasaki Disease in Japan: A Japanese Nationwide Survey. Mitani Y, Tsuda E, Kato H, Higaki T, Fujiwara M, Ogawa S, Satoh F1, Nakamura Y, Takahashi K, Ayusawa M, Kobayashi T, Ichida F, Matsushima M, Kamada M, Suda K, Ohashi H, Sawada H, Komatsu T, Waki K, Shinoda M, Tsunoda R, Yokoi H, Hamaoka K: Front Pediatr 2019/7; 7: 275. (²¡¶q1: 1@ã)
[wïE€ï]
721003. [wï (S)] (ÁÊu) üÌ}ÆSÌÁî«ÌÏ»ÆÌÖAÉ¢Ä. ²¡¶q (@ã): æ84ñú{·òCóšãwïïEwpWï (2019/5/18), ªR.
722011. [wï (S)] (µÒu) «ãtª@ãwÌæÅô·éœßÉ. ²¡¶q (@ã): æ103ú{@ãwïwpSWï (2019/6/14), åä.
723093. [wï (S)] (êÊu) ðÊ̹Éæè}«SØ[Ǫ¶µœ1Uá. ü]@Â1, ºãçq1, ²XØçõq1, Û®ü2, ã{q2, ·åœ2, ²¡¶q1 (1@ã, 2`Ôn): æ103ú{@ãwïwpSWï (2019/6/13), åä.
723094. [wï (S)] (êÊu) ¢ãV[PT[Éæé
ÌÌ16S rRNA^QmðÍ. ºãçq1, ü]@Â1, ²XØçõq1, Û®ü2, ã{q2, ·åœ2, ²¡¶q1 (1@ã, 2`Ôn): æ103ú{@ãwïwpSWï (2019/6/13), åä.
723095. [wï (S)] (êÊu) k¢åw@ãòšXN[jOªÍÊÌWvñ. ²XØçõq1, ºãçq1, ü]@Â1, Û®ü2, ã{q2, ·åœ2, ²¡¶q1 (1@ã, 2`Ôn): æ103ú{@ãwïwpSWï (2019/6/13), åä.
723096. [wï (S)] (êÊu) ¶Ì¿ªÍðsÁœXCZÌëHÉæéHÅ3á. gºvmq1, ÛŽFº2, åä^¢Þ2, IŽSŸY2, ²XØçõq3, î_×l2, ²¡¶q3, ó@õ2 (1aÔEfÃn, 2~œ, 3@ã): æ41ñú{ÅwïïEwpWï (2019/7/21), éÊ.
723097. [wï (S)] (êÊu) LC-MS/MSðp¢œqgŽRšæÑK^~ÌèʪÍ@. ²XØçõq1, gºvmq2, î_×l3, ºãçq1, ü]@Â1, c@«, ÂËBY, ó@õ3, ²¡¶q1 (1@ã, 2aÔEfÃn, 3~œ): æ44ñú{ãp}XXyNgwïNï (2019/9/12), ŒÃ®.
733016. [wï (nûïE€ï)] (êÊu) PFPJðp¢œRšæÑK^~ÌLC-MS/MSªÍ@Ì¢. ²XØçõq1, ºãçq1, ü]@Â1, Û®ü2, ã{q2, ·åœ2, ²¡¶q1 (1@ã, 2`Ôn): æ88ñú{@ãwïwpÖnûWï (2019/10/12), (äÌœßãJÃ).
733017. [wï (nûïE€ï)] (êÊu) agDW{ì»Éš¯éLVãÖipÌæègÝÉ¢Ä. Û®ü1, ã{q1, ºãçq2, ü]@Â2, ²XØçõq2, ·åœ1, ²¡¶q2 (1`Ôn, 2@ã): æ88ñú{@ãwïwpÖnûWï (2019/10/12), (äÌœßãJÃ).
À±®šw
[wïE€ï]
713009. [wï (Û)] (êÊu) Application of CRISPR Cas9 based genome editing system in the spontaneous mutant mouse STR/Ort. Okubo T1, Uchida K2, Takaso M2: The 15th Transgenic Technology Meeting (TT2019) (2019/4/8), Kobe, Japan. (åvÛŒ1, àcŸY2, »m2: 1À®, 2®O)
723098. [wï (S)] (êÊu) The effect of retinoic acid signaling on the expression of Ripply3 gene in pharyngeal arch development. åvÛŒ1, Ž@iq, @åG1, cT¡ (1À®): æ52ñú{¶¶šwïåï (2019/5/15), åã.
723099. [wï (S)] (êÊu) â`«p[L\a³ÒiPS×ERP
n×EÌ컚æÑ@\ðÍ. VcŽl, ŸcxN1, žl2, vÛ@œ1, iä^Mq3, ²¡rÆ4, ªìhV (1ãÃq¶w, 2åw@ãÃn€È, 3]_oà, 4À®): æ14ñú{Õ°žw³çwïwpåï (2019/8/22), F{.
733018. [wï (nûïE€ï)] (êÊu) â`«p[L\a³ÒiPS×ERP
n×EÌ컚æÑ@\ðÍ. VcŽl, ŸcxN1, žl2, vÛ@œ1, iä^Mq3, ²¡rÆ4, ªìhV (1ãÃq¶w, 2åw@ãÃn€È, 3]_oà, 4À®): æ32ñk¢åwoCITCGXtH[Eæ22ñk¢÷¶šAJf~[€Wï (2019/8/7), à.
733019. [wï (nûïE€ï)] (êÊu) TDP-43×EàÇÝXCb`§äÉæéØÞk«€õd»ÇfÌì¬. ²¡rÆ1, åvÛŒ1 (1À®): 2019Nx]€€¯p€¯€ (ùªÇ) (2020/1/8), V.
Æuw
[wp_¶]
110059. [Ž] Attenuation of experimental autoimmune uveoretinitis in mice by IKKÀ inhibitor IMD-0354. Liu Y, Kitaichi N, Wu D, Hase K, Satoh M1, Iwata D, Namba K, Kanda A, Noda K, Itai A, Iwabuchi K1, Ishida S: Biochem Biophys Res Commun 2020/2; 525 (3): 589-94. (²¡@ë1, âºaç1: 1Æu)
110060. [Ž] NF-ÈB-inducing kinase contributes to normal development of cortical thymic epithelial cells: its possible role in shaping a proper T-cell repertoire. Eshima K1, Misawa K2, Ohashi C2, Noma H2, Iwabuchi K1: Immunology 2020/3; 160 (2): 198-208. doi. 10.1111/imm.13186. (]kñ1, OàVÀÞ2, åŽçq2, ìÔt2, âºaç1: 1Æu, 2åw@ãÃn€È)
110061. [Ž] The disruption of invariant natural killer T cells exacerbates cardiac hypertrophy and failure caused by pressure overload in mice. Takahashi M, Kinugawa S, Takada S, Kakutani N, Furihata T, Sobirin MA, Fukushima A, Obata Y, Saito A, Ishimori N, Iwabuchi K1, Tsutsui H: Exp Physiol 2020/3; 105 (3): 489-501. (âºaç1: 1Æu)
110062. [Ž] De novo generation of CD1d1-deficient NKT-cell hybridomas from CD1d-/- mice or by gene editing of CD1d+ hybridomas. Satoh M1, Saeki M2, Yoshino K3, Mita K3, Iizuka M4, Hattori A3, Takeuchi E1, Eshima K1, Iwabuchi K1: Kitasato Med J 2020/3; 50 (1): 34-43. (²¡@ë1, ²ü¿2, gìav3, Ocê¿3, ÑËݳð4, žl3, |àbüq1, ]kñ1, âºaç1: 1Æu, 2k¢åwk¢€a@, 3åw@ãÃn€È, 4\hãwn)
110063. [Ž] Leucine-Rich Repeat Kinase 2 Controls Inflammatory Cytokines Production through NF-ÈB Phosphorylation and Antigen Presentation in Bone Marrow-Derived Dendritic Cells. Kubo M1, Nagashima R, Kurihara M, Kawakami F, Maekawa T, Eshima K2, Ohta E1, Kato H, Obata F3: Int J Mol Sci 2020/3; 21 (5): 1890. (vÛ@œ1, ]kñ2, ŸcxN1, ¬Š¶í3: 1ãÃq¶w, 2Æu, 3k¢åwÛq¶êåw@)
110064. [Ž] Amelioration of experimental autoimmune myocarditis through activation of invariant natural killer T cells by administration of ¿-galactosylceramide. Yoshino K1, Satoh M2, Iwayama T1, Kobayashi S1, Okamoto H3, Eshima K2, Watarai H, Iwabuchi K2: Kitasato Med J 2020/3; 50 (1): 60-72. (gìav1, ²¡@ë2, âRrk1, ¬ÑGô1, ª{_k3, ]kñ2, âºaç2: 1åw@ãÃn€È, 2Æu, 3)
511001. [ðà]yEditorial on the Research TopiczEditorial: Role of CD1- and MR1-restricted T cells in Immunity and Disease. Iwabuchi K1, Van Kaer L: Front Immunol 2019/8; 10: 1837. (âºaç1: 1Æu)
522014. [uÀ]yÁW: ÆunðVXeAÖ: Pí«ÌÛÆj]zV. ÆuÆãÓ@NKT×EÆbgD. âºaç1, ²¡@ë1 (1Æu): ¶ÌÌÈw 2019/4; 70 (2): 130-4.
[wïE€ï]
713010. [wï (Û)] (êÊu) The role of NKT cell-macrophage interaction in obesity. Satoh M1, Iwabuchi K1: EMBO Workshop CD1-MR1: Beyond MHC-restricted lymphocytes (2019/9/4), Oxford, UK. (²¡@ë1, âºaç1: 1Æu)
723100. [wï (S)] (êÊu) T×E査ɚ¯é, ]ÊöqEomesoderminÌðÌðÍ. ºã@ì, XìD÷1, åŽçq1, âºaç2 (1åw@ãÃn€È, 2Æu): æ29ñKyoto T Cell Conference (2019/6/8), s.
723101. [wï (S)] (êÊu) In vitroÉš¯é}EXD
ÌNETosisU±Æ×EOJVEZxÌÖWÉ¢Ä. |àbüq1, |àNY2 (1Æu, 2tà): æ47ñú{Õ°Æuwïï (2019/10/18), Dy.
723102. [wï (S)] (êÊu) The Roles of Eomesodermin in T cell exhaustion. ºã@ì1, ]kñ2, âºaç2 (1åw@ãÃn€È, 2Æu): æ48ñú{ÆuwïwpWï (2019/12/11), lŒ.
723103. [wï (S)] (êÊu) An overview of innate lymphocytes: unconventional T cells and innate lymphoid cells. âºaç (Æu): æ48ñú{ÆuwïwpWï (2019/12/12), lŒ.
723104. [wï (S)] (êÊu) The interaction of NKT cell and macrophage has regulatory function in obesity. ²¡@ë1, âºaç1 (1Æu): æ48ñú{ÆuwïwpWï (2019/12/12), lŒ.
723105. [wï (S)] (êÊu) Potential role of invariant NKT cells in experimental autoimmune myocarditis in mice. gìav1, ²¡@ë2, Watarai H, âºaç2 (1åw@ãÃn€È, 2Æu): æ48ñú{ÆuwïwpWï (2019/12/12), lŒ.
723106. [wï (S)] (êÊu) Relapse of experimental autoimmune uveoretinitis (EAU) with super antigen is ameliorated by concomitant NKT-cell activation. cKÄC1, ²¡@ë2, âºaç2 (1åw@ãÃn€È, 2Æu): æ48ñú{ÆuwïwpWï (2019/12/12), lŒ.
723107. [wï (S)] (êÊu) The alteration of NKT-cell function in mice fed on high fat diet. Hªõi1, ²¡@ë2, âºaç2 (1åw@ãÃn€È, 2Æ): æ48ñú{ÆuwïwpWï (2019/12/12), lŒ.
723108. [wï (S)] (êÊu) MR1/MAIT cell alleviates allergic contact dermatitis through reduction of IL-17 production. ¡Ž®ç1, ²¡@ë2, âºaç2 (1åw@ãÃn€È, 2Æu): æ48ñú{ÆuwïwpWï (2019/12/12), lŒ.
723109. [wï (S)] (êÊu) Role of T-box transcription factor Eomesodermin, in Perforin/Granzyme exocytosis pathway of cytolysis by CD8+ CTLs. XìD÷1, ]kñ2, ºã@ì1, Kondou H, âºaç2 (1åw@ãÃn€È, 2Æu): æ48ñú{ÆuwïwpWï (2019/12/12), lŒ.
723110. [wï (S)] (êÊu) The association between calcium influx and NETosis induced through the NADPH oxidase independent pathway. |àbüq1, |àNY2, âºaç1 (1Æu, 2tà): æ48ñú{ÆuwïwpWï (2019/12/13), lŒ.
733020. [wï (nûïE€ï)] (êÊu) T×E査ɚ¯éT-boxt@~[]ÊöqEomesoderminÌðÌðÍ. ]kñ1, ºã@ì2, XìD÷2, âºaç1 (1Æu, 2åw@ãÃn€È): æ29ñsTZJt@X (KTCC) (2019/6/8), s.
733021. [wï (nûïE€ï)] (êÊu) ×EQ«×EÌ×EQ@\Éš¯éNkg7Ìð. XìD÷1, ]kñ2, âºaç2 (1åw@ãÃn€È, 2Æu): æ32ñk¢åwoCITCGXtH[Eæ22ñk¢÷¶šAJf~[€Wï (2019/8/7), .
733022. [wï (nûïE€ï)] (êÊu) T×E査ɚ¯éT-boxt@~[]ÊöqEomesoderminÌð. ºã@ì1, ]kñ2, âºaç2 (1åw@ãÃn€È, 2Æu): æ32ñk¢åwoCITCGXtH[Eæ22ñk¢÷¶šAJf~[€Wï (2019/8/8), .
733023. [wï (nûïE€ï)] (êÊu) ©ÈÆu«ÔÇ€ÄfÉæéNKT×EÌ@\. cKÄC1, ²¡@ë2, ksL`, âºaç2 (1åw@ãÃn€È, 2Æu): æ32ñk¢åwoCITCGXtH[Eæ22ñk¢÷¶šAJf~[€Wï (2019/8/8), .
733024. [wï (nûïE€ï)] (êÊu) HaU±«ìÉš¯éNKT×EÌ@\ðÍ. Hªõi1, R{Þ¢, ²¡@ë2, âºaç2 (1åw@ãÃn€È, 2Æu): æ32ñk¢åwoCITCGXtH[Eæ22ñk¢÷¶šAJf~[€Wï (2019/8/8), .
733025. [wï (nûïE€ï)] (êÊu) MAIT×E/MR1ÉæéÚG«ç̧ä. ¡Ž®ç1, ²¡@ë2, âºaç2 (1åw@ãÃn€È, 2Æu): æ32ñk¢åwoCITCGXtH[Eæ22ñk¢÷¶šAJf~[€Wï (2019/8/8), .
n涞_ÈãÃw
ĶãÃ`¬OÈw
næãÃw
Ç«°Ÿ³³çEÕ°€w
¬|¬zÂínæãÃw
Á»íàÈw
[wp_¶]
110065. [Ž] Analysis of BRCAness with multiplex ligation-dependent probe amplification using formalin-fixed and paraffin-embedded pancreatic ductal adenocarcinoma tissue obtained via endoscopic ultrasound-guided fine-needle aspiration biopsy. Okuwaki K1, Masutani H2, Imaizumi H1, Yoshida T3, Kida M1, Iwai T1, Yamauchi H1,4, Tadehara M2, Adachi K2, Watanabe M1, Kurosu T1, Koizumi W1: Pancreatology 2019/4; 19 (3): 419-23. (e»î1, ¡J°È2, ¡ò@O1, gc@÷3, ØcõL1, âämv1, Rà_j1,4, äøŽ«Ç2, ÀB@õ2, nÓ^è1, {M_1, ¬òaOY1: 1Á»íà, 2åw@ãÃn€È, 3a, 4~œ)
110066. [Ž] Efficacy and safety of ombitasvir/paritaprevir/ritonavir and ribavirin for chronic hepatitis patients infected with genotype 2a in Japan. Atsukawa M, Tsubota A, Toyoda H, Takaguchi K, Nakamuta M, Watanabe T, Tada T, Tsutsui A, Ikeda H, Abe H, Kato K, Uojima H1, Ikegami T, Asano T, Kondo C, Koeda M, Okubo T, Arai T, Iwashita-Nakagawa A, Itokawa N, Kumada T, Iwakiri K: Hepatol Res 2019/4; 49 (4): 369-76. (°I1: 1Á»íà)
110067. [Ž] Current status of esophageal endoscopy including the evaluation of smoking and alcohol consumption in Japan: an analysis based on the Japan endoscopy database. Katada C1,2, Horimatsu T2, Muto M2, Tanaka K2,3, Matsuda K2,3, Fujishiro M2,3, Saito Y2,3, Ohtsuka K2, Oda I2, Kato M2, Kida M1,2, Kobayashi K1,2,4, Hoteya S2, Kodashima S2, Matsuda T2, Yamamoto H2, Ryozawa S2, Iwakiri R3, Kutsumi H3, Miyata H3, Kato M3, Haruma K3, Fujimoto K3, Uemura N3, Kaminishi M3, Tajiri H3 (2MSED-J (Minimal Standard Endoscopic Database) Creation Subcommittee, Japan Gastroenterological Endoscopy Society, 3JED (Japan Endoscopy Database) Project Committee, Japan Gastroenterological Endoscopy Society): Esophagus 2019/4; 16 (2): 174-9. (ce1,2, ØcõL1,2, ¬ÑŽT1,2,4: 1Á»íà, 4V¢IãÃE¡fIãÃ)
110068. [Ž] Trends and Efficacy of Interferon-Free Anti-hepatitis C Virus Therapy in the Region of High Prevalence of Elderly Patients, Cirrhosis, and Hepatocellular Carcinoma: A Real-World, Nationwide, Multicenter Study of 10 688 Patients in Japan. Toyoda H, Atsukawa M, Uojima H1,2, Nozaki A, Tamai H, Takaguchi K, Fujioka S, Nakamuta M, Tada T, Yasuda S, Chuma M, Senoh T, Tsutsui A, Yamashita N, Hiraoka A, Michitaka K, Shima T, Akahane T, Itobayashi E, Watanabe T, Ikeda H, Iio E, Fukunishi S, Asano T, Tachi Y, Ikegami T, Tsuji K, Abe H, Kato K, Mikami S, Okubo H, Shimada N, Ishikawa T, Matsumoto Y, Itokawa N, Arai T, Tsubota A, Iwakiri K, Tanaka Y, Kumada T: Open Forum Infect Dis 2019/4; 6 (5): ofz185. (°I1,2: 1Á»íà, 2Ãìqa@)
110069. [Ž] Lusutrombopag Reduces Need for Platelet Transfusion in Patients With Thrombocytopenia Undergoing Invasive Procedures. Hidaka H1, Kurosaki M, Tanaka H, Kudo M, Abiru S, Igura T, Ishikawa T, Seike M, Katsube T, Ochiai T, Kimura K, Fukuhara T, Kano T, Nagata T, Tanaka K, Kurokawa M, Yamamoto K, Osaki Y, Izumi N, Imawari M: Clin Gastroenterol Hepatol 2019/5; 17 (6): 1192-200. (ú@1: 1Á»íà)
110070. [Ž] Subgroup analysis of efficacy and safety of orantinib in combination with TACE in Japanese HCC patients in a randomized phase III trial (ORIENTAL). Hidaka H1, Izumi N, Aramaki T, Ikeda M, Inaba Y, Imanaka K, Okusaka T, Kanazawa S, Kaneko S, Kora S, Saito H, Furuse J, Matsui O, Yamashita T, Yokosuka O, Morita S, Arioka H, Kudo M, Arai Y: Med Oncol 2019/5; 36 (6): 52. (ú@1: 1Á»íà)
110071. [Ž] Risk factors for loss of skeletal muscle mass in patients with cirrhosis. Sung JH1, Uojima H1,2, Hidaka H2, Tanaka Y2, Wada N2, Kubota K2, Nakazawa T2, Shibuya A2,3, Fujikawa T, Yamanoue H, Kako M1, Koizumi W2: Hepatol Res 2019/5; 49 (5): 550-8. (°I1,2, ú@2. c«Ÿ2, ac®v2, EcKî2, àVMG2, aJŸ²2,3, ¬òaOY2: 1Ãìqa@, 2Á»íà, 3ãÃÇ)
110072. [Ž] The efficacy and safety of glecaprevir plus pibrentasvir in 141 patients with severe renal impairment: a prospective, multicenter study. Atsukawa M, Tsubota A, Toyoda H, Takaguchi K, Nakamuta M, Watanabe T, Michitaka K, Ikegami T, Nozaki A, Uojima H1, Fukunishi S, Genda T, Abe H, Hotta N, Tsuji K, Ogawa C, Tachi Y, Shima T, Shimada N, Kondo C, Akahane T, Aizawa Y, Tanaka Y, Kumada T, Iwakiri K: Aliment Pharmacol Ther 2019/5; 49 (9): 1230-41. (°I1: 1Á»íà)
110073. [Ž] Effectiveness and safety of endoscopic aspiration mucosectomy and endoscopic submucosal dissection in patients with superficial esophageal squamous-cell carcinoma. Furue Y1, Katada C1, Tanabe S1,2, Ishido K1, Kondo Y3, Kubota Y3, Kawanishi N1, Yamane S1, Watanabe A1, Moriya H4, Yamashita K4,5, Wada T1, Yano T1, Azuma M1, Koizumi W1: Surg Endosc 2019/5; 33 (5): 1433-440. (Ã]NŸ1, ce1, cç³@1,2, Î˪1, ß¡YI3, vÛcz3, ÍŒÞÃq1,RªIq1, nç³W¯1, XJGõ4, Rºpk4,5, acñç1, îìMj1, @q1, ¬òaOY1: 1Á»íà, 2V¢IãÃEæ[ãÃ, 3åw@ãÃn€È, 4ãÁ»ÇO, 5V¢IãÃE¡fIãÃ)
110074. [Ž] Failure Factors to Reach the Blind End Using a Short-Type Single-Balloon Enteroscope for ERCP with Roux-en-Y Reconstruction: A Multicenter Retrospective Study. Kawaguchi Y1,2, Yamauchi H2,3, Kida M1,2, Okuwaki K2, Iwai T2, Uehara K1,2, Hasegawa R2, Imaizumi H2, Kobayashi K2,4, Koizumi W2: Gastroenterol Res Pract 2019/5; 2019: 3536487. (ìûCã1,2, Rà_j2,3, ØcõL1,2, e»î2, âämv2, ãŽê¿1,2, ·JìÍç2, ¡ò@O2, ¬ÑŽT2,4, ¬òaOY2: 1k¢åwfBJZ^[, 2Á»íà, 3~œ, 4V¢IãÃE¡fIãÃ)
110075. [Ž] Assessing the characteristics and feasibility of preventing early mortality in patients with hepatocellular carcinoma. Watanabe M1,2, Yokomori H2,3, Takahashi Y2,4, Okada T2, Shibuya A1,5, Koizumi W1: Turk J Gastroenterol 2019/6; 30 (6): 541-8. (nç²^²1,2, ¡XOº2,3, Žõl2,4, ªcÏ2, aJŸ²1,5, ¬òaOY1: 1Á»íà, 2k¢åwfBJZ^[, 3fÃ, 4êÊE¬EÌ_äXO, 5ãÃÇ)
110076. [Ž] Retrospective Assessment of the Diagnostic Accuracy of the Depth of Invasion by Narrow Band Imaging Magnifying Endoscopy in Patients with Superficial Esophageal Squamous Cell Carcinoma. Katada C1, Tanabe S1,2, Wada T1, Ishido K1, Yano T1, Furue Y1, Kondo Y3, Kawanishi N1, Yamane S1, Watanabe A1, Azuma M1, Koizumi W1: J Gastrointest Cancer 2019/6; 50 (2): 292-7. (ce1, cç³@1,2, acñç1, Î˪1, îìMj1, Ã]NŸ1, ß¡YI3, ÍŒÞÃq1, RªIq1, nç³W¯1, @q1, ¬òaOY1: 1Á»íà, 2V¢IãÃEæ[ãÃ, 3åw@ãÃn€È)
110077. [Ž] Docetaxel plus cisplatin and S-1 versus cisplatin and S-1 in patients with advanced gastric cancer (JCOG1013): an open-label, phase 3, randomised controlled trial. Yamada Y, Boku N, Mizusawa J, Iwasa S, Kadowaki S, Nakayama N, Azuma M1, Sakamoto T, Shitara K, Tamura T, Chin K, Hata H, Nakamori M, Hara H, Yasui H, Katayama H, Fukuda H, Yoshikawa T, Sasako M, Terashima M: Lancet Gastroenterol Hepatol 2019/7; 4 (7): 501-10. (@q1: 1Á»íà)
110078. [Ž] Stent-induced symptomatic pancreatic duct stricture after endoscopic prophylactic pancreatic duct stent placement for the normal pancreas. Adachi K1, Yamauchi H2,3, Kida M2,4, Okuwaki K2, Iwai T2, Tadehara M1, Uehara K2,4, Nakatani S2, Imaizumi H2, Koizumi W2: Pancreatology 2019/7; 19 (5): 665-71. (ÀB@õ11, Rà_j2,3, ØcõL2,4, e»î2, âämv2, äøŽ«Ç1, ãŽê¿2,4, Jªá2, ¡ò@O2, ¬òaOY2: 1åw@ãÃn€È, 2Á»íà, 3~œ, 4k¢åwfBJZ^[)
110079. [Ž] Complications of Long-Term Indwelling Transmural Double Pigtail Stent Placement for Symptomatic Peripancreatic Fluid Collections. Complications of Long-Term Indwelling Transmural Double Pigtail Stent Placement for Symptomatic Peripancreatic Fluid Collections. Yamauchi H1,2, Iwai T2, Kida M2,3, Okuwaki K2, Kurosu T2, Watanabe M2, Adachi K4, Tadehara M4, Imaizumi H2, Koizumi W2: Dig Dis Sci 2019/7; 64 (7): 1976-84. (Rà_j1,2, âämv2, ØcõL2,3, e»î2, {M_2, nÓ^è2, ÀB@õ4, äøŽ«Ç4, ¡ò@O2, ¬òaOY2: 1~œ, 2Á»íà, 3k¢åwfBJZ^[, 4åw@ãÃn€È)
110080. [Ž] Predictors of invasive cancer of large laterally spreading colorectal tumors: A multicenter study in Japan. Kobayashi K1,2,3, Tanaka S1, Murakami Y1, Ishikawa H1, Sada M1,3, Oka S1, Saito Y1, Iishi H1, Kudo S1, Ikematsu H1, Igarashi M1, Saitoh Y1, Inoue Y1, Hisabe T1, Tsuruta O1, Sano Y1, Yamano H1, Shimizu S1, Yahagi N1, Matsuda K1, Nakamura H1, Fujii T1, Sugihara K1 (1the Colorectal Endoscopic Resection Standardization Implementation Working Group of the Japanese Society for Cancer of the Colon and Rectum): JGH Open 2019/7; 4 (1): 83-9 (¬ÑŽT1,2,3, ²cüa1,3: 2V¢IãÃE¡fIãÃ, 3Á»íà)
110081. [Ž] Transpapillary Biliary Cannulation is Difficult in Cases with Large Oral Protrusion of the Duodenal Papilla. Watanabe M1, Okuwaki K1, Kida M1,2, Imaizumi H1, Yamauchi H1,3, Kaneko T1, Iwai T1, Hasegawa R1, Miyata E1, Masutani H4, Tadehara M4, Adachi K4, Koizumi W1: Dig Dis Sci 2019/8; 64 (8): 2291-9. (nÓ^è1, e»î1, ØcõL1,2, ¡ò@O1, Rà_j1,3, àq@1, âämv1, ·JìÍç1, {cp¡1, ¡J°È4, äøŽ«Ç4, ÀB@õ4, ¬òaOY1: 1Á»íà, 2k¢åwfBJZ^[, 3~œ, 4åw@ãÃn€È)
110082. [Ž] Efficacy of Endoscopic Resection and Selective Chemoradiotherapy for Stage I Esophageal Squamous Cell Carcinoma. Minashi K, Nihei K, Mizusawa J, Takizawa K, Yano T, Ezoe Y, Tsuchida T, Ono H, Iizuka T, Hanaoka N, Oda I, Morita Y, Tajika M, Fujiwara J, Yamamoto Y, Katada C1, Hori S, Doyama H, Oyama T, Nebiki H, Amagai K, Kubota Y, Nishimura K, Kobayashi N, Suzuki T, Hirasawa K, Takeuchi T, Fukuda H, Muto M: Gastroenterology 2019/8; 157 (2): 382-90.e3. (ce1: 1Á»íà)
110083. [Ž] Middle-term prognosis in patients with ulcerative colitis who achieved clinical and endoscopic remission by budesonide rectal foam. Naganuma M1, Hirai F1, Kobayashi K1,2,3, Watanabe K1, Takeuchi K1, Aoyama N1, Nozawa H1, Motoya S1, Ohmori T1, Harada A1, Nagai Y1, Abe T1, Yamada Y1, Inagaki K1, Shimizu N1, Kanai T1, Watanabe M1 (1ESCORT study Group): PLoS One 2019/8; 14 (8): e0220413. (¬ÑŽT1,2,3: 2V¢IãÃE¡fIãÃ, 3Á»íà)
110084. [Ž] Gene expression profiles of genes related to canceration, invasion or conversion for metastasis in patients with poorly differentiated gastric adenocarcinoma treated by gastric endscopic submucosal dissection. Kawanishi N1, Azuma M1, Takeuchi A1, Yamane S1, Ishido K1, Katada C1, Tanabe S1,2, Yoshida T3, Koizumi W1: Kitasato Med J 2019/9; 49 (2): 125-33. (ÍŒÞÃq1, @q1, |àÖq1, RªIq1, Î˪ 1, ce1, cç³@1,2, gc@÷3, ¬òaOY1: 1Á»íà, 2V¢IãÃEæ[ãÃ, 3a)
110085. [Ž] Usefulness of serum lipase for early diagnosis of post-endoscopic retrograde cholangiopancreatography pancreatitis. Tadehara M1, Okuwaki K2, Imaizumi H2, Kida M2, Iwai T2, Yamauchi H2,3, Kaneko T2, Hasegawa R2, Miyata E2, Kawaguchi Y2, Masutani H1, Koizumi W2: World J Gastrointest Endosc 2019/9; 11 (9): 477-85. (äøŽ«Ç1, e»î2, ¡ò@O2, ØcõL2, âämv2, Rà_j2,3, àq@2, ·JìÍç2, {cp¡2, ìûCã2, ¡J°È1, ¬òaOY2: 1åw@ãÃn€È, 2Á»íà, 3~œ)
110086. [Ž] Sex differences in the safety of S-1 plus oxaliplatin and S-1 plus cisplatin for patients with metastatic gastric cancer. Yamada Y, Koizumi W1, Nishikawa K, Gotoh M, Fuse N, Sugimoto N, Nishina T, Amagai K, Chin K, Niwa Y, Tsuji A, Imamura H, Tsuda M, Yasui H, Fujii H, Yamaguchi K, Yasui H, Hironaka S, Shimada K, Hyodo I: Cancer Sci 2019/9; 110 (9): 2875-83. (¬òaOY1: 1Á»íà)
110087. [Ž] Objective evaluation of the visibility of colorectal lesions using eye tracking. Kumahara K1, Ikematsu H1, Shinmura K1, Murano T1, Inaba A1, Okumura K1, Nishihara K1, Sunakawa H1, Furue Y1,2, Ito R1, Sato D1, Minamide T1, Okamoto N1, Yamamoto Y1, Suyama M1, Takashima K1, Nakajo K1, Yoda Y1, Hori K1, Oono Y1, Yano T1 (1Department of Gastroenterology and Endoscopy, National Cancer Center Hospital East): Dig Endosc 2019/9; 31 (5): 552-7. (Ã]NŸ1,2: 2Á»íà)
110088. [Ž] Comparison of the histopathological characteristics of large colorectal laterally spreading tumors according to growth pattern. Saito T1, Kobayashi K1,2, Sada M1, Matsumoto Y1, Mukae M1, Kawagishi K1, Yokoyama K1, Koizumi W1, Saegusa M3, Murakami Y: J Anus Rectum Colon 2019/10; 3 (4): 152-9. (âV¡öÆ1, ¬ÑŽT1,2, ²cüa1, Œ{çG1, }@üK1, ìÝÁÞ1, ¡R@O1, ¬òaOY1, O}@M3: 1Á»íàÈ, 2V¢IãÃE¡fIãÃ, 3a)
110018. [Ž] Thromboxane A 2 receptor signaling in endothelial cells attenuates monocrotaline-induced liver injury. Otaka F1, Ito Y2, Inoue T3, Ohkubo H4, Nishizawa N5, Kojo K6, Betto T3, Yamane S3, Narumiya S, Koizumi W3, Majima M2: Toxicol Appl Pharmacol 2019/10; 381: 114733. (åj¹1, É¡`ç2, äãqm3, åvÛ¢4, ŒàVL±5, Ãé@6, ÊácüL3, RªIq3, ¬òaOY3, n³²2: 1åw@ãÃn€È, 2ò, 3Á»íà, 4SÇO, 5êÊE¬EÌ_äXO, 6ºÁ»ÇO)
110089. [Ž] Randomized, phase II trial of sequential hepatic arterial infusion chemotherapy and sorafenib versus sorafenib alone as initial therapy for advanced hepatocellular carcinoma: SCOOP-2 trial. Kondo M, Morimoto M, Kobayashi S, Ohkawa S, Hidaka H1, Nakazawa T1, Aikata H, Hatanaka T, Takizawa D, Matsunaga K, Okuse C, Suzuki M, Taguri M, Ishibashi T, Numata K, Maeda S, Tanaka K: BMC Cancer 2019/10; 19 (1): 954. (ú@1, àVMG1: 1Á»íà)
110090. [Ž] Impact of the Charlson Comorbidity Index on the treatment strategy and survival in elderly patients after non-curative endoscopic submucosal dissection for esophageal squamous cell carcinoma: a multicenter retrospective study. Nakajo K, Abe S, Oda I, Ishihara R, Tanaka M, Yoshio T, Katada C1, Yano T: J Gastroenterol 2019/10; 54 (10): 871-80. (ce1: 1Á»íà)
110091. [Ž] Evaluation of 8-week glecaprevir/pibrentasvir treatment in direct-acting antiviral-na?ve noncirrhotic HCV genotype 1 and 2infected patients in a real-world setting in Japan. Ikeda H, Watanabe T, Atsukawa M, Toyoda H, Takaguchi K, Nakamuta M, Matsumoto N, Okuse C, Tada T, Tsutsui A, Yamashita N, Kondo C, Hayama K, Kato K, Itokawa N, Arai T, Shimada N, Asano T, Uojima H1, Ogawa C, Mikami S, Ikegami T, Fukunishi S, Asai A, Iio E, Tsubota A, Hiraoka A, Nozaki A, Okubo H, Tachi Y, Moriya A, Oikawa T, Matsumoto Y, Tsuruoka S, Tani J, Kikuchi K, Iwakiri K, Tanaka Y, Kumada T: J Viral Hepat 2019/11; 26 (11): 1266-75. (°I1: 1Á»íà)
110092. [Ž] An international, multi-institution survey of the use of EUS in the diagnosis of pancreatic cystic lesions. Ge N, Brugge WR, Saxena P, Sahai A, Adler DG, Giovannini M, Pausawasdi N, Santo E, Mishra G, Tam W, Kida M1,2, de la Mora-Levy JG, Sharma M, Umar M, Katanuma A, Lee L, Garg PK, Eloubeidi MA, Yu HK, Raijman I, Arturo Arias BL, Bhutani M, Carrara S, Rai P, Mukai S, Palazzo L, Dietrich CF, Nguyen NQ, El-Nady M, Poley JW, Guaraldi S, Kalaitzakis E, Sabbagh LC, Lari?o-Noia J, Gress FG, Lee YT, Rana SS, Fusaroli P, Hocke M, Dhir V, Lakhtakia S, Ratanachu-Ek T, Chalapathi Rao AS, Vilmann P, Okasha HH , Irisawa A, Ponnudurai R, Leong AT, Artifon E, Iglesias-Garcia J, Saftoiu A, Larghi A, Robles-Medranda C, Sun S: Endosc Ultrasound 2019/11-12; 8 (6): 418-27. (ØcõL1,2: 1k¢åwfBJZ^[, 2Á»íà)
110093. [Ž] On-site stereomicroscope quality evaluations to estimate white core cutoff lengths using EUS-FNA biopsy sampling with 22-gauge needles. Masutani H1, Okuwaki K2, Kida M2,3, Yoshida T4, Imaizumi H2, Yamauchi H2,5, Iwai T2, Kaneko T2, Hasegawa R2, Miyata E2, Koizumi W2: Gastrointest Endosc 2019/12; 90 (6): 947-56. (¡J°È1, e»î2, ØcõL2,3, gc@÷4, ¡ò@O2, Rà_j2,5, âämv2, àq@2, ·JìÍç2, {cp¡2, ¬òaOY2: 1åw@ãÃn€È, 2Á»íà, 3k¢åwfBJZ^[, 4a, 5~œ)
110094. [Ž] Endoscopic Balloon Dilation for Benign Bilioenteric Stricture: Outcomes and Factors Affecting Recurrence. Yamauchi H1,2, Kida M2,3, Miyata E2, Okuwaki K2, Iwai T2, Minato N2, Tadehara M4, Watanabe M2, Imaizumi H2, Koizumi W2: Dig Dis Sci 2019/12; 64 (12): 3557-67. (Rà_j1,2, ØcõL2,3, {cp¡2, e»î2, âämv2, ©@®M2, äøŽ«Ç4, nÓ^è2, ¡ò@O2, ¬òaOY2: 1~œ, 2Á»íà, 3k¢åwfBJZ^[, 4åw@ãÃn€È)
110095. [Ž] A clinical trial to assess the feasibility and efficacy of nab-paclitaxel plus gemcitabine for elderly patients with unresectable advanced pancreatic cancer. Hasegawa R1, Okuwaki K1, Kida M1,2, Yamauchi H1,3, Kawaguchi Y1, Matsumoto T1, Kaneko T1, Miyata E1, Uehara K1,2, Iwai T1, Watanabe M1, Kurosu T1, Imaizumi H1, Ohno T4, Koizumi W1: Int J Clin Oncol 2019/12; 24 (12): 1574-81. (·JìÍç1,e»î1, ØcõL1,2, Rà_j1,3, ìûCã1, Œ{Ÿ1, àq@1, {cp¡1, ãŽê¿1,2, âämv1, nÓ^è1, {M_1, ¡ò@O1, åì@²4, ¬òaOY1: Á»íà, 2k¢åwfBJZ^[, 3~œ, 4ÉšŽŠ¯a@)
110096. [Ž] Usefulness of autotaxin for the complications of liver cirrhosis. Shao X1, Uojima H1, Setsu T, Okubo T, Atsukawa M, Furuichi Y, Arase Y, Hidaka H1, Tanaka Y1, Nakazawa T1, Kako M, Kagawa T, Iwakiri K, Terai S, Koizumi W1: World J Gastroenterol 2020/1; 26 (1): 97-108. (Xue Shao1, °I1, ú@1, c«Ÿ1, àVMG1,¬òaOY1: 1Á»íà)
110097. [Ž] Meta-analysis of two randomized phase III trials (TCOG GI-0801 and ECRIN TRICS) of biweekly irinotecan plus cisplatin versus irinotecan alone as second-line treatment for advanced gastric cancer. Nishikawa K, Koizumi W1, Tsuburaya A, Yamanaka T, Morita S, Fujitani K, Akamaru Y, Shimada K, Hosaka H, Nakayama N, Tsujinaka T, Sakamoto J: Gastric Cancer 2020/1; 23 (1): 160-7. (¬òaOY1: 1Á»íà)
110098. [Ž] Early Changes in Circulating FGF19 and Ang-2 Levels as Possible Predictive Biomarkers of Clinical Response to Lenvatinib Therapy in Hepatocellular Carcinoma. Chuma M, Uojima H1, Numata K, Hidaka H1, Toyoda H, Hiraoka A, Tada T, Hirose S, Atsukawa M, Itokawa N, Arai T, Kako M, Nakazawa T1, Wada N1, Iwasaki S1, Miura Y, Hishiki S, Nishigori S, Morimoto M, Hattori N, Ogushi K, Nozaki A, Fukuda H, Kagawa T, Michitaka K, Kumada T, Maeda S: Cancers (Basel) 2020/1; 12 (2): 293. (°I1,ú@1, àVMG1, ac®v1, âèGêY1: 1Á»íà)
110099. [Ž] Furosemide Dose Changes Associated with Furosemide/Tolvaptan Combination Therapy in Patients with Cirrhosis. Uojima H1, Hidaka H1, Tanaka Y1, Wada N1, Kubota K1, Nakazawa T1, Shibuya A1,2, Sung JH, Kako M, Koizumi W1: Dig Dis 2020/1; 38 (1): 38-45. (°I1, ú@1, c«Ÿ1, ac®v1, EcKî1, àVMG1, aJŸ²1,2, ¬òaOY1: 1Á»íà, 2ãÃÇ)
110100. [Ž] Prediction of lymph-node metastasis and lymphatic invasion of superficial pharyngeal cancer on narrow band imaging with magnifying endoscopy. Katada C1, Okamoto T2, Ichinoe M3, Sakamoto Y4, Kano K2, Hosono H2, Miyamoto S2, Tanabe S1,5, Koizumi W1, Yamashita T2: Auris Nasus Larynx 2020/2; 47 (1): 128-34. (ce1, ª{·l2, ê˹Ÿ3, â{×4, Á[Fê2, ×ì_j2, {{rã2, cç³@1,5, ¬òaOY1, Rº@ñ2: 1Á»íà, 2š@ôAEªèòO, 3a, 4Õ°€EvWFNg, 5V¢IãÃEæ[ãÃ)
110101. [Ž] Surgical outcomes of elderly patients with Stage I gastric cancer from the nationwide registry of the Japanese Gastric Cancer Association. Nunobe S1, Oda I1, Ishikawa T1, Akazawa K1, Katai H1, Isobe Y1, Miyashiro I1, Tsujitani S1, Ono H1, Tanabe S1,2,3, Fukagawa T1, Suzuki S1, Kakeji Y1 (1Registration Committee of the Japanese Gastric Cancer): Gastric Cancer 2020/3; 23 (2): 328-38. (cç³@1,2,3: 2V¢IãÃEæ[ãÃ, 3Á»íà)
210002. [Ž] The large-balloon occlusion technique: A new method for conversion to EUS-guided hepaticogastrostomy in patient with prior self-expanding metal stent placement The large-balloon occlusion technique: A new method for conversion to EUS-guided hepaticogastrostomy in patient with prior self-expanding metal stent placement. Okuwaki K1, Yamauchi H1,2, Kida M1,3, Imaizumi H1, Matsumoto T1, Tadehara M4, Iwai T1, Kaneko T1, Hasegawa R1, Miyata E1, Koizumi W1: Endosc Ultrasound 2019/5-6; 8 (3): 209-10. (e»î1, Rà_j1,2, ØcõL1,3, ¡ò@O1, Œ{Ÿ1, äøŽ«Ç4, âämv1, àq@1, ·JìÍç1, {cp¡1, ¬òaOY1: 1Á»íà, 2~œ, 3k¢åwfBJZ^[, 4åw@ãÃn€È)
210003. [Ž] The effectiveness and safety of glecaprevir/pibrentasvir in chronic hepatitis C patients with refractory factors in the real world: a comprehensive analysis of a prospective multicenter study. Nozaki A1, Atsukawa M1, Kondo C1, Toyoda H1, Chuma M1, Nakamuta M1, Uojima H1,2, Takaguchi K1, Ikeda H1, Watanabe T1, Ogawa S1, Itokawa N1, Arai T1, Hiraoka A1, Asano T1, Fujioka S1, Ikegami T1, Shima T1, Ogawa C1, Akahane T1, Shimada N1, Fukunishi S1, Abe H1, Tsubota A1, Genda T1, Okubo H1, Mikami S1, Morishita A1, Moriya A1, Tani J1, Tachi Y1, Hotta N1, Ishikawa T1, Okanoue T1, Tanaka Y1, Kumada T1, Iwakiri K1, Maeda S1 (1KTK49 Liver Study Group): Hepatol Int 2020/3; 14 (2): 225-38. (°I1,2: 2Á»íà)
210004. [Ž] ALBI-U grading, which integrates albumin-bilirubin grade (ALBI) and the up-to-seven criteria (UTS), is a simple and useful prognostic prediction model for a small patient group with hepatocellular carcinoma (HCC): a single-center, retrospective analysis. Watanabe M1,2, Yokomori H2,3: Turk J Gastroenterol 2019/9; 30 (Suppl 3): S234-6. (nç²^²1,2, ¡XOº2,3: 1Á»íà, 2k¢åwfBJZ^[, 3fÃ)
310005. [Çáñ] A suspected case of Clostridium perfringens sepsis with intravascular hemolysis after transhepatic arterial chemoembolization: a case report. Uojima H1, Onoue M1, Hidaka H1, Wada N1, Tanaka Y1, Inoue T1, Kubota K1, Nakazawa T1, Shibuya A1,2, Koizumi W1: J Med Case Rep 2019/4; 13 (1): 125. (°I1, öãüb1, ú@1. ac®v1, c«Ÿ1, äãqm1, EcKî1, àVMG1, aJŸ²1,2, ¬òaOY1: 1Á»íà, 2ãÃÇ)
310006. [Çáñ] Hepatic methotrexate-associated lymphoproliferative disorders identified by multiple liver tumors: a case report and review of the literature. Ono R, Kumagae T, Uojima H1,2, Teshima S, Kudo M, Kitagawa I, Yoshizawa M: J Med Case Rep 2019/6; 13 (1): 196. (°I1,2: 1Á»íà, 2Ãìqa@)
310007. [Çáñ] Comparison of narrow-band imaging, volumetric laser endomicroscopy, and pathologic findings in Barrett's esophagus. Comparison of Narrow Band Imaging, Volumetric Laser Endomicroscopy and Pathological Findings in Barrett's Esophagus. Katada C1, Pai RK, Fukami N: VideoGIE 2019/7; 4 (7): 319-22. (ce1: 1Á»íà)
310008. [Çáñ] Pancreatic granular cell tumor diagnosed by endoscopic ultrasound-guided fine needle aspiration biopsy. Krutsri C, Iwai T1, Kida M1,2, Imaizumi H1, Kawano T1, Tadehara M3, Watanabe M1, Okuwaki K1, Yamauchi H1,4, Koizumi W1: Clin J Gastroenterol 2019/8; 12 (4): 347-54. (âämv1, ØcõL1,2, ¡ò@O1, ììæ1, äøŽ«Ç3, nÓ^è1, e»î1, Rà_j1,4, ¬òaOY1: 1Á»íà, 2k¢åwfBJZ^[, 3åw@ãÃn€È, 4~œ)
310009. [Çáñ] A case of extrahepatic bile duct cancer with distant metastases showing pathological complete response to treatment combining gemcitabine and cisplatin. Adachi K1, Okuwaki K2, Nishiyama R2, Kida M2,3, Imaizumi H2, Iwai T2, Yamauchi H2,4, Kaneko T2, Hasegawa R2, Miyata E2, Kumamoto Y5, Koizumi W2: Clin J Gastroenterol 2019/10; 12 (5): 466-72. (ÀB@õ1, e»î2, ŒR@³2, ØcõL2,3, ¡ò@O2, âämv2, Rà_j2,4, àq@2, ·JìÍç2, {cp¡2, G³Yî5, ¬òaOY2: 1åw@ãÃn€È, 2Á»íà, 3k¢åwfBJZ^[, 4~œ, 5êÊE¬EÌ_äXO)
310010. [Çáñ] Ischemic pancreatitis with infected walled-off necrosis with a colonic fistula after cardiopulmonary bypass successfully treated by endoscopic ultrasound-guided drainage. Masuda S1, Koizumi K1, Uojima H1,2, Tazawa T1, Tasaki J1, Ichita C1, Nishino T1, Kimura K1 Sasaki A1, Egashira H1, Kako M1: Clin J Gastroenterol 2020/2; 13 (1): 127-33. (°I1,2: 1Á»íà, 2Ãìqa@)
320001. [Çáñ] àŸIûªØpÉÄffµŸœûª_oàªåîáÌêá. œÇÑ1, ìûCã1,2, áÁDì1,2, ãŽê¿1,2, åËra1,2, cŽvüq1, nç²^²1,2, ØcõL1,2 (1k¢åwfBJZ^[, 2Á»íà): Progress of Digestive Endoscopy 2019/6; 94 (1): 81-3.
320002. [Çáñ] L¿ûÅ°ðÛES¡üðFßœ×á«å°ÌêÇá. O}zê1, ¡ò@O1, à@ŸN, ÎèY, Á¡@Ê, Köèm, OŽ·, Œ³âX1, åäc³l1 (1Á»íà): Progress of Digestive Endoscopy 2019/6; 94 (1): 119-21.
320003. [Çáñ] EUSÅáGR[îáƵÄ`oÂ\Å ÁœäXãçààÌ1á. áÁDì1,2, ãŽê¿1,2, œÇÑ2, ìûCã1,2, åËra1,2, cŽvüq2, nç²^²1,2, ØcõL1,2 (1Á»íà, 2k¢åwfBJZ^[): Progress of Digestive Endoscopy 2019/6; 94 (1): 149-51.
320004. [Çáñ] EUS-FNBÉÄaff🜜«îÌäX]ÚÌ1á. ²ìBÆ1, e»î1, ØcõL1,2, ©@®M1, ŒŽÀØ, {cp¡1, ·JìÍç1, àq@1, Rà_j1,3, âämv1, ¡ò@O1, ¬òaOY1 (1Á»íà, 2k¢åwfBJZ^[, 3~œ): Progress of Digestive Endoscopy 2019/6; 94 (1): 155-7.
320005. [Çáñ] äXÇàÉÞµœŽ¹gàŸæð浜äX_oàªåîáÌ1á. ÊuŸ°1, e»î1, ØcõL1,2, {M_1, ©@®M1, nÓ^è1, Jªá1, {cp¡1, Œ{Ÿ1, ·JìÍç1, àq@1, Rà_j1,3, âämv1, ¡ò@O1, ¬òaOY1 (1Á»íà, 2k¢åwfBJZ^[, 3~œ): Progress of Digestive Endoscopy 2019/6; 94 (1): 161-3.
320006. [Çáñ] pOffª¢ïÅ ÁœäX÷t«XEBîÌ1á. Œº¹T1, ·JìÍç1, {cp¡1, àq@1, Rà_j1,2, e»î1, âämv1, ¡ò@O1, CÃMj3, G³Yî3, ØcõL1,4, ¬òaOY1 (1Á»íà, 2~œ, 3êÊE¬EÌ_äXO, 4k¢åwfBJZ^[): Progress of Digestive Endoscopy 2019/6; 94 (1): 167-9.
510003. [à] Current status of endoscopic retrograde cholangiopancreatography in patients with surgically altered anatomy. Krutsri C, Kida M1,2, Yamauchi H1,3, Iwai T1, Imaizumi H1, Koizumi W1: World J Gastroenterol 2019/7; 25 (26): 3313-33. (ØcõL1,2, Rà_j1,3, âämv1, ¡ò@O1, ¬òaOY1: 1Á»íà, 2k¢åwfBJZ^[, 3~œ)
510004. [à] Recent innovations in therapeutic endoscopy for pancreatobiliary diseases. Irisawa A, Miyoshi H, Itoi T, Ryozawa S, Kida M1,2, Inui K: Dig Endosc 2020/3; 32 (3): 309-15. (ØcõL1,2: 1k¢åwfBJZ^[, 2Á»íà)
520003. [à]y嬳ŽiÇup to datez嬳ŽiÇÉηéàŸI¡Ã. ú@1, °I1, ªÎ (1Á»íà): ú{Á»íawïG 2019/5; 116 (5): 395-403.
520004. [à]yåè: ×á«å°ÖAîá|ffE¡ÃÌ»óÆÛèzÊíàŸÉæé×á«å°ÖAîáffÌ»óÆÛè. ¬ÑŽT1,2, ààV@2, ÊácüL2, ìÝÁÞ2, }@üK2, ¡R@O2, ²cüa2, ¬òaOY2 (1V¢IãÃE¡fIãÃ, 2Á»íà): ÝÆ° 2020/2; 55 (2): 133-41.
522015. [uÀ]yÀkï: ¡IBDNjJJt@X æ2ñzXeChïR«dÇUCÍÇÌæ€Éf÷׫©. ¡R@O1, åXSœ, gàV@É, C€u, Rº^K (1Á»íà): IBDNjJJt@X 2019/5; 1 (2): 47-58.
522016. [uÀ]y±ñÈÉ éòÜ«Á»ÇQz[e_] 3. ¬°šæÑå°@S-1ÉæéÁ»ÇQ. }@üK1, ¬ÑŽT1,2, ÊácüL1, ìÝÁÞ1, ¡R@O1, ²cüa1, ¬òaOY1 (1Á»íà, 2V¢IãÃE¡fIãÃ): Á»íàŸ 2019/6; 31 (6): 934-8.
522017. [uÀ]yÁW: Ç«°Ÿ³fÃÌupdate| ffE¡ÃÌÅVm©zÇ«°Ÿ³Ìž@: Xüž. ¡R@O (Á»íà): Õà¬Á»íàÈ 2019/6; 34 (7): 736-40.
522018. [uÀ]ypãàŸfÃÌ·×Äz[e_] 1. Á»íèpãÌàŸž|T[xCXÆÙ«aÏÌff|@Ç«°Ÿ³èpãÌàŸž. ¬ÑŽT1,2, ÊácüL2, ìÝÁÞ2, }@üK2, ¡R@O2, ²cüa2, ¬òaOY2 (1V¢IãÃE¡fIãÃ, 2Á»íà): Á»íàŸ 2019/9; 31 (9): 1318-23.
522019. [uÀ]yuÀ: IBDÌXyVV`
G[VðÇ€fé©?zæ1ñ@DPEoYðó]·éIBD³Ò³ñðÇ€fé©?|»Ì2|. ¡R@O (Á»íà): IBD Research 2019/9; 13 (3): 173-6.
522020. [uÀ]yÁW: Á»íXegÌ»µÆÛèz3. Interventional EUSÉæéXeg¯u. ØcõL1,2, nÓ^è2, {M_2, ãŽê¿1,2, ìûCã1,2, ·JìÍç2, {cp¡2, àq@2, Rà_j2,3, e»î2, âämv2, ¡ò@O2, (1k¢åwfBJZ^[, 2Á»íà, 3~œ): Õà¬Á»íàÈ 2019/9; 34 (10): 1285-94.
522021. [uÀ]y·×Īí©éIBDÌàŸz[e_] ×á«å°ÌàŸ@dÇx]¿ÆS¡ÃÌ»è. ¡R@O1, ¬ÑŽT1,2, ÊácüL1, ìÝÁÞ1, }@üK1, ²cüa1, ¬òaOY1 (1Á»íà, 2V¢IãÃE¡fIãÃ): Á»íàŸ 2020/2; 32 (2): 206-12.
522022. [uÀ]yAÚ: ESDÌÀÛ (65)zNBIgåàŸðp¢œàŸÏ@Æúå°àESDî{èZ. Ã]NŸ1,2, ºì³N1, Vºî1, rŒON1 (1§ªñ€Z^[a@, 2Á»íà): Á»íÌÕ° 2020/2; 23 (1): 54-9.
522023. [uÀ]yÁW: EUSÌ»óÆ«z¡Ã@6. EUSKChºäXÇhi[W. âämv1, ØcõL1,2, e»î1, Rà_j1,3, àq@1, ·JìÍç1, nÓ^è1, {M_1, ¡ò@O1, ¬òaOY1 (1Á»íà, 2k¢åwfBJZ^[, 3~œ): Ì_äX 2020/3; 80 (3): 503-10.
522024. [uÀ]y_äXàŸ¡ÃÉš¯éguV
[eBOz1. ERCPÖA¡ÃÉš¯éôÇ\hÆguV
[eBO@o[àŸðp¢œERCPÖA¡ÃÌRcÆôÇÎô. Rà_j1,2, ØcõL2,3, âämv2, e»î2, ·JìÍç2, ¡ò@O2, ¬òaOY2 (1~œ, 2Á»íà, 3k¢åwfBJZ^[k¢åwfBJZ^[): Á»íàŸ 2020/3; 32 (3): 408-13.
[@]
610005. [wp (ªS·M)]yThe Evolving Landscape of Liver Cirrhosis ManagementzChapter 11: Esophagogastric Varices in Liver Cirrhosis, p.131-9. Hidaka H1, Uojima H1, Eds: Yoshiji H, Kaji K, Springer, Japan, 2019/8. (ú@1, °I1: 1Á»íà)
620008. [wp (ªS·M)]yÁ»ÇŸ³ÌªÞ2019|g¢û, gíêû (ÝÆ°2019N5§)z¡¬°Eå°@Crohna@CDEIS (àŸ©ÉæéªÞ), p.724. ¬ÑŽT1,2 (1V¢IãÃE¡fIãÃ, 2Á»íà), ãw@, , 2019/5s.
620009. [wp (ªS·M)]yÁ»ÇŸ³ÌªÞ2019|g¢û, gíêû (ÝÆ°2019N5§)z¡¬°Eå°@Crohna@SES-CD (àŸ©ÉæéªÞ), p.725. ¬ÑŽT1,2 (1V¢IãÃE¡fIãÃ, 2Á»íà), ãw@, , 2019/5s.
620010. [wp (ªS·M)]yÁ»ÇŸ³ÌªÞ2019|g¢û, gíêû (ÝÆ°2019N5§)z¡¬°Eå°@Crohna@Rutgeerts score (àŸ©ÉæéªÞ), p.726 ¬ÑŽT1,2 (1V¢IãÃE¡fIãÃ, 2Á»íà), ãw@, , 2019/5s.
620011. [wp (ªS·M)]y±êŸ¯ÍÇñÅš«œ¢!@Á»íãÌœßÌdv_¶240Ñ <Ç«°Ÿ³Ò>zoßE\ã@Q195. ¬úÇÌIBDÍSŠªŒ€©·éÌ©?, p.204. Q196. UCÉš¯éå°àÌ»pxÍ?, p.205. Q197. UCÉš¯éKØÈT[xCXÌûüÍ?, p.206. Q198. UCÉš¯éå°à̶ŠÍ?, p.207. Q199. ±Ì30NÔÅIBDÉš¯éå°àÌXNÍžµœÌ©?, p.208. ¡R@O (Á»íà), ÒWå²: Œ{åV, V[r[A[, , 2019/11s.
620012. [wp (ªS·M)]yÌdÏ¡Ã}j
A@GLXp[gÌRcƳ¶Ážzæ3Í ¹Ç¡ÃÌRcƳ¶Áž@3. Á»Ço (H¹Ýìá, PHG), p.140-6. ú@ (Á»íà), Ò: g¡mu, ì]°, , 2019/12s.
620013. [wp (ªS·M)]yÁ»ÇÇóQ (æ3Å) II|»ÌŒÌÁ»ÇŸ³ðÜßÄ| (Êûú{Õà¬@ÌæÊÇóQV[Y No.10)zIV. @1. ŽõÇ@(1) j, p.197-8. ¬ÑŽT1,2, ¡R@O2, ²cüa2, ¬òaOY2 (1V¢IãÃE¡fIãÃ, 2Á»íà), ú{Õà¬Ð, , 2020/2s.
[wïE€ï]
712003. [wï (Û)] (µÒu)yLuncheon Symposium FujifilmzOiagnostic EUS`Basic and application to clinical practice`. Iwai T1: Asian EUS Congress 2019 (2019/4/13), Tokyo, Japan. (âämv1: 1Á»íà)
712004. [wï (Û)] (µãÙu) Diagnostic EUS for pancreatobiliary disease. Iwai T1: æ16ñÁ»íàŸwï (2019/6/22), Yangzhou, China. (âämv1: 1Á»íà)
712005. [wï (Û)] ([NVbv) BONASTENT M-Intraductal for benign biliary strictures. Iwai T1: úØ_äXàŸfÃ[NVbv (2019/12/6), Korea. (âämv1: 1Á»íà)
713011. [wï (Û)] (|X^[) A new method of sample isolation processing by stereo microscopy for improve tissue diagnosis performance in EUS-FNA. Okuwaki K1, Kida M1,2, Masutani H3, Imaizumi H1,4, Iwai T1, Yamauchi H1,5, Kaneko T1, Hasegawa R1, Miyata E1, Watanabe M1, Minato N1, Kurosu T1, Koizumi W1: Asian EUS Congress 2019 (2019/4/12), Tokyo, Japan. (e»î1, ØcõL1, ¡J°È3, ¡ò@O1,4, âämv1, Rà_j1,5, àq@1, ·JìÍç1, {cp¡1, nç²^è1, ©@®M1, {M_1, ¬òaOY1: 1Á»íà, 2k¢åwfBJZ^[, 3åw@ãÃn€È, 4Íìa@, 5~œ)
713012. [wï (Û)] (êÊû) Role of Forward-Viewing EUS. Imaizumi H1,2, Iwai T2, Okuwaki K2, Yamauchi H1,3, Kaneko T2, Hasegawa R2, Miyata E2, Kida M2,4, Koizumi W2: Asian EUS Congress 2019 (2019/4/12), Tokyo, Japan. (¡ò@O1,2, âämv2, e»î2, Rà_j1,3, àq@2, ·JìÍç2, {cp¡2, ØcõL2,4, ¬òaOY2: 1Íìa@, 2Á»íà, 3~œ, 4k¢åwfBJZ^[)
713013. [wï (Û)] (|X^[) EUS hands-on training in a small-scale hospital- Examination with learning curve analysis. Ishizaki J1, Imaizumi H1,2, Kim M1, Saegusa Y1, Watanabe M2, Kurosu T2, Miyata E2, Hasegawa R2, Kaneko T2, Yamauchi H2,3, Okuwaki K2, Iwai T2, Kida M2,4: Asian EUS Congress 2019 (2019/4/12), Tokyo, Japan. (¡ò@O1,2, nÓ^è2, {M_2, {cp¡2, ·JìÍç2, àq@2, Rà_j2,3, e»î2, âämv2, ØcõL2,4: 1Íìa@, 2Á»íà, 3~œ, 4k¢åwfBJZ^[)
713014. [wï (Û)] (êÊû) Role of EUS in the Management of Colorectal Lesions. Kobayashi K1,2: Asian EUS Congress 2019 (2019/4/12), Tokyo, Japan. (¬ÑŽT1,2: 1V¢IãÃE¡fIãÃ, 2Á»íà)
713015. [wï (Û)] (êÊu) Balloon enteroscopy assisted ERCP and EUS-guided biliary drainage in patients with surgically altered gastrointestinal anatomy. Iwai T1: Asian EUS Congress 2019 (2019/4/13), Tokyo, Japan. (âämv1: 1Á»íà)
713016. [wï (Û)] (|X^[) Technical feasibility of ESD for superficial esophageal squamous cell carcinoma (SESCC) on the scar of the previous endoscopic resection (ER). Furue Y1, Yoda Y, Hori K, Nakajo K, Ito R, Sato D, Minamide T, Suyama M, Yamamoto Y, Takashima K, Shinmura K, Ikematsu H, Yano T: DDW2019 (ÄÁ»íaTÔ) (2019/5/18), San Diego, USA. (Ã]NŸ1: 1Á»íà)
713017. [wï (Û)] (êÊu) Clinical significance and problems related to the diagnosis of early colorectal cancer on endoscopic ultrasonography. Kobayashi K1,2, Kawagishi K2, Mukae M2, Yokoyama K2, Kubota M2, Koizumi W2: DDW 2019 (ÄÁ»íaTÔ) (2019/5/18-21), San Diego, USA. (¬ÑŽT1,2, ìÝÁÞ2, }@üK2, ¡R@O2, vÛc (²c) üa2, ¬òaOY2: 1V¢IãÃE¡fIãÃ, 2Á»íà)
713018. [wï (Û)] (|X^[) Short-term Response to the Anti-TNF-agent Golimumab in Patients With Ulcerative Colitis in Daily Clinical Practice. Yokoyama K1, Kawagishi K1, Mukae M1, Kubota M1, Kobayashi K1,2, Koizumi W1: The 7th Annual Meeting of Asian Organization for Crohn's & Colitis (2019/6/15), Taipei, Taiwan. (¡R@O1, ìÝÁÞ1, }@üK1, vÛcüa1, ¬ÑŽT1,2, ¬òaOY1: 1Á»íà, 2V¢IãÃE¡fIãÃ)
713019. [wï (Û)] (êÊu) Usefulness of Narrow Band Imaging Magnifying Endoscopy for the Diagnosis of Ulcerative Colitis-associated Tumors. Mukae M1, Kobayashi K1,2, Kawagishi K1, Yokoyama K1, Kubota M1, Koizumi W1: The 7th Annual Meeting of Asian Organization for Crohn's & Colitis (2019/6/15), Taipei, Taiwan. (}@üK1, ¬ÑŽT1,2, ìÝÁÞ1, ¡R@O1, vÛc (²c) üa1, ¬òaOY1: 1Á»íà, 2V¢IãÃE¡fIãÃ)
713020. [wï (Û)] (êÊu) Outcomes of Single Balloon Dilatation for Small Bowel Strictures in Patients With Crohn's Disease. Kawagishi K1, Mukae M1, Yokoyama K1, Kobayashi K1,2: The 7th Annual Meeting of Asian Organization for Crohn's & Colitis (2019/6/15), Taipei, Taiwan. (ìÝÁÞ1, }@üK1, ¡R@O1, ¬ÑŽT1,2: 1Á»íà, 2V¢IãÃE¡fIãÃ)
713021. [wï (Û)] (|X^[) EUS-guided transjejunal drainage using forward-viewing echoendoscope in the patients with surgically altered anatomy. Iwai T1, Kida M1,2, Okuwaki K1, Yamauchi H1,3, Kaneko T1, Hasegawa R1, Imaizumi H1,4, Koizumi W1: UEGW 2019 (æ27ñ¢BÁ»íaTÔ) (2019/10/19), Barcelona, Spain. (âämv1, ØcõL1,2, e»î1, Rà_j1,3, àq@1, ·JìÍç1, ¡ò@O1,4, ¬òaOY1: 1Á»íà, 2k¢åwfBJZ^[, 3~œ, 4Íìa@)
713022. [wï (Û)] (|X^[) Metachronous Multiple Lesions Developing Near Scars After ESD for Early Gastric Cancer. Tanabe S1,2, Kitahara G2, Ishido K2, Kubota Y3, Wada T2, Watanabe A2, Azuma M2, Katada C2, Koizumi W2: UEGW 2019 (æ27ñ¢BÁ»íaTÔ) (2019/10/21), Barcelona, Spain. (cç³@1,2, kŽ@Ÿ2, Î˪2, vÛcz3, acñç2, nç³W¯2, @q2, ce2, ¬òaOY2: 1V¢IãÃEæ[ãÃ, 2Á»íà, 3åw@ãÃn€È)
713023. [wï (Û)] (|X^[) Sample Isolation Processing Using Stereomicroscopy as an Alternative to Rapid On-site Evaluation in Endoscopic Ultrasound-guided Fine-needle Aspiration Biopsy for the Diagnosis of Pancreatic Malignant Neoplasms. Tamaki A1, Okuwaki K1, Kida M1,2, Masutani H3, Iwai T1, Yamauchi H1,4, Kaneko T1, Hasegawa R1, Miyata E1, Watanabe M1, Kurosu T1, Imaizumi H1,5, Koizumi W1: The 50th Anniversary Joint Meeting of American Pancreatic Association (APA) and Japan Pancreas Society (JPS) (2019/11/9), Maui, USA. (ÊuŸ°1, e»î1, ØcõL1,2, ¡J°È3, âämv1, Rà_j1,4, àq@1, ·JìÍç1, {cp¡1, nÓ^è1, {M_1, ¡ò@O1,5, ¬òaOY1: 1Á»íà, 2k¢åwfBJZ^[, 3åw@ãÃn€È, 4~œ, 5Íìa@)
713024. [wï (Û)] (|X^[) Efficacy of Sample Isolation Processing by Stereomicroscopy as a Novel Procedure in Endoscopic Ultrasound-Guided Fine-Needle Aspiration Biopsy for the Diagnosis of Malignant Neoplasms of the Pancreas. Okuwaki K1, Kida M1,2, Masutani H3, Kurosu T1, Iwai T1, Yamauchi H1,4, Kaneko T1, Hasegawa R1, Miyata E1, Watanabe M1, Imaizumi H1,5, Koizumi W1: The 50th Anniversary Joint Meeting of American Pancreatic Association (APA) and Japan Pancreas Society (JPS) (2019/11/6-9), Maui, USA. (e»î1, ØcõL1,2, ¡J°È3, {M_1, âämv1, Rà_j1,4, àq@1, ·JìÍç1, {cp¡1, nÓ^è1, ¡ò@O1,5, ¬òaOY1: 1Á»íà, 2k¢åwfBJZ^[, 3åw@ãÃn€È, 4~œ, 5Íìa@)
713025. [wï (Û)] (|X^[) Diagnostic Efficacy of a Novel Franseen Needle in EUS-Guided Fine-Needle Aspiration Biopsy of Malignant Neoplasms of the Pancreas. Watanabe M1, Okuwaki K1, Kida M1,2, Imaizumi H1,3, Iwai T1, Yamauchi H1,4, Kaneko T1, Hasegawa R1, Miyata E1, Kurosu T1, Tamaki A1, Koizumi W1: The 50th Anniversary Joint Meeting of American Pancreatic Association (APA) and Japan Pancreas Society (JPS) (2019/11/6-9), Maui, USA. (nÓ^è1, e»î1, ØcõL1,2, ¡ò@O1,3, âämv1, Rà_j1,4, àq@1, ·JìÍç1, {cp¡1, {M_1, ÊuŸ°1, ¬òaOY1: 1Á»íà, 2k¢åwfBJZ^[, 3Íìa@, 4~œ)
713026. [wï (Û)] (|X^[) Clinical usefulness of Wisteria Floribunda agglutinin-positive human Mac-2 binding protein in patients with liver cirrhosis. Uojima H1: AASLD2019 (æ70ñÄÌwïc) (2019/11/8-12), Boston, USA. (°I1: 1Á»íà)
721004. [wï (S)] (ÁÊu) ÏRžÏõï©çÌñ|ú{å°ãèåawïÌÏwjÉWé\¿É¢Ä. ¬ÑŽT1,2 (1V¢IãÃE¡fIãÃ, 2Á»íà): ú{å°ãèåawïæ28ñ³çZ~i[ (2019/5/26), .
721005. [wï (S)] (ÁÊu) àŸÉæéôªXN[jO. ce (Á»íà): æ73ñú{H¹wïwpWï³çZ~i[ (2019/6/5), ª.
721006. [wï (S)] (ÁÊu) îÒÌÝESDÌ»óÆÛè. cç³@1,2 (1V¢IãÃEæ[ãÃ, 2Á»íà): æ22ñú{îÁ»íawïï (2019/8/2), _Ë.
721007. [wï (S)] (ÁÊu) ú{å°ãèåawïÌÏwjÆèo^É œÁÄÌÓ. ¬ÑŽT1,2 (1V¢IãÃE¡fIãÃ, 2Á»íà): æ74ñú{å°ãèåawïwpWï (2019/10/12), .
721008. [wï (S)] (ÁÊu) ÌdÏÌaÔ©çå¬ðÇðlŠé. ú@ (Á»íà): JDDW2019 KOBE (2019/11/21), _Ë.
722012. [wï (S)] (î²u) 嬳ŽiÇfÃÌVµ¢ª¬. ú@ (Á»íà): æ105ñú{Á»íawïï (2019/5/10), Îì.
722013. [wï (S)] (V|WE)yIBDfÃÌÅOüzIBDÌà». ¬ÑŽT1,2 (1V¢IãÃE¡fIãÃ, 2Á»íà): ú{å°ãèåawïæ28ñ³çZ~i[ (2019/5/26), .
722014. [wï (S)] (plfBXJbV) Ì«]ÇÉηéB-RTOÌB_ÆÛè. c«Ÿ1, ú@1, °I1 (1Á»íà): æ55ñú{Ìwïï (2019/5/30), .
722015. [wï (S)] ([NVbv) Strategy for treatments of biliary tract diseases in patients with surgically altered intestinal anatomy. âämv (Á»íà): æ97ñú{Á»íàŸwïï (2019/5/31), .
722016. [wï (S)] (V|WE) îÒúÝàESDãñ¡üØÇáÌ\ã. öãüb1,2, acñç2, cç³@2,3 (1§a@@\ÍŽa@Á»íàÈ, 2Á»íà, 3V¢IãÃEæ[ãÃ): æ22ñú{îÁ»íawïï (2019/8/2), _Ë.
722017. [wï (S)] (V|WE) ÌdϳÒÉš¯éL-FABPæ袵œ
ÌLp«. °I1, ú@1, c«Ÿ1 (1Á»íà): æ26ñú{嬳ŽiÇwïï (2019/9/12), Rû.
722018. [wï (S)] (V|WE) RGPIIb/IIIaRÌY¶B×Eªg{|G`óeÌASjXg^ãÌ¡ÃøÊÉ^Šée¿. °I1, ú@1, êÃ@áÁ, ac®v1, EcKî1, c«Ÿ1 (1Á»íà): æ26ñú{嬳ŽiÇwïï (2019/9/12), Rû.
722019. [wï (S)] (plfBXJbV) ÌüÛ»iWÉš¯éAutotaxinÌÁ¥ÉÖ·é¢. °I1, ú@1, êÃ@áÁ, ac®v1, EcKî1, c«Ÿ1 (1Á»íà): æ26ñú{嬳ŽiÇwïï (2019/9/12), Rû.
722020. [wï (S)] ([NVbv) TRyjAÉηéo`ju±üÌh{Ã@ÌKv«. °I1, erØäq2, ú@1 (1Á»íà, 2h{): æ26ñú{嬳ŽiÇwïï (2019/9/13), Rû.
722021. [wï (S)] (V|WE) ñØ««Ìå_Ç·óÉηéhi[Wíª. âämv1, ØcõL1,2, ¬òaOY1 (1Á»íà, 2k¢åwfBJZ^[): æ55ñú{_¹wïwpWï (2019/10/4), ŒÃ®.
722022. [wï (S)] (plfBXJbV) Rðòp³ÒÉηéCold polypectomyÌÀS«É¢ÄÌ¢. ìÝÁÞ1, vÛc (²c) üa1, ÊácüL1, }@üK1, ¡R@O1, ¬ÑŽT1,2, ¬òaOY1 (1Á»íà, 2V¢IãÃE¡fIãÃ): æ74ñú{å°ãèåawïwpWï (2019/10/11), .
722023. [wï (S)] (V|WE) ×á«å°ÉηéúífÃÉš¯éÖJveN`ÌLp«. ÔªŸY1, ¡R@O1, ¬ÑŽT1,2 (1V¢IãÃE¡fIãÃ, 2Á»íà): æ37ñú{å°žwïï (2019/11/2), .
722024. [wï (S)] (plfBXJbV) å°T1àÌ[BxffšæÑ¡Ã@ÌIðÉš¯éŽ¹gàŸÌÕ°ILp«. }@üK1, ¬ÑŽT1,2 (1Á»íà, 2V¢IãÃE¡fIãÃ): JDDW2019 KOBE (2019/11/21), _Ë.
722025. [wï (S)] ([NVbv) äXE_Çó°«·óÉηéàŸI¡ÃÌHv. Rà_j1,2, e»î2, ¬òaOY2 (1~œ, 2Á»íà): JDDW2019 KOBE (2019/11/21), _Ë.
722026. [wï (S)] ([NVbv) ÌüÛ»iWÉš¯éAutotaxinÌÏ»ÉÖ·é¢. °I1, ú@1, êÃ@^2 (1Á»íà, 2Ãìqa@EÁ»íaZ^[): JDDW2019 KOBE (2019/11/22), _Ë.
722027. [wï (S)] ([NVbv) SJe[eAu[V{s³ÒÉš¯éàŸ©É¢ÄÌ¢. acñç1, cç³@1,2, ¬òaOY1 (1Á»íà, 2V¢IãÃEæ[ãÃ): JDDW2019 KOBE (2019/11/22), _Ë.
722028. [wï (S)] (V|WE) îÒ×á«å°Ìü@á|àÈ¡ÃðDZÜÅs€©?|. É¡²m1, ¡R@O1, ¬ÑŽT1,2 (1Á»íà, 2V¢IãÃE¡fIãÃ): æ10ñú{Ç«°Ÿ³wpWï (2019/11/29), ª.
723111. [wï (S)] (|X^[) ×á«å°Éš¯éÖJveN`lÆàŸ©Ì¢. ÔªŸY1, ¡R@O1, Œ{çG1, ìÝÁÞ1, }@üK1, vÛc (²c) üa1, ¬ÑŽT1,2, ¬òaOY1 (1Á»íà, 2V¢IãÃE¡fIãÃ): æ105ñú{Á»íawïï (2019/5/10), Îì.
723112. [wï (S)] (|X^[) ALBI gradeÆUp-to-seven criteriaÌgÝí¹ÉæéÌ×EàÌ\ã\ª. nç²^²1,2, ¡XOº1,3 (1k¢åwfBJZ^[, 2Á»íà, 3fÃ): æ105ñú{Á»íawïï (2019/5/10), Îì.
723113. [wï (S)] (|X^[) CrohnaÉš¯éadalimumab{Ê^Í¡ÃúÔð·Å«é©? ààV@1, ¡R@O1, ¬ÑŽT1,2 (1Á»íà, 2V¢IãÃE¡fIãÃ): æ105ñú{Á»íawïï (2019/5/10), Îì.
723114. [wï (S)] (|X^[) C^ÌÉηéŒÚìp^RECXò±üãÌRGPIIb/IIIaRÌY¶B×EÌÏ»ÉÖ·é¢. ac®v1, °I1, EcKî1, c«Ÿ1, àVMG1, aJŸ²1,2, ú@1, ¬òaOY1 (1Á»íà, 2ãÃÇ): æ55ñú{Ìwïï (2019/5/31), .
723115. [wï (S)] (|X^[) Ì«]ÇÉηét@LV~ + Jj`¹pÌÓ`. âèGêY1, °I1,2, c«Ÿ1, ac®v1, EcKî1, ú@1 (1Á»íà, 2Ãìqa@): æ55ñú{Ìwïï (2019/5/31), .
723116. [wï (S)] (êÊè) _rKgNö«H¹É¢ÄÌ¢. acñç1, cç³@1,2, yì@~3, nç³W¯1, Î˪1, [Jpœ3, @q1, ce1, ¬òaOY1 (1Á»íà, 2V¢IãÃEæ[ãÃ, 3zÂíà): æ97ñú{Á»íàŸwïï (2019/6/1), .
723117. [wï (S)] (êÊè) å°îáÉηéJNETgåNBIªÞÌÕ°ILp«É¢ÄÌ¢. }@üK1, ¬ÑŽT1,2, vÛc (²c) üa1, Œ{çG1, ìÝÁÞ1, ¡R@O1, ¬òaOY1 (1Á»íà, 2V¢IãÃE¡fIãÃ): æ97ñú{Á»íàŸwïï (2019/6/1), .
723118. [wï (S)] (êÊè) EUS-HGS{sÌà®XegÆvX`bNXegÌär. àq@1, ØcõL1,2, {cp¡1, ·JìÍç1, Rà_j1,3, e»î1, âämv1, ¡ò@O1,4 (1Á»íà, 2k¢åwfBJZ^[, 3~œ, 4Íìa@): æ97ñú{Á»íàŸwïï (2019/6/1), .
723119. [wï (S)] (êÊè) ¬äXàÌffÉš¯é_äXàŸÌLp«. ©@®M1, e»î1, ØcõL1,2, Œ{Ÿ1, âämv1, Rà_j1,3, àq@1, ·JìÍç1, {cp¡1, {M_1, nÓ^è1, ¡ò@O1,4, ¬òaOY1 (1Á»íà, 2k¢åwfBJZ^[, 3~œ, 4Íìa@): æ97ñú{Á»íàŸwïï (2019/6/2), .
723120. [wï (S)] (êÊè) Ê««_¹·óÉηéSelf-expandable metallic stent¯uãÌ_ùNÇÌë¯öqÉÖ·é¢. nÓ^è1, e»î1, ØcõL1,2, âämv1, Rà_j1,3, àq@1, ·JìÍç1, Œ{Ÿ1, {cp¡1, ìûCã1,2, ãŽê¿1,2, ¡J°È4, ÀB@õ4, äøŽ«Ç4, Jªá1, {M_1, ©@®M1, ¡ò@O1,5, ¬òaOY1 (1Á»íà, 2k¢åwfBJZ^[, 3~œ, 4åw@ãÃn€È, 5Íìa@): æ97ñú{Á»íàŸwïï (2019/6/2), .
723121. [wï (S)] (|X^[) àŸØãáãÌ\Ý^H¹GœãçàÉηéESD̡ìÑ. Ã]NŸ1,2, ËcYî1, x@\î1, åcqT1, bêY1, Vºî1, rŒON1, îìFK1 (1§ªñ€Z^[a@, 2Á»íà): æ73ñú{H¹wïwpWï (2019/6/6), ª.
723122. [wï (S)] (êÊè) îÒ×á«å°Éη鶚wI»Ü¡ÃÌÀÛ. É¡²m1, ¡R@O1, ¬ÑŽT1,2 (1Á»íà, 2V¢IãÃE¡fIãÃ): æ74ñú{å°ãèåawïwpWï (2019/10/11), .
723123. [wï (S)] (êÊû) ¡ñàŸžð{sµ, ffÉïaµœ¬°®Ã¬ï`Ì1á. kìV1, Îè âß1, âEŸ1, yíŸY1, c¹O2, ÍŒèûŸY2, enGF2, ¢¹NF2, ŒR@³2, RèDì2, ìo@œ2, ìç³×ê, H¹TS2, J@as2, ŒŽ@C (1Á»íà, 2œË€Ïa@): æ68ñ€Ïãwï (2019/10/23), Dy.
723124. [wï (S)] (êÊû) KÍa@Éš¯éÇ«°Ÿ³Ì`[ãÃÆnæãÃv£ O}zê1, ¡ò@O1,2, à@ŸN1,2, äôCî1,2, åäc³l1 (1JCHOÍìa@, 2Á»íà): æ5ñJCHOnæãÃãwï (2119/11/2), ¡l.
723125. [wï (S)] (|X^[) àŸØãáãÌ\Ý^H¹GœãçàÉηéESD̡ìÑ. Ã]NŸ1,2, ËcYî2, x@\î2, åcqT2, bêY2, Vºî2, rŒON2, îìFK2 (1Á»íà, 2§ªñ€Z^[a@): JDDW2019 KOBE (2019/11/21), _Ë.
723126. [wï (S)] (|X^[) RÃÅòpÒÌúãÁ»ÇîáÉηéESDãoÌ¢. ÎèY1, acñç1, nç³W¯1, Î˪1, @q1, ce1, cç³@1,2, ¬òaOY1 (1Á»íà, 2V¢IãÃEæ[ãÃ): JDDW2019 KOBE (2019/11/21), _Ë.
723127. [wï (S)] (|X^[) îÒ×á«å°ÉηéÆuäÃ@ÌÀÛÆãIÏJ. É¡²m1, ¡R@O1, |J@Ê1, Œ{çG1, ìÝÁÞ1, }@üK1, vÛc (²c) üa1, ¬ÑŽT1,2, ¬òaOY1 (1Á»íà, 2V¢IãÃE¡fIãÃ): JDDW2019 KOBE (2019/11/21), _Ë.
723128. [wï (S)] (|X^[) «ÌŸ³Éš¯éÌTRyjAffÌÓ`ÉÖ·éœ{ÝOü«¢. âèGêY1, ú@1, °I1 (1Á»íà): JDDW2019 KOBE (2019/11/21), _Ë.
723129. [wï (S)] (|X^[) @Éš¯éØs\EÄݪñÉηéNivolumab̡ìÑ. kŽ@Ÿ1, Î˪1, vÛcz2, nç³W¯1, acñç1, @q1, ce1, cç³@1,3, ¬òaOY1 (1Á»íà, 2åw@ãÃn€È, 3V¢IãÃEæ[ãÃ): JDDW2019 KOBE (2019/11/22), _Ë.
723130. [wï (S)] (|X^[) @Éš¯éØs\isEÄÝàÉηénab-PTX + RAMÃ@̡ìÑ. vÛcz1, @q2, ÎŽ@Ð2, nç³W¯2, acñç2, Î˪2, ce2, cç³@2,3, ¬òaOY2 (1åw@ãÃn€È, 2Á»íà, 3V¢IãÃEæ[ãÃ): JDDW2019 KOBE (2019/11/22), _Ë.
723131. [wï (S)] (|X^[) _ÇÎÉηéàŸIûª[Wo[g£pÉš¯éôÇÌ¢. ÊuŸ°1, Rà_j1,2, ØcõL1,3, ãŽê¿1,3, e»î1, âämv1, ¡ò@O1,4, {cp¡1, ·JìÍç1, àq@1, ¬òaOY1 (1Á»íà, 2~œ, 3k¢åwfBJZ^[, 4Íìa@): JDDW2019 KOBE (2019/11/23), _Ë.
723132. [wï (S)] (|X^[) å°|[vÉηéCold polypectomyÌLp«É¢ÄÌ¢. cç³üÞ1, ìÝÁÞ1, vÛc (²c) üa1, ÊácüL1, }@üK1, ¡R@O1, ¬ÑŽT1,2, ¬òaOY1 (1Á»íà, 2V¢IãÃE¡fIãÃ): JDDW2019 KOBE (2019/11/23), _Ë.
723133. [wï (S)] (|X^[) pãÄ°ÇðL·é««_¹·óÉηé^bNXeg¯upÆvX`bNXeg¯up̡ìÑÌär¢. ·JìÍç1, ØcõL1,2, {M_1, nÓ^è1, {cp¡1, àq@1, Rà_j1,3, e»î1, âämv1, ¡ò@O1,4, ¬òaOY1 (1Á»íà, 2k¢åwfBJZ^[, 3~œ, 4Íìa@): JDDW2019 KOBE (2019/11/23), _Ë.
723134. [wï (S)] (|X^[) äX««îáÉηéEUS-FNABÉš¯éÌ@: Sample Isolation Processing by Stereo-microscopeÌLp«. {M_1, e»î1, ØcõL1,2, ¡J°È3, âämv1, Rà_j1,4, àq@1, ·JìÍç1, {cp¡1, nÓ^è1, ¡ò@O1,5, ¬òaOY1 (1Á»íà, 2k¢åwfBJZ^[, 3åw@ãÃn€È, 4~œ, 5Íìa@): JDDW2019 KOBE (2019/11/23), _Ë.
723135. [wï (S)] (|X^[) ×á«å°Éš¯éÖJveN`ªèÍúífÃÉš¢ÄLp©? ÔªŸY1, ¡R@O1, Œ{çG1, ìÝÁÞ1, }@üK1, vÛc (²c) üa1, ¬ÑŽT1,2, ¬òaOY1 (1Á»íà, 2V¢IãÃE¡fIãÃ): æ10ñú{Ç«°Ÿ³wïwpWï (2019/11/29), ª.
723136. [wï (S)] (êÊè) ¹§Ýð浜Helicobacter pyloriA«Ìêá. cç³üÞ1, ìÝÁÞ1, cç³@1,2, ¡R@O1, vÛcz3, nç³W¯1, acñç1, Î˪1, @q1, ce1, ¬òaOY1 (1Á»íà, 2V¢IãÃEæ[ãÃ, 3åw@ãÃn€È): æ16ñú{Á»ÇwïïwpWï (2020/2/7), ºÉ.
723137. [wï (S)] (êÊè) úÝàÉεÄESD ð{sµœî³ÒÅ, ñ¡üØÅ ÁœÇáÌ¢. kŽ@Ÿ (Á»íà): æ92ñú{Ýàwïï (2020/3/5), _Þì.
723027. [wï (S)] (êÊu) ÌÞŽÂÇÇóQÉš¯ég{LTA2óeÌÌðÉ墀 (Thromboxane A2 receptor signaling attenuates monocrotaline-induced liver injury by affecting endothelial cells, but not platelets). åj¹1, É¡`ç2, äãqm3, åvÛ¢4, 1, ×ìÁÞq2, ¬òaOY3, n³²2 (1åw@ãÃn€È, 2ò, 3Á»íà, 4SÇO): æ93ñú{òwïNï (2020/3/16-18), ãJÃ.
731002. [wï (nûïE€ï)] (ÁÊu) Á·éÇ«°Ÿ³|¡, næAgðlŠé|. ¡R@O (Á»íà): Takeda Ulcerative ColitisSWebZ~i[ (2019/4/9), Web.
731003. [wï (nûïE€ï)] (ÁÊu) G^CrIÌPhV±¬ÑÆ×á«å°Ì¡ÃÉ¢Ä. ¡R@O (Á»íà): ×á«å°ÌVµ¢¡Ãíª (2019/4/17), .
731004. [wï (nûïE€ï)] (ÁÊu) IBDÉš¯é¡ÃStep UpÌ^C~O. ¡R@O (Á»íà): k«§SIBDZ~i[ (2019/4/18), éÊ.
731005. [wï (nûïE€ï)] (ÁÊu) VKIBD¡ÃòÌgpo±. ¡R@O (Á»íà): æ52ñ_ÞìIBD~jJt@X (2019/5/13), _Þì.
731006. [wï (nûïE€ï)] (ÁÊu) N[afÃÉš¯éŽj^O. ¡R@O (Á»íà): áÇWEBuï (2019/5/23), Web.
731007. [wï (nûïE€ï)] (ÁÊu) G^CrIÌæ3±¬ÑÆ×á«å°Ì¡ÃÉ¢Ä. ¡R@O (Á»íà): ŒÃE§Á»ía€ï (2019/6/19), _Þì.
731008. [wï (nûïE€ï)] (ÁÊu) ÝñÈÅfæ€IBDfÃ. ¡R@O (Á»íà): IBD€ï (2019/7/26), çt.
731009. [wï (nûïE€ï)] (ÁÊu) Š±¯é×á«å°`¡±»ÝñÈÅféœßÉ`. ¡R@O (Á»íà): æ2ñ³¢œÜIBDafAgZ~i[ (2019/8/29), éÊ.
731010. [wï (nûïE€ï)] (ÁÊu) ×á«å°ÉηéàÈ¡Ã@Ìià. ¬ÑŽT1,2 (1Á»íà, 2V¢IãÃE¡fIãÃ): næUCZ~i[ (2019/9/5), çt.
731011. [wï (nûïE€ï)] (ÁÊu) ¡±»IBDÌ`[ãÃðlŠé. ¡R@O (Á»íà): IBDlbgtH[ (2019/9/6), Web.
731012. [wï (nûïE€ï)] (ÁÊu) ×á«å°ÌÕ°ÆàÈ¡ÃÌÀÛ. ¡R@O (Á»íà): åasÁ»ía€ï (2019/9/18), _Þì.
731013. [wï (nûïE€ï)] (ÁÊu) ×á«å°Éš¯éCAPÌð`@Ì¡Ão±©çlŠé`. ¡R@O (Á»íà): ÖåssIBDZ~i[ (2019/9/20), ª.
731014. [wï (nûïE€ï)] (ÁÊu) N[aÉš¯éàÈIEOÈIAv[`ÌÝð. ¡R@O (Á»íà): Crohn's Disease Web seminar (2019/9/25), Web.
731015. [wï (nûïE€ï)] (ÁÊu) IBDfÃÌ»óÆÛè`næÅfé×á«å°`. ¡R@O (Á»íà): _Þì Ulcerative colitis Conference (2019/9/26), _Þì.
731016. [wï (nûïE€ï)] (ÁÊu) N[a¡ÃÉš¯é¶šwI»ÜÌ¡Ãíª. ¡R@O (Á»íà): æ114ñú{Á»íawïãBxáïEæ108ñú{Á»íàŸwïãBxáï (2019/11/9), {è.
731017. [wï (nûïE€ï)] (ÁÊu) ×á«å°ÌúífÃÅxhY}uðÇ€gÁÄ¢©. ¡R@O (Á»íà): æ109ñú{Á»íàŸwïÖxáï (2019/12/14), .
731018. [wï (nûïE€ï)] (ÁÊu) IBDfÃÉš¯éShared-decision making. ¡R@O (Á»íà): ãBIBD up-to-date Meeting (2020/1/11), ª.
731019. [wï (nûïE€ï)] (ÁÊu) ×á«å°¡ÃÌî{ò`5-ASA»ÜðÇ€g€©`. ¡R@O (Á»íà): Ãì×á«å°¡ÃZ~i[ (2020/1/16), _Þì.
731020. [wï (nûïE€ï)] (ÁÊu) N[a¡ÃÉš¯é¶šwI»ÜÌ¡Ãíª. ¡R@O (Á»íà): æ2ñö¹ IBD-Meeting (2020/2/4), L.
732006. [wï (nûïE€ï)] (plfBXJbV) gåàŸÏ@ª¶ÝffÉLpÅ ÁœUCÖAîáÌ1á. ÊácüL1, vÛc (²c) üa1, ¬ÑŽT1,2 (1Á»íà, 2V¢IãÃE¡fIãÃ): æ108ñú{Á»íàŸwïÖxáï (2019/6/8), .
732007. [wï (nûïE€ï)] (plfBXJbV) j«ÌúH¹àÉηéàŸØãÌÙ«H¹à̶ÆMacrocytosisÌÖA. ce1, ¡RO¢2, ¡@w3 (1Á»íà, 2§ÛãÃÈw@¶UN€, 3så®a@îáàÈ): æ108ñú{Á»íàŸwïÖxáï (2019/6/9), .
732008. [wï (nûïE€ï)] (rfI[NVbv) EUS-FNAÉš¯éúh¢ïáÉηéguV
[eBO. {M_1, ·JìÍç1, âämv1, ØcõL1,2, ¬òaOY1 (1Á»íà, 2k¢åwfBJZ^[): æ108ñú{Á»íàŸwïÖxáï (2019/6/9), .
732009. [wï (nûïE€ï)] (µÒu) ú{l×á«å°³ÒðÎÛƵœG^CrIæ1±É¢ÄÌÊñ. ¬ÑŽT1,2 (1Á»íà, 2V¢IãÃE¡fIãÃ): ŒÃE§Á»ía€ï (2019/6/19), CVŒ.
732010. [wï (nûïE€ï)] (V|WE) ÁÃO`FbNXgÉæéàŸfÃÌÁÃO³Ò]¿ÌæègÝ. Î˪1, cç³@1,2, âV3 (1Á»íà, 2V¢IãÃEæ[ãÃ, 3): æ109ñú{Á»íàŸwïÖxáï (2019/12/14), .
732011. [wï (nûïE€ï)] (plfBXJbV) ×á«å°ÖAîáÉηéNBIgåàŸffÌLp«É¢ÄÌ¢. }@üK1, ¬ÑŽT1,2, ¬òaOY1 (1Á»íà, 2V¢IãÃE¡fIãÃ): æ109ñú{Á»íàŸwïÖxáï (2019/12/14), .
732012. [wï (nûïE€ï)] (plfBXJbV) äX««îáÉηéEUS-FNABÉš¯éRapid on-site evaluationÌLp«ÉÖ·éØ. ÊuŸ°1, e»î1, âämv1, ØcõL1,2, ¬òaOY1 (1Á»íà, 2k¢åwfBJZ^[): æ109ñú{Á»íàŸwïÖxáï (2019/12/14), .
732013. [wï (nûïE€ï)] (plfBXJbV)yHelicobacter pylori¢ŽõEÛãݪñÌàŸffz@Éš¯éHPA«ÝàffÌÀÛ. äôCî1, à@ŸN1,2, O}zê2, ¡ò@O1,2, cç³@1,3 (1Á»íà, 2JCHOÍìa@, 3V¢IãÃEæ[ãÃ): æ109ñú{Á»íàŸwïÖxáï (2019/12/15), .
732014. [wï (nûïE€ï)] (rfI[NVbv) å°eºoÉηéàŸI~@̡ìÑ. ìÝÁÞ1, ¬ÑŽT1,2, Œ{çG1, vÛc (²c) üa1, ¬òaOY1 (1Á»íà, 2V¢IãÃE¡fIãÃ): æ109ñú{Á»íàŸwïÖxáï (2019/12/15), .
733026. [wï (nûïE€ï)] (êCãZbV) ÌÇ÷îÆÌÓʪ¢ïÅ ÁœÌÁaÌ1Uá. É¡²m1, °I1, ú@1, ac®v1, EcKî1, c«Ÿ1, aJŸ²1,2, ¬òaOY1 (1Á»íà, 2ãÃÇ): ú{Á»íawïÖxæ354ñáï (2019/4/13), .
733027. [wï (nûïE€ï)] (€CãZbV) ÇãZúÔÅú¬°à𹵜N[aÌ1á. ¬ôCÞ1, ¬àäê²1, C€u1, ñØ@¹1, Øî1, c@º1, Ñ@Gs2, ¡R@O3 (1¡ls§s¯a@Ç«°Ÿ³È, 2¡ls§s¯a@affÈ, 3Á»íà): ú{Á»íawïÖxæ354ñáï (2019/4/13), .
733028. [wï (nûïE€ï)] (êÊè) ¹§ÝÌ©ð浜N[aÌ1á. äôÀØ1, cç³üÞ1, ìÝÁÞ1, cç³@1,2, }@üK1, ¡R@O1, vÛc (²c) üa1, ¬ÑŽT1,3, ¬òaOY1 (1Á»íà, 2V¢IãÃEæ[ãÃ, 3V¢IãÃE¡fIãÃ): ú{àÈwïæ650ñÖnûï (2019/5/18), .
733029. [wï (nûïE€ï)] (êÊû) @Åo±µœÝêB^ÝàÉ¢ÄÌ¢. ÎèY1, acñç1, HJ¹j2, nç³W¯1, Î˪1, @q1, ce1, cç³@1,3, gc@÷2, ¬òaOY1 (1Á»íà, 2a, 3V¢IãÃEæ[ãÃ): æ108ñú{Á»íàŸwïÖxáï (2019/6/9), .
733030. [wï (nûïE€ï)] (êÊû) EUS-FNBÅffµŸœO«`¿×EîÌ1á. ²ìBÆ (Á»íà): æ146ñ_ÞìÌ_äXŸ³€ï (2019/6/27), ¡l.
733031. [wï (nûïE€ï)] (êÊû) pOffÉ궵LÍÍÌdyspiasiaðºÁœcolitis associated rectal cancerÌ1á. cç³üÞ1, ¬ÑŽT1,2, ìÝÁÞ1, }@üK1, ¡R@O1, vÛc (²c) üa1, ¬òaOY1, OY[æ3, O}@M4 (1Á»íà, 2V¢IãÃE¡fIãÃ, 3ºÁ»ÇO, 4a): æ64ñ_Þì§Á»ía€ï (2019/7/6), ¡l.
733032. [wï (nûïE€ï)] (êÊû) 14ά_ÇÎÇÌ1á. yíŸY1, ŒR@³1,2, âEŸ1,2, kìV2, c¹O2, ÍŒèûŸY2, enGF2, ¢¹NF2, RèDì2 (1Á»íà, 2œË€Ïa@): æ64ñ_Þì§Á»ía€ï (2019/7/6), ¡l.
733004. [wï (nûïE€ï)] (êÊu) ÌÞŽÂÇÇóQÉš¯ég{LTóeÌÌð. åj¹1, É¡`ç2, äãqm3, ŒàVL±4, {Ci1, 1, ¿q5, {cëq1, ×ìÁÞq2, ¬òaOY3, n³²2 (1åw@ãÃn€È, 2ò, 3Á»íà, 4êÊE¬EÌ_äXO, 5YÈ): æ140ñú{òwïÖï (2019/7/6), .
733033. [wï (nûïE€ï)] (êÊu) ©ÈÆu«äXÉηéXeChÁÃÉäXàðǵœ1á. ¬ì§1, nÓ^è1, Rà_j1,2, {M_1, ·JìÍç1, àq@1, e»î1, âämv1, ¡ò@O1,3, ØcõL1,4, ¬òaOY1 (1Á»íà, 2~œ, 3JCHOÍìa@, 4k¢åwfBJZ^[): ú{Á»íawïÖxæ355ñáï (2019/7/13), .
733034. [wï (nûïE€ï)] (êÊè) Sxâ~h¶ãÉǵœ«¬°Ì1á. âEŸ1, }@üK1, ÊácüL1, ìÝÁÞ1, ¡R@O1, vÛc (²c) üa1, ¬òaOY1, ¬ÑŽT1,2, º²r3 (1Á»íà, 2¢IãÃE¡fIãÃ, 3ºÁ»ÇO): ú{àÈwïæ653ñÖnûï (2019/9/14), .
733035. [wï (nûïE€ï)] (êCãZbV) ØÂ\ÈH¹_oàªåªñÉεĻwúËüÃ@ªLøÅ Áœ1á. Ž@Eã1, nç³W¯1, ce1, vÛcz2, acñç1, Î˪1, @q1, cç³@1,3 (1Á»íà, 2åw@ãÃn€È, 3V¢IãÃEæ[ãÃ): ú{Á»íawïÖxæ356ñáï (2019/9/21), .
733036. [wï (nûïE€ï)] (êÊè) ¡ñÌsalvagePDTÅïaµsalvageèpðÀ{µœH¹àÌêá. Ã]NŸ1,2, ËcYî2, åcqT2, îìFK2, ¡cY2, ¡Ž®u2, åKGK2 (1Á»íà, 2§ªñ€Z^[a@): æ44ñH¹àWwI¡Ã¢ï (2019/10/18), .
733037. [wï (nûïE€ï)] (êÊè) H¹ÊßáQð_@ÉffµŸœäXöàÌ1á. ä¯ÔqI1, {M_1, nÓ^è1, ·JìÍç1, àq@1, Rà_j1,2, e»î1, âämv1, ØcõL1,3, ¬òaOY1 (1Á»íà, 2~œ, 3k¢åwfBJZ^[): ú{àÈwïæ655ñÖnûï (2019/11/9), .
733038. [wï (nûïE€ï)] (êÊû) AÂÉæèAjAÇ, Ó¯áQ𶶜1á. äôCî1, iª¢2, Ž@É2, ÐRì¢3,4, Îä²i3,4, îàŽqq4, ¡èM¶4, O}zê4, ¡ò@O1,4, à@ŸN1,4 (1Á»íà, 2tà, 3tà, 4JCHOÍìa@): ú{àÈwïæ655ñÖnûï (2019/11/9), .
733039. [wï (nûïE€ï)] (êÊû) ÝSºîáÌff. ŒR@³1,2, yíŸY2, âEŸ2, c¹O1, kìV1, ÍŒ°ŸY1, enGF1, ¢¹NF1, Rú±Dì1 (1œË€Ïa@, 2Á»íà): æ51ñœË€Ïa@EœËsãtï¯Õ°§bï (2019/11/20), œË.
733040. [wï (nûïE€ï)] (êCãZbV) @Éš¯é×á«å°ÉηévedolizumabÌZú¡Ã¬ÑÉ¢Ä. ààV@1, ¡R@O1, ÊácüL1, Œ{çG1, ìÝÁÞ1, }@üK1, vÛc (²c) üa1, ¬òaOY1, ¬ÑŽT1,2 (1Á»íà, 2V¢IãÃE¡fIãÃ): ú{Á»íawïÖxæ357ñáï (2019/12/7), .
733041. [wï (nûïE€ï)] (êCãZbV) q{œØ÷îpãÉSg]ÚÄðFß, EUS-FNAÅffÉÁœêá. äôCî1,2, ¡ò@O1,2, à@ŸN1,2, O}zê2, Vä³G2,3, äøŽ«Ç4, ¡J°È4, nÓ^è1, {M_1, ÀB@õ4, ·JìÍç1, àq@1, Rà_j1,5, e»î1, âämv1, ØcõL1,6 (1Á»íà, 2Íìa@, 3wl, 4åw@ãÃn€È, 5~œ, 6k¢åwfBJZ^[): ú{Á»íawïÖxæ357ñáï (2019/12/7), .
733042. [wï (nûïE€ï)] (êÊè) ffÉïaµœÌ¢ª»Ù«÷îÌ1á. áÁDì1, ú@1, ac®v1, EcKî1, °I1, c«Ÿ1, àVMG1, aJŸ²1,2, ¬òaOY1, CÃMj3, G³Yî3 (1Á»íà, 2ãÃÇ, 3êÊE¬EÌ_äXO): ú{Á»íawïÖxæ357ñáï (2019/12/7), .
733043. [wï (nûïE€ï)] (êÊè) Ž¹gàŸºÉÄG^m[üÃ@ð{sµœöótÌÌ×EàÌ1á. kŽ@Ÿ1, àq@1, {M_1, nÓ^è1, ·JìÍç1, e»î1, âämv1, ØcõL1,2, ¬òaOY1 (1Á»íà, 2k¢åwfBJZ^[): ú{Á»íawïÖxæ357ñáï (2019/12/7), .
733044. [wï (nûïE€ï)] (êÊè)uVKKChC[U±®uVvðgpµœ_Ç·óÉηéuVCß×EfÌff\É¢Ä. {cp¡1, ØcõL1,2, âämv1, e»î1, Rà_j1,3, àq@1, ·JìÍç1, ¬òaOY1 (1Á»íà, 2k¢åwfBJZ^[, 3~œ): ú{Á»íawïÖxæ357ñáï (2019/12/7), .
733045. [wï (nûïE€ï)] (êÊè) ªß^_XBØîÇɹµœ_XàÌêá. äôÀØ1, âämv1, cç³@1,2, {M_1, nÓ^è1, {cp¡1, ·JìÍç1, àq@1, Rà_j1,3, e»î1, ¡ò@O1,4, ØcõL1,5, ¬òaOY1 (1Á»íà, 2V¢IãÃEæ[ãÃ, 3~œ, 4Íìa@, 5k¢åwfBJZ^[): ú{Á»íawïÖxæ357ñáï (2019/12/7), .
733046. [wï (nûïE€ï)] (êÊè) pOffª¢ïÅ ÁœN[a¹¬°àÌ1á. ²ìBÆ1, ÊácüL1, ìÝÁÞ1, }@üK1, ¡R@O1, vÛc (²c) üa1, ¬òaOY1, ¬ÑŽT1,2, º²r3, O}@M4 (1Á»íà, 2¢IãÃE¡fIãÃ, 3ºÁ»ÇO, 4a): ú{Á»íawïÖxæ357ñáï (2019/12/7), .
733047. [wï (nûïE€ï)] (êÊû) 14ά_ÇÎÇÌ1á. yíŸY1, ŒR@³1,2, âEŸ1,2, kìV2, c¹O2, ÍŒ°ŸY2, enGF2, ¢¹NF2, RèDì2 (1Á»íà, 2œË€Ïa@): ú{Á»íawïÖxæ357ñáï (2019/12/7), .
733048. [wï (nûïE€ï)] (êCãZbV) Ý|[vƵĩ³êœt×EàÝ]ÚÉÎµàŸ¡Ãð{sµœÕ°o±. ÎèY1, @q1, vÛcz2, acñç1, nç³W¯1, Î˪1, ce1, cç³@1,3, ¬òaOY1 (1Á»íà, 2åw@ãÃn€È, 3V¢IãÃEæ[ãÃ): æ109ñú{Á»íàŸwïÖxáï (2019/12/14), .
733049. [wï (nûïE€ï)] (êCãZbV) Ý]Ú𜵜t×EàÌêá. ãŸY1,2, ìûCã1,2, [ìØü1,2, ãŽê¿1,2, åËra1,2, nç²^²1,2, cŽvüq2, ØcõL1,2 (1Á»íà, 2k¢åwfBJZ^[): æ109ñú{Á»íàŸwïÖxáï (2019/12/14), .
733050. [wï (nûïE€ï)] (êCãZbV) EUSðp¢ÄStXîðffµ oŸºEopð{sµœêá. [ìØü1,2, ãŽê¿1,2, ãŸY1,2, ìûCã1,2, åËra1,2, cŽvüq2, nç²^²1,2, ØcõL1,2 (1Á»íà, 2k¢åwfBJZ^[): æ109ñú{Á»íàŸwïÖxáï (2019/12/14), .
733051. [wï (nûïE€ï)] (êCãZbV) äXàpã díÄÉæéAürÇóQÉεÄàŸºSelf-expandable metallic stent¯uªLpÅ Áœêá. yíŸY1, nÓ^è1, {M_1, ·JìÍç1, àq@1, Rà_j1,2, e»î1, âämv1, ¡ò@O1,3, ØcõL1,4, ¬òaOY1 (1Á»íà, 2~œ, 3Íìa@, 4k¢åwfBJZ^[): æ109ñú{Á»íàŸwïÖxáï (2019/12/14), .
733052. [wï (nûïE€ï)] (êCãZbV) EUS-FNBÉÄffµŸœ]Ú«äXœØ÷îÌ1á. Îè âß1, e»î1, nÓ^è1, {M_1, ·JìÍç1, àq@1, Rà_j1,2, âämv1, ¡ò@O1,3, ØcõL1,4, ¬òaOY1 (1Á»íà, 2~œ, 3Íìa@, 4k¢åwfBJZ^[): æ109ñú{Á»íàŸwïÖxáï (2019/12/14), .
733053. [wï (nûïE€ï)] (êCãZbV) ]Ú«äXîáÉæéÂÇ«äXÉεÄEUS-PD rendezvous@ðp¢œoûªIäXÇhi[Wð{sµœ1á. ¬ì§1, e»î1, nÓ^è1, {M_1, ·JìÍç1, àq@1, Rà_j1,2, âämv1, ¡ò@O1,3, ØcõL1,4, ¬òaOY1 (1Á»íà, 2~œ, 3Íìa@, 4k¢åwfBJZ^[): æ109ñú{Á»íàŸwïÖxáï (2019/12/14), .
733054. [wï (nûïE€ï)] (€CãZbV) Á»ÇÙšÉæé¬ÌÂÇ«CEXÉεàŸIÙšpð{sµœ1á. î@©1, ìÝÁÞ1, ÊácüL1, }@üK1, ¡R@O1, vÛc (²c) üa1, ¬ÑŽT1,2, ¬òaOY1 (1Á»íà, 2V¢IãÃE¡fIãÃ): æ109ñú{Á»íàŸwïÖxáï (2019/12/14), .
733055. [wï (nûïE€ï)] (êÊû) ¬°®Ã¬ï`Ì1á. âEŸ1,2, kìV2, yíŸY1, c¹O2, ÍŒ°ŸY2, enGF2, ¢¹NF2, RèDì2, ŒR@³1,2, ŒŽ@C2 (1Á»íà, 2œË€Ïa@): æ109ñú{Á»íàŸwïÖxáï (2019/12/14), .
733056. [wï (nûïE€ï)] (êÊû) EXeLk}uªúÉLøÅ ÁœTCgKŽõ¹, N[aÌÇá. O}zê1, ¡ò@O1,2, Á¡@Ê3, à@ŸN1,2, äôCî1,2, Köèm1, OŽ·1, Œ³âX1, ºh1, åäc³l1 (1JCHOÍìa@, 2Á»íà, 3ì¬ca@): æ109ú{Á»íàŸwïÖxáï (2019/12/15), .
733057. [wï (nûïE€ï)] (êÊè) ×á«å°ÌoßÉ°j𹵜1á. áÁDì1, ¬ÑŽT1,2, ÊácüL1, ìÝÁÞ1, }@üK1, ¡R@O1, vÛc (²c) üa1, ¬òaOY1, O}@M3 (1Á»íà, 2V¢IãÃE¡fIãÃ, 3a): æ109ñú{Á»íàŸwïÖxáï (2019/12/15), .
733058. [wï (nûïE€ï)] (êÊè) CEXð_@Éff, ¡ÃÉÁœŽ«¬°àÌ1á. ÔªŸY1, vÛcz2, Î˪1, nç³W¯1, acñç1, @q1, ce1, cç³@1,3, ¬òaOY1 (1Á»íà, 2åw@ãÃn€È, 3V¢IãÃEæ[ãÃ): æ109ñú{Á»íàŸwïÖxáï (2019/12/15), .
733059. [wï (nûïE€ï)] (êÊè) ChildÏ@ãÌ«·óÉεÄ, Œ^RxbNXðp¢ÄŽ¹gàŸºäXÇó°«pð{sµœ1á. cç³üÞ1, àq@1, ØcõL1,2, {M_1, nÓ^è1, ·JìÍç1, Rà_j1,3, e»î1, âämv1, ¬òaOY1 (1Á»íà, 2k¢åwfBJZ^[, 3~œ): æ109ñú{Á»íàŸwïÖxáï (2019/12/15), .
åw@ãÃn€È@Á»íàÈw
ñuÀuÇ«°Ÿ³Õ°€uÀv
[wp_¶]
110102. [Ž] Individualized treatment based on CYP3A5 single-nucleotide polymorphisms with tacrolimus in ulcerative colitis. Okabayashi S, Kobayashi T1,2, Saito E, Toyonaga T, Ozaki R, Sagami S, Nakano M, Tanaka J, Yagisawa K, Kuronuma S, Takeuchi O, Hibi T1,2: Intest Res 2019/4; 17 (2): 218-26. (¬Ñ@ñ1,2, úäI¶1,2: 1åw@ãÃn€È, 2k¢€a@)
110103. [Ž] Risk Factors for Mortality in Pneumocystis jirovecii Pneumonia in Patients with Inflammatory Bowel Disease. Yoshida A1, Kamata N, Yamada A, Yokoyama Y, Omori T, Fujii T, Hayashi R, Kinjo T, Matsui A, Fukata N, Takahashi S, Sakemi R, Ogata N, Ashizuka S, Bamba S, Ooi M, Kanmura S, Endo K, Yoshino T, Tanaka H, Morizane T, Shinzaki S, Kobayashi T1,2: Inflamm Intest Dis 2019/4; 3 (4): 167-2. (¬Ñ@ñ1,2: 1åw@ãÃn€È, 2k¢€a@)
110104. [Ž] Efficacy and safety of abrilumab, an ¿4À7 integrin inhibitor, in Japanese patients with moderate-to-severe ulcerative colitis: a phase II study. Hibi T1,2, Motoya S, Ashida T, Sai S, Sameshima Y, Nakamura S, Maemoto A, Nii M, Sullivan BA, Gasser RA Jr, Suzuki Y: Intest Res 2019/7; 17 (3): 375-86. (úäI¶1,2: 1åw@ãÃn€È, 2k¢€a@)
110105. [Ž] Certolizumab pegol for induction of remission in Crohn's disease. Yamazaki H, So R, Matsuoka K, Kobayashi T1,2, Shinzaki S, Matsuura M, Okabayashi S, Kataoka Y, Tsujimoto Y, Furukawa TA, Watanabe N: Cochrane Database Syst Rev 2019/8; 8 (8): CD012893. (¬Ñ@ñ1,2: 1åw@ãÃn€È, 2k¢åwk¢€a@)
110106. [Ž] Concerns and Side Effects of Azathioprine During Adalimumab Induction and Maintenance Therapy for Japanese Patients With Crohn's Disease: A Subanalysis of a Prospective Randomised Clinical Trial [DIAMOND Study]. Hisamatsu T1, Matsumoto T1, Watanabe K1, Nakase H1, Motoya S1, Yoshimura N1, Ishida T1, Kato S1, Nakagawa T1, Esaki M1, Nagahori M1, Matsui T1, Naito Y1, Kanai T1, Suzuki Y1, Nojima M1, Watanabe M1, Hibi T1,2 (1DIAMOND study group): J Crohns Colitis 2019/9; 13 (9): 1097-104. (úäI¶1,2: 2k¢åwk¢€a@)
110107. [Ž] Ustekinumab as Induction and Maintenance Therapy for Ulcerative Colitis. Sands BE, Sandborn WJ, Panaccione R, O'Brien CD, Zhang H, Johanns J, Adedokun OJ, Li K, Peyrin-Biroulet L, Van Assche G, Danese S, Targan S, Abreu MT, Hisamatsu T, Szapary P, Marano C, UNIFI?Study Group (Kobayashi T1,2): N Engl J Med 2019/9; 381 (13): 1201-14. (¬Ñ@ñ1,2: 1åw@ãÃn€È, 2k¢åwk¢€a@)
110108. [Ž] Phosphoinositide 3-Kinase P110Â-Signaling Is Critical for Microbiota-Activated IL-10 Production by B Cells that Regulate Intestinal Inflammation. Oka A, Mishima Y, Liu B, Herzog JW, Steinbach EC, Kobayashi T1,2, Plevy SE, Sartor RB: Cells 2019/9; 8 (10): 1121. (¬Ñ@ñ1,2: 1åw@ãÃn€È, 2k¢åwk¢€a@)
110109. [Ž] Ulcerative colitis outcomes research in Japan: protocol for an observational prospective cohort study of YOURS (YOu and Ulcerative colitis: Registry and Social network). Yamazaki H, Matsuoka K, Fernandez J, Hibi T1, Watanabe M, Hisamatsu T, Shunichi Fukuhara S: BMJ Open 2019/9; 9 (9): e030134. (úäI¶1: 1k¢åwk¢€a@)
110110. [Ž] Infliximab biosimilar CT-P13 is interchangeable with its originator for patients with inflammatory bowel disease in real world practice. Nakagawa T, Kobayashi T1,2, Nishikawa K, Yamada F, Asai S, Sameshima Y, Suzuki Y, Watanabe M, Hibi T2: Intest Res 2019/10; 17 (4): 504-15. (¬Ñ@ñ1,2, úäI¶2: 1åw@ãÃn€È, 2k¢åwk¢€a@)
110111. [Ž] Withdrawal of thiopurines in Crohn's disease treated with scheduled adalimumab maintenance: a prospective randomised clinical trial (DIAMOND2). Hisamatsu T, Kato S, Kunisaki R, Matsuura M, Nagahori M, Motoya S, Esaki M, Fukata N, Inoue S, Sugaya T, Sakuraba H, Hirai F, Watanabe K, Kanai T, Naganuma M, Nakase H, Suzuki Y, Watanabe M, Hibi T1, Nojima M, Matsumoto T, DIAMOND2 Study Group (Kobayashi T1,2): J Gastroenterol 2019/10; 54 (10): 860-70. (úäI¶1, ¬Ñ@ñ1,2: 1k¢åwk¢€a@, 2åw@ãÃn€È)
110112. [Ž] Adverse events in patients with ulcerative colitis treated with indigo naturalis: a Japanese nationwide survey. Naganuma M, Sugimoto S, Suzuki H, Matsuno Y, Araki T, Shimizu H, Hayashi R, Fukuda T, Nakamoto N, Iijima H, Nakamura S, Kataoka M, Tamura Y, Tatsumi K, Hibi T1, Suzuki Y, Kanai T, INDIGO survey Group: J Gastroenterol 2019/10; 54 (10): 891-6. (úäI¶1: 1k¢åwk¢€a@)
110113. [Ž] Tofacitinib as Induction and Maintenance Therapy in Japanese Patients with Active Ulcerative Colitis. Suzuki Y, Watanabe M, Matsui T, Motoya S, Hisamatsu T, Yuasa H, Tabira J, Isogawa N, Tsuchiwata S, Arai S, Hibi T1: Inflamm Intest Dis 2019/10; 4 (4): 131-43. (úäI¶1: 1k¢åwk¢€a@)
510005. [à] Mechanism-Based Treatment Strategies for IBD: Cytokines, Cell Adhesion Molecules, JAK Inhibitors, Gut Flora, and More. Schreiner P, Neurath MF, Ng SC, El-Omar EM, Sharara AI, Kobayashi T1,2, Hisamatsu T, Hibi T2, Rogler G: Inflamm Intest Dis 2019/8; 4 (3): 79-96. (¬Ñ@ñ1,2, úäI¶2: 1åw@ãÃn€È, 2k¢åwk¢€a@)
[wïE€ï]
713027. [wï (Û)] (êÊu) Does switching between 5-aminosalicylates affest thiopurine metabolism and clinical outcomes in patients with ulcerative colitis? Morikubo H1, Kobayashi T1,2, Ozaki R, Okabayashi S, Kiyohara H1, Matsubayashi M1, Sagami S1,3, Nakano M1, Ikezaki O, Hisamatsu T, Hibi T1: Digestive Disease Week 2019 (2019/5/18-21), San Diego, USA. (XvÛñ1, ¬Ñ@ñ1,2, ŽŽTM1, ŒÑ^1, ²ãWŸY1,3, ì@ë1, úäI¶1: 1k¢åwk¢€a@, 2åw@ãÃn€È, 3Ç«°Ÿ³)
713028. [wï (Û)] (êÊu) Clinical characteristics and outcomes of 5-ASA intolerance in patients with ulcerative colitis. Kiyohara H1, Kobayashi T1,2, Morikubo H1, Matsubayashi M1, Sagami S1,3, Koike Y, Hibi T1: AOCC 2019 (2019/6/14-16), Taipei, Taiwan. (ŽŽTM1, ¬Ñ@ñ1,2, XvÛñ1, ŒÑ^1, ²ãWŸY1,3, ¬rSi, úäI¶1: 1k¢åwk¢€a@, 2åw@ãÃn€È, 3Ç«°Ÿ³)
722029. [wï (S)] (`Z~i[)yiïzUC¡ÃÉš¯éTNFjQÃ@ÌVœÈÊut¯ðßÄ. úäI¶ (k¢åwk¢€a@): æ105ñú{Á»íawïï (2019/5/9), àò.
722030. [wï (S)] (CujOZ~i[ )yiïzIBDÉš¯éÖoCI}[J[ÌW]ÆÛè. úäI¶ (k¢åwk¢€a@): æ105ñú{Á»íawïï (2019/5/9), àò.
722031. [wï (S)] (V|WE)uIBDÌVK¡Ã@vDrug-tolerant assayÉæéRCtLV}uR̪èÌLp«. úä¥F, ¬Ñ@ñ1,2, XvÛñ2, ŽŽTM2, ŒÑ^2, ²ãWŸY2,3, ì@ë2, vŒê, úäI¶2 (1åw@ãÃn€È, 2k¢åwk¢€a@, 3Ç«°Ÿ³): æ56ñú{Á»íÆuwïï (2019/8/2), s.
722032. [wï (S)] (³çu)yiïzIBDÆDP|êqÉyÚ·òš¡ÃÌe¿. úäI¶ (k¢åwk¢€a@): æ56ñú{Á»íÆuwïï (2019/8/2), s.
722033. [wï (S)] (ubNt@[XgZ~i[)yiïzChallenge! °ÇS§ß«©çIBD¡ÃðÄl·é. úäI¶ (k¢åwk¢€a@): æ61ñú{Á»íawïåï (JDDW 2019 KOBE) (2019/11/21), _Ë.
722034. [wï (S)] (µÒu)yiïzCommon mistakes in the treatment of the gospitalized patient with UC. úäI¶ (k¢åwk¢€a@): æ61ñú{Á»íawïåï (JDDW 2019 KOBE) (2019/11/21), _Ë.
722035. [wï (S)] (TeCgV|WE)yÀ·zJAKjQÜÌîbÆÕ°. úäI¶ (k¢åwk¢€a@): æ61ñú{Á»íawïåï (JDDW 2019 KOBE) (2019/11/23), _Ë.
723138. [wï (S)] (êÊu) ×á«å°³ÒÉš¯é5-ASA»ÜXCb`ª`Iv»ÜãÓÈçÑÉòøÊÉ^Šée¿. XvÛñ1, öè@Ç, ŽŽTM1, ºã»q, ŒÑ^1, ²ãWŸY1,2, ì@ë1, vŒê, úäI¶1, ¬Ñ@ñ1,3 (1k¢åwk¢€a@, 2Ç«°Ÿ³, 3åw@ãÃn€È): æ105ñú{Á»íawïï (2019/5/9), àò.
723139. [wï (S)] (êÊu) Drug-tolerant assayÉæéRCtLV}uR̪èÌLp«. úä¥F, ¬Ñ@ñ1,2, XvÛñ1, ŽŽTM1, ŒÑ^1, ²ãWŸY1,3, ì@ë1, úäI¶1 (1k¢åwk¢€a@, 2åw@ãÃn€È, 3Ç«°Ÿ³): æ56ñú{Á»íÆuwïï (2019/8/1-2), s.
723140. [wï (S)] (êÊu) Ç«°Ÿ³Éš¯éÌO®Ž¹gžÌLp«. ²ãWŸY1,2, ¬Ñ@ñ2,3, ŽÀßq, àòOY, Ñ@K², ì@ë2, úäI¶2 (1Ç«°Ÿ³, 2k¢åwk¢€a@, 3åw@ãÃn€È): æ37ñú{å°žwïï (2019/11/2), .
723141. [wï (S)] (êÊu) ÀÕ°Éš¯éuf\jh°ÌgpÆ»ÌLp«. ŒÑ^1, ¬Ñ@ñ1,2, úäI¶1 (1k¢åwk¢€a@, 2åw@ãÃn€È): æ61ñú{Á»íawïåï (JDDW 2019 KOBE) (2019/11/21), _Ë.
723142. [wï (S)] (êÊu) Mirikizumab (RIL23p19RÌ»Ü) Ìú{lðÜÞN[a (CD) ³ÒÅÌæII±Ì52TÌLø«yÑÀS«. {J@, nÓ@ç, úäI¶1 (1k¢åwk¢€a@): æ61ñú{Á»íawïåï (JDDW 2019 KOBE) (2019/11/21), _Ë.
723143. [wï (S)] (êÊu) Drug-tolerant assay ÉæéRCtLV}uR̪èÌLp«. úä¥F, ¬Ñ@ñ1,2, XvÛñ2, ŽŽTM2, ŒÑ^2, ²ãWŸY2,3, ì@ë2, vŒê, úäI¶2 (1åw@ãÃn€È, 2k¢åwk¢€a@, 3Ç«°Ÿ³): æ61ñú{Á»íawïåï (JDDW 2019 KOBE) (2019/11/22), _Ë.
723144. [wï (S)] (êÊu) ×á«å°Éš¯éoïAŽ¹gÌffžx. ŽÀßq, ²ãWŸY1,2, ~cüç, àòOY, Ñ@K², XvÛñ2, ŒÑ^2, ŽŽTM2, ì@ë2, úäI¶2, ¬Ñ@ñ2,3 (1Ç«°Ÿ³, 2k¢åwk¢€a@, 3åw@ãÃn€È): æ10ñú{Ç«°Ÿ³wïwpWï (2019/11/29), ª.
723145. [wï (S)] (êÊu) ×á«å°³ÒªøŠé¢è|web ÉæéAP[g²žÊ|. ÎŽÆæÝ, ¬Ñ@ñ1,2, rãRÀ, gŽÇê, úäI¶2 (1åw@ãÃn€È, 2k¢åwk¢€a@): æ10ñú{Ç«°Ÿ³wïwpWï (2019/11/29), ª.
723146. [wï (S)] (êÊu) Mirikizumab (RIL23p19RÌ»Ü) Ìú{lðÜÞN[a (CD) ³ÒÅÌæII±Ì12TÌLø«yÑÀS«. œäèm, Bruce E Sands, William J Sandborn, Laurent Peyrin-Biroulet, Peter DR Higgins, @q, ¢ämê, Ruth Belin, Elisa Gomez Valderas, Debra Miller, MaryAnn Morgan-Cox, April Naegeli, Paul Pollack, Jay Tuttle, nÓ@ç, úäI¶1 (1k¢åwk¢€a@): æ10ñú{Ç«°Ÿ³wïwpWï (2019/11/29), ª.
723147. [wï (S)] (êÊu) ×á«å°Éš¯éoïAŽ¹gÌóe«: AP[g²ž. ~cüç, ²ãWŸY1,2, ŽÀßq, àòOY, Ñ@K², XvÛñ2, ŒÑ^2, ŽŽTM2, ì@ë2, úäI¶2, ¬Ñ@ñ2,3 (1Ç«°Ÿ³, 2k¢åwk¢€a@, 3åw@ãÃn€È): æ10ñú{Ç«°Ÿ³wïwpWï (2019/11/29), ª.
723148. [wï (S)] (êÊu) ×á«å°ÉηéSgXeCh¡ÃÉÖ·éãtÌÓ¯šæÑÀî: EFu²žÊæè. ¬Ñ@ñ1,2, Ž²k, Ž{Fj, ¬Ñ^q (1åw@ãÃn€È, 2k¢åwk¢€a@): æ10ñú{Ç«°Ÿ³wïwpWï (2019/11/29), ª.
723149. [wï (S)] (êÊu) UCfÃÉš¯éÖJveN`Ìp. ¬Ñ@ñ1,2 (1åw@ãÃn€È, 2k¢åwk¢€a@): æ10ñú{Ç«°Ÿ³wïwpWï (2019/11/29), ª.
723150. [wï (S)] (êÊu) å°Ç𫜵œXeChïR«ÌdÇ×á«å°ÉεÄCtLV}uªt÷µœêá. {JÐC1, ¬Ñ@ñ1,2, ªÑTñ, öè@Ç, ²ãWŸY1,3, ì@ë1, úäI¶1 (1k¢åwk¢€a@, 2åw@ãÃn€È, 3Ç«°Ÿ³): æ16ñú{Á»ÇwïïwpWï (2020/2/7-8), ºÉ.
723151. [wï (S)] (êÊu) ñ®ú×á«å°³ÒÌ·ú\ã\ªÉCapsule Scoring of Ulcerative Colitis (CSUC) ÍLpÅ é. ŒÑ^1, ªÑTñ, ¬Ñ@ñ1,2, ì@ë1, ²ãWŸY1,3, öè@Ç, ŽŽTM1, XvÛñ1, ¢]ÀM1,3, {JÐC1, úäI¶1 (1k¢åwk¢€a@, 2åw@ãÃn€È, 3Ç«°Ÿ³): æ13ñú{JvZàŸwïwpWï (2020/2/9), ºÉ.
zÂíàÈw
[wp_¶]
110114. [Ž] Incidence, factors, and clinical significance of cholesterol crystals in coronary plaque: An optical coherence tomography study. Fujiyoshi K1, Minami Y1, Ishida K1, Kato A2, Katsura A2, Muramatsu Y2, Sato T2, Kakizaki R1, Nemoto T1, Hashimoto T1, Sato N1, Meguro K1, Shimohama T1, Tojo T1, Ako J1: Atherosclerosi. 2019/4; 283: 79-84. (¡ga1, ì@®«1, ÎcOB1, Á¡Êü2, j@Lq2, ºŒTî2, ²¡r[2, `èÇŸ1, ª{Æ¢u1, Ž{ñí1, ²¡Lm1, ÚŸY1, ºlFY1, å÷1, ¢ÃÆ1: 1zÂíà, 2åw@ãÃn€È)
110115. [Ž] Frequency and prognostic impact of intravascular imaging-guided urgent percutaneous coronary intervention in patients with acute myocardial infarction: results from J-MINUET. Okura H1, Saito Y1, Soeda T1, Nakao K1, Ozaki Y1, Kimura K1, Ako J1,2, Noguchi T1, Yasuda S1, Suwa S1, Fujimoto K1, Nakama Y1, Morita T1, Shimizu W1, Hirohata A1, Morita Y1, Inoue T1, Okamura A1, Uematsu M1, Hirata K1, Tanabe K1, Shibata Y1, Owa M1, Tsujita K1, Nishimura K1, Miyamoto Y1, Ishihara M1 (1J-MINUET investigators): Heart Vessels 2019/4; 34 (4): 564-71. (¢ÃÆ1,2: 2zÂíà)
110116. [Ž] Admission Heart Rate Is a Determinant of Effectiveness of Beta-Blockers in Acute Myocardial Infarction Patients. Okuno T1, Aoki J1, Tanabe K1, Nakao K1, Ozaki Y1, Kimura K1, Ako J1,2, Noguchi T1, Yasuda S1, Suwa S1, Fujimoto K1, Nakama Y1, Morita T1, Shimizu W1, Saito Y1, Hirohata A1, Morita Y1, Inoue T1, Okamura A1, Mano T1, Hirata K1, Shibata Y1, Owa M1, Tsujita K1, Funayama H1, Kokubu N1, Kozuma K1, Uemura S1, Tobaru T1, Saku K1, Ohshima S1, Nishimura K1, Miyamoto Y1, Ogawa H1, Ishihara M1 (1J-MINUET Investigators): Circ J 2019/4; 83 (5): 1054-63. (¢ÃÆ1,2: 2zÂíà)
110117. [Ž] Impaired Flow-Mediated Dilation and Severity and Vulnerability of Culprit Plaque in Patients with Coronary Artery Disease. Nemoto T1, Minami Y1, Yamaoka-Tojo M2, Sato T3, Muramatsu Y3, Kakizaki R1, Fujiyoshi K1, Hashimoto T1, Meguro K1, Shimohama T1, Tojo T1, Ako J1: Int Heart J 2019/5; 60 (3): 539-45. (ª{Æ¢u1, ì@®«1, üÞq2, ²¡r[3, ºŒTî3, `èÇŸ1, ¡ga1, Ž{ñí1, ÚŸY1, ºlFY1, å÷1, ¢ÃÆ1: 1zÂíà, 2ãÃq¶w, 3åw@ãÃn€È)
110118. [Ž] Clinical experience of idarucizumab use in cases of cardiac tamponade under uninterrupted anticoagulation of dabigatran during catheter ablation of atrial fibrillation. Okishige K, Yamauchi Y, Hanaki Y, Inoue K, Tanaka N, Yamaji H, Murakami T, Manita M, Tabata K, Ooie T, Tatsukawa Y, Sakai H, Yamaki M, Murakami M, Takada T, Osaka Y, Ono Y, Handa K, Sugiyama K, Yoshizawa T1, Fukaya H1, Tashiro H, Takase S, Harada M, Watanabe E, Yamane T, Yamashita S, Aonuma K: J Thromb Thrombolysis 2019/5; 47 (4): 487-94. (öàVq`1, [Jpœ1: 1zÂíà)
110119. [Ž] Investigation into Lipid Management in Acute Coronary Syndrome Patients from the EXPLORE-J Study. Nakamura M, Ako J1, Arai H, Hirayama A, Murakami Y, Nohara A, Uno K, Ozaki A, Harada-Shiba M: J Atheroscler Thromb 2019/6; 26 (6): 559-72. (¢ÃÆ1: 1zÂíà)
110120. [Ž] Lipoprotein (a) level is associated with plaque vulnerability in patients with coronary artery disease: An optical coherence tomography study. Muramatsu Y1, Minami Y2, Kato A1, Katsura A1, Sato T1, Kakizaki R2, Nemoto T2, Hashimoto T2, Fujiyoshi K2, Meguro K2, Shimohama T2, Ako J2: Int J Cardiol Heart Vasc 2019/6; 24: 100382. (ºŒTî1, ì@®«2, Á¡Êü1, j@Lq1, ²¡r[1, `èÇŸ2, ª{Æ¢u2, Ž{ñí2, ¡ga2, ÚŸ2, ºlFY2, ¢ÃÆ2: 1åw@ãÃn€È, 2zÂíà)
110121. [Ž] Liraglutide suppresses atrial electrophysiological changes. Nakamura H1, Niwano S1, Niwano H, Fukaya H1, Murakami M1, Kishihara J1, Satoh A1, Yoshizawa T1, Ishizue N1, Igarashi T1, Fujiishi T1, Ako J1: Heart Vessels 2019/8; 34 (8): 1389-93. (ºmÍ1, ëìTê1, [Jpœ1, ºãëü1, ÝŽ@~1, ²¡@z1, gàVq¡1, άÆ1, Ü\1, ¡Îìü1, ¢ÃÆ1: 1zÂíà)
110122. [Ž] Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial. Ray KK1, Colhoun HM1, Szarek M1, Baccara-Dinet M1, Bhatt DL1, Bittner VA1, Budaj AJ1, Diaz R1, Goodman SG1, Hanotin C1, Harrington RA1, Jukema JW1, Loizeau V1, Lopes RD1, Moryusef A1, Murin J1, Pordy R1, Ristic AD1, Roe MT1, Tunn J1, White HD1, Zeiher AM1, Schwartz GG1, Steg PG1 (1ODYSSEY OUTCOMES Committees and Investigators, Collaborators: Ako J2): Lancet Diabetes Endocrinol 2019/8; 7 (8): 618-28. (¢ÃÆ2: 2zÂíà)
110123. [Ž] Contrast Volume and Decline in Kidney Function in Optical Coherence Tomography-Guided Percutaneous Coronary Intervention. Nemoto T1, Minami Y1, Sato T2, Muramatsu Y2, Kakizaki R1, Hashimoto T1, Oikawa J1, Fujiyoshi K1, Meguro K1, Shimohama T1, Tojo T1, Ako J1: Int Heart J 2019/9; 60 (5): 1022-9. (ª{Æ¢u1, ì@®«1, ²¡r[2, ºŒTî2, `èÇŸ1, Ž{ñí1, yì@~1, ¡ga1, ÚŸY1, ºlFY1, å÷1, ¢ÃÆ1: 1zÂíà, 2åw@ãÃn€È)
110124. [Ž] Antithrombotic Therapy for Atrial Fibrillation with Stable Coronary Disease. Yasuda S1, Kaikita K1, Akao M1, Ako J1,2, Matoba T1, Nakamura M1, Miyauchi K1, Hagiwara N1, Kimura K1, Hirayama A1, Matsui K1, Ogawa H1 (1AFIRE Investigators): N Engl J Med 2019/9; 381 (12): 1103-13. (¢ÃÆ1,2: 2zÂíà)
110125. [Ž] Effect of Alirocumab on Coronary Atheroma Volume in Japanese Patients With Acute Coronary Syndrome - The ODYSSEY J-IVUS Trial. Ako J1, Hibi K, Tsujita K, Hiro T, Morino Y, Kozuma K, Shinke T, Otake H, Uno K, Louie MJ, Takagi Y, Miyauchi K: Circ J 2019/9; 83 (10): 2025-33. (¢ÃÆ1: 1zÂíà)
110126. [Ž] Efficacy and Safety of Ivabradine in Japanese Patients With Chronic Heart Failure - J-SHIFT Study. Tsutsui H1, Momomura SI1, Yamashina A1, Shimokawa H1, Kihara Y1, Saito Y1, Hagiwara N1, Ito H1, Yano M1, Yamamoto K1, Ako J1,2, Inomata T1,2, Sakata Y1, Tanaka T1, Kawasaki Y1 (1J-SHIFT Study Investigators): Circ J 2019/9; 83 (10): 2049-60. (¢ÃÆ1,2, F³1,2: 2zÂíà)
110127. [Ž] Real-World Antithrombotic Therapy in Atrial Fibrillation Patients with a History of Percutaneous Coronary Intervention. Horiguchi A1, Fukaya H2, Oikawa J2, Shirakawa Y1, Kobayashi S1, Arakawa Y1, Nishinarita R1, Nakamura H2, Ishizue N2, Igarashi G, Satoh A2, Kishihara J2, Niwano S2, Ako J2: Int Heart J 2019/11; 60 (6): 1321-7. (xû@€1, [Jpœ2, yì@~2, ìTî1, ¬Ñüœ1, rìYI1, Œ¬cº1, ºmÍ2, άÆ2, ²¡@z2, ÝŽ@~2, ëìTê2, ¢ÃÆ2: 1åw@ãÃn€È, 2zÂíà)
110128. [Ž] Current Status and Clinical Outcomes of Oral Anticoagulant Discontinuation After Ablation for Atrial Fibrillation in Japan - Findings From the AF Frontier Ablation Registry. Okumura Y1, Nagashima K1, Arai M1, Watanabe R1, Yokoyama K1, Matsumoto N1, Otsuka T1, Suzuki S1, Hirata A1, Murakami M1, Takami M1, Kimura M1, Fukaya H1,2, Nakahara S1, Kato T1, Shimizu W1, Iwasaki YK1, Hayashi H1, Harada T1, Nakajima I1, Okumura K1, Koyama J1, Tokuda M1, Yamane T1, Momiyama Y1, Tanimoto K1, Soejima K1, Nonoguchi N1, Ejima K1, Hagiwara N1, Harada M1, Sonoda K1, Inoue M1, Kumagai K1, Hayashi H1, Satomi K1, Yazaki Y1, Watari Y1 (1AF Ablation Frontier Registry): Circ J 2019/11; 83 (12): 2418-27. ([Jpœ1,2: 2zÂíà)
110129. [Ž] Effect of combination of non-slip element balloon and drug-coating balloon for in-stent restenosis lesions (ELEGANT study). Aoki J1, Nakazawa G1, Ando K1, Nakamura S1, Tobaru 1, Sakurada M1, Okada H1, Hibi K1, Zen K1, Habara S1, Fujii K1, Habara M1, Ako J1,2, Asano T1, Ozaki S1, Fusazaki T1, Kozuma K1 (1ELEGANT Investigators): J Cardiol 2019/11; 74 (5): 436-42. (¢ÃÆ1,2: 2zÂíà)
110130. [Ž] Clinical and Laboratory Predictors for Plaque Erosion in Patients With Acute Coronary Syndromes. Yamamoto E, Yonetsu T, Kakuta T, Soeda T, Saito Y, Yan BP, Kurihara O, Takano M, Niccoli G, Higuma T, Kimura S, Minami Y1, Ako J1, Adriaenssens T, Boeder NF, Nef HM, Fracassi F, Sugiyama T, Lee H, Crea F, Kimura T, Fujimoto JG, Fuster V, Jang IK: J Am Heart Assoc 2019/11; 8 (21): e012322. (ì@®«1, ¢ÃÆ1: 1zÂíà)
110131. [Ž] Association of onset-season with characteristics and long-term outcomes in acute myocardial infarction patients: results from the Japanese registry of acute myocardial infarction diagnosed by universal definition (J-MINUET) substudy. Okuno T1, Aoki J1, Tanabe K1, Nakao K1, Ozaki Y1, Kimura K1, Ako J1,2, Noguchi T1, Yasuda S1, Suwa S1, Fujimoto K1, Nakama Y1, Morita T1, Shimizu W1, Saito Y1, Hirohata A1, Morita Y1, Inoue T1, Okamura A1, Mano T1, Hirata K1, Shibata Y1, Owa M1, Tsujita K1, Funayama H1, Kokubu N1, Kozuma K1, Uemura S1, Tobaru T1, Saku K1, Ohshima S1, Nishimura K1, Miyamoto Y1, Ogawa H1, Ishihara M1 (1J-MINUET investigators): Heart Vessels 2019/12; 34 (12): 1899-908. (¢ÃÆ1,2: 2zÂíà)
110132. [Ž] Risk Factors of In-Hospital Lethal Arrhythmia Following Acute Myocardial Infarction in Patients Undergoing Primary Percutaneous Coronary Intervention -Insight From the J-MINUET Study-. Oikawa J1, Fukaya H1, Ako J1, Nakao K, Ozaki Y, Kimura K, Noguchi T, Suwa S, Fujimoto K, Nakama Y, Morita T, Shimizu W, Saito Y, Hirohata A, Morita Y, Inoue T, Okamura A, Mano T, Miyamoto Y, Ogawa H, Ishihara M, on behalf the J-MINUET investigators: Circulation Reports 2020/1; 2 (1): 17-23. (yì@~1, [Jpœ1, ¢ÃÆ1: 1zÂíà)
110133. [Ž] Guideline adherence and long-term clinical outcomes in patients with acute myocardial infarction: a Japanese Registry of Acute Myocardial Infarction Diagnosed by Universal Definition (J-MINUET) substudy. Wada H1, Ogita M1, Suwa S1, Nakao K1, Ozaki Y1, Kimura K1, Ako J1,2, Noguchi T1, Yasuda S1, Fujimoto K1, Nakama Y1, Morita T1, Shimizu W1, Saito Y1, Hirohata A1, Morita Y1, Inoue T1, Okamura A1, Mano T1, Hirata K1, Tanabe K1, Shibata Y1, Owa M1, Tsujita K1, Funayama H1, Kokubu N1, Kozuma K1, Uemura S1, Toubaru T1, Saku K1, Oshima S1, Nishimura K1, Miyamoto Y1, Ogawa H1, Ishihara M1 (1J-MINUET investigators): Eur Heart J Acute Cardiovasc Care 2020/1; 2048872620902024. (¢ÃÆ1,2: 2zÂíà)
110134. [Ž] Age- and Gender-Related Differences in Coronary Lesion Plaque Composition on Optical Coherence Tomography. Sato T1, Minami Y2, Asakura K1, Katamine M1, Kato A1, Katsura A1, Muramatsu Y1, Kakizaki R2, Nemoto T2, Hashimoto T2, Fujiyoshi K2, Kameda R2, Meguro K2, Shimohama T2, Ako J2: Circ J 2020/2; 84 (3): 463-70. (²¡r[1, ì@®«2, ©qŽj1, Ðô³á©1, Á¡Êü1, j@Lq1, ºŒTî1, `èÇŸ2, ª{Æ¢u2, Ž{ñí2, ¡ga2, Tc@Ç2, ÚŸY2, ºlFY2, ¢ÃÆ2: 1åw@ãÃn€È, 2zÂíà)
110135. [Ž] Novel volumetric analysis for stent expansion after drug-eluting stent implantation: An optical coherence tomography study. Katsura A1, Minami Y2, Kato A1, Muramatsu Y1, Sato T1, Hashimoto T2, Meguro K2, Shimohama T2, Ako J2: Catheter Cardiovasc Interv 2020/11; 96 (5): E501-7. doi: 10.1002/ccd.28871. Epub 2020 Mar 23. (j@Lq1, ì@®«2, Á¡Êü1, ºŒTî1, ²¡r[1, Ž{ñí2, ÚŸY2, ºlFY2, ¢ÃÆ2: 1åw@ãÃn€È, 2zÂíà)
110136. [Ž] Wearable Cardioverter Defibrillator -Initial Experience in the Outpatient Setting in Japan. Horiguchi A1, Kishihara J2, Niwano S2, Saito D1, Matsuura G1, Sato T1, Shirakawa Y1, Kobayashi S1, Arakawa Y1, Nishinarita R1, Nakamura H2, Ishizue N2, Oikawa J2, Satoh A2, Fukaya H2, Ako J2: Circulation Reports 2020/3; 2 (3): 137-142. (xû@€1, ÝŽ@~2, ëìTê2, âV¡å÷1, ŒY@³1, ²¡r[1, ìTî1, ¬Ñüœ1, rìYI1, Œ¬cº1, ºmÍ2, άÆ2, yì@~2, ²¡@z2, [Jpœ2, ¢ÃÆ2: 1åw@ãÃn€È, 2zÂíà)
110137. [Ž] Admission During Off-Hours Does Not Affect Long-Term Clinical Outcomes of Japanese Patients with Acute Myocardial Infarction. Suwa S1, Ogita M1, Ebina H1, Nakao K1, Ozaki Y1, Kimura K1, Ako J1,2, Noguchi T1, Yasuda S1, Fujimoto K1, Nakama Y1, Morita T1, Shimizu W1, Saito Y1, Hirohata A1, Morita Y1, Inoue T1, Okamura A1, Mano T1, Hirata K1, Tanabe K1, Shibata Y1, Owa M1, Tsujita K1, Funayama H1, Kokubu N1, Kozuma K1, Uemura S1, Toubaru T1, Saku K1, Oshima S1, Nishimura K1, Miyamoto Y1, Ogawa H1, Ishihara M1 (1J-MINUET investigators): Int Heart J 2020/3; 61 (2): 215-22. (¢ÃÆ1,2: 2zÂíà)
120004. [Ž] k¢åwa@~}åÉš¯éž_fÃÌ»ó. Œ¬cº1, ëìTê2, ŒY@³1, rìYI1, ¬Ñüœ1, ìTî1, xû@€1, ºmÍ2, άÆ2, yì@~2, Ü\µ2, ÝŽ@~2, ²¡@z2, [Jpœ2, ÂRŒP3, ¢ÃÆ2 (1åw@ãÃn€È, 2zÂíà, 3fÃ): Sd} 2019/8; 39 (suppl 2): 4147.
310011. [Çáñ] Use of idarucizumab for dabigatran reversal in cardiac tamponade during atrial fibrillation ablation: A case report. Yoshizawa T1, Niwano S1, Fukaya H1, Saitoh D2, Fujiyoshi K1, Nakamura H1, Igarashi T1, Oikawa J1, Satoh A1, Kishihara J1, Ako J1: J Cardiol Cases 2019/5; 20 (1): 27-9. (gàVq¡1, ëìTê1, [Jpœ1, âV¡å÷2, ¡ga1, ºmÍ1, Ü\1, yì@~1, ²¡@z1, ÝŽ@~1, ¢ÃÆ1: 1zÂíà, 2åw@ãÃn€È)
310012. [Çáñ] Early inappropriate shock in a subcutaneous cardiac defibrillator due to subcutaneous air. Nishinarita R1, Kishihara J2, Matsuura G1, Arakawa Y1, Kobayashi S1, Shirakawa Y1, Horiguchi A1, Nakamura H2, Ishizue N2, Oikawa J2, Fukaya H2, Niwano S2, Ako J2: J Arrhythm 2019/6; 35 (4): 682-4. (Œ¬cº1, ÝŽ@~2, ŒY@³1, rìYI1, ¬Ñüœ1, ìTî1, xû@€1, ºmÍ2, άÆ2, yì@~2, [Jpœ2, ëìTê2, ¢ÃÆ2: 1åw@ãÃn€È, 2zÂíà)
310013. [Çáñ] Transaortic Access Using Vascular Graft for Transcatheter Aortic Valve Implantation. Kakizaki R1, Meguro K1, Kitamura T2, Hashimoto T1, Ako J1: Int Heart J 2019/7; 60 (4): 990-3. (`èÇŸ1, ÚŸY1, kº@¥2, Ž{ñí1, ¢ÃÆ1: 1zÂíà, 2SÇO)
310014. [Çáñ] Early Safety and Efficacy of Sapien 3 20 mm Transcatheter Heart Valve Implantation in Small Japanese Body Size. Meguro K1, Kakizaki R1, Hashimoto T1, Yanagisawa T1, Koitabashi T1, Kitamura T2, Ako J1: Heart Surg Forum 2018/8; 21 (5): E341-4. (ÚŸY1, `èÇŸ1, Ž{ñí1, öàVq`1, ¬ÂŽrü1, kº@¥2, ¢ÃÆ1: 1zÂíà, 2SÇO)
310015. [Çáñ] Zero-Contrast Optical Coherence Tomography- and Physiology-Guided Percutaneous Coronary Intervention for Severely Calcified Lesion. Asakura K1, Minami Y2, Shimohama T2, Ako J2: Circ J 2019/10; 83 (11): 2326. (©qŽj1, ì@®«2, ºlFY2, ¢ÃÆ2: 1åw@ãÃn€È, 2zÂíà)
310016. [Çáñ] Coronary Artery Injury Caused by Leadless Pacemaker Implantation. Fukaya H1, Kishihara J1, Ishizue N1, Kameda R1, Shimohama T1, Arakawa Y2, Nishinarita R2, Horiguchi A2, Oikawa J1, Niwano S1, Ako J1: Circ J 2020/2; 84 (3): 530. ([Jpœ1, ÝŽ@~1, άÆ1, Tc@Ç1, ºlFY1, rìYI2, Œ¬cº2, xû@€2, yì@~1, ëìTê1, ¢ÃÆ1: 1zÂíà, 2åw@ãÃn€È)
511002. [ðà]yEditorialzBleeding risk score in Japanese patients on antiplatelets plus an anticoagulant. Fukaya H1, Ako J1: J Cardiol 2019/6; 73 (6): 466-7. ([Jpœ1, ¢ÃÆ1: 1zÂíà)
511003. [ðà] Editorial to ""Bipolar radiofrequency catheter ablation between the left ventricular endocardium and great cardiac vein for refractory ventricular premature complexes originating from the left ventricular summit"". Niwano S1: J Arrhythm 2020/2; 36 (2): 367. (ëìTê1: 1zÂíà)
522025. [uÀ] Epoch-making: CABANA trialðó¯ÄÌJe[eAu[VÌK. [Jpœ (zÂíà): CATH LAB JIN 2019/8; 2 (3): 81-4.
522026. [uÀ]yÁW: ¥®¬sÄãÌR¬ÂERÃÅÃ@É¢ÄzoXNðº€ÇáÉηéPCI¡Ã: ÁÉoðº€Á»í««îáÌpOÉPCIðs€æ€ÈP[XÅ, Ç꟯ÒÄÎèpªÂ\ÈÌ©? ºlFY1, ¢ÃÆ1 (1zÂíà): ú{¥Ÿ³wïG 2019/9; 1: 38-41.
522027. [uÀ]yÁWu¶KµavfÃÌVª¬: ±Ì10NÅœªÏíÁœzÇáQÌúffEV¡ÃÆdÇ»\h@¥®¬Ÿ³. ºlFY1, Tc@Ç1, ¢ÃÆ1 (1zÂíà): ffÆ¡Ã 2019/9; 107 (9): 1059-67.
522028. [uÀ]yÁW: }«¥ÇóQ@ÀÕ°É«éòš¡ÃÌm¯ÆXLðgɯéz¡oçI¥®¬C^[xVãÌRðÃ@Q&A@5. RÃÅò (oûRÃÅòàÜÞ) Í¢ÂEÇ̳ÒÉEÇ€g€©? Tc@Ç1, ºlFY1, ¢ÃÆ1 (1zÂíà): òÇ 2019/11; 70 (12): p.61-70.
530005. [»ÌŒ (Guideline)] JCS 2018 Guideline on Diagnosis and Treatment of Acute Coronary Syndrome. Kimura K1, Kimura T1, Ishihara M1, Nakagawa Y1, Nakao K1, Miyauchi K1, Sakamoto T1, Tsujita K1, Hagiwara N1, Miyazaki S1, Ako J1,2, Arai H1, Ishii H1, Origuchi H1, Shimizu W1, Takemura H1, Tahara Y1, Morino Y1, Iino K1, Itoh T1, Iwanaga Y1, Uchida K1, Endo H1, Kongoji K1, Sakamoto K1, Shiomi H1, Shimohama T1,2, Suzuki A1, Takahashi J1, Takeuchi I1, Tanaka A1, Tamura T1, Nakashima T1, Noguchi T1, Fukamachi D1, Mizuno T1, Yamaguchi J1, Yodogawa K1, Kosuge M1, Kohsaka S1, Yoshino H1, Yasuda S1, Shimokawa H1, Hirayama A1, Akasaka T1, Haze K1, Ogawa H1, Tsutsui H1, Yamazaki T1 (1Japanese Circulation Society Joint Working Group): Circ J 2019/4; 83 (5): 1085-96. (¢ÃÆ1,2, ºlFY1,2: 2zÂíà)
[@]
620014. [wp (ªS·M)]yzÂíÇóQ (æ3Å) I|»ÌŒÌzÂퟳðÜßÄ| (Êûú{ÕଠÌæÊÇóQV[Y No.5)zII. SØŸ³@43. ×E«SØ, p.308-11. çc@1, ¢ÃÆ1 (1zÂíà), ú{Õà¬Ð, , 2019/9s.
620015. [wp (ªS·M)]yzÂíÇóQ (æ3Å) II|»ÌŒÌzÂퟳðÜßÄ| (Êûú{ÕଠÌæÊÇóQV[Y No.6)zVI. ¥®¬E쟳EsÙí@39. XegàðÇ (}«E}«Ex«), p.193-7. ºlFY1, ¢ÃÆ1 (1zÂíà), ú{Õà¬Ð, , 2019/10s.
620016. [wp (ªS·M)]yúífÃÉ©·fÃKChCUP-TO-DATE 2020-2021zIII. zÂퟳ@3. ·SÇ, p.163-7. ºŒTî1, ºlFY2, ¢ÃÆ2 (1åw@ãÃn€È, 2zÂíà), ÄC: åe@F, ¬ºê¬, {nÇ÷, fBJr
[Ð, , 2020/2s.
620017. [wp (ªS·M)]yzÂínre[VÌ_ÆZp üùæ2ÅzI ðUwÌm¯@SÌ\¢Æ@\, p.2-18. IV nre[VÌœß̳Ò]¿@Sd}Ìfû, p.135-65. c@ì1 (1ãÃq¶w), Ò: c@ì1, ŒiÄF1, WJr
[Ð, , 2020/3s.
620018. [wp (ªS·M)]yzÂínre[VÌ_ÆZp üùæ2ÅzIII zÂퟳÌaÔÆ¡Ã@³«SŸ³, p.75-83. üÞq1 (1ãÃq¶w), Ò: c@ì1, ŒiÄF1, WJr
[Ð, , 2020/3s.
620019. [wp (ªS·M)]yzÂínre[VÌ_ÆZp üùæ2ÅzIII zÂퟳÌaÔÆ¡Ã@SsS, p.84-93. F³1 (1zÂíà), Ò: c@ì2, ŒiÄF2 (2ãÃq¶w), WJr
[Ð, , 2020/3s.
620020. [wp (ªS·M)]yzÂínre[VÌ_ÆZp üùæ2ÅzIII zÂퟳÌaÔÆ¡Ã@åÇŸ³, p.94-108. V nre[V (_)@Ö, p.307-13. ìcçt1 (1zÂíà), Ò: c@ì2, ŒiÄF2 (2ãÃq¶w), WJr
[Ð, , 2020/3s.
620021. [wp (ªS·M)]yzÂínre[VÌ_ÆZp üùæ2ÅzIV nre[VÌœß̳Ò]¿@Snre[VÉÖ·éSGR[©Ìð, p.211-25. Oìbü1 (1zÂíà), Ò: c@ì2, ŒiÄF2 (2ãÃq¶w), WJr
[Ð, , 2020/3s.
[wïE€ï]
713029. [wï (Û)] (êÊu) The one-year follow-up of SAPIEN 3 20 mm Transcatheter Heart Valve Implantation in Asian, small body size patients. Meguro K1, Kakizaki R1, Hashimoto T1, Yanagisawa T1, Ako J1: Euro PCR 2019 (2019/5/21), Paris, France. (ÚŸY1, `èÇŸ1, Ž{ñí1, öàVq`1, ¢ÃÆ1: 1zÂíà)
713030. [wï (Û)] (êÊu) Coronary Stenosis & Plaque Characterization. Ako J1: Asian Pacific Society of Cardiology 2019 (APSC 2019) (2019/5/24), Manila, Philippines. (¢ÃÆ1: 1zÂíà)
713031. [wï (Û)] (êÊu) The outcome of transcatheter aortic valve implantation in patients with small annulus and the comparison between intra-annular and supra-annular devices in small annulus@From the analysis of the Japanese nationwide registry (J-TVT registry). Meguro K1, Hashimoto T1, Kitamura T2, Ako J1: European Society of Cardiology (2019/9/1), Paris, France. (ÚŸY1, Ž{ñí1, kº@¥2, ¢ÃÆ1: 1zÂíà, 2SÇO)
713032. [wï (Û)] (êÊu) CORONARY ARTERY DISEASE Updates & Controversies in ACS. Ako J1: ACC Asia Conference 2019 (2019/9/13), Nagoya, Japan. (¢ÃÆ1: 1zÂíà)
713033. [wï (Û)] (êÊu) PCI For HBR Patients In Japan: Current Clinical Treatment And Post-Market Treatment. Ako J1: CRT 2020 (2020/2/24), Washington DC, USA. (¢ÃÆ1: 1zÂíà)
722036. [wï (S)] (µÒu) pê_¶ð±€! ¢ÃÆ (zÂíà): Tokyo Percutaneous cardiovascular Intervention Conference (TOPIC) 2019 (2019/7/12), .
722037. [wï (S)] (V|WE)yOê¢_z·ú±«S[×®Éηé¡Ãíª@Ž²¥ðúÒÅ«éÇáð»ÊÅ«é©. [Jpœ1, ëìTê1, ¢ÃÆ1 (1zÂíà): æ67ñú{SawïwpWï (2019/9/14), ŒÃ®.
722038. [wï (S)] (µÒu) ACS³ÒÉš¯éµi¿Ç. ¢ÃÆ (zÂíà): æ67ñú{SawïwpWï (2019/9/15), ŒÃ®.
722039. [wï (S)] (µÒu) StAÖðl¶µœAa¡Ã. ¢ÃÆ (zÂíà): æ67ñú{SawïwpWï (2019/9/15), ŒÃ®.
722040. [wï (S)] (µÒu) SÇCxg}§ðl¶µœ¿ÙíÇ¡Ãíª. ¢ÃÆ (zÂíà): æ28ñú{SÇC^[xV¡ÃwïwpWï: CVIT2019 (2019/9/20), ŒÃ®.
722041. [wï (S)] (µÒu) PCI̹Ç|XegðÇ. ¢ÃÆ (zÂíà): æ28ñú{SÇC^[xV¡ÃwïwpWï: CVIT2019 (2019/9/20), ŒÃ®.
722042. [wï (S)] (µÒu) Effect of Alirocumab on Coronary Atheroma Volume in Japanese Patients with Acute Coronary Syndrome: The ODYSSEY J-IVUS Trial. ¢ÃÆ (zÂíà): æ28ñú{SÇC^[xV¡ÃwïwpWï: CVIT2019 (2019/9/20), ŒÃ®.
722043. [wï (S)] (µÒu) PCSK9jQÜ. ¢ÃÆ (zÂíà): æ60ñú{¬Çwïï (2019/10/10), .
722044. [wï (S)] (µÒu) zÂíÌæÉš¯éæìI¡Ã. ¢ÃÆ (zÂíà): æ16ñú{zÂíÅìwïwpWï (2019/11/2), .
722045. [wï (S)] (µÒu) tTTÁÄœ? NOAC? DOAC? ¢ÃÆ (zÂíà): æ16ñú{zÂíÅìwïwpWï (2019/11/2), .
722046. [wï (S)] (µÒu) ȺzÂíãÍRðòðg€Ì©. ¢ÃÆ (zÂíà): JDDW 2019 KOBE (æ27ñú{Á»íÖAwïTÔ) (2019/11/22), _Ë.
722047. [wï (S)] (µÒu) TWILIGHT±. ¢ÃÆ (zÂíà): ARIA (Alliance for Revolution and Interventional Cardiology Advancement) 2019 (2019/11/23), ª.
722048. [wï (S)] (µÒu) AFIRE±. ¢ÃÆ (zÂíà): ARIA (Alliance for Revolution and Interventional Cardiology Advancement) 2019 (2019/11/23), ª
723152. [wï (S)] (êÊu) S[SºAÖÌüPÉæè^®üú«ÄzÏ®ªÁžµœS[u¹ÇpãÌ1á. Oìbü1, _JŸY2, sìM¶3, ìèNœ3, lèLŸ3, R{Ðq4, ìÁÞq3, Ü\óq4, ÚŸY1, ìcçt1, ºlFY1, üÞq2, c@ì2, ¢ÃÆ1 (1zÂíà, 2ãÃq¶w, 3nr, 4Åì): æ25ñú{Snre[VwïwpWï (2019/7/14), åã.
723153. [wï (S)] (êÊu) Zero-Contrast Optical Coherence Tomography- and Physiology- Guided Percutaneous Coronary Intervention for Severe Calcified Lesion. ©qŽj1, ì@®«2, ºlFY2, ¢ÃÆ2 (1åw@ãÃn€È, 2zÂíà): æ28ñú{SÇC^[xV¡ÃwïwpWï: CVIT2019 (2019/9/19), ŒÃ®.
723154. [wï (S)] (êÊu) Subsequent accumulation of organized thrombus overlying irregular protrusion caused restenosis after drug-eluting stent implantation. άÆ1, ì@®«1, ÚŸY1, ºlFY1, ¢ÃÆ1 (1zÂíà): æ28ñú{SÇC^[xV¡ÃwïwpWï: CVIT2019 (2019/9/19), ŒÃ®.
723155. [wï (S)] (êÊu) Biodegradable polymer SES had greater incidence of target lesion revascularization than 2nd-generation DES in a real-world cohort. `èÇŸ1, ì@®«1, ©qŽj2, j@Lq2, Á¡Êü2, ºŒTî2, ²¡r[2, ª{Æ¢u1, ¡ga1, ÎcOB1, Ž{ñí1, ÚŸY1, ºlFY1, ¢ÃÆ1 (1zÂíà, 2åw@ãÃn€È): æ28ñú{SÇC^[xV¡ÃwïwpWï: CVIT2019 (2019/9/19), ŒÃ®.
723156. [wï (S)] (êÊu) The efficacy and safety of dextran-based optical coherence tomography-guided percutaneous coronary intervention in patients with chronic kidney disease. Ðô³á©1, ì@®«2, ª{Æ¢u2, ºŒTî1, ©qŽj1, Á¡Êü1, j@Lq1, ²¡r[1, `èÇŸ2, Ž{ñí2, ¡ga2, ÚŸY2, ºlFY2, ¢ÃÆ2 (1åw@ãÃn€È, 2zÂíà): æ28ñú{SÇC^[xV¡ÃwïwpWï: CVIT2019 (2019/9/19), ŒÃ®.
723157. [wï (S)] (êÊu)yYIAm~l[gzü@Éš¯éàs¬xÌüPÍîSsS³Ò̶œ\ãðÇDÉ·é. cLí1, _JŸY2, lèLŸ3, ìèNœ3, Oìbü4, ìcçt4, üÞq2, ŒiÄF2, ¢ÃÆ4 (1åw@ãÃn€È, 2ãÃq¶w, 3nr, 4zÂíà): æ23ñú{SsSwïwpWï (2019/10/4), L.
731021. [wï (nûïE€ï)] (ÁÊu) IVUS guideÌ^. ºlFY (zÂíà): Tokyo Live Demonstration 2019 (2019/10/11), .
732015. [wï (nûïE€ï)] (µÒu) STENTAŠÝãRðÃ@ÌßÆ¢. ¢ÃÆ (zÂíà): æ46ñú{SÇC^[xV¡Ãwïknûï (2019/8/17), Hc.
732016. [wï (nûïE€ï)] (µÒu) Safety and effectiveness of transcatheter mitral leaflet approximation with MitraClip in heart failure patients with secondary mitral regurgitation. ¢ÃÆ (zÂíà): PCR Tokyo Valves 2020 (2020/2/16), .
'18NxÈOª
[wp_¶]
'18-110004. [Ž] Dual Anti-Thrombotic Therapy With Dabigatran After Percutaneous Coronary Intervention in Atrial Fibrillation - Japanese and East-Asian Subgroup Analysis of the RE-DUAL PCI Trial. Ako J1,2, Okumura K1, Nakao K1, Kozuma K1, Morino Y1, Okazaki K1, Fukaya T1, Kimura T1 (1RE-DUAL PCI Trial Investigators): Circ J 2019/1; 83 (2): 327-33. (¢ÃÆ1,2: 2zÂíà)
'18-110005. [Ž] Calcified Plaques in Patients With Acute Coronary Syndromes. Sugiyama T, Yamamoto E, Fracassi F, Lee H, Yonetsu T, Kakuta T, Soeda T, Saito Y, Yan BP, Kurihara O, Takano M, Niccoli G, Crea F, Higuma T, Kimura S, Minami Y1, Ako J1, Adriaenssens T, Boeder NF, Nef HM, Fujimoto JG, Fuster V, Finn AV, Falk E, Jang IK.: JACC Cardiovasc Interv 2019/3; 12 (6): 531-40. (ì@®«1, ¢ÃÆ1: 1zÂíà)
'18-522002. [uÀ]yAÚz ¡±»âë€SGR[! ¬ÂŽrü (zÂíà): Medical Practice 2019/1; 36 (1): .153.
'18-522003. [uÀ]yÁW: Common diseaseƵÄÌS[×®zIII. S[×®Ìf©çêåãÐîÜÅ. [Jpœ (zÂíà): ú{àÈwïG 2019/2; 108 (2); 212-8.
[@]
'18-620002. [wp (ªS·M)]yüYúSØÇfÃÌèø«zæVIIIÍ DYwÉš¯éÇóEgÌ©ÌfûÆžÌißû, p.54-61. ¬ÂŽrü (zÂíà), OãwÐ, , 2019/3s.
'18-620003. [wp (ªS·M)]yüYúSØÇfÃÌèø«zæIXÍ ÓÊff, p62-70. ¬ÂŽrü (zÂíà), OãwÐ, , 2019/3s.
[wïE€ï]
'18-713002. [wï (Û)] (êÊu) Antithrombotic therapy in atrial fibrillation patients undergoing PCI. Ako J1: Taiwan Transcatheter Therapeutics 2019 (2019/1/13), Taipei, Taiwan. (¢ÃÆ1: 1zÂíà)
'18-713003. [wï (Û)] (êÊu) Perspectives of AF patients with Acute Coronary Syndrome. Ako J1: 5th Myanmar Cardiac Society Conference (2019/3/3), Yangon, Myanmar. (¢ÃÆ1: 1zÂíà)
'18-722001. [wï (S)] (µÒu) The trend of double/triple therapy from Japanese investigation. ¢ÃÆ (zÂíà): æ83ñú{zÂíwïwpWï (2019/3/30), ¡l.
]_oàÈw
[wp_¶]
110138. [Ž] A cluster of disseminated small cortical lesions in MELAS: its distinctive clinical and neuroimaging features. Hongo Y1, Kaneko J1, Suga H1, Ishima D1, Kitamura E1, Akutsu T1, Onozawa Y2, Kanazawa N3, Goto T, Nishiyama K1, Iizuka T1: J Neurol 2019/6; 266 (6): 1459-72. ({œ@I1, àq~ŸY1, {êT÷1, äåã1, kºpñ1, ¢vÃñv1, ¬ìàVTç2, ààVŒü3, ŒRa1, ÑË_1: 1]_oà, 2Õ, 3aÔEfÃn)
110139. [Ž] Effectiveness of Nonvitamin K Antagonist Oral Anticoagulants and Warfarin for Preventing Further Cerebral Microbleeds in Acute Ischemic Stroke Patients with Nonvalvular Atrial Fibrillation and At Least One Microbleed: CMB-NOW Multisite Pilot Trial. Yokoyama M1, Mizuma A1, Terao T1, Tanaka F1, Nishiyama K1,2, Hasegawa Y1, Nagata E1, Nogawa S1, Kobayashi H1, Yanagimachi N1, Okazaki T1, Kitagawa K1, Takizawa S1 (1CMB-NOW Study Investigators): J Stroke Cerebrovasc Dis 2019/7; 28 (7): 1918-25. (ŒRa1,2: 2]_oà)
110140. [Ž] Transplantation of Mesenchymal Stem Cells Improves Amyloid-À Pathology by Modifying Microglial Function and Suppressing Oxidative Stress. Yokokawa K, Iwahara N, Hisahara S, Emoto MC, Saito T, Suzuki H, Manabe T, Matsumura A, Matsushita T, Suzuki S, Kawamata J1, Sato-Akaba H, Fujii HG, Shimohama S: J Alzheimers Dis 2019/11; 72 (3): 867-84. (ì@1: 1]_oà)
110141. [Ž] A mutant MATR3 mouse model to explain multisystem proteinopathy. Zhang X, Yamashita S, Hara K, Doki T, Tawara N, Ikeda T, Misumi Y, Zhang Z, Matsuo Y, Nagai M1, Kurashige T, Maruyama H, Ando Y: J Pathol 2019/10; 249 (2): 182-92. (iä^Mq1: 1_oà)
110142. [Ž] Differences in clinical features of cluster headache between drinkers and nondrinkers in Japan. Imai N, Kitamura E1: PLoS One 2019/11; 14 (11): e0224407. (kºpñ1: 1]_oà)
110143. [Ž] CD14 and Toll-Like Receptor 4 Promote Fibrillar AÀ42 Uptake by Microglia Through A Clathrin-Mediated Pathway. Fujikura M, Iwahara N, Hisahara S, Kawamata J1, Matsumura A, Yokokawa K, Saito T, Manabe T, Matsushita T, Suzuki S, Shimohama S: J Alzheimers Dis 2019/12; 68 (1): 323-37. (ì@1: 1]_oà)
110144. [Ž] Early administration of galantamine from preplaque phase suppresses oxidative stress and improves cognitive behavior in APPswe/PS1dE9 mouse model of Alzheimer's disease. Saito T, Hisahara S, Iwahara N, Emoto MC, Yokokawa K, Suzuki H, Manabe T, Matsumura A, Suzuki S, Matsushita T, Kawamata J1, Sato-Akaba H, Fujii HG, Shimohama S: Free Radic Biol Med 2019/12; 145: 20-32. (ì@1: 1]_oà)
110145. [Ž] Safety of tapering tacrolimus dose in patients with well-controlled anti-acetylcholine receptor antibody-positive myasthenia gravis. Nishida Y, Takahashi YK, Kanai T, Nose Y, Ishibashi S, Sanjo N, Uzawa A, Oda F, Ozawa Y, Kuwabara S, Noguchi E, Suzuki S, Nakahara J, Suzuki N, Ogawa T, Yokoyama K, Hattori N, Konno S, Fujioka T, Kawaguchi N, Hatanaka Y, Sonoo M, Kaneko J1, Ogino M, Nishiyama K1, Nomura K, Yokota T: Eur J Neurol 2020/1; 27 (1): 100-4. (àq~ŸY1, ŒRa1: 1]_oà)
110146. [Ž] Cognitive and behavioral status in Japanese ALS patients: a multicenter study. Watanabe Y1, Raaphorst J1, Izumi Y1, Yoshino H1, Ito S1, Adachi T1, Takigawa H1, Masuda M1, Atsuta N1, Adachi Y1, Isose S1, Arai K1, Yokota O1, Oda M1, Ogino M1, Ichikawa H1, Hasegawa K1, Kimura H1, Shimizu T1, Aiba I1, Yabe H1, Kanba M1, Kusumi K1, Aoki T1, Hiroe Y1, Watanabe H1, Nishiyama K1,2, Nomoto M1, Sobue G1, Beeldman E1, Hanajima R1, Nakashima K1 (1ALS-FTD-Q-J research group): J Neurol 2020/5; 267 (5): 1321-30. doi: 10.1007/s00415-019-09655-9. Epub 2020 Jan 18. (ŒRa1,2: 2]_oà)
110147. [Ž] Effect of rovatirelin in patients with cerebellar ataxia: two randomised double-blind placebo-controlled phase 3 trials. Nishizawa M1, Onodera O1, Hirakawa A1, Shimizu Y1, Yamada M1 (1Rovatirelin Study Group, Collaborators: Nishiyama K2): J Neurol Neurosurg Psychiatry 2020/3; 91 (3): 254-62. (ŒRa2: 2]_oà)
310017. [Çáñ] Autoimmune Encephalitis as an Extra-articular Manifestation of Rheumatoid Arthritis. Kitamura E1, Kondo Y1, Kanazawa N2, Akutsu T1, Nishiyama K1, Iizuka T1: Intern Med 2019/4; 58 (7): 1007-9. (kºpñ1, ß¡Tq1, ààVŒü2, ¢vÃñv1, ŒRa1, ÑË_1: 1]_oà, 2aÔEfÃn)
310018. [Çáñ] An autopsy case of MM2-thalamic subtype of sporadic Creutzfeldt-Jakob disease with Lewy bodies presenting as a sleep disorder mimicking anti-IgLON5 disease. Hongo Y1, Iizuka T1, Kaneko A1, Suga H1, Uchino A1, Murayama S, Namba K, Inoue Y, Nishiyama K1: J Neurol Sci 2019/9; 404: 36-9. ({œ@I1, ÑË_1, àq@ú1, {êT÷1, àì²q1, ŒRa1: 1]_oà)
310019. [Çáñ] Ramsay-Hunt syndrome and subsequent sensory neuropathy as potential immune-related adverse events of nivolumab: a case report. Sakoh T, Kanzaki M1, Miyamoto A, Mochizuki S, Kakumoto T, Sato K, Uesaka Y, Kishi K: BMC Cancer 2019/12; 19 (1): 1220. (_è^À1: 1]_oà)
310020. [Çáñ] An autopsy case of G M1 gangliosidosis type II in a patient who survived a long duration with artificial respiratory support. Uchino A, Nagai M1, Kanazawa N2, Ichinoe M3, Yanagisawa N, Adachi K, Nanba E, Ishiura H, Mitsui J, Tsuji S, Suzuki K, Murayama S, Nishiyama K1: Neuropathology 2020/8; 40 (4): 379-88. doi: 10.1111/neup.12651. Epub 2020 Mar 27. (iä^Mq1, ààVŒü2, ê˹Ÿ3, ŒRa1: 1]_oà, 2aÔEfÃn, 3a)
310021. [Çáñ] Focal hyperperfusion and elevated lactate in the cerebral lesions with anti-GABAaR encephalitis: A serial MRI study. Ueno H, Iizuka T1, Tagane Y, Yamasaki F, Akiyama Y, Hosomi N, Maruyama H: J Neuroradiol 2020/5; 47 (3): 243-6. doi: 10.1016/j.neurad.2019.10.001. Epub 2019 Nov 5. (ÑË_1: 1]_oà)
410001. [Õ°±] Induced pluripotent stem cell-based Drug Repurposing for Amyotrophic lateral sclerosis Medicine (iDReAM) study: protocol for a phase I dose escalation study of bosutinib for amyotrophic lateral sclerosis patients. Imamura K, Izumi Y, Banno H, Uozumi R, Morita S, Egawa N, Ayaki T, Nagai M1, Nishiyama K1, Watanabe Y, Hanajima R, Oki R, Fujita K, Takahashi N, Ikeda T, Shimizu A, Morinaga A, Hirohashi T, Fujii Y, Takahashi R, Inoue H: BMJ Open 2019/12; 9 (12): e033131. (iä^Mq1, ŒRa1: 1]_oà)
520005. [à] ]_oàÈÌæÉš¯éï¡«TRCh[VX̡îü. ŒRa (]_oà): ú{TRCh[VXwï 2019/9; 39 (1/2): 29-32.
520006. [à] ©ÈÆu«]šæÑ»ÌÞŸ³Éš¯éÅßÌià. ÑË_ (]_oà): Õ°_ow 2019/8; 59 (8): 491-501.
520007. [à] ]_oàÈÌæÉš¯éï¡«TRCh[VX̡îü. ŒRa (]_oà): ú{TRCh[VX^÷èî«Ÿ³wïG 2019/9; 39 (1/2): 29-32.
522029. [uÀ]yÁW: Æu«_oŸ³Ì¡Ãwz©ÈÆu«]ÌffÆ¡Ã. ÑË_ (]_oà): BIO Clinica 2019/4; 34 (5): 480-4.
530006. [»ÌŒ (Correction)] Correction to: A cluster of disseminated small cortical lesions in MELAS: its distinctive clinical and neuroimaging features. Hongo Y1, Kaneko J1, Suga H1, Ishima D1, Kitamura E1, Akutsu T1, Onozawa Y2, Kanazawa N3, Goto T, Nishiyama K1, Iizuka T1: J Neurol 2019/6; 266 (6): 1473. ({œ@I1, àq~ŸY1, {êT÷1, äåã1, kºpñ1, ¢vÃñv1, ¬ìàVTç2, ààVŒü3, ŒRa1, ÑË_1: 1]_oà, 2Õ, 3aÔEfÃn)
540033. [»ÌŒ]yú{_owï¯V|WE: _o~}EW¡ÃÉš¯é]_oàÈãÌv[XðßéœßÉziïÌŸt. ŒRa1, iR³Y (1]_oà): _o¡Ãw 2019/4; 36 (4): 478.
[@]
620022. [wp (ªS·M)] y1361êåÆÉæé Ì¡Ã [2019-20NxÅ]z8 _oEØŸ³@©ÈÆu«], p.588-90. ÑË_ (]_oà), ÄC: cj, kºyêY, ú{ãVñÐ, , 2019/7s.
620023. [wp (ªS·M)]yàÈwüèæ9Å (Vol.6)z_oŸ³@14. œ_oŸ³ (j
[p`[)@Å«j
[p`[, p.572-4. _è^À1, Cc«ê (1]_oà), ÒW: ìw³b, ÒWŠÍ: ò¹p, Ò: cÍi, RX, , 2019/8s.
620024. [wp (ªS·M)] yPTEOTÌœßÌæÌÝ©œ [æ2Å]zæ2Í _oŸ³@V. EEÏ«Ÿ³@ÒóŽÇ, p.103. ì@ (]_oà), ÄC: RºqF, ºà_@r, àŽoÅ, , 2019/12s.
[wïE€ï]
713034. [wï (Û)] (êÊu) A clinically-based score that predicts cryptogenic new-onset refractory status epilepticus (C-NORSE). Iizuka T1, Kaneko J1, Kaneko A1, Yanagida A2, Nonoda Y3, Onozawa Y4, Kanazawa N5, Dalmau J, Nishiyama K1: AAN 2019 (The 71st AAN Annual Meeting) (2019/5/5), Philadelphia, USA. (ÑË_1, àq~ŸY1, àq@ú1, öcÖq2, ìXcL3, ¬ìàVTç4, ààVŒü5, ŒRa1: 1]_oà, 2åw@ãÃn€È, 3¬, 4Õ, 5aÔEfÃn)
713035. [wï (Û)] (êÊu) Atypical Clinical Manifestations and Overlapping Immunities associated with NMDA Receptor Antibodies. Kaneko A1, Iizuka T1, Suga H1, Kaneko J1, Yamaguchi Y2, Arai H2, Matsumoto Y, Tokimura R, Murakami T, Nakatani-Enomoto S, Kanai K, Ugawa Y, Amano E, Kitamura E1, Kanazawa N3, Dalmau J, Nishiyama K1: AAN 2019 (The 71st AAN Annual Meeting) (2019/5/5), Philadelphia, USA. (àq@ú1, ÑË_1, {êT÷1, àq~ŸY1, RûFIY2, Väv«2, kºpñ1, ààVŒü3, ŒRa1: 1]_oà, 2ž_, 3aÔEfÃn)
713036. [wï (Û)] (êÊu) Neuronal Autoantibodies and Clinical Significance in Stiff-Person Spectrum Disorder. Kaneko J1, Iizuka T1, Kondo Y1, Abe Y1, Kaneko A1, Hattori K, Kobayashi S, Ugawa Y, Sekiguchi K, Maeda K, Matsumoto Y, Kanazawa N2, Kitamura E1, Dalmau J, Nishiyama K1: AAN 2019 (The 71st AAN Annual Meeting) (2019/5/5), Philadelphia, USA. (àq~ŸY1, ÑË_1, ß¡Tq1, ¢LN1, àq@ú1, ààVŒü2, kºpñ1, ŒRa1: 1]_oà, 2aÔEfÃn)
713037. [wï (Û)] (êÊu) A cluster of disseminated small cortical lesions in MELAS: its distinctive clinical and neuroimaging features. Iizuka T1, Hongo H, Kaneko J1, Suga H1, Ishima D1, Kitamura E1, Akutsu T1, Kanazawa N2, Nishiyama K1: The 16th Conference of Asian Society for Mitochondrial Research and Medicine [ASMRM] and The 19th conference of Japanese Society of Mitochondrial Research and Medicine [J-mit] (2019/10/3-5), Fukuoka, Japan. (ÑË_1, àq~ŸY1, {êT÷1, äåã1, kºpñ1, ¢vÃñv1, ààVŒü2, ŒRa1: 1]_oà, 2aÔEfÃn)
721009. [wï (S)] (ÁÊu) ž_áQð·RNMDAóeÌ]|ffÆ¡ÃãÌsbgtH[Ng|. ÑË_ (]_oà): æ66ñú{ž³ãwïï (2019/10/24), .
722049. [wï (S)] (µÒu) ©ÈÆu«]ÌXyNgÆ¡Ã. ÑË_ (]_oà): æ31ñú{_oÆuwïwpWï (2019/9/26), çt.
723158. [wï (S)] (êÊu) Physician Lead Clinical Trial of Bosutinib in ALS: iPSC-based Drug Repurposing for ALS Medicine (iDReAM) study. Imamura K, Izumi Y, Banno H, Uozumi R, Morita S, iä^Mq1, ŒRa1, Watanabe Y, Hanajima R, Takahashi N, Ikeda T, Ito T, Kusunoki Y, Shimizu A, Morinaga A, Koide Y, Hirohashi T, Fujii Y, Takahashi R, Inoue H (1]_oà): æ60ñú{_owïwpåï (2019/5/24), åã.
723159. [wï (S)] (êÊu) SOD1â`qÏÙðFßœALS³Ò5áÌÕ°oß. Icl¢q1, iä^Mq1, ìQ@¶1, ß¡Tq1, ŒRa1 (1]_oà): æ60ñú{_owïwpåï (2019/5/24), åã.
723160. [wï (S)] (êÊu) A clinically-based sacore predicting cryptogenic new-onset refractory status epilepticus (CNORSE). öcÖq1, ÑË_1, àq~ŸY1, àq@ú1, ìXcL2, ¬ìàVTç3, ààVŒü4, ŒRa1 (1]_oà, 2¬, 3Õ, 4aÔEfÃn): æ60ñú{_owïwpåï (2019/5/25), åã.
723161. [wï (S)] (êÊu) Ž}«úÄó¬Ã@ð{sµœáN«][ÇÌ¢. ¢vÃñv1, àq@ú1, {êT÷1, iärs1, Oä@É1, äåã1, àq~ŸY1, {œ@I, kºpñ1, ÑË_1, R{åã2, ŒRa1 (1]_oà, 2]O): æ60ñú{_owïwpåï (2019/5/25), åã.
723162. [wï (S)] (êÊu) Zonisamide suppression effect on CSD in a rat CSD model. kºpñ1, ÑË_1, ààVŒü2, ŒRa1 (1]_oà, 2aÔEfÃn): æ60ñú{_owïwpåï (2019/5/25), åã.
723163. [wï (S)] (êÊu) îÒü@³ÒÉš¯é¹ñÏJÆú£°ÉÖ·é¢. c@, ÑJüô1, Ž@b2, ¶Eca}, acÞüq (1]_oà, 2ž_): æ61ñú{VNãwïwpWï (2019/6/8), åä.
723164. [wï (S)] (êÊu) Autoimmune Post-Herpes Simplex Encephalitis (Post-HSE) ÉÖ·éÇáWÏ€. àq~ŸY1, ÑË_1, â£Èq1, kºpñ1, ycmü, Ü\§, üª@², ààVŒü2, ŒRa1 (1]_oà, 2aÔEfÃn): æ31ñú{_oÆuwïwpWï (2019/9/26-27), çt.
723165. [wï (S)] (êÊu) ÇŽösŸÌÄñ©ñdÏóÔÉš¯éR_o×E\ÊRŽRÌÌÖ^: ãûI¢. {êT÷1, ÑË_1, àq@ú1, öcÖq1, àq~ŸY1, kºpñ1, ààVŒü2, ŒRa1 (1]_oà, 2aÔEfÃn): æ31ñú{_oÆuwïwpWï (2019/9/26-27), çt.
723166. [wï (S)] (êÊu) Cryptogenic NORSE 27áÉÀ{³êœ}«úÆuÃ@ÉÖ·éãûI€: »óÆÛè. öcÖq1, ÑË_2, ààVŒü3, kºpñ2, ¢vÃñv2, ŒRa2 (1åw@ãÃn€È, 2]_oà, 3aÔEfÃn): æ37ñú{_o¡ÃwïwpWï (2019/11/6), ¡l.
723167. [wï (S)] (êÊu) ·xãžÆcortical spreading depressionÌÖWÉ¢Ä. kºpñ1, ààVŒü2, Øñn1, ·@œ1, ÑË_1, ŒRa1 (1]_oà, 2aÔEfÃn): æ47ñú{ªÉwïï (2019/11/16), Ya.
731022. [wï (nûïE€ï)] (ÁÊu) ©ÈÆu«]šæÑ»ÌÞŸ³ÌaÔÆ¡Ã. ÑË_ (]_oà): æ3ñNeuro Rescue Meeting (2019/6/22), q~.
731023. [wï (nûïE€ï)] (ÁÊu) ©ÈÆu«^®áQÌÕ°ÆaÔ. ÑË_ (]_oà): æ15ñKOSHIEN Movement Disorder Seminar (2019/9/12), q~.
731024. [wï (nûïE€ï)] (ÁÊu) Stroke mimicsÐá«ÐªÉÆ]²lìÌaÔðlŠé. ÑË_ (]_oà): æ43ñMetropolitan Stroke Forumwpuï (2019/11/19), .
732017. [wï (nûïE€ï)] (µÒu) II ЪÉÌffÆÇ|OÌ éЪÉ|. ÑË_ (]_oà): HMSJ 2019: Headache Master School Japan 2019 (2019/7/14), åä.
733060. [wï (nûïE€ï)] (êÊu) ]²EÒÉUÝ·éEaÏðFß, RMOGR̪tÌÝ©ço³êœ32Îj«. ·@œ1, àq~ŸY1, ÀBqü1, ¢LN1, ààVŒü2, ÑË_1, ŒRa1 (1]_oà, 2aÔEfÃn): æ229ñú{_owïÖEbMznûï (2019/6/1), .
733061. [wï (nûïE€ï)] (êÊu) œ^çÞkÇEäFSkyÑxüÛÇ𹵜Ê^~Ip`[Ì62Ϋá. R{qü1, iä^Mq1, PäkŸY1, ÀBqü1, ¢LN1, Oä@É1, kºpñ1, ŒRa1 (1]_oà): æ230ñú{_owïÖ EbMznûï (2019/9/7), .
733162. [wï (nûïE€ï)] (êÊu) ]ꮬÌÂÇ@]ÉÖ·é¢. ¢vÃñv (]_oà): ŒÃ-§_olbg[N (2019/9/12), CVŒ.
733063. [wï (nûïE€ï)] (êÊu) PwyX]Ç6TãÉ_oÇ󪫵œ45Îj«. â£Èq1, àq~ŸY1, ÑË_1, rä³ü, ààVŒü2, ŒRa1 (1]_oà, 2aÔEfÃn): æ21ñ_Þì§_oÆutH[ (2019/12/4), ¡l.
733064. [wï (nûïE€ï)] (êÊu) Propionibacterium acnesRÌ (PABRÌ) ÆuõFªz«Å Áœ]À¿^TRCh[VXÌ27Îj«á. OàVCî1, غ¶«1, àq~ŸY1, ÀBqü1, Øñn1, ·@œ1, ÑË_1, ŒRa1 (1]_oà): æ231ñú{_owïÖEbMznûï (2019/12/7), .
733065. [wï (nûïE€ï)] (êÊu) Ïíèä][ÇÌŽ}«ú¡ÃÆÄ\hÉ¢Ä. ¢vÃñv (]_oà): Face to Face ]ÇESŸ³Jt@X in ÍŽ (2019/12/9), ÍŽ.
'18NxÈOª
[wp_¶]
'18-110006. [Ž] Evaluation of Mitochondrial Oxidative Stress in the Brain of a Transgenic Mouse Model of Alzheimer's Disease by in vitro Electron Paramagnetic Resonance Spectroscopy. Manabe T, Matsumura A, Yokokawa K, Saito T, Fujikura M, Iwahara N, Matsushita T, Suzuki S, Hisahara S, JKawamata J1, Suzuki H, Emoto MC, Fujii HG, Shimohama S: J Alzheimers Dis 2019/2; 67 (3): 1079-87. (ì@1: 1]_oà)
'18-320001. [Çáñ] RglycineóeÌRÌz«Ìstiff-limbÇóQÌ1á. Ocá, Ž
F÷, ŽFq, ààVŒü1, ÑË_2 (1aÔEfÃn, 2]_oà): Õ°_ow 2019/2; 59 (2): 98-101.
'18-522004. [uÀ]yÁW: ][Ç|ÅVÌòš¡ÃíªÆÀH|CgÜÆßz¡ÅVÌGrfXÉîâœ][ÇÌòš¡Ãíª@Ni[Ç. ·@œ1, ŒRa1 (1]_oà): òÇ 2019/3; 70 (3): 379-83.
[@]
H29-620004. [wp (ªS·M)]y1336êåÆÉæé Ì¡Ã [2017-18NxÅ]z08 _oEØŸ³ (63Ÿ³)@Ç«EE«Ÿ³@[30] ×Û« (¬l), p.623-5. _è^À1, Cc«ê, (1]_oà) ÄC: cj, kºyêY, ú{ãVñÐ, , 2017/7s.
'18-620005. [wp (ªS·M)]yAnnual Review _o2019zII. {NÌ®ü@2 ©ÈÆu«]€Ìià, p.72-81. ÑË_ (]_oà), ÒW: éØ¥G, rØMv, Fì`ê, KŽ@, ìFº, OãwÐ, , 2019/3s.
[wïE€ï]
'18-723006. [wï (S)] (êÊu) ]²ÇãÝ°ÇÂÇÇÌÕ°IÁ¥Æ\ã. ²¡@I1, kºpñ1, àq@ú1, {êT÷1, iärs1, Oä@É1, äåã1, àq~ŸY1, {œ@I1, ¢vÃñv1, ÑË_1, ŒRa1 (1]_oà): æ44ñú{]²wïwpWï (2019/3/21-23), ¡l.
tàÈw
[wp_¶]
110148. [Ž] Bendamustine-120 plus rituximab therapy for relapsed or refractory follicular lymphoma: a multicenter phase II study. Sakai R, Ohmachi K, Sano F, Watanabe R, Takahashi H, Takasaki H, Tanaka M, Hattori Y, Kimura H1, Takimoto M, Tachibana T, Tanaka E, Ishii Y, Ishiyama Y, Hagihara M, Miyazaki K2, Yamamoto K, Tomita N, Ando K: Ann Hematol 2019/9; 98 (9): 2131-8. (غTa1, {ø_ñ2: 1tà, 2AE×EÚA)
110149. [Ž] Serum ferritin levels at diagnosis predict prognosis in patients with low blast count myelodysplastic syndromes. Kawabata H1, Usuki K1, Shindo-Ueda M1, Kanda J1, Tohyama K1, Matsuda A1, Araseki K1, Hata T1, Suzuki T1,2, Kayano H1, Shimbo K1, Chiba S1, Ishikawa T1, Arima N1, Nohgawa M1, Miyazaki Y1, Kurokawa M1, Arai S1, Mitani K1, Takaori-Kondo A1 (1Japanese National Research Group on Idiopathic Bone Marrow Failure Syndromes): Int J Hematol 2019/11; 110 (5): 533-42. (éز_1,2: 2tà)
522030. [uÀ]yAÚ: Ì¡ÃzSR«n. éز_ (tà): ú{ãVñ 2019/7; 4970: 39.
522031. [uÀ]yAÚ: Ì¡ÃzÔè
«n. éز_ (tà): ú{ãVñ 2019/8; 4971: 46.
522032. [uÀ]yÁW: Ù`¬ÇóQ (MDS)|îbEÕ°ÌÅV®üzIV. MDSÌ¡Ã@1. {MÉš¯é¡ÃÌ»ó@(2) AÃ@ÆSL[gÜ. éز_ (tà): ú{Õଠ2019/9; 7 7(9): 1489-95.
522033. [uÀ]yÁW: ¢sSÇÌaÔð̀ơÃÌiàupdatezsSÇ (MDS/PNH/AA) ÌaÔÚs|lŠçêé1ÂÌf|. éز_ (tà): tàÈ 2019/8; 79 (2): 127-33.
522034. [uÀ]yAÚ: Ÿ³ÆžlÌÚzSR«n. éز_ (tà): žÆZp 2019/11; 47 (11): 1302-7.
[@]
620025. [wp (ªS·M)]yãòiìpw (æ3Å) º|òÜÌÀSgpAbvf[g| (ú{Õà¬77ª§4)zVI. íEnÊìpe_|dåÈìpðSÉ|@4. t@(10) ÃÅáQ, p.210-7. xÄCê (tà), ú{Õà¬Ð, , 2019/7s.
620026. [wp (ªS·M)]yàÈw üùæ9Å (Vol.6)ztE¢ínŸ³@5. Ô
nðåaÏƷ音@n̬öEªÞEff, p.104-9. éز_ (tà), ÒW: ìw³b, ÒWŠÍ: ò¹p, RX, , 2019/8s.
620027. [wp (ªS·M)]yàÈw üùæ9Å (Vol.6)ztE¢ínŸ³@5. Ô
nðåaÏƷ音@Ù`¬ÇóQ, p.124-31. éز_ (tà), ÒW: ìw³b, ÒWŠÍ: ò¹p, RX, , 2019/8s.
620028. [wp (ªS·M)]ytêåãeLXg üùæ3ÅzæIIIÍ åvÈ¥óÆžlÙí@2. nÌÓÊ, p.33-8. éز_ (tà), Ò: ú{twï, ì]°, , 2019/10s.
620029. [wp (ªS·M)]ytêåãeLXg üùæ3ÅzæVIIIÍ Ô
nŸ³@4. ©ÈÆu«n«n: ·®, â®, p.183-5. éز_ (tà), Ò: ú{twï, ì]°, , 2019/10s.
620030. [wp (ªS·M)]ytêåãeLXg üùæ3ÅzæIXÍ
nŸ³: îá«Ÿ³@8. Ù`¬ÇóQ, p.263-8. éز_ (tà), Ò: ú{twï, ì]°, , 2019/10s.
620031. [wp (ªS·M)]ytêåãeLXg üùæ3ÅzæXIIIÍ xÃ@@4. SL[gÃ@, p.498-9. éز_ (tà), Ò: ú{twï, ì]°, , 2019/10s.
620032. [wp (ªS·M)]y¡úÌ¡Ãwj@2020NxÅz10. tŸ³@©ÈÆu«n«Ÿ³, p.678-80. éز_ (tà), ÒW: äî, Ø@œ, ¬ºê¬, ãw@, , 2020/1s.
620033. [wp (ªS·M)]yKChCOfÃ2020@¡úÌfÃÌœßÉ (æ20Å)zII êåãÌÇE¡ÃªKvÈŸ³ÌKChC@tŸ³@13. Ù`¬ÇóQ, p.490-3. éز_ (tà), ÒWå²: ò@Fp, úoBP, , 2020/3s.
[wïE€ï]
723168. [wï (S)] (êÊu) ««a³ÒÉš¯ée`VLi[[jQÜÉæétáQÌär (Risk of Renal Dysfunction Induced by Each Tyrosine Kinase Inhibitor in CML). {Žmü1, c_«1, ¥@cœ1, cÍs1, xÄCê1, ¹ºYî1, HRdÈ1, òRav1, ]šWê1, Îc@²2, {ø_ñ2, éز_1 (1tà, 2AE×EÚA): æ81ñú{twïwpWï (2019/10/11-13), , Õ°tWEBŽ^2019; PS1-3-5: S255.
723169. [wï (S)] (êÊu) DPæ2úÉǵœ}«aÌ2Çá (Two cases of acute leukemia (AL) which occurred during the 2nd trimester of pregnancy). xÄCê1, cÍs1, ¹ºYî1, {Žmü1, Îc@²2, ¥@cœ1, c_«1, {ø_ñ2, éز_1 (1tà, 2AE×EÚA): æ81ñú{twïwpWï (2019/10/11-13), , Õ°tWEBŽ^2019; PS2-8-8: S315.
733066. [wï (nûïE€ï)] (êÊu) p`¿×E«pî (LPL) ÉεÄBRÃ@ð{sÉKaposi÷î (KS) Ì«ðµœêá. xÄCê1, ¥@cœ1, c_«1, cÍs1, ¹ºYî1, Îc@²2, HRdÈ1, {Žmü1, ]šWê1, òRav1, {ø_ñ2, éز_1 (1tà, 2AE×EÚA): æ11ñú{twïÖbMznûï (2019/7/27), úõ, Õ°t 2019; 60 (10): 1504.
'18NxÈOª
[wp_¶]
'18-522005. [uÀ] Ù`¬ÇóQ|ffÌ|Cg|. éز_ (tà): ú{žtwïG 2019/2; 20 (1): 99-109.
ÄzíàÈw
[wp_¶]
110150. [Ž] Evaluation of osimertinib efficacy according to body surface area and body mass index in patients with non-small cell lung cancer harboring an EGFR mutation: A prospective observational study. Ono T1, Igawa S1, Ozawa T1, Kasajima M1, Ishihara M1, Hiyoshi Y1, Kusuhara S1, Nishinarita N1, Fukui T1, Kubota M2, Sasaki J3, Hisashi M4, Katagiri M2, Naoki K1: Thorac Cancer 2019/4; 10 (4): 880-9. (¬ìל1, äì@1, ¬àVMT1, }^u1, ÎŽ¢óq1, úgNO1, íŽêY1, Œ¬cÙq1, äüç1, vÛc2, ²XØ¡êY3, O¡@v4, ÐË^l2, PØF1: 1Äzíà, 2ãÃq¶w, 3V¢IãÃE¡fIãÃ, 4Åìw)
110151. [Ž] Prognostic differences between oligometastatic and polymetastatic extensive disease-small cell lung cancer. Shirasawa M1, Fukui T1, Kusuhara S1, Harada S2, Nishinarita N1, Hiyoshi Y1, Ishihara M1, Kasajima M1, Igawa S1, Yokoba M3, Mitsufuji H4, Kubota M3, Katagiri M3, Sasaki J5, Naoki K1: PLoS One 2019/4; 14 (4): e0214599. (àV¹V1, äüç1, íŽêY1, Žc^ç2, Œ¬cÙq1, úgNO1, ÎŽ¢óq1, }^u1, äì@1, ¡ê³T3, O¡@v4, vÛc3, ÐË^l3, ²XØ¡êY5, PØF1: 1Äz@à, 2åw@ãÃn€È, 3ãÃq¶w, 4Åìw, 5V¢IãÃE¡fIãÃ)
110152. [Ž] Impact of EGFR genotype on the efficacy of osimertinib in EGFR tyrosine kinase inhibitor-resistant patients with non-small cell lung cancer: a prospective observational study. Igawa S1, Ono T1, Kasajima M1, Ishihara M1, Hiyoshi Y1, Kusuhara S1, Nishinarita N1, Fukui T1, Kubota M2, Sasaki J3, Mitsufuji H4, Yokoba M2, Katagiri M2, Naoki K1: Cancer Manag Res 2019/5; 11: 4883-92. (äì@1, ¬ìל1, }^u1, ÎŽ¢óq1, úgNO1, íŽêY1, Œ¬cÙq1, äüç1, vÛc2, ²XØ¡êY3, O¡@v4, ¡ê³T2, ÐË^l2, PØF1: 1Äzíà, 2ãÃq¶w, 3V¢IãÃE¡fIãÃ, 4Åìw)
110153. [Ž] Activity of Nivolumab and Utility of Neutrophil-to-Lymphocyte Ratio as a Predictive Biomarker for Advanced Non-Small-Cell Lung Cancer: A Prospective Observational Study. Fukui T1, Okuma Y1, Nakahara Y1, Otani S1, Igawa S1, Katagiri M2, Mitsufuji H3, Kubota M2, Hiyoshi Y1, Ishihara M1, Kasajima M1, Sasaki J4, Naoki K1: Clin Lung Cancer 2019/5; 20 (3): 208-14.e2. (äüç1, åFFq1, ŽPN1, åJçq1, äì@1, ÐË^l2, O¡@v3, vÛc2, úgNO1, ÎŽ¢óq1, }^u1, ²XØ¡êY4, PØF1: 1Äzíà, 2ãÃq¶w, 3Åìw, 4V¢IãÃE¡fIãÃ)
110154. [Ž] Monomer Preference of EGFR Tyrosine Kinase Inhibitors Influences the Synergistic Efficacy of Combination Therapy with Cetuximab. Oashi A, Yasuda H, Kobayashi K, Tani T, Hamamoto J, Masuzawa K, Manabe T, Terai H, Ikemura S, Kawada I, Naoki K1, Soejima K: Mol Cancer Ther 2019/9; 18 (9): 1593-601. (PØF1: 1Äzíà)
110155. [Ž] Multicenter study of zoledronic acid administration in non-small-cell lung cancer patients with bone metastasis: Thoracic Oncology Research Group (TORG) 1017. Nakahara Y1, Hosomi Y, Shibuya M, Mitsufuji H2, Katagiri M3, Naoki K1, Soejima K, Nogami N, Nagase S, Nishikawa M, Minato K, Takiguchi Y, Seki N, Yamada K, Seto T, Okamoto H: Mol Clin Oncol 2019/10; 11 (4): 349-53. (ŽPN1, O¡@v2, ÐË^l3, PØF1: 1Äzíà, 2Åìw, 3ãÃq¶w)
110156. [Ž] A phase II trial of induction of erlotinib followed by cytotoxic chemotherapy for EGFR mutation-positive non-squamous non-small cell lung cancer patients. Tani T, Naoki K1, Yasuda H, Arai D, Ishioka K, Ohgino K, Yoda S, Nakayama S, Satomi R, Terai H, Ikemura S, Sato T, Soejima K: Cancer Chemother Pharmacol 2019/11; 84 (5): 1065-71. (PØF1: 1Äzíà)
110157. [Ž] Multicenter, placebo-controlled, double-blind, randomized study of fosnetupitant in combination with palonosetron for the prevention of chemotherapy-induced nausea and vomiting in patients receiving highly emetogenic chemotherapy. Sugawara S, Inui N, Kanehara M, Morise M, Yoshimori K, Kumagai T, Fukui T1, Minato K, Iwashima A, Takeda Y, Kubota K, Saeki T, Tamura T: Cancer 2019/11; 125 (22): 4076-83. (äüç1: 1Äzíà)
110158. [Ž] Prognostic significance of IMMT expression in surgically-resected lung adenocarcinoma. Hiyoshi Y1, Sato Y2, Ichinoe M3, Nagashio R2, Hagiuda D, Kobayashi M, Kusuhara S1, Igawa S1, Shiomi K4, Goshima N, Murakumo Y3, Saegusa M3, Satoh Y4, Masuda N1, Naoki K1: Thorac Cancer 2019/11; 10 (11): 2142-51. (úgNO1, ²¡Yê2, ê˹Ÿ3, ·@º2, íŽêY1, äì@1, ©@a4, º_F÷3, O}@M3, ²¡Vr4, vcTK1, PØF1: 1Äzíà, 2ãÃq¶w, 3a, 4ÄzíO)
110159. [Ž] TRAP1 is a predictive biomarker of platinum-based adjuvant chemotherapy benefits in patients with resected lung adenocarcinoma. Kuchitsu Y1, Nagashio R2, Igawa S3, Kusuhara S3, Tsuchiya B2, Ichinoe M4, Satoh Y5, Naoki K3, Murakumo Y4, Saegusa M4, Sato Y2: Biomed Res 2020/1; 41 (1): 53-65. (ÃLI1, ·@º2, äì@3, íŽêY3, y®g2, ê˹Ÿ4, ²¡Vr5, PØF3, º_F÷4, O}@M4, ²¡Yê2: 1åw@ãÃn€È, 2ãÃq¶w, 3Äzíà, 4a, 5ÄzíO)
110160. [Ž] The Clinical Impact of the Post-progression Survival on the Overall Survival in Elderly Patients or Those with a Poor Performance Status and Extensive-disease Small-cell Lung Cancer. Igawa S1, Yokoba M2, Fukui T1, Sasak J3, Naoki K1: Japanese Journal of Lung Cancer 2020/2; 60 (1): 10-6. (äì@1, ¡ê³T2, äüç1, ²XØ¡êY3, PØF1: 1Äzíà, 2ãÃq¶w, 3V¢IãÃE¡fIãÃ)
310022. [Çáñ] Molecular dynamics simulation-guided drug sensitivity prediction for lung cancer with rare EGFR mutations. Ikemura S, Yasuda H, Matsumoto S, Kamada M, Hamamoto J, Masuzawa K, Kobayashi K, Manabe T, Arai D, Nakachi I, Kawada I, Ishioka K, Nakamura M, Namkoong H, Naoki K1, Ono F, Araki M, Kanada R, Ma B, Hayashi Y, Mimaki S, Yoh K, Kobayashi SS, Kohno T, Okuno Y, Goto K, Tsuchihara K, Soejima K: Proc Natl Acad Sci U S A 2019/5; 116 (20): 10025-30. (PØF1: 1Äzíà)
522035. [uÀ]yÁW: xªñEªèòªñzTMB highxªñÉηénivolumabÆipilimumab̹pÃ@. PØF (Äzíà): îáàÈ 2019/5; 23 (5): 503-8.
540034. [»ÌŒ (_])] Chin, et al. ""A Complete Spontaneous Regression of Lung Cancer with Variations in Size over 38 Months"" (Chinçu38ÉíœéTCYÌÏ®ðºÁœxàÌ®SÈ©RÞk). PØF (Äzíà): CÇxw 2019/5; 41 (3): 231-2.
[wïE€ï]
713038. [wï (Û)] (êÊu) A multicenter, open label, randomized phase II study of osimertinib plus ramucirumab versus osimertinib alone as initial chemotherapy for EGFR mutation-positive non-squamous non-small cell lung cancer: TORG1833. Nakahara Y1, Kato T, Isomura R, Seki N, Furuya N, Naoki K1, Yamanaka T, Okamoto H: 2019 ASCO Annual Meeting (2019/6/2), Chicago, USA. (ŽPN1, PØF1: 1Äzíà)
713039. [wï (Û)] (êÊu) Impact of EGFR Genotype on the Efficacy of Osimertinib in Patients with Non-Small Cell Lung Cancer: A Prospective Observational Study. Igawa S1, Ono T1, Ozawa T1, Sone H1, Kusuhara S1, Harada S, Ishihara M1, Kasajima M1, Hiyoshi Y1, Fukui T1, Kubota M2, Sasaki J3, Mitsufuji H4, Naoki K1: IASLC 2019 WCLC World Conference on Lung Cancer (2019/9/8), Barcelona, Spain. (äì@1, ¬ìל1, ¬àVMT1, ]ªpV1, íŽêY1, ÎŽ¢óq1, }^u1, úgNO1, äüç1, vÛc2, ²XØ¡êY3, O¡@v4, PØF1: 1Äzíà, 2ãÃq¶w, 3V¢IãÃE¡fIãÃ, 4Åìw)
713040. [wï (Û)] (êÊu) MULTICENTER, SINGLE-ARM PHASE II STUDY OF@NAB-PACLITAXEL/CARBOPLATIN IN UNTREATED PS2@PATIENTS WITH ADVANCED NSCLC: TORG1426. Naoki K1, Ichikawa Y, Bessho A, Hosokawa S, Shimokawa T, Yomota M, Hosomi Y, Otani S1, Nakahara Y1, Iwasawa S, Tokito T, Seki N, Okamoto H: IASLC 2019 WCLC World Conference on Lung Cancer (2019/9/8), Barcelona, Spain. (PØF1, åJçq1, ŽPN1: 1Äzíà)
713041. [wï (Û)] (êÊu) Efficacy of Immune Checkpoint Inhibitors for Locally Advanced Non-Small Cell Lung Cancer Patients Before Durvalumab Approval. Fukui T1, Hosotani S1, Soda I2, Kakegawa M1, Kasajima M1, Hiyoshi Y1, Igawa S1, Katagiri M3, Ishiyama H2, Naoki K1: IASLC 2019 WCLC World Conference on Lung Cancer (2019/9/9), Barcelona, Spain. (äüç1, ×J^i1, c@i2, |ì¢óq1, }^u1, úgNO1, äì@1, ÐË^l3, ÎR2, PØF1: 1Äzíà, 2úËü (îá), 3ãÃq¶w)
713042. [wï (Û)] (êÊu) THE USEFULNESS OF "SERUM" SAMPLES TO DETECT EGFR T790M MUTATION IN EGFR-TKI-RESISTANT NON-SMALL CELL LUNG CANCER. Kobayashi K, Naoki K1, Ikemura S, Yasuda H, Kawada I, Soejima K: IASLC 2019 WCLC World Conference on Lung Cancer (2019/9/7-10), Barcelona, Spain (PØF1: 1Äzíà)
713043. [wï (Û)] (êÊu) Prediction of FEV1 and DLco in lung cancer patients undergoing lobectomy: Comparison between quantitative computed tomography, scintigraphy, and anatomy. Yokoba M1, Ichikawa T, Harada S2, Fukui T3, Igawa S3, Mitsufuji H4, Kubota M1, Sasaki J5, Naoki K3, Sato Y1, Katagiri M1: ERS 2019 International Congress (2019/9/28-10/2), Madrid, Spain. (¡ê³T1, Žc^ç2, äüç3, äì@3, O¡@v4, vÛc1, ²XØ¡êY5, PØF3, ²¡Yê1, ÐË^l1: 1ãÃq¶w, 2åw@ãÃn€È, 3Äzíà, 4Åìw, 5V¢IãÃE¡fIãÃ)
713044. [wï (Û)] (êÊu) Prediction of FEV1 and DLCO in lung cancer patients undergoing lobectomy: comparison between anatomy, scintigraphy, and quantitative computed tomography. Yokoba M1, Ichikawa T, Harada S2, Fukui T3, Igawa S3, Mitsufuji H4, Kubota M1, Naoki K3, Sato Y1, Katagiri M1: APSR2019 The 24th Congress of the Asian Pasific Society of Respirology (2019/11/14-17), Hanoi, Vietnam. (¡ê³T1, Žc^ç2, äüç3, äì@3, O¡@v4, vÛc1, PØF3, ²¡Yê1, ÐË^l1: 1ãÃq¶w, 2åw@ãÃn€È, 3Äzíà, 4Åìw, 4ÄzíO)
723170. [wï (S)] (êÊu) îÒù¡ÃiW^¬×Exà³ÒÖÌArVPÜ: øÊÆÀS«É¢ÄÌ¢. ]ªpV1, äì@1, ×J^i1, ¬àVMT1, Ôç1, å]rŸY1, É¡OI1, LËX÷1, qÑTŸY1, Œ¬cÙq1, íŽêY1, Žc^ç2, äüç1, O¡@v3, ²XØ¡êY4, vÛc5, PØF1 (1Äzíà, 2åw@ãÃn€È, 3Åìw, 4V¢IãÃE¡fIãÃ, 5ãÃq¶w): æ59ñú{Äzíwïwpuï (2019/4/12), .
723171. [wï (S)] (êÊu) xtسÒÉš¯éØxtÌCîeÊÆÄz@\ÌϻɢÄ. ¡ê³T1, sì@B, Žc^ç2, }^u3, |ì¢óq3, úgNO3, ²¡Vr4, PØF3, ÐË^l1 (1ãÃq¶w, 2åw@ãÃn€È, 3Äzíà, 4ÄzíO): æ59ñú{Äzíwïwpuï (2019/4/12), .
723172. [wï (S)] (êÊu) ù¡Ãñ¬×Exªñ³ÒÉηéj{}uÃ@Ì¡ÃøÊÆD
/p
ä (NLR) ÌÖ. åFFq1, äüç1, ¬ìל1, |ì¢óq1, }^u1, úgNO1, ¡ê³T2, ÐË^l2, PØF1 (1Äzíà, 2ãÃq¶w): æ59ñú{Äzíwïwpuï (2019/4/13), .
723173. [wï (S)] (êÊu) 75ÎÈãÌîÒÉηéAt@`juÌæII±. ¡cÔ, åòj,
`GI, ŽcqV, äì@1, KŸê, @@É, nç²iŸ, xc®œ, õº_V, ²@Ë, öºO°, à_cNš (1Äzíà): æ59ñú{Äzíwïwpuï (2019/4/14), .
723174. [wï (S)] (êÊu) EGFR-TKIÏ«xàÌIV`juÌøÊ\ªÉš¯égŽhžÌLp«. ¬Ñdå, PØF1, àV[Ÿ, áÁçÛu, rºCVî, Àc_V, ìcêY, Êðqq, €¢ (1Äzíà): æ59ñú{Äzíwïwpuï (2019/4/12-14), .
723175. [wï (S)] (êÊu) òÜãÓðl¶µœ¹p¡Ãªtøµœñj«R_ÛǹEGFRz«xàÌêá. É¡OI1, |ì¢óq1, LËé÷1, äüç1, äì@1, vÛc2, ²XØ¡êY3, ÑŽå«, Ñ@G÷, PØF1 (1Äzíà, 2ãÃq¶w, 3V¢IãÃE¡fIãÃ): ãw¶E€CãÌú{àÈwï±Æꦧ (æ116ñú{àÈwïïEuï) (2019/4/27), ŒÃ®.
723176. [wï (S)] (êÊu) Å`ªñÉηéîáâ`qÔ
IðÍÊÉÖ·éÏ@€. äüç1, äì@1, âäaq, c^K, à_²K, ìaF, Œöal, PØF1 (1Äzíà): æ23ñú{ªñªqWI¡ÃwïwpWï (2019/6/13), åã.
723177. [wï (S)] (êÊu) œxìaÏÉηé×aCÇxàŸðp¢œtraction drive@ (Œ) ÌJ (ïc^). ¬àVMT1, O¡@v2, LËX÷1, ×J^i1, Žc^ç3, Œ¬cÙq1, }^u1, |ì¢óq1, äüç1, äì@1, ¡ê³T4, ²XØ¡êY5, vÛc4, ÐË^l4, PØF1 (1Äzíà, 2Åìw, 3åw@ãÃn€È, 4ãÃq¶w, 5V¢IãÃE¡fIãÃ): æ42ñú{ÄzíàŸwïwpWï (2019/7/4-5), , CÇxw 2019/6; 41 (Suppl): S190.
723178. [wï (S)] (êÊu) T790MgDĶA«, LbhoCIvV[z«isñ¬×ExàÉš¯éIV`ju¡ÃøÊÌ¢. }^u1, Ôç1, É¡OI1, å]rŸY1, ¬ìל1, íŽêY1, úgNO1, äüç1, äì@1, ¡ê³T2, O¡@v3, ²XØ¡êY4, ÐË^l2, vÛc2, PØF1 (1Äzíà, 2ãÃq¶w, 3Åìw, 4V¢IãÃE¡fIãÃ): æ42ñú{ÄzíàŸwïwpWï (2019/7/4-5), , CÇxw 2019/6; 41 (Suppl): S337.
723179. [wï (S)] (êÊu) Galectin-3 expression in patients with resected NSCLC treated with platinum-based adjuvant chemotherapy. íŽêY1, äì@1, úgNO1, ¬àVMT1, |ì¢óq1, O¡@v2, ÐË^l3, vÛc3, öcá, ·@º3, ²¡Yê3, PØF1 (1Äzíà, 2Åìw, 3ãÃq¶w): æ17ñú{Õ°îáwïwpWï (2019/7/18), s.
723180. [wï (S)] (êÊu) EGFRÏÙz«NSCLCÉηé, IV`ju + V}uÆIV`juÌ_»æII± (TORG1833). {c@, ŽPN1, éºæq, îŒ÷, PØF1, t@Ž², FJ@Z, êûTê, ©@_ê, ºìP¶, R|t, ª{_Ÿ, Á¡Wj (1Äzíà): æ17ñú{Õ°îáwïwpWï (2019/7/18), s.
723181. [wï (S)] (êÊu) Evaluation of osimertinib efficacy according to BSA and BMI in patients with NSCLC harboring an EGFR mutation. ¬ìל1, äì@1, É¡OI1, å]rŸY1, qÑTŸY1, Žc^ç2, ¡ê³T3, vÛc3, PØF1 (1Äzíà, 2åw@ãÃn€È, 3ãÃq¶w): æ17ñú{Õ°îáwïwpWï (2019/7/20), s.
723182. [wï (S)] (êÊu) Current Status of Concurrent Chemoradiotherapy in Patients with Unresectable Locally Advanced Non-Small Cell Lung Cancer. ×J^i1, äüç1, cºqq, c@i2, ¬àVMT1, íŽêY1, |ì¢óq1, }^u1, úgNO1, äì@1, PØF1 (1Äzíà, 2úËü (îá)): æ17ñú{Õ°îáwïwpWï (2019/7/20), s.
723183. [wï (S)] (êÊu) Final results for TORG 1425: A Multicenter Phase II Study of Low-dose Erlotinib in Frail Patients with EGFR Mutation-positive, Non-small Cell Lung Cancer. Aono H, Yamada K, Miyamoto S, Tokito T, Bessho A, Misumi Y, Tanaka H, äüç1, Kusaka K, Hosomi Y, Kikuchi N, Mori Y, Itani H, Kasai T, Ichiki M, Seki N, Kunitoh H, Okamoto H (1Äzíà): æ17ñú{Õ°îáwïwpWï (2019/7/20), s.
723184. [wï (S)] (êÊu) iW^¬×ExàÉš¯éM«D
žÇÇpxÆPeg-G-CSF»Ügpª¶¶ÉyÚ·e¿É¢Ä. |ì¢óq1, äüç1, ¬ìל1, R{_M1, áÁç³pŸ1, ªãL¢1, LËé÷1, É¡OI1, ×J^i1, {@1, äì@1, ²XØ¡êY2, PØF1 (1Äzíà, 2V¢IãÃE¡fIãÃ): æ4ñú{ªñT|[eBuPAwïwpWï (2019/9/7), ÂX.
723185. [wï (S)] (êÊu) PS2isñ¬×EàÉηéJ{v` + AuLTÌæII± (TORG1426). ã©tq, sìõq, n粎, ʺG, ×ì@E, PØF1, lûc^Iq, âàVrêY, CÍ, Ö@F, ª{_Ÿ (1Äzíà): æ57ñú{à¡ÃwïwpWï (2019/10/25), ª.
723186. [wï (S)] (êÊu) îÜœÍPSsÇiW^¬×Exà³ÒÉš¯éñ»wÃ@ãÌPost progression survival timeÌðÍ. qÑTŸY1, äì@1, ªãL¢1, R{_M1, áÁç³pŸ1, {@1, ¬ìל1, äüç1, O¡@v2, vÛc3, ²XØ¡êY4, PØF1 (1Äzíà, 2Åìw, 3ãÃq¶w, 4V¢IãÃE¡fIãÃ): æ60ñú{xàwïwpWï (2019/12/6), åã.
723187. [wï (S)] (êÊu) Å`ªñÉηéîáâ`qÔ
IðÍÊÉÖ·éÏ@€. {@1, äüç1, ²XØ¡êY2, |ì¢óq1, úgNO1, äì@1, âäaq, c^K, à_²K, ìaF, Œöal, PØF1 (1Äzíà, 2V¢IãÃE¡fIãÃ): æ60ñú{xàwïwpWï (2019/12/6), åã.
723188. [wï (S)] (êÊu) æ1, 2, 3¢ãEEGFR-TKIÏ«xà×EÌ÷§ÆlŸÏ«@ÌðÍ. |ì¢óq1, c^, ì»q, ¬àVMT1, íŽêY1, Žc^ç2, úgNO1, }^u1, äüç1, äì@1, ²XØ¡êY3, PØF1 (1Äzíà, 2åw@ãÃn€È, 3V¢IãÃE¡fIãÃ): æ60ñú{xàwïwpWï (2019/12/6), åã.
731025. [wï (nûïE€ï)] (ÁÊu) xà¡ÃÌÅßÌià (Æu`FbN|CgjQòðSÉ). PØF (Äzíà): æ60ñú{àÈwïÖxåöU³çuï (2019/7/14), .
733067. [wï (nûïE€ï)] (êÊu) žŽìÉæèN]`juÄ^ªÂ\Å ÁœROS1]Àz«xàÌêá. âéåã, íŽêY1, áÁç³pŸ1, R{_M1, ªãL¢1, {@1, qÑTŸY1, ¬ìל1, ¬àVMT1, |ì¢óq1, úgNO1, }^u1, äüç1, äì@1, O¡@v2, vÛc3, ²XØ¡êY4, PØF1 (1Äzíà, 2Åìw, 3ãÃq¶w, 4V¢IãÃE¡fIãÃ): æ185ñú{xàwïÖxwpWï (2019/7/6), .
733068. [wï (nûïE€ï)] (êÊu) VOj[h§ÍÉš¯éÝè¬ÊÆì³ÉÖ·éîbI¢. çc1, ºãÀí, LãŒÆ, ¬Ñ±žb1, ¬vÛªê1, vÛc1, âjªG1 (1ãÃq¶w): æ22ñÝît§Í€ï (2019/11/3), b{.
733069. [wï (nûïE€ï)] (êÊu) yuY}u^ãÉ
æÃHÇóQðǵœñ¬×ExàÌ1áÌêá. R{_M1, úgNO1, ªãL¢1, áÁç³pŸ1, LËé÷1, É¡OI1, ¬ìל1, äì@1, äüç1, PØF1 (1Äzíà): æ237ñú{ÄzíwïÖnûï (2019/11/23), .
'18NxÈOª
[wp_¶]
'18-110007. [Ž] Exploration of germline variants responsible for adverse events of crizotinib in anaplastic lymphoma kinase-positive non-small cell lung cancer by target-gene panel sequencing Mizugaki H, Hamada A, Shibata T, Hosoda F, Nakamura H, Okuma Y, Shukuya T, Shigeki Umemura S, Horiike A, Fukui T1, Kogure Y, Daga H, Urata Y, Yamada K, Saeki S, Fujisaka Y, Nakamura Y, Sato M, Oizumi S, Fujiwara Y, Ohe Y, Fujiwara Y: Lung Cancer 2019/2; 128: 20-5. (äüç1: 1Äzíà)
[wïE€ï]
'18-713004. [wï (Û)] (êÊu) Phase II Study of Amrubicin Plus Erlotinib in Previously Treated, Advanced Non-Small Cell Lung Cancer Patients with Wild-Type EGFR: TORG 1320. Hosokawa S, Otani S1, Sasaki J2, Fukui T1, Nakahara Y1, Bessho A, Fukamatsu N, Nakamura Y, Kasai T, Sugiyama T, Tokitho T, Seki N, Hamada A, Masuda N, Okamoto H: The IASLC 19th World Conference on Lung Cancer (2018/9/23), Toronto, Canada. (åJçq1, ²XØ¡êY2, äüç1, ŽPN1: 1Äzíà, 2V¢IãÃE¡fIãÃ)
'18-722002. [wï (S)] (µÒu) Øs\Çisñ¬×Exªñ³ÒÉš¯é¡ÃÌ»óÆià. äüç1, cºqq, ×J^i1, c@i2, Îã@«3, PØF1 (1Äzíà, 2úËü (îá), 3úËü): æ38ñú{æãwïwpWï (2019/3/8), .
àªåãÓàÈw
[wp_¶]
110161. [Ž] Effects of canagliflozin on body composition and hepatic fat content in type 2 diabetes patients with non-alcoholic fatty liver disease. Inoue M1, Hayashi A2, Taguchi T1, Arai R2, Sasaki S1, Takano K2, Inoue Y3, Shichiri M2: J Diabetes Investig 2019/7; 10 (4): 1004-11. (äãõq1, Ñ@NÍ2, cû@ü1, Väßß2, ²XعçÁ1, ìKH2, äãDî3, µ¢áÁ`2: 1åw@ãÃn€È, 2àªåãÓà, 3úËü (æ))
110162. [Ž] Identification of plasma binding proteins for glucose-dependent insulinotropic polypeptide. Hoshiyama A1, Fujimoto K2, Konno R, Sasaki S1, Momozono A1, Kodera Y, Shichiri M2: Endocr J 2019/7; 66 (7): 621-8. (¯R»q1, ¡{aÀ2, ²XعçÁ1, @Ÿ1, µ¢áÁ`2: 1åw@ãÃn€È, 2àªåãÓà)
110163. [Ž] Basal glucagon hypersecretion and response to oral glucose load in prediabetes and mild type 2 diabetes. Ichikawa R1, Takano K1, Fujimoto K1, Motomiya T, Kobayashi M, Kitamura T, Shichiri M1: Endocr J 2019/8; 66 (8): 663-75. (sìt1, ìKH1, ¡{aÀ1, µ¢áÁ`1: 1àªåãÓà)
110164. [Ž] Molecular form and concentration of serum ¿2-macroglobulin in diabetes. Yoshino S1, Fujimoto K2, Takada T2,3, Kawamura S1, Ogawa J, Kamata Y2, Kodera Y, Shichiri M2: Sci Rep 2019/9; 9 (1): 12927. (gìü1, ¡{aÀ2, cNG2,3, 캹Fó1, cTñ2, µ¢áÁ`2: 1åw@ãÃn€È, 2àªåãÓà, 3k¢åwfBJZ^[)
110165. [Ž] Oxidised Met147 of human serum albumin is a biomarker of oxidative stress, reflecting glycaemic fluctuations and hypoglycaemia in diabetes. Momozono A1, Kodera Y, Sasaki S1, Nakagawa Y, Konno R, Shichiri M2: Sci Rep 2020/1; 10 (1): 268. (@Ÿ1, ²XعçÁ1, µ¢áÁ`2: 1åw@ãÃn€È, 2àªåãÓà)
110166. [Ž] Role of oxidized Met111 of human serum albumin for an oxidative stress biomarker in diabetes. Momozono A1, Kodera Y, Sasaki S1, Nakagawa Y, Konno R, Shichiri M2: Kitasato Med J 2020/3; 50 (1): 80-5. (@Ÿ1, ²XعçÁ1, µ¢áÁ`2: 1åw@ãÃn€È, 2àªåãÓà)
120005. [Ž] Aa§Í³ÒÉš¯é§ÍÖAÏ®ÌàªåwIaÔÌ¢. Ñ@NÍ1, IêŸ, å©NG1, Ž
ç1, éØVŒ1, ç@Må, ¡ä¢]1, ²¡Üèd1, ìKH1, µ¢áÁ`1 (1àªåãÓà): ú{§ÍãïG 2019/5; 34 (2): 276-80.
320007. [Çáñ] CtGUN`ÚíãÉǵœ}«Ç1^AaÌ1á. äãõq1, cTñ2, Â@d1, cû@ü1, ºcHä2, Väßß2, ²XØÑçÁ1, Ñ@NÍ2, ìKH2, µ¢áÁ`2 (1åw@ãÃn€È, 2àªåãÓà): Aa 2019/4; 62 (4): 214-9.
540035. [»ÌŒ (ñ)]yö倬 29NxñzAa§Í³ÒÉš¯é§ÍÖAÏ®ÌàªåwIaÔÌ¢. Ñ@NÍ1, IêŸ2, å©NG1, Ž
ç1, éØVŒ1, ç@Må1, ¡ä¢]1, ²¡Üèd1, ìKH1, µ¢áÁ`1 (1àªåãÓà, 2Õw): ú{§ÍãïG 2019/8; 34 (2): 276-80.
[@]
620034. [wp (ªS·M)] yÕ°òweLXgV[Y@zÂí/tEåAí/ãÓ/àªåzæ4Í àªåŸ³@B. Ÿ³e_@1. °ºEºÌŸ³, p.295-316. ìKH (àªåãÓà), ÄC: £@«ê, Ò: ÔrºI, É¡åÃ, ãìas, RX, , 2020/1s.
[wïE€ï]
722050. [wï (S)] (µÒu) ï¡«NbVOaÌ¡ÃE_. ìKH (àªåãÓà): æ92ñú{àªåwïwpï (2019/5/9-11), åä.
722051. [wï (S)] (µÒu) àÈãªlŠé_oàªåîáÌèpK. ìKH (àªåãÓà): æ31ñú{àªåOÈwïï (2019/6/14), .
722052. [wï (S)] (µÒu) äXEÁ»Ç_oàªåîá (NEN) fÃKChC (æ2Å) ffÉ¢ÄÌðà. ìKH (àªåãÓà): æ50ñú{äXwïåï (2019/7/13), .
722053. [wï (S)] (µÒu) ȺgWVúƬlúÉGHâ[ªKv©. ìKH (àªåãÓà): æ61ñú{¬tEªñwïwpWï (2019/11/16), L.
723189. [wï (S)] (êÊu) ¬l¬·zªåsSÇÉš¯ésomapacitanTêñ^Éæéë²bÊÌž. ìKH (àªåãÓà): æ92ñú{àªåwïwpï (2019/5/9), åä.
723190. [wï (S)] (êÊu) qgzÂ÷vj̪q¶Ýl®ÆVKªènÉš¯é»ÌZx. ¡{aÀ1, â@d2, 캹Fó2, gìü1, cTñ1, ¬`j, µ¢áÁ`1 (1àªåãÓà, 2åw@ãÃn€È): æ92ñú{àªåwïwpï (2019/5/9-11), åä, ú{àªåwïG 2019; 95 (1): 385.
723191. [wï (S)] (êÊu) Gravesa³ÒÌ¡ÃoßÉæéÀÃãÓÊÌϻ̢`íÒÆÌär`. å©NG1, Ñ@NÍ1, éØVŒ1, Ž
ç1, ¯R»q2, cTñ1, ìKH1, µ¢áÁ`1 (1àªåãÓà, 2åw@ãÃn€È): æ92ñú{àªåwïwpï (2019/5/9-11), åä, ú{àªåwïG 2019; 95 (1): 393.
723192. [wï (S)] (êÊu) y÷ÈcortisolY¶\ðLµ, pOÉЀÌtç¿àð^ÁœŒ€tBîÌêá. éØVŒ1, cTñ1, cû@ü2, ìKH1, RèLl, ùìöL, µ¢áÁ`1 (1àªåãÓà, 2åw@ãÃn€È): æ92ñú{àªåwïwpï (2019/5/9-11), åä, ú{àªåwïG 2019; 95 (1): 469.
723193. [wï (S)] (êÊu) factitious hypoglycemiaÌÓÊÉÙÈéCXªèLbgªLpÅ Áœ1Çá. ¬ì°j (àªåãÓà): æ68ñú{ãwžwï (2019/5/18-19), ºÖ.
723194. [wï (S)] (êÊu) §Í³ÒÉš¯étbV
OR[Xj^O̳m«Ì¢. IêŸ1,2, Ñ@NÍ2, ²¡Üèd2, ç@Må, ¬ì°j2, cTñ2, Xû¢Ô«, ¬ÑŒV, ìKH2, µ¢áÁ`2 (1Õw, 2àªåãÓà): æ62ñú{AawïNwpWï (2019/5/23-25), åä, Aa 2019; 62: S138.
723195. [wï (S)] (êÊu) Sensor Augmented Pump 640GÉš¯éPredictive Low GlucoseÌøÊ`áñðð¢·é`. Ž
ç1, Ñ@NÍ1, å©NG1, éØVŒ1, ¡ä¢]1, Väßß, éØzF1, sìt1, ìKH1, µ¢áÁ`1 (1àªåãÓà): æ62ñú{AawïNwpWï (2019/5/23-25), åä, Aa 2019; 62: S182.
723196. [wï (S)] (êÊu) vs`IEV^JnãÉêß«ÉŸÈgOZChÇð浜oZhEaÌêá. cTñ1, Ž
ç1, ²¡Üèd1, cû@ü2, cßß, sìt1, ìKH1, µ¢áÁ`1 (1àªåãÓà, 2åw@ãÃn€È): æ62ñú{bóBwïwpWï (2019/10/10-12), OŽ.
723197. [wï (S)] (êÊu) WwIXNÇÅDP𮵊œ][Çùì³2^Aa¹DPá. غ¢1, sìt1, êRÁq1, ìKH1, µ¢áÁ`1 (1àªåãÓà): æ35ñú{AaEDPwïNwpWï (2019/11/22-23), , AaÆDP 2019; 19 (3): S105.
723198. [wï (S)] (êÊu) @Éš¯éãÓÙí¹OlDwÌÀÔÉ¢Ä. êRÁq1, sìt1, غ¢1, ìKH1, µ¢áÁ`1 (1àªåãÓà): æ35ñú{AaEDPwïNwpWï (2019/11/22-23), , AaÆDP 2019; 19 (3): S110.
723199. [wï (S)] (êÊu) ¢jô®¬á̹ðFßœæ[åÇÌ1á. å©NG1, cû@ü2, 亮q, Rc³O, ìKH1, µ¢áÁ`1 (1àªåãÓà, 2åw@ãÃn€È): æ29ñú{àªåwïÕ°àªåãÓ Update (2019/11/29-30), m, ú{àªåwïG 2019; 95 (2): 713.
723200. [wï (S)] (êÊu) oZhEaÌÄð_@ÉǵœàáØáQÌ1á. ¬c@d1, yòìç1, ¡ä¢]1, sìt1, cTñ1, ìKH1, µ¢áÁ`1 (1àªåãÓà): æ29ñú{àªåwïÕ°àªåãÓ Update (2019/11/29-30), m, ú{àªåwïG 2019; 95 (2): 725.
723201. [wï (S)] (êÊu) æ[åÇÌ¡ÃÉæèüPµœÅ«œß«bóBîÌêá. Ž
ç1, cû@ü2, Á¡@O3, Rc³O, ìKH1, µ¢áÁ`1 (1àªåãÓà, 2åw@ãÃn€È, 3ûBEbóBO): æ29ñú{àªåwïÕ°àªåãÓ Update (2019/11/29-30), m, ú{àªåwïG 2019; 95 (2): 790.
731026. [wï (nûïE€ï)] (ÁÊu) ºÌŸ³ÌgÌ©Ìf©œ. ìKH (àªåãÓà): æ19ñú{àªåwïkC¹xwpWï (2019/10/20), Dy.
733070. [wï (nûïE€ï)] (êÊu) GHRP-2ױɚ¯éœÆáœÇáÅÌGHâ[ÊÌ¢. cû@ü1, ìKH2, µ¢áÁ`2 (1åw@ãÃn€È, 2àªåãÓà): æ20ñú{àªåwïÖbMzxwpWï (2019/9/13-14), .
733071. [wï (nûïE€ï)] (êÊu) @ù𺀫@@oð¹µC@SgD¶ÉÄIgG4ÖAŸ³ÉæéRlºÌÆffµœ1á. غ¢1. cTñ1, ¡ä¢]1, sìt1, ìKH1, µ¢áÁ`1 (1àªåãÓà): æ20ñú{àªåwïÖbMzxwpWï (2019/9/13-14), .
733072. [wï (nûïE€ï)] (êÊu) bóBN[[ð_@ÉæžÉÄäXÌxbu·ðFßœ1A^AaÌ1á. êRÁq1, cTñ1, Ž
ç1, ¬c@d1, غ¢1, ºèmG1, ìKH1, µ¢áÁ`1 (1àªåãÓà): æ57ñú{AawïÖbMznûï (2020/1/18), ¡l, Aa 2020; 63 (7): 413.
733073. [wï (nûïE€ï)] (êÊu) àö«CXªå\ÌáºðFßœÓúÇ^ÚAãAaÌ1á. ¬c@d1, ¡ä¢]1, IêŸ2, êRÁq1, غ¢1, ºèmG1, cTñ1, ìKH1, µ¢áÁ`1 (1àªåãÓà, 2Õw): æ57ñú{AawïÖbMznûï (2020/1/18), ¡l, Aa 2020; 63 (7): 413.
733074. [wï (nûïE€ï)] (êÊu) Aa«PgAVh[VX¡ÃãÉᳪJµœ1á. ºèmG1, sìt1, å©NG1, êRÁq1, ¬c@d1, غ¢1, ìKH1, µ¢áÁ`1 (1àªåãÓà): æ57ñú{AawïÖbMznûï (2020/1/18), ¡l, Aa 2020; 63 (7): 413.
733075. [wï (nûïE€ï)] (êÊu) CtGUxÉæéARDSðECMO±üÅ~œµœ2^AaÌ1á. éØVŒ1, sìt1, cTñ1, ìKH1, µ¢áÁ`1 (1àªåãÓà): æ57ñú{AawïÖbMznûï (2020/1/18), ¡l, Aa 2020; 63 (7): 413.
733076. [wï (nûïE€ï)] (êÊu) TÒØ÷àƶtÉœ·é^á𹵜Aa«PgAVh[VX (DKA) Ì1á. Rc@ó1, yòìç1, ¡@à1, ìKH1, µ¢áÁ`1 (1àªåãÓà): æ57ñú{AawïÖbMznûï (2020/1/18), ¡l, Aa 2020; 63 (7): 413.
733077. [wï (nûïE€ï)] (êÊu) 2íÞÌCXªèLbgðp¢ÄU«áÇðffµœ1á. غ¢1, ¬ã¢G1, ¬ì°j1, sìt1, cTñ1, ìKH1, µ¢áÁ`1, êRÁq1, ¬c@d1, ºèmG1 (1àªåãÓà): æ57ñú{AawïÖbMznûï (2020/1/18), ¡l, Aa 2020; 63 (7): 413.
733078. [wï (nûïE€ï)] (êÊu) îážÊpªt÷µœIGF-IIY¶îáÌ1á. å©NG1, ¬ì°j1, êRÁq1, غ¢1, ¬c@d1, ºèmG1, yòìç1, sìt1, cTñ1, ìKH1, µ¢áÁ`1 (1àªåãÓà): æ57ñú{AawïÖbMznûï (2020/1/18), ¡l, Aa 2020; 63 (7): 413.
'18NxÈOª
[wp_¶]
'18-110008. [Ž] Serum ¿2-macroglobulin levels in ischemic heart disease. Yoshino S1, Takada T1,2, Fujimoto K1, Shiono T2,3, Shichiri M1: Kitasato Med J 2019/3; 49 (1):46-51. (gìü1, cNG1,2, ¡{aÀ1, ìûŸ2,3, µ¢áÁ`1: 1àªåãÓà, 2k¢åwfBJZ^[, 3zÂíà)
[wïE€ï]
'18-713005. [wï (Û)] (êÊu) Efficacy and Safety of Once-weekly Somapacitan in Adult Growth Hormone Deficiency (AGHD) Confirmed in a 53-week Real 1 Trial Extension. Johannsson G, Gordon MB, Rasmussen MH, Hkonsson IH, SvŸrke C, Tahara S, Takano K1, Biller BMK: Endocrine Society 2019 (2019/3/23-26), New Orleans, USA. (ìKH1: 1àªåãÓà)
tàÈw
[wïE€ï]
723202. [wï (S)] (êÊu) ÷ð·ÆXeChÃ@ªt÷µœ
ÌIgAŸ
Üðº€RGBMRÌ^tÌêá. NÑ@r1, ²ì@²1, äc^¶q1, àVc@Ê1, xiåu1, iª¢1, ³ØM³1, ðäj1, ࡳg1, ÂRÜ1, |àNY1 (1tà): æ64ñú{§ÍãwïwpWïEï (2019/6/29), ¡l.
723203. [wï (S)] (êÊu) TNF-¿U±«œCüsSltÁÉæé¬EÌXgX}[J[Ì»Ži. ìiq1, ࡳg1 (1tà): æ92ñú{¶»wïåï (2019/9/18), ¡l.
733079. [wï (nûïE€ï)] (êÊu) ó
Ìd»ÇÌ¡ÃÉNIOuÇ«
Ìt𹵜êá. àVc@Ê1, ³ØM³1, NÑ@r1, äc^¶q1, xiåu1, iª¢1, cü2, ðäj1, ࡳg1, ÂRÜ1, ²ì@²1, ¥@cœ3, |àNY1 (1tà, 2åw@ãÃn€È, 3tà): æ97ñ_Þìt€ï (2019/6/1), ¡l.
733080. [wï (nûïE€ï)] (êÊu) »^«ÅÔÂÌ¡ÃÉ°Ø^áÆŽõ«®¬á𹵡ÃÉïaµœÛt§Í³ÒÌêá. NÑ@r1, ðäj1, äc^¶q1, àVc@Ê1, xiåu1, Ž{bq1, iª¢1, ³ØM³1, ࡳg1, ÂRÜ1, ²ì@²1, |àNY1 (1tà): æ97ñ_Þìt€ï (2019/6/1), ¡l.
733081. [wï (nûïE€ï)] (êÊu) (ÅDGèÜ (2019) óÜ) tÉš¯é_«¿GM3Ìdv«. RûaÔ, ìiq1, Î_Œq, iªå², Rº@§, ࡳg1 (1tà): Free Radical Summer School 2019 (ú{_»XgXwït[WJXN[) (2019/8/10-11), V.
733082. [wï (nûïE€ï)] (êÊu) ÷¬Ï»^lt[[ÇóQðǵœbNOnE[aÌ1á. NÑ@r1, ²ì@²1, äc^¶q1, Ž{bq1, cü2, ðäj1, ࡳg1, ÂRÜ1, |àNY1 (1tà, 2åw@ãÃn€È): æ49ñú{twïwpåï (2019/10/4), .
733083. [wï (nûïE€ï)] (êÊu) Aa«tÇÉæéð«÷¬ÇÇÉæè§Í±üÆÈÁœ1á. {â³n1, ࡳg1, NÑ@r1, iª¢1, xiåu1, àVc@Ê1, äc^¶q1, Ž{bq1, ³ØM³1, ðäj1, ÂRÜ1, ²ì@²1, |àNY1 (1tà): æ49ñú{twïwpåï (2019/10/4), .
733084. [wï (nûïE€ï)] (êÊu) _oüÛîÇI^Élt[[ÇóQð¹µt¶Éæè[vXtÆff³êœ1á. Rèñç1, ðäj1, 캹Rü1, åŽFq1, ŒRiq1, {â³n1, äc^¶q1, ¢Nç1, Ž{bq1, cü2, ࡳg1, ÂRÜ1, ²ì@²1, |àNY1 (1tà, 2åw@ãÃn€È): æ49ñú{twïwpåï (2019/10/4), .
733085. [wï (nûïE€ï)] (êÊu) V}u (VEGFjQò) Éæèlt[[ÇóQðµœêá. äc^¶q1, ࡳg1, NÑ@r1, àVc@Ê1, xiåu1, iª¢1, ³ØM³1, ðäj1, ÂRÜ1, ²ì@²1, |àNY1 (1tà): æ49ñú{twïwpåï (2019/10/5), .
733086. [wï (nûïE€ï)] (êÊu) ŒºÁÅǵÝ઻ŸµœIgAǹ«tÇÌêá. 캹Rü1, ²ì@²1, ŒRiq1, {â³n1, Rèñç1, åŽFq1, äc^¶q1, Ž{bq1, cü2, ¢Nç1, ðäj1, ࡳg1, ÂRÜ1, |àNY1 (1tà, 2åw@ãÃn€È): æ49ñú{twïwpåï (2019/10/5), .
733087. [wï (nûïE€ï)] (êÊu) GBEopÌÝÅA©ªyõµœ¬lÇIgAÇÌêá. åŽFq1, ÂRÜ1, äc^¶q1, ¢Nç1, ðäj1, ࡳg1, ²ì@²1, |àNY1 (1tà): æ49ñú{twïwpåï (2019/10/5), .
733088. [wï (nûïE€ï)] (êÊu) R€ÂòÉæéòÜ«÷èî«Ô¿«tÆlŠçêœ1á. ŒRiq1, ðäj1, 캹Rü1, åŽFq1, Rèñç1, {â³n1, äc^¶q1, ¢Nç1, Ž{bq1, cü2, ࡳg1, ÂRÜ1, ²ì@²1, |àNY1 (1tà, 2åw@ãÃn€È): æ49ñú{twïwpåï (2019/10/5), .
733089. [wï (nûïE€ï)] (êÊu) XeCh¡ÃɳüÇðǵœ÷¬Ï»^lt[[ÇóQÌêá. Õâß®Ý, ²ì@²1, 캹Rü1, åŽFq1, ²ìiq1, {â³n1, Rèñç1, äc^¶q1, ¢Nç1, ðäj1, ࡳg1, ÂRÜ1, |àNY1 (1tà): ú{àÈwïæ656ñÖnûï (2019/12/14), .
733090. [wï (nûïE€ï)] (êÊu) ov_ÉæéRltRÌU±«FSGSÌ\hE¡ÃøÊ. ìiq1, R«ê, Î_Œq, ࡳg1 (1tà): æ4ñ|hTCg€ï (2020/3/14), .
733091. [wï (nûïE€ï)] (êÊu) ¿GM3ÌtÛìøÊÌ¢. RûaÔ, ìiq1, Rº@§, ࡳg1 (1tà): æ4ñ|hTCg€ï (2020/3/14), .
äPŽaEŽõàÈw
[wp_¶]
110167. [Ž] Anti-ribosomal P protein antibodies influence mortality of patients with diffuse psychiatric/neuropsychological syndromes in systemic lupus erythematous involving a severe form of the disease. Arinuma Y1, Kikuchi H, Hirohata S1: Mod Rheumatol 2019/7; 29 (4): 612-8. (LÀÇK1, Ašr¬1: 1äPŽaEŽõà)
110168. [Ž] Efficacy and safety of tofacitinib in Japanese patients with rheumatoid arthritis by background methotrexate dose: A post hoc analysis of clinical trial data. Takeuchi T, Yamanaka H, Yamaoka K1, Arai S, Toyoizumi S, DeMasi R, Fukuma Y, Hirose T, Sugiyama N, Zwillich SH, Tanaka Y: Mod Rheumatol 2019/9; 29 (5): 756-66. (RªMG1: 1äPŽaEŽõà)
110169. [Ž] Identification of a novel arthritis-associated osteoclast precursor macrophage regulated by FoxM1. Hasegawa T, Kikuta J, Sudo T, Matsuura Y, Matsui T, Simmons S, Ebina K, Hirao M, Okuzaki D, Yoshida Y, Hirao A, Kalinichenko VV, Yamaoka K1, Takeuchi T, Ishii M: Nat Immunol 2019/12; 20 (12): 1631-43. (RªMG1: 1äPŽaEŽõà)
110170. [Ž] Skeletal unloading reduces cluster of differentiation (CD) 38 expression in the bone marrow and osteoblasts of mice. Moridera K, Uchida S, Tanaka S, Menuki K, Utsunomiya H, Yamaoka K1, Sonomoto K, Tanaka Y, Sakai A: J Orthop Sci 2020/3; 25 (2): 331-7. (RªMG1: 1äPŽaEŽõà)
110171. [Ž] Synergistic effect of IgG4 antibody and CTLs causes tissue inflammation in IgG4-related disease. Sasaki T, Yajima T, Shimaoka T, Ogawa S, Saito T, Yamaoka K1, Takeuchi T, Kubo M: Int Immunol 2020/3; 32 (3): 163-74. (RªMG1: 1äPŽaEŽõà)
110172. [Ž] Latent left ventricular dysfunction in patients with pulmonary arterial hypertension associated with systemic sclerosis. Tanaka S1, Matsueda Y1, Kondo J1, Yamaoka K1: Kitasato Med J 2020/3; 50 (1): 1-6. (cZŸ1, Œ}@C1, ß¡Õê1, RªMG1: 1äPŽa¥Žõà)
310023. [Çáñ] Reversible cerebral vasoconstriction syndrome triggered by tacrolimus mimicked neuropsychiatric involvement in systemic lupus erythematosus. Inamo J, Kikuchi J, Suzuki K, Kaneko Y, Yasuoka H, Fujiwara H, Yamaoka K1, Takeuchi T: Mod Rheum Case Rep 2019/6; 3 (2): 119-23. (RªMG1: 1äPŽaEŽõà)
320008. [Çáñ] oßÉÂt«]ǹkÇóQ (RCVS) 𹵡ÃÉïaµœRMDA5RÌz«çØÌêá. ºŒ@ 1, ìrm2, ·Jìõ_1, àRFY2, ß¡Õê1, Œ}@C2, ²vÔTq2, H¡Yå, ¯R²s2, acBF2, LÀÇK2, iä§v2, cZŸ2 (1åw@ãÃn€È, 2äPŽaEŽõà): ÖE}` 2019; 52: 68-72.
510006. [à] Tofacitinib for the treatment of rheumatoid arthritis: an update. Yamaoka K1: Expert Rev Clin Immunol 2019/6; 15 (6): 577-88. (RªMG1: 1äPŽaEŽõà)
520008. [à] ÇÆÆu̧äÃ@. RªMG (äPŽaEŽõà): k¢ãw 2019/6; 49 (1): 1-7.
522036. [uÀ]yÁW: ÖßE}`@¡Ãòðg¢±È· "U" Æ "mb"zVœÉo굜ÖßE}`¡Ãòðg¢±È·š@ERANKLjQò. RªMG (äPŽaEŽõà): òÇ 2019/4; 70 (5): 1155-60.
522037. [uÀ]yÁW: JAKjQòÌîbÆÕ°zTCgJCVOi`BÉš¯éJAK-STATÌð. RªMG (äPŽaEŽõà): E}`È 2019/7; 62 (1): 1-5.
522038. [uÀ]yÁW: ÖßE}`|u^Ì°ðvÆuÀS«vðÚw·¡Ã|z[¡Ã: ÀnãƪmÁĚ׫ÖßE}`ÌÅV¡Ã]@JAKjQò. RªMG (äPŽaEŽõà): Medical Practice 2019/7; 36 (7): 1115-9.
540036. [»ÌŒ (wïŽ^)]yæ61ñMBE}`äPŽa§kïzÙ«
ávð浜D_
«œÇ«÷èîÇÌ1á. ³Ël, ѺKÆ, qÈ~ê, Àº§O, cm÷1, ¬ìÃê, Yì[O, éØå (1äPŽaEŽõà): MBãwG 2019/4; 67 (2): 141.
540037. [»ÌŒ (wïŽ^)]yæ61ñMBE}`äPŽa§kïzLÍÍáuÉðåiƵÄófµœOlÒÅÖß³ÒÌÀÔ. Yì[O, ¬ìÃê, ѺKÆ, qÈ~ê, Àº§O, cm÷1, éØå (1äPŽaEŽõà): MBãwG 2019/4; 67 (2): 1429.
540038. [»ÌŒ (wïŽ^)]y_ÞìŽõÇãwïæ86ñãwïzAST®ÌAEgJ]¿É¢Ä. acBF1,2, ¬Œq²2,3, ñ{öL2,4, crç2, ²XØ°q2, éRüq2, [xMq2, Rzq2,5 (1äPŽaEŽõà, 2ŽõǺ, 3òÜ, 4Õ, 5V¢IãÃE¡fIãÃ): _ÞìãwïG 2020/1; 47 (1): 115.
@]
620035. [wp (ªS·M)]y1336êåÆÉæé@Ì¡Ã [2019-2020NxÅ]z€11@äPŽaEAM[Ÿ³@¬«gDa, p. 843-4. RªMG (äPŽaEŽõà), ÄC: cj, kºyêY, ú{ãVñÐ, , 2019/7s.
620036. [wp (ªS·M)]ySg«Ge}g[fXfÃKChC2019zæ3Í _ož_[vX@CQ11 ffE¡ÃøÊ»fÉš¢ÄKvȞ͜©?, p. 70-3. LÀÇK1, Ašr¬1 (1äPŽaEŽõà), Ò: ú¶JÈw€ïâàï¡«Ÿ³ô€Æ ©ÈÆuŸ³Éַ鲞€ (©ÈÆuÇ), ú{E}`wï, ìR°, , 2019/10s.
620037. [wp (ªS·M)]ySg«Ge}g[fXfÃKChC2019zæ3Í _ož_[vX@CQ12KØÈ°ð±üÌ¡ÃÍœ©?, p. 74-8. LÀÇK1, åvÛŒI, ãì§f, âc@ AcÇÆ, Ašr¬1 (1äPŽaEŽõà), Ò: ú¶JÈw€ïâàï¡«Ÿ³ô€Æ ©ÈÆuŸ³Éַ鲞€ (©ÈÆuÇ), ú{E}`wï, ìR°, , 2019/10s.
[wïE€ï]
712006. [wï (Û)] (µãÙu) JAK inhibitors for Rheumatoid Arthritis and more. Yamaoka K1: MET International Seminar (2020/1/16), Finland. (RªMG1: 1äPŽaEŽõà)
713045. [wï (Û)] (êÊu) Anti-Sm Antibody Directly Decreases Tight Junction Protein Composing Blood Brain Barrier on Brain Endothelial Cells by MMP-2 Activation. Arinuma Y1, Hirohata S1, Matsueda Y1, Yamaoka K1: 21st The Asia Pacific League of Associations for Rheumatology 2019 (APLAR2019) (2019/4/8-11), Brisbane Australia. (LÀÇK1, Ašr¬1, Œ}@C1, RªMG1: 1äPŽaEŽõà)
713046. [wï (Û)] (êÊu) Safety and efficacy of filgotinib in Japanese patients enrolled in a global phase 3 trial of patients with active rheumatoid arthritis and inadequate response or tolerance to biologic DMARDs. Takeuchi T, Matsubara T, Atsumi T, Amano K, Ishiguro N, Sugiyama E, Yamaoka K1, Genovese MC, Kalunian K, Walker D, Gottenberg J-E, de Vlam K, Mozaffarian N, Bartok B, Matzkies F, Gao J, Guo Y, Tasset C, Sundy J, Tanaka Y: EULAR Congress 2019-The European League Against Rheumatism (2019/6/12-15), Madrid, Spain. (RªMG1: 1äPŽaEŽõà)
713047. [wï (Û)] (êÊu) Interkeukin-6 Level in Cerebrospinal Fluid as a Biomarker for Systemic Lupus Erythematosus Patients with Longitudinally Extensive Transverse Myelitis like Neuromyelitis Optica Spectrum Disease. Hasegawa Y1, Arinuma Y2, Yamaoka K2: The 8th East Asian Group of Rheumatology (EAGOR 2019) (2019/9/6-7), Seoul, Korea. (·Jìõ_1, LÀÇK2, RªMG2: 1åw@ãÃn€È, 2äPŽaEŽõà)
713048. [wï (Û)] (êÊu) The Effects of Anti-glutamate Receptor Subunit Antiantibodies on Systemic Lupus Erythematosus Without Neuropsychiatric Involvement. Arinuma Y1, Hasegawa Y2, Muramatsu T2, Matsueda Y1, Yamaoka K1: 2019 ACR/ARP Annual Meeting (2019/11/8-13), Atlanta, GA, USA. (LÀÇK1, ·Jìõ_2, ºŒ@ 2, Œ}@C1, RªMG1: 1äPŽaEŽõà, 2åw@ãÃn€È)
713049. [wï (Û)] (êÊu) The Safety Profile of Upadacitinib in Japanese Patients with Rheumatoid Arthritis. Yamaoka K1, Tanaka Y, Kameda H, Hendrickson B, Meerwein S, Zhang Y, Takeuchi T: 2019 ACR/ARP Annual Meeting (2019/11/8-13), Atlanta, GA, USA. (RªMG1: 1äPŽaEŽõà)
722054. [wï (S)] (µÒu) çÇ-3: çÇɹ·é«E^x³Ì·ú\ãÌ¢. cZŸ1, Œ}@C1, iä§v1, RªMG1 (1äPŽaEŽõà): æ63ñú{E}`wïïEwpWï (2019/4/15), s.
722055. [wï (S)] (V|WE)JAKjQòÌoêÉæé¡ãÌÖßE}`¡Ã: JAKjQòsÌãSᲞơãÌÀÕ° (taperingðÜßÄ). RªMG (äPŽaEŽõà): æ63ñú{E}`wïïEwpWï (2019/4/16), s.
722056. [wï (S)] (V|WE) ReBuVh[Ì\h (gÌÆœðxŠé^®ínÌAÂVXe©çÌAv[`): ÖßaÔ̧ä@\. RªMG (äPŽaEŽõà): æ92ñú{®`OÈwïwpï (2019/5/12), ¡l.
722057. [wï (S)] (³çu) ³çu1. RªMG (äPŽaEŽõà): æ40ñú{ǥĶãwï (2019/7/16), _Ë.
722058. [wï (S)] (³çu) ³çu3. RªMG: æ6ñJCRx[VbNT[`Jt@X (2019/10/26), .
722059. [wï (S)] (³çu) ÆuŸ³Éš¯éªqWIÃ@|JAKjQòðSÉ|. RªMG (äPŽaEŽõà): æ40ñú{Õ°òwïwpï (2019/12/5), , Õ°ò 2019; 50 (suppl): S120.
723204. [wï (S)] (êÊu) ÖßE}`Éš¯éIL-6jQÌLp«. RªMG (äPŽaEŽõà): æ63ñú{E}`wïïEwpWï (2019/4/15-17), s.
723205. [wï (S)] (êÊu) ÖßE}`¡Ã̱êÜÅƱê©ç. RªMG (äPŽaEŽõà): æ63ñú{E}`wïïEwpWï (2019/4/15-17), s.
723206. [wï (S)] (êÊu) JAKjQÜÌîbÆÕ°. RªMG (äPŽaEŽõà): æ63ñú{E}`wïïEwpWï (2019/4/15-17), s.
723207. [wï (S)] (êÊu) ÖßÇóðL·éx[`Fbga³ÒÌÕ°Á¥. ìrm1, Ašr¬1, enOq, òcN¡, xìõm, iºTq, Ëìmœ, {ìêœ, cÇÆ, RªMG1 (1äPŽaEŽõà): æ63ñú{E}`wïïEwpWï (2019/4/15-17), s.
723208. [wï (S)] (êÊu) ÈÉš¯éD_
«œÇ«÷èîÇÌÕ°Ì¢. ºŒ@ 1, Éìan2, ·Jìõ_1, ß¡Õê1, Œ}@C2, ¯R²s2, ìrm2, LÀÇK2, acBF2, iä§v, cZŸ2, RªMG2 (1åw@ãÃn€È, 2äPŽaEŽõà): æ63ñú{E}`wïïEwpWï (2019/4/15-17), s.
723209. [wï (S)] (êÊu) ÈÅÌRMDA5RÌz«çسÒÌÕ°Ì¢. Éìan1, ¯R²s1, ºŒ@ 2, ·Jìõ_2, ß¡Õê2, ìrm1, LÀÇK1, iä§v, cZŸ1, RªMG1 (1äPŽaEŽõà, 2åw@ãÃn€È): æ63ñú{E}`wïïEwpWï (2019/4/15-17), s.
723210. [wï (S)] (êÊu) {ÝÉš¯éSg«Ge}g[fX (SLE) ÉηéqhLVNL (HCQ) Ì¡ÃÆ¢. ß¡Õê1, Œ}@C2, Éìan2, ·Jìõ_1, ºŒ@ 1, ¯R²s2, ìrm2, LÀÇK2, acBF2, iä§v, cZŸ2, RªMG2 (1åw@ãÃn€È, 2äPŽaEŽõà): æ63ñú{E}`wïïEwpWï (2019/4/15-17), s.
723211. [wï (S)] (êÊu) RSmRÌÆRRNPRÌÉæéP
ÌÇ«TCgJCY¶ÉηéæIøÊÌ¢. Œ}@C1, LÀÇK1, iä§v, cZŸ1, Ašr¬1, RªMG1 (1äPŽaEŽõà): æ63ñú{E}`wïïEwpWï (2019/4/15-17), s.
723212. [wï (S)] (êÊu) SLE (îb) ]Çàç×EÉš¯éMMP-2»ãžÆclaudin-5žÉηéRSmRÌÌŒÚìp. LÀÇK1, RªMG1 (1äPŽaEŽõà): æ63ñú{E}`wïïEwpWï (2019/4/15-17), s.
723213. [wï (S)] (êÊu) çÇ-3 çÇɹ·é«E^x³Ì·ú\ãÌ¢. cZŸ1, Œ}@C1, iä§v, RªMG1 (1äPŽaEŽõà): æ63ñú{E}`wïïEwpWï (2019/4/15-17), s.
723214. [wï (S)] (êÊu) SLE (Õ°) -1 }Nt@[W«»ÇóQð浜Sg«Ge}g[fXÌÕ°IÁ¥Ì¢. ·Jìõ_1, LÀÇK2, Éìan2, ß¡Õê1, ºŒ@ 1, Œ}@C2, ¯R²s2, ìrm2, acBF2, iä§v, cZŸ2, RªMG2 (1åw@ãÃn€È, 2äPŽaEŽõà): æ63ñú{E}`wïïEwpWï (2019/4/15-17), s.
723215. [wï (S)] (êÊu) JAKjQÜ (RCT) ]^¬DMARDÅøÊs\ªÈú{l®«ÖßE}`³ÒðÎÛƵœIðIJAK-1jQòEp_V`juÌæ2b/3³ì×»vZ{ÎÆñdӱɚ¯é·ú^ÌLø«yÑÀS«¬Ñ. TcGl, |à@Î, RªMG1, D³A, ìì[O, Zhou Yijie, Othman Ahmed A, Pangan Aileen L, óLê, kº@§, Meerwein Sebastian, cÇÆ (1äPŽaEŽõà): æ63ñú{E}`wïïEwpWï (2019/4/15-17), s.
723216. [wï (S)] (êÊu) E}`«Ÿ³ÌKChC x[`FbgafÃKChC. xìõm, Ašr¬1, enOq, KŒ³², âV¡a`, cÇÆ, iºTq, òcN¡, ìrm1, Ëìmœ, g©³î, yŽ_Í, Rû«ê, àqÀãq, É¡Gê, |à³÷, ÎØÇŸ,
ØMv, ú¶JÈx[`FbgaÉַ鲞€Ç (1äPŽaEŽõà): æ63ñú{E}`wïïEwpWï (2019/4/15-17), s.
723217. [wï (S)] (êÊu) ÖßE}`¡ÃÉš¯éeé Ç¡ÃÌÀÛ. RªMG (äPŽaEŽõà): æ47ñú{Õ°Æuwïï (2019/10/17-19), Dy.
723218. [wï (S)] (êÊu) Sg«Ge}g[fXÉš¯éRNMDAóeÌTujbgGluN2RÌÌ_ož_[vXÈOÌŸ³®«É^Šée¿. LÀÇK1, ·Jìõ_2, ºŒ@ 2, Œ}@C1, RªMG1 (1äPŽaEŽõà, 2åw@ãÃn€È): æ47ñú{Õ°Æuwïï (2019/10/17-19), Dy.
723219. [wï (S)] (êÊu) Sg«Ge}g[fXÉš¯éx}uÌqhLVNLÆ̹pšæÑPÜÃ@Ì¡ÃøÊ. ·Jìõ_1, LÀÇK2, ºŒ@ 1, ß¡Õê1, Œ}@C2, RªMG2 (1åw@ãÃn€È, 2äPŽaEŽõà): æ47ñú{Õ°Æuwïï (2019/10/17-19), Dy.
723220. [wï (S)] (êÊu) awI¢ªÂ\Å Áœ¬°úE𫜵œIgG4ÖAŸ³Ìêá. Éìan1, LÀÇK1, ºèöî1, i¡¹1, àRFY1, ºŒ@ 2, ·Jìõ_2, cm÷1, ¯R²s1, ìrm1, acBF1, cZŸ1, RªMG1 (1äPŽaEŽõà, 2åw@ãÃn€È): æ47ñú{Õ°Æuwïï (2019/10/17-19), Dy.
723221. [wï (S)] (êÊu) ÖßE}`³ÒÉš¯éA_}uÆgVY}uªÑóáv]ÇÉ^Šée¿. ºŒ@ 1, LÀÇK2, ·Jìõ_1, RªMG2 (1åw@ãÃn€È, 2äPŽaEŽõà): æ34ñú{Õ°E}`wï (2019/11/30), ŒÃ®.
732018. [wï (nûïE€ï)] (³çu) ÖßE}`¡ÃÌÅVî. RªMG (äPŽaEŽõà): ú{àÈwïæ61ñkC¹x¶U³çuï (2019/7/7), Dy.
733092. [wï (nûïE€ï)] (êÊu) RMDA5RÌÆRARSR̪€z«Å Áœ³ØÇ«çØÌ1á. i¡¹1, ìrm1, ºèöî1, Éìan1, àRFY1, cm÷1, ¯R²s1, LÀÇK1, cZŸ1, RªMG1 (1äPŽaEŽõà): æ30ñú{E}`wïÖxwpWï (2019/12/7), .
733093. [wï (nûïE€ï)] (êÊu) SLEÌÁÃÉŒºŽoÙíðæ·éNMOSD𹵜êá. åëIM1, àV@Œ÷, nç³@x, ¢ä[Ÿ, äFåã,
ìTî, œŒ¢Àq, Rà^V, zKBç, Œìüä, LÀÇK2, {@ò, ãâ`a, RªMG2, ûŽP¶ (1ÕÌåa@ª@E}`äPŽaÈ, 2äPŽaEŽõà): æ30ñú{E}`wïÖxwpWï (2019/12/7), .
'18NxÈOª
[wp_¶]
'18-510001. [à] Janus kinases to jakinibs: from basic insights to clinical practice. Gadina M, Le MT, Schwartz DM, Silvennoinen O, Nakayamada S, Yamaoka K1, O'Shea JJ: Rheumatology (Oxford) 2019/2; 58 (Suppl 1): i4-i16. (RªMG1: 1äPŽaEŽõà)
'18-522006. [uÀ]yÁW: ©ÈÆuŸ³ÌÂÊ»ãÃz3. ÖßE}`ÌÂÊ»ãÃ. RªMG (äPŽaEŽõà): Precision Medicine 2018/12; 2 (1): 19-21.
[@]
'18-620006. [wp (ªS·M)yVòW]2019 (ãòW[i55ª§)zæIII ¡ÃÉš¯éÅßÌVòÌÊuï@<òøÊ> VòÌLê@RE}`ò, p. 361-4. RªMG (äPŽaEŽõà), ãòW[iÐ. åã, 2019/1s.
'18-620007. [wp (ªS·M)]y¡úÌ¡Ãwj@ͱ€¡ÃµÄ¢é@2019NÅz14DäPŽašæÑÞŸ³@RE}`òE¶šwI»ÜÌìpÆÎô, p. 858-9. RªMG (äPŽaEŽõ), ÒW: äî, Ø@œ, ¬ºê¬, ãw@, , 2019/1s.
[wïE€ï]
'18-713006. [wï (Û)] (êÊu) Interkeukin-6 Level in Cerebrospinal Fluid As a Biomarker for Systemic Lupus Erythematosus Patients with Longitudinally Extensive Transverse Myelitis like Neuromyelitis Optica Spectrum Disease. Hasegawa Y1, Arinuma Y2, Ino K2, Muramatsu T1, Kondo J1, Matsueda Y2, Hoshiyama T2, Tono T2, Wada T2, Nagai T2, Tanaka S2, Yamaoka K2: 2018 ACR/ARHP Annual Meeting (2018/10/21), Chicago, USA. (·Jìõ_1, LÀÇK2, Éìan2, ºŒ@ 1, ß¡Õê1, Œ}@C2, ¯R²s2, ìrm2, acBF2, iä§v2, cZŸ2, RªMG2: 1åw@ãÃn€È, 2äPŽaEŽõà)
ûBEbóBOÈw
[wp_¶]
110173. [Ž] Differential Prognostic Relevance of Promoter DNA Methylation of CDO1 and HOPX in Primary Breast Cancer. Tanaka Y1, Kosaka Y2, Waraya M2, Yokota K1, Harada H1, Kaida T1, Kikuchi M2, Minatani N, Nishimiya H2, Katoh H2, Sengoku N2, Watanabe M3, Yamashita K4,5: Anticancer Res 2019/5; 39 (5): 2289-98. (cuq1, ¬âù«2, mJüÞ2, ¡caq1, ŽcGP1, bãcu1, er^q2, Œ{mj2, Á¡@O2, åÎIF2, nç²¹F3, Rºpj4,5: 1åw@ãÃn€È, 2ûBEbóBO, 3k¢åwk¢€a@, 4V¢IãÃE¡fIãÃ, 5ãÁ»ÇO)
110174. [Ž] Anthracycline could be essential for triple-negative breast cancer: A randomised phase II study by the Kanagawa Breast Oncology Group (KBOG) 1101. Narui K, Ishikawa T, Shimizu D, Yamada A, Tanabe M, Sasaki T, Oba MS, Morita S, Nawata S, Kida K, Mogaki M, Doi T, Tsugawa K, Ogata H, Ota T, Kosaka Y1, Sengoku N1, Kuranami M, Niikura N, Saito Y, Suzuki Y, Suto A, Arioka H, Chishima T, Ichikawa Y, Endo I, Tokuda Y: Breast 2019/10; 47: 1-9. (¬âù«1, åÎIF1: 1ûBEbóBO)
110175. [Ž] Epigenetic silencing of HOPX is critically involved in aggressive phenotypes and patient prognosis in papillary thyroid cancer. Ooizumi Y1, Katoh H2, Yokota M1, Watanabe M3, Yamashita K4,5: Oncotarget 2019/10; 10 (57): 5906-18. (åòzî1, Á¡@O2, ¡cõ1, nç²¹F3, Rºpj4,5: 1åw@ãÃn€È, 2ûBEbóBO, 3k¢åwk¢€a@, 4V¢IãÃE¡fIãÃ, 5ãÁ»ÇO)
110176. [Ž] Analysis of the selection of CDK4/6 inhibitors based on experience using palbociclib. Kikuchi M1, Tanaka Y2, Yokota M2, Nishimiya H1, Katoh H1, Sengoku N1, Kosaka Y1: Biomed Rep 2019/12; 11 (6): 253-6. (er^q1, cuq2, ¡cõ2, Œ{mj1, Á¡@O1, åÎIF1, ¬âù«1: 1ûBEbóBO, 2åw@ãÃn€È)
110177. [Ž] Lymphocyte-Monocyte Ratio Significantly Predicts Recurrence in Papillary Thyroid Cancer. Yokota M1, Katoh H2, Nishimiya H2, Kikuchi M2, Kosaka Y2, Sengoku N2, Watanabe M3, Yamashita K4: J Surg Res 2020/2; 246: 535-43. (¡cõ1, Á¡@O2, Œ{mj2, er^q2, ¬âù«2, åÎIF2, nç²¹F3, Rºpj4: 1åw@ãÃn€È, 2ûBEbóBO, 3k¢åwk¢€a@, 4V¢IãÃE¡fIãÃ)
110178. [Ž] BRCAness as an Important Prognostic Marker in Patients with Triple-Negative Breast Cancer Treated with Neoadjuvant Chemotherapy: A Multicenter Retrospective Study. Kosaka Y1, Yamamoto Y, Tanino H, Nishimiya H1, Yamamoto-Ibusuki M, Hirota Y, Iwase H, Nakamura S, Akashi-Tanaka S: Diagnostics (Basel) 2020/2; 10 (2): 119. (¬âù«1, Œ{mj1: 1ûBEbóBO)
320009. [Çáñ] SgÃ@ÌÝÅClinical Complete Responseð±µÄ¢éûàÌ1á. R{öê, Ñ@q1, mJüÞ1, HAm, ×J@q, ¬âù«1, åÎIF1, ìad2, ¢@~3, nç²¹F4 (1ûBEbóBO, 2úËü (îá), 3a, 4k¢åwk¢€a@): àÆ»wÃ@ 2019/4; 46 (4): 757-9.
511004. [ðà]yEditorial CommentaryzHistorical progress of the 8th edition of the American Joint Committee on Cancer (AJCC) Cancer Staging Manual in patients with breast cancer. Kosaka Y1, Nishimiaya H1, Kikuchi M1, Waraya M1, Katoh H1, Sengoku N1: Transl Cancer Res 2019/6; 8 (3): 719-21. (¬âù«1, Œ{mj1, er^q1, mJüÞ1, Á¡@O1, åÎIF1: 1ûBEbóBO)
[wïE€ï]
723222. [wï (S)] (êÊu) Ž¹gKChºzø®gD¶ (VAB) Éš¯épÇNP©ÆZ`lp߶ÊÉÖ·é¢. cuq1, ¬âù«2, ¡ìD, ¡cõ1, er^q2, Œ{mj2, {Iq, Á¡@O2, åÎIF2, ¬ìco, åUÀ@, nç²¹F3 (1åw@ãÃn€È, 2ûBEbóBO, 3k¢åwk¢€a@): æ119ñú{OÈwïèúwpWï (2019/4/18), åã.
723223. [wï (S)] (êÊu) pO»wÃ@ð{sµœHER2z«ûà̡ìÑ. æÑ@Tº1, ¬âù«1, ¡cõ2, cuq2, er^q1, Œ{mj1, Á¡@O1, cçüT3, åÎIF1, nç²¹F4 (1ûBEbóBO, 2åw@ãÃn€È, 3a, 4k¢åwk¢€a@): æ119ñú{OÈwïèúwpWï (2019/4/19), åã.
723224. [wï (S)] (êÊu) «ûüvÌKv«Æâè_. Œ{mj1, ª{õFq2, cuq3, er^q1, Á¡@O1, ¬âù«1, åÎIF1, nç²¹F4 (1ûBEbóBO, 2êÊE¬EÌ_äXO, 3åw@ãÃn€È, 4k¢åwk¢€a@): æ119ñú{OÈwïèúwpWï (2019/4/19), åã.
723225. [wï (S)] (êÊu) ú{Éš¯éVKûªñ¡ÃòÌJ@gvlKeBuûà¡ÃÌRpjIffòJÆJ{v`ÌÄ}§øÊÌæ3Õ°±. JìTê1, éسl1, C£j1, {º@1, ç²i1, Ñ@õO1, ODNY1, ñº@w1, åJ²êY1, iŽ¹K1, ŸcqF1, ¬âù«1,2, Îì@F1, ·JìP}1, Ecqs1, OKMj1,2, âJû¶1, Rc°õ1, ÔàVGœ1, ÍìÍj1 (1JONIEO[v, 2ûBEbóBO): æ27ñú{ûàwïwpï (2019/7/11), .
723226. [wï (S)] (êÊu) ñ20NãÉ·¶û[àĵœûàÌZ`lpߪ΀ãüâ|ɯè³êœÄûàÌ1á. Fžm, ŽÞ, ãìêY, îcGm, ß¡Nj1, ¬âù«1, åÎIF1 (1ûBEbóBO): æ27ñú{ûàwïwpï (2019/7/11), .
723227. [wï (S)] (êÊu) p{VNugpo±ÉæéCDK4/6jQòÌIðÉÖ·é¢. er^q1, ¬âù«1, ¡cõ2, cuq2, Œ{mj1, Á¡@O1, åÎIF1 (1ûBEbóBO, 2åw@ãÃn€È): æ27ñú{ûàwïwpï (2019/7/11), .
723228. [wï (S)] (êÊu) @Éš¯édose-dense ECÃ@Ìgp¬ÑÆEe«É¢ÄÌ¢. Œ{mj1, ¬âù«1, ¡cõ2, cuq2, er^q1, Á¡@O1, åÎIF1 (1ûBEbóBO, 2åw@ãÃn€È): æ27ñú{ûàwïwpï (2019/7/11), .
723229. [wï (S)] (êÊu) @Éš¯éBRACAnalysisÌffÆ{sÇáÉÖ·é¢. mJüÞ1, ¬âù«1, cuq2, er^q1, Œ{mj1, Á¡@O1, Ñ@q1, åÎIF1, cjj2 (1ûBEbóBO, 2åw@ãÃn€È): æ27ñú{ûàwïwpï (2019/7/12), .
723230. [wï (S)] (êÊu) s@ØÝÌûà³Ò¡ÃÉš¯éâè_. åÎIF1, cuq2, er^q1, Œ{mj1, Xcz}3, £Ëqq3, ¬âù«1 (1ûBEbóBO, 2åw@ãÃn€È, 3Åì): æ27ñú{ûàwïwpï (2019/7/13), .
723231. [wï (S)] (êÊu) @Éš¯éisÄûàÉηéEribulin^ÌLø«EÀS«É¢Ä. ¬âù«1, cuq2, ¡cõ2, er^q1, Œ{mj1, Á¡@O1, åÎIF1, nç²¹F3 (1ûBEbóBO, 2åw@ãÃn€È, 3k¢åwk¢€a@): æ27ñú{ûàwïwpï (2019/7/13), .
723232. [wï (S)] (êÊu) ûàÉš¯éà/žRŽÌâ`q»É¢ÄÌ¢. ß¡Nj1,2, R@², RºÚß, ñnM], C1,3, nî1,4, çìTêY3, ºa¿1,5, vÛCj5, ri@œ1,2, ¬Ñ1, Rè@1,6, Žõl1,5, Œ@ªk1, nç²¹F7 (1k¢åwfBJZ^[, 2ûBEbóBO, 3ºÁ»ÇO, 4ãÁ»ÇO, 5êÊE¬EÌ_äXO, 6a, 7k¢åwk¢€a@): æ27ñú{ûàwïwpï (2019/7/13), .
723233. [wï (S)] (êÊu) @\«ßªûªàÅ ÁœMarine-LenhartÇóQÌ1á. ¡cõ1, Á¡@O2, Œ{mj2, er^q2, ¬âù«2, åÎIF2 (1åw@ãÃn€È, 2ûBEbóBO): æ52ñú{àªåOÈwïwpåï (2019/10/17), .
723234. [wï (S)] (êÊu) FEC{sûà³ÒÉš¯é±^G-CSF^±üÉæéÀS«Ì¢. à¡ÂÞq1, Œ{mj2, er^q2, ¬âù«2, Á¡@O2, åÎIF2 (1ºÁ»ÇO, 2ûBEbóBO): æ81ñú{Õ°OÈwïï (2019/11/16), m.
êÊE¬EÌ_äXOÈw
[wp_¶]
110179. [Ž] Validation of index-based IWATE criteria as an improved difficulty scoring system for laparoscopic liver resection. Tanaka S, Kawaguchi Y, Kubo S, Kanazawa A, Takeda Y, Hirokawa F, Nitta H, Nakajima T, Kaizu T1, Kaibori M, Kojima T, Otsuka Y, Fuks D, Hasegawa K, Kokudo N, Kaneko H, Gayet B, Wakabayashi G: Surgery 2019/4; 165 (4): 731-40. (CÃMj1: 1êÊE¬EÌ_äXO)
110180. [Ž] Diagnostic potential of hypermethylation of the cysteine dioxygenase 1 gene (CDO1) promoter DNA in pancreatic cancer. Nishizawa N1, Harada H2, Kumamoto Y1, Kaizu T1, Katoh H3, Tajima H1, Ushiku H2, Yokoi K2, Igarashi K, Fujiyama Y4, Okuwaki K5, Iwai T5, Watanabe M6, Yamashita K2,7: Cancer Sci 2019/9; 110 (9): 2846-55. (ŒàVL±1, ŽcGP2, G³Yî1, CÃMj1, Á¡@O3, c@O1, vG÷2, ¡ä\å2, ¡RF÷4, e»î5, âämv5, nç²¹F6, Rºpj2,7: 1êÊE¬EÌ_äXO, 2ãÁ»ÇO, 3ûBEbóBO, 4åw@ãÃn€È, 5Á»íà, 6k¢åwk¢€a@, 7V¢IãÃE¡fIãÃ)
110181. [Ž] Expression of Kita-Kyushu Lung Cancer Antigen-1 as Detected by a Novel Monoclonal Antibody in Gastric Cancer. Takahashi Y1,2, Fukuyama T, Futawatari N, Ichiki Y, Ohmiya H, Chuman M1,3, Yamashita T, Hiki N3, Kumamoto Y2, Yamazaki H1,4: Anticancer Res 2019/11; 39 (11): 6259-63. (Žõl1,2, nî1,3, äéŒ÷3, G³Yî2, Rè@1,4: 1k¢åwfBJZ^[, 2êÊE¬EÌ_äXO, 3ãÁ»ÇO, 4a)
110020. [Ž] EP3 signaling in dendritic cells promotes liver repair by inducing IL-13-mediated macrophage differentiation in mice. Nakamoto S1, Ito Y2, Nishizawa N3, Goto T1, Kojo K4, Kumamoto Y3, Watanabe M5, Narumiya S, Majima M2: FASEB J 2020/4; 34 (4): 5610-27. doi: 10.1096/fj.201901955R. Epub 2020 Feb 28. ({Ci1, É¡`ç2, ŒàVL±3, ã¡ìç1, Ãé@4, G³Yî3, nç²¹F5, n³²2: 1åw@ãÃn€È, 2ò, 3êÊE¬EÌ_äXO, 4ºÁ»ÇO, 5k¢åwk¢€a@)
310024. [Çáñ] Colorectal cancer with peritoneal carcinomatosis in a teenager. Nakamoto S1, Tanaka K2,3, Watanabe E, Takeda N, Nakamura T4, Kumamoto Y3: Journal of Pediatric Surgery Case Reports 2020/3; 54: 101385. ({Ci1, c@2,3, º²r4, G³Yî3: 1åw@ãÃn€È, 2V¢IãÃEæ[fIãÃ, 3êÊE¬EÌ_äX, 4ºÁ»ÇO)
320010. [Çáñ] ¡ÌlIW¥Îðëùµ, Ýó°úÊðµœ1á. ÇØGé1, c@1,2, R{TP1 (1êÊE¬EÌ_äXO, 2V¢IãÃEæ[ãÃ): ú{¬~}ãwïG 2019/10; 18 (3): 366-9.
320011. [Çáñ] oŸºå°àŽÌ]Ú¯Øp{sãÉDsSÌ©ªxêœêá. i@ ³1, CÃMj1, RL2, ŒàVL±1, c@O1, G³Yî1, nç²¹F3 (1êÊE¬EÌ_äXO, 2ºÁ»ÇO, 3k¢åwk¢€a@): _ÞìãwïG 2019/7; 46 (2): 190.
320012. [Çáñ] HALSÚsÅεœ oŸºÌØY_KXÇðÌ1á. â{ê1, i@ ³1, CÃMj1, c@O1, G³Yî1, nç²¹F2 (1êÊE¬EÌ_äXO, 2k¢åwk¢€a@): ú{Õ°OÈwïG 2020/1; 81 (1): 65-71.
520009. [à] äXàÌOÈ¡ÃÌÏJ. G³Yî1, CÃMj1, c@O1, vÛCj1, ŒàVL±1, {Ci2, ¡RF÷2, Ü\ê°, ª{õFq1, æÑ@ Tº3 (1êÊE¬EÌ_äXO, 2åw@ãÃn€È, 3ûBEbóBO): k¢ãw 2019/12; 49 (2): 67-71.
521002. [ðà]yÌ_äXOÈèpÉš¯éguV
[eBO (èp2019N6å)z¡èpèZ@ oŸº¶öótØÌèpèZ, p.1099-104. CÃMj1, G³Yî1, c@O1, i@ ³1, ŒàVL±1, nç²¹F2 (1êÊE¬EÌ_äXO, 2k¢åwk¢€a@): àŽoÅ, , 2019/6s.
522039. [uÀ]yÁÊéæ: æ55ñú{_¹wïwpWïæèzåüùªÈ³êœ}«_ùNÌfÃt[`[g. óä_i, ch, ª{Di, éØ, ~àVºq, X@×õ, ¢YŸ, G³Yî1, {ÔT÷ (1êÊE¬EÌ_äXO): Ì_äX 2020/1; 80 (1): 202-207.
522040. [uÀ]yÁÊéæ: æ55ñú{_¹wïwpWïæèz}«_ùNÉηé oŸº_ùNEopÅTG18ª§·éë¯ñðèZšæÑñðèp. ~àVºq, ch, ¢YŸ, G³Yî1, Ûö[q, åRNi, óìVv, {ÔS÷, X@×õ (1êÊE¬EÌ_äXO): Ì_äX 2020/1; 80 (1): 208-14.
522041. [uÀ]yÁW: »±ªm蜢V[Y: èpÅKvÈÇðU ( Ò)zRamstedtèp (ìú«Hå·óÇ). c@1,2, R{TP2, oÆê2, ÇØGé2, ãŒR¹2 (1V¢IãÃEæ[ãÃ, 2êÊE¬EÌ_äXO): ¬OÈ 2020/2; 52 (2): 114-7.
522042. [uÀ]yÁW: ¬OÈÉš¯éœfÃÈAgz@Éš¯éüYêq¬çãÃZ^[ÌAg|V¶OÈŸ³Ìo¶OffÌ»ó|. ÇØGé1, c@1,2, R{TP1, oÆê1 (1êÊE¬EÌ_äXO, 2V¢IãÃEæ[ãÃ): ¬OÈ 2020/3; 52 (3): 231-3.
[@]
620038. [wp (ªS·M)]yÌ_äXOÈèpÉš¯éguV
[eBO (èp2019N6å)z¡èpèZ@ oŸº¶öótØÌèpèZ, p.1099-104. CÃMj1, G³Yî1, c@O1, i@ ³1, ŒàVL±1, nç²¹F2 (1êÊE¬EÌ_äXO, 2k¢åwk¢€a@): àŽoÅ, , 2019/6s.
[wïE€ï]
713050. [wï (Û)] (êÊu) Utero-vesical anastomosis: A novel operation for a girl of cloacal exstrophy with vaginal agenesis. Tanaka K1,2, Yamamoto Y2, Deie K2, Oiki H2: The 6th World Congress of the World Federation of Associations of Pediatric Surgery (WOFAPS 2019) (2019/11/2), Doha, Qatar. (c@1,2, R{TP2, oÆê2, ÇØGé2: 1V¢IãÃEæ[ãÃ, 2êÊE¬EÌ_äXO)
713051. [wï (Û)] (êÊu) A case of penile duplication with ectopic intestinal tissue. Oiki H1, Tanaka K1,2, Yamamoto Y1, Deie K1: The 6th World Congress of the World Federation of Associations of Pediatric Surgery (WOFAPS 2019) (2019/11/3), Doha, Qatar. (ÇØGé1, c@1,2, R{TP1, oÆê1: 1êÊE¬EÌ_äXO, 2V¢IãÃEæ[ãÃ)
722060. [wï (S)] (µÒu) CDO1â`qDNA`»ÉÚµœäXàff@Ì¢. ŒàVL±1, Rºpj2,3, ¡RF÷4, {Ci4, Ü\ê°, c@O1, CÃMj1, G³Yî1 (1êÊE¬EÌ_äXO, 2V¢IãÃE¡fIãÃ, 3ãÁ»ÇO, 4åw@ãÃn€È): æ50ñú{äXwïåï (2019/7/12), .
722061. [wï (S)] (µÒu) ã èpùÌ éÇáÉηé oŸºÌØ. CÃMj1, G³Yî1, c@O1, ŒàVL±1, i@ ³1, nç²¹F2 (1êÊE¬EÌ_äXO, 2k¢åwk¢€a@): æ74ñú{Á»íOÈwïï (2019/7/18), .
723235. [wï (S)] (êÊu) oŸºäB·¶ö€äXØ (äB®Ã¬) ÅÌConvesionÌ¢. c@O1, G³Yî1, ŒàVL±1, i@ ³1, CÃMj1, nç²¹F2 (1êÊE¬EÌ_äXO, 2k¢åwk¢€a@): æ119ñú{OÈwïèúwpWï (2019/4/18), åã.
723236. [wï (S)] (êÊu) oŸºÌØpÌ¢ïÇáÉÖ·é¢. i@ ³1, CÃMj1, ŒàVL±1, c@O1, G³Yî1, nç²¹F2 (1êÊE¬EÌ_äXO, 2k¢åwk¢€a@): æ119ñú{OÈwïèúwpWï (2019/4/18), åã.
723237. [wï (S)] (êÊu) IPMCÉš¯éCDO1â`q`»ÌÕ°awIÓ`. ¡RF÷1, Rºpj2,3, Yìl¶1, ¡cõ1, {Ci1, bãcu1, ¡caq1, cuq1, ŽcGP1, i@ ³, ŒàVL±4, c@O4, CÃMj4, G³Yî4, nç²¹F5 (1åw@ãÃn€È, 2V¢IãÃE¡fIãÃ, 3ãÁ»ÇO, 4êÊE¬EÌ_äXO, 5k¢åwk¢€a@): æ119ñú{OÈwïèúwpWï (2019/4/18), åã.
723238. [wï (S)] (êÊu) AsA¹, A¹·ó, H^äNã÷äTáðºÁœåA¶BŽï`Ì2á. ãŒR¹1, c@1,2, R{TP1, ÇØGé1 (1êÊE¬EÌ_äXO, 2V¢IãÃEæ[ãÃ): æ119ñú{OÈwïèúwpWï (2019/4/19), åã.
723239. [wï (S)] (êÊu) oŸºÌØ¢ïÇáÉηéHALSÌÏÉIp. CÃMj1, G³Yî1, c@O1, i@ ³1, ŒàVL±1, nç²¹F2 (1êÊE¬EÌ_äXO, 2k¢åwk¢€a@): æ119ñú{OÈwïèúwpWï (2019/4/20), åã.
723240. [wï (S)] (êÊu) V¶úEûúÉèpðsÁœóâ|á4áÌ¢. ÇØGé1, c@1,2, R{TP1 (1êÊE¬EÌ_äXO, 2V¢IãÃEæ[ãÃ): æ56ñú{¬OÈwïwpWï (2019/5/23), ª.
723241. [wï (S)] (êÊu) III^äXOÉηé¡Ãíª\èp? Û¶¡Ã? c@1,2, R{TP2, ÇØGé2 (1V¢IãÃEæ[ãÃ, 2êÊE¬EÌ_äXO): æ56ñú{¬OÈwïwpWï (2019/5/25), ª.
723242. [wï (S)] (êÊu) Éáo¶ÌdÌXg}ÂœúÉÖ·é¢. R{TP1, c@1,2, ÇØGé1 (1êÊE¬EÌ_äXO, 2V¢IãÃEæ[ãÃ): æ56ñú{¬OÈwïwpWï (2019/5/25), ª.
723243. [wï (S)] (êÊu) x«æV«¡uwjAÉηéàŸèp|¹oŸ? oŸ? ãŒR¹1, c@1,2, R{TP1, ÇØGé1 (1êÊE¬EÌ_äXO, 2V¢IãÃEæ[ãÃ): æ56ñú{¬OÈwïwpWï (2019/5/25), ª.
723244. [wï (S)] (êÊu) Clinical significance of promoter DNA hypermethylation of the cysteine dioxygenase 1 (CDO1) gene in pancreatic ductal adenocarcinoma. ŒàVL±1, Rºpj2,3, ¡RF÷4, {Ci4, c@O1, CÃMj1, G³Yî1 (1êÊE¬EÌ_äXO, 2ãÁ»ÇO, 3V¢IãÃE¡fIãÃ, 4åw@ãÃn€È): æ31ñú{Ì_äXOÈwïEwpWï (2019/6/14), ì.
723245. [wï (S)] (êÊu) Laparoscopic distal pancreatectomy for pancreatic cancers put the emphasis on the distal margin. c@O1, CÃMj1, i@ ³1, ŒàVL±1, G³Yî1 (1êÊE¬EÌ_äXO): æ31ñú{Ì_äXOÈwïEwpWï (2019/6/15), ì.
723246. [wï (S)] (êÊu) Hand-assisted laparoscopic surgery (HALS) for the troubleshooting in laparoscopic liver resection. CÃMj1, G³Yî1, c@O1, ŒàVL±1, i@ ³1, nç²¹F2 (1êÊE¬EÌ_äXO, 2k¢åwk¢€a@): æ31ñú{Ì_äXOÈwïEwpWï (2019/6/15), ì.
723247. [wï (S)] (êÊu) ¬}«Éš¯éŽ¹gžECTžÌÓ`. c@1,2, R{TP2, ÇØGé2 (1V¢IãÃEæ[ãÃ, 2êÊE¬EÌ_äXO): æ33ñú{¬~}ãwïwpWï (2019/6/21), éÊ.
723248. [wï (S)] (êÊu) úE«, Ä« ÉæésÇ«VbN©çSxâ~ÉÁœ1á. ÇØGé1, c@1,2, R{TP1, À¡@õ3, ôöb3 (1êÊE¬EÌ_äXO, 2V¢IãÃEæ[ãÃ, 3¬): æ33ñú{¬~}ãwïwpWï (2019/6/22), éÊ.
723249. [wï (S)] (êÊu) V¶úÉêúIª¡pð{sµœ³áE^œãèÌ3á. c@1,2, R{TP2, ÇØGé2 (1V¢IãÃEæ[ãÃ, 2êÊE¬EÌ_äXO): æ55ñú{üYúEV¶ãwïwpWï (2019/7/13), ·ì.
723250. [wï (S)] (êÊu) ó°ÂœÇÆo¶Off³ê, ä`Ñ×á𹵜°ñ]ÙíÇE°²P]Ì1á. ÇØGé1, c@1,2, R{TP1 (1êÊE¬EÌ_äXO, 2V¢IãÃEæ[ãÃ): æ55ñú{üYúEV¶ãwïwpWï (2019/7/14), ·ì.
723251. [wï (S)] (êÊu) V¶bPeºúEÌ1á. àcÇ1, c@2,3, R{TP3, ÇØGé3 (1ºÁ»ÇO, 2V¢IãÃEæ[ãÃ, 3êÊE¬EÌ_äXO): æ55ñú{üYúEV¶ãwïwpWï (2019/7/14), ·ì.
723022. [wï (S)] (êÊu) vX^OWEP3óeÌVOiðÌ÷ó×EÌÌC£iìp. {Ci1, É¡`ç2, ŒàVM±3, åj¹1, 1, ¿q4, {cëq1, Vìp÷2, n³²2 (1åw@ãÃn€È, 2ò, 3êÊE¬EÌ_äXO, 4YÈ): æ40ñú{ǥĶãwï (2019/7/16), _Ë.
723252. [wï (S)] (êÊu) ÈÉš¯éå°àÌ]ÚÇáÉηéÌØèp¬ÑÌ¢. ¡RF÷1, i@ ³2, CÃMj2, {Ci1, ŒàVL±2, c@O2, G³Yî2 (1åw@ãÃn€È, 2êÊE¬EÌ_äXO): æ74ñú{Á»íOÈwïï (2019/7/17), .
723253. [wï (S)] (êÊu) oŸºö€äXØÌPitfallÆguV
[eBO. c@O1, CÃMj1, i@ ³1, ŒàVL±1, G³Yî1 (1êÊE¬EÌ_äXO): æ74ñú{Á»íOÈwïï (2019/7/18), .
723254. [wï (S)] (êÊu) äXîáÉηéLiquid biopsy CDO1â`q`»Ìff}[J[ƵÄÌLp«. ¡RF÷1, ŒàVL±2, {Ci1, YìF¶1, ¡cõ1, bãcu1, e»î3, âämv3, c@O2, vÛCj2, CÃMj2, G³Yî2, Rºpj4,5 (1åw@ãÃn€È, 2êÊE¬EÌ_äXO, 3Á»íà, 4V¢IãÃE¡fIãÃ, 5ãÁ»ÇO): æ78ñú{àwïwpï (2019/9/27), s.
723255. [wï (S)] (êÊu) bîÆÌÓʪ¢ïÅ ÁœEtŽîáÌêá. R{TP1, c@1,2, oÆê1, ÇØGé1 (1êÊE¬EÌ_äXO, 2V¢IãÃEæ[ãÃ): æ61ñú{¬tEªñwïwpWï (2019/11/14), L.
723256. [wï (S)] (êÊu) x«æV«¡uwjAÉηéàŸèp|¹oŸ? oŸ? ãŒR¹1, c@1,2, R{TP1, oÆê1, ÇØGé3 (1êÊE¬EÌ_äXO, 2V¢IãÃEæ[ãÃ): æ32ñú{àŸOÈwïï (2019/12/5), ¡l.
723257. [wï (S)] (êÊu) oŸºÌS7ææØÌèpèZšæÑ»ÌÀS«. CÃMj1, c@O1, ŒàVL±1, vÛCj1, G³Yî1 (1êÊE¬EÌ_äXO): æ32ñú{àŸOÈwïï (2019/12/7), ¡l.
723258. [wï (S)] (êÊu) oŸºäXª\ñw°Øp̱ü. c@O1, ŒàVL±1, vÛCj1, CÃMj1, G³Yî1 (1êÊE¬EÌ_äXO): æ32ñú{àŸOÈwïï (2019/12/7), ¡l.
723259. [wï (S)] (êÊu) äXàÉηé oŸºäXÌöØÌèZơìÑ. ŒàVL±1, c@O1, vÛCj1, CÃMj1, G³Yî1 (1êÊE¬EÌ_äXO): æ32ñú{àŸOÈwïï (2019/12/7), ¡l.
732019. [wï (nûïE€ï)] (µÒu) å°àÌ]Ú oŸºèp114ÇáÌ¢. ¡RF÷1, CÃMj2, {Ci1, i@ ³2, ŒàVL±2, vÛCj2, c@O2, G³Yî2 (1åw@ãÃn€È, 2êÊE¬EÌ_äXO): æ13ñÌàŸOÈ€ïEæ11ñäXàŸOÈ€ï (2019/12/4), ¡l.
732020. [wï (nûïE€ï)] (µÒu) BÚWð€ÊF¯µœpìWJ| oŸºäXÌöØp|. ŒàVL±1, c@O1, vÛCj1, CÃMj1, G³Yî1 (1êÊE¬EÌ_äXO): æ13ñÌàŸOÈ€ïEæ11ñäXàŸOÈ€ï (2019/12/4), ¡l.
733094. [wï (nûïE€ï)] (êÊu) ÇÂœãÌä`¹Éηéì1@Éæéä``¬pÌo±. c@1,2, R{TP2, ÇØGé2 (1V¢IãÃEæ[ãÃ, 2êÊE¬EÌ_äXO): æ5ñú{¬Ö»€ï (2019/4/19), åã.
733095. [wï (nûïE€ï)] (êÊu) oŸºÌS7ææØÉš¯éèpèZÌHv. CÃMj1, G³Yî1, c@O1, ŒàVL±1, i@ ³1, nç²¹F2 (1êÊE¬EÌ_äXO, 2k¢åwk¢€a@): æ73ñèpèZ€ï (2019/5/24), .
733096. [wï (nûïE€ï)] (êÊu) @Éš¯é oŸº_Çó°«pÌHv. c@O1, G³Yî1, i@ ³1, ŒàVL±1, CÃMj1, nç²¹F2 (1êÊE¬EÌ_äXO, 2k¢åwk¢€a@): æ73ñèpèZ€ï (2019/5/24), .
733097. [wï (nûïE€ï)] (êÊu) oŸº_Çó°«ÌHv. c@O1, æÑ@Tº2, ŒàVL±1, vÛCj1, CÃMj1, G³Yî1 (1êÊE¬EÌ_äXO, 2ûBEbóBO): æ8ñT}[Z~i[in«ê (2019/6/29), «ê.
733098. [wï (nûïE€ï)] (êÊu) oŸºö€äXØÌ©®Díðp¢ÄÌäXأƻÌpitfall. æÑ@Tº1, c@O2, ŒàVL±2, vÛCj2, CÃMj2, G³Yî2 (1ûBEbóBO, 2êÊE¬EÌ_äXO): æ8ñT}[Z~i[in«ê (2019/6/29), «ê.
733099. [wï (nûïE€ï)] (êÊu) o¶OffÇáÉš¯éüYêq¬çãÃZ^[ÌAg. ÇØGé1, c@1,2, R{TP1, oÆê1 (1êÊE¬EÌ_äXO, 2V¢IãÃEæ[ãÃ): æ117ñ¬OÈ€ï (2019/6/4), .
733100. [wï (nûïE€ï)] (êÊu) Ž«äXàÉš¯épO×EfÌðp¢œCDO1â`qDNA`»ÌÓ`. {Ci1, ¡RF÷1, ŒàVL±2, c@O2, vÛCj2, CÃMj2, G³Yî2, Rºpj3,4 (1åw@ãÃn€È, 2êÊE¬EÌ_äXO, 3V¢IãÃE¡fIãÃ, 4ãÁ»ÇO): æ39ñú{ªqîá}[J[€ï (2019/9/25), s.
733101. [wï (nûïE€ï)] (êÊu) ¬OÈÌæÉš¯éàŸOÈZpFè±ÌS\ŠÆ|Cg. oÆê1, c@1,2, R{TP1, ÇØGé1, ãŒR¹1 (1êÊE¬EÌ_äXO, 2V¢IãÃEæ[ãÃ): æ155ñ_Þì§Õ°OÈãwïWkï (2019/9/28), _Þì.
733102. [wï (nûïE€ï)] (êÊu) Ù«°ÇgDðº€ïAîá𹵜d¡AsÌ1á. ÇØGé1, c@1,2, oÆê1, R{TP1 (1êÊE¬EÌ_äXO, 2V¢IãÃEæ[ãÃ): æ54ñú{¬OÈwïÖbMznûï (2019/10/12), éÊ.
733103. [wï (nûïE€ï)] (êÊu) °ñ]ÙíÇ°²P]ðºÁœV¶ÝjôÌêá. Ÿc@œ1, c@2,3, R{TP3, oÆê3, ÇØGé3 (1ºÁ»ÇO, 2V¢IãÃEæ[ãÃ, 3êÊE¬EÌ_äXO): æ54ñú{¬OÈwïÖbMznûï (2019/10/12), éÊ.
733104. [wï (nûïE€ï)] (êÊu) oJe[e®¬ÇðpÉæéz®ÔÀè»ã, Äoª°Ý»µÙ}J ~pðvµœœOÌ1á. ãŒR¹1, Ô@2, ЪSê2, ~©¶}2, cº@q2, cq¬2, à@@I2, c@3,4, ó@õ2 (1ºÁ»ÇO, 2~œ, 3V¢IãÃEæ[ãÃ, 4êÊE¬EÌ_äXO): æ39ñú{¬àŸOÈEèpèZ€ï (2019/10/18), åã.
733105. [wï (nûïE€ï)] (êÊu) ¬Éš¯éåäXǹðºÁœäXOÉηéÛ¶¡Ã. c@1,2, R{TP2, oÆê2, ÇØGé2 (1V¢IãÃEæ[ãÃ, 2êÊE¬EÌ_äXO): æ39ñú{¬àŸOÈEèpèZ€ï (2019/10/18), åã.
733106. [wï (nûïE€ï)] (êÊu) @ÌV¶æV«¡uwjAÉηéW¡ÃÇÌ¢. oÆê1, c@1,2, R{TP1, ÇØGé1, ãŒR¹1, À¡@õ3, ôöb3 (1êÊE¬EÌ_äXO, 2V¢IãÃEæ[ãÃ, 3¬): æ27ñ¬W¡Ã[NVbv (2019/10/19-20), åã.
733107. [wï (nûïE€ï)] (êÊu) EoíÌÒ[ª¢ïÈåä`ÑwjAÉεÄÛ¶I¡ÃðsÁœ1á. ÇØGé1, c@1,2, R{TP1, oÆê1 (1êÊE¬EÌ_äXO, 2V¢IãÃEæ[ãÃ): æ11ñ_ÞìwjA€ï (2019/11/30), _Þì.
733108. [wï (nûïE€ï)] (êÊu) oŸºÄÌØÌèp¬ÑšæѯÓ_. CÃMj1, c@O1, ŒàVL±1, vÛCj1, G³Yî1 (1êÊE¬EÌ_äXO): æ13ñÌàŸOÈ€ïEæ11ñäXàŸOÈ€ï (2019/12/4), ¡l.
733109. [wï (nûïE€ï)] (êÊu) äXàÉš¯é oŸºäXÌöØÌsŽÌHv. c@O1, ŒàVL±1, vÛCj1, CÃMj1, G³Yî1 (1êÊE¬EÌ_äXO): æ13ñÌàŸOÈ€ïEæ11ñäXàŸOÈ€ï (2019/12/4), ¡l.
733110. [wï (nûïE€ï)] (êÊu) oŸºäXÌöØp (LDP) Éš¯éäXØ£ÌHv. c@O1, ŒàVL±1, vÛCj1, CÃMj1, G³Yî1 (1êÊE¬EÌ_äXO): æ13ñÌàŸOÈ€ïEæ11ñäXàŸOÈ€ï (2019/12/4), ¡l.
733111. [wï (nûïE€ï)] (êÊu) }«äXðǵCèpÉïaµœVäBEݲPÌ1á. c@1,2, R{TP2, oÆê2, ÇØGé2, ãŒR¹2 (1V¢IãÃEæ[ãÃ, 2êÊE¬EÌ_äXO): æ33ñú{¬äBE嬀ï (2020/3/8), (ãJÃ).
'18NxÈOª
[wp_¶]
'18-320002. [Çáñ] oŸº_XEop̺ÎÉæèpã9NÅ oà^á, Ç^áð`¬µœ1á. Ã@«, Éìan, G³Yî1, CÃMj1, c@O1, Í@°, ŒR@º, nç²¹F2 (1êÊE¬EÌ_äXO, 2k¢åwk¢€a@): _ÞìãwïG 2019/1; 46 (1): 18.
ãÁ»ÇOÈw
[wp_¶]
110182. [Ž] Cancer-specific promoter DNA methylation of Cysteine dioxygenase type 1 (CDO1) gene as an important prognostic biomarker of gastric cancer. Harada H1, Hosoda K2, Moriya H2, Mieno H2, Ema A2, Ushiku H2, Washio M2, Nishizawa N3, Ishii S2, Yokota K1, Tanaka Y1, Kaida T1, Soeno T1, Kosaka Y4, Watanabe M5, Yamashita K2,6: PLoS One 2019/4; 14 (4): e0214872. (ŽcGP1, ×c@j2, XJGõ2, Odì_N2, ]Ô@æ2, vG÷2, hö^€2, ŒàVL±3, Îä@q2, ¡caq1, cuq1, bãcu1, YìF¶1, ¬âù«4, nç²¹F5, Rºpj2,6: 1åw@ãÃn€È, 2ãÁ»ÇO, 3êÊE¬EÌ_äXO, 4ûBEbóBO, 5k¢åwk¢€a@, 6V¢IãÃE¡fIãÃ)
110183. [Ž] Lymph Node Progression and Optimized Node Dissection of Middle Thoracic Esophageal Squamous Cell Carcinoma in the Latest Therapeutic Surgical Strategy. Soeno T1, Harada H1, Hosoda K2, Mieno H2, Ema A2, Ushiku H2, Washio M2, Kosaka Y3, Watanabe M4, Yamashita K2,5: Ann Surg Oncol 2019/4; 26 (4): 996-1004. (YìF¶1, ŽcGP1, ×c@j2, Odì_N2, ]Ô@æ2, vG÷2, hö^€2, ¬âù«3, nç²¹F4, Rºpj2,5: 1åw@ãÃn€È, 2ãÁ»ÇO, 3ûBEbóBO, 4k¢åwk¢€a@, 5V¢IãÃE¡fIãÃ)
110184. [Ž] A phase II study of neoadjuvant chemotherapy with docetaxel, cisplatin, and S-1, followed by gastrectomy with D2 lymph node dissection for high-risk advanced gastric cancer: results of the KDOG1001 trial. Hosoda K1, Azuma M2, Katada C2, Moriya H1, Mieno H1, Ishido K2, Ema A1, Ushiku H1, Wada T2, Washio M1, Watanabe A2, Higuchi K2, Tanabe S2,3, Koizumi W2, Watanabe M4, Yamashita K1,5: Gastric Cancer 2019/5; 22 (3): 598-606. (×c@j1, @q2, ce2, XJGõ1, Odì_N1, Î˪2, ]Ô@æ1, vG÷1, acñç2, hö^€1, nç³W¯2, óûF2, cç³@2,3, ¬òaOY2, nç²¹F4, Rºpk1,5: 1ãÁ»ÇO, 2Á»íà, 3V¢IãÃEæ[ãÃ, 4k¢åwk¢€a@, 5V¢IãÃE¡fIãÃ)
110185. [Ž] Safety and Feasibility of Robotic Distal Gastrectomy for Stage IA Gastric Cancer: A Phase II Trial. Hosoda K1, Mieno H1, Ema A1, Ushiku H1, Washio M1, Song I, Watanabe M2, Yamashita K1,3: J Surg Res 2019/6; 238: 224-31. (×c@j1, Odì_N1, ]Ô@æ1, vG÷1, hö^€1, nç²¹F2, Rºpj1,3: 1ãÁ»ÇO, 2k¢åwk¢€a@, 3V¢IãÃE¡fIãÃ)
110186. [Ž] Prospective feasibility study for single-tracer sentinel node mapping by ICG (indocyanine green) fluorescence and OSNA (one-step nucleic acid amplification) assay in laparoscopic gastric cancer surgery. Shoji Y, Kumagai K, Kamiya S, Ida S, Nunobe S, Ohashi M, Yoshimizu S, Horiuchi Y, Yoshio T, Ishiyama A, Hirasawa T, Osako T, Yamamoto N, Fujisaki J, Sano T, Hiki N1: Gastric Cancer 2019/7; 22 (4): 873-80. (äéŒ÷1: 1ãÁ»ÇO)
110187. [Ž] Epstein-Barr virus status is a promising biomarker for endoscopic resection in early gastric cancer: proposal of a novel therapeutic strategy. Osumi H, Kawachi H, Yoshio T, Ida S, Yamamoto N, Horiuchi Y, Ishiyama A, Hirasawa T, Tsuchida T, Hiki N1, Takeuchi K, Fujisaki J: J Gastroenterol 2019/9; 54 (9): 774-83. (äéŒ÷1: 1ãÁ»ÇO)
110188. [Ž] Surgical outcomes and risk assessment for anastomotic complications after laparoscopic proximal gastrectomy with double-flap technique for upper-third gastric cancer. Shoji Y, Nunobe S, Ida S, Kumagai K, Ohashi M, Sano T, Hiki N1: Gastric Cancer 2019/9; 22 (5): 1036-43. (äéŒ÷1: 1ãÁ»ÇO)
110189. [Ž] Duodenal stump reinforcement might reduce both incidence and severity of duodenal stump leakage after laparoscopic gastrectomy with Roux-en-Y reconstruction for gastric cancer. Ri M, Hiki N1, Ishizuka N, Ida S, Kumagai K, Nunobe S, Ohashi M, Sano T: Gastric Cancer 2019/9; 22 (5): 1053-9. (äéŒ÷1: 1ãÁ»ÇO)
110190. [Ž] Oncological feasibility of laparoscopic subtotal gastrectomy compared with laparoscopic proximal or total gastrectomy for cT1N0M0 gastric cancer in the upper gastric body. Kano Y, Ohashi M, Ida S, Kumagai K, Nunobe S, Sano T, Hiki N1: Gastric Cancer 2019/9; 22 (5): 1060-8. (äéŒ÷1: 1ãÁ»ÇO)
110191. [Ž] Should pylorus-preserving gastrectomy be performed for overweight/obese patients with gastric cancer? Tsujiura M, Hiki N1, Ohashi M, Nunobe S, Kumagai K, Ida S, Ohashi T, Sano T, Yamaguchi T: Gastric Cancer 2019/11; 22 (6): 1247-55. (äéŒ÷1: 1ãÁ»ÇO)
110192. [Ž] Timing and site-specific trends of recurrence in patients with pathological stage II or III gastric cancer after curative gastrectomy followed by adjuvant S-1 monotherapy. Takahashi R, Ohashi M, Kano Y, Ida S, Kumagai K, Nunobe S, Chin K, Yamaguchi K, Nagino M, Sano T, Hiki N1: Gastric Cancer 2019/11; 22 (6): 1256-62. (äéŒ÷1: 1ãÁ»ÇO)
110193. [Ž] Development of a novel tool to assess skills in laparoscopic gastrectomy using the Delphi method: the Japanese operative rating scale for laparoscopic distal gastrectomy (JORS-LDG). Kurashima Y, Watanabe Y, Hiki N1, Poudel S, Kitagami H, Ebihara Y, Murakami S, Shichinohe T, Hirano S: Surg Endosc 2019/12; 33 (12): 3945-52. (äéŒ÷1: 1ãÁ»ÇO)
110194. [Ž] Comprehensive Exploration to Identify Predictive DNA Markers of ¢Np63/SOX2 in Drug Resistance in Human Esophageal Squamous Cell Carcinoma. Ooizumi Y1, Kojima K 2, Igarashi K, Tanaka Y1, Harada H1, Yokota K1, Kaida T1, Ishii S3, Tanaka T 2, Yokoi K 2, Nishizawa N4, Washio M3, Ushiku H3, Katoh H5, Kosaka Y5, Mieno H3, Hosoda K3, Watanabe M6, Katada C7, Hiki N3, Yamashita K3,8: Ann Surg Oncol 2019/12; 26 (13): 4814-25. (åòzî1, ¬žcŸ 2, cuq1, ŽcGP1, ¡caq1, bãcu1, Îä@q3, cr¹ 2, ¡ä\å 2, ŒàVL±4, hö^€3, vG÷3, Á¡@O5, ¬âù«5, Odì_N3, ×c@j3, nç²¹F6, ce7, äéŒ÷3, Rºpj3,8: 1åw@ãÃn€È, 2ºÁ»ÇO, 3ãÁ»ÇO, 4êÊE¬EÌ_äXO, 5ûBEbóBO, 6k¢åwk¢€a@, 7Á»íà, 8V¢IãÃE¡fIãÃ)
110195. [Ž] CD33+ Immature Myeloid Cells Critically Predict Recurrence in Advanced Gastric Cancer. Soeno T1, Katoh H2, Ishii S3, Ushiku H3, Hosoda K3, Hiki N3, Watanabe M4, Yamashita K3,5: J Surg Res 2020/1; 245: 552-63. (YìF¶1, Á¡@O2, Îä@q3, vG÷3, ×c@j3, äéŒ÷3, nç²¹F4, Rºpj3,5: 1åw@ãÃn€È, 2ûBEbóBO, 3ãÁ»ÇO, 4k¢åwk¢€a@, 5V¢IãÃE¡fIãÃ)
110196. [Ž] Billroth-I vs Roux-en-Y after distal gastrectomy: A comparison of long-term nutritional status and survival rates from a large-scale multicenter cohort study. Kinoshita T, Honda M, Matsuki A, Enomoto N, Aizawa M, Nunobe S, Yabusaki H, Abe T, Hiki N1: Ann Gastroenterol Surg 2020/2; 4 (2): 142-50. (äéŒ÷1: 1ãÁ»ÇO)
310025. [Çáñ] Two cases of a perforated duodenal diverticulum after gastrectomy with Roux-en-Y reconstruction. Yagi S, Ida S, Ohashi M, Kumagai K, Hiki N1, Sano T, Nunobe S: Surg Case Rep 2019/11; 5 (1): 169. (äéŒ÷1: 1ãÁ»ÇO)
320013. [Çáñ] Ramucirumab + Paclitaxel¹pÃ@ÉæècCRªŸçêœpãÄÝàÌ1á. nî1,2, Žõl1,3, C1,4, çìTêY1,4, ]Ô@æ2, vG÷2, ºa¿1,3, vÛCj3, ࡳK1,4, ß¡Nj1,5, Œ@ªk1, äéŒ÷2: 1k¢åwfBJZ^[, 2ãÁ»ÇO, 3êÊE¬EÌ_äXO, 4ºÁ»ÇO, 5ûBEbóBO) àÆ»wÃ@ 2019/12; 46 (13): 1931-3.
522043. [uÀ]yãfBx[gæ18ñ: Hå€ÝØãÅBillroth-I@ĪūȢêÌÄû@ÌIðzRoux-en-Y@ vs. Billroth-II@: Roux-en-Y@̧ê©ç. hö^€1, äéŒ÷1 (1ãÁ»ÇO): Á»íOÈ 2019/10; 42 (11): 1600-2.
522044. [uÀ]yÁW: oŸºÝèpÌ·×Äz¡îbÒ@äXtá[ðߎµœpßsŽp. hö^€1, äéŒ÷1 (1ãÁ»ÇO): Õ°OÈ 2019/10; 74 (10): 1156-62.
522045. [uÀ]yÁW: Á»íîáÉηé oŸEàŸ¯èp (LECS) up datezI. _@LECST_|LECSJÌoÜÆ»ÌãÌW. äéŒ÷ (ãÁ»ÇO): Õ°GOÈ 2019/10; 81 (11): 1105-8.
522046. [uÀ]yÁW: üpúENPºÉš¯éGrfXÆâè_züpúPPNÌ¥ñ. VŽ³å1, äéŒ÷1 (1ãÁ»ÇO): OÈÆãÓ¥h{ 2020/2; 54 (1): 31-5.
[@]
620039. [wp (ªS·M)]yÊûuãwÌ äÝv{bgxèpÌÅOüze_@15. ÝàÉηé{bgxÝØp, p.76-82. ×c@j1, Rºpj1,2 (1ãÁ»ÇO, 2V¢IãÃE¡fIã), Ò: vÄtì, ãòoÅ, , 2019/8s.
620040. [wp (ªS·M)]yàÈãÉßçêéŒÈÌm¯ (Õ°GàÈ2019N9å)z<æ1Í OÈ>@C. Á»íOÈ@ݪñ, p.1749-51. ×c@j1, äéŒ÷1 (1ãÁ»ÇO), ì]°, , 2019/9s.
620041. [wp (ªS·M)]yàÈãÉßçêéŒÈÌm¯|êåƪ`ŠéDo/Don't (Õ°GàÈ2019N9å)zæ1Í OÈ@C. Á»íOÈ@ݪñ, p.1749-51. ×c@j1, äéŒ÷1 (1ãÁ»ÇO), ì]°, , 2019/9s.
620042. [wp (ªS·M)]y·®ÉgŠéüpúÇ}j
A (Õ°OÈ2019N10§)z¡IÍ üpúÇE_@pOpãh{Ç, p.11-4. vG÷1, äéŒ÷1, ×c@j1, VŽ³å1, NJüMq1, hö^€1, ŽcGP1, Rºpj1,2 (1ãÁ»ÇO, 2V¢IãÃE¡fIãÃ), ãw@, , 2019/10s.
[wïE€ï]
721010. [wï (S)] (ÁÊu) LECSÌ»µÆW]. äéŒ÷ (ãÁ»ÇO): æ97ñú{Á»íàŸwïï (2019/6/1), .
721011. [wï (S)] (ÁÊu) æêé©çæçÈ¢ÝOÈã, xbhTChÅlŠéÝOÈãÉÈÁÄÙµ¢. äéŒ÷ (ãÁ»ÇO): æ81ñú{Õ°OÈwïï (2019/11/16), m.
722062. [wï (S)] (µÒu) Á»ÇOÈèpÉš¯éDsSÎôÉ¢ÄlŠé1@Hå€ÝØ, Billroth-1ÄÉš¯éZÝ®¬·¶Tension free«ÌHv. hö^€1, ×c@j1, YìF¶2, ŽcGP1, NJüMq1, vG÷1, VŽ³å1, Rºpj1,3, äéŒ÷1 (1ãÁ»ÇO, 2åw@ãÃn€È, 3V¢IãÃE¡fIãÃ): æ81ñú{Õ°OÈwïï (2019/11/14), m.
722063. [wï (S)] (µÒu) àŸOÈèpÁL̹ÇÉ¢ÄlŠé@ oŸÝØÉš¯éäXãsŽÌäX]ªµ@ÌHv. vG÷1, ×c@j1, VŽ³å1, NJüMq1, hö^€1, ŽcGP1, Rºpj1,2, äéŒ÷1 (1ãÁ»ÇO, 2V¢IãÃE¡fIãÃ): æ81ñú{Õ°OÈwïï (2019/11/14), m.
722064. [wï (S)] (µÒu) {bgèpÌKƹÇÉ¢ÄlŠé@{bgx oŸºÝØpÌpEpã¹Ç. hö^€1, ×c@j1, YìF¶2, ŽcGP1, NJüMq1, vG÷1, VŽ³å1, Rºpj1,3, äéŒ÷1 (1ãÁ»ÇO, 2åw@ãÃn€È, 3V¢IãÃE¡fIãÃ): æ81ñú{Õ°OÈwïï (2019/11/14), m.
722065. [wï (S)] (µÒu) ÝØãÌÄû@É¢ÄlŠé@ oŸº¬å€ÝØp, pã¹ÇÌ¢. YìF¶1, ŽcGP2, hö^€2, NJüMq2, vG÷2, VŽ³å2, ×c@j2, Rºpj2,3, äéŒ÷2 (1åw@ãÃn€È, 2ãÁ»ÇO, 3V¢IãÃE¡fIãÃ): æ81ñú{Õ°OÈwïï (2019/11/15), m.
723260. [wï (S)] (êÊu) Ýà³ÒÉš¯éABCffÆKK-LC-1»ÌÖA«É¢ÄÌ¢. nî1,2, MŸºq3, R@², ñnM], RºÚß, C1,4, çìTêY4, vÛCj5, ß¡Nj1,6, Œ@ªk1, ri@œ1,6, Žõl1,5, ¬Ñ1, Rè@1,3, nç²¹F7 (1k¢åwfBJZ^[, 2ãÁ»ÇO, 3a, 4ºÁ»ÇO, 5êÊE¬EÌ_äXO, 6ûBEbóBO, 7k¢åwk¢€a@): æ119ñú{OÈwïèúwpWï (2019/4/18), åã.
723261. [wï (S)] (êÊu) {bgx oŸºÝØpÌLp«Æâè_. ×c@j1, Odì_N1, ]Ô@æ1, vG÷1, hö^€1, nç²¹F2, Rºpj1,3 (1ãÁ»ÇO, 2k¢åwk¢€a@, 3V¢IãÃE¡fIãÃ): æ119ñú{OÈwïèúwpWï (2019/4/18), åã.
723262. [wï (S)] (êÊu) H¹ÝÚàÌ¡Ãíª. rØ꺟1, ×c@j1, hö^€1, vG÷1, ]Ô@æ1, Odì_N1, nç²¹F2, Rºpj1,3 (1ãÁ»ÇO, 2k¢åwk¢€a@, 3V¢IãÃE¡fIãÃ): æ119ñú{OÈwïèúwpWï (2019/4/18), åã.
723263. [wï (S)] (êÊu) H¹àèpÉš¯éüpúT|[gÌ¢: e-sheeṯü. vG÷1, erÞäq2, ×c@j1, hö^€1, ]Ô@æ1, Odì_N1, XJGõ1, Rºpj1,3, nç²¹F4 (1ãÁ»ÇO, 2h{, 3V¢IãÃE¡fIãÃ, 4k¢åwk¢€a@): æ119ñú{OÈwïèúwpWï (2019/4/18), åã.
723264. [wï (S)] (êÊu) H¹GœãçàÉη骡I»wúËüÃ@ãÌSalvageèpÌ¢. ŽcGP1, YìF¶2, hö^€1, vG÷1, ]Ô@æ1, Odì_N1, ×c@j1, nç²¹F3, Rºpj1,4, äéŒ÷1 (1ãÁ»ÇO, 2åw@ãÃn€È, 3k¢åwk¢€a@, 4V¢IãÃE¡fIãÃ): æ73ñú{H¹wïwpWï (2019/6/6), ª
723265. [wï (S)] (êÊu) {bgx¹oŸºH¹ØpÌÀSȱü. ×c@j1, Odì_N1, ]Ô@æ1, vG÷1, hö^€1, Rºpj1,2, nç²¹F3, äéŒ÷1 (1ãÁ»ÇO, 2V¢IãÃE¡fIãÃ, 3k¢åwk¢€a@): æ73ñú{H¹wïwpWï (2019/6/7), ª
723266. [wï (S)] (êÊu) èò¹«EH¹à̡ìÑ, íª. YìF¶1, Rºpj2,3, ŽcGP3, hö^€3, vG÷3, ]Ô@æ3, Odì_N3, ×c@j3, nç²¹F4, äéŒ÷3 (1åw@ãÃn€È, 2V¢IãÃE¡fIãÃ, 3ãÁ»ÇO, 4k¢åwk¢€a@): æ73ñú{H¹wïwpWï (2019/6/7), ª
723267. [wï (S)] (êÊu) H¹àèpÉš¯éüpúT|[gÌ¢: e-sheeṯü. ŽcGP1, vG÷1, erÞäq2, ×c@j1, hö^€1, NJüMq1, VŽ³å1, XJGõ1, Rºpj1,3, äéŒ÷1 (1ãÁ»ÇO, 2h{, 3V¢IãÃE¡fIãÃ): ú{OÈãÓh{wïæ56ñwpWï (2019/7/5), ºÉ.
723268. [wï (S)] (êÊu) {bgxÝàèpÌÁ¥Æ¡ãÌÛè. ×c@j1, Odì_N1, ]Ô@æ1, vG÷1, hö^€1, Rºpj1,2, nç²¹F3 (1ãÁ»ÇO, 2V¢IãÃE¡fIãÃ, 3k¢åwk¢€a@): æ74ñú{Á»íOÈwïï (2019/7/17), .
723269. [wï (S)] (êÊu) Á»ÇOÈÌæÉš¯éVKoCI}[J[@H¹GœãçàÉš¯éòÜÏ«ÉÖ^·é¢Np63/SOX2â`qÌ\ª}[J[ƵÄÌ¢. ŽcGP1, åòzî2, YìF¶2, hö^€1, vG÷1, ]Ô@æ1, Odì_N1, ×c@j1, nç²¹F3, Rºpj1,4 (1ãÁ»ÇO, 2åw@ãÃn€È, 3k¢åwk¢€a@, 4V¢IãÃE¡fIãÃ): æ74ñú{Á»íOÈwïï (2019/7/17), .
723270. [wï (S)] (êÊu) Øs\isÝàÉηéDocetaxel + CDDP + S-1 (DCS) conversion surgery. hö^€1, ×c@j1, YìF¶2, ŽcGP1, vG÷1, ]Ô@æ1, Odì_N1, nç²¹F3, Rºpj1,4 (1ãÁ»ÇO, 2åw@ãÃn€È, 3k¢åwk¢€a@, 4V¢IãÃE¡fIãÃ): æ74ñú{Á»íOÈwïï (2019/7/18), .
723271. [wï (S)] (êÊu) díÝàÉηéDocetaxel + CDDP + S-1 (DCS) Ã@ãÌØáÉÖ·é¢. vG÷1, ×c@j1, Odì_N1, hö^€1, ŽcGP1, ]Ô@æ1, Rºpj1,2, nç²¹F3 (1ãÁ»ÇO, 2V¢IãÃE¡fIãÃ, 3k¢åwk¢€a@): æ74ñú{Á»íOÈwïï (2019/7/19), .
723272. [wï (S)] (êÊu) isÝàÉš¯épãâ»wÃ@ÌøÊ\ª}[J[Å éàÁÙICDO1â`qÌDNA`»ÌÓ` (Prediction of efficacy of postoperative chemotherapy by promoter DNA methylation of CDO1 gene in advanced gastric cancer). ŽcGP1, YìF¶2, ¡ä\å3, hö^€1, vG÷1, NJüMq1, ×c@j1, äéŒ÷1, Rºpj1,4 (1ãÁ»ÇO, 2åw@ãÃn€È, 3ºÁ»ÇO, 4V¢IãÃE¡fIãÃ): æ78ñú{àwïwpï (2019/9/27), s.
723273. [wï (S)] (êÊu) Á»ÇOÈÌæÉš¯é{bgxèpÌÊuï: ãÁ»ÇOÈÌæÉš¯é{bgèp. ×c@j1, YìF¶2, ŽcGP1, hö^€1, NJüMq1, vG÷1, VŽ³å1, Rºpj1,3, äéŒ÷1 (1ãÁ»ÇO, 2åw@ãÃn€È, 3V¢IãÃE¡fIãÃ): æ81ñú{Õ°OÈwïï (2019/11/14), m.
723274. [wï (S)] (êÊu) pã¹ÇÅêµñŸÇá1 (ãÁ»Ç): cÝSEpãÌx« oàoÉε, poJe[e®¬Çðð{sµœêá. ŽcGP1, YìF¶2, hö^€1, vG÷1, NJüMq1, VŽ³å1, ×c@j1, Rºpj1,3, äéŒ÷1 (1ãÁ»ÇO, 2åw@ãÃn€È, 3V¢IãÃE¡fIãÃ): æ81ñú{Õ°OÈwïï (2019/11/14), m.
723275. [wï (S)] (êÊu) H¹àª¡pÉεÄDsS[ðÚwµœHv. VŽ³å1, ×c@j1, vG÷1, hö^€1, NJüMq1, ŽcGP1, Rºpj1,2, äéŒ÷1 (1ãÁ»ÇO, 2V¢IãÃE¡fIãÃ): æ81ñú{Õ°OÈwïï (2019/11/16), m.
723276. [wï (S)] (êÊu) oŸº¬å€ÝØpÌÄ@ oŸº¬å€ÝØp: ãì@ vs Orvil@. YìF¶1, ŽcGP2, hö^€2, NJüMq2, vG÷2, VŽ³å2, ×c@j2, Rºpj2,3, äéŒ÷2 (1åw@ãÃn€È, 2ãÁ»ÇO, 3V¢IãÃE¡fIãÃ): æ32ñú{àŸOÈwïï (2019/12/5), ¡l.
723277. [wï (S)] (êÊu) üßÄÌÊÉæéãcusŽÌá¢ðlŠé: {bgxèpÉü¯Ä. VŽ³å1, ×c@j1, vG÷1, hö^€1, NJüMq1, ŽcGP1, Rºpj1,2, äéŒ÷1 (1ãÁ»ÇO, 2V¢IãÃE¡fIãÃ): æ32ñú{àŸOÈwïï (2019/12/5), ¡l.
723278. [wï (S)] (êÊu) {bgx¹oŸºH¹ØpÌLp«. ×c@j1, YìF¶2, ŽcGP1, hö^€1, NJüMq1, vG÷1, VŽ³å1, Rºpj1,3, äéŒ÷1 (1ãÁ»ÇO, 2åw@ãÃn€È, 3V¢IãÃE¡fIãÃ): æ32ñú{àŸOÈwïï (2019/12/5), ¡l.
723279. [wï (S)] (êÊu) 80ÎÈãîÒÝàÌOȡìÑƻ̻µ. ŽcGP1, YìF¶2, hö^€1, vG÷1, NJüMq1, VŽ³å1, ×c@j1, Rºpj1,3, äéŒ÷1 (1ãÁ»ÇO, 2åw@ãÃn€È, 3V¢IãÃE¡fIãÃ): æ32ñú{àŸOÈwïï (2019/12/6), ¡l.
723280. [wï (S)] (êÊu) H¹ÝÚàÉηéÄÌHv: ¹oŸºãì@Ä. vG÷1, ×c@j1, VŽ³å1, NJüMq1, hö^€1, ŽcGP1, YìF¶2, Rºpj1,3, äéŒ÷1 (1ãÁ»ÇO, 2åw@ãÃn€È, 3V¢IãÃE¡fIãÃ): æ32ñú{àŸOÈwïï (2019/12/7), ¡l.
723281. [wï (S)] (êÊu) ÝàÉηé{bgxèpÌZú¬Ñ. NJüMq1, ×c@j1, YìF¶2, ŽcGP1, hö^€1, vG÷1, VŽ³å1, Rºpj1,3, äéŒ÷1 (1ãÁ»ÇO, 2åw@ãÃn€È, 3V¢IãÃE¡fIãÃ): æ32ñú{àŸOÈwïï (2019/12/7), ¡l.
723282. [wï (S)] (êÊu) oŸàŸ¯èp (LECS) ÌVWJ: nCXN¹¶ÇðL·éisÝà³ÒÉηéÉaLECSÌêá. hö^€1, äéŒ÷1, YìF¶2, ŽcGP1, NJüMq1, vG÷1, VŽ³å1, ×c@j1, Rºpj1,3 (1ãÁ»ÇO, 2åw@ãÃn€È, 3V¢IãÃE¡fIãÃ): æ32ñú{àŸOÈwïï (2019/12/7), ¡l.
732021. [wï (nûïE€ï)] (µÒu) àŸðp¢œOÈÆàÈÌR{[V¡Ã: LECSÍÝÇØÌè^èZÆÈé©? äéŒ÷ (ãÁ»ÇO): æ108ñú{Á»íàŸwïÖxáï (2019/6/8), .
733112. [wï (nûïE€ï)] (êÊu) oŸâº¬å€ÝØpÄÌÝH¹t¬Ì\hÉš¯éDouble-flap@ÄÆOrvil@ÄÌ¢. ×c@j1, vG÷1, Odì_N1, ]Ô@æ1, hö^€1, ŽcGP1, VŽ³å1, NJüMq1, Rºpj1,2, äéŒ÷1 (1ãÁ»ÇO, 2V¢IãÃE¡fIãÃ): æ28ñÁ»íŸ³aԡÀï (2019/9/7), €m.
733113. [wï (nûïE€ï)] (êÊu) CDO1â`q`»ðpµœVKff@: ÝàDNA
ôò×EfÌm§. ŽcGP1, YìF¶2, hö^€1, NJüMq1, vG÷1, VŽ³å1, ×c@j1, Rºpj1,3, äéŒ÷1 (1ãÁ»ÇO, 2åw@ãÃn€È, 3V¢IãÃE¡fIãÃ): æ39ñú{ªqîá}[J[€ï (2019/9/25), s.
733114. [wï (nûïE€ï)] (êÊu) @Éš¯éÝØãERASÌm§Éü¯Ä`»óÆ¡ãÌW]É¢Ä`. NJüMq1, äéŒ÷1, YìF¶2, ŽcGP1, hö^€1, vG÷1, VŽ³å1, ×c@j1, Rºpj1,3 (1ãÁ»ÇO, 2åw@ãÃn€È, 3V¢IãÃE¡fIãÃ): æ8ñ_ÞìüpúÇ€ï (2020/2/12), _Þì
'18NxÈOª
[wp_¶]
'18-110009. [Ž] Comparison of double-flap and OrVil techniques of laparoscopy-assisted proximal gastrectomy in preventing gastroesophageal reflux: a retrospective cohort study. Hosoda K1, Washio M1, Mieno H1, Moriya H1, Ema A1, Ushiku H1, Watanabe M2, Yamashita K1,3: Langenbecks Arch Surg 2019/2; 404 (1): 81-91. (×c@j1, hö^€1, Odì_N1, XJGõ1, ]Ô@æ1, vG÷1, nç²¹F2, Rºpj1,3: 1ãÁ»ÇO, 2k¢åwk¢€a@, 3V¢IãÃE¡fIãÃ)
'18-110010. [Ž] Prediction of onset of remnant gastric cancer by promoter DNA methylation of CDO1/ HOPX/ Reprimo/ E-cadherin. Kojima K, Minatani N, Ushiku H1, Ishii S1, Tanaka T2, Yokoi K2, Nishizawa N3, Ooizumi Y, Igarashi K, Hosoda K2, Moriya H2, Mieno H, Watanabe M4, Yamashita K1,5: Oncotarget 2019/3; 10 (25): 2423-34. (¬žcŸ1, vG÷2, Îä@q2, cr¹3, ¡ä\å3, ŒàVL±4, ×c@j2, XJGõ2, Odì_N, nç²¹F5, Rºpj2,6: 1åw@ãÃn€È, 2ãÁ»ÇO, 3ºÁ»ÇO, 4êÊE¬EÌ_äXO, 5k¢åwk¢€a@, 6V¢IãÃE¡fIãÃ)
[wïE€ï]
'18-723007. [wï (S)] (êÊu) cStage II/III H¹GœãçàÉηéDCFÉæéneoadjuvant chemotherapyÌøÊ. Rºpj1,2, XJGõ2, Odì_N2, ]Ô@æ2, hö^€2, ŽcGP2, nç²¹F3 (1V¢IãÃE¡fIãÃ, 2ãÁ»ÇO, 3k¢åwk¢€a@): æ73ñú{Á»íOÈwïï (2018/7/12), .
'18-723008. [wï (nûïE€ï)] (êÊu) H¹GœãçàÉš¯éHDACjQÜÌŽó«Kèöqóâ̯èSOX2/¢Np63»ÌÓ`. åòzî1, Rºpj2,3, Á¡@O4, Ü\ê°, ¬žcŸ, cuq1, ŽcGP3, ¡caq1, {Ci1, nç²¹F5 (1åw@ãÃn€È, 2V¢IãÃE¡fIãÃ, 3ãÁ»ÇO, 4ûBEbóBO, 5k¢åwk¢€a@): æ38ñú{ªqîá}[J[€ï (2018/9/26), åã.
ºÁ»ÇOÈw
[wp_¶]
110197. [Ž] Short-term and midterm outcomes of single-incision laparoscopic surgery for right-sided colon cancer. Ishii Y1,2, Yahagi M2, Ochiai H2, Sako H2, Amemiya R2, Maeda H2, Ogiri M2, Kamiya N2,3, Watanabe M1,2 (1Department of Lower Gastrointestinal Surgery, Kitasato University School of Medicine, 2Department of Surgery, Kitasato University Kitasato Institute Hospital, 3Department of Thoracic Surgery, Kitasato University School of Medicine): Surg Laparosc Endosc Percutan Tech 2019/7; 12 (3): 275-80. (ÎäÇK1,2, _JIP2,3, nç²¹F1,2: 1ºÁ»ÇO, 2k¢åwk¢€a@, 3ÄzíO)
110198. [Ž] Influence of chemoradiotherapy on nutritional status in locally advanced rectal cancer: Prospective multicenter study. Yamano T, Tomita N, Sato T1, Hayakawa K, Kamikonya N, Matoba S, Uki A, Baba H, Oya N, Hasegawa H, Shigematsu N, Hiraoka M, Shimada M, Noda M, Sakai Y, Sato H, Saegusa M2, Takeuchi M, Oguchi M, Oya M, Watanabe M1,3: Nutrition 2020/9; 77: 110807. doi: 10.1016/j.nut.2020.110807. Epub 2020 Mar 19. (²¡Y1, O}@M2, nç²¹F1,3: 1ºÁ»ÇO, 2a, 3k¢åwk¢€a@)
110199. [Ž] Exploration of potential prognostic biomarkers in aflibercept plus FOLFIRI in Japanese patients with metastatic colorectal cancer. Hamaguchi T, Denda T, Kudo T, Sugimoto N, Ura T, Yamazaki K, Fujii H, Kajiwara T, Nakajima TE, Takahashi S, Otsu S, Komatsu Y, Nagashima F, Moriwaki T, Esaki T, Sato T1, Itabashi M, Oki E, Sasaki T, Chiron M, Yoshino T: Cancer Sci 2019/11; 110 (11): 3565-72. (²¡Y1: 1ºÁ»ÇO)
110200. [Ž] WiNTRLINC1/ASCL2/c-Myc Axis Characteristics of Colon Cancer with Differentiated Histology at Young Onset and Essential for Cell Viability. Yokota K1, Tanaka Y1, Harada H1, Kaida T1, Nakamoto S1, Soeno T1, Fujiyama Y1, Yokota M1, Kojo K2, Miura H2, Yamanashi T2, Sato T2, Nakamura T2, Watanabe M2,3, Yamashita K4,5: Ann Surg Oncol 2019/12; 26 (13): 4826-34. (¡caq1, cuq1, ŽcGP1, bãcu1, {Ci1, YìF¶1, ¡RF÷1, ¡cõ1,Ãé@2, OY[æ2, RL2, ²¡Y2, º²r2, nç²¹F2,3, Rºpj4,5: 1åw@ãÃn€È, 2ºÁ»ÇO, 3k¢åwk¢€a@, 4V¢IãÃE¡fIãÃ, 5ãÁ»ÇO)
110201. [Ž] Laparoscopic surgery to treat leiomyosarcomas of the sigmoid colon:a case report and literature review. Yahagi M1, Ishii Y1,2, Hara A, Watanabe M1,2 (1Department of Surgery, Kitasato University Kitasato Institute Hospital, 2Department of Surgery, Kitasato University School of Medicine): Surg Case Rep 2019/12; 5: 20. (ÎäÇK1,2, nç²¹F1,2: 1k¢åwk¢€a@, 2ºÁ»ÇO)
110202. [Ž] Risk Factors for Wound Infection After Laparoscopic Surgery for Colon Cancer. Nakamura T1, Takayama Y2, Sato T1, Watanabe M1,3: Surg Laparosc Endosc Percutan Tech 2020/2; 30 (1): 45-8. (º²r1, Rzq2, ²¡Y1, nç²¹F1,3: 1ºÁ»ÇO, 2V¢IãÃE¡fIãÃ, 3k¢åwk¢€a@)
110203. [Ž] The superior approach with the stomach roll-up technique improves intraoperative outcomes and facilitates learning laparoscopic distal pancreatectomy: a comparative study between the superior and inferior approach. Morikawa T, Ishida M, Takadate T, Hata T, Iseki M, Kawaguchi K, Ohtsuka H, Mizuma M, Hayashi H, Nakagawa K, Motoi F, Kamei T, Naitoh T1, Unno M: Surg Today 2020/2; 50 (2): 153-62. (à¡@1: 1ºÁ»ÇO)
310026. [Çáñ] Mixed adenoneuroendocrine carcinoma of the ampulla of Vater: a case report and literature review. Yoshimachi S, Ohtsuka H, Aoki T, Miura T, Ariake K, Masuda K, Ishida M, Mizuma M, Hayashi H, Nakagawa K, Morikawa T, Motoi F, Kanno A, Masamune A, Fujishima F, Sasano H, Kamei T, Naitoh T1, Unno M: Clin J Gastroenterol 2020/2; 13 (1): 37-45. (à¡@1: 1ºÁ»ÇO)
320014. [Çáñ] ãèåÇGœãçàÉηéWwI¡ÃÌIð|3áÌ¢|. Ãé@1, ¬qŒl1, ª{¹V, cO÷, ×cÄu1, ¡ìjD1, X£¹÷, º²r1, nç²¹F1,2 (1ºÁ»ÇO, 2k¢åwk¢€a@): k¢ãw 2019/6; 49 (1): 15-9.
320015. [Çáñ] ®SàtÊɹµœSó°àÉε oŸºSó°Øð{sµœ1á. çìTêY1,2, ࡳK1,2, vG÷3, bãcu4, vÛCj5, Rº@q1, nî1,3, C1,2, ß¡Nj1,6, Œ@ªk1, Žõl1,5, nç²¹F2,7 (1k¢åwfBJZ^[, 2ºÁ»ÇO, 3ãÁ»ÇO, 4åw@ãÃn€È, 5êÊE¬EÌ_äXO, 6ûBEbóBO, 7k¢åwk¢€a@) àÆ»wÃ@ 2019/6; 46 (6): 1073-5.
320016. [Çáñ] Mesodiverticular bandðº€MeckeleºÉæéiN«°ÂÇÌ1á. ã¡ìç1, º²r2, YìF¶1, Îä@q3 (1åw@ãÃn€È, 2ºÁ»ÇO, 3ãÁ»ÇO): ú{ ~}ãwïG 2019/9; 39 (6): 1091-3.
320017. [Çáñ] ¬°q{àÇðffµ oŸºñÓØpð{sµœ1á. ¬Ëë¢1, å÷1, ÎäÇK1,2, J{²î1, @TV1, OcúØq1, _JIP1,3, åì¹`1, Übê1, ì@ë1, nç²¹F1,2 (1k¢åwk¢€a@, 2ºÁ»ÇO, 3ÄzíO): Progress of Digestive Endoscopy 2019/12; 95 (1): 87-9.
320018. [Çáñ] »wÃ@ªtøµäNã÷𷶵ŸœäNã÷ZŒ°àÌ1Øá. ¬vÛãÄu, àVGŸ, ŽåP, åÀ@E, éØGK, _RÄj, nÓaG, ÎcFé, Tä@®, à¡@1, CìÏŸ (1ºÁ»ÇO): àÆ»wÃ@ 2020/1; 47 (1): 135-7.
522047. [uÀ]yÁW: InnovativeÈå°àffE¡Ãz6. ÇisŒ°àÉηé»wúËüÃ@{sãÌwatch and waitÌÀÛ. ²¡Y1, º²r1, RL1, OY[æ1, Ãé@1, ¡ä\å1, Žçb1, ÛR³T2, â{ê3 (1ºÁ»ÇO, 2êÊE¬EÌ_äXO, 3ûBEbóBO): Õ°GOÈ 2019/9; 81 (10): 1036-41.
522048. [uÀ]yÁW: IPMNEMCNÛfÃKChCÜÆßzk¬èp. Îc»º, XìF¥, ÙBV, ³ä~F, à¡@1, CìÏŸ (1ºÁ»ÇO): _ÆäX 2020/1; 41 (1): 59-64.
522049. [uÀ]yÁW: Á»íOÈÉš¯ére-doèpzI. Á»Ç@2. žÊèpÉš¯érevision surgery. ä{¶, à¡@1 (1ºÁ»ÇO): Õ°GOÈ 2020/2; 82 (2): 106-10.
522050. [uÀ]yÁW: êÊEÁ»íOÈãÌœßÌ@Å«é! ¿ûz¡üpúð¿ûÅT|[g·é@ãÁ»Çèp@ oŸºHå€ÝØpãÇÖÌZNq̱üøÊ. ÒGº, ä{¶, RºŸ°, ÂØ@, cŒ÷, à¡@1, Tä@®, CìÏŸ (1ºÁ»ÇO): Õ°OÈ 2020/3; 75 (3): 292-8.
530007. [»ÌŒ (Comment)] ASO Author Reflections: ASCL2, a Marker of Dynamic Colon Stem Cell, Involved in Wnt Pathway Activation Reflects Anti-cancer Drug Resistance in Primary Colorectal Cancer. Tanaka T1, Yamashita K2,3: Ann Surg Oncol 2019/12; 26 (Suppl 3): 634. (cr¹1, Rºpj2,3: 1ºÁ»ÇO, 2V¢IãÃEæ[ãÃ, 3ãÁ»ÇO)
[@]
620043. [wp (ªS·M)]ySãƵıÌæ€ÉŠœ¢ ªñ³ÒEÆ°©çÌ¿âzæ2Í e_: íÊ̪ñ@¬°Eå°Ìªñ@Q74. lHãèåÌíÞÆÁ¥É¢ijŠÄŸ³¢, p.154-5. ÎäÇK1,2, îìëj2, nç²¹F1,2 (1ºÁ»ÇO, 2k¢åwk¢€a@OÈ), ÄC: Rûr°3 (3ªñ€LŸa@), Ò: ¡º³V4, àöSV3, Ž
p¡5, üä¶6, nêGv7, œì@8, Ä£~ñ3, nç²¹F1,2 (4ÖŒdÍa@, 5œ¬€ï€LOa@, 6§ªñ€Z^[a@, 7F{åwåw@Á»íOÈw³º, 8kC¹åwåw@Á»íOÈw³º), Öé·oÅ, , 2019/4s.
620044. [wp (ªS·M)]y¡úÌffwj (æ8Å)zII Ÿ³Ò@24. O̬OÈIŸ³@ð«O€j, p.1970-1. ÎäÇK1,2 (1ºÁ»ÇO, 2k¢åwk¢€a@), ÒW: iäÇO3 (3©¡ãÈåw), ãw@, , 2020/3s.
[wïE€ï]
722066. [wï (S)] ([NVbv) ÌØÉš¯éV~
[VEirQ[VÌp: Right intersectional planeðÓ¯µœÌ£f. J{²î1, ¢YŸ2, ¬Ëëã1, OcúØq1, @TV1, å÷1, åì¹`1, _JIP1,3, ÎäÇK1,4, nç²¹F1,4 (1k¢åwk¢€a@, 2cä`måwãwêÊEÁ»íOÈ, 3ÄzíO, 4ºÁ»ÇO): æ119ñú{OÈwïèúwpWï (2019/4/19), åã, ú{OÈwïèúwpWïŽ^W 119ñŽ^W 2019/4; WS10-10.
722067. [wï (S)] (µÒu) oŸº°àèpÌnŽõÎô (ICTÆŠÍ̧Ì\z). º²r1, ²¡Y1, RL1, OY[æ1, Ãé@1, ࡳK1, nç²¹F1,2 (1ºÁ»ÇO, 2k¢åwk¢€a@): æ74ñú{å°ãèåawïwpWï (2019/10/11), .
722068. [wï (S)] (wpZ~i[) l¶100Nã Á»íÇ«Ÿ³ðlŠé. ÎäÇK1,2 (1ºÁ»ÇO, 2k¢åwk¢€a@): æ81ñú{Õ°OÈwïï (2019/11/15), m, ú{Õ°OÈwïG 2019/10; 80 (§): 37.
722069. [wï (S)] ([NVbv) }«Éηéèp|J ? oŸ?|: }«Éηé¡ÃûjÌ¢. J{²î1, ÎäÇK1,2, k@pT1, @TV1, å÷1, _JIP1,3, nç²¹F1,2 (1k¢åwk¢€a@OÈ, 2ºÁ»ÇO, 3ÄzíO): æ32ñú{àŸOÈwïï (2019/12/6), ¡l, ú{àŸOÈwïG 2019/12; 24 (7): WS13-6.
722070. [wï (S)] ([NVbv) ãÃÞ¿Ì}lWg @Éš¯éãÃÞ¿}lWgÌ»óÆüã. ÎäÇK1,2, J{²î2, @TV2, å÷2, _JIP2,3, nç²¹F1,2 (1ºÁ»ÇO, 2k¢åwk¢€a@, 3ÄzíO): æ32ñú{àŸOÈwïï (2019/12/7), ¡l, ú{àŸOÈwïG 2019/12; 24 (7): WS35-4.
722071. [wï (S)] (µÒu) oŸºãÉš¯éStoma¢ÝÌgh. ²¡Y1, OY[æ1, Ãé@1, ¡ä\å1, Žçb1, RL1, º²r1 (1ºÁ»ÇO): æ37ñú{Xg[}Ernre[Vwïï (JSSCR) (2020/2/8), ê.
723283. [wï (S)] (êÊu) ºŒ°àÉηépOúËü»wÃ@ãÌ oŸºèpÌLp«. Ãé@1, º²r1, ²¡Y1, RL1, OY[æ1, Ã@«, nç²¹F1,2 (1ºÁ»ÇO, 2k¢åwk¢€a@): æ119ñú{OÈwïèúwpWï (2019/4/18), åã.
723284. [wï (S)] (êÊu) oŸº°àpãÌnŽõÇë¯öqÌ¢. º²r1, ²¡Y1, RL1, OY[æ1, Ãé@1, Ã@«, nç²¹F1,2 (1ºÁ»ÇO, 2k¢åwk¢€a@): æ119ñú{OÈwïèúwpWï (2019/4/18), åã.
723285. [wï (S)] (êÊû) N[aÉηéQOLüãðÚwµœIBDZ^[àÈãÆå°OÈãÆÌRrl[V. å÷1, ÎäÇK1,2, _JIP1,3, åì¹`1, @TV1, J{²î1, OcúØq1, ¬Ëëã1, nç²¹F1,2 (1k¢åwk¢€a@, 2ºÁ»ÇO, 3ÄzíO): æ119ñú{OÈwïèúwpWï (2019/4/18), åã, ú{OÈwïèúwpWïŽ^W 119ñ 2019/4; SF023-8.
723286. [wï (S)] (êÊu) ô€çìJbg_E@ÉæéSì|[g}üÉηéÀS«ÆLp«Ì¢. ࡳK1,2, çìTêY1,2, ß¡Nj1,3, vÛCj1,4, nî1,5, C1,2, ºa¿1,4, Œ@ªk1, Žõl1,4, nç³¹F6 (1k¢åwfBJZ^[, 2ºÁ»ÇO, 3ûBEbóBO, 4êÊE¬EÌ_äXO, 5ãÁ»ÇO, 6k¢åwk¢€a@): æ119ñú{OÈwïèúwpWï (2019/4/19), åã.
723287. [wï (S)] (|X^[) American joint committee on Cancer (AJCC) æ8ÅuPathologic Prognostic StageªÞ (ppStage)vÉîÃaúÊ\ãÌ¢. OcúØq1, rc@³1, ¬Ëë¢1, J{²î1, @TV1, å÷1, _JIP1,2, åì¹`1, ÎäÇK1,3, nç²¹F1,3 (1k¢åwk¢€a@, 2ÄzíO, 3ºÁ»ÇO): æ119ñú{OÈwïèúwpWï (2019/4/20), åã, ú{OÈwïèúwpWïŽ^W 119ñ 2019/4; PS1924.
723288. [wï (S)] (êÊu) ICTÆàÞVµ¢ºÁ»ÇèpÌnŽõÎô. º²r1, ²¡Y1, RL1, OY[æ1, Ãé@1, nç²¹F1,2 (1ºÁ»ÇO, 2k¢åwk¢€a@): æ74ñú{Á»íOÈwïï (2019/7/17), .
723289. [wï (S)] (êÊu) å°àæèµ¢Kñæ9ÅÉš¯éStage IIIå°àÌ¢. Ãé@1, º²r1, ²¡Y1, RL1, OY[æ1, Ã@«, nç²¹F1,2 (1ºÁ»ÇO, 2k¢åwk¢€a@): æ74ñú{Á»íOÈwïï (2019/7/17), .
723290. [wï (S)] (êÊu) pStage II, III¡s°àÉηé oŸºèp̡ìÑ. OY[æ1, ²¡Y1, Ã@«, Ãé@1, RL1, º²r1, nç²¹F1,2 (1ºÁ»ÇO, 2k¢åwk¢€a@): æ74ñú{Á»íOÈwïï (2019/7/17), .
723291. [wï (S)] (êÊû) ï¡«×á«å°Éηé@IBDÁ»ÇàÈãÆOÈãÌR{[V. å÷1, ÎäÇK1,2, åì¹`1, @TV1, J{²î1, OcúØq1, ¬Ëëã1, _JIP1,3, nç²¹F1,2 (1k¢åwk¢€a@, 2ºÁ»ÇO, 3ÄzíO): æ74ñú{Á»íOÈwïï (2019/7/17), , ú{Á»íOÈwïï74ñŽ^W 2019/7; P96-3.
723292. [wï (S)] (êÊû) ÌEtÉš¯éRight intersectional planeETransverse planeÆVœÈææÌñ¥. J{²î1, ¢YŸ2, ¬Ëëã1, OcúØq1, @TV1, å÷1, åì¹`1, _JIP1,3, ÎäÇK1,4, nç²¹F1,4 (1k¢åwk¢€a@, 2cä`måwãwêÊEÁ»íOÈ, 3ÄzíO, 4ºÁ»ÇO): æ74ñú{Á»íOÈwïï (2019/7/17), , ú{Á»íOÈwïï74ñŽ^W 2019/7; RS8-3.
723293. [wï (S)] (êÊu) oŸºSó°ØãÌDsSÇáÌ¢. Žçb1, º²r1, Ãé@1, OY[æ1, RL1, ²¡Y1, nç²¹F1,2 (1ºÁ»ÇO, 2k¢åwk¢€a@): æ74ñú{Á»íOÈwïï (2019/7/18), .
723294. [wï (S)] (êÊû) lHãèå¢ÝpEÂœpÉš¯é@ÌHvšæÑPitfall. ¬Ëë¢1, å÷1, ÎäÇK1,2, OcúØq1, J{²î1, @TV1, _JIP1,3, åì¹`1, nç²¹F1,2 (1k¢åwk¢€a@, 2ºÁ»ÇO, 3ÄzíO): æ74ñú{Á»íOÈwïï (2019/7/18), , ú{Á»íOÈwïï74ñŽ^W2019/7; P127-5.
723295. [wï (S)] (êÊû) cÝàÌÕ°awI¢ÆäBEÌÓ`. @TV1, åì¹`1, ¬Ëë¢1, OcúØq1, J{²î1, å÷1, ÎäÇK1,2, _JIP1,3, erjY1,4, nç²¹F1,2 (1k¢åwk¢€a@, 2ºÁ»ÇO, 3ÄzíO, 44a@Ag³ç): æ74ñú{Á»íOÈwïï (2019/7/18), , ú{Á»íOÈwïï74ñŽ^W 2019/7; P32-1.
723296. [wï (S)] (êÊu) Œ°îáÉηé{bgx oŸºèpÌZú¬Ñ. ¡ä\å1, º²r1, Ã@«, Ãé@1, OY[æ1, ࡳK1, ²¡Y1, nç²¹F1,2 (1ºÁ»ÇO, 2k¢åwk¢€a@): æ74ñú{Á»íOÈwïï (2019/7/19), .
723297. [wï (S)] (êÊu) ãwfBv[}|V[ÉîâœáèãtÉš¯éAP[g²žÉæéwC¬ÊÌ]¿. erjY1, ç®À2, |àº, ¬ì³V3 (14a@Ag³ç, 2ãw³ç, 3ðU): æ51ñú{ãw³çwïåï (2019/7/26), s, æ51ñú{ãw³çwïåï\eW 2019; 50: 96.
723298. [wï (S)] (êÊu) °àÉš¯éWiNTRLINC1/Ascl 2/c-myc²ÌÕ°IÓ`. ¡caq1, cuq1, ŽcGP2, bãcu1, Ãé@2, OY[æ2, RL2, ²¡Y2, º²r2, nç²¹F2,3, Rºpj4,5 (1åw@ãÃn€È, 2ºÁ»ÇO, 3k¢åwk¢€a@, 4V¢IãÃE¡fIãÃ, 5ãÁ»ÇO): æ78ñú{àwïwpï (2019/9/28), s.
723299. [wï (S)] (êÊu) oŸºå°Øp©çJ ÚsÖÌKØÈ^C~O. ²¡Y1, º²r1, RL1, OY[æ1, Ãé@1, ¡ä\å1, Žçb1, ÛR³T2, â{ê3, nç²¹F1,4 (1ºÁ»ÇO, 2êÊE¬EÌ_äXO, 3ûBEbóBO, 4k¢€a@): æ74ñú{å°ãèåawïwpWï (2019/10/11), .
723300. [wï (S)] (êÊu) oŸºå°ØpÉš¯éüpúáuÉÇ@ÌdO@ vs AZgA~mtFìà^@Ìär¢. OY[æ1, ²¡Y1, Ãé@1, RL1, º²r1, nç²¹F1,2 (1ºÁ»ÇO, 2k¢åwk¢€a@): æ74ñú{å°ãèåawïwpWï (2019/10/11), .
723301. [wï (S)] (êÊu) oŸºå°Øpð{sµœXe[WII°àÉš¯éÄXNöqÌ¢. Ãé@1, º²r1, ²¡Y1, RL1, OY[æ1, ¡ä\å1, Žçb1, nç²¹F1,2 (1ºÁ»ÇO, 2k¢åwk¢€a@): æ74ñú{å°ãèåawïwpWï (2019/10/11), .
723302. [wï (S)] (êÊu) Gant-OÖ + Thiersch@Éæ錰EèpãÉŒ°úEðµœ1á. çìTêY1, ࡳK1,2, C1,2, nî2,3, ºa¿2,4, vÛCj4, ß¡Nj2,5, Œ@ªk2, Žõl2,4, nç²¹F6 (1ºÁ»ÇO, 2k¢åwfBJZ^[, 3ãÁ»ÇO, 4êÊE¬EÌ_äXO, 5ûBEbóBO, 6k¢åwk¢€a@): æ74ñú{å°ãèåawïwpWï (2019/10/11), .
723303. [wï (S)] (êÊu) áNP«ðÚwµœÇisŒ°àÉηé¡Ãíª. Ãé@1, º²r1, ²¡Y1, RL1, OY[æ1, ¡ä\å1, Žçb1 (1ºÁ»ÇO): æ57ñú{à¡ÃwïwpWï (2019/10/24), ª.
723304. [wï (S)] (êÊu) ßÝ^Sì|[gÌpãŽõÌë¯öqÆ»ÌÎô. º²r1, ²¡Y1, RL1, OY[æ1, Ãé@1, nç²¹F1,2 (1ºÁ»ÇO, 2k¢åwk¢€a@): æ57ñú{à¡ÃwïwpWï (2019/10/24), ª.
723305. [wï (S)] (êÊu) pT1Œ°àÉηé oŸºèp¬ÑÉpOàŸ¡Ãª^Šée¿. Žçb1, º²r1, ¡ä\å1, Ãé@1, OY[æ1, RL1, ²¡Y1, nç²¹F1,2 (1ºÁ»ÇO, 2k¢åwk¢€a@): æ57ñú{à¡ÃwïwpWï (2019/10/24), ª.
723306. [wï (S)] (êÊu) °àÉηéâ»wÃ@̧ÉÄXRAª^Šée¿ (SUNRISE-DI±). êì`K, «@p, O¹D, rc³F, ãìG÷, Á¡u, í{Nç, CÎr÷, Rû€¬, ààV®é, mÈqT, ŸcvR, ²¡Y1, R|t, gìFV (1ºÁ»ÇO): æ57ñú{à¡ÃwïwpWï (2019/10/24), ª.
723307. [wï (S)] (êÊu) ÇisŒ°àÉηé»wúËüÃ@ÅÌh{óÔÆìpEüpú¹ÇÌÖW. Rìqî, ²¡Y1, ìad2, yc®T, IêüêY, nêGv, ·Jìr, ìcòî, Úqv, à¡@1, cõ¶, åËKì, ŽûzñY, |à³O, nç²¹F1,3 (1ºÁ»ÇO, 2úËü (îá), 3k¢åwk¢€a@): æ57ñú{à¡ÃwïwpWï (2019/10/24), ª.
723308. [wï (S)] (êÊû) ®S©RÉð𫜵œÌ×EàÆÓ°àÆ̯«d¡àÌ1á. k@pT1, J{²î1, ÎäÇK1,2, å@œ1, _JIP1,3, Übê1, å÷1, @TV1, OcúØq1, nç²¹F1,2 (1k¢åwk¢€a@, 2ºÁ»ÇO, 3ÄzíO): æ81ñú{Õ°OÈwïï (2019/11/14), m, ú{Õ°OÈwïG 2019/10; 80 (§): 599.
723309. [wï (S)] (êÊu) ã{àÄžžÉ©³êœ¡s°_oàªå×EàÌêá. ¥YGV1, º²r1, ¡örò1, ª{õFq2, Žçb1, ¡ä\å1, Ãé@1, OY[æ1, RL1, ²¡Y1 (1ºÁ»ÇO, 2êÊE¬EÌ_äXO): æ81ñú{Õ°OÈwïï (2019/11/14-16), m.
723310. [wï (S)] (êÊu) pã°ÂÇÉηé oŸºèpÌLp«ÆÀE. º²r1, ²¡Y1, OY[æ1, RL1, Ãé@1, ¡ä\å1, Žçb1 (1ºÁ»ÇO): æ81ñú{Õ°OÈwïï (2019/11/16), m.
723311. [wï (S)] (êÊu) oŸº°àèpÌLp« (ZúE·ú¬Ñ). º²r1, ²¡Y1, RL1, OY[æ1, Ãé@1, nç²¹F1,2 (1ºÁ»ÇO, 2k¢åwk¢€a@): JDDW 2019 (æ17ñú{Á»íOÈwïåï) (2019/11/23), _Ë.
723312. [wï (S)] (êÊu) ÇisŒ°àÉηépO»wúËü¡ÃãÉWatch-and-wait approachðsÁœ17áÌ¢. Ãé@1, º²r1, ²¡Y1, RL1, OY[æ1, ¡ä\å1, Žçb1, ª{õFq2, Ã@«, nç²¹F1,3 (1ºÁ»ÇO, 2êÊE¬EÌ_äXO, 3k¢åwk¢€a@): JDDW 2019 (æ17ñú{Á»íOÈwïåï) (2019/11/23), _Ë.
723313. [wï (S)] (êÊu) pã°ÂÇÉ뵀 oŸºèpÍ{ÉLp©? ²¡Y (ºÁ»ÇO): æ32ñú{àŸOÈwïï (2019/12/5-7), ¡l.
723314. [wï (S)] (êÊu) Œ°àÉηé{bgxºèpÌZú¬Ñ. ²¡Y (ºÁ»ÇO): æ32ñú{àŸOÈwïï (2019/12/6), ¡l.
723315. [wï (S)] (êÊu) ÇisŒ°àÉηépO»wúËü¡ÃãÌSalvageèp. Ãé@1, Žçb1, ¡ä\å1, OY[æ1, RL1, ²¡Y1, º²r1 (1ºÁ»ÇO): æ32ñú{àŸOÈwïï (2019/12/6), ¡l.
723316. [wï (S)] (êÊu) «°Éæé`Ro«Ý°ÉεÄOÈIØð{sµœ1á. C£Â1, Žçb1, ¡ä\å1, Ãé@1, OY[æ1, RL1, ²¡Y1, º²r1 (1ºÁ»ÇO): æ32ñú{àŸOÈwïï (2019/12/6), ¡l.
723317. [wï (S)] (êÊû) PE®ñÓØð{sµœï¡«N[aÌ1á. k@pT1, å÷1, ÎäÇK1,2, J{²î1, @TV1, åì¹`1, _JIP1,3, nç²¹F1,2 (1k¢åwk¢€a@, 2ºÁ»ÇO, 3ÄzíO): æ32ñú{àŸOÈwïï (2019/12/6), ¡l, ú{àŸOÈwïG 2019/12; 24 (7): MO221-2.
723318. [wï (S)] (êÊu) oŸºSó°ØãÌDsSÌë¯öq. Žçb1, º²r1, ¡ä\å1, Ãé@1, OY[æ1, RL1, ²¡Y1 (1ºÁ»ÇO): æ32ñú{àŸOÈwïï (2019/12/7), ¡l.
723319. [wï (S)] (êÊu) @Éš¯éãs°àÉηé oŸºEŒ°ØpÌ¢. ¡ä\å1, º²r1, Žçb1, Ãé@1, OY[æ1, RL1, ²¡Y1 (1ºÁ»ÇO): æ32ñú{àŸOÈwïï (2019/12/7), ¡l.
723320. [wï (S)] (êÊû) îÒÉηé oŸÝØpÌÀS«Ì¢. @TV1, åì¹`1, k@pT1, J{²î1, å÷1, ÎäÇK1,2, _JIP1,3, erjY1,4, nç²¹F1,2 (1k¢åwk¢€a@, 2ºÁ»ÇO, 3ÄzíO, 44a@Ag³ç): æ32ñú{àŸOÈwïï (2019/12/7), ¡l, ú{àŸOÈwïG 2019/12; 24 (7): MO239-5.
723321. [wï (S)] (êÊû) Só°eºÉæé°äNã÷áÌ oŸèpo±. å÷1, ÎäÇK1,2, @TV1, J{²î1, åì¹`1, k@pT1, _JIP1,3, nç²¹F1,2 (1k¢åwk¢€a@, 2ºÁ»ÇO, 3ÄzíO): æ32ñú{àŸOÈwïï (2019/12/7), ¡l, ú{àŸOÈwïG 2019/12; 24 (7): SF104-4.
723322. [wï (S)] (êÊû) PE®EŒ°ØÉš¯éD3pßsŽÌèpèZơìÑ. ÎäÇK1,2, å÷2, @TV2, J{²î2, nç²¹F1,2 (1ºÁ»ÇO, 2k¢åwk¢€a@): æ32ñú{àŸOÈwïï (2019/12/7), ¡l, ú{àŸOÈwïG 2019/12; 24 (7): SF098-4.
723323. [wï (S)] (êÊu) MeckeleºðŽöÆ·éiN«°ÂÇð oŸºÉ¡Ãµœ1á. çìTêY1, ࡳK1,2, ÛR³T2,3, C1,2, nî2,4, ºa¿2,3, vÛCj3, Œ@ªk2, Žõl2,3, nç²¹F5 (1ºÁ»ÇO, 2k¢åwfBJZ^[, 3êÊE¬EÌ_äXO, 4ãÁ»ÇO, 5k¢åwk¢€a@): æ32ñú{àŸOÈwïï (2019/12/7), ¡l.
723324. [wï (S)] (êÊu) Þk×a°ÇÉηék宫ÉæéXg[}ÂœèZ. nÓaG, åÀ@E, _RÄj, àVGŸ, éØGK, ŽåP, nç²Áq, Tä@®, à¡@1, CìÏŸ (1ºÁ»ÇO): æ37ñú{Xg[}Ernre[Vwïï (JSSCR) (2020/2/7), ê.
723325. [wï (S)] (êÊu) Œ°àpãÌXg[}guÉš¯éë¯öqÌ¢. _RÄj, nÓaG, éØGK, àVGŸ, ŽåP, åÀ@E, Ž^I, nÓÁq, Tä@®, à¡@1, CìÏŸ (1ºÁ»ÇO): æ37ñú{Xg[}Ernre[Vwïï (JSSCR) (2020/2/7), ê.
732022. [wï (nûïE€ï)] (µÒu) Stage II°àÌת»yÑpãâ»wÃ@Ì¢. Žçb1, º²r1, ¡ä\å1, Ãé@1, OY[æ1, ²¡Y1 (1ºÁ»ÇO): æ92ñå°à€ï (2020/1/24), L.
733115. [wï (nûïE€ï)] (êÊu) Œ°àÉηé{bgx oŸºèp|TMEèZÌW»Éü¯Ä|. RL1, º²r1, ²¡Y1, OY[æ1, Ãé@1, nç²¹F1,2 (1ºÁ»ÇO, 2k¢åwk¢€a@): æ73ñèpèZ€ï (2019/5/24), .
733116. [wï (nûïE€ï)] (êÊu) oŸº°àèpÌè^»ðÚwµœèpèZ (ZúE·ú¡Ã¬Ñ). RL1, º²r1, ²¡Y1, OY[æ1, Ãé@1, nç²¹F1,2 (1ºÁ»ÇO, 2k¢åwk¢€a@): æ73ñèpèZ€ï (2019/5/24), .
733117. [wï (nûïE€ï)] (êÊu) ºŒ°àÉεÄpOúËü»wÃ@ãÉ{sµœ oŸºèp̡ìÑ. Ãé@1, Žçb1, ¡ä\å1, Ã@«, OY[æ1, RL1, ²¡Y1, º²r1, nç²¹F1,2 (1ºÁ»ÇO, 2k¢åwk¢€a@): æ73ñèpèZ€ï (2019/5/24), .
733118. [wï (nûïE€ï)] (êÊu) å°à¯«Ì]ÚØãÉηéâ»wÃ@ÍLø©. ¡ä\å1, ²¡Y1, Ãé@1, OY[æ1, RL1, º²r1 (1ºÁ»ÇO): æ91ñå°à€ï (2019/7/5), .
'18NxÈOª
[wp_¶]
'18-320003. [Çáñ] \ñw°àð_@ÉffµØµŠœLynchÇóQÌ2á. ¢hå1, éØcê1, îìëj1, ºc@1, @TV1, ÎäÇK1,2, Ž@Öq (1k¢åwk¢€a@, 2ºÁ»ÇO): ú{Á»íOÈwïG 2019/1; 52 (1): 27-35.
'18-320004. [Çáñ] oŸâºÉصŠœ¬°fXChîáÌ1á. nWq1, º²r1, äÖq1, OY[æ1, RL1, ²¡Y1, nç²¹F2 (1ºÁ»ÇO, 2k¢åwk¢€a@): ú{OÈnAwï 2019/2; 44 (1): 136-42.
[wïE€ï]
'18-723009. [wï (S)] (êÊu) oà^áð_@É©³êœ°ÔfXChîáÌ1á. óÃLIq, ࡳK1,2, çìTêY1,2, nî1,3, C1,2, vÛCj1,4, Œ@ªk1, Žõl1,4, nç²¹F5 (1k¢åwfBJZ^[, 2ºÁ»ÇO, 3ãÁ»ÇO, 4êÊE¬EÌ_äXO, 5k¢åwk¢€a@): æ55ñú{ ~}ãwïï (2019/3/7-8), åä, ú{ ~}ãwïG 2019/2; 39 (2): 413.
'18-723010. [wï (S)] (êÊu) pOffµŠœÓ°²P]ÇÌ1á. C1,2, ࡳK1,2, nî1,3, çìTêY1,2, ºa¿1,4, vÛCj1,4, ß¡Nj1,5, Œ@ªk1, Žõl1,4, nç²¹F6 (1k¢åwfBJZ^[, 2ºÁ»ÇO, 3ãÁ»ÇO, 4êÊE¬EÌ_äXO, 5ûBEbóBO, 6k¢åwk¢€a@): æ55ñú{ ~}ãwïï (2019/3/7-8), åä, ú{ ~}ãwïG 2019/2; 39 (2): 418.
'18-723011. [wï (S)] (êÊu) ^á`¬ÉæéÀÇ« 𫜵œMeckeleºÌêá. ¥YGV1, º²r1, Ã@«, ÛR³T2, ã¡ìç3, Žçb1, Ãé@1, OY[æ1, RL1, ²¡Y1 (1ºÁ»ÇO, 2êÊE¬EÌ_äXO, 3åw@ãÃn€È): æ55ñú{ ~}ãwïï (2019/3/7), åä.
'18-723012. [wï (S)] (êÊu) °ÂÇðJèÔµœ¬°eºÉ뵀 oŸºèpð{sµœêá. ÄØrœ1, ÛR³T2, º²r1, Žçb1, Ã@«, Ãé@1, OY[æ1, RL1, ²¡Y1, nç²¹F1,3 (1ºÁ»ÇO, 2êÊE¬EÌ_äXO, 3k¢åwk¢€a@): æ55ñú{ ~}ãwïï (2019/3/7), åä.
'18-723013. [wï (S)] (êÊu) `Ro«Ý°Çð浜¬°·óÉεÄOÈIØð{sµœêá. Žçb1, º²r1, ã¡ìç2, ÛR³T3, Ã@«, Ãé@1, OY[æ1, RL1, ²¡Y1, nç²¹F1,4 (1ºÁ»ÇO, 2åw@ãÃn€È, 3êÊE¬EÌ_äXO, 4k¢åwk¢€a@): æ55ñú{ ~}ãwïï (2019/3/7), åä.
'18-723014. [wï (S)] (êÊu) ñ°lHãèå¢ÝãÌOutlet obstructionÇáÌ¢. ÛR³T1, º²r2, Žçb2, Ã@«, Ãé@2, OY[æ2, RL2, ²¡Y2, nç²¹F2,3 (1êÊE¬EÌ_äXO, 2ºÁ»ÇO, 3k¢åwk¢€a@): æ55ñú{ ~}ãwïï (2019/3/7), åä.
'18-723015. [wï (S)] (êÊu) pã°ÂÇÉ뵀 oŸºèpÍLp©? º²r1, ²¡Y1, RL1, OY[æ1, Ãé@1, Ã@«, nç²¹F1,2 (1ºÁ»ÇO, 2k¢åwk¢€a@): æ55ñú{ ~}ãwïï (2019/3/8), åä.
'18-733001. [wï (nûïE€ï)] (êÊu) pO»wúËüÃ@{sãÉsÁœ oŸèp̡ìÑ. ²¡Y1, º²r1, RL1, OY[æ1, Ãé@1, Ã@«, Žçb1, ÛR³T2, â{ê3, nç²¹F1,4 (1ºÁ»ÇO, 2êÊE¬EÌ_äXO, 3ûBEbóBO, 4k¢åwk¢€a@): æ90ñå°à€ï (2019/1/25), s.
'18-733002. [wï (nûïE€ï)] (êÊu) @ÅÌT1Œ°àÉηé oŸºèpÌ»óÆZú¬Ñ. ²¡Y (ºÁ»ÇO): æ90ñå°à€ï (2019/1/25), s.
SÇOÈw
[wp_¶]
110204. [Ž] Novel Surgical Strategy for Complicated Pulmonary Stenosis Using Haemodynamic Analysis Based on a Virtual Operation With Numerical Flow Analysis. Miyaji K1, Miyazaki S, Itatani K2, Oka N1, Kitamura T1, Horai T1: Interact Cardiovasc Thorac Surg 2019/5; 28 (5): 775-82. ({n@Ó1, ÂJcê2, ª@¿F1, kº@¥1, óNç1: SÇO, 2s{§åw)
310027. [Çáñ] Ketoacidosis related to sodium glucose cotransporter 2 inhibitors after emergency coronary surgery. Horikoshi R1, Kitamura T1, Miyaji K1: Interact Cardiovasc Thorac Surg 2019/8; 29 (2): 323-4. (xzm1, kº@¥1, {n@Ó1: 1SÇO)
310028. [Çáñ] The Modified Ross Reversal Operation: A New Approach for Preserving the Autograft Wall. Horikoshi R1, Kitamura T1, Miyaji K1: Interact Cardiovasc Thorac Surg 2020/2; 30 (2): 324-6. (xzm1, kº@¥1, {n@Ó1: 1SÇO)
522051. [uÀ]yÁW: ¬læV«SŸ³ÌOÈ¡ÃzæV«SŸ³Cpãuúx®¬Ùt¬Éηéx®¬Ùu·pÌLp«. ª@¿F1, {n@Ó1 (1SÇO): ¹OÈ 2019/4; 72 (4): 248-50.
[wïE€ï]
713052. [wï (Û)] (êÊu) Surgical Indications of Adult Ebstein Anomaly with NYHA IV. Miyamoto T1: The 10thEuropean Meeting onAdult Congenital Heart Disease (Euro GUCH) (2019/4/5-6), Zagreb, Croatia. ({{²i1: 1SÇO)
713053. [wï (Û)] (êÊu) Is BNP Biomarker in Reoperation of Grown-Up Congnital Heart Disease? Fukunishi T1: The 10thEuropean Meeting onAdult Congenital Heart Disease (Euro GUCH) (2019/4/5-6), Zagreb, Croatia. (Œô^1: 1SÇO)
713054. [wï (Û)] (êÊu) Chimney aortic repair for ruptured TAAA in a high-risk patient. Ohkubo H1: The 5th Asia-Pacific Angiology Academic Alliance Conference and 2019 International Annual Congress of Macau Health Bureau & Medical Doctors' Association (2019/6/21), Macau. (åvÛ¢1: 1SÇO)
713055. [wï (Û)] (êÊu) Surgical repair of vascular ring. Tadokoro Y1, Ohkubo H1, Miyamoto T1: The 5th Asia-Pacific Angiology Academic Alliance Conference and 2019 International Annual Congress of Macau Health Bureau & Medical Doctors' Association (2019/6/21), Macau. (cSI1, åvÛ¢1, {{²i1: 1SÇO)
713056. [wï (Û)] (êÊu) Wait-and-watch strategy for type A intramural haematoma and acute aortic dissection with thrombosed false lumen of the ascending aorta: 50 mm or less, pain under control and no ulcer-like projection. Kitamura T1, Torii S2, Miyamoto T1, Fujioka S1, Araki H1, Tadokoro Y1, Onishi Y1, Miyaji K1: The33th Annual Meeting of European Association for Cardio-Thoracic Surgery (EACTS) (2019/10/3-5), Lisbon, Portugal. (kº@¥1, ¹äWO2, {{²i1, ¡ªrêY1, rLtÞ1, cSI1, åŒ`F1, {n@Ó1: 1SÇO, 2ãÃÀSw³ç)
713057. [wï (Û)] (êÊu) Preoperative Factors for Acute Lung Injury After Pediatric Open-Heart Surgery. Fukunishi T1, Kohira S2, Inoue N1, Miyamoto T1, Kitamura T1, Miyaji K1: The 56th Annual Meeting of Society of Thoracic Surgeons (STS) (2020/1/25-28), New Orleans, USA. (Œô^1, Ãœ@2, äãMK1, {{²i1, kº@¥1, {n@Ó1: 1SÇO, 2ME)
713058. [wï (Û)] (êÊu) Staged open repair for chronic thoracoabdominal aortic dissection. Fujioka S1, Kitamura T1, Onishi Y1, Tadokoro Y1, Araki H1, Matushiro T1, Yakuwa K1, Ohkubo H1, Mishima T1, Miyamoto T1, Torii S2, Miyaji K1: The 28th Congress of the Asian Society for Cardiovascular and Thoracic Surgery (ASCVTS) (2020/2/7-10), Chiang Mai, Thailand. (¡ªrêY1, kº@¥1, åŒ`F1, cSI1, rLtÞ1, Œãìç1, ªLêM1, åvÛ¢1, üº1, {{²i1, ¹äWO2, {n@Ó1: 1SÇO, 2ãÃÀSw³ç)
713059. [wï (Û)] (êÊu) Preoperative Neutrophil-Lymphocyte Ratio Predicts Bleeding Tendency During Elective Total Arch Replacement. Kitamura T1, Torii S2, Miyamoto T1, Mishima T1, Ohkubo H1, Fujioka S1, Matsushiro T1, Yakuwa K1, Araki H1, Tadokoro Y1, Onishi Y1, Miyaji K1: The 28th Congress of the Asian Society for Cardiovascular and Thoracic Surgery (ASCVTS) (2020/2/7-10), Chiang Mai, Thailand. (kº@¥1, ¹äWO2, {{²i1, üº1, åvÛ¢1, ¡ªrêY1, Œãìç1, ªLêM1, rLtÞ1, cSI1, åŒ`F1, {n@Ó1: 1SÇO, 2ãÃÀSw³ç
713060. [wï (Û)] (êÊu) Surgical strategy for thoraco-abdominal aortic aneurysm in high risk patient. Onishi Y1, Fujioka S1, Kitamura T1, Torii S2, Miyamoto T1, Mishima T1, Ohkubo H1, Yakuwa K1, Araki H1, Kondo S1, Tamura Y1, Tadokoro Y1, Miyaji K1: The 28th Congress of the Asian Society for Cardiovascular and Thoracic Surgery (ASCVTS) (2020/2/7-10), Chiang Mai, Thailand. (åŒ`F1, ¡ªrêY1, kº@¥1, ¹äWO2, {{²i1, üº1, åvÛ¢1, ªLêM1, rLtÞ1, ß¡@^1, cºKä1, cSI1,{n@Ó1: 1SÇO, 2ãÃÀSw³ç)
713061. [wï (Û)] (êÊu) Effectiveness of Simultaneous Reconstructions in Congenital Open-Heart Surgery: Blalock-Taussig Shunt with Pulmonary Artery Plasty. Fukunishi T1, Inoue N1, Miyamoto T1, Kitamura T1, Miyaji K1: The 28th Congress of the Asian Society for Cardiovascular and Thoracic Surgery (ASCVTS) (2020/2/7-10), Chiang Mai, Thailand. (Œô^1, äãMK1, {{²i1, kº@¥1, {n@Ó1: 1SÇO)
713062. [wï (Û)] (êÊu) Initiating of Perioperative Inhaled Nitric Oxide Therapy in Patients with Open Heart Surgery. Inoue N1, Fukunishi T1, Kondo S1, Ohtomo Y1, Kitamura T1, Miyaji K1: The 28th Congress of the Asian Society for Cardiovascular and Thoracic Surgery (ASCVTS) (2020/2/7-10), Chiang Mai, Thailand. (äãMK1, Œô^1, ß¡@^1, åFE÷1, kº@¥1, {n@Ó1: 1SÇO)
713063. [wï (Û)] (êÊu) Chimney aortic repair for ruptured TAAA in a high-risk patient. Ohkubo H1, Fujioka S1, Kitamura T1, Onishi Y1, Araki H1, Mishima T1, Miyamoto T1, Torii S2, Miyaji K1: The 28th Congress of the Asian Society for Cardiovascular and Thoracic Surgery (ASCVTS) (2020/2/7-10), Chiang Mai, Thailand. (åvÛ¢1, ¡ªrêY1, kº@¥1, åŒ`F1, rLtÞ1, üº1, {{²i1, ¹äWO2, {n@Ó1: 1SÇO, 2ãÃÀSw³ç)
713064. [wï (Û)] (êÊu) Effectiveness of Intraoperative Pulmonary Artery Pressure Monitoring in Patients with Ventricular Septal Defect and Pulmonary Hypertension. Araki H1, Miyaji K1, Miyamoto T1, Torii S2, Kitamura T1, Mishima T1, Ohkubo H1, Fujioka S1, Matsushiro T1, Yakuwa K1: The 28th Congress of the Asian Society for Cardiovascular and Thoracic Surgery (ASCVTS) (2020/2/7-10), Chiang Mai, Thailand. (rLtÞ1, {n@Ó1, {{²i1, ¹äWO2, kº@¥1, üº1, åvÛ¢1, ¡ªrêY1, Œãìç1, ªLêM1: 1SÇO, 2ãÃÀSw³ç)
713065. [wï (Û)] (êÊu) Newly created canine model of sinus node dysfunction by minimally invasive procedure. Miyamoto T1, Ishido H1, Aoki T, Miyaji K1: 49. Jahrestagung der DGTHG/52. Jahrestagung der DGPK (HERZMEDIZIN) (2020/2/29-3/3), Wiesbaden, Germany. ({{²i1, ΰh1, {n@Ó1: 1SÇO)
723326. [wï (S)] (êÊu) Consideration for indications and procedures in adult congenital heart disease. {{²i1, Œô^1, ŒäªŸ1, ΰh1, ºäCŸ1, Lc^õ1, ºDò1, xzm1, rLtÞ1, ¡ªrêY1, åvÛ¢1, äãMK1, ¬Ñî1, üº1, kº@¥1, ¹äWO2, {n@Ó1 (1SÇO, 2ãÃÀSw³ç): æ119ñú{OÈwïèúwpWï (2019/4/18-20), åã, ú{OÈwïèúwpWïŽ^W 2020/4; 119: PD-3-4.
723327. [wï (S)] (êÊu) Challenging neck Éηé 宬áXegOtgà}pÌ¢. åvÛ¢1, ¡ªrêY1, üº1, ŒäªŸ1, ºDò1, Lc^õ1, xzm1, rLtÞ1, Œô^1, ¬Ñî1, kº@¥1, {{²i1, ¹äWO2, {n@Ó1 (1SÇO, 2ãÃÀSw³ç): æ119ñú{OÈwïèúwpWï (2019/4/18-20), åã, ú{OÈwïèúwpWïŽ^W 2020/4; 119: PS-147-2.
723328. [wï (S)] (êÊu) LupiaeOtgÒðp¢œå®¬ÕfÉæé|宬Su·pð{sµœ2Çá. Œô^1, kº@¥1, ¹äWO2, üº1, äãMK1, åvÛ¢1, ¡ªrêY1, rLtÞ1, {{²i1, {n@Ó1 (1SÇO, 2ãÃÀSw³ç): æ47ñú{ÇOÈwïwpï (2019/5/22-24), ŒÃ®, ú{ÇOÈwïG 2019/5; 28iSuppl): 89.
723329. [wï (S)] (êÊu) Iliac Branch Endoprosthesis (IBE) ðp¢œXegOtg¡ÃÌ¢. ¡ªrêY1, åvÛ¢1, üº1, ΰh1, ºäCŸ1, rLtÞ1, Œô^1, äãMK1, kº@¥1, {{²i1, ¹äWO2, {n@Ó1 (1SÇO, 2ãÃÀSw³ç): æ47ñú{ÇOÈwïwpï (2019/5/22-24), ŒÃ®, ú{ÇOÈwïG 2019/5; 28iSuppl): 90.
723330. [wï (S)] (êÊu) jô« 宬áE°®¬áÉηéXegOtgà}p. åvÛ¢1, üº1, ¡ªrêY1, ºäCŸ1, ΰh1, rLtÞ1, Œô^1, äãMK1, kº@¥1, {{²i1, ¹äWO2, {n@Ó1 (1SÇO, 2ãÃÀSw³ç): æ47ñú{ÇOÈwïwpï (2019/5/22-24), ŒÃ®, ú{ÇOÈwïG 2019/5; 28iSuppl): 92.
723331. [wï (S)] (êÊu) 宬áE°®¬áÉηéAFXÌú¬ÑÌ¢. ºäCŸ1, åvÛ¢1, ¡ªrêY1, üº1, ΰh1, rLtÞ1, Œô^1, äãMK1, kº@¥1, {{²i1, ¹äWO2, {n@Ó1 (1SÇO, 2ãÃÀSw³ç): æ47ñú{ÇOÈwïwpï (2019/5/22-24), ŒÃ®, ú{ÇOÈwïG 2019/5; 28iSuppl): 112.
723332. [wï (S)] (êÊu) @Éš¯éâc¿®¬áÌ¡Ão±. ycEŸ1, ºÍŽBç2, ºäCŸ1, aJTŸY2, ]ìqv2 (1SÇO, 2϶ï¡lsa@): æ60ñú{¬Çwïï (2019/10/10-12), , ¬Çw 2019/10; 59 (Suppl): S84.
723333. [wï (S)] (êÊu) Pulmonary coarctationÉηéV¶úÌxZèpÆx®¬`¬p¯èp. {n@Ó1, {{²i1, ªLêM1, cSI1, ¹äWO2, kº@¥1, ¡ªrêY1, rLtÞ1, ß¡@^1, åŒ`F1 (1SÇO, 2ãÃÀSw³ç): æ72ñú{¹OÈwïèúwpWï (2019/10/30-11/2), s, ú{¹OÈwïG 2019/10; (Suppl): 158.
723334. [wï (S)] (êÊu) ñSºCQÉš¯éŒ€x®¬iNpÉæéuúœx®¬·óÌ¢. ª@¿F1, FÛM1, Ñ@G1, {{²i1, {n@Ó1 (1SÇO): æ72ñú{¹OÈwïèúwpWï (2019/10/30-11/2), s, ú{¹OÈwïG 2019/10; (Suppl): 158.
723335. [wï (S)] (êÊu) ãs宬UoÂÇ^Stanford A^}«å®¬ð£ÉηéúÛ¶Ã@Ì¢. rLtÞ1 kº@¥1, åŒ`F1, cSI1, cºÀü1, ß¡@^1, ªLêM1, ¡ªrêY1, åvÛ¢1, üº1, {{²i1, ¹äWO2, {n@Ó1 (1SÇO, 2ãÃÀSw³ç): æ72ñú{¹OÈwïèúwpWï (2019/10/30-11/2), s, ú{¹OÈwïG 2019/10; (Suppl): 223.
723336. [wï (S)] (êÊu) V¶JSppãÌûѹ
ÉηépÇ¢eÌLp«. cSI1, {{²i1, ªLêM1, ¹äWO2, kº@¥1, ¡ªrêY1, rLtÞ1, ß¡@^1, cºÀü1, åŒ`F1, {n@Ó1 (1SÇO, 2ãÃÀSw³ç): æ72ñú{¹OÈwïèúwpWï (2019/10/30-11/2), s, ú{¹OÈwïG 2019/10; (Suppl): 237.
723337. [wï (S)] (êÊu) ¬lJSpÉš¯éê_»fzüÃ@JnúÌ¢. äãMK1, åFE÷1, rLtÞ1, Œô^1, ¡ªrêY1, åvÛ¢1, üº1, kº@¥1, {{²i1, ¹äWO2, {n@Ó1 (1SÇO, 2ãÃÀSw³ç): æ72ñú{¹OÈwïèúwpWï (2019/10/30-11/2), s, ú{¹OÈwïG 2019/10; (Suppl): 238.
723338. [wï (S)] (êÊu) A±Dðp¢œTrifecta, Magna EASE, InspirisÉæé宬Ùu·pÌú¬ÑÌär¢. åŒ`F1, kº@¥1, ¹äWO2, {{²i1, üº1, äãMK1, åvÛ¢1, ¡ªrêY1, Œô^1, ªLêM1, rLtÞ1, ß¡@^1, cºÀü1, cSI1, {n@Ó1 (1SÇO, 2ãÃÀSw³ç): æ72ñú{¹OÈwïèúwpWï (2019/10/30-11/2), s, ú{¹OÈwïG 2019/10; (Suppl): 245.
723339. [wï (S)] (êÊu) Low riskÌAS³ÒÉηéTAVIKÌë. kº@¥1, ¹äWO2, {{²i1, üº1, åvÛ¢1, ¡ªrêY1, ªLêM1, rLtÞ1, ß¡@^1, cºÀü1, cSI1, åŒ`F1, ¢ÃÆ3, ÚŸY3, {n@Ó1 (1SÇO, 2ãÃÀSw³ç, 3zÂíà): æ72ñú{¹OÈwïèúwpWï (2019/10/30-11/2), s, ú{¹OÈwïG 2019/10; (Suppl): 289.
723340. [wï (S)] (êÊu) §Í³ÒÌSåÇèpÉš¯éSÌë¯öqÉ¢ÄÌ¢. cºÀü1, kº@¥1, ¹äWO2, {{²i1, üº1, äãMK1, åvÛ¢1, ¡ªrêY1, Œô^1, ªLêM1, rLtÞ1, ß¡@^1, cSI1, åŒ`F1, {n@Ó1 (1SÇO, 2ãÃÀSw³ç): æ72ñú{¹OÈwïèúwpWï (2019/10/30-11/2), s, ú{¹OÈwïG 2019/10; (Suppl): 294.
723341. [wï (S)] (êÊu) @Éš¯éâc¿®¬áÌ¡Ão±. {n@Ó1, {{²i1, ªLêM1, cSI1, ¹äWO2, kº@¥1, ¡ªrêY1, rLtÞ1, ß¡@^1, åŒ`F1 (1SÇO, 2ãÃÀSw³ç): æ72ñú{¹OÈwïèúwpWï (2019/10/30-11/2), s.
723342. [wï (S)] (êÊu) Só°à𹵜Ѐ°®¬áÉε, Œ€à°®¬ð·¶µœEVARð{sµœêá. ycEŸ1, ºÍŽBç2, ºäCŸ1, aJTŸY2, ]ìqv2 (1SÇO, 2϶ï¡lsa@): æ81ñú{Õ°OÈwïï (2019/11/14-16), m, ú{Õ°OÈwïïG 2019/11; 80 (§): 807.
723343. [wï (S)] (êÊu) SlHÒÖßu·pãÉåÂœ®¬á𫜵œ1á. åvÛ¢1, ¡ªrêY1, üº1, ŒäªŸ1, Lc^õ1, ºDò1, ¬Ñî1, kº@¥1, {{²i1, ¹äWO2, {n@Ó1 (1SÇO, 2ãÃÀSw³ç): æ182ñÇOÈÇá¢ï (2019/12/14), ìè, ÇOÈ 2019/11; 38 (1): 142.
723344. [wï (S)] (êÊu) åt®¬áÉηéÇà¡ÃÌ1á. åvÛ¢1, üº1, ¡ªrêY1, ºäCŸ1 {n@Ó1 (1SÇO): æ182ñÇOÈÇá¢ï (2019/12/14), ìè, ÇOÈ 2019/11; 38 (1): 170-1.
723345. [wï (S)] (êÊu) ¬læV«SŸ³ÌèpÌSåǹÌÎ@É¢Ä. {{²i1, ªLêM1, cSI1, åŒ`F1, ¡cSœ2, ¬ÂŽrü2, kº@¥1, {n@Ó1 (1SÇO, 2zÂíà): æ22ñú{¬læV«SŸ³wïïEwpWï (2020/1/17-19), , ú{æV«SŸ³wïG 2020/1; 9 (1): 195.
723346. [wï (S)] (êÊu) ÂNúÉš¯éTOFpãx®¬¶ÌÙu·pÌúu¬Ñ. {n@Ó1, {{²i1, ªLêM1, cSI1, ¬ÂŽrü2, ¡cSœ2, ¢ÃÆ2 (1SÇO, 2zÂíà): æ22ñú{¬læV«SŸ³wïïEwpWï (2020/1/17-19), , ú{æV«SŸ³wïG 2020/1; 9 (1): 209.
733119. [wï (nûïE€ï)] (êÊu) MRIBðp¢œ¬ðÍÅffEèpíªð§ÄœEºñoÇÌ1á. Œicõ1, Lc^õ1, ¬Ñî1, ¬ŽM`, æÑ@³î, {n@Ó1 (1SÇO): æ180ñú{¹OÈwïÖbMznûï (2019/6/8), , ú{¹OÈwïÖbMznûïv|W 2019/6; 180: 9.
733120. [wï (nûïE€ï)] (êÊu) ¹ºs宬lHÇu·pã, lHÇŽõð¹µÙ}TEVARyÑH¹²ÉÁœêÇá. õM1, g¢zî1, Øõl1, {n@Ó1 (1SÇO): æ180ñú{¹OÈwïÖbMznûï (2019/6/8), , ú{¹OÈwïÖbMznûïv|W 2019/6; 180: 15.
733121. [wï (nûïE€ï)] (êÊu) ACTA2â`qÏÙð^íêœå®¬ÙÖg£ÇÌ1á. åŒ`F1, rLtÞ1, kº@¥1, ¹äWO2, {{²i1, üº1, åvÛ¢1, ¡ªrêY1, ªLêM1, ß¡@^1, cºÀü1, cSI1, {n@Ó1 (1SÇO, 2ãÃÀSw³ç): æ180ñú{¹OÈwïÖbMznûï (2019/6/8), , ú{¹OÈwïÖbMznûïv|W 2019/6; 180: 21.
733122. [wï (nûïE€ï)] (êÊu) œ·éxì·óð浜¬^xìҬÙíÇÌ1á. cSI1, ªLêM1, {{²i1, kº@¥1, ¹äWO2, üº1, åvÛ¢1, ¡ªrêY1, rLtÞ1, ß¡@^1, cºÀü1, {n@Ó1 (1SÇO, 2ãÃÀSw³ç): æ180ñú{¹OÈwïÖbMznûï (2019/6/8), , ú{¹OÈwïÖbMznûïv|W 2019/6; 180: 26.
733123. [wï (nûïE€ï)] (êÊu) JèÔµ][Ç𫜵œñ×Û«ð«SàÌ1á. åŒ`F1, rLtÞ1, ¹äWO2, {{²i1, kº@¥1, üº1, åvÛ¢1, ¡ªrêY1, ªLêM1, ß¡@^1, cºÀü1, cSI1, {n@Ó1 (1SÇO, 2ãÃÀSw³ç): æ181ñú{¹OÈwïÖbMznûï (2019/11/9), , ú{¹OÈwïÖbMznûïv|W 2019/11; 181: 14.
733124. [wï (nûïE€ï)] (êÊu) v^~VbN³ÒÉηé2DebranchTEVARðs¢¡ÃµœêÇá. õM1, g¢zî1, Øõl, {n@Ó1 (1SÇO): æ181ñú{¹OÈwïÖbMznûï (2019/11/9), , ú{¹OÈwïÖbMznûïv|W 2019/11; 181: 15.
733125. [wï (nûïE€ï)] (êÊu) u·pãÉÌÊϷɺ€á_fÇð_@É©³êœS[u¹ÇÌêá. Œicõ1, ¬Ñî1, cºKä1, ¬ŽM`, æÑ@³î, {n@Ó1 (1SÇO): æ181ñú{¹OÈwïÖbMznûï (2019/11/9), , ú{¹OÈwïÖbMznûïv|W 2019/11; 181: 20.
733126. [wï (nûïE€ï)] (êÊu) ®S^d¡å®¬|Ìêá. cSI1, {{²i1, ªLêM1, ¹äWO2, kº@¥1, ¡ªrêY1, rLtÞ1, ß¡@^1, cºÀü1, åŒ`F1, {n@Ó1 (1SÇO, 2ãÃÀSw³ç): æ181ñú{¹OÈwïÖbMznûï (2019/11/9), , ú{¹OÈwïÖbMznûïv|W 2019/11; 181: 23.
733127. [wï (nûïE€ï)] (êÊu) EbsteinaÉεÄConeèpð{sµœ1á. åŒ`F1, {{²i1, ¹äWO2, kº@¥1, üº1, åvÛ¢1, ¡ªrêY1, Œãìç1, ªLêM1, rLtÞ1, cSI1, {n@Ó1 (1SÇO, 2ãÃÀSw³ç): æ182ñú{¹OÈwïÖbMznûï (2020/3/7), ãJÃ, ú{¹OÈwïÖbMznûïv|W 2020/3; 182: 9.
733128. [wï (nûïE€ï)] (êÊu) 宬ð£pÉMalperfusionÉ×è}ç¯ãs宬ŒÚÉÏXµÄèp𮵜êÇá. õM1, g¢zî1, Øõl1, {n@Ó1 (1SÇO): æ182ñú{¹OÈwïÖbMznûï (2020/3/7), ãJÃ, ú{¹OÈwïÖbMznûïv|W 2020/3; 182: 14.
733129. [wï (nûïE€ï)] (êÊu) ]^á𹵜Žõ«SàÌ¡Ão±. Œicõ1, ¬Ñî1, cºKä1, ¬ŽM`, æÑ@³î, {n@Ó1 (1SÇO): æ182ñú{¹OÈwïÖbMznûï (2020/3/7), ãJÃ, ú{¹OÈwïÖbMznûïv|W 2020/3; 182: 30.
733130. [wï (nûïE€ï)] (êÊu) 宬Ùu·ppãúÉmXÙt¬ð浜Žõ« SàÌ1á. cSI1, rLtÞ1, ¹äWO2, {{²i1, kº@¥1, üº1, åvÛ¢1, ¡ªrêY1, Œãìç1, ªLêM1, åŒ`F1, {n@Ó1 (1SÇO, 2ãÃÀSw³ç): æ182ñú{¹OÈwïÖbMznûï (2020/3/7), ãJÃ, ú{¹OÈwïÖbMznûïv|W 2020/3; 182: 31.
ÄzíOÈw
[wp_¶]
110205. [Ž] Ultra-late recurrence of non-small cell lung cancer over 10 years after curative resection. Sonoda D1, Matsuura Y, Ichinose J, Nakao M, Ninomiya H, Mun M, Ishikawa Y, Nakagawa K, Satoh Y2, Okumura S: Cancer Manag Res 2019/7; 11: 6765-74. (c@å1, ²¡Vr2: 1åw@ãÃn€È, 2ÄzíO)
110206. [Ž] EGFR mutation genotyping and ALK status determination in liquid-based cytology samples of non-small cell lung cancer. Satoh Y1, Matsuo Y2, Kuba T3, Yamashita K3, Sawano M, Tozaka S, Yamazaki H1, Sonoda D4, Mikubo M1, Naito M1, Matsui Y1, Shiomi K1, Yoshida T5, Murakumo Y5: Virchows Arch 2020/5; 476 (5): 753-62. doi: 10.1007/s00428-019-02692-9. Epub 2019 Dec 10. (²¡Vr1, ŒöRIq2, vê@÷3, Rºaç3, RèGp1, c@å4, OE«j1, à¡ëm1, Œä[v1, ©@a1, gc@÷5, º_F÷5: 1ÄzíO, 2aÔEfÃn, 3a, 4åw@ãÃn€È, 5a)
310029. [Çáñ] A case report of a thymic neuroblastoma associated with syndrome of inappropriate secretion of antidiuretic hormone: Ten-year follow-up results after surgical treatment. Satoh Y1: Int J Surg Case Rep 2019/5; 58: 45-7. (²¡Vr1: 1ÄzíO)
310030. [Çáñ] Ciliated muconodular papillary tumors of the lung: Cytologic features and diagnostic pitfalls in intraoperative examinations. Mikubo M1, Maruyama R1, Kakinuma H2, Yoshida T3, Satoh Y1: Diagn Cytopathol 2019/7; 47 (7): 716-9. (OE«j1, ÛRô1, `ÀAM2, gc@÷3, ²¡Vr1: 1ÄzíO, 2a, 3a)
540039. [»ÌŒ (])] ×EfðwÔlÌœßÉ. ²¡Vr (ÄzíO): žÆZp 2019/12; 47 (12): 1403.
540040. [»ÌŒ (])] PICO©çnßéãw¶£õÌ··ß. ²¡Vr (ÄzíO): ¹OÈ 2019/6; 72 (6): 454.
540041. [»ÌŒ (])] bóB×EfAgX@ñl®^pÌÀÛ. ²¡Vr (ÄzíO): Õ°ž 2020/1; 64 (1): 44.
[@]
621002. [wp (ÒW)]y×Ežm×E±âèW æ2ÅzÄzí@âèEðEðà. Ò: ²¡Vr1,2 (1ÄzíO, 2övÐc@lú{Õ°×Ewï), ãòoÅ, , 2019/4s.
621003. [wp (ÒW)]yñ««Äzí×EfAgX: xàÆÌÓÊÉYñŸÆ«ÉzÒ: ²¡Vr1, àV@N (1ÄzíO), ì]°, , 2020/2s.
[wïE€ï]
712007. [wï (Û)] (µÒu) Consensus Terminology in Cytology Symposium. International Cytology Reporting System of Lung Tumors. Satoh Y1: The 42nd European Congress of Cytology (2019/6/16-19), Malmo, Sweden. (²¡Vr1: 1ÄzíO)
713066. [wï (Û)] (êÊu) Effect of formaldehyde in liquid-based cytology preservation solutions on molecular testing of lung cancer specimens. Satoh Y1, Matsuo Y2, Yamashita K3, Yoshida T4: The 20th International Congress Of Cytology 2019 (2019/5/5-9), Sydney, Australia. (²¡Vr1, ŒöRIq2, Rºaç3, gc@÷4: 1ÄzíO, 2aÔEfÃn, 3a, 4a)
713067. [wï (Û)] (êÊu) Clinical genomic test on cytology: Current status and future perspective in Japan (JSCC Working Group on cytological roles in genome medicine era). Motoi N, Hatanaka Y, Hamakawa S, Kawahara A, Nagatomo T, Kuwata T, Oda Y, Okamoto A, Maeda I, Satoh Y1, Morii E: The 20th International Congress Of Cytology 2019 (2019/5/5-9), Sydney, Australia. (²¡Vr1: 1ÄzíO)
713068. [wï (Û)] (êÊu) International cytology reporting system of lung tumors. Satoh Y1: The 20th International Congress Of Cytology 2019 (2019/5/5-9), Sydney, Australia. (²¡Vr1: 1ÄzíO)
713069. [wï (Û)] (êÊu) Typical Carcinoid with Pleural Dissemination: report of a rare case. Mitsui A1, Tamagawa S1, Hayashi S1, Naito M1, Mathui Y1, Shiomi K1, Satoh Y1, Tochimoto M2, Ichinohe M2, Nakagawa H3, Kakinuma Y3, Kakinuma H3: 18th Japan-Korea Joint Meeting for Diagnostic Cytopathology (2019/9/7), Korea. (Oä@€1, Êì@B1, Ñ@Ëq1, à¡ëm1, Œä[v1, ©@a1, ²¡Vr1, È{¹F2, ê˹Ÿ2, ìmü3, `ÀDüq3, `ÀAM3: 1ÄzíO, 2a, 3a)
713070. [wï (Û)] (êÊu) Clinical significances of intra-tumor CD8+ lymphocytes in NSCLCs (ñ¬×ExàÉš¯éîáZCD8z«p
ÌÓ`). Shiomi K1: IASLC 20th World Conference on Lung Cancer (WCLC 2019) (2019/9/9), Barcelona, Spain. (©@a1: 1ÄzíO)
713071. [wï (Û)] (êÊu) The Possible Clinical Significances of Infiltration of CD8+ Lymphocytes in Non-Small Cell Lung Cancers. Shiomi K1, Ichinohe M2, Jiang SX, Naito M1, Mikubo M1, Matsui Y1, Tamagawa S1, Mitsui A1, Hayashi S1, Satoh Y1, Matsuo Y3: IASLC 20th World Conference on Lung Cancer (WCLC 2019) (2019/9/7-10), Barcelona, Spain. (©@a1, ê˹Ÿ2, à¡ëm1, OE«j1, Œä[v1, Êì@B1, Oä@€1, Ñ@Ëq1, ²¡Vr1, ŒöRIq3: 1ÄzíO, 2a, 3aÔEfÃn)
722072. [wï (S)] (v]u) Äzí. ²¡Vr (ÄzíO): æ60ñú{Õ°×Ewïï (túåï) (2019/6/7-9), .
722073. [wï (S)] (V|WE) ¡ãÌQmfÃÉš¯é×EfÌ èû: wïÉš¯éæègÝ. š@L, ³äIq, à_ì^¡, ÍŽŸF, ·F, Kc@, ¬c`Œ, ª{€õ, OcêY, ²¡Vr1, Xäpê (1ÄzíO): æ60ñú{Õ°×Ewïï (túåï) (2019/6/7-9), .
722074. [wï (S)] (µÒu) JSCC-JLCSÉæéVœÈ»èîÌñÄ. AO, ²¡Vr1, gc@÷2, `ÀAM3, ·örF, ŒÑ@, Oî^i, ËLê, áÁ\³K, |Ÿü, ³äIq, àFØNY, ì@Dq, gàVŸF, Hêç, ÍŽMõ (1ÄzíO, 2a, 3a): æ60ñú{Õ°×Ewïï (túåï) (2019/6/9), .
722075. [wï (S)] (µÒu) ueíÌ×Efñl®@»ÌpêÆwiÉ¢Äc_·év`xà×EfÌñl®`. àFØNY, ²¡Vr1, AO, ì@Dq, gàVŸF, Hêç, ÍŽMõ, |Ÿü, Oî^i, `ÀAM2 (1ÄzíO, 2a): æ58ñú{Õ°×EwïHúåï (2019/11/16-17), ªR.
723347. [wï (S)] (êÊu) [À«îáEàÉZ·éCD8z«×EÌÆpãÄÌÖA«Ì¢. ©@a1, ê˹Ÿ2, à¡ëm1, OE«j1, Ñ@Ëq1, Œ\á1, ÛRP1, Êì@B1, Oä@€1, Ó@¢®, Œä[v1, ²¡Vr1 (1ÄzíO, 2a): æ36ñú{ÄzíOÈwïwpWï (2019/5/16), åã.
723348. [wï (S)] (|X^[) cuH¹aÏÉηé¹oŸèp. _JIP1,2, ¬Ëë¢1, OcúØq1, J{²î1, @TV2, å÷1, ÎäÇK1,3, åì¹`1, nç²¹F1 (1k¢åwk¢€a@, 2ÄzíO, 3ºÁ»ÇO): æ36ñú{ÄzíOÈwïwpWï (2019/5/16), åã, ú{ÄzíOÈwïG 2019/5; 3 (3): P57-5.
723349. [wï (S)] (êÊu) ««pîÌd¡àƵÄÌŽ«xàÉε®Sصœ13áÌ¢. Œ\á1, ÛRP1, Ñ@Ëq1, à¡ëm1, OE«j1, Œä[v1, ©@a1, ²¡Vr1 (1ÄzíO): æ36ñú{ÄzíOÈwïwpWï (2019/5/16-17), åã.
723350. [wï (S)] (êÊu) äXEUS-FNAÅ¢ª»àÆÌÓʪ¢ïÅ Áœ¢ª»å×E^pîÌ1Çá. âŒO¶, RüH, ²¡r, ŒYêM, äoLç, àV@N, Âöå÷, ÎTA÷, ìCK, ²¡Vr1 (1ÄzíO): æ60ñú{Õ°×Ewïï (túåï) (2019/6/7-9), .
723351. [wï (S)] (êÊu) xàpOÉš¯é×Sd}žÌÓ`Ì¢. Êì@B1, Oä@€1, Ñ@Ëq1, à¡ëm1, Œä[v1, ©@a1, ²¡Vr1 (1ÄzíO): æ72ñú{¹OÈwïèúwpWï (2019/10/31), s.
723352. [wï (S)] (êÊu) Äzí×EfÞ¿Éš¯éJSCC-JLCSñl®É¢Ä. gàVŸF, AO, ²¡Vr1 (1ÄzíO)æ58ñú{Õ°×EwïHúåï (2019/11/16-17), ªR.
723353. [wï (S)] (êÊu) VœÈxà×Ef»èæªÌñÄ. AO, ²¡Vr1 (1ÄzíO): æ60ñú{xàwïwpWï (2019/12/6-8), åã.
733131. [wï (nûïE€ï)] (êÊu) ¹díðFßœxè^J`mChÌ1á. Oä@€1, Êì@B1, Ñ@Ëq1, à¡ëm1, Œä[v1, ©@a1, ²¡Vr1, È{¹F2, ê˹Ÿ2 (1ÄzíO, 2a): æ185ñú{xàwïÖxwpWï (2019/7/6), .
733132. [wï (nûïE€ï)] (êÊu) Äzí×EfÉš¯éñl®É¢Ä: ÛîÌñ¥. ²¡Vr (ÄzíO): æ33ñÖÕ°×EwïwpWï/æ38ñsÕ°×EwïïEwpWï (2019/9/28), .
733133. [wï (nûïE€ï)] (êÊu) ¹ÇüÛîÇÌ1Øá. Ñ@Ëq1, Oä@€1, Êì@B1, à¡ëm1, Œä[v1, ©@a1, ²¡Vr1 (1ÄzíO): æ181ñú{¹OÈwïÖbMznûï (2019/11/9), .
733134. [wï (nûïE€ï)] (êÊu) O¹ÇCÈópÇîÌ1Øá. öcñY, Oä@€1, Êì@B1, Ñ@Ëq1, à¡ëm1, Œä[v1, ©@a1, ²¡Vr1 (1ÄzíO): æ182ñú{¹OÈwïÖbMznûï (2020/3/7), .
]_oOÈw
[wp_¶]
110207. [Ž] Novel concept of the border niche: glioblastoma cells use oligodendrocytes progenitor cells (GAOs) and microglia to acquire stem cell-like features. Hide T1, Shibahara I1, Kumabe T1: Brain Tumor Pathol 2019/4; 36 (2): 63-73. (GñêY1, ÄŽêz1, GrG1: 1]O)
110208. [Ž] Clinically practical formula for preoperatively estimating the cutting rate of the spinal nerve root in a functional posterior rhizotomy. Morota N1: Childs Nerv Syst 2019/4; 35 (4): 665-72. (tcMl1: 1]O)
110209. [Ž] Intraoperative neurophysiological monitoring of the bulbocavernosus reflex during surgery for conus spinal lipoma: what are the warning criteria? Morota N1: J Neurosurg Pediatr 2019/5; 23 (5): 369-47. (tcMl1: 1]O)
110210. [Ž] Half-tied Stay Suture Technique for Cerebrovascular End-to-side Anastomosis: A Technique to Expand the View of the Hidden Ostium. Shimizu S1,2, Osawa S2, Kuroda H1,2, Koizumi H1, Mochizuki T2, KumabeT1: Neurol Med Chir (Tokyo) 2019/8; 59 (8): 326-29. (Ž
@ú1,2, åàV¬V2, cI1,2, ¬ò°V1,3, ]O2, GrG1: 1]O, 2¡ls§]²E_oÒÅZ^[, 3~œ)
110211. [Ž] Visual disorders caused by cranial arteriovenous fistula with venous drainage into the superior ophthalmic vein. Kondo R, Kumabe T1, Yamamoto D1, Koizumi H1,2, Kuroda H1, Miyasaka K1: Interv Neuroradiol 2019/8; 25 (4): 460-8. (GrG1, R{åã1, ¬ò°V1,2, cI1, {âaO1: 1]O, 2~œ)
110212. [Ž] Temporal Glioblastoma Mimicking Basal Ganglia Invasion: Distinguishing Removable and Unremovable Tumors. Shibahara I1, Hanihara M, Miyasaka K1, Sato S1, Hide T1, Kumabe T1: World Neurosurg 2019/10; 130: e213-21. (ÄŽêz1, ûŽõl, {âaO1, ²¡l1, GñêY1, GrG1: 1]O)
110213. [Ž] Recurrent noncoding U1 snRNA mutations drive cryptic splicing in SHH medulloblastoma. Suzuki H, Kumar SA, Shuai S, Diaz-Navarro A, Gutierrez-Fernandez A, De Antonellis P, Cavalli FMG, Juraschka K, Farooq H, Shibahara I1, Vladoiu MC, Zhang J, Abeysundara N, Przelicki D, Skowron P, Gauer N, Luu B, Daniels C, Wu X, Forget A, Momin A, Wang J, Dong W, Kim SK, Grajkowska WA, Jouvet A, F`evre-Montange M, Garr`e ML, Rao AAN, Giannini C, Kros JM, French PJ, Jabado N, Ng HK, Poon WS, Eberhart CG, Pollack IF, Olson JM, Weiss WA, Kumabe T1, Lpez-Aguilar E, Lach B, Massimino M, Van Meir EG, Rubin JB, Vibhakar R, Chambless LB, Kijima N, Klekner A, Bogn L, Chan JA, Faria CC, Ragoussis J, Pfister SM, Goldenberg A, Wechsler-Reya RJ, Bailey SD, Garzia L, Morrissy AS, Marra MA, Huang X, Malkin D, Ayrault O, Ramaswamy V, Puente XS, Calarco JA, Stein L, Taylor MD: Nature 2019/10; 574 (7780): 707-11. (ÄŽêz1, GrG1: 1]O)
110214. [Ž] Angiographic Characterization of the External Carotid Artery: Special Attention to Variations in Branching Patterns. Yamamoto D1, Koizumi H1,2, Ishima D3, Kuroda H1, Shibahara I1, Niki J1, Miyasaka K1, Watanabe T, Kondo R, Kumabe T1: Tohoku J Exp Med 2019/11; 249 (3): 185-92. (R{åã1, ¬ò°V1,2, äåã3, ÄŽêz1, mØ@~1, {âaO1, GrG1: 1]O, 2~œ, 3]_oà)
110215. [Ž] Medulloblastoma has a global impact on health related quality of life: Findings from an international cohort. de Medeiros CB, Moxon-Emre I, Scantlebury N, Malkin D, Ramaswamy V, Decker A, Law N, Kumabe T1, Leonard J, Rubin J, Jung S, Kim SK, Gupta N, Weiss W, Faria CC, Vibhakar R, Lafay-Cousin L, Chan J, Kros JM, Janzen L, Taylor MD, Bouffet E, Mabbott DJ: Cancer Med 2020/1; 9 (2): 447-59. (GrG1: 1]O)
110216. [Ž] Intratumoural immune cell landscape in germinoma reveals multipotent lineages and exhibits prognostic significance. Takami H1, Fukushima S1, Aoki K1, Satomi K1, Narumi K1, Hama N1, Matsushita Y1, Fukuoka K1, Yamasaki K1, Nakamura T1, Mukasa A1, Saito N1, Suzuki T1, Yanagisawa T1, Nakamura H1, Sugiyama K1, Tamura K1, Maehara T1, Nakada M1, Nonaka M1, Asai A1, Yokogami K1, Takeshima H1, Iuchi T1, Kanemura Y1, Kobayashi K1, Nagane M1, Kurozumi K1, Yoshimoto K1, Matsuda M1, Matsumura A1, Hirose Y1, Tokuyama T1, Kumabe T1,2, Ueki K1, Narita Y1, Shibui S1, Totoki Y, Shibata T, Nakazato Y, Nishikawa R1, Matsutani M1, Ichimura K1 (1Intracranial Germ Cell Tumor Genome Analysis Consortium (the iGCT Consortium)): Neuropathol Appl Neurobiol 2020/2; 46 (2): 111-24. (GrG1,2: 2]O)
110217. [Ž] Phase I trial of convection-enhanced delivery of nimustine hydrochloride (ACNU) for brainstem recurrent glioma. Saito R, Kanamori M, Sonoda Y, Yamashita Y, Nagamatsu K, Murata T, Mugikura S, Kumabe T, Wembacher-Schrder E, Thomson R, Tominaga T: Neurooncol Adv 2020 /3; 2 (1): vdaa033. (GrG1: 1]O)
120006. [Ž] ÙO_oäPîEoÉš¯ép¢eCTðp¢œúÊ}`ÊÌLp«. h@@[, ÄŽêz1, ûŽõl, {âaO1, cI1, ²¡l1, GrG1 (1]O): CI€ 2019/6; 41 (1): 7-15.
120007. [Ž] O€ãªWâ|Av[`Éš¯épOàzìƀsH]¿Ìdv«. v{ü^1,2, ª@GG1,2, ²¡l2, ß¡G¡1,2, GrG2 (1k¢åwfBJZ^[, 2]O): ]_oOȬ 2019/11; 29 (11): 1190-6.
310031. [Çáñ] Characteristics of Recurrent Congenital Sinus Pericranii: Case Report and Review of the Literature. Tamura G, Ogiwara H, Morota N1: Pediatr Neurosurg 2019/8; 54 (4): 265-9. (tcMl1: 1]O)
320019. [Çáñ] jô®¬áÉηéÇà¡ÃãÉñÂÇ«°Çðǵœ1á. ¬ò°V1,2, R{åã2, Ô@1, ÛŽFº1, ЪSê1, ó@õ1, GrG2 (1~œ, 2]O): ]_oOȬñ 2019/10; 29 (10): 1110-5.
320020. [Çáñ] ÝIªOÉæèå]®¬M2NnÉŒ«®¬á𶶜1á. Ž
@ú1,2, ]O2, cI1,2, ª@GG1,3, GrG1 (1]O, 2¡ls§]²E_oÒÅZ^[, 3k¢åwfBJZ^[): ]_oOÈ 2019/11; 47 (11): 1185-91.
320021. [Çáñ] áâ|à_oâîÉÄff³êœÆ°«schwannomatosisÌ1á. {âaO1, ÄŽêz1, GñêY1, ¢@~2, O}@M2, ìÃq, sºKê, »m3, GrG1: (1]O, 2a, 3®O): ]_oOÈ 2020/1; 48 (1): 71-7.
510007. [à] Oligodendrocyte Progenitor Cells in the Tumor Microenvironment. Hide T1, Komohara Y: Adv Exp Med Biol 202/1; 1234: 107-22. (GñêY1: 1]O)
522052. [uÀ]yCurrent Knowledge: ]OÈúífà ÌHvzJªh[vÌ €ÉRêœtÌðñûµ°õðh~·éHv. Ž
@ú1,2, ]O2, cI1,2, åàV¬V2, ¬ò°V1,3, Öûüq1, GrG1 (1]O, 2¡ls§]²E_oÒÅZ^[, 3~œ): ]_oOȬñ 2019/10; 29 (10): 1104-6.
522053. [uÀ]y]OÈúífÃ: ÌHvzJªh[vÌ €ÉRêœtÌðñûµ°õðh~·éHv. Ž
@ú1, ]O, cI1, åàV¬V, ¬ò°V1,2, Öûüq1, GrG1 (1]O, 2~œ): ]_oOȬñ 2019/10; 29 (10): 1104-6.
522054. [uÀ]yAÚ: ãtH[z¬ÒÅŸ³. A_¢, â{º, Jû ^, ¬Žp÷, vÛcîv, |Ñ€l, tcMl1 (1]O): ÒOÈ 2019/12; 33 (3): 258-266.
[@]
610006. [wp (ªS·M)]yPediatric HydrocephaluszPrenatal Hydrocephalus, p.1-19. Morota N, Editors: Cinalli Giuseppe,
zek MM, Sainte-Rose C, Springer, Switzerland AG, Published: 2019. (tcMl1: 1]O)
620045. [wp (ªS·M)]y]îáOÈ o±µœ¢èp16 X^_[h©çAhoXzIII èpÌÀÛ@[egã[îá] €]ºîá: Jªèp, p.146-60. v{ü^1,2, ª@GG1,2 (1k¢åwfBJZ^[, 2]O), Ò: öŒV, äì[v, WJr
[Ð, , 2019/4s.
620046. [wp (ªS·M)]y]îáOÈ o±µœ¢èp16 X^_[h©çAhoXzIII èpÌÀÛ@[OI[}] Low grade glioma, p.314-29. GrG (]O), Ò: öŒV, äì[v, WJr
[Ð, , 2019/4s.
620047. [wp (ªS·M)]y]_oOÈ üpúÇÌ·×Ä@æ5ÅzIII ]îá@oÁºèp, p.301-14. GrG (]O), Ò: ŒJë¶, cº@W, ¡ªõ, XcŸv, WJr
[Ð, , 2019/5s.
620048. [wp (ªS·M)]y]îáfÃKChC 2019NÅ 2019NÅ@1 ¬l]îáÒE2 ¬]îáÒz2 ¬]îáÒ@1. æff, p.175-80. tcMl1, äŽ@N (1]O), ÄC: ú{]_oOÈwï, Ò: ú{]îáwï, àŽoÅ, , 2019/5s.
[wïE€ï]
711001. [wï (Û)] (ÁÊu) The Chiari malformation. Morota N1: AASPN2019 - 3rd Congress of Asian-Australasian Society for Pediatric Neurosurgery (2019/5/11), Incheon, Korea. (tcMl1: 1]O)
711002. [wï (Û)] (ÁÊu) Epidemiology of cervical spine traumatic lesions in children. Morota N1: The 3rd European Society for Pediatric Neurosurgery Hands-on workshop on craniovertebral junction surgery (2019/6/30), Lyon, France. (tcMl1: 1]O)
711003. [wï (Û)] (ÁÊu) Posterior fossa decompression, when, why and how I perform a duraplasty. Morota N1: The 3rd European Society for Pediatric Neurosurgery Hands-on workshop on craniovertebral junction surgery (2019/7/2), Lyon, France. (tcMl1: 1]O)
711004. [wï (Û)] (ÁÊu) Spinal lipoma and tethered cord - when and what to intervene. Morota N1: Neurosurgeons Association of Sri Lanka Annual Academic Sessions - 2019 (2019/9/29), Colombo, Sri Lanka. (tcMl1: 1]O)
711005. [wï (Û)] (ÁÊu) Complex hydrocephalus and management of shunt complications. Morota N1: Neurosurgeons Association of Sri Lanka Annual Academic Sessions - 2019 (2019/9/29), Colombo, Sri Lanka. (tcMl1: 1]O)
711006. [wï (Û)] (ÁÊu) Neurosurgical management of midline and posterior fossa cyst. Morota N1: Neurosurgeons Association of Sri Lanka Annual Academic Sessions - 2019 (2019/9/29), Colombo, Sri Lanka. (tcMl1: 1]O)
712008. [wï (Û)] (µÒu) Surgery for spinal lipoma: New classification and the use of intraoperative neurophysiology. Morota N1: The 6th Listserv Webinar (The International Pediatric Neurosurgery Series) (2019/9/1), Webinar. (tcMl1: 1]O)
713072. [wï (Û)] (êÊu) Craniovertebral junction surgery associated with craniosynostosis. Morota N1: 47th Annual Meeting of the International Society for Pediatric Neurosurgery (2019/10/21), Birmingham, UK. (tcMl1: 1]O)
713073. [wï (Û)] (|X^[) How to treat the incidental thalamic presumed low-grade gliomas. Kumabe T1, Shibahara I1, Kanamori M, Saito R, Hide T1, Sonoda Y, Tominaga T: The 24th Annual Meeting of the Society for Neuro-Oncology (2019/11/23), Phoenix, USA. (GrG1, ÄŽêz1, GñêY1: 1]O)
713074. [wï (Û)] (|X^[) Immunohistochemical analysis of tumor associated macrophage induced after carmustine wafer implantation in human glioblastoma. Shibahara I1, Miyasaka K1, Sato S1, Inukai M2, Hide T1, Kumabe T1: The 24th Annual Meeting of the Society for Neuro-Oncology (2019/11/24), Phoenix, USA. (ÄŽêz1, {âaO1, ²¡l1, ¢@~2, GñêY1, GrG1: 1]O, 2a)
722076. [wï (S)] (µÒu) {MÌKeyholeEÙ}èpgpÂ\ÈV¬^FIAGONirQ[VVXe. ª@GG1,2, v{ü^1,2, ß¡G¡1,2 (1k¢åwfBJZ^[, 2]O): æ28ñ]_oOÈèpÆ@íwï (CNTT) (2019/4/13), ªR.
722077. [wï (S)] (µÒu) DORO JA[gN^[VXeÌ¢ë¢ëÈAv[`ÖÌgp@. v{ü^1,2, ª@GG1,2, ß¡G¡1,2, GrG2 (1k¢åwfBJZ^[, 2]O): æ28ñ]_oOÈèpÆ@íwï (CNTT) (2019/4/13), ªR.
722078. [wï (S)] (µÒu) ]²îáÌffE¡ÃÌparadigm shiftÆ¡ãÌW]. tcMl (]O): æ47ñú{¬_oOÈwïwpWï (2019/6/14), V.
722079. [wï (S)] (µÒu) ¬ªWèòÅÚsÅèp: »óÆÛè. tcMl (]O): æ34ñú{ÒOÈwï (2019/6/20), Dy.
722080. [wï (S)] (µÒu) Oª|ªžÙW_oäPîEo̹Ç. GrG1, ÄŽêz1, âV¡³Ÿ, àXV, ²¡l1, GñêY1, cF, yiîñ (1]O): æ24ñú{]îáÌOÈwï (2019/9/13), lŒ.
722081. [wï (S)] (µÒu) 2010-2017NÉö\³êœ_¶©çmF³êéoÁºèpÌãÏJ. GrG (]O): æ17ñú{Awake Surgerywï (2019/10/12), åã.
722082. [wï (S)] (µÒu) ªWêèpÉš¯éŒa4 mm ICGàŸÌLp«. GñêY1, Œc@£1, {âaO1, ÄŽêz1, ¬ò°V1, GrG1 (1]O): æ26ñêÊÐc@lú{_oàŸwï (2019/11/8), ¡l.
723354. [wï (S)] (êÊu) Cyanoacrylate Skin Sealantðp¢œÄJªpÌh[sO: ù¶ÌçØJüÌF«ðßéHv. Ž
@Å1, ]O, cI1, GrG1 (1]O): æ12ñú{®e]_oOÈwï (2019/4/13), ªR.
723355. [wï (S)] (êÊu) ®_oîáÌgsubperineuriumhdissectionÉš¯éãR®£xÌLp«. v{ü^1,2, ª@GG1,2, ß¡G¡1,2, GrG2 (1k¢åwfBJZ^[, 2]O): æ28ñ]_oOÈèpÆ@íwï (CNTT) (2019/4/13), ªR.
723356. [wï (S)] (êÊu) JX`]à¯upܯuã]gDZ}Nt@[WÌawI¢. ÄŽêz1, {âaO1, ²¡l1, ¢@~2, Àäü]3, GñêY1, GrG1 (1]O, 2a, 3`Ôn): æ37ñú{]îáawï (2019/6/1), ŒÃ®.
723063. [wï (S)] (|X^[) ]À`¬sSEbîÉCalcifying pseudoneoplasms of the neuroaxis (CAPNON) 𹵜êá. ¢@~1, {âaO2, ÄŽêz2, ²¡l2, GñêY2, O}@M1, GrG2 (1a, 2]O): æ37ñú{]îáawï (2019/6/1), ŒÃ®.
723357. [wï (S)] (êÊu) IDHâ`qÏÙ^¯×EîÌ\ãöq. àXV, nÓÝ©, âV¡³Ÿ, ·cÀ®, ÄŽêz1, cF, GrG1, yiîñ (1]O): æ37ñú{]îáawï (2019/6/1), ŒÃ®.
723358. [wï (S)] (êÊu) áâ|àîáÉηéEop: A±10áÌo±©ç. ÄŽêz1, GñêY1, {âaO1, Œc@£1, ²¡l1, GrG1 (1]O): æ24ñú{]îáÌOÈwï (2019/9/13), lŒ.
723359. [wï (S)] (|X^[) }«ú][ÇÖÌÄJÊÃ@ãßó¬Éº€cortical neural loss Iomazenil SPECTÉæé¢. cI1, R{åã1, ¬ò°V1,2, Ž
@ú1, GrG1 (1]O, 2~œ): ú{]_oOÈwïæ78ñwpï (2019/10/9), åã.
723360. [wï (S)] (êÊu) å²®¬ªÖ^µœäPèî̡ìÑ. cF, ŒcêN, âV¡³Ÿ, àXV, GrG1, yiîñ (1]O): êÊÐc@lú{]_oOÈwïæ78ñwpï (2019/10/9), åã.
723361. [wï (S)] (êÊu) ªWôªîÉηéèpûjÌÏe. v{ü^1,2, ª@GG1,2, ß¡G¡1,2, GrG2 (1k¢åwfBJZ^[, 2]O): ú{]_oOÈwïæ78ñwpï (2019/10/10), åã.
723362. [wï (S)] (|X^[) äPèîÉηéEopEMAf¯uãúËüEe]~h¹pÃ@ãÌîáiW`®Ì¢. ÄŽêz1, {âaO1, Öû©ß2, ÎR2, ²¡l1, GñêY1, GrG1 (1]O, 2úËü (îá)): ú{]_oOÈwïæ78ñwpï (2019/10/10), åã.
723363. [wï (S)] (êÊu) ªWàãóî¡ÃãÌàªåáQEñ«îáE]². àXV, âV¡³Ÿ, cF, GrG1, yiîñ (1]O): êÊÐc@lú{]_oOÈwïæ78ñwpï (2019/10/10), åã.
723364. [wï (S)] (êÊu) k¢åwa@ÌðñûÃ@Éš¯é]Çà¡ÃãÌ«ơìÑ. R{åã1, äåã2, Oä@É2, Œc@£1, {âaO1, ÄŽêz1, mØ@~1, caMq1, ¬ò°V1,3, ó@õ3, ŒRa2, GrG1 (1]O, 2]_oà, 3~œ): ú{]_oOÈwïæ78ñwpï (2019/10/11), åã.
723365. [wï (S)] (|X^[) ªWêîáÉηéŒÈ¯èpÌÓ`ÆLp«. GñêY1, {âaO1, caMq1, Œc@£1, ÄŽêz1, ²¡l1, Rº@ñ2, GrG1 (1]O, 2š@ôAEªèòO): ú{]_oOÈwïæ78ñwpï (2019/10/11), åã.
723366. [wï (S)] (|X^[) `^v[gðgpµÈ¢œßÌJªÌHv: ÁÉ¢jô]®¬áNbsOpÉš¢Ä. ¬ò°V1, R{åã1, caMq1, Œc@£1, {âaO1, Ž
@ú1, ²¡l1, GñêY1, GrG1 (1]O): ú{]_oOÈwïæ78ñwpï (2019/10/11), åã.
723367. [wï (S)] (|X^[) JªîáEopÉš¯éºMEPÌLp«. ²¡l1, ÄŽêz1, {âaO1, GñêY1, ¬ìàVTç2, GrG1 (1]O, 2Õ): ú{]_oOÈwïæ78ñwpï (2019/10/11), åã.
723368. [wï (S)] (|X^[) ôR©³êœá««x_oäPŽ³êé°aÏÉεĢ©É¡Ãîü·é©? GrG1, ÄŽêz1, àXV, âV¡³Ÿ, GñêY1, ²¡l1, cF, yiîñ (1]O): ú{]_oOÈwïæ78ñwpï (2019/10/11), åã.
723369. [wï (S)] (êÊu) Grade 2/3 _oäPîáÉš¯éIDHÏÙÆîáÖAÄñ©ñšæÑ[ìðÇÉ¢ÄÌ¢. ·cj®, âV¡³Ÿ, ¯iñå, ·ìëu, ÄŽêz1, àXV, cF, GrG1, nç³Ý©, yiîñ (1]O): êÊÐc@lú{]_oOÈwïæ78ñwpï (2019/10/11), åã.
723370. [wï (S)] (êÊu) sKÈ]AðÆÁœ_oAXyMXÇÌ1á. Œc@£1, GñêY1, {âaO1, caMq1, ¢@~2, GrG1 (1]O, 2a): æ26ñêÊÐc@lú{_oàŸwï (2019/11/7), ¡l.
723371. [wï (S)] (êÊu) ªWôªîÉηéèpûjÌÏe. v{ü^1,2, ª@GG1,2, ß¡G¡1,2 (1k¢åwfBJZ^[, 2]O): æ26ñêÊÐc@lú{_oàŸwï (2019/11/8), ¡l.
723372. [wï (S)] (|X^[) ]ÇBeÉæéoßÏ@É©RÁžµœd®Ã¬á3áÌ¢. mØ@~ (]O): æ35ñNPO@lú{]_oÇà¡Ãwïwpï (2019/11/22), ª.
723373. [wï (S)] (êÊu) k¢åwa@ÌðñûÃ@Éš¯é]Çà¡ÃãÌ«ơìÑ. R{åã (]O): æ35ñNPO@lú{]_oÇà¡Ãwïwpï (2019/11/23), ª.
723374. [wï (S)] (êÊu) }«ú][ÇÖÌÄJÊÃ@ãßó¬Éº€_o×EE. cI1, R{åã1, ¬ò°V1,2, Ž
@ú1, GrG1 (1]O, 2~œ): æ62ñú{]zÂãÓwïwpWï (2019/11/30), åä.
731027. [wï (€ïEnûï)] (ÁÊu) NTRKZâ`qz«Å`àÉηéGkgN`ju: ]îá¡ÃÖÌúÒ. GrG (]O): ·è]îá¡ÃJt@X (2019/9/19), ·è.
731028. [wï (nûïE€ï)] (ÁÊu) NTRKZâ`qz«Å`àÉηéGkgN`ju: ]îá¡ÃÖÌúÒ. GrG (]O): ·è]îá¡ÃJt@X (2019/9/19), ·è.
731029. [wï (nûïE€ï)] (ÁÊu) œèpÉæé¬]îáÇRg[. GrG (]O): ÝñÈÅwÚ€««]îá (2020/1/10), s.
733135. [wï (€ïEnûï)] (êÊu) ®_oîáèpÉš¢Ä쎹ÆçÊ_oáðð¯éœßÉ. v{ü^1,2, ª@GG1,2, ß¡G¡1,2, GrG2 (1k¢åwfBJZ^[, 2]O): æ28ñú{®_oîá€ï (2019/6/8), .
733136. [wï (€ïEnûï)] (êÊu) sKÈ]AðÆÁœ_oAXyMXÇÌ1á. Œc@£1, GñêY1, {âaO1, caMq1, ¢@~2, GrG1 (1]O, 2a): æ139ñú{]_oOÈwïÖxï (2019/9/21), .
733137. [wï (nûïE€ï)] (êÊu) ffÉ궵sKÈ]AðÆÁœ_oAXyMXÇÌ1á. Œc@£1, GñêY1, {âaO1, caMq1, ¢@~2, GrG1 (1]O, 2a): æ139ñú{]_oOÈwïÖxï (2019/9/21), .
733138. [wï (€ïEnûï)] (êÊu) ]®Ã¬ï`jôÉæé]àoÉηé}«ú_oàŸºîpã, Çà¡ÃšæÑŒBpðsÁœ2Çá. ¬ò°V1,2, R{åã2, GñêY2, GrG2 (1~œ, 2]O): æ32ñ_Þì]_oOÈèpèZ€ï (2020/1/18), ¡l.
'18NxÈOª
[wïE€ï]
'18-711001. [wï (Û)] (ÁÊu) Septostomy: Anatomy and indications. Morota N1: IFNE-JSNE-GLEN-ISNE Hands-on workshop on cerebral and ventricular neuroendoscopy (2019/1/21), Naples, Italy. (tcMl1: 1]O)
'18-711002. [wï (Û)] (ÁÊu) Intravetrivular, quadrigeminal and posterior fossa cysts: endoscopic surgical technique. Morota N1: IFNE-JSNE-GLEN-ISNE Hands-on workshop on cerebral and ventricular neuroendoscopy (2019/1/22), Naples, Italy. (tcMl1: 1]O)
'18-731001. [wï (nûïE€ï)] (ÁÊu) ¬ªWèòÅÚsaÏÌOÈ¡Ã. tcMl (]O): æ26ñ€mÒÅÒŸ³€ïwpuï (2019/2/21), ŒÃ®.
¬Èw
[wp_¶]
110218. [Ž] Toll-Like Receptor 9 Plays a Pivotal Role in Angiotensin II-Induced Atherosclerosis. Fukuda D, Nishimoto S, Aini K, Tanaka A, Nishiguchi T, Kim-Kaneyama JR, Lei XF, Masuda K, Naruto T, Tanaka K, Higashikuni Y, Hirata Y1, Yagi S, Kusunose K, Yamada H, Soeki T, Imoto I, Akasaka T, Shimabukuro M, Sata M: J Am Heart Assoc 2019/4; 8 (7): e010860. (œczêY1: 1¬)
110219. [Ž] Lisinopril versus lisinopril and losartan for mild childhood IgA nephropathy: a randomized controlled trial (JSKDC01 study). Shima Y1, Nakanishi K1, Sako M1, Saito-Oba M1, Hamasaki Y1, Hataya H1, Honda M1, Kamei K1, Ishikura K1,2, Ito S1, Kaito H1, Tanaka R1, Nozu K1, Nakamura H1, Ohashi Y1, Iijima K1, Yoshikawa N1 (1Japanese Study Group of Kidney Disease in Children (JSKDC)): Pediatr Nephrol 2019/5; 34 (5): 837-46. (Îqi1,2: 2¬)
110220. [Ž] Clinicopathological features of TAFRO syndrome complicated by acquired hemophilia A and development of cardiopulmonary arrest that were successfully treated with VA-ECMO and tocilizumab. Suzuki K, Matsumoto T, Iwashita Y, Ishikura K1, Fujioka M, Wada H, Katayama N, Imai H: Int J Hematol 2019/6; 109 (6): 737-43. (Îqi1: 1¬)
110221. [Ž] Evaluation of the optimal timing of VATS-PDA in preterm infants before 28 weeks of gestation. Kemmochi M1, Senzaki H1,2, Miyaji K3, Hashimoto M1, Yamaguchi A1, Ooka M1, Yokozeki Y1, Ishii M1: Pediatr Int 2019/6. DOI: 10.1111/ped.13909 (çÝ@w1, æèGŸ1,2, {n@Ó3, Ž{èvü1, Rû»T1, åª1, ¡ÖSêY1, Îä³_1: 1¬, 2V¢IãÃEæ[ãÃ, 3SÇO)
110222. [Ž] Cardiac Rhythm Disturbances in Heterotaxy Syndrome. Ozawa Y, Asakai H, Shiraga K, Shindo T, Hirata Y1, Hirata Y, Inuzuka R: Pediatr Cardiol 2019/6; 40 (5): 909-13. (œczêY1: 1¬)
110223. [Ž] Estimated GFR at Dialysis Initiation and Mortality in Children and Adolescents. Okuda Y1, Soohoo M, Tang Y, Obi Y, Laster M, Rhee CM, Streja E, Kalantar-Zadeh K: Am J Kidney Dis 2019/6; 73 (6): 797-805. (cYî1: 1¬)
110224. [Ž] Nurses' perceptions regarding transitional care for adolescents and young adults with childhood-onset chronic diseases. Suzuki S, Kita S, Morisaki M, Kikuchi R, Sato I, Iwasaki M, Otomo E, Sekiguchi H, Hirata Y1, Sato A, Sugiyama M, Kamibeppu K: Jpn J Nurs Sci 2020/7; 17 (3): e12323. (œczêY1: 1¬)
110225. [Ž] Association between the clinical presentation of congenital anomalies of the kidney and urinary tract (CAKUT) and gene mutations: an analysis of 66 patients at a single institution. Ishiwa S, Sato M, Morisada N, Nishi K, Kanamori T, Okutsu M, Ogura M, Sako M, Kosuga M, Kamei K, Ito S, Nozu K, Iijima K, Ishikura K1: Pediatr Nephrol 2019/8; 34 (8): 1457-64. (Îqi1: 1¬)
110226. [Ž] Favorable Kidney Function in Pediatric Liver Transplant Recipients: Results of a Single-center Cohort Study. Sato M, Kaneko T, Ogura M, Kamei K, Ito S, Fukuda A, Sakamoto S, Kasahara M, Ishikura K1: Transplantation 2019/8; 103 (8): 1655-62. (Îqi1: 1¬)
110227. [Ž] Study protocol: multicenter double-blind, randomized, placebo-controlled trial of rituximab for the treatment of childhood-onset early-stage uncomplicated frequently relapsing or steroid-dependent nephrotic syndrome (JSKDC10 trial). Nagano C, Sako M, Kamei K, Ishikura K1, Nakamura H, Nakanishi K, Omori T, Nozu K, Iijima K: BMC Nephrol 2019/8; 20 (1): 293. (Îqi1: 1¬)
110228. [Ž] Optimal timing of video-assisted thoracoscopic surgery for patent ductus arteriosus in preterm infants born at £ 28 weeks of gestation. Kemmochi M1, Senzaki H1,2, Miyaji K3, Hashimoto M1, Yamaguchi A1, Ooka M1, Yokozeki Y1, Ishii M1: Pediatr Int 2019/8; 61 (8): 792-6. (@w1, æèGŸ1,2, {n@Ó3, Ž{èvü1, Rû»T1, åª1, ¡ÖSêY1, Îä³_1: 1¬, 2V¢IãÃEæ[ãÃ, 3SÇO)
110229. [Ž] Detailed clinical manifestations at onset and prognosis of neonatal-onset Denys-Drash syndrome and congenital nephrotic syndrome of the Finnish type. Nishi K, Inoguchi T, Kamei K, Hamada R, Hataya H, Ogura M, Sato M, Yoshioka T, Ogata K, Ito S, Nakanishi K, Nozu K, Hamasaki Y, Ishikura K1: Clin Exp Nephrol 2019/8; 23 (8): 1058-65. (Îqi1: 1¬)
110230. [Ž] Fenestration in the Fontan circulation as a strategy for chronic cardioprotection. Saiki H1, Kuwata S1, Iwamoto Y, Ishido H, Taketazu M, Masutani S, Nishida T1, Senzaki H1,2: Heart 2019/8; 105 (16): 1266-72. (âVØG¶1, øvc¹q1, Œc®j1, æèGŸ1,2: 1¬, 2V¢IãÃEæ[ãÃ)
110231. [Ž] Clinical characteristics of HNF1B-related disorders in a Japanese population. Nagano C, Morisada N, Nozu K, Kamei K, Tanaka R, Kanda S, Shiona S, Araki Y, Ohara S, Matsumura C, Kasahara K, Mori Y, Seo A, Miura K, Washiyama M, Sugimoto K, Harada R, Tazoe S, Kourakata H, Enseki M, Aotani D, Yamada T, Sakakibara N, Yamamura T, Minamikawa S, Ishikura K1, Ito S, Hattori M, Iijima K: Clin Exp Nephrol 2019/9; 23 (9): 1119-29. (Îqi1: 1¬)
110232. [Ž] Prognosis and acute complications at the first onset of idiopathic nephrotic syndrome in children: a nationwide survey in Japan (JP-SHINE study). Sato M, Ishikura K1, Ando T, Kikunaga K, Terano C, Hamada R, Ishimori S, Hamasaki Y, Araki Y, Gotoh Y, Nakanishi K, Nakazato H, Matsuyama T, Iijima K, Yoshikawa N, Ito S, Honda M: Nephrol Dial Transplant 2019/9; gfz185. doi: 10.1093/ndt/gfz185. Online ahead of print. (Îqi1: 1¬)
110233. [Ž] Vildagliptin, a DPP-4 Inhibitor, Attenuates Endothelial Dysfunction and Atherogenesis in Nondiabetic Apolipoprotein E-Deficient Mice. Aini K, Fukuda D, Tanaka K, Higashikuni Y, Hirata Y1, Yagi S, Kusunose K, Yamada H, Soeki T, Sata M: Int Heart J 2019/11; 60 (6): 1421-9. (œczêY1: 1¬)
110234. [Ž] Ultrafiltration Rate Effects Declines in Residual Kidney Function in Hemodialysis Patients. Lee Y, Okuda Y1, Sy J, Kim SR, Obi Y, Kovesdy CP, Rhee CM, Streja E, Kalantar-Zadeh K: Am J Nephrol 2019/10; 50 (6): 481-8. (cYî1: 1¬)
110235. [Ž] Serum albumin and hospitalization among pediatric patients with end-stage renal disease who started dialysis therapy. Okuda Y1, Obi Y, Streja E, Laster M, Rhee C, Langman CB, Jernigan SM, Salusky IB, Tentori F, Schreiber MJ, Brunelli SM, Kalantar-Zadeh K: Pediatr Nephrol 2019/10; 34 (10): 1799-809. (cYî1: 1¬)
110236. [Ž] Brain-type natriuretic peptide level in pregnant women with congenital heart disease predicts SGA offspring. Ishida S1, Uchiyama A, Imai K, Kusuda S: Pediatr Int 2019/12; 61 (12): 1221-6. (Îc@i1: 1¬)
110237. [Ž] Association of Mineral Bone Disorder With Decline in Residual Kidney Function in Incident Hemodialysis Patients. Lee YJ, Okuda Y1, Sy J, Obi Y, Kang DH, Nguyen S, Hsiung JT, Park C, Rhee CM, Kovesdy CP, Streja E, Kalantar-Zadeh K: J Bone Miner Re. 2020/2; 35 (2): 317-25. (cYî1: 1¬)
110238. [Ž] Biodegradable Extremely-Small-Diameter Vascular Graft Made of Silk Fibroin can be Implanted in Mice. Tanaka K, Fukuda D, Higashikuni Y, Hirata Y1, Komuro I, Saotome T, Yamashita Y, Asakura T, Sata M: J Atheroscler Thromb 2020/2. doi: 10.5551/jat.52720. Online ahead of print. (œczêY1: 1¬)
110239. [Ž] Levels of Adiponectin Expression in Peri-Renal and Subcutaneous Adipose Tissue and Its Determinants in Human Biopsied Samples. Maimaituxun G, Fukuda D, Izaki H, Hirata Y1, Kanayama HO, Masuzaki H, Sata M, Shimabukuro M: Front Endocrinol (Lausanne) 2020/2; 10: 897. (œczêY1: 1¬)
110240. [Ž] Both the rituximab dose and maintenance immunosuppression in steroid-dependent/frequently-relapsing nephrotic syndrome have important effects on outcomes. Chan EY, Webb H, Yu E, Ghiggeri GM, Kemper MJ, Ma AL, Yamamura T, Sinha A, Bagga A, Hogan J, Dossier C, Vivarelli M, Liu ID, Kamei K, Ishikura K1, Saini P, Tullus K: Kidney Int 2020/2; 97 (2): 393-401. (Îqi1: 1¬)
110241. [Ž] Long-term outcomes of pediatric kidney transplantation: A single-center experience over the past 34 years in Japan. Aoki Y, Hamasaki Y, Satoh H, Matsui Z, Muramatsu M, Hamada R, Harada R, Ishikura K1, Hataya H, Honda M, Sakai K, Shishido S: Int J Urol 2020/2; 27 (2): 172-8. (Îqi1: 1¬)
110242. [Ž] Primary causes of kidney disease and mortality in dialysis-dependent children. Okuda Y1, Soohoo M, Ishikura K1, Tang Y, Obi Y, Laster M, Rhee CM, Streja E, Kalantar-Zadeh K: Pediatr Nephrol 2020/5; 35 (5): 851-60. doi: 10.1007/s00467-019-04457-7. Epub 2020 Feb 4. (cYî1, Îqi1: 1¬)
110243. [Ž] Ultrafiltration Rate, Residual Kidney Function, and Survival Among Patients Treated With Reduced-Frequency Hemodialysis. Lee YJ, Okuda Y1, Sy J, Lee YK, Obi Y, Cho S, Chen JLT, Jin A, Rhee CM, Kalantar-Zadeh K, Streja E: Am J Kidney Dis 2020/3; 75 (3): 342-50. (cYî1: 1¬)
110244. [Ž] Kidney function of Japanese children undergoing kidney transplant with preemptive therapy for cytomegalovirus infection. Gotoh Y, Shishido S, Hamasaki Y, Watarai Y, Hattori M, Miura K, Ishizuka K, Fujita N, Saito K, Nakagawa Y, Hotta K, Hataya H, Hamada R, Sato H, Kitayama H, Ishikura K1, Honda M, Uemura O: Transpl Infect Dis 2020/6; 22 (3): e13271. doi: 10.1111/tid.13271. Epub 2020 Mar 11. (Îqi1: 1¬)
110245. [Ž] Nonosmotic secretion of arginine vasopressin and salt loss in hyponatremia in Kawasaki disease. Miura K, Harita Y, Takahashi N, Tsurumi H, Yasudo H, Isojima T, Hirata Y1, Inuzuka R, Takizawa K, Toyofuku E, Nishimoto H, Takamizawa M, Ando T, Sugawa M, Yanagisawa A, Inatomi J, Nogimori Y, Kinumaki A, Namai Y, Hattori M, Oka A: Pediatr Int 2020/3; 62 (3): 363-70. (œczêY1: 1¬)
110246. [Ž] Noonan syndrome-associated biallelic LZTR1 mutations cause cardiac hypertrophy and vascular malformations in zebrafish. Nakagama Y, Takeda N, Ogawa S, Takeda H, Furutani Y, Nakanishi T, Sato T, Hirata Y1, Oka A, Inuzuka R: Mol Genet Genomic Med 2020/3; 8 (3): e1107. (œczêY1: 1¬)
110247. [Ž] Hypoxic activation of glucose-6-phosphate dehydrogenase controls the expression of genes involved in the pathogenesis of pulmonary hypertension through the regulation of DNA methylation. Joshi SR, Kitagawa A1, Jacob C, Hashimoto R, Dhagia V, Ramesh A, Zheng C, Zhang H, Jordan A, Waddell I, Leopold J, Hu CJ, McMurtry IF, D'Alessandro A, Stenmark KR, Gupte SA: Am J Physiol Lung Cell Mol Physiol 2020/4; 318 (4): L773-86. doi: 10.1152/ajplung.00001.2020. Epub 2020 Mar 11. (kìÄj1: 1¬)
110248. [Ž] Recombinant Measles AIK-C Vaccine Strain Expressing Influenza HA Protein. Ito T1, Kumagai T, Yamaji Y, Sawada A, Nakayama T: Vaccines (Basel) 2020/3; 8 (2): 149. (É¡®u1: 1¬)
120008. [Ž] V¶e}EXZx_f\IxáQfÉš¯éxE÷¬ÇáQÌ`ÔwIÁ¥. ŒGF1,2 (1V¢IãÃEæ[ãÃ, 2¬): qãÈåwG 2019/7; 89 (Extra1): E123]33.
310032. [Çáñ] No preventive or therapeutic efficacy of infliximab against macrophage activation syndrome due to systemic juvenile idiopathic arthritis. Kiuchi Z, Ogura M, Sato M, Kamei K, Ishikura K1, Abe J, Ito S: Scand J Rheumatol 2019/5; 48 (3): 246-8. (Îqi1: 1¬)
310033. [Çáñ] Successful salvage of the left pulmonary artery in a neonate with isolated unilateral absence of the pulmonary artery. Kawada K, Saiki H1, Kemmochi M1, Kuwata S, Takanashi M1, Miyaji K2, Senzaki H1,3: J Cardiol Cases 2020/1; 21 (5): 169-71. (âVØG¶1, @w1, @w1, {n@Ó2, æèGŸ1,3: 1¬, 2SÇO, 3V¢IãÃEæ[IãÃ)
320022. [Çáñ] ŒÌ`¬«tð浜C3tÌ4Î. TäGê, ²¡@, àX@§, ÃüÄ, Îa@ãÄ, ŒŸN, ¬žëv, àVärG, cYî1, `ªFq, ûªŸY, Îqi1 (1¬): ú{¬tsSwïG 2019/7; 39: 119-22.
320023. [Çáñ] ³Çó«`AÌžžÅWT1â`qÙíª»Ÿµœ17Îá. àX@§, TäGê, ŒŸN, ÃüÄ, Îa@ãÄ, ²¡@, ¬žëv, É¡Gê, Œ[Ÿ, ìðå, Ñêœ, Îqi1 (1¬): ú{¬tsSwïG 2019/7; 39: 207-10.
510008. [à] Treatment guidelines for persistent cloaca, cloacal exstrophy, and Mayer-Rokitansky-K?ster-H?user syndrome for the appropriate transitional care of patients. Kubota M, Osuga Y, Kato K, Ishikura K1, Kaneko K, Akazawa K, Yonekura T, Tazuke Y, Ieiri S, Fujino A, Ueno S, Hayashi Y, Yoshino K, Yanai T, Iwai J, Yamaguchi T, Amae S, Yamazaki Y, Sugita Y, Kohno M, Kanamori Y, Bitoh Y, Shinkai M, Ohno Y, Kinoshita Y: Surg Today 2019/12; 49 (12): 985-1002. (Îqi1: 1¬)
510009. [à] Rituximab therapy for refractory steroid-resistant nephrotic syndrome in children. Kamei K, Ishikura K1, Sako M, Ito S, Nozu K, Iijima K: Pediatr Nephrol 2020/1; 35 (1): 17-24. (Îqi1: 1¬)
510010. [à] History and Future of Treatment for Acute Stage Kawasaki Disease. Ishii M, Ebato T1, Kato H: Korean Circ J 2020/2; 50 (2): 112-19. (]gËFã1: 1¬)
520010. [à] ¬s«ØÉÇÆqgpRECX. ÎcÏç, äGK1, äGŒ1, yò@œ1, ìXcL1, âèrV1, Îqi1, ìXRl, ²ìMq (1¬): ¬È 2019/9; 60 (10): 1395-400.
522055. [uÀ]yÁW: V¶EûÌçazÕ°á: ûcúÉǵœï¡«Ìá. ]gËFã1, âRI1,2 (1¬, 2k¢åwfBJZ^[): çafà 2019/5; 41 (5): 453-6.
522056. [uÀ]yV¶ÌÄzáQ ÇóE¶ãÔÊųŠéÎÌRcz_: V¶ÌÄzÌÁ¥. ŒGF1,2 (1V¢IãÃEæ[ãÃ, 2¬): with NEO 2019/8; 32 (4): 496-9.
522057. [uÀ]yV|WE: XyVXgÉ·! ¬§ÍÅìEw±ÌRczêqÌ€
`ƒ
ÚµœûúÉ éPD³ÒÌÅì. Œc²q, ²¡@, ¬žëv, TäGê, Îqi1 (1¬): ú{¬PDEHD€ïG 2019/10; 31: 17-21.
522058. [uÀ]yÁW: ""with NEO"" Update ""Ž"" í©é! gŠé! V¶ÌtKXžzV¶ÌtKXîl/Ùíl©ç\ªµŸéaÔ/V¶ÌtKXpêê. ŒGF1,2 (1V¢IãÃEæ[IãÃ, 2¬): with NEO 2020/2; 33 (1): 6-7.
522059. [uÀ]yÁW: ""with NEO"" Update ""Ž"" í©é! gŠé! V¶ÌtKXžzv[O €|qƱÕ|Ìoï¢. ŒGF1,2 (1V¢IãÃEæ[IãÃ, 2¬): with NEO 2020/2; 33 (1): 8.
522060. [uÀ]yÁW: ""with NEO"" Update ""Ž"" í©é! gŠé! V¶ÌtKXžz1. ܞͱ±©ç! tKXÊðÇÞœßÉÍ. ŒGF1,2 (1V¢IãÃEæ[IãÃ, 2¬): with NEO 2020/2; 33 (1): 9-19.
522061. [uÀ]yÁW: ""with NEO"" Update ""Ž"" í©é! gŠé! V¶ÌtKXžz6. ÀH! (2) V¶tKX©çœªí©é? ǀ⳷é? Îc@i1 (1¬): with NEO 2020/2; 33 (1): 52-62.
522062. [uÀ]yÁW: ""with NEO"" Update ""Ž"" í©é! gŠé! V¶ÌtKXžz7. ÀH! (3) tKXðÇñÅÝæ€. ŒGF1,2 (1V¢IãÃEæ[IãÃ, 2¬): with NEO 2020/2; 33 (1): 64-78.
522063. [uÀ]yÁW: ""with NEO"" Update ""Ž"" í©é! gŠé! V¶ÌtKXžzGs[O èªÆ€, ±Õ|. ŒGF1,2 (1V¢IãÃEæ[IãÃ, 2¬): with NEO 2020/2; 33 (1): 79.
[@]
620049. [wp (ªS·M)]y¬ ê~}}j
A|AîÂ\©? ñ~}©? »fÌœßÌèø«|(¬È2019N4Õ§)z3. ê~}ÅÝçêéåÈŸ³@tEåAíÌæ, p.742-7. àX@§, ·JìYê, Îqi1 (1¬), àŽoÅ, , 2019/4s.
620050. [wp (ªS·M)]y¬Ì×±2019 (¬àÈ4å)z[t@\ž]@ú{l¬ÌeGFRÌZo@|NA`j, VX^`C, À2~NOu|, p.539-41. àX@§, Îqi1 (1¬), ãwÐ, , 2019/4s.
620051. [wp (ªS·M)]y±êÅí©é, V¶ÄzÇ (üYúãw4å)z<ÄzÇÌÀÛ>@lHÄzíÉæéÄzÇ@CLiO2: closed-loop inspired oxygen, p.430-5. ŒGF1,2 (1V¢IãÃEæ[ãÃ, 2¬), ãwÐ, , 2019/4s.
620052. [wp (ªS·M)]y¬ÌfÃèZ (¬ÈfÃ82ª§)zI. ~œ@M
̬Éηéê~œu, p.33-6. ìì (¬), ffÆ¡ÃÐ, , 2019/4s.
620053. [wp (ªS·M)]ySsS (æ2Å) º|ÅVÌîbEÕ°€Ìià| (ú{Õà¬77ª§2)zXXII. »ÌŒaÔENîwÌSsSÌÕ°I@2. ¢nEV¶SsS (Sàï`ðºíÈ¢), p.496-502. Îc@i1, ÖJ¢À1, yòüv1, ìcFœ1, @w1, æèGŸ1,2 (1¬, 2V¢IãÃEæ[ãÃ), ú{Õà¬Ð, , 2019/5s.
620054. [wp (ªS·M)]ywèïayfBA2019 (ú{ãtïG148ªEÁÊ (1))zIII. ÂÊÌwèïa@F. zÂín@14. Sºu¹Çðº€x®¬ÂœÇ [wèïa214], p.217-8. @w1, æèGŸ1,2 (1¬, 2V¢IãÃEæ[IãÃ), ú{ãtï, , 2019/6s.
620055. [wp (ªS·M)]ywèïayfBA2019 (ú{ãtïG148ªEÁÊ (1))zIII. ÂÊÌwèïa@H. tEåAín@12. MEFCEgÇóQ [wèïa219], p.251. ËûTN, Îqi1 (1¬), ú{ãtï, , 2019/6s.
620056. [wp (ªS·M)]yàÈw üùæ9Å (Vol.3 zÂퟳ)z11. æV«SŸ³@~gRhASØÇ, p.255-6. äGŒ1, æèGŸ1,2 (1¬, 2V¢IãÃEæ[IãÃ), RX, , 2019/8s.
620057. [wp (ªS·M)]yàÈw üùæ9Å (Vol.3 zÂퟳ)z11. æV«SŸ³@æV«mXÙŸ³ (æV«mXÙ·óÇ, æV«mXÙÂœsSÇ), p. 256-7. @w1, æèGŸ1,2 (1¬, 2V¢IãÃEæ[IãÃ), RX, , 2019/8s.
620058. [wp (ªS·M)]yüYúk310 šê³ñÖÌñ}j
A æ3Å (üYúãw2019N49ª§)zV¶¥ûÒ@III.åA¶Bí@¡¶ã1J @Q203. š¿ñ¿ñÌæÌçªÔîêĢܷª?, p.467-68. åª1, ŒGF1,2 (1¬, 2V¢IãÃEæ[IãÃ), ãwÐ, , 2019/12s.
620059. [wp (ªS·M)]yüYúk310 šê³ñÖÌñ}j
A æ3Å (üYúãw2019N49ª§)zV¶¥ûÒ@III.åA¶Bí@¡¶ã1J @Q204. jÌqÌpCÍÆÁœÙ€ªæ¢Å·©? »Ìû@Í?, p.469-70. åª1, ŒGF1,2 (1¬, 2V¢IãÃEæ[IãÃ), ãwÐ, , 2019/12s.
[wïE€ï]
711007. [wï (Û)] (ÁÊu) Role of nasal high flow post-extubation in neonates-Current status in Japan-. Nakanishi H1,2: International Meeting Pediatric and neonatal nasal high flow (2019/4/13-14), New Deli, India. (ŒGF1,2: 1V¢IãÃEæ[ãÃ, 2¬)
712009. [wï (Û)] (V|WE) Epidemiology of CKD and ESKD according to Registry data Data from the Japanese Registry. Ishikura K1: IPNA2019 (2019/10/17-21), Venice, Italy. (Îqi1: 1¬)
713075. [wï (Û)] (êÊu) WT1 gene mutation might cause thrombotic microangiopathy which is not responsive to Eculizumab. Tomari K, Terano C, Hamada R, Okuda Y1, Harada R, Nozu K, Ishikura K1, Hataya H, Iijima K, Ogata K, Joseph L Alge, Honda M: The 17th China-Japan-Korea Pediatric Nephrology Seminar 2019 (2019/4/13), Hangzhou, China. (cYî1, Îqi1: 1¬)
713076. [wï (Û)] (|X^[) Rasmussen syndrome: Assessment of clinical features in patients with different intellectual levels. Toki T1, Shimizu-Motohashi Y, Sumitomo N, Takeshita E, Ishiyama A, Saito T, Sugai K, Komaki H, Nakagawa E, Sasaki M: Child Neuro 2019 in Nagoya (The 20th annual meeting of infantile seizure society) (2019/5/31-6/2), Nagoya, Japan. (yò@œ1: 1¬)
713077. [wï (Û)] (|X^[) A case of fatal legionella pneumonia during ACTH therapy for West syndrome. Toki T1, Shirai H1, Nonoda Y1, Iwasaki T1: Child Neuro 2019 in Nagoya (The 20th annual meeting of infantile seizure society) (2019/5/31-6/2), Nagoya, Japan. (yò@œ1, äGŒ1, ìXcL1, âèrV1: 1¬)
713078. [wï (Û)] (êÊu) Trends in the incidence and pathology of pedi-atric PD peritonitis: a single center experience spanning 30 years. Hamada R, Hataya H, Inoguchi T, Terano C, Harada R, Aoki Y, Sato H, Hamasaki Y, Ishikura K1, Honda M: The 9th Asia Pacific Chapter Meeting of International Society for Peritoneal Dialysis (APCM-ISPD2019) (2019/9/5-7), Nagoya, Japan. (Îqi1: 1¬)
713079. [wï (Û)] (êÊu) Subepithelial electron-dense deposits do not predict treatment response in C3 Glomerulopathy. Tomari K, Hamada R, Omori N, Mikami N, Anno A, Shimabukuro W, Shirane S, Inoguchi T, Okuda Y1, Terano C, Harada R, Hamasaki Y, Ishikura K1, Hataya H, Honda M: IPNA2019 (2019/10/17-21), Venice, Italy. (cYî1, Îqi1: 1¬)
713080. [wï (Û)] (êÊu) Adolescent age and risk of first and subsequent allograft failure among pediatric kidney transplant recipients. Okuda Y1, Streja E, Rhee CM, Tantisattamo E, Reddy U, Laster M, Tang Y, Rajpoot D, Molnar MZ, Ichii H, Obi Y, Kalantar-Zadeh K: IPNA2019 (2019/10/17-21), Venice, Italy. (cYî1: 1¬)
713081. [wï (Û)] (êÊû) Predictors of Kidney and liver morbidity in patients with autosomal recessive polycystic Kidney disease. Sato M, Ishikura K1, Ogura M, Nishi K, Kanamori T, Kamae C, Suzuki R, Murakoshi M, Sako M, Ito Sakamoto S, Kasahara M, Kamei K: IPNA2019 (2019/10/17-21), Venice, Italy. (Îqi1: 1¬)
713082. [wï (Û)] (|X^[) Intelligence quotient in eskd children: comparison between pre-emptive Kidney transplantation and transplantation after dialysis. Kikunaga K, Hamada R, Inoguchi T, Terano C, Harada R, Hamasaki Y, Ishikura K1, Hataya H, Matsuyama T, Honda M: IPNA2019 (2019/10/17-21), Venice, Italy. (Îqi1: 1¬)
713083. [wï (Û)] (|X^[) A cross-sectional nationwide survey of congenital and infantile nephrotic syndrome in Japan. Hamasaki Y, Hamada R, Matsumoto S, Muramatsu M, Aya K, Ishikura K1, Iijima K: IPNA2019 (2019/10/17-21), Venice, Italy. (Îqi1: 1¬)
713084. [wï (Û)] (|X^[) Presenting clinical features of pediatric renovascular hypertension at diagnosis: a single-center experience fromjapan. Inoguchi T, Hamada R, Anno A, Shimabukuro W, Shirane S, Tomari K, Akamine K, Terano C, Harada R, Hamasaki Y, Hataya H, Ishikura K1, Honda M: IPNA2019 (2019/10/17-21), Venice, Italy. (Îqi1: 1¬)
713085. [wï (Û)] (|X^[) Prospective examinationof relationship between clinical features and relapse of Nephrotic syndrome after flu vaccines. Ishimori S, Horinouchi T, Fujimura J, Minamikawa S, Yamamura T, Matsunoshita N, Kamiyoshi N, Ogura M, Kaito H, Nozu K, Kamei K, Ishikura K1, Iijima K: IPNA2019 (2019/10/17-21), Venice, Italy. (Îqi1: 1¬)
713086. [wï (Û)] (|X^[) National survey of live attenuated vaccines for patients receiving Immunosuppressive agents or biological agents. Kamei K, Miyairi I, Shoji K, Ishikura K1, Sako M, Nakamura H: IPNA2019 (2019/10/17-21), Venice, Italy. (Îqi1: 1¬)
713087. [wï (Û)] (|X^[) A nation-wide survey of long-term prognosis of epstein syndrome. Miura K, Shirai Y, Kunishima S, Ishiguro A, Hamada R, Ishikura K1, Hattori M: IPNA2019 (2019/10/17-21), Venice, Italy. (Îqi1: 1¬)
713088. [wï (Û)] (|X^[) Strategy for discontinuing steroids in pediatric patients with lupus nephritis: a single center experience. Nishi K, Ogura M, Kamei K, Kanamori T, Ishiwa S, Okutsu M, Sato M, Ishikura K1, Ito S: IPNA2019 (2019/10/17-21), Venice, Italy. (Îqi1: 1¬)
713089. [wï (Û)] (|X^[) Clinical significance of collapsing variant in childhood focal segmental Glomerulosclerosis. Okutsu M, Kamei K, Sato M, Ishiwa S, Kanamori T, Nishi K, Ogura M, Sako M, Ito S, Yoshioka T, Ogata K, Ishikura K1: IPNA2019 (2019/10/17-21), Venice, Italy. (Îqi1: 1¬)
713090. [wï (Û)] (|X^[) C1q nephropathy in siblings with nphs1 gene mutations. Omori T, Kamei K, Nozu K, Ogata K, Takahashi M, Nagano C, Ishikura K1, Iijima K, Misawa M: IPNA2019 (2019/10/17-21), Venice, Italy. (Îqi1: 1¬)
713091. [wï (Û)] (|X^[) Epidemiologyand treatment protocol of henoch-sch?nlein purpura nephritis: a Nationwide survey in japan. Terano C, Hamada R, Kaneko T, Honda M, Koichi N, Ishikura K1: IPNA2019 (2019/10/17-21), Venice, Italy. (Îqi1: 1¬)
713092. [wï (Û)] (|X^[) Neutrophil-to-lymphocyte ratio and hospitalization among pediatric dialysis patients. Tang Y, Okuda Y1, Park C, Hsiung J, Streja E, Wu Y, Kalantar-Zadeh K: IPNA2019 (2019/10/17-21), Venice, Italy. (cYî1: 1¬)
713093. [wï (Û)] (|X^[) A faster decline of residual kidney function and erythropoietin hyporesponsiveness in incident hemodialysis patients. Kimura H, Okuda Y1, Rhee C, Kovesdy CP, Streja E, Kalantar-Zadeh K: American Society of Nephrology Kidney Week 2019 (2019/11/5-10), Washington DC, USA. (cYî1: 1¬)
713094. [wï (Û)] (|X^[) A rapid decline of residual kidney function and anemia in incident hemodialysis patients. Kimura H, Okuda Y1, Rhee C, Kovesdy CP, Streja E, Kalantar-Zadeh K: American Society of Nephrology Kidney Week 2019 (2019/11/5-10), Washington DC, USA. (cYî1: 1¬)
713095. [wï (Û)] (|X^[) Rates of prevalent fracture differ by race and ethnicity in children with CKD. Laster M, Denburg M, Okuda Y1, Kumar J, Furth S, Norris K, Kalantar-Zadeh K, Warady B, Salusky I: American Society of Nephrology Kidney Week 2019 (2019/11/5-10), Washington DC, USA. (cYî1: 1¬)
713096. [wï (Û)] (|X^[) Dietary protein intake, kidney function, and mortality in a nationally representative cohort. Narasaki Y, Okuda Y1, Moore L, You A, Nakata T, Nguyen D, Kalantar-Zadeh K, Rhee C: American Society of Nephrology Kidney Week 2019 (2019/11/5-10), Washington DC, USA. (cYî1: 1¬)
713097. [wï (Û)] (|X^[) Association of lower dietary potassium intake with higher death risk in a prospective hemodialysis cohort. Narasaki Y, Okuda Y1, Kalantar S, You A, Novoa A, Nguyen T, Streja E, Nakata T, Colman S, Nguyen D, Rhee C: American Society of Nephrology Kidney Week 2019 (2019/11/5-10), Washington DC, USA. (cYî1: 1¬)
713098. [wï (Û)] (|X^[) Nonpreemptive vs Preemptive "Second" Kidney Transplant with Graft Failure Risk among Pediatric Kidney Transplant Recipients. Okuda Y1, Rhee CM, Tantisattamo E, Laster M, Tang Y, Rajpoot D, Molnar MZ, Ichii H, Obi Y, Kalantar-Zadeh K, Streja E: American Society of Nephrology Kidney Week 2019 (2019/11/5-10), Washington DC, USA. (cYî1: 1¬)
713099. [wï (Û)] (êÊu) Effect of Remote Ischemic Postconditioning on Inflammatory Cytokines, Cardiac Damage, Ventricular Function, and Mortality in Lipopolysaccharide-Induced Sepsis. Honda T1, He Q, Wang F, Redington AN: American Heart Association Scientific Sessions 2019 (2019/11/16-18), Philadelphia, USA. ({c@1: 1¬)
721012. [wï (S)] (ï·ÜIÊu)yœÌæêåEåï·ÜóÜz¬zÂퟳ³ÒÉš¯éÚsúxOÌóføÊ: _»är±ÌÊ©ç. Xè^Rü, éتá, ¬ÑŸú, âèüa, œczêY1, ²¡Öu, ¢Ë@º, L^Kq, ²¡ÉD, ª@@Ÿ, ãÊ{\q (1¬): æ55ñú{¬zÂíwïïEwpWï (2019/6/27-29), Dy.
722083. [wï (S)] (|X^[¢_)yÀ·zÆuEäPŽa: ÇE»ÌŒ. âRI (¬): æ122ñú{¬ÈwïwpWï (2019/4/19-21), àò.
722084. [wï (S)] ([NVbv) ¬tŸ³ÌKChCÌ»óÆ¡ã@¬Á«lt[[ÇóQfÃKChC2019. Îqi (¬): æ54ñú{¬tawïwpWï (2019/6/7-8), åã.
722085. [wï (S)] (V|WE) Je[ežðSÉñNPIªèÖÌWJ. {c@1, @w1, øwc¹q, ÖØG¶1, {i, â{mê, Î˲, J@, æèGŸ1,2 (1¬, 2V¢IãÃEæ[ãÃ): æ55ñú{¬zÂíwïïEwpWï (2019/6/27-29), Dy.
722086. [wï (S)] (V|WE) Post tolvaptan eraÌ€Áðíp`¬Éš¯égZ~h, gov^ÌøÊ`. @w1, âVØG¶1, øwc¹q, Œô^2, â{mê, Î˲, J@, {{²i2, {n@Ó2, {i, æèGŸ1,3 (1¬, 2SÇO, 3V¢IãÃEæ[ãÃ): æ55ñú{¬zÂíwïïEwpWï (2019/6/27-29), Dy.
722087. [wï (S)] (plfBXJbV)yÀ·z¬ú©çs€Úsx|ÚsúðÝ·ŠÄ, Ùú©çÆ°ÆÇ€©©íé©|. œczêY (¬): æ55ñú{¬zÂíwïïEwpWï (2019/6/27-29), Dy.
722088. [wï (S)] (V|WE) «ûüvªàœç·üYúãÃņ̃ÌÏv. ŒGF1,2 (1V¢IãÃEæ[ãÃ, 2¬): æ55ñú{üYúEV¶ãwïwpWï (2019/7/13-15), ·ì.
722089. [wï (S)] (V|WE) pã¹Ç©çÝœ¢n®¬ÇJ¶ÇÉηéOÈI¡ÃîüúÌ¢. Îc@i1, Rû»T1, åª1, çÝ@w1, ŒGF1,2, {n@Ó3 (1¬, 2V¢IãÃEæ[ãÃ, 3SÇO): æ55ñú{üYúEV¶ãwïwpWï (2019/7/13-15), ·ì, ú{üYúEV¶ãwïG 2019; 55 (2): 476.
722090. [wï (S)] (V|WE)yÀ·zç]©çlŠé©Šµâ·¢¬çŸ³. âRI1,2, (1k¢åwfBJZ^[, 2¬): æ43ñú{¬çÈwïwpåï (2019/7/20-21), å{.
722091. [wï (S)] (V|WE)yÚsxÌúíÀHÉü¯Äza@ (åwa@) Éš¯éÚsx`[ÌðÆ®ÌÀÛ. âRI1,2, (1k¢åwfBJZ^[, 2¬): æ29ñú{¬E}`wïïEwpWï (2019/10/4-6), Dy.
722092. [wï (S)] (V|WE)yÀ·z¬E}`ãðÂïéœßÉLA`¬ÆvtFbViYðÇ€lŠé? âRI1,2, (1k¢åwfBJZ^[, 2¬): æ29ñú{¬E}`wïïEwpWï (2019/10/4-6), Dy.
722093. [wï (S)] (V|WE)yÀ·zœÊÈ©ÈÇ«Ÿ³ðRð. âRI1,2, (1k¢åwfBJZ^[, 2¬): æ29ñú{¬E}`wïïEwpWï (2019/10/4-6), Dy.
722094. [wï (S)] (V|WE) œÊÈ©ÈÇ«Ÿ³ðRðType I Interferonopathy. ]gËFã1, àqëI1, âRI1,2, Îqi1 (1¬, 2k¢åwfBJZ^[): æ29ñú{¬E}`wïïEwpWï (2019/10/4-6), Dy.
722095. [wï (S)] (V|WE) ï¡«ìèaÉηéXeChpX¹pÃ@ðp¢œ¡Ãíª`@ÅÌ€¬Êð¥ÜŠÄ`. ]gËFã (¬): æ39ñú{ìèawïEwpWï (2019/10/25-26), .
723375. [wï (S)] (êÊu) Trends in morbidity and mortality in 22-24 weeks from 2003-2012: A retrospective cohort study in Neonatal Research Network, Japan (NRNJ). ŒGF1,2 (1V¢IãÃEæ[ãÃ, 2¬): æ122ñú{¬ÈwïwpWï (2019/4/19-21), àò.
723376. [wï (S)] (êÊu) NRNJ10NÔÌðÍÉæéÉáo¶ÌdÉš¯ésÇÌpxÆÖAöq. åé@œ, ŒGF1,2, íc@ (1V¢IãÃEæ[ãÃ, 2¬): æ122ñú{¬ÈwïwpWï (2019/4/19-21), àò.
723377. [wï (S)] (|X^[) sS^CantrelÇóQÉ}«O
«a (APL) ðǵœw¶Ìêá. çÝ@w1, ]gËFã1, Žû[Vî1, º@q, ã¡TŸ, ŒGF1,2 (1¬, 2V¢IãÃEæ[ãÃ): æ122ñú{¬ÈwïwpWï (2019/4/19-21), àò.
723378. [wï (S)] (êÊu) IgAÇÌXeCh˶«Ì ÇóÉAU`IvªLøÅ Áœ2á. Á[D¡, ¬žëv, ŒŸN, àX@§, ÃüÄ, Îa@ãÄ, ²¡@, TäGê, gŽdü, Îqi1 (1¬): æ122ñú{¬ÈwïwpWï (2019/4/19-21), àò.
723379. [wï (S)] (êÊu) Æu}§ò⶚wI»ÜgpºÅ̶N`ÚíSÀÔ²ž. TäGê, {ü@ó, ¯iî, ²ÃÜäÝ, ºG¶, Îqi1 (1¬): æ122ñú{¬ÈwïwpWï (2019/4/19-21), àò.
723380. [wï (S)] (êÊu) MFN2weÚÌÏÙðº€Charcot-Marie-toothaÉRMDA5RÌz«ÌáN«çØ𹵜1á. àX@§, ¬žëv, ŒŸN, @ü, Îa@ãÄ, ²¡@, TäGê, É¡Gê, Îqi1 (1¬): æ122ñú{¬ÈwïwpWï (2019/4/19-21), àò.
723381. [wï (S)] (êÊu) ¬Á«lt[[ÇóQ³ÒÌXeCh¡Ããt@\]¿. ŽcÁq, eiÀD, TäGê, à_c@€, icTq, ìçq, ²¡@, ¬žëv, 㡳, ·Jìsm, À¡u, ŠJ_j, Îqi1, {cëh (1¬): æ122ñú{¬ÈwïwpWï (2019/4/19-21), àò.
723382. [wï (S)] (êÊu) ûcúÉǵœï¡«álç]Ì2Çá. ]gËFã1, âRI1,2 (1¬, 2k¢åwfBJZ^[): æ122ñú{¬ÈwïwpWï (2019/4/19-21), àò.
723383. [wï (S)] (êÊu) ¬úÇtŸ³³ÒÌŸ³ð, ©§xͬlúdzÒƯŠé. ìçq, ŠJ_j, vÛcj, äûqm, eiÀD, ŽcÁq, à_c@€, à_@Sq, Îqi1, {cëh (1¬): æ122ñú{¬ÈwïwpWï (2019/4/19-21), àò.
723384. [wï (S)] (êÊu) V¶úÉt@\áQðæ·éæV«tAHÙíÉš¯éNA`jlÆt\ãÌÖW. ŒŸN, ¬žëv, àX@§, Îa@ãÄ, ÃüÄ, ²¡@, ²ÃÜäÝ, ÐRNÆ, TäGê, É¡Gê, É¡Ti, Îqi1 (1¬): æ122ñú{¬ÈwïwpWï (2019/4/19-21), àò.
723385. [wï (S)] (êÊu) @PICUÉš¯é¬ddzÒ}ŠÀÌÀÔ. ôöb1, À¡@õ1, cºCœ1, ©@Lç1,2, àqO, Îqi1 (1¬, 2~œ): æ122ñú{¬ÈwïwpWï (2019/4/19-21), àò.
723386. [wï (S)] (êÊu) ð«÷¬ÇáQÇðǵœSg«Ge}g[fXlÇóQÌûá. ©@q, cYêY, cšmY, ŒŸN, Îìžm, ¬žëv, Í®, Îqi1, Ec@, Î@ž (1¬): æ122ñú{¬ÈwïwpWï (2019/4/19-21), àò.
723387. [wï (S)] (êÊu) NP«x
ÛŽõÇ©çŽõ«SàðN±µœå®¬kóÇÌcá. @w1, âVØG¶1, øwc¹q, {c@1, غl1, {i1, Œô^2, {{²i2, {n@Ó2, X@P÷1,3, æèGŸ1,4, Îqi1 (1¬, 2SÇO, 3k¢åwfBJZ^[, 4V¢IãÃEæ[ãÃ): æ122ñú{¬ÈwïwpWï (2019/4/19-21), àò.
723388. [wï (S)] (êÊu) @ÅJݵœ¬AM[fOðUèÔÁÄ. ÎcãÄñ1, ®ì@õ1,2, ¡{Üä1,2, î_@µ1,2, åJŽF1, Ž
rŸ1 (1ÍŽŠ¯a@, 2¬): æ122ñú{¬ÈwïwpWï (2019/4/19-21), àò, ú{¬ÈwïG 2019/2; 123 (2): 428.
723389. [wï (S)] (êÊu) @Éš¯éHšoû×±z«áÌ¢(ïc^) ®ì@õ1,2, ÎcãÄñ2, ¡{Üä1,2, î_@µ1,2, åJŽF2 (1¬, 2ÍŽŠ¯a@): æ122ñú{¬ÈwïwpWï (2019/4/19-21), àò, ú{¬ÈwïG 2019/2; 123 (2): 429.
723390. [wï (S)] (êÊu) RbgbgÖÌvXECXo@ÚíÆÆuŽ«]¿. É¡®u1, RHËW, àVc¬j, RNv (1¬): æ60ñú{Õ°ECXwï (2019/5/25-26), €m.
723391. [wï (S)] (êÊu) óªß«
Ìd»ÇColumbiaªÞÉš¯écollapsing variantÌÕ°IÓ`. ÃüÄ, TäGê, Îa@ãÄ, ²¡@, àX@§, ŒŸN, ¬žëv, ²ÃÜäÝ, É¡Gê, `ªFq, ûªŸY, Îqi1 (1¬): æ54ñú{¬tawïwpWï (2019/6/7-8), åã.
723392. [wï (S)] (êÊu) lt[[ÇóQÖÌcLV}u^ãÉ, B×EÍÌJ, ³OuÇ, œ«äFâ, üÛÇðµœêá. É¡Gê, ît@Ê, ¬cTV, ²¡@, ¬žëv, Îqi1, TäGê (1¬): æ54ñú{¬tawïwpWï (2019/6/7-8), åã.
723393. [wï (S)] (êÊu) cLV}uPñ^ãB×EÍÉĵœï¡«lt[[ÇóQÌÕ°IÁ¥. TäGê, ²¡@, àX@§, ÃüÄ, Îa@ãÄ, ŒŸN, ¬žëv, É¡Gê, Îqi1 (1¬): æ54ñú{¬tawïwpWï (2019/6/7-8), åã.
723394. [wï (S)] (êÊu) ¬tÚA³ÒÌm\w@tÚAO§ÍÌL³Éæéär. eiÀD, à_c@€, A£@¶, ª³êY, @OB, __@C, Ôäh¡, ì@TÀ, o¹D, äûqm, OãŒN, ìçq, ŽcÁq, à_èSq, Îqi1, {cëh (1¬): æ54ñú{¬tawïwpWï (2019/6/7-8), åã.
723395. [wï (S)] (êÊu) ¬úÇï¡«lt[[ÇóQÉš¯écLV}u^ãÌT×ETuZbgÌðÍ129áÌ¢. àX@§, TäGê, ŒŸN, ÃüÄ, Îa@ãÄ, ²¡@, ¬žëv, ²ÃÜäÝ, Í®, É¡Gê, Îqi1 (1¬): æ54ñú{¬tawïwpWï (2019/6/7-8), åã,
723396. [wï (S)] (êÊu) @Éš¯é¬Sg«Ge}g[fXÌÕ°I¢. ©@Lç1,2, ºMç2, ŒìÅq2, âgŒü, åF_], ç®rî, ÍŒIº, Îqi2 (1~œ, 2¬): æ54ñú{¬tawïwpWï (2019/6/7-8), åã.
723397. [wï (S)] (êÊu) @Éš¯élt[[óÔð浜Áa«tÌ¢. o¹D, à_c@€, Ôôh¡, __@C, ª³êY, @OB, ì@TÀ, äûqm, eiÀD, OãŒN, ìçq, ŽcÁq, à_èSq, Îqi1, ŠJ_j, {cëh (1¬): æ54ñú{¬tawïwpWï (2019/6/7-8), åã.
723398. [wï (S)] (êÊu) nAÛŽõ_@Éǵ, XeChÜÆ^NX¹pªøð浜C3NeFz«C3tÌ1á. Œºçbq, Jël, ¡c^Ë, ¬Ñëã, LìTê, à{`, kºi, àVärG, cYî1, Ëc@ª, ìðå, öcu (1¬): æ54ñú{¬tawïwpWï (2019/6/7-8), åã.
723399. [wï (S)] (êÊu) ¬Á«lt[[ÇóQÉš¯éCtGUECXN`ÚíÆlt[[ašÆÌÖA@œ{Ý€¯€. ÎX^á, xVàqq, ¡ºç, ìì«á, RºqF, ŒìºÄ÷, _gŒ, ¬žëv, L¡Tj, ìðå, TäGê, Îqi1, Ñêœ (1¬): æ54ñú{¬tawïwpWï (2019/6/7-8), åã.
723400. [wï (S)] (êÊu) XeChïR«lt[[ÇóQÉš¯édÇ}«táQ: P{Ý62áÌðÍ. Îa@ãÄ, ²¡@, ŒŸN, àX@§, ÃüÄ, ¬žëv, ²ÃÜäÝ, TäGê, É¡Gê, Îqi1 (1¬): æ54ñú{¬tawïwpWï (2019/6/7-8), åã.
723401. [wï (S)] (êÊu) Œ€x®¬ÇðÇ©çSxâ~ÆÈÁœï¡«pñÄ^lt[[ÇóQÌ1á. ì@TÀ, à_c@€, A£@¶, ª³êY, @OB, __@C, Ôôh¡, o¹D, äûqm, eiÀD, ìçq, ŽcÁq, Îqi1, ŠJ_j, ãq@E, {cëh (1¬): æ54ñú{¬tawïwpWï (2019/6/7-8), åã.
723402. [wï (S)] (êÊu) ûúÉAÝ^×®í (ICD) AÝðsÁœ2á. yòüv1, À¡@õ1, ôöb1, غl1, @w1, Îqi1 (1¬): æ33ñú{¬~}ãwïwpWï (2019/6/21-22), å{.
723403. [wï (S)] (êÊu) cLV}uPñ^ãB×EÍÉĵœï¡«lt[[ÇóQ³ÒÌÕ°IÁ¥. TäGê, ²¡@, àX@§, ÃüÄ, Îa@ãÄ, ŒŸN, ¬žëv, É¡Gê, Îqi1 (1¬): æ62ñú{twïwpï (2019/6/21-23), ŒÃ®.
723404. [wï (S)] (êÊu) GvX^CÇóQÌ·ú\ãÉÖ·éÇÕ²ž. OYêY, äzq, L¡, à_c@€, Îqi1, ³j (1¬): æ62ñú{twïwpï (2019/6/21-23), ŒÃ®.
723405. [wï (S)] (êÊu) ¬Á«lt[[ÇóQSuw²ž (JP-SHINE study) CtGUECXN`ÉæéÄžøÊ. ÎX^á, Îqi1, ²¡@, eiD, ìçq, à_èSq, À¡u, É¡Gê, {cëh (1¬): æ62ñú{twïwpï (2019/6/21-23), ŒÃ®.
723406. [wï (S)] (êÊu) ¬ï¡«lt[[ÇóQÉηécLV}u¡ÃÉš¯éB×EÍÆ°ðÛÌÖW. à_c@€, ŠJ_j, @OB, ìçq, ŽcÁq, à_èSq, Îqi1, {cëh (1¬): æ62ñú{twïwpï (2019/6/21-23), ŒÃ®.
723407. [wï (S)] (êÊu) ffJe[eû@ÌHvÉæéïISÇ@\]¿Æz®Ôð. Œº@s, â{mê, Î˲, J@, øwc¹q, {c@1, @w1, {i, âVØG¶1, æèGŸ1,2 (1¬, 2V¢IãÃEæ[ãÃ): æ55ñú{¬zÂíwïïEwpWï (2019/6/27-29), Dy.
723408. [wï (S)] (êÊu) NT/BNPÌFontan³ÒÉš¯éSsS}[J[ƵÄÌLp«. {c@1, @w1, øwc¹q, âVØG¶1, {i, â{mê, Î˲, J@, X@P÷1, æèGŸ1,2 (1¬, 2V¢IãÃEæ[ãÃ): æ55ñú{¬zÂíwïïEwpWï (2019/6/27-29), Dy.
723409. [wï (S)] (êÊu) ×ñ˶ÌVµ¢ûk«ÌwW`Sº³Å¬Ï»Š|ûkúeÏÖW`. @w1, âVØG¶1, øwc¹q, {c@1, غl1, {i, X@P÷1, æèGŸ1,2 (1¬, 2V¢IãÃEæ[ãÃ): æ55ñú{¬zÂíwïïEwpWï (2019/6/27-29), Dy.
723410. [wï (S)] (|X^[) PêS©çûkú³eÏÖWðßéaVÈû@. @w1, âVØG¶1, øwc¹q, {c@1, غl1, {i, X@P÷1, æèGŸ1,2 (1¬, 2V¢IãÃEæ[ãÃ): æ55ñú{¬zÂíwïïEwpWï (2019/6/27-29), Dy.
723411. [wï (S)] (êÊu) Post tolvaptan eraÌ€Áðíp`¬Éš¯égZ~h, gov^ÌøÊ`. @w1, âVØG¶1, øwc¹q1, Œô^2, â{mê, {i, Î˲, J@, {{²i2, {n@Ó2, æèGŸ1,3 (1¬, 2SÇO, 3V¢IãÃEæ[ãÃ): æ55ñú{¬zÂíwïïEwpWï (2019/6/27-29), Dy, ú{¬zÂíwïG 2019/6; 35 (Suppl 1): s1-128.
723412. [wï (S)] (êÊu) Sì³Ìá¢Fontanpã`Ro«Ý°ÇÉηé¡Ãíª. @w1, âVØG¶1, øwc¹q, Œô^2, {i, {{²i2, {n@Ó2, æèGŸ1,3 (1¬, 2SÇO, 3V¢IãÃEæ[ãÃ): æ55ñú{¬zÂíwïïEwpWï (2019/6/27-29), Dy, ú{¬zÂíwïG 2019/6; 35 (Suppl 1): s1-387.
723413. [wï (S)] (êÊu) 宬œ𺀮SåÇ]ÊÇ|ÙzÂÆo¶ãoß©çÌl@|. øw¹q1, âVØG¶1, @w1, Œô^2, {i, {{²i2, {n@Ó2, æèGŸ1,3 (1¬, 2SÇO, 3V¢IãÃEæ[ãÃ): æ55ñú{¬zÂíwïïEwpWï (2019/6/27-29), Dy, ú{¬zÂíwïG 2019/6; 35 (Suppl 1): s1-394.
723414. [wï (S)] (êÊu) @ÌPD±ü³Ò70ŒÌŽŸ³E±üNîE\ã. TäGê, àX@§, ÃüÄ, Îa@ãÄ, ŒŸN, ²¡@, ¬žëv, Îqi1 (1¬): æ64ñú{§ÍãwïwpWïEï (2019/6/28-30), ¡l.
723415. [wï (S)] (êÊu) pã¹Ç©çÝœ¢n®¬ÇJ¶ÇÉηéOÈI¡ÃîüúÌ¢. Îc@i1, Rû»T1, åª1, çÝ@w1, ŒGF1,2, {n@Ó3 (1¬, 2V¢IãÃEæ[ãÃ, 3SÇO): æ55ñú{üYúEV¶ãwïwpWï (2019/7/13-15), ·ì, ú{üYúEV¶ãwïG 2019/7; 55 (2): 476.
723416. [wï (S)] (êÊu) Ù}ÇðǵœMELASÌ3ÇáÌ¢. yò@œ1, {ŽTq, ZFTq, |ºG¢, ÎRºF, ¬qG¶, ìhñ, ²Xتs (1¬): æ45ñú{dÇSgáQwïwpWï (2019/9/20-21), ªR.
723417. [wï (S)] (êÊu) 22q11.2žÇóQɹµœáN«Á«ÖßÌ1á. c~Þ, ]gËFã1 (1¬): æ29ñú{¬E}`wïïEwpWï (2019/10/4-6), Dy.
723418. [wï (S)] (êÊu) ÂNútÚAÆñyÑ»Ìã¡ñÌÚAtržXN, SÌÖA. cYî1, Îqi1, GjEXg[W, JEJ^[ (1¬): æ55ñú{ÚAwïï (2019/10/10-12), L.
723419. [wï (S)] (|X^[) ìèaÌffî𜵜HPVB19ŽõÇÌ1á. ÖJ¢À1, ]gËFã1, Œ (1¬): æ39ñú{ìèawïEwpWï (2019/10/25-26), .
723420. [wï (S)] (|X^[) ACTHÃ@ÉWIlxðǵœûÌêá. çÝ@w1, åª1, ìXcL1, äGŒ1, ]gËFã1, ŒGF1,2 (1¬, 2V¢IãÃEæ[ãÃ): æ51ñú{¬ŽõÇwïïEwpWï (2019/10/26-27), ®ì, ú{¬ŽõÇwïï¥wpWïvO¥Ž^W 2019; 51: 269.
723421. [wï (S)] (êÊu) Eculizumab^ãÌKlebsiella pneumoniaeÛÇ. ¬ìpP, ¯iî, ²¡@, Îqi1, }ŽQ¶, {ü@ó (1¬): æ51ñú{¬ŽõÇwïïEwpWï (2019/10/26-27), ®ì.
723422. [wï (S)] (|X^[) ¬AM[³ÒîÌ«®õÉæé_jyÑ_jAQñðÆÇóüPÌœß̲ž€. âRI1,2, Œ (1k¢åwfBJZ^[, 2¬): æ56ñú{¬AM[wïwpåï (2019/11/2-3), çt.
723423. [wï (S)] (êÊu) @Éš¯éu·øPvfÃÌ»ó. ìì (¬): æ52ñú{¬Äzíwï (2019/11/15-16), .
723424. [wï (S)] (êÊu) AªCǪ£pãÉCÇrª®¬áðǵ~œµŸœêá. ËËYI, ìì1 (1¬): æ52ñú{¬Äzíwï (2019/11/15-16), .
723425. [wï (S)] (êÊu) ³CxðJèÔ·ÇáÉεa@, {Ý, KâX^btÌÄzPAðê·é±ÆªLøÅ Áœ1á. åȳ÷, ìì1 (1¬): æ52ñú{¬Äzíwï (2019/11/15-16), .
723426. [wï (S)] (êÊu) çÊÃ@ªLøŸÁœcuCîðº€CtGUAxÌ1cá. àqO1, ãcNv, ôöb2, À¡@õ2, Χœl, `, Ž@^l, ~Ž@À, Îqi2 (1ö§ua@~}È, 2¬): æ52ñú{¬Äzíwï (2019/11/15-16), .
723427. [wï (S)] (êÊu) LoweÇóQÌ·úIt\ãÉÖ·é¢. ÷àqN, Îa@ãÄ, OYêY, £c@L, ÎËì¢L, _cËêY, ²¡Öu, é@, à_c@€, Îqi1, Ü\², ³j (1¬): æ41ñú{¬tsSwïwpWï (2019/11/28-29), m.
723428. [wï (S)] (êÊu)uHFOÌîbÆÅß̪¬vHFOÉæéCLDÇðl@µæ€`\h©çdváÌ¡ÃÜÅ`. ŒGF1,2 (1V¢IãÃEæ[ãÃ, 2¬): æ22ñV¶ÄzÃ@Ej^OtH[ (2020/2/13-15), ·ì.
723429. [wï (S)] (êÊu) PIJe[eV[g^CvÌLp«É¢Ä: PIJe[eÌÂÜçÈ¢b`p[gIII`. ŒGF1,2 (1V¢IãÃEæ[ãÃ, 2¬): æ22ñV¶ÄzÃ@Ej^OtH[ (2020/2/13-15), ·ì
731030. [wï (nûïE€ï)] (ÁÊu) V¶ÌÌÌÝ©œ. ŒGF1,2 (1V¢IãÃEæ[ãÃ, 2¬): fBJoÅZ~i[ (2019/5/12), åã.
731031. [wï (nûïE€ï)] (ÁÊu) ŽYÌÇ. ŒGF1,2 (1V¢IãÃEæ[ãÃ, 2¬): V¶WPAFèÅìttH[Abv€C (2019/6/15), .
731032. [wï (nûïE€ï)] (ÁÊu) V¶ÌÌÌÝ©œ. ŒGF1,2 (1V¢IãÃEæ[ãÃ, 2¬): fBJoÅZ~i[ (2019/7/27), .
731033. [wï (nûïE€ï)] (ÁÊu) ¬Ì«ta`uwÆt@\Ì]¿É¢Ä. Îqi (¬): æ358ñú{¬Èwï_Þì§nûï (2019/9/21), ¡l.
731034. [wï (nûïE€ï)] (ÁÊu) ¯Ó·×«¬Ì«tŸ³Æú©Ìœß̳mÈt@\]¿. Îqi (¬): _Þì§wZtŸ³Ç€ïuï (2019/9/28), ¡l.
731035. [wï (nûïE€ï)] (ÁÊu) ¬Ì×. cYî (¬): MCwZÛ€Cï@ZãÆ{ì³@ÌW¢ (2019/11/12), MC.
731036. [wï (nûïE€ï)] (ÁÊu) t[TCgg[ðp¢œPBMCsÌÔ
IðÍ: ìèaÌaÔÉé. ]gËFã (¬): k€ìèa€ï (2019/12/7), àò.
731037. [wï (nûïE€ï)] (ÁÊu) ƱÆñâ³µ¢V¶ÄzÇÌ·×Ä. ŒGF1,2 (1V¢IãÃEæ[ãÃ, 2¬): fBJoÅZ~i[ (2019/12/14), åã.
731038. [wï (nûïE€ï)] (ÁÊu) ¬³Èœð~€Ó¡. ŒGF1,2 (1V¢IãÃEæ[ãÃ, 2¬): æ11ñk¢åwãw®V¢IãÃJZ^[V|WE (2019/12/15), Íåì.
732023. [wï (nûïE€ï)] (³çu) HšAM[ÌÅVîñƱê©çÌúÉü¯Ä. âRI1,2 (1k¢åwfBJZ^[, 2¬): sqçÄxcÌ HšAM[Áqð¬ï (2019/4/13), .
732024. [wï (nûïE€ï)] (³çu) ïafÃAgÆCKDRz[g. Îqi (¬): ãB¬taZ~i[2019 in Fukuoka (2019/5/11), ª.
732025. [wï (nûïE€ï)] (³çu) _¶ðÇÞÆ«àÆ«àðɧ¶švw. Îqi1, àqO¡ (1¬): ãB¬taZ~i[2019 in Fukuoka (2019/5/11), ª.
732026. [wï (nûïE€ï)] (³çu) wZÉš¯éKØÈHšAM[EAitBLV[ÎÌÝèû. âRI1,2 (1k¢åwfBJZ^[, 2¬): k{s³çÏõï HšAM[EAitBLV[΀Cï (2019/8/8), éÊ.
732027. [wï (nûïE€ï)] (µÒu) ¬ÌCKDÆâ`«tŸ³|CAKUTðSÉ|. Îqi (¬): æ2ñâ`tŸ³ðlŠéï (2019/10/4), ÍŽ.
732028. [wï (nûïE€ï)] (s¯öJuÀ) ybgÆÌL©ÈéçµðmÁÄš«œ¢: ±±ÜÅí©ÁÄ¢é¢ELAM[. âRI1,2 (1k¢åwfBJZ^[, 2¬): 2019NxövÐc@lú{®ša@Šï (JAHA) Nåï (2019/10/13-14), .
732029. [wï (nûïE€ï)] (³çu) ¬tÌæÌóEï¡«Ÿ³ÆCKDRz[g. Îqi (¬): kC¹¬taZ~i[2019 in Sapporo (2019/11/9), Dy.
732030. [wï (nûïE€ï)] (³çu) |Cgvw. Îqi1, àqO¡ (1¬): kC¹¬taZ~i[2019 in Sapporo (2019/11/10), Dy.
732031. [wï (nûïE€ï)] (s¯öJuÀ) ¢ðxŠé (ŽYAwóµAP[gÊ). çÝ@w (¬): æ11ñk¢åwãw®V¢IãÃJZ^[V|WE (2019/12/15), Íåì.
732032. [wï (nûïE€ï)] (³çu) ®šîÝÃ@Ì»óšæÑ€³çÌÛè: k¢åwfBJZ^[Éš¯é®šîÝÃ@ÌÀÛ. âRI1,2 (1k¢åwfBJZ^[, 2¬): âèåwåw@bãw€ÈöJV|WE (2019/12/4), âè.
732033. [wï (nûïE€ï)] (³çu) @Ì¢ófDw (ÁèDw) ©çÝœ{qE¢e§x. çÝ@w (¬): {qg¯Ô Á¹ñ@Ö¬Æ (2020/1/14), ¡ò.
732034. [wï (nûïE€ï)] (µÒu) wZA: Ý©音, ©Š·Ÿ³. Îqi (¬): ¬csãtïwpuï (2020/2/19), .
733139. [wï (nûïE€ï)] (êÊu) ¬§Í³ÒÉš¯é, §Í±ü̹¶ÇƵÄ̳ÆSÌÖA. cYî1, ©@Lç1,2, Îqi1 (1¬, 2~œ): æ26ñú{¬³€ï (2019/9/14), .
733140. [wï (nûïE€ï)] (êÊu) ìèaÌåvÇóð浜]Ì1já. cºCœ1, ²¡Áãq1, غl1, ¥Y¥1 (1¬): æ358ñú{¬Èwï_Þì§nûï (2019/9/21), ¡l.
733141. [wï (nûïE€ï)] (êÊu) SsSð_@É©³ê, §Í±ü³êœltá^¢Ìvtúá. cYî1, ©@Lç1,2, Îqi1 (1¬, 2~œ): æ12ñú{¬CKD€ï (2019/9/29), .
733142. [wï (nûïE€ï)] (êÊu) íõFÌò«œ«ùNEtÌ·ú\ã: ÌÚAÆtÚAÌíª. ²¡@, TäGê, Îqi1, }ŽQ¶ (1¬): æ33ñú{¬PDEHD€ï (2019/11/1-2), ŒÃ®.
733143. [wï (nûïE€ï)] (êÊu) V¶úÉt@\áQðæ·éæV«tAHÙíÉš¢ÄNA`jlÍt@\\ã\ªÉLp©. ŒŸN, ¬žëv, àX@§, Îa@ãÄ, ÃüÄ, ²¡@, ²ÃÜäÝ, ÐRNÆ, TäGê, É¡Gê, É¡Ti, Îqi1 (1¬): æ33ñú{¬PDEHD€ï (2019/11/1-2), ŒÃ®.
733144. [wï (nûïE€ï)] (êÊu) ltá. cYî1, ÃüÄ, {\, à_èSq (1¬): kC¹¬taZ~i[2019 in Sapporo. (2019/11/9-10), Dy.
733145. [wï (nûïE€ï)] (êÊu) @Éš¯éìèafÃ. {ì^Øq, ìì1, ØNç (1¬): ú{¬Èwïênûï (2019/11/10), ê.
733146. [wï (nûïE€ï)] (êÊu) ¬lÚsxÌ»óÆÛè. œczêY (¬): æ440ñÍŽ¬Èãïá§bï (2019/11/20), ÍŽ.
733147. [wï (nûïE€ï)] (êÊu) XeCh¡ÃºÅüPÆ«ðJèԵĢé}«A×ÇÔ¿«tÌ13Îá. cYî1, ÚàVzØ1, ©@Lç1,2, ºMç1, Îqi1 (1¬, 2~œ): æ440ñÍŽ¬Èãïá§bï (2019/11/20), ÍŽ.
'18NxÈOª
[wp_¶]
'18-120001. [Ž] Æ©É쬵œ²ž[ðp¢œúAèü@ÌHšoû×±ÉÖ·éÓ¯²ž. ÎcãÄñ1, ÄRrV1, ®ì@õ1,2, ¡{Üä1,2, î_@µ1,2, åJŽF1 (1ÍŽŠ¯a@, 2¬): ú{_ºãwïG 2019/3; 67 (6): 669-77.
'18-540004. [»ÌŒ (€ñ)] IgAtÇÆ÷¬Ï»^lt[[ÇóQÌfÃKChCÌFmxÆpóµÉÖ·éAP[g²žÌñ. OYêY, ²ÃÜäÝ, °c@Ÿ, Îqi1, äã@×, ã¡F[, ¬ŒNG, dŒ@², R@Ä, ìçq, Œ_ê, ŒöD, ŠJ_j, ¡³ºê, üRu, gîMF, {cëh, âì³V, ³j (1¬): ú{twï 2019/3; 61 (2): 51-7.
[@]
'18-620009. [wp (ªS·M)]yàªåÇóQ (æ3Å) IV|»ÌŒÌàªåŸ³ðÜßÄ| (Êûú{ÕଠÌæÊÇóQV[Y No.4)zXII. «@\áºðº€â`« (æV«) ÇóQ@2. Denys-DrashÇóQ, p.480-3. ŒŸN, xìæq, Îqi1 (1¬), ú{Õà¬Ð, , 2019/3s.
[wïE€ï]
'18-723016. [wï (S)] (êÊu) ¬Éš¯éfNXfg~WÌøÊ. ôöb1, À¡@õ1, cºCœ1, æèGŸ1,2 (1¬, 2V¢IãÃEæ[ãÃ): æ46ñú{W¡ÃãwïwpWï (2019/3/1-3), s.
'18-731002. [wï (nûïE€ï)] (ÁÊu) ƱÆñâ³µ¢V¶ÄzÇÌ·×Ä. ŒGF1,2 (1V¢IãÃEæ[ãÃ, 2¬): fBJoÅZ~i[ (2019/1/12), .
'18-733003. [wï (nûïE€ï)] (êÊu) ACTHÃ@ÉWIlxÅSµœWestÇóQÌêá. äGŒ1, ìXcL1, ÎcÏç (1¬): æ61ñ_Þì¬_o§bï (2019/3/2), ¡l.
YÈw^wlÈw
[wp_¶]
110249. [Ž] Autophagy is a new protective mechanism against the cytotoxicity of platinum nanoparticles in human trophoblasts. Nakashima A, Higashisaka K, Kusabiraki T, Aoki A, Ushijima A, Ono Y, Tsuda S, Shima T, Yoshino O1,2, Nagano K, Yoshioka Y, Tsutsumi Y, Saito S: Sci Rep 2019/4; 9 (1): 5478. (gì@C1,2: 1YÈ, 2wl)
110250. [Ž] Serum Brain-derived Neurotrophic Factor Levels Mirror Bone Mineral Density in Amenorrheic and Eumenorrheic Athletes. Nose S, Yoshino O1,2, Nomoto K, Harada M, Dohi M, Kawahara T, Osuga Y, Fujii T, Saito S: Int J Sports Med 2019/4; 40 (4): 276-82. (gì@C1,2: 1YÈ, 2wl)
110015. [Ž] VEGF Receptor 1-Expressing Macrophages Recruited from Bone Marrow Enhances Angiogenesis in Endometrial Tissues. Sekiguchi K1, Ito Y2, Hattori K1, Inoue T3, Hosono K2, Honda M4, Numao A1, Amano H2, Shibuya M, Unno N1, Majima M2: Sci Rep 2019/5; 9 (1): 7037. (Öûaé1, É¡`ç2, ¿q1, äãqm3, ×ìÁÞq2, {cëq4, Àö²q1, Vìp÷2, CìMç1, n³²2: 1YÈ, 2ò, 3Á»íà, 4åw@ãÃn€È)
110251. [Ž] Uterine receptivity, embryo attachment, and embryo invasion: Multistep processes in embryo implantation. Fukui Y, Hirota Y, Matsuo M, Gebril M, Akaeda S, Hiraoka T1, Osuga Y: Reprod Med Biol 2019/5; 18 (3): 234-40. (œªBå1: 1wl)
110252. [Ž] Comparison of survival between primary debulking surgery and neoadjuvant chemotherapy for stage III/IV ovarian, tubal and peritoneal cancers in phase III randomised trial. Onda T1, Satoh T, Ogawa G, Saito T, Kasamatsu T, Nakanishi T, Mizutani T, Takehara K, Okamoto A, Ushijima K, Kobayashi H, Kawana K, Yokota H, Takano M, Kanao H, Watanabe Y, Yamamoto K, Yaegashi N, Kamura T, Yoshikawa H: Eur J Cancer 2020/5; 130: 114-25. (¶cMu1: 1wl)
110253. [Ž] The mesenchymal transition subtype more responsive to dose dense taxane chemotherapy combined with carboplatin than to conventional taxane and carboplatin chemotherapy in high grade serous ovarian carcinoma: A survey of Japanese Gynecologic Oncology Group study (JGOG3016A1). Murakami R, Matsumura N, Michimae H, Tanabe H, Yunokawa M, Iwase H1, Sasagawa M, Nakamura T, Tokuyama O, Takano M, Sugiyama T, Sawasaki T, Isonishi S, Takehara K, Nakai H, Okamoto A, Mandai M, Konishi I: Gynecol Oncol 2019/5; 153 (2): 312-9. (â£tq1: 1wl)
110254. [Ž] Decreased effector regulatory T cells and increased activated CD4+ T cells in premature ovarian insufficiency. Kobayashi M, Nakashima A, Yoshino O1,2, Yoshie M, Ushijima A, Ito M, Ono Y, Shima T, Kawamura K, Ishizuka B, Saito S: Am J Reprod Immunol 2019/6; 81 (6): e13125. (gì@C1,2: 1YÈ, 2wl)
110255. [Ž] Real prevalence of neural tube defects in Japan: How many of such pregnancies have been terminated? Kondo A, Akada S, Akiyama K, Arakawa M, Ichi S, Inamoto Y, Ishida T, Ishikawa H, Itoh T, Izumi A, Kimura F, Kondo AS, Matsuoka R, Miyauchi A, Mochizuki J1, Momohara Y, Morikawa S, Morioka M, Morota N2, Nakabe K, Obayashi S, Oku M, Samura O, Sasahara J, Sase M, Shimamoto K, Shimamura K, Sumigama S, Tada K, Takahashi H, Tani A, Wada S, Wada-HIraike O, Watanabe T, Yamaguchi M, Yasui T, Yokomine M: Congenit Anom (Kyoto) 2019/7; 59 (4): 118-24. (]q1, tcMl2: 1YÈ, 2]O)
110256. [Ž] Endoplasmic reticulum stress disrupts lysosomal homeostasis and induces blockade of autophagic flux in human trophoblasts. Nakashima A, Cheng SB, Kusabiraki T, Motomura K, Aoki A, Ushijima A, Ono Y, Tsuda S, Shima T, Yoshino O1,2, Sago H, Matsumoto K, Sharma S, Saito S: Sci Rep 2019/8; 9 (1): 11466. (gì@C1,2: 1YÈ, 2wl)
110257. [Ž] PARP inhibitors for BRCA wild type ovarian cancer; gene alterations, homologous recombination deficiency and combination therapy. Matsumoto K, Nishimura M, Onoe T, Sakai H, Urakawa Y, Onda T1, Yaegashi N: Jpn J Clin Oncol 2019/8; 49 (8): 703-7. (¶cMu1: 1wl)
110258. [Ž] Risk factors of stress fractures due to the female athlete triad: Differences in teens and twenties. Nose-Ogura S, Yoshino O1,2, Dohi M, Kigawa M, Harada M, Hiraike O, Onda T2, Osuga Y, Fujii T, Saito S: Scand J Med Sci Sports 2019/10; 29 (10): 1501-10. (gì@C1,2, ¶cMu2: 1YÈ, 2wl)
110259. [Ž] Sphingosine 1 Phosphate (S1P) Increased IL-6 Expression and Cell Growth in Endometriotic Cells. Yoshino O1,2, Yamada-Nomoto K, Kano K, Ono Y, Kobayashi M, Ito M, Yoneda S, Nakashima A, Shima T, Onda T2, Osuga Y, Aoki J, Saito S: Reprod Sci 2019/11; 26 (11): 1460-7. (gì@C1,2, ¶cMu2: 1YÈ, 2wl)
110260. [Ž] Endometriosis Triggers Excessive Activation of Primordial Follicles via PI3K-PTEN-Akt-Foxo3 Pathway. Takeuchi A, Koga K, Satake E, Makabe T, Taguchi A, Miyashita M, Takamura M, Harada M, Hirata T, Hirota Y, Yoshino O1,2, Wada-Hiraike O, Fujii T, Osuga Y: J Clin Endocrinol Metab 2019/11; 104 (11): 5547-54. (gì@C1,2: 1YÈ, 2wl)
110261. [Ž] Quantitative analysis of ovarian cysts and tumors by using T2 star mapping. Takahashi N, Yoshino O1,2, Hayashida E, Nakamura M, Hori M, Iwahata S2, Onda T2, Unno N1, Fujii T, Osuga Y: J Obstet Gynaecol Res 2020/1; 46 (1): 140-6. (gì@C1,2, â[rã2, ¶cMu2, CìMç1: 1YÈ, 2wl)
110262. [Ž] Levonorgestrel Inhibits Embryo Attachment by Eliminating Uterine Induction of Leukemia Inhibitory Factor. Matsuo M, Hirota Y, Fukui Y, Fujita H, Saito-Fujita T, Kaku T, Gebril M, Hirata T, Akaeda S, Hiraoka T1, Tanaka T, Haraguchi H, Saito-Kanatani M, Shimizu-Hirota R, Takeda N, Fujii T, Osuga Y: Endocrinology 2020/2; 161 (2): bqz005. (œªBå1: 1wl)
110263. [Ž] IL-33 Exacerbates Endometriotic Lesions via Polarizing Peritoneal Macrophages to M2 Subtype. Ono Y, Yoshino O1,2, Hiraoka T2, Akiyama I, Sato E3, Ito M, Kobayashi M, Nakashima A, Wada S, Onda T2, Unno N1, Osuga Y: Reprod Sci 2020/3; 27 (3): 869-76. (gì@C1,2, œªBå2, ²¡G¢Þ3, ¶cMu2, CìMç1: 1YÈ, 2wl, 3aÔEfÃn3)
120009. [Ž] áNq{ÌàÇáÉš¯é·¶ÌÂ\«É¢Ä: LogisticñAªÍðp¢œ¢. Ã]Ÿq1, â£tq1, ¡^ê1, Ãì³`1, ²¡pM, cGLI1, c±b1, Vä³G1, ¶cMu1 (1wl): ú{wlÈîáwïG 2019/4; 37 (2): 131-9.
120010. [Ž] q{èòàIB2/IIA2, IIBúLÄq{SEpÇáÌÕ°I¢ÆúËüÃ@ÇáÆÌ\ãÌär. c±b1, ¡^ê1, Ãì³`1, cGLI1, ²¡pM, Vä³G1, â£tq1, ¶cMu1 (1wl): ú{wlÈîáwïG 2019/10; 37 (4): 723-30.
120011. [Ž] œ¬30Nx@_ÞìYÈwlÈwï@wlÈ««îáo^Wvñ. Àèßq, CY¡cÞü, gc@_, Y «, åŽ@÷, c±b1, ØÒv, ²XØN, ÄRê, Ñ@Nq, œàV@Ò, Xª@², éèŸê, nç²L¡, Oã²j, Á¡v·, ìáÁ²j, éØ@Œ, ŽPj (1wl): _ÞìYÈwlÈwï 2019/10; 56 (1): 50-8.
310034. [Çáñ] Prenatal skeletal sonographic findings of Jeune syndrome. Mochizuki J1, Kanai Y1, Onishi Y1, Kishimoto Y, Hata K, Unno N1: Jpn J Med Ultrasonics 2019/12; 46 (6): 551-4. (]q1, àäYñ1, åŒfq1, CìMç1: 1YÈ)
320024. [Çáñ] ¬YèpÌpOžð_@ÉTAFROÇóQÌffÉÁœ1á. Rè@D1, ]q1, åŒfq1, gºÃL1, àNq1, Öûaé1, Îì²O1, àäYñ1, CìMç1 (1YÈ): ÖAYÈwlÈwï 2019/11; 56 (4): 507-13.
320025. [Çáñ] êð_@ÉffÉÁœeXgXeY¶îáÌêá. ÜTV1, c±b1, ºî°2, ¡^ê2, Ãì³`2, cGLI2 ²¡pM, Vä³G2, â£tq2, ¶cMu2, CìMç1 (1YÈ, 2wl): _ÞìYÈwlÈwï 2020/2; 56 (2): 13-8.
320026. [Çáñ] @Éš¯é~ŹDPÌ3á. Œê1, ºî°2, HRG¢q1,3, ÎäGä»q, ªÃKä1, v¥s3, OØŸ¿1,3 (1YÈ, 2wl, 3k¢åwfBJZ^[): éÊYÈwlÈwïG 2020/3; 50 (1): 26-32.
410002. [Õ°±] The mesenchymal transition subtype more responsive to dose dense taxane chemotherapy combined with carboplatin than to conventional taxane and carboplatin chemotherapy in high grade serous ovarian carcinoma: A survey of Japanese Gynecologic Oncology Group study (JGOG3016A1). Murakami R, Matsumura N, Michimae H Tanabe H, Yunokawa M, Iwase H1, Sasagawa M, Nakamura T, Tokuyama O, Takano M, Sugiyama T, Sawasaki T, Isonishi S, Takehara K, Nakai H, Okamoto A, Mandai M, Konishi I: Gynecol Oncol 2019/5; 153 (2): 312-9. (â£tq1: 1wl)
522064. [uÀ]yÁW: üYúÆãÃÀSze_ [YÈ]@³ÉªØ. CìMç (YÈ): üYúãw 2019/5; 49 (5): 696-701.
522065. [uÀ]yæ63ñwpWïu^z³çu: ãtÌ«ûüvÆüYúãÃ. CìMç (YÈ): ú{V¶¬çãwïG 2019/6; 31 (2): 356-8.
522066. [uÀ] yÁW: ÀSÅÀSȳɪØðÉßéz4. ³ÉªØÌ}¬Ø@. àäYñ (YÈ): YwlÈÌÀÛ 2019/6; 68 (6): 579-87.
522067. [uÀ]yÁW: Lªéq{àÇÌ¢EzIII. aöEaÔÌÅVm©@15. q{àÇÉš¯é_oöq. gì@C1,2, å{êõ, âV¡@ , ¶cMu2 (1YÈ, 2wl): YÈÆwlÈ 2019/7; 86 (7): 873-7.
522068. [uÀ]yÁW: Female genital tractÌûkðÄl·ézñDPÉš¯éqgq{ûkÌÏ@@(1) q{Øîðº€q{Ìûk. gì@C1,2, å{êõ, ¶cMu2 (1YÈ, 2wl): HORMONE FRONTIER IN GYNECOLOGY 2019/9; 26 (3): 223-8.
530008. [»ÌŒ (Guidelines)] Guidelines for office gynecology in Japan: Japan Society of Obstetrics and Gynecology (JSOG) and Japan Association of Obstetricians and Gynecologists (JAOG) 2017 edition. Kawaguchi R, Matsumoto K, Akira S, Ishitani K, Iwasaku K, Ueda Y, Okagaki R, Okano H, Oki T, Koga K, Kido M, Kurabayashi T, Kuribayashi Y, Sato Y, Shiina K, Takai Y, Tanimura S, Chaki O, Terauchi M, Todo Y, Noguchi Y, Nose-Ogura S, Baba T, Hirasawa A, Fujii T, Fujii T, Maruyama T, Miyagi E, Yanagida K, Yoshino O1,2, Iwashita M, Maeda T, Minegishi T, Kobayashi H: J Obstet Gynaecol Res 2019/4; 45 (4): 766-86. (gì@C1,2: 1YÈ, 2wl)
[@]
620060. [wp (ªS·M)] yYwlÈ ~}EŒ Î}j
A (Õ°wlÈYÈ2019N§)z¡III. YÈÒ@DYåñw̹Ÿ³ÖÌÎ@@tEåAퟳ AHÎ, p302-5. àäYñ (YÈ), ãw@, , 2019/4s.
620061. [wp (ªS·M)]ywlȪñ|€EÕ°ÌVWJ (ÊûEãwÌ äÝ)zàEÇàE à@17. ãç«àEÇàE à: èpÃ@Ì^C~O, p.127. ¶cMu (wl), Ò: Á¡¹q, ãòoÅ, , 2019/5s.
620062. [wp (ªS·M)]yÙ}YÈèpÌÉõŠé üùæ2ÅzIIÍ ÇáñŠ@12. DPÖAÌ]², p.174-83. ]q1, ²¡ör, GrG2, Á¡¢G (1YÈ, 2]O), Ò: xrV3, Á¡¢G, Vì@® (3), œ°oÅ, , 2019/11s.
[wïE€ï]
712010. [wï (Û)] (µãÙu) Infertility Workup Overview in Japan/ Japanese Lipiodol? HSG experience. Yoshino O1,2: International Federation of Fertility Societies (IFFS) Guerbet Conference (2019/4/11-14), Shanghai, China. (gì@C1,2: 1YÈ, 2wl)
712011. [wï (Û)] (µãÙu) Oil-Soluble Contrast Medium (OSCM) for Hysterosalpingography Modulates Dendritic Cell and Regulatory T Cell Profiles in the Peritoneal Cavity: A Possible Mechanism by Which OSCM Enhances Fertility. Yoshino O1,2, Izumi G, Koga K, Fujii T, Osuga Y: International Federation of Fertility Societies (IFFS) World Congress (2019/4/11-14), Shanghai, China. (gì@C1,2: 1YÈ, 2wl)
712012. [wï (Û)] (V|WE) The involvement of Damage-associated molecular patterns (DAMP) and macrophages on the etiology of endometriosis. Yoshino O1,2, Ono Y, Unno N1, Onda T2, Saito S, Osuga Y: the 39th annual meeting of the American Society for Reproductive Immunology (2019/6/12-15), Grand Rapids, USA. (gì@C1,2, CìMç1, ¶cMu2: 1YÈ, 2wl)
712013. [wï (Û)] (µÒu) Water-based, or Oil-based medium for hysterosalpingography (HSG), that is the question. Yoshino O1,2: Taiwan Guerbet Conference (2019/9/23), Taiwan. (gì@C1,2: 1YÈ, 2wl)
712014. [wï (Û)] (V|WE) Endometriosis, from where the initial inflammation comes? Yoshino O1,2: the 14th Congress of the International Society for Immunology of Reproduction (ISIR) 2019 (2019/11/15), Nara, Japan. (gì@C1,2: 1YÈ, 2wl)
713100. [wï (Û)] (êÊè) Efficacy of salvage hysterectomy following radiotherapy for uterine cervical adenocarcinoma. Iwase H1, Furukawa S1, Endo S1 Tazo Y1, Sato H, Takada T1, Arai M1, Onda T1: International Meeting of the Europian Society of Gynaecological Oncology (ESGO 2019) (2019/11/2-5), Athens, Greek. (â£tq1, Ãì³`1, ¡^ê1, cGLI1, c±b1, Vä³G1, ¶cMu1: 1wl)
713101. [wï (Û)] (êÊè) The significance of positive peritoneal cytology in G1/G2 endometrioid carcinoma of uterine body. Furukawa S1, Iwase H1, Endo S1, Ohnishi K1, Tazo Y1, Sato H, Takada T1, Arai M1, Yoshino O1,2, Onda T1: International Meeting of the Europian Society of Gynaecological Oncology (ESGO 2019) (2019/11/2-5), Athens, Greek. (Ãì³`1, â£tq1, ¡^ê1, 匫l1, cGLI1, c±b1, Vä³G1, gì@C1,2, ¶cMu1: 1wl, 2YÈ)
721013. [wï (S)] (ÁÊu) ÐQ¬üYúG]AŠcï. CìMç (YÈ): æ71ñú{YÈwlÈwïwpuï (2019/4/14), ŒÃ®.
721014. [wï (S)] (ÁÊu) üYúãÃEÛÉš¯éãtÆYtÌAg. CìMç (YÈ): 2019Nxú{YtïïEæ75ñú{Ytwï (2019/5/25), ÈØ.
721015. [wï (S)] (ÁÊu) wlÈÇ«Ÿ³Éš¯éèpKÇáÌIèðÚwµÄ. gì@C1,2, ¶cMu1, å{êõ (1YÈ, 2wl): JSAWI 2019 (2019/9/7), ºÉ.
721016. [wï (S)] (ÁÊu) Patient-centered medicine©çÝœo¢ïÇ. gì@C1,2 (1YÈ, 2wl): SWF~[iWEBuï (2020/3/2), WEBu.
722096. [wï (S)] (w±ãuKï)uYwlÈãÌ«ûüv@éŸÆñŸvÉ¢Ä. CìMç (YÈ): æ71ñú{YÈwlÈwïwpuï (2019/4/14), ŒÃ®.
722097. [wï (S)] (V|WE) YwlÈã̧êÅ, ú{ÐïÌÅÌNIPTÌ èûÉ¢ÄlŠé. CìMç (YÈ): æ55ñú{üYúEV¶ãwïwpWï (2019/7/14), Œ{.
722098. [wï (S)] (V|WE) üYúãÃÉš¯é«ûüvÌÛè. CìMç (YÈ): æ55ñú{üYúEV¶ãwïwpWï (2019/7/14), Œ{.
722099. [wï (S)] (`Z~i[) ÐQÉêqðçéœßÌæègÝ|œÌõÆÐÌÎÉ¢Ä|. CìMç (YÈ): æ55ñú{üYúEV¶ãwïwpWï (2019/7/15), Œ{.
722100. [wï (S)] (plfBXJbV) råÐQÉηéêåfÃÈ (wï) ÌÎVXeÌ»óÆ¢. CìMç (YÈ): æ25ñú{ÐQãwïïEwpWï (2020/2/21), _Ë.
722101. [wï (S)]yV|WE2: ªñèp|K³ÈèpÌ^C~OÆØÍÍzÄàÉηéSDSÌÓ`. ¶cMu (wl): æ42ñú{YwlÈèpwï (2020/2/22), s.
722102. [wï (S)] (V|WE) ãðS€YtÉßçêé¿ÆÍ. CìMç (YÈ): æ34ñú{YwïwpWï (2020/3/20-22), webJÃ.
723430. [wï (S)] (|X^[) PUBSÌÊÅJèÔµÙ¡ÃðsÁœÙbóBî5ÇáÌ¢. ¢@1, àäYñ1, åŒfq1, gºÃL1, àNq1, Öûaé1, Îì²O1, ]q1, CìMç1 (1YÈ): æ71ñú{YÈwlÈwïwpuï (2019/4/13), ŒÃ®.
723431. [wï (S)] (|X^[) åKÍkÐÉõŠœnæüYúãÃ̧®õÖÌæègÝ. ¿q1, ]q1,
JüM, ÍìÆq1, Vä@w2, àc\À, çÝ@«, Ö¡@, ·Jìu, CìMç1 (1YÈ, 2wl): æ71ñú{YÈwlÈwïwpuï (2019/4/13), ŒÃ®.
723432. [wï (S)] (|X^[) DPúÉ[ìðÇðǵœ7ÇáÌ¢. ¬@è1, åŒfq1, Öûaé1, Îì²O1, àNq1, ¿q1, gºÃL1, àäYñ1, ]q1, CìMç1 (1YÈ): æ71ñú{YÈwlÈwïwpuï (2019/4/13), ŒÃ®.
723433. [wï (S)] (|X^[) ùé€ØJãoäTªØsáÉš¯é³ÉªØ¹pÌe¿. Öûaé1, ]q1, gºÃL1, ¿q1, àNq1, Îì²O1, åŒfq1, àäYñ1, CìMç1 (1YÈ): æ71ñú{YÈwlÈwïwpuï (2019/4/13), ŒÃ®.
723434. [wï (S)] (|X^[) q{èòBàÉη鯻wúËüÇ\ÉÖ·éœ{Ý€¯²ž€. ·ä@T, Oã²j, G@F, ìœìº, ·ö¹ñ, ËàVWq, Œö@^, ¬Ñhm, ¶
^Iv, {éxq, ¡c¡d, }ŒRÀ, ÂØzê, â£tq1, Rû@, ÕŽ@«, ¡R³r, ªd~L¶, R@õ, |ŽaG, ºrº, §åã, £Çñ, ºal, cš@±, ãYËi, â²®ü, œàV@Ò, ì@L, òO¢, ¬Ñ@_, Œ³@², XdêY, k@³l, ÂLŸ, er@N, Y^|, ¡ŽtêY, ¿R@¡, åÎOY, ¬ÑTŸ, np¹,
ìü, gcDY, ºã¶m, Žcs, ¡ä@Ò, èŽvi, ¬Gœ, ¡RÇm, «@ŸT, Œcì,
V]mÆ, R@O (1wl): æ71ñú{YÈwlÈwïwpuï (2019/4/13), ŒÃ®.
723435. [wï (S)] (|X^[) DP20TÈOÉj
µDP22TÈ~Éo¶µœ3ÇáÌ]A. ÜTV1, gºÃL1, Öûaé1, ¢@1, Ü\šmu1, àNq1, Îì²O1, åŒfq1, àäYñ1, ]q1, CìMç1 (1YÈ): æ71ñú{YÈwlÈwïwpuï (2019/4/14), ŒÃ®.
723436. [wï (S)] (êÊû) q{ÌÞààG1šæÑG2Ìp
×Ef]¿ðs€Õ°IÓ`. Ãì³`1, â£tq1, cGLI1, c±b1, Vä³G1, ¶cMu1 (1wl): æ60ñú{Õ°×Ewïï (túåï) (2019/6/8), .
723437. [wï (S)] (êÊu) Two cases of malignant mixed germ cell tumors of ovary in young girls. Mary NHEB, Wakasa T, Kalyan M, Aun K, Yahata H, cGLI1, â£tq1, Enoki E, Banno K, Kawai T (1wl): æ60ñú{Õ°×Ewïï (túåï) (2019/6/8), .
723438. [wï (S)] (êÊu) Peritoneal neoplasm with massive ascites. Vitou L, Kawai T, Wakasa T, Sophana S, Linka K, cGLI1, â£tq1, Katayama H, Hiroi S, Enoki E (1wl): æ60ñú{Õ°×Ewïï (túåï) (2019/6/8), .
723439. [wï (S)] (|X^[) @Éš¯éq{èòàÉη鯻wúËü@ÌfeasibilityÉ¢ÄÌ¢. ¡^ê1, c±b1, Ãì³`1, cGLI1, Vä³G1, gì@C1,2, â£tq1, ¶cMu1 (1wl, 2YÈ): æ61ñú{wlÈîáwïwpuï (2019/7/4), V.
723440. [wï (S)] (|X^[) q{èòàÉš¯éD
/p
äÆ\ãÆÌÖW. cGLI1, â£tq1, ¡^ê1, Ãì³`1, ²¡pM, c±b1, Vä³G1, gì@C1,2, ¶cMu1 (1wl, 2YÈ): æ61ñú{wlÈîáwïwpuï (2019/7/4), V.
723441. [wï (S)] (|X^[) äTŽ««FîÌ7á. ¬@è1, cGLI2, ¡^ê2, Ãì³`2, c±b2, Vä³G2, gì@C1,2, â£tq2, ¶cMu2 (1YÈ, 2wl): æ61ñú{wlÈîáwïwpuï (2019/7/5), V.
723442. [wï (S)] (|X^[) àÄ»wÃ@Éǵœj
[VX`XxÌêá. CòÎ1, â£tq2, ¡^ê2, Ãì³`2, cGLI2, c±b2, Vä³G2, gì@C1,2, ¶cMu2 (1YÈ, 2wl): æ61ñú{wlÈîáwïwpuï (2019/7/5), V.
723443. [wï (S)] (|X^[) DPãú©çYåñúɪ赜BNPlÆÕ°oß. gºÃL1, ]q1, ¿q1, àNq1, Öûaé1, åŒfq1, àäYñ1, CìMç1 (1YÈ): æ55ñú{üYúEV¶ãwïwpWï (2019/7/13), Œ{.
723444. [wï (S)] (|X^[) åKÍkÐÉü¯œ@üYúêqãÃZ^[ÌæègÝ. ¿q1, ]q1, gºÃL1, Rû»T2, àNq1, Öûaé1, åª2, Îì²O1, åŒfq1, àäYñ1, çÝ@w2, ŒGF2,3, CìMç1 (1YÈ, 2¬, 3V¢IãÃEæ[ãÃ): æ55ñú{üYúEV¶ãwïwpWï (2019/7/13-15), ·ì, ú{üYú¥V¶ãwïG 2019; 55 (2): 609.
723445. [wï (S)] (êÊu) Aa¹DwÌDPOÇÌÀÔ. ]q1, åŒfq1, çÝ@w2, Rû»T2, åª2, gºÃL1, àNq1, ŒàVWã1, Öûaé1, àäYñ1, CìMç1 (1YÈ, 2¬): æ55ñú{üYúEV¶ãwïwpWï (2019/7/13-15), ·ì.
723025. [wï (S)] (êÊu) q{àÇÉš¯épÇV¶ð§ä·éVEGFR1ÌððŸ. ¿q1, É¡`ç2, {cëq3, Öûaé1, ×ìÁÞq2, CìMç1, n³²2 (1YÈ, 2ò, 3åw@ãÃn€È): æ40ñú{ǥĶãwï (2019/7/16), _Ë.
723446. [wï (S)] (|X^[) q{ìàœØîÇ (IVL) ðpOffµ oŸÉÄq{SEðš±ÈÁœêá. ºî°1, ªÃKä2, ¬@è2, ÜTV2, É¡À1,3, HRG¢q2,3, v¥s3, OØŸ¿2,3 (1wl, 2YÈ, 3k¢åwfBJZ^[): æ59ñú{YÈwlÈàŸwïwpuï (2019/9/12), s.
723447. [wï (S)] (|X^[) oØwIãóÚA@É¢ÄÌÄl. â[rã1, gì@C1,2, É¡À1, œªBå1, {cëq3, ºc²m2 (1wl, 2YÈ, 3åw@ãÃn€È): æ64ñú{¶BãwïwpuïEï (2019/11/7), _Ë.
723448. [wï (S)] (êÊû) M2 MacrophageÍ,
°OúÌq{àÌproliferation differentiation switching (PDS) ð§ä·é±ÆÅ
°¬§Éñ^·é. ¬ìmã, gì@C1,2, Éëü, œªBå1, äåa, Ô}@r, ac^êY, Ac@×, å{êõ, âV¡@ (1wl, 2YÈ): æ64ñú{¶BãwïwpuïEï (2019/11/8), _Ë.
723449. [wï (S)] (êÊu) JALAu³ÉªØÖWwïEcÌAŠcïv®ñ. CìMç (YÈ): æ123ñú{YÈwïwpWï (2019/11/23), .
723450. [wï (S)] (êÊû) q{àÇ«XEÌà»Éš¯ézóeÌÌ@\IÓ`ÉÖ·é¢. œªBå1, gì@C1,2, Œ{rp3, ²¡G¢Þ4, â[rã1, É¡À1, {cëq5, â£tq1, CòÎ2, O}@M3, ¶cMu1 (1wl, 2YÈ, 3a, 4aÔEfÃn, 5åw@ãÃn€È): æ41ñú{GhgI[VXwïwpuï (2020/1/19), ºÖ.
723451. [wï (S)] (êÊû) t¬oÌSphingosine 1-phosphate (S1P) Í, oà«ðM2MacrophageDÊɳ¹, q{àÇÌiWÉñ^·é. ¬ìmã, gì@C1,2, Éëü, ÂìMs, ²r, Ÿc@n, m`«, ac^êY, ¡ìhj, ÂØ~«, âV¡@ (1YÈ, 2wl): æ41ñú{GhgI[VXwïwpuï (2020/1/19), ºÖ.
723030. [wï (S)] (êÊu) RAMP1Éæé}EXq{àÇÉš¯éÇEpÇV¶£iìp (RAMP1 signaling facilitates angiogenesis and lymphangiogenesis in the endometriotic lesions in mice). {cëq1, É¡`ç2, ¿q3, ×ìÁÞq2, {Ci1, åj¹1, 1, n³²2 (1åw@ãÃn€È, 2ò, 3YÈ): æ93ñú{òwïNï (2020/3/16-18), ãJÃ.
731039. [wï (nûïE€ï)] (ÁÊu) ÌsÁÄ¢éq{àÇfÃ. gì@C1,2 (1YÈ, 2wl): ÍŽYwlÈãï (2019/4/4), ÍŽ.
731040. [wï (nûïE€ï)] (ÁÊu) zɧä³êé¶B¶É£¹çêÄ. gì@C1,2 (1YÈ, 2wl): _ÞìYwlÈãï ªZ~i[ (2019/4/27), ª.
731041. [wï (nûïE€ï)] (ÁÊu) €É§rµœq{àÇ¡ÃÌXgeW[. gì@C1,2 (1YÈ, 2wl): œËYwlÈãï (2019/7/18), œË.
731042. [wï (nûïE€ï)] (ÁÊu) ÌsÁÄ¢éq{àÇ¡Ã. gì@C1,2 (1YÈ, 2wl): ÀÔ»£YwlÈãï (2019/7/23), CVŒ.
731043. [wï (nûïE€ï)] (ÁÊu) q{àÇÉš¯éHR-QOL. gì@C1,2 (1YÈ, 2wl): WEB conference: wlÈŸ³Éš¯éQOLÌÓ`ðlŠé (2019/9/5), .
731044. [wï (nûïE€ï)] (ÁÊu) üYúÌæÌÐQÎô|©E€EöÌ èû. CìMç (YÈ): üæYwlÈãï (2019/9/20), ü.
731045. [wï (nûïE€ï)] (ÁÊu) ³ÉªØÌÀS«üãÌœßÌûô. CìMç (YÈ): ßa³Nxæ2ñ ê§YÈwlÈãïwp€Cï (2019/9/21), åÃ.
731046. [wï (nûïE€ï)] (ÁÊu) \õ\Í©çÝœ¶BãÃ. gì@C1,2 (1YÈ, 2wl): æ27ñ_Þ짧ænæYwlÈ€Cï (2019/10/17), ÍŽ.
731047. [wï (nûïE€ï)] (ÁÊu) œ¿ÌsÁÄ¢éàŸ¡ÃÌHv. gì@C1,2 (1YÈ, 2wl): æ11ñÝÈÆYwlÈàŸ€ï (2019/10/18), .
731048. [wï (nûïE€ï)] (ÁÊu) ÌsÁÄ¢éq{àÇfÃ. gì@C1,2 (1YÈ, 2wl): æ3ñ_Þìq{àÇEBØÇ€ï (2019/10/23), ¡l.
732035. [wï (nûïE€ï)] (µãÙu) ÌsÁÄ¢éq{àÇ€šæÑÕ°. gì@C1,2 (1YÈ, 2wl): ÍŽYwlÈãï (2019/4/1), ÍŽ.
732036. [wï (nûïE€ï)] (µÒu) Functional MRI techniques to evaluate uterine fibroid. gì@C1,2, Takahashi N, ¶cMu2, Osuga Y (1YÈ, 2wl): æ10ñwlÈz˶«Ÿ³€ï (2019/6/8), .
733148. [wï (nûïE€ï)] (êÊu) åKÍÐQÌüYúãÃņ̃ÌmÛÉ¢Ä: YȨ̀ê©ç. CìMç (YÈ): ŒÃ®æêÔ\a@üYúêqãÃZ^[20üNLOuï (2019/6/15), ŒÃ®.
733149. [wï (nûïE€ï)] (êÊû) oçISxâuð±üµœé€ØJ4ÇáÌoÊ. ¢@1, Rè@D1, Œê1, gºÃL1, ¿q1, Öûaé1, àNq1, Îì²O1, åŒfq1, àäYñ1, ]q1, CìMç1 (1YÈ): æ137ñÖAYÈwlÈwïïEwpWï (2019/6/16), .
733150. [wï (nûïE€ï)] (êÊû) dÇßèhÇóQ (OHSS) Ì2Çá. Ü\šmu1, â[rã2, ºc²m1, {cëq3, ìàl, gì@C1,2, ¶cMu2, CìMç1 (1YÈ, 2wl, 3åw@ãÃn€È): æ137ñÖAYÈwlÈwïïEwpWï (2019/6/16), .
733151. [wï (nûïE€ï)] (êÊu) üYúãÃÌÀS«üãÖÌÆèÝ|³ÉªØÖWwïEcÌAŠcï (JALA) ̮̲ÐîÆÈÌæ¶ûÖÌšè¢|. CìMç (YÈ): æ6ñkZ~i[ (2019/6/22), åä.
733152. [wï (nûïE€ï)] (êÊû) @ÌwlÈ««îáÉš¯éDs«·¶É¢Ä. É¡À1, c±b1, Ãì³`1, 匫l1, cGLI1, gì@C1,2, â£tq1, ¶cMu1, CìMç2 (1wl, 2YÈ): æ381ñl
ï (2019/6/26), .
733153. [wï (nûïE€ï)] (êÊû) {ÝÅo±µœq{àœÇÌoÊÉÖ·é¢. J@ìç1, ]q1, gºÃL1, ¿q1, àNq1, Öûaé1, Îì²O1, åŒfq1, àäYñ1, CìMç1 (1YÈ): æ426ñ_ÞìYÈwlÈwïwpuï (2019/6/29), ¡l.
733154. [wï (nûïE€ï)] (êÊû) œ¬30Nx _ÞìYÈwlÈwï wlÈ««îáo^Wvñ. Àèßq, CY¡cÞü, gc@_, Y@«, åŽ@÷, c±b1, Vä@w1, ØÒv, ²XØN, ÄRê, Ñ@Nq, œàV@Ò, Xª@², éèŸê, nç²L¡, Oã²j, Á¡v·, ìáÁ²j, éØ@Œ, ŽPj (1wl): æ426ñ_ÞìYÈwlÈwïwpuï (2019/6/29), ¡l.
733005. [wï (nûïE€ï)] (êÊu) q{àÇÉš¯é¬ÇV¶ð§ä·é_oyv`hCGRPÌð. {cëq1, É¡`ç2, ¿q3, ×ìÁÞq2, {Ci1, åj¹1, s¯¢¢1, n³²2 (1åwåw@ãÃn€È, 2ò, 3YÈ): æ140ñú{òwïÖï (2019/7/6), .
733155. [wï (nûïE€ï)] (êÊu) jR`ªãóÌq{à
°É^Šée¿É¢ÄÌ¢. gì@C1,2, ¬ìmã, Éëü, âV¡@ (1YÈ, 2wl): ¬€\ï (iÈw€àc) (2019/7/23), .
733156. [wï (nûïE€ï)] (êÊû) EXITð{sµœÙzîáÌêá. Ü\šmu1, åŒfq1, gºÃL1, ¿q1, àNq1, Öûaé1, Îì²O1, àäYñ1, ]q1, CìMç1 (1YÈ): æ427ñ_ÞìYÈwlÈwï (2019/9/21), ìè.
733157. [wï (nûïE€ï)] (êÊû) Klippel-Trenanay-WeberÇóQÌêá. Rè@D1, Îì²O1, CòÎ1, gºÃL1, ¿q1, àNq1, Öûaé1, åŒfq1, àäYñ1, ]q1, CìMç1 (1YÈ): æ427ñ_ÞìYÈwlÈwï (2019/9/21), ìè.
733158. [wï (nûïE€ï)] (êÊû) q{èò~ØpãÉÇÁ¡Ãðvµœ4á. Œê1, Vä³G2, ŒRD1, ŒàVWã1, nêªê, ÍìÆq1, åì@×, ]€Y, gŽ@ê, ãVqq (1YÈ, 2wl): æ427ñ_ÞìYÈwlÈwï (2019/9/21), ìè.
733159. [wï (nûïE€ï)] (êÊû) q{ŸèpOÉGnRHA^SjXg (ONX) ð^µœ6Çá. É¡À1, â[rã1, œªBå1, ºc²m2, {cëq3, gì@C1,2, ¶cMu1 (1wl, 2YÈ, 3åw@ãÃn€È): æ427ñ_ÞìYÈwlÈwï (2019/9/21), ìè.
733160. [wï (nûïE€ï)] (êÊu) ÀSȳɪØņ̃Ì\zÌœßÉ. CìMç (YÈ): ßa³Nxê§êÌÛì@wèãt€Cï (2019/9/23), ê.
733161. [wï (nûïE€ï)] (|X^[) DPÉRMDA5RÌz«çØðǵœÙçsSÌ1á. ÜTV1, ]q1, gºÃL1, àNq1, Öûaé1, Îì²O1, åŒfq1, àäYñ1, CìMç1 (1YÈ): æ138ñÖAYÈwlÈwïïEwpWï (2019/10/19), OŽ.
733162. [wï (nûïE€ï)] (|X^[) åaϪ¶ã oɶݵ, pOffª¢ïÅ Áœq{BØÇRÆlŠçêéÞààGIÌêá. J@ìç1, â£tq2, ¬@è1, Œê1, ¡^ê2, Ãì³`2, 匫l2, cGLI2, c±b2, gì@C1,2, ¶cMu2 (1YÈ, 2wl): æ138ñÖAYÈwlÈwïïEwpWï (2019/10/19), OŽ.
733163. [wï (nûïE€ï)] (|X^[) Dysgerminoma𹵜46, XY pure gonadal dysgenesis (SwyerÇóQ) Ìêá. Rè@D1, â£tq2, Ãì³`2, 匫l2, â[rã2, cGLI2, c±b2, gì@C1,2, ¶cMu2 (1YÈ, 2wl): æ138ñÖAYÈwlÈwïïEwpWï (2019/10/19), OŽ.
733164. [wï (nûïE€ï)] (|X^[) tBumQ»ÜðgpµœªØãÙío8ÇáÌ\ã. Ü\šmu1, ]q1, åŒfq1, ¿q1, gºÃL1, àNq1, Öûaé1, Îì²O1, àäYñ1, CìMç1 (1YÈ): æ138ñÖAYÈwlÈwïïEwpWï (2019/10/19), OŽ.
733165. [wï (nûïE€ï)] (êÊû) xoVc}uÉæè·ú°ððŸçêœàÄÌêá. Ü\šmu1, ª¶1, F@p÷, Vä@w2 (1YÈ, 2wl): æ428ñ_ÞìYÈwlÈwïwpuï (2019/11/10), Íåì.
733166. [wï (nûïE€ï)] (êÊû) pã12NÅĵœq{œØ÷îÌ1á. Rè@D1, Vä³G2, ŒRD1, ŒàVWã1, nêªê, ÍìÆq1, åì@×, ]€Y, gŽ@ê, ãVqq (1YÈ, 2wl): æ428ñ_ÞìYÈwlÈwïwpuï (2019/11/10), Íåì.
733167. [wï (nûïE€ï)] (êÊû) ŽÙ}é€ØJpð{sµœ¬ÂžÇÌ1á. ã¡SêN1, gºÃL2, àNq2, ¿q2, Öûaé2, Îì²O2, åŒfq2, àäYñ2, ]q2, CìMç2 (1€Cã, 2YÈ): æ428ñ_ÞìYÈwlÈwïwpuï (2019/11/10), Íåì.
733168. [wï (nûïE€ï)] (êÊû) pOžÅ³Çó«átBumQÇÆ»Ÿµœq{ÌàÌêá. œcxj1, â£tq2, ÜTV3, Ãì³`2, 匫l2, cGLI2, c±b2, gì@C2,3, ¶cMu2 (1€Cã, 2wl, 3YÈ): æ428ñ_ÞìYÈwlÈwïwpuï (2019/11/10), Íåì.
733169. [wï (nûïE€ï)] (êÊû) äXªsÁÄ¢é oŸfÃ. â[rã1, gì@C1,2, É¡À1, œªBå1, {cëq3, ¶cMu1 (1wl, 2YÈ, 3åw@ãÃn€È): æ382ñl
ï (2019/11/20), .
'18NxÈOª
[wïE€ï]
H29-722001. [wï (S)] ([NVbv) åKÍkжɚ¯éüYúêqãÃZ^[ÌƱp±væ (BCP) ì¬ÌÛè. ¿q1, CìMç1 (1YÈ): æ23ñú{WcÐQãwïïEwpWï (2018/2/3), ¡l
H29-723001. [wï (S)] (êÊè) DPÉFBN1ÏÙ (c.364C>T) ðàÂ}t@ÇóQÆffµœêá. åŒfq1,2, ]q1,2, x ·©2, CìMç1, cjj2,3 (1YÈ, 2a@â`fÃ, 3åw@ãÃn€È): ú{lÞâ`wïæ62ñåï (2017/11/16), _Ë.
'18-733004. [wï (S)] (êÊû) Massive ovarian edemaÉ뵀 oŸºèpð{sµœ2Çá. Rè@D1, OØŸ¿1,2, ªÃKä1, ÎäGä»q, HRG¢q1, ºî°3, v¥s2, âRI2,4 (1YÈ, 2k¢åwfBJZ^[, 3wl, 4¬): æ56ñéʧãwïï (2019/2/24), éÊ.
®`OÈw
[wp_¶]
110264. [Ž] Hooks at the Upper Instrumented Vertebra Can Adjust Postoperative Shoulder Balance in Patients with Adolescent Idiopathic Scoliosis: 5 Years or More of Follow-up. Kuroya S, Akazawa T, Kotani T, Sakuma T, Minami S, Torii Y, Umehara T, Iinuma M, Murakami K, Orita S, Inage K, Eguchi Y, Fujimoto K, Shiga Y, Nakamura J, Inoue G1, Miyagi M1, Saito W1, Ohtori S, Niki H: Asian Spine J 2019/5; 13 (5): 793-800. (äã@º1, {é³s1, âV¡@j1: 1®O)
110265. [Ž] ISSLS PRIZE IN CLINICAL SCIENCE 2019: clinical importance of trunk muscle mass for low back pain, spinal balance, and quality of life-a multicenter cross-sectional study. Hori Y, Hoshino M, Inage K, Miyagi M1, Takahashi S, Ohyama S, Suzuki A, Tsujio T, Terai H, Dohzono S, Sasaoka R, Toyoda H, Kato M, Matsumura A, Namikawa T, Seki M, Yamada K, Habibi H, Salimi H, Yamashita M, Yamauchi T, Furuya T, Orita S, Maki S, Shiga Y, Inoue M, Inoue G1, Fujimaki H, Murata K2, Kawakubo A2, Kabata D, Shintani A, Ohtori S, Takaso M1, Nakamura H: Eur Spine J 2019/5; 28 (5): 914-21. ({é³s1, äã@º1, ºcKC2, ìvÛà2, »m1: 1®O, 2åw@ãÃn€È)
110266. [Ž] Elevated leptin levels induce inflammation through IL-6 in skeletal muscle of aged female rats. Tazawa R1, Uchida K2, Fujimaki H, Miyagi M2, Inoue G2, Sekiguchi H2, Murata K1, Takata K1, Kawakubo A1, Takaso M2: BMC Musculoskelet Disord 2019/5; 20 (1): 199. (càV@È1, àcŸY2, {é³s2, äã@º2, ÖûTV2, ºcKC1, c@€1, ìvÛà1, »m2: 1åw@ãÃn€È, 2®O)
110267. [Ž] Transforming growth factor-À stimulates nerve growth factor production in osteoarthritic synovium. Takano S1, Uchida K1, Itakura M2, Iwase D1, Aikawa J1, Inoue G1, Mukai M3, Miyagi M1, Murata K3, Sekiguchi H1, Takaso M1: BMC Musculoskelet Disord 2019/5; 20 (1): 204. (잟Y1, àcŸY1, Âq@œ2, â£@å1, ì@~1, äã@º1, }@@w3, {é³s1, ºcKC3, ÖûTV1, »m1: 1®O, 2¶», 3åw@ãÃn€È)
110268. [Ž] Minimally invasive manganese-enhanced magnetic resonance imaging for the sciatic nerve tract tracing used intra-articularly administrated dextran-manganese encapsulated nanogels. Eguchi Y, Murayama S, Kanamoto H, Abe K, Miyagi M1, Takahashi K, Ohtori S, Aoki I: JOR Spine 2019/6; 2 (2): e1059. ({é³s1: 1®O)
110269 [Ž] Long-term outcomes of Wagner self-locking stem with bone allograft for Paprosky type II and III bone defects in revision total hip arthroplasty: A mean 15.7-year follow-up. Zang J, Uchiyama K1, Moriya M1, Fukushima K1, Takahira N2, Takaso M1: J Orthop Surg (Hong Kong) 2019/6; 27 (2): 2309499019854156. (àR¶1, XJõr1, î1, œ®L2, »m1: 1®O, 2ãÃq¶w)
110270. [Ž] Osteoarthritis patients with high haemoglobin A1c have increased Toll-like receptor 4 and matrix metalloprotease-13 expression in the synovium. Murata K1, Uchida K2, Takano S2, Shoji S1, Iwase D2, Inoue G2, Aikawa J2, Yokozeki Y1, Sekiguchi H2, Takaso M2: Diabetes Metab Syndr Obes 2019/7; 12: 1151-9. (ºcKC1, àcŸY2, 잟Y2, ¯i^ŸY1, â£@å2, äã@º2, ì@~2, ¡ÖYi1, ÖûTV2, »m2: 1åw@ãÃn€È, 2®O)
110271. [Ž] Spinal Alignments of Residual Lumbar Curve Affect Disc Degeneration after Spinal Fusion in Patients with Adolescent Idiopathic Scoliosis: Follow-up after 5 or More Years. Akazawa T, Umehara T, Iinuma M, Asano K, Kuroya S, Torii Y, Murakami K, Kotani T, Sakuma T, Minami S, Orita S, Inage K, Shiga Y, Nakamura J, Inoue G1, Miyagi M1, Saito W1, Eguchi Y, Fujimoto K, Takahashi H, Ohtori S, Niki H: Spine Surg Relat Res 2019/8; 4 (1): 50-6. (äã@º1, {é³s1, âV¡@j1: 1®O)
110272. [Ž] Changes in Nerve Growth Factor Expression and Macrophage Phenotype Following Intervertebral Disc Injury in Mice. Nakawaki M1, Uchida K2, Miyagi M2, Inoue G2, Kawakubo A1, Sato M3, Takaso M2: J Orthop Res 2019/8; 37 (8): 1798-804. (e[Í1, àcŸY2, {é³s2, äã@º2, ìvÛà1, ²¡@ë3, »m2: 1åw@ãÃn€È, 2®O, 3Æu)
110273. [Ž] IL-1À mediates NGF and COX-2 expression through transforming growth factor-activating kinase 1 in subacromial bursa cells derived from rotator cuff tear patients. Nagura N, Uchida K1, Kenmoku T1, Inoue G1, Nakawaki M2, Miyagi M1, Takaso M1: J Orthop Sci 2019/9; 24 (5): 925-9. àcŸY1, ©ÚqI1,äã@º1, e[Í2, {é³s1, »m1: 1®O, 2åw@ãÃn€È)
110274. [Ž] Vascular Endothelial Growth Factor Is Regulated by the Canonical and Noncanonical Transforming Growth Factor-À Pathway in Synovial Fibroblasts Derived from Osteoarthritis Patients. Takano S1, Uchida K1, Shoji S2, Itakura M3, Iwase D1, Aikawa J1, Mukai M2, Sekiguchi H1, Inoue G1, Takaso M1: Biomred Res Int 2019/9; Article ID 6959056. https://doi.org/10.1155/2019/6959056 (잟Y1, àcŸY1, ¯i^ŸY2, Âq@œ3, â£@å1, ì@~1, }@@w2, ÖûTV1, äã@º1, »m1: 1®O, 2åw@ãÃn€È, 3¶»)
110275. [Ž] Clinical usefulness of multiplex PCR-lateral flow for the diagnosis of orthopedic-related infections. Minegishi Y1, Uchiyama K1, Sakurai K2, Ibe S, Kanda H, Nihonyanagi S2,3, Nakamura M4, Ikeda S, Takaso M1: Mod Rheumatol 2019/9; 29 (5): 867-73. (õÝmY1, àR¶1, Näc¢2, ñ{öL2,3, º³÷4, »m1: 1®O, 2Õ, 3ŽõǺ, 4ãÃq¶w)
110276. [Ž] Wrapping With Basic Fibroblast Growth Factor-Impregnated Collagen Sheet Reduces Rat Sciatic Nerve Allodynia. Mukai M, Uchida K1, Hirosawa N, Murakami K, Kuniyoshi K, Inoue G1, Miyagi M1, Sekiguchi H1, Shiga Y, Inage K, Orita S, Suzuki T, Matsuura Y, Takaso M1, Ohtori S: J Orthop Res 2019/10; 37 (10) :2258-63. (àcŸY1, äã@º1, {é³s1, ÖûTV1, »m1: 1®O)
110277. [Ž] Comparison of glenohumeral joint rotation between asymptomatic subjects and patients with subacromial impingement syndrome using cine-magnetic resonance imaging: a cross-sectional study. Kenmoku T1,2, Matsuki K, Ochiai N, Sonoda M, Ishida T, Sasaki S, Tanaka Y, Nakawaki M3, Nagura N, Tazawa R3, Sasaki u, Takaso M2: BMC Musculoskelet Disord 2019/10; 20 (1): 475. (©ÚqI1,2, e[Í3, càV@È3, »m2: 1k¢åwk¢€a@, 2®O, 3åw@ãÃn€È)
110278. [Ž] Differential mRNA Expression of COX-2 and Proinflammatory Mediators in Patients with Rotator Cuff Tears and Osteoarthritis of the Hip. Kenmoku T1,2, Uchida K2, Nagura N, Fujimaki H, Nakawaki M3, Takahira N4, Fukushima K2, Tazawa R3, Muneshige K3, Inoue G2, Takaso M2: Open Journal of Orthopaedics 2019/11; 9 (11): 254-63. (©ÚqI1,2, àcŸY2, e[Í3, œ®L4, î2, càV@È3, @d¿q3, äã@º2, »m2: 1k¢åwk¢€a@, 2®O, 3åw@ãÃn€È, 4ãÃq¶w)
110279. [Ž] Surgical outcomes of spinal fusion for osteoporotic vertebral fracture in the thoracolumbar spine: Comprehensive evaluations of 5 typical surgical fusion techniques. Watanabe K, Katsumi K, Ohashi M, Shibuya Y, Hirano T, Endo N, Kaito T, Yamashita T, Fujiwara H, Nagamoto Y, Matsuoka Y, Suzuki H, Nishimura H, Terai H, Tamai K, Tagami A, Yamada S, Adachi S, Yoshii T, Ushio S, Harimaya K, Kawaguchi K, Yokoyama N, Oishi H, Doi T, Kimura A, Inoue H, Inoue G1, Miyagi M1, Saito W1, Nakano A, Sakai D, Nukaga T, Ikegami S, Shimizu M, Futatsugi T, Ohtori S, Furuya T, Orita S, Imagama S, Ando K, Kobayashi K, Kiyasu K, Murakami H, Yoshioka K, Seki S, Hongo M, Kakutani K, Yurube T, Aoki Y, Oshima M, Takahata M, Iwata A, Endo H, Abe T, Tsukanishi T, Nakanishi K, Watanabe K, Hikata T, Suzuki S, Isogai N, Okada E, Funao H, Ueda S, Shiono Y, Nojiri K, Hosogane N, Ishii K: J Orthop Sci 2019/11; 24 (6): 1020-6. (äã@º1, {é³s1, âV¡@j1: 1®O)
110280. [Ž] Complications after spinal fixation surgery for osteoporotic vertebral collapse with neurological deficits: Japan Association of Spine Surgeons with ambition multicenter study. Sakai Y, Kaito T, Takenaka S, Yamashita T, Makino T, Hosogane N, Nojiri K, Suzuki S, Okada E, Watanabe K, Funao H, Isogai N, Ueda S, Hikata T1,2, Shiono Y, Watanabe K, Katsumi K, Fujiwara H, Nagamoto Y, Terai H, Tamai K, Matsuoka Y, Suzuki H, Nishimura H, Tagami A, Yamada S, Adachi S, Ohtori S, Orita S, Furuya T, Yoshii T, Ushio S, Inoue G2, Miyagi M2, Saito W2, Imagama S, Ando K, Sakai D, Nukaga T, Kiyasu K, Kimura A, Inoue H, Nakano A, Harimaya K, Doi T, Kawaguchi K, Yokoyama N, Oishi H, Ikegami S, Futatsugi T, Shimizu M, Kakutani K, Yurube T, Oshima M, Uei H, Aoki Y, Takahata M, Iwata A, Seki S, Murakami H, Yoshioka K, Endo H, Hongo M, Nakanishi K, Abe T, Tsukanishi T, Ishii K: J Orthop Sci 2019/11; 24 (6): 985-90. (úûqG1,2, äã@º2, {é³s2, âV¡@j2: 1k¢åwk¢€a@, 2®O)
110281. [Ž] MRI evaluation of dural sac enlargement by interspinous process spacers in patients with lumbar spinal stenosis: Does it play a role in the long term? Akazawa T, Kotani T, Sakuma T, Torii Y, Iinuma M, Asano K, Ueno J, Yoshida A, Murakami K, Minami S, Orita S, Inage K, Shiga Y, Nakamura J, Inoue G1, Miyagi M1, Saito W1, Eguchi Y, Fujimoto K, Takahashi H, Ohtori S, Niki H: J Orthop Sci 2019/11; 24 (6): 979-84. (äã@º1, {é³s1, âV¡@j1: 1®O)
110282. [Ž] Effect of Single Injection of Recombinant Human Bone Morphogenetic Protein-2-Loaded Artificial Collagen-Like Peptide in a Mouse Segmental Bone Transport Model. Tazawa R1, Minehara H2, Matsuura T3, Kawamura T3, Uchida K3, Saito W3, Inoue G3, Takaso M3: Biomed Res Int 2019/12; 2019: 1014594. doi: 10.1155/2019/1014594. eCollection 2019. (càV@È1, ôŽG¹2, ŒYW³3, ìº@Œ3, àcŸY3, äã@º3, âV¡@j3, »m3: 1åw@ãÃn€È, 2~œ, 3®O)
110283. [Ž] Occupational Characteristics of Low Back Pain Among Standing Workers in a Japanese Manufacturing Company. Inoue G1, Uchida K1, Miyagi M1, Saito W1, Nakazawa T1, Imura T1, Shirasawa E1, Akazawa T, Orita S, Inage K, Takaso M1, Ohtori S: Workplace Health Saf 2020/1; 68 (1): 13-23. (äã@º1, àcŸY1, {é³s1, âV¡@j1, àVrV1, äºMV1, àVh÷1, »m1: 1®O)
110284. [Ž] Polyglycolic acid-collagen tube combined with collagen-binding basic fibroblast growth factor accelerates gait recovery in a rat sciatic nerve critical-size defect model. Fujimaki H, Uchida K1, Inoue G1, Matsushita O, Nemoto N, Miyagi M1, Inage K, Takano S1, Orita S, Ohtori S, Tanaka K, Sekiguchi H1, Takaso M1: J Biomed Mater Res B Appl Biomater 2020/2; 108 (2): 326-32. (àcŸY1, äã@º1, {é³s1, 잟Y1, ÖûTV1, »m1: 1®O)
120012. [Ž] êwCMÖßÇÉηébLOv[gðgpµœCMÖßÅèpÌ¡Ão±. ¬À«¡1, ì_m1, å|IÆ1, ¡ªõq, »m1 (1®O): ú{èOÈwïG 2019; 36 (2): 16-20.
120013. [Ž] DupuytrenSkÉηéèpÃ@|DãÌç٣ɶĪIJúÃ@ÆêúIÂœÃ@ðIð·éû@É¢Ä|. ¬À«¡1, ì_m1, å|IÆ1, ¬ÑŸ³, »m1 (1®O): ú{èOÈwïG 2019; 36 (2): 59-63.
120014. [Ž] Neer type IIœÊ[ÜÉηéÛ¶Ã@ÆèpÃ@Ìär. àì³², è@1,2, ¬£N¡, œìIq1,2 (1k¢åwfBJZ^[, 2®O): Ü 2019/6; 41 (3): 807-10.
120015. [Ž] Remplissage@ÉæéšÖßOû§®øÊÉÖ·é¢. càV@È1, ©ÚqI2,3, ŒqŒd, e[Í1, ì_m3, »m3 (1åw@ãÃn€È, 2k¢åwk¢€a@, 3®O): šÖß 2019/9; 43 (3): 688-92.
120016. [Ž] Periacetabular osteotomyªC7 plumb lineÉ^Šée¿. å|IÆ1, î1, äã@º1, {é³s1, àR¶1, œ®L2, »m1 (1®O, 2ãÃq¶w): Hip Joint 2019/9; 45 (1): 231-3.
120017. [Ž] p¿ÜÌffÉš¯éúÌàsPûÌ믫|åEÕÜ̹|. Ä¡cŸ, î1 (1®O): Hip Joint 2019/9; 45 (2): 263-5.
120018. [Ž] ZgXlHÒÖßVFÌ`óªúÅèÍšæÑPolar gapÖ^Šée¿|Œ
`šæÑŒÈ~
^ÔÌär|. gcaO1, î2, ðäÞ1, àR¶2, œ®L1, œL1 (1ãÃq¶w, 2®O): Õ°oCIJjNX 2019/10; 40: 135-9.
120019. [Ž] ãøR|[lgÌZgÅèÉæéÊuÌÚ®ÆÚAÉæé»Ì§ä. CcMë, ¬£N¡, œìIq1,2, è@1,2 (1k¢åwfBJZ^[, 2®O): ú{lHÖßwï 2019/12; 48: 137-8.
310035. [Çáñ] Regression of Retro-odontoid Pseudotumor Using External Orthosis without Atlantoaxial Fusion: A Case Report. Nakazawa T1, Inoue G1, Imura T1, Miyagi M1, Saito W1, Shirasawa E1, Kawakubo A2, Takaso M1: JBJS Case Connect 2019/7-9; 9 (3): e0329. (àVrV1, äã@º1, äºMV1, {é³s1, âV¡@j1, àVh÷1, ìvÛà2, »m1: 1®O, 2åw@ãÃn€È)
320027. [Çáñ] åÚ]qÜpãÉŒ«®¬á𶶜1á. ŽÜFT1, XJõr1, c@€2, â£@å1, c«ñ, àR¶1, »m1 (1®O, 2åw@ãÃn€È): Ö®`ÐQOÈwïG 2019/8; 50 (4): 194-8.
522069. [uÀ]yÁW: ÒÖßÆ»ÌüÍÌX|[cQzÖßàaÏÌff. î1, œ®L2, àR¶1, »m1 (1®O, 2ãÃq¶w): ®`EÐQOÈ 2019/7; 62 (8): 959-65.
522070. [uÀ]yÁW: X|[cfÃÉš¯éæff|ãÃÀSãKvÈRcÆƵ|zII. e_: ʲÆÌX|[cOEáQ@Õ, ÒÖß, åÚÌX|[cOEáQ. î1, œ®L2, »m1 (1®O, 2ãÃq¶w): ÖßOÈ 2019/10; 38 (11): 1190-7.
522071. [uÀ]yÁW: _oØŸ³, VœÈ¡ÃÌãÖzIII. ¹ÇÖÌîü@ÒÏ`ÖÌAv[`. »m1, Ö¡@j1, {é³s1, äã@º1, àVrV1, äºMV1, àVh÷1, ìvÛà2 (1®O, 2åw@ãÃn€È): ¬Èfà 2019/12; 83 (1): 113-22.
522072. [uÀ]yÁW: eé Ç«ÅÌÜ¡ÃÌÅVm©zeé ÇEÅÌÜÆȪè {é³s1, àcŸY1, äã@º1, »m1 (1®O): ®`EÐQOÈ 2020/2; 63 (2): 195-202.
522073. [uÀ]yÁW: ÛRZTX©çÝœ®`OÈŽõÎôÉš¯éÅVm©zlHÖßüÍŽõÌRÛòðÜßœ¡Ã. àR¶1, rcMî1, XJõr1, î1, »m1, œ®L2 (1®O, 2ãÃq¶w): ®`¥ÐQOÈ 2020/3; 63 (3): 281-6.
540042. [»ÌŒ (wïŽ^)] ÖßÊðÜÞLÍÍî¹ÉηéVµ¢Äû@ÌÝ è@1,2, œìIq1,2, ôÝmY1,2, {@î (1k¢åwfBJZ^[, 2®O): ú{gDÚAwïG 2019/7; 18 (1): 63.
540043. [»ÌŒ (wïŽ^)] oR}CVÜL_JVEZgñ¶ÌàüãÌoR}CVRÛ«]¿ àcŸY1, F, Öû_V1, è@1,2, »m1 (1®O, 2k¢åwfBJZ^[): ú{®`OÈwï 2019/9; 93 (8): 1746.
540044. [»ÌŒ (wïŽ^)] ~³òàÌlHGÖßSu·pOãÌñXeCh«RÇòÆt@\ϻ̢. œìIq1,2, è@1,2 (1k¢åwfBJZ^[, 2®O): ú{Ößawï 2019/10; 38 (3): 256.
[@]
620063. [wp (€)]yTEXTV[Y TEXT®`OÈw æ5Åz. »m1 (1®O), Ò: 幞i, »m1, oƳ², gîWê, ì]°, , 2019/8s.
620064. [wp (ªS·M)]yWfgÍÇÌ¡Ã@ðIð·êÎæ¢Ì©|úíæö·éŸ³|(ÖßOÈ2019N10§)zII. e_@1. Ï«Ÿ³, ãÓŸ³, îáÈÇ@Ï`«ÒÖßÇ, p.30-44. R{Ÿ, àR¶1, œ®L2 (1®O, 2ãÃq¶w), éæEÒW: ²xj, WJr
[Ð, , 2019/9s.
620065. [wp (ªS·M)]yqÇà©çålÜűÌ1û!@ófNîÊ ç«ÒÖß`¬sSÌf©œE¡µ©œzgsbNX@
D{[_[CDDHÉš¯éâè, p.107. î (®O), Ò: ît@T, N°, WJr
[Ð, , 2019/11s.
620066. [wp (ªS·M)]yOS NEXUS 20@ÖߟèpÌî{@[`ìÆfoCX̵¢ûzII º@ÒÖߟÌ[`ì, p.88-95. î (®O), SÒWÏõ: @c@å, WJr
[Ð, , 2019/11s.
620067. [wp (ªS·M)]y\hɱX|[c®`OÈzIV. ÒÖßÉ@2. åÚ°PCsWg muwn ú{lÉš¯éFAI, p.375-8. î (®O), Ò: ÃêpV, ñºº³, âVcÇm, R¡@, Á¡Ôu, ¶õ°, , 2019/11s.
620068. [wp (ªS·M)]y¡úÌ¡Ãwj 2020NÅ@ͱ€¡ÃµÄ¢éz18. ®`OÈŸ³@ÜÌÛ¶I¡Ã, p.1116. è@1,2 (1k¢åwfBJZ^[, 2®O), ÒW: äî, Ø@œ, ¬ºê¬, ãw@, , 2020/1s.
622003. [wp (|ó)]y®`OÈŽõÎôÉš¯éÛRZTX@lHÖßüÍŽõðÜÞØinŽõSÊ|Proceeding of the Second International Consensus Meeting on Musculoleletal Infection|zPART 1 GENERAL ASSEMBRY@SECTION 1: PREVENTION@1.10. \h: èpº, , p.13. 1.11. \h: èpº, X^bt, p.13-5. 1.12. \h: èpº, «, p.15-6. rcMî1, àR¶2, »m2 (1åw@ãÃn€È, 2®O), Ò: cNm, @{@[, WJr
[Ð, , 2019/9s.
622004. [wp (|ó)]y®`OÈŽõÎôÉš¯éÛRZTX@lHÖßüÍŽõðÜÞØinŽõSÊ|Proceeding of the Second International Consensus Meeting on Musculoleletal Infection|zPART 1 GENERAL ASSEMBRY@SECTION 1: PREVENTION@1.13. \h: èpº, OÈèp, p.16-7. 1.14. \h: èpº, èpÌæ, p.17-8. 1.15. \h: ôòt, p.18-9. 1.16. \h: èpº, èpèZ, p.19-20. õÝmY1,2, àR¶2, »m2 (1k¢åwfBJZ^[, 2®O), Ò: cNm, @{@[, WJr
[Ð, , 2019/9s.
[wïE€ï]
712015. [wï (Û)] (µÒu) The Patho-mechanism of Pain due to Aging Intervertebral Disc and Muscle. Miyagi M1: 2019 ISSLS (2019/6/3-7), Kyoto, Japan. ({é³s1: 1®O)
712016. [wï (Û)] (µÒu) The present situation of allograft bone graft in Japan. Inoue G1: AOA-JOA fellowship (2019/7/1), Reno Orthopaedic Clinic, Nevada, USA. (äã@º1: 1®O)
712017. [wï (Û)] (µÒu) Can Teriparatide Contribute to Success Fusion Surgery in Patients with Osteoporosis? Inoue G1: AOA-JOA fellowship (2019/7/3), Cedars-Sinai Medical Center, California, USA. (äã@º1: 1®O)
712018. [wï (Û)] (µÒu) The present situation of allograft bone graft in Japan. Inoue G1: AOA-JOA fellowship (2019/7/5), Mayo Clinic, Minnesota, USA. (äã@º1: 1®O)
712019. [wï (Û)] (µÒu) Application of the Allograft Bone for Orthopaedic Surgery. Inoue G1: AOA-JOA fellowship (2019/7/9), Stanford University, California, USA. (äã@º1: 1®O)
712020. [wï (Û)] (µÒu) The present situation of allograft bone graft in Japan. Inoue G1: AOA-JOA fellowship (2019/7/12), University of California, California, USA. (äã@º1: 1®O)
712021. [wï (Û)] (µÒu) Treatment for osteoprosis to success fusion surgery in patients in elderly. Inoue G1: AOA-JOA fellowship (2019/7/12), University of California, Sanfrancisco, Fresno, California, USA. (äã@º1: 1®O)
712022. [wï (Û)] (µÒu) Application of the Allograft Bone for Spinal Surgery - Differences Between the US and Japan. Inoue G1: AOA-JOA fellowship (2019/7/17), University of Washington, Seatle, Washington, USA. (äã@º1: 1®O)
712023. [wï (Û)] (µÒu) Radiological and clinical results of corrective surgery in patients with parkinson disease. Inoue G1, Saito W1, Miyagi M1, Imura T1, Shirasawa E1, Kawakubo A2, Nakazawa T1, Takaso M1: 1st Society of Lateral Access Surgery Asia Pacific & Japan Combined Meeting (2019/10/5), Tokyo, Japan. (äã@º1, âV¡@j1, {é³s1, äºMV1, àVh÷1, ìvÛà2, àVrV1, »m1: 1®O, 2åw@ãÃn€È)
713102. [wï (Û)] (êÊu) Factors Associated with Low Back Pain in Osteoporosis. Miyagi M1, Murata K2, Koyama T2, Kawakubo A2, Fujimaki H, Uchida K1, Inoue G1, Takaso M1: The World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2019) (2019/4/4-7), Paris, France. ({é³s1, ºcKC2, ¬Rqv2, ìvÛà2, àcŸY1, äã@º1, »m1: 1®O, 2åw@ãÃn€È)
713103. [wï (Û)] (êÊu) Relationships among spinal alignment, bone mineral density, and muscle mass@in elderly patients with osteoporosis. Kawakubo A1, Miyagi M2, Fujimaki H, Inoue G2, Nakazawa T2, Imura T2, Saito W2, Uchida K2, Shirasawa E2, Ohtori S, Inage K, Takaso M2: The World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2019) (2019/4/4-7), Paris, France. (ìvÛà1, {é³s2, äã@º2, àVrV2, äºMV2, âV¡@j2, àcŸY2, àVh÷2, »m2: 1åw@ãÃn€È, 2®O)
713104. [wï (Û)] (êÊu) Does Body Mass Index Affect Spinal Alignment and Low Back Pain in Patients with Primary Osteoporosis? Inoue S1, Miyagi M1, Murata K2, Koyama T2, Otake Y1, Kuroda A2, Kawakubo A2, Ohtori S, Inage K, Uchida K1, Inoue G1, Takaso M1: 2019 ISSLS (2019/6/3-7), Kyoto, Japan. (äã@ãÄ1, {é³s1, ºcKC2, ¬Rqv2, å|IÆ1, cW`2, ìvÛà2, àcŸY1, äã@º1, »m1: 1®O, 2åw@ãÃn€È)
713105. [wï (Û)] (êÊu) Incidence and characteristics of postoperative vertebral fractures after fusion surgery in elderly patients. Inoue G1, Miyagi M1, Saito W1, Imura T1, Shirasawa E1, Kawakubo A2, Nakazawa T1, Takaso M1: 2019 ISSLS (2019/6/3-7), Kyoto, Japan. (äã@º1, {é³s1, âV¡@j1, äºMV1, àVh÷1, ìvÛà2, àVrV1, »m1: 1®O, 2åw@ãÃn€È)
713106. [wï (Û)] (êÊu) Relationship among spinal alignment, bone mineral density, and muscle mass in elderly osteoporosis patients. Kawakubo A1, Miyagi M2, Fujimaki H, Inoue G2, Nakazawa T2, Imura T2, Saito W2, Uchida K2, Shirasawa E2, Ohtori S, Inage K, Takaso M2: 2019 ISSLS (2019/6/3-7), Kyoto, Japan. (ìvÛà1, {é³s2, äã@º2, àVrV2, äºMV2, âV¡@j2, àcŸY2, àVh÷2, »m2: 1åw@ãÃn€È, 2®O)
713107. [wï (Û)] (êÊu) Impact of Total Hip Arthroplasty for Low Back Pain and Radiological Spinopelvic Sagittal Parameters in Patients with Hip Diseases. Shoji S1, Inoue G2, Miyagi M2, Saito W2, Uchiyama K22, Nakazawa T2, Imura T2, Fukushima K2, Shirasawa E2, Uchida K2, Takahira N3, Takaso M2: 2019 ISSLS (2019/6/3-7), Kyoto, Japan. (¯i^ŸY1, äã@º2, {é³s2, âV¡@j2, àR¶2, àVrV2, äºMV2, î2, àVh÷2, àcŸY2, œ®L3, »m2: 1åw@ãÃn€È, 2®O, 3ãÃq¶w)
713108. [wï (Û)] (êÊu) The effect of total hip arthroplasty on the low back pain and lumbar spine function in hip patients with or without scoliosis in lumbar spine. Shirasawa E1, Inoue G1, Miyagi M1, Saito W1, Imura T1, Nkazawa T1, Shoji S2, Takaso M1: 2019 ISSLS (2019/6/3-7), Kyoto, Japan. (àVh÷1, äã@º1, {é³s1, âV¡@j1, äºMV1, àVrV1, ¯i^ŸY2, »m1: 1®O, 2åw@ãÃn€È)
713109. [wï (Û)] (êÊu) Possible regulation of nerve growth factor by M1 and M2 macrophages following intervertebral disc injury in mice. Nakawaki M1, Uchida K2, Miyagi M2, Inoue G2, Takaso M2: 2019 ISSLS (2019/6/3-7), Kyoto, Japan. (e[Í1, àcŸY2, {é³s2, äã@º2, »m2: 1åw@ãÃn€È, 2®O)
713110. [wï (Û)] (êÊu) The Relationship between Degree of Scoliosis and Body Composition In Adolescent Idiopathic Scoliosis. Takei S1, Miyagi M1, Saito W1, Inoue G1, Nakazawa T1, Imura T1, Shirasawa E1, Uekusa Y1, Inage K, Ohtori S, Uchida K1, Takaso M1: 2019 ISSLS (2019/6/3-7), Kyoto, Japan. (ä³êY1, {é³s1, âV¡@j1, äã@º1, àVrV1, äºMV1, àVh÷1, ARÉ1, àcŸY1, »m1: 1®O)
713111. [wï (Û)] (êÊu) Assessment Of The Relationship Between Hip Pain And Bone Marrow Edema Lesion In Hip Joint In The Patients With Pre-And/Or Early Osteoarthritis. Koyama T1, Fukushima K2, Ohashi Y1, Uchiyama K2, Takahira N3, Takaso M2: 20th European Federation of National Associations of Orthopaedics and Traumatology (EFORT) 2019 (2019/6/6), Lisbon, Portugal. (¬Rqv1, î2, åŽcv1, àR¶2, œ®L3, »m2: 1åw@ãÃn€È, 2®O, 3ãÃq¶w)
713112. [wï (Û)] (êÊu) Hip arthroscopy versus periacetabular osteotomy in patients with borderline dysplasia: A comparative study involving a minimum of 3years of follow-up. Fukushima K1, Takahira N2, Koyama T1, Ohashi Y1, Tsuchiya M1, Uchiyama K1, Takaso M1: 20th European Federation of National Associations of Orthopaedics and Traumatology (EFORT) 2019 (2019/6/6), Lisbon, Portugal. (î1, œ®L2, ¬Rqv1, åŽcv1, y®^ä1, àR¶1, »m1: 1®O, 2ãÃq¶w)
713113. [wï (Û)] (êÊu) Efficacy of arthroscopic treatment for acute septic arthritis of hip joints in adult patients. Uekusa Y1, Fukushima K1, Koyama T2, Ohashi Y2, Matsumoto M1, Uchiyama K1, Takahira N3, Takaso M1: 20th European Federation of National Associations of Orthopaedics and Traumatology (EFORT) 2019 (2019/6/7), Lisbon, Portugal. (ARÉ1, î1, ¬Rqv2, åŽcv2, Œ{õ\1, àR¶1, œ®L3, »m1: 1®O, 2åw@ãÃn€È, 3ãÃq¶w)
713114. [wï (Û)] (êÊu) The incidence of deep vein thrombosis (DVT) during hip arthroscopic surgery. Matsumoto M1, Fukushima K1, Takahira N2, Uchiyama K1, Moriya M1, Minato T1, Takaso M1: 20th European Federation of National Associations of Orthopaedics and Traumatology (EFORT) 2019 (2019/6/7), Lisbon, Portugal. (Œ{õ\1, î1, œ®L2, àR¶1, XJõr1, ©@÷1, »m1: 1®O, 2ãÃq¶w)
713115. [wï (Û)] (êÊu) Thumb Carpometacarpal Arthrodesis using Locking Plate for Thumb Base Osteoarthritis. Onuma K1, Sukegawa K1, Otake Y1, Takaso M1: American Society for Surgery of the Hand (ASSH) Annual Meeting 2019 (2019/9/5), Las Vegas, USA. (¬À«¡1, ì_m1, å|IÆ1, »m1: 1®O)
713116. [wï (Û)] (êÊu) Melting temperature mapping method for rapid identification of unknown pathogenic microorganisms for periprosthetic hip joint infection. Uchiyama K1, Niimi H, Sakurai K2, Ikeda S1, Fukushima K1, Moriya M1, Takahira N3, Kitajima I, Takaso M1: SICOT 2019 (2019/12/5), Muscat, Oman. (àR¶1, mä©p÷, Näc¢2, rcMî1, î1, XJõr1, œ®L3, k@M, »m1: 1®O, 2Õ, 3ãÃq¶w)
721017. [wï (S)] (ÁÊu) íªÉš¯é, FAIÌffÆ¡Ã. î (®O): æ46ñú{ÒÖßwïwpWï (2019/10/25), {è.
721018. [wï (S)] (ÁÊu) ÈPEmÀÉtFAEFCðL[v·éTHA|HipGrid Droneðp¢œpx|. î (®O): æ50ñú{lHÖßwï (2020/2/22), ª.
722103. [wï (S)] (µÒu) lHÖßüÍŽõÉš¯év¬ffÌÝ|PCR@Æ¿-Defensin|. àR¶1, Näc¢2, mä©p÷, _cGü, õÝmY1, rcMî3, î1, œ®L4, »m1, Rzq5, acBF6, º³÷4, ÔØGŸ (1®O, 2Õ, 3åw@ãÃn€È, 4ãÃq¶w,5V¢IãÃE¡fIãÃ, 6äPŽaEŽõà): æ93ñú{ŽõÇwïïEwpuï (2019/4/4), ŒÃ®.
722104. [wï (S)] (µÒu) ú{ÌgDÚAÌ»ó@ÚAÌ»ó. è@1,2 (1k¢åwfBJZ^[, 2®O): æ92ñú{®`OÈwïwpï (2019/5/9), ¡l.
722105. [wï (S)] (µÒu) lHÒÖßüÍŽõÌ\h©ç©œüpúÌÓ_. àR¶1, rcMî2, õÝmY1, î1, XJõr1, œ®L3, »m1 (1®O, 2åw@ãÃn€È, 3ãÃq¶w): æ92ñú{®`OÈwïwpï (2019/5/10), ¡l.
722106. [wï (S)] (µÒu) ÒÅOÈÌæÌY¯wAgÉš¯éÕ°ãÌð@ÒÅOÈÌæÉš¯ésÆÕ°»êÌŽnµÉÖ·éÕ°ãÌð. {é³s1, àcŸY1, äã@º1, »m1 (1®O): æ93ñú{®`OÈwïwpï (2019/6/11-8/31), webJÃ.
722107. [wï (S)] (µÒu) Diagnosis for femoroacetabular impingement (FAI) in Japan. î1, œ®L2, àR¶1, »m1 (1®O, 2ãÃq¶w): æ11ñú{ÖߟEGEX|[c®`OÈwï (JOSKAS2019) (2019/6/13), Dy.
722108. [wï (S)] (µÒu) lHÒÖßüÍŽõÎô|ffÆ¡Ã|. àR¶1, rcMî2, õÝmY1, XJõr1, î1, œ®L3, Näc¢4, mä©p÷, »m (1®O, 2åw@ãÃn€È, 3ãÃq¶w, 4Õ): æ42ñú{EÖߎõÇwï (2019/7/20), ¡l.
722109. [wï (S)] (µÒu) ÅÔ«ɫ»@ÉÖ·é¢. {é³s1, àcŸY1, e[Í2, ìvÛà2, äã@º1, »m1 (1®O, 2åw@ãÃn€È): æ27ñú{Éwï (2019/9/13-14), _Ë.
722110. [wï (S)] (µÒu) lHÖßüÍŽõÌff|oCI}[J[ÆPCR|. àR¶1, Näc¢2, mä©p÷, _cGü, õÝmY1, rcMî3, î1, XJõr1, ëìLì4, œ®L5, »m1 (1®O, 2Õ, 3åw@ãÃn€È, 4Õw, 5ãÃq¶w): æ34ñú{®`OÈwïîbwpWï (2019/10/18), ¡l
722111. [wï (S)] (µÒu) ÉfÌm§Æ¡Ã^[Qbg. {é³s1, e[Í2, ìvÛà2, àcŸY1, äã@º1, »m1 (1®O, 2åw@ãÃn€È): æ34ñú{®`OÈwïîbwpWï (2019/10/17-18), ¡l.
722112. [wï (S)] (µÒu) ï¡«€^ÇÌ¡Ã|Çó«ðÜßÄ|. »m1, àVrV1, äºMV1, äã@º1, ê¡@j1, {é³s1, àVh÷1 (1®O): æ53ñú{€]ÇwïwpWï (2019/11/8-9), Qn.
723452. [wï (S)] (êÊu) ÅÔÂÖÌ×dתáuÉÖAš¿Ì»ðäN·é. {é³s1, e[Í2, àcŸY1, 잟Y1, äã@º1, àVrV1, äºMV1, âV¡@j1, àVh÷1, ìvÛà2, »m1 (1®O, 2åw@ãÃn€È): æ48ñú{ÒÅÒawïwpWï (2019/4/18-20), ¡l.
723453. [wï (S)] (êÊu) ÒÏ`ž³ÅèpãÌÄèpáÌ¢. cW`1, äºMV2, äã@º2, âV¡@j2, àVrV2, {é³s2, àVh÷2, »m2 (1åw@ãÃn€È, 2®O): æ48ñú{ÒÅÒawïwpWï (2019/4/18-20), ¡l.
723454. [wï (S)] (êÊu) lHÒÖßSu·pªÒÕACgÈçÑÉÉÖ^Šée¿. ¯i^ŸY1, äã@º2, àR¶2, àVrV2, {é³s2, âV¡@j2, äºMV2, î2, àVh÷2, œ®L3, »m2 (1åw@ãÃn€È, 2®O, 3ãÃq¶w): æ48ñú{ÒÅÒawïwpWï (2019/4/18-20), ¡l.
723455. [wï (S)] (êÊu) ]Ú«ÒÅîáÉæé_oáÉεÙ}èpðvµœ42áÌèp¬ÑÌ¢. zêB, àVh÷1, ðäåã, äã@º1, wRŸF, c^O, Á¡TK, ²¡³l, àVrV1, äºMV1, {é³s1, âV¡@j1, »m1, nÓëF (1®O): æ48ñú{ÒÅÒawïwpWï (2019/4/18-20), ¡l.
723456. [wï (S)] (êÊu) ̲ØÊÌaÔÓ`@É, Å@\, ÒoXÉyÚ·e¿. x@Iî, ¯ìër, Ž^¡, éØš, ÒöBY, äGx, °@«, uêN_, îÑêG, Ücv, ºcKC1, {é³s2, äã@º2, 幞i, »m2, ºº (1åw@ãÃn€È, 2®O): æ48ñú{ÒÅÒawïwpWï (2019/4/18-20), ¡l.
723457. [wï (S)] (êÊu) eé dzÒÌÒã]ÇgܪèhÌLaŠÆ»ÌÁ¥. ŒiVV1, {é³s1, ºcKC2, äã@ãÄ1, ¬Rqv2, å|IÆ1, cW`2, ìvÛà2, 幞i, îÑêG, ÖûTV1, àcŸY1, äã@º1, »m1 (1®O, 2åw@ãÃn€È): æ48ñú{ÒÅÒawïwpWï (2019/4/18-20), ¡l.
723458. [wï (S)] (êÊu) TRyjA𹵜Ž«eé dzÒÌÉÆh{óÔ. îìV1, {é³s1, ºcKC2, äã@ãÄ1, ¬Rqv2, å|IÆ1, cW`2, ìvÛà2, 幞i, îÑêG, ÖûTV1, àcŸY1, äã@º1, »m1 (1®O, 2åw@ãÃn€È): æ48ñú{ÒÅÒawïwpWï (2019/4/18-20), ¡l.
723459. [wï (S)] (êÊu) «taªeé dzÒÌÉâÒACgÉyÚ·e¿. Œ{õ\1, {é³s1, ºcKC2, äã@ãÄ1, ¬Rqv2, å|IÆ1, cW`2, 幞i, àcŸY1, äã@º1, »m1 (1®O, 2åw@ãÃn€È): æ48ñú{ÒÅÒawïwpWï (2019/4/18-20), ¡l.
723460. [wï (S)] (êÊu) lHÒÖßSu·p³ÒÌpOÒ€]ÍpãÉEÅ@\Ée¿ð^Šé©? àVh÷1, äã@º1, âV¡@j1, {é³s1, äºMV1, àVrV1, »m1 (1®O): æ48ñú{ÒÅÒawïwpWï (2019/4/18-20), ¡l.
723461. [wï (S)] (êÊu) vtúÁ«€]ÇÌâcÏ`ÉηéÁ¥: èpáÉš¯é¢. âV¡@j1, äã@º1, {é³s1, äºMV1, àVrV1, àVh÷1, àcŸY1, »m1 (1®O): æ48ñú{ÒÅÒawïwpWï (2019/4/18-20), ¡l.
723462. [wï (S)] (êÊu) ÒÖßO¹šæÑfemoroacetabular impingement (FAI) ƵÄÐî³êœ³ÒÌÅIffÌ¢. ¡ÖYi1, î2, ¬Rqv1, åŽcv1, àR¶2, œ®L3, »m2 (1åw@ãÃn€È, 2®O, 3ãÃq¶w): æ92ñú{®`OÈwïwpWï (2019/5/11), ¡l.
723463. [wï (S)] (êÊu) w¶úX|[cQÉηéÒÖߟºèp. ¬Rqv1, î2, åŽcv1, àR¶2, œ®L3, »m2 (1åw@ãÃn€È, 2®O, 3ãÃq¶w): æ92ñú{®`OÈwïwpWï (2019/5/11), ¡l.
723464. [wï (S)] (êÊu) °Pí¢ÆÒÅÕîóÊACgÆÌÖAÌ¢. î1, {é³s1, äã@º1, àVh÷1, å|IÆ1, àR¶1, œ®L2, »m1 (1®O, 2ãÃq¶w): æ92ñú{®`OÈwïwpWï (2019/5/11), ¡l.
723465. [wï (S)] (êÊu) ÅÔÂÖÌJjJXgXÆáuÉÖAš¿Ì»ÆÌÖW. {é³s1, e[Í2, àcŸY1, 잟Y1, äã@º1, ÖûTV1, àVrV1, äºMV1, âV¡@j1, àVh÷1, »m1 (1®O, 2åw@ãÃn€È): æ93ñú{®`OÈwïwpï (2019/6/11-8/31), webJÃ.
723466. [wï (S)] (êÊu) ÒÅèpÉš¯éåÊoÌë¯öqÉÖ·é¢. íŽj1, äã@º1, âV¡@j1, àVrV1, {é³s1, äºMV1, àVh÷1, äã@ãÄ1, {mœ1, »m1 (1®O): æ93ñú{®`OÈwïwpï (2019/6/11-8/31), webJÃ.
723467. [wï (S)] (êÊu) ãúîÒÉηé¬lÒÏ`èp̬Ñ. âV¡@j1, äã@º1, äºMV1, àVrV1, {é³s1, àVh÷1, àcŸY1, »m1 (1®O): æ93ñú{®`OÈwïwpï (2019/6/11-8/31), webJÃ.
723468. [wï (S)] (êÊu) Ï`«GÖßdzÒÌgDÉš¢ÄTGF-ÀÍ_o¬·öqÌåœé»§äöqÅ é. 잟Y1, àcŸY1, }@@w2, â£@å1, ì@~1, {é³s1, äã@º1, ÖûTV1, åÑTq3, »m1 (1®O, 2åw@ãÃn€È, 3aÔEfÃn): æ93ñú{®`OÈwïwpï (2019/6/11-8/31), webJÃ.
723469. [wï (S)] (êÊu) lHÒÖßSu·pªÉâÒÅÕp[^[É^Šée¿. ¯i^ŸY1, äã@º2, àR¶2, àVrV2, {é³s2, âV¡@j2, äºMV2, î2, àVh÷2, œ®L3, »m2 (1åw@ãÃn€È, 2®O, 3ãÃq¶w): æ93ñú{®`OÈwïwpï (2019/6/11-8/31), webJÃ.
723470. [wï (S)] (êÊu) eé dzÒÌÒã]ÇuܪèvLaŠÆÁ¥. ŒiVV1, {é³s1, ºcKC2, àcŸY1, äã@º1, »m1, 幞i, îÑêG, ÖûTV1 (1®O, 2åw@ãÃn€È): æ93ñú{®`OÈwïwpï (2019/6/11-8/31), webJÃ.
723471. [wï (S)] (êÊu) lHÒÖßSu·p (THA) ³ÒÌpOÌÒ€]ªpãÉEÅ@\É^Šée¿. àVh÷1, äã@º1, ¯i^ŸY2, {é³s1, âV¡@j1, äºMV1, àVrV1, î1, àR¶1, œ®L3, »m1 (1®O, 2åw@ãÃn€È, 3aÔEfÃn): æ93ñú{®`OÈwïwpï (2019/6/11-8/31), webJÃ.
723472. [wï (S)] (êÊu) ÒÏ`ž³ÅèpãÌÄèpáÌ¢. cW`1, äºMV2, äã@º2, âV¡@j2, {é³s2, àVrV2, àVh÷2, »m2 (1åw@ãÃn€È, 2®O): æ93ñú{®`OÈwïwpï (2019/6/11-8/31), webJÃ.
723473. [wï (S)] (êÊu) ÒÏ`ÉηéØèpÌAv[`ÉÖ·é¢. äã@º1, äºMV1, âV¡@j1, {é³s1, àVrV1, àVh÷1, ìvÛà2, »m1 (1®O, 2åw@ãÃn€È): æ93ñú{®`OÈwïwpï (2019/6/11-8/31), webJÃ.
723474. [wï (S)] (êÊu) eé ÇÆNÖAQOLÌÖW. OºIS1, {é³s1, ºcKC2, äã@ãÄ1, ¬Rqv2, å|IÆ1, cW`2, ìvÛà2, àcŸY1, äã@º1, »m1 (1®O, 2åw@ãÃn€È): æ93ñú{®`OÈwïwpï (2019/6/11-8/31), webJÃ.
723475. [wï (S)] (êÊu) rXtHXtHl[g»ÜÌO^ªweekly PTH»ÜÌ¡ÃøÊÉ^Šée¿. ºcKC1, {é³s2, Äc¹L2, cGêY2, ¬Rqv1, äã@ãÄ2, ìvÛà1, àcŸY2, äã@º2, »m2 (1åw@ãÃn€È, 2®O): æ93ñú{®`OÈwïwpï (2019/6/11-8/31), webJÃ.
723476. [wï (S)] (êÊu) °Pí¢ÆÒÅÕîóÊACgÆÌÖWÌ¢. î1, {é³s1, äã@º1, àVh÷1, å|IÆ1, àR¶1, œ®L2, »m1 (1®O, 2ãÃq¶w): æ93ñú{®`OÈwïwpï (2019/6/11-8/31), webJÃ.
723477. [wï (S)] (êÊu) eé Ç¡ÃðÌÈ¢³ÒÉηélHGÖßu·pOãÉš¯éßÊåÚ§xÌoIϻ̢. ©²ãq1, â£@å1, ì@~11, Rç¡1, {é³s1, àcŸY1, 잟Y1, }@@w2, ÚLób1, »m1 (1®O, 2åw@ãÃn€È): æ93ñú{®`OÈwïwpï (2019/6/11-8/31), webJÃ.
723478. [wï (S)] (êÊu) ÈÉš¯éÒÖßO¹ÉηéÒÖߟºfuh}Ì5N¬Ñ. ä³êY1, î1, ¬Rqv2, åŽcv2, àR¶1, œ®L3, »m1 (1®O, 2åw@ãÃn€È, 3ãÃq¶w): æ11ñú{ÖߟEGEX|[c®`OÈwï (JOSKAS2019) (2019/6/14), Dy.
723479. [wï (S)] (êÊu) èòÅEPÜpãɶ¶œ]²[ÇÌêá. ËcTü1, {é³s1, äºMV1, äã@º1, àVrV1, ê¡@j1, àVh÷1, ôŽG¹2, ŒYW³1, »m1 (1®O, 2~œ): æ45ñú{Ü¡Ãwï (2019/6/28-29), ª.
723480. [wï (S)] (êÊu) bg¿_o¹fÉηéî«üÛè×EBöqYÁR[QV[gÌÉoßq}§øÊÆHO-1U±\Ì¢. üä±W, àcŸY1, AàVŒç, uêN_, îÑêG, Ücv, uêN_, {é³s1, äã@º1, »m1, 幞i (1®O): æ41ñú{áuÉwï (2019/7/12-13), ŒÃ®.
723481. [wï (S)] (êÊu) ÖßÊðÜÞLÍÍî¹ÉηéVµ¢Äû@ÌÝ. è@1,2, œìIq1,2, ôÝmY1,2, {@î (1k¢åwfBJZ^[, 2®O): æ18ñú{gDÚAwïïEwpWï (2019/8/3), ŒÃ®.
723482. [wï (S)] (êÊu) ¯íÚAÆÔtn×EÚAð¹pµœî¹Ä¶@ÌLp«Ì¢. ¬À«¡1, àcŸY1, ºcKC2, ì_m1, }ŽÝÇè, R»q, Œ{@, äã@º1, è@1,3, »m1 (1®O, 2åw@ãÃn€È, 3k¢åwfBJZ^[): æ18ñú{gDÚAwïïEwpWï (2019/8/3), ŒÃ®.
723483. [wï (S)] (êÊu) j«eé ÇÌÉÆàs@\áQÉÖ^·éöq. gàV@×1, {é³s1, ¡ÖYi2, ºcKC2, ¬Rqv2, ìvÛà2, 幞i, îÑêG, àcŸY1, äã@º1, »m1 (1®O, 2åw@ãÃn€È): æ27ñú{Éwï (2019/9/13-14), _Ë.
723484. [wï (S)] (êÊu) îeé dzÒÉš¯éNÖAQOLÌ¢. OºIS1, {é³s1, cGêY1, ºcKC2, äã@ãÄ1, ¬Rqv2, ¡ªõq, àcŸY1, {Ö@]1, »m1 (1®O, 2åw@ãÃn€È): æ27ñú{Éwï (2019/9/13-14), _Ë.
723485. [wï (S)] (êÊu) eé dzÒÌÝH¹t¬ÇóÆÒîóÊACg. Œ{õ\1, ä³êY1, {é³s1, ºcKC2, ¬Rqv2, ìvÛà2, àcŸY1, äã@º1, »m1 (1®O, 2åw@ãÃn€È): æ27ñú{Éwï (2019/9/13-14), _Ë.
723486. [wï (S)] (êÊu) «taªeé dzÒÌÕ°©ÉyÚ·e¿Ì¢. ä³êY1, {é³s1, Œ{õ\1, ºcKC2, ¬Rqv2, å|IÆ1, ê¡L÷1, ìvÛà2, äã@º1, »m1 (1®O, 2åw@ãÃn€È): æ21ñú{eé Çwï (2019/10/11-13), _Ë.
723487. [wï (S)] (êÊu) lHGÖßu·pOãÉš¯éßÊåÚ§xÌoIϻɢÄ. ©²ãq1, â£@å1, }@@w2, ì@~1, Rç¡1, 잟Y1, {é³s1, àcŸY1, ÚLób1, »m1 (1®O, 2åw@ãÃn€È): æ21ñú{eé Çwï (2019/10/11-13), _Ë.
723488. [wï (S)] (êÊu) fmX}u^Éš¯é¹pr^~D»Üª^Šée¿ÉÖ·é¢: fm^XÆGfJVg[Ìá¢. ê¡L÷1, å|IÆ1, {é³s1, Îìhi, iä²m, J@ñ, y®O÷, äã@º1, î_L, »m1 (1®O): æ21ñú{eé Çwï (2019/10/11-13), _Ë.
723489. [wï (S)] (êÊu) XeCh«eé ÇÉηéfmX}u^ÌøÊÌ¢: Ž«eé ÇÆÌär. å|IÆ1, ê¡L÷1, {é³s1, Îìhi, iä²m, J@ñ, y®O÷, äã@º1, î_L, »m1 (1®O): æ21ñú{eé Çwï (2019/10/11-13), _Ë.
723490. [wï (S)] (êÊu) eé dzÒÌÉÉηéWeekly PTH»ÜÌøÊ. ºcKC1, {é³s2, ¬Rqv1, ìvÛà1, Œ{õ\2, Äc¹L2, ªê2, àcŸY2, äã@º2, »m2 (1åw@ãÃn€È, 2®O): æ21ñú{eé Çwï (2019/10/11-13), _Ë.
723491. [wï (S)] (êÊu) eé dzÒÌÒîóÊACgÙígܪèhÌLaŠÆ»ÌÁ¥. ŒiVV1, {é³s1, ºcKC2, ¬Rqv2, ä³êY1, ËcTü1, ìvÛà2, àcŸY1, äã@º1, »m1 (1®O, 2åw@ãÃn€È): æ21ñú{eé Çwï (2019/10/11-13), _Ë.
723492. [wï (S)] (êÊu) ÒÅèp̹ÅdObîÉæèffµŸœ±«eé ÇÌ1á. ccG1, {é³s1, ©²ãq1, äã@º1, àVrV1, äºMV1, ê¡@j1, àVh÷1, ìvÛà2, »m1 (1®O, 2åw@ãÃn€È): æ21ñú{eé Çwï (2019/10/11-13), _Ë.
723493. [wï (S)] (êÊu) eé dzÒÌNÖAQOLÉ^Šée¿öqÌ¢. ¬Rqv1, {é³s2, ºcKC1, cW`1, ìvÛà1, 幞i, îÑêG, àcŸY2, äã@º2, »m2 (1åw@ãÃn€È, 2®O): æ21ñú{eé Çwï (2019/10/11-13), _Ë.
723494. [wï (S)] (êÊu) Áîɺ€iØv`»ãžÍ, ØgDàÉš¯éIL-6Y¶ðU±·é. càV@È1, àcŸY2, {é³s2, ¡ªõq, äã@º2, ºcKC1, ÖûTV2, c@€1, ìvÛà1, »m2 (1åw@ãÃn€È, 2®O): æ21ñú{eé Çwï (2019/10/11-13), _Ë.
723495. [wï (S)] (êÊu) Áî«Ø÷žÇTRyjA𹵜Ž«eé dzÒÌÉÆh{óÔ. îìV1, {é³s1, ºcKC2, ¬Rqv2, {c@÷1, 幞i, îÑêG, äã@º1, »m1 (1®O, 2åw@ãÃn€È): æ21ñú{eé Çwï (2019/10/11-13), _Ë.
723496. [wï (S)] (êÊu) ÒÇ·óÇèpÉš¯éØ÷ÊÌe¿Ì¢. ìvÛà1, {é³s2, àVrV2, äºMV2, âV¡@j2, àVh÷2, 幞i, îÑêG, äã@º2, »m2 (1åw@ãÃn€È, 2®O): æ21ñú{eé Çwï (2019/10/11-13), _Ë.
723497. [wï (S)] (êÊu) î«üÛè×EBöqÜLÇd»qA_Q, Çd»fLXgQÌ`¬£i\Ìär¢. ¯i^ŸY1, àcŸY2, ÖûTV2, äã@º2, {é³s2, ºcKC1, ìvÛà1, »m2 (1åw@ãÃn€È, 2®O): æ34ñú{®`OÈwïîbwpWï (2019/10/17-18), ¡l.
723498. [wï (S)] (êÊu) bg¿_o¹fÉηéî«@Ûè×EBöqYÁR[QV[gÌÉoßq}§øÊÆHO-1U±\Ì¢. üä±W, àcŸY1, AàVŒç, ºã«ê, îÑêG, Ücv, ŒYSî, äã@º1, gê÷, »m1, 幞i (1®O): æ34ñú{®`OÈwïîbwpWï (2019/10/17-18), ¡l.
723499. [wï (S)] (êÊu) äFÂfô³ÒÌgDÉš¢ÄNGF»ªãž·é. càV@È1, ©ÚqI2, àcŸY2, ŒqŒd, e[Í1, åÑTq3, äã@º2, »m2 (1åw@ãÃn€È, 2®O, 3aÔEfÃn): æ34ñú{®`OÈwïîbwpWï (2019/10/17-18), ¡l.
723500. [wï (S)] (êÊu) ÅÔÂàÝ«}Nt@[W̪»\Ì¢. ìvÛà1, àcŸY2, {é³s2, e[Í1, äã@º2, âV¡@j2, ÖûTV2, »m2 (1åw@ãÃn€È, 2®O): æ34ñú{®`OÈwïîbwpWï (2019/10/17-18), ¡l.
723501. [wï (S)] (êÊu) GFPL}EXðp¢œÅÔÂáQãÉÁ·é}Nt@[WÌN¹ðÍ. ìvÛà1, àcŸY2, {é³s2, e[Í1, äã@º2, âV¡@j2, ÖûTV2, »m2 (1åw@ãÃn€È, 2®O): æ34ñú{®`OÈwïîbwpWï (2019/10/17-18), ¡l.
723502. [wï (S)] (êÊu) Ï`«GÖßÇÌgDÉš¢ÄTGF-ÀÉæÁÄU±³êé_oyv`hÌTõ. 잟Y1, àcŸY1, ì@~1, â£@å1, }@@w2, {é³s1, äã@º1, ÖûTV1, åÑTq3, »m1 (1®O, 2åw@ãÃn€È, 3aÔEfÃn): æ34ñú{®`OÈwïîbwpWï (2019/10/17-18), ¡l.
723503. [wï (S)] (êÊu) äFÂfôÌApelin̢̻. e[Í1, ©ÚqI2, àcŸY2, ŒqŒd, càV@È1, @d¿q1, äã@º2, »m2 (1åw@ãÃn€È, 2®O): æ34ñú{®`OÈwïîbwpWï (2019/10/17-18), ¡l.
723504. [wï (S)] (êÊu) äFÂfôãÌ«úÉš¯éTGF-ÀãžÍNGFY¶ÉÖ^·é. ŒqŒd, ©ÚqI1, e[Í2, àcŸY1, càV@È2, @d¿q2, äã@º1, »m1 (1®O, 2åw@ãÃn€È): æ34ñú{®`OÈwïîbwpWï (2019/10/17-18), ¡l.
723505. [wï (S)] (êÊu) oR}CVÜL_JVEZg̶ÌàüãÌoR}CVRÛ«]¿. àcŸY1, ¶@, F, ÖûTV1, è@1,2, »m1 (1®O, 2k¢åwfBJZ^[): æ34ñú{®`OÈwïîbwpWï (2019/10/17-18), ¡l.
723506. [wï (S)] (êÊu) BMP-2ÜLlHR[QQÍÚ®pÉš¯édocking siteÌüð£i·é. càV@È1, ôŽG¹2, ŒYW³3, ͺ@Œ3, àcŸY3, äã@º3, ¯i^ŸY1, âûµC1, åÑTq4, »m3 (1åw@ãÃn€È, 2~œ, 3®O, 4aÔEfÃn): æ34ñú{®`OÈwïîbwpWï (2019/10/17-18), ¡l.
723507. [wï (S)] (êÊu) ì³Ò̺gDÅÍCOL1A1, COL3A1Ì»ªŽiµÄ¢é. e[Í1, àcŸY2, ¬À«¡2, ì_m2, ©ÚqI2, ŒqŒd, càV@È1, åÑTq3, äã@º2, »m2 (1åw@ãÃn€È, 2®O, 3aÔEfÃn): æ34ñú{®`OÈwïîbwpWï (2019/10/17-18), ¡l.
723508. [wï (S)] (êÊu) qgÅÔÂgDÉš¯éTGF-ÀðNGF»§ä. {é³s1, àcŸY1, e[Í2, ìvÛà2, äã@º1, àVrV1, äºMV1, âV¡@j1, àVh÷1, ÖûTV1, »m1 (1®O, 2åw@ãÃn€È): æ34ñú{®`OÈwïîbwpWï (2019/10/17-18), ¡l.
723509. [wï (S)] (êÊu) h{óÔsÇÅÅÔÂÉš¯éÇ«TCgJCÌ»ªãž·é. ¡ÖYi1, {é³s2, àcŸY2, ìvÛà1, åÑTq3, äã@º2, àVrV2, äºMV2, âV¡@j2, àVh÷2, »m2 (1åw@ãÃn€È, 2®O, 3aÔEfÃn): æ34ñú{®`OÈwïîbwpWï (2019/10/17-18), ¡l.
723510. [wï (S)] (êÊu) Öß
E}`³ÒÌ}Nt@[WÉš¢ÄC^N`óeÌmacrophage inducible C-type lectin̻͎iµÄ¢é. XJõr1, àcŸY1, 잟Y1, â£@å1, äã@º1, {é³s1, ÖûTV1, åÑTq2, »m1 (1®O, 2aÔEfÃn): æ34ñú{®`OÈwïîbwpWï (2019/10/17-18), ¡l.
723511. [wï (S)] (êÊu) Vein wrappingÉæéÉoßq}§øÊ, _oÛìøÊÍveinRt«öqÆwrappingøÊÉæèU±³êé. üä±W, àcŸY1, AàVŒç, uêN_, Ücv, {é³s1, ºã«ê, ŒYCî, gê÷, »m1, 幞i (1®O): æ34ñú{®`OÈwïîbwpWï (2019/10/17-18), ¡l.
723512. [wï (S)] (êÊu) ETMºäF·fðp¢œbLO@\ðL·éXCh·ÌÅèxÌ¢. â£@å1, àcŸY1, ì@~1, ÖûTV1, ÚLób1, ©²ãq1, Œö@Ä, Œö@², »m1 (1®O): æ34ñú{®`OÈwïîbwpWï (2019/10/17-18), ¡l.
723513. [wï (S)] (êÊu) rX}XÜLlXvP[u̶ÌK«ÉÖ·é¢. ìvÛà1, âV¡@j2, àcŸY2, äã@º2, àVrV2, äºMV2, {é³s2, àVh÷2, »m2 (1åw@ãÃn€È, 2®O): æ34ñú{®`OÈwïîbwpWï (2019/10/17-18), ¡l.
723514. [wï (S)] (êÊu) Ï`«GÖßdzÒÌgDÉš¯éCXl¬·öq1̧ä@\. }@@w1, àcŸY2, 잟Y2, â£@å2, ì@~2, {é³s2, äã@º2, ÖûTV2, åÑTq3, »m2 (1åw@ãÃn€È, 2®O, 3aÔEfÃn): æ34ñú{®`OÈwïîbwpWï (2019/10/17-18), ¡l.
723515. [wï (S)] (êÊu) ìÏ`«GÖßdzÒÌgDÉš¢ÄÁ·émast cellÌðÌ¢. àcŸY1, 잟Y1, â£@å1, ì@~1, äã@º1, {é³s1, ÖûTV1, åÑTq2, »m1 (1®O, 2aÔEfÃn): æ34ñú{®`OÈwïîbwpWï (2019/10/17-18), ¡l.
723516. [wï (S)] (êÊu) HbA1clÌÏ`«GÖßdzÒÌgDÅÍToll-like receptor-4ÆMMP-13ªŽiµÄ¢é. ºcKC1, àcŸY2, 잟Y2, ì@~2, â£@å2, äã@º2, ÖûTV2, åÑTq3, »m2 (1åw@ãÃn€È, 2®O, 3aÔEfÃn): æ34ñú{®`OÈwïîbwpWï (2019/10/17-18), ¡l.
723517. [wï (S)] (êÊu) üÛè×EÉš¯éÃToHÆñÃToHÌNXg[NðTGF-ÀÉæéVEGF§ä@\. 잟Y1, àcŸY1, ¯i^ŸY2, ì@~1, â£@å1, }@@w2, {é³s1, ÖûTV1, åÑTq3, »m1 (1®O, 2åw@ãÃn€È, 3aÔEfÃn): æ34ñú{®`OÈwïîbwpWï (2019/10/17-18), ¡l.
723518. [wï (S)] (êÊu) RXe[ÇðL·éÏ`«GÖßdzÒÌGgDÅÍapoptpsis inhibitor of macrophageªãž·é. ¯i^ŸY1, àcŸY2, 잟Y2, ì@~2, â£@å2, }@@w1, {é³s2, äã@º2, ÖûTV2, »m2 (1åw@ãÃn€È, 2®O): æ34ñú{®`OÈwïîbwpWï (2019/10/17-18), ¡l.
723519. [wï (S)] (êÊu) ëaúÔÌÙÈéiN«_oáQɳpðsÁœfƵÄÌVKbgfì¬ÌÝ. üä±W, àcŸY1, AàVŒç, îÑêG, ºã«ê, Ücv, äã@º1, ŒYCî, gê÷, »m1, 幞i (1®O): æ34ñú{®`OÈwïîbwpWï (2019/10/17-18), ¡l.
723520. [wï (S)] (êÊu) Žeé ÇfÉš¯é_o¬·öq̻ƻ̧ä@\¢. càV@È1, àcŸY2, {é³s2, ¡ªõq, äã@º2, »m2 (1åw@ãÃn€È, 2®O): æ34ñú{®`OÈwïîbwpWï (2019/10/17-18), ¡l.
723521. [wï (S)] (êÊu) `¬` (BMP-2) ÜLlHR[QQÍ}EXï¡«ÜfÉš¯é`¬Æüð£i·é. ÖûTV1, àcŸY1, äã@º1, ¯i^ŸY2, {é³s1, âV¡@j1, åÑTq3, »m1 (1®O, 2åw@ãÃn€È, 3aÔEfÃn): æ34ñú{®`OÈwïîbwpWï (2019/10/17-18), ¡l.
723522. [wï (S)] (êÊu) ÂçÊ|[^uirQ[VHipAligṉüOãÉš¯éJbvÝužxÌ¢. ÄcŒí1, àR¶1, ê¡L÷1, î1, XJõr1, åŽcv2, ¬Rqv2, ŽÜFT1, œ®L3, »m1 (1®O, 2åw@ãÃn€È, 3ãÃq¶w): æ46ñú{ÒÖßwïwpWï (2019/10/25), {è.
723523. [wï (S)] (êÊu) åÚ]qÜÉæè¬]qÐ]ÚÌL³ªàs`ÔÉ^Šée¿. ¬öÀã, î1, Á¡¹mq, åèKq, Ö¡cŸ (1®O): æ46ñú{ÒÖßwïwpWï (2019/10/26), {è.
723524. [wï (S)] (êÊu) vtúÁ«€^ÇÌâcÏ`èpáÌÁ¥. âV¡@j1, äã@º1, {é³s1, äºMV1, àVrV1, àVh÷1, àcŸY1, »m1 (1®O): æ53ñú{€]ÇwïwpWï (2019/11/8-9), Qn.
723525. [wï (S)] (êÊu) X}[gtHAvðp¢œvtúÁ«€^ÇoÌÝ. äã@º1, äºMV1, âV¡@j1, {é³s1, àVrV1, àVh÷1, ÔàV@w, ¹Çº, ÑÀë, ¡¹q, ¬JrŸ, ²vÔB, RhŸ, Ñ@õ, »m1 (1®O): æ53ñú{€]ÇwïwpWï (2019/11/8-9), Qn.
723526. [wï (S)] (êÊu) eé dzÒÌÒã^Çg ܪèhÌLaŠÆ»ÌÁ¥. àVh÷1, {é³s1, ŒiVV1, ºcKC2, äã@ãÄ1, cW`2, ìvÛà2, 幞i, îÑ êG, ÖûTV1, àcŸY1, äã@º1, »m1 (1®O, 2åw@ãÃn€È): æ53ñú{€]ÇwïwpWï (2019/11/8-9), Qn.
723527. [wï (S)] (êÊu) ~³òàÌlHGÖßSu·pOãÌñXeCh«RÇòÆt@\ϻ̢. œìIq1,2, è@1,2 (1k¢åwfBJZ^[, 2®O): æ47ñú{Ößawï (2019/11/21), ª.
723528. [wï (S)] (êÊu) ÒÖßèp³ÒÉš¯é«Žì̶Ý. åŽcv1, î2, äã@º2, {é³s2, àcŸY2, ¬Rqv1, àR¶2, œ®L3, »m2 (1åw@ãÃn€È, 2®O, 3ãÃq¶w): æ12ñú{^®íáuÉwï (2019/11/30-12/1), .
731049. [wï (nûïE€ï)] (ÁÊu) úíOÉš¯éêaÉÌfÃ-gÌ©ðSÉ. î (®O): HIP Total Solution Seminar (2019/5/25), .
731050. [wï (nûïE€ï)] (ÁÊu) úíOÉš¯éêaÉÌfÃ|fBLZ`ÌÕ°o±ðÜßÄ|. î (®O): æ3ñ Mt.Fuji PainZ~i[ (2019/5/28), xm.
731051. [wï (nûïE€ï)] (ÁÊu) Öß·¶pƵÄÌÒÖߟºèp. î (®O): æ4ñ_ÞìÒÖ߀ï (2019/6/1), ¡l.
731052. [wï (nûïE€ï)] (ÁÊu) aÔJjYðl¶µœÏ`ÖßÇÌfÃÆfBLZ`ÌÊuï. î (®O): Lilly Kanagawa OA Expert Conference (2019/6/20), ¬c.
731053. [wï (nûïE€ï)] (ÁÊu) aÔJjYðl¶µœÏ`«ÒÖßÇÌfÃÆf
LZ`ÌÊuï. î (®O): ÉÝÉηéAv[`ðlŠéï (2019/7/18), xR.
731054. [wï (nûïE€ï)] (ÁÊu) ÅÏ«Ÿ³ÌffÆ¡ÃI. äã@º (®O): æ17ñú{®`OÈwïEÒÅÒaã€Cï (2019/8/25), åã.
731055. [wï (nûïE€ï)] (ÁÊu) aÔJjYðl¶µœÏ`«ÒÖßÇÌfÃÆf
LZ`ÌÊuï. î (®O): Lilly Pain webJt@X (2019/9/18), ¡l.
731056. [wï (nûïE€ï)] (ÁÊu) HipGrid Drone. î (®O): 3rd THA Users Seminar 2019 (2019/9/28), .
731057. [wï (nûïE€ï)] (ÁÊu) History and design concept of fully HA stem. î (®O): Avenir Complete Stem Seminar (2019/10/25), {è.
731058. [wï (nûïE€ï)] (ÁÊu) Clinical experience of Avenir stem in Japan. î (®O): Avenir Complete Stem Seminar (2019/10/25), {è.
732037. [wï (nûïE€ï)] (µÒu) åÚèòÜÉηéCvgèp (lHªu·p, lHÒÖßSu·p) k¢åwa@Éš¯éåÚßÊÜÉηé¡Ãíª2019. àR¶1, î1, XJõr1, ôŽG¹2, ͺ@Œ1, ŒYW³1, »m1, œ®L3 (1®O, 2~œ, 3ãÃq¶w): æ166ñ_Þì®`ÐQOÈ€ï (2019/7/13), ¡l, _Þì®`ÐQOÈ€ïGŽ^@2019; 32 (1): 12.
732038. [wï (nûïE€ï)] (µÒu) lHÒÖß (lHª) üÍŽõÌ¡Ã. àR¶ (®O): æ29ñOOåw®`OÈÄÌ€Cï (2019/8/2), OO.
732039. [wï (nûïE€ï)] (µÒu) lHÒÖßüÍMRSAŽõ (PJI) Îô 2019|ÛRZTX~[eBOÌàeàÜßÄ|. àR¶ (®O): VpãŽõÇZ~i[ (2019/11/28), V.
732040. [wï (nûïE€ï)] (µÒu) Ï`«GÖßÇÉη霬ÂÇÉæé¡Ã. è@1,2 (1k¢åwfBJZ^[, 2®O): êÊÐc@l k«§Ssãtïuï (2019/12), éÊ.
733170. [wï (nûïE€ï)] (êÊu) ÚAµœÛ¶¯íÉε©ÆîÚApðsÁœ1á. è@1,2, ÍìJI2, œìIq1,2, ôÝmY1,2 (1k¢åwfBJZ^[, 2®O): æ68ñú{®`ÐQOÈwï (2019/9/6), .
733171. [wï (nûïE€ï)] (êÊu) ¹ÅdObîÉæèffµŸœNbVOÇóQÉæ鱫eé ÇÌ1á. ä@T1, {é³s1, ccG1, ©²ãq1, äã@º1, àVrV1, äºMV1, âV¡@j1, àVh÷1, ìvÛà2, »m1 (1®O, 2åw@ãÃn€È): æ68ñú{®`ÐQOÈwï (2019/9/5-6), .
733172. [wï (nûïE€ï)] (êÊu) eé dzÒÌÉÉηéWeekly PTH»ÜÌøÊ. ºcKC1, {é³s2, ¬Rqv1, ìvÛà1, Œ{õ\2, Äc¹L2, ªê2, àcŸY2, äã@º2, »m2 (1åw@ãÃn€È, 2®O): æ68ñú{®`ÐQOÈwï (2019/9/5-6), .
733173. [wï (nûïE€ï)] (êÊu) «taªeé dzÒÌÕ°©ÉyÚ·e¿. Îäåã1, {é³s1, Œ{õ\1, ä³êY1, ºcKC2, ¬Rqv2, ìvÛà2, 幞i, äã@º1, »m1 (1®O, 2åw@ãÃn€È): æ68ñú{®`ÐQOÈwï (2019/9/5-6), .
733174. [wï (nûïE€ï)] (êÊu) ÒÖߟºÖßàìÌÝšõŠœ°ptïÌ1á. åŽcv1, î2, ¬Rqv1, àR¶2, œ®L3, »m2 (1åw@ãÃn€È, 2®O, 3ãÃq¶w): æ15ñú{ÒÖߟ€ï (2019/9/7), Dy.
733175. [wï (nûïE€ï)] (êÊu) 20NÈãsÀè«ðLµÄ¢œIÖßãO€ñùsÀèÇ|·¶ØäFÆIØÉÄĵœ1á|. ¬cüœ1, ì_m1, ¬À«¡1, å|IÆ1, ©ÚqI1, »m1 (1®O): æ25ñ_ÞìãOÈ€ï (2019/10/5), ¡l.
733176. [wï (nûïE€ï)] (êÊu) TbJ[ÌS[L[p[ɶ¶œMóßÊÜÌ2á. œcñî1, ¬À«¡1, ì_m1, å|IÆ1, ©ÚqI1, »m1 (1®O): æ25ñ_ÞìãOÈ€ï (2019/10/5), ¡l.
733177. [wï (nûïE€ï)] (êÊu) S[L[p[Ìè¶ÉV
[g{[ªœèóµœÆlŠçêœMóÜÌ2á. œcñî1, ¬À«¡1, ì_m1, å|IÆ1, ¬cCœ1, »m1 (1®O): æ34ñú{èOÈ€ï (2020/2/1), .
733178. [wï (nûïE€ï)] (êÊu) TbJ[ÌS[L[p[ɶ¶œãrOªØçºfôÌ1á. ÄcŒí1, ¬À«¡1, ì_m1, å|IÆ1, »m1 (1®O): æ696ñÖ®`ÐQOÈwïáï (2020/2/22), .
'18NxÈOª
[wp_¶]
'18-110011. [Ž] Transforming Growth Factor-Beta (TGF- ) Regulates Nerve Growth Factor and Cyclooxygenase-2 Expression in Subsynovial Connective Tissue in Patients with Carpal Tunnel Syndrome. Nakawaki M1, Uchida K2, Onuma K2, Sukegawa K2, Matsumoto T3, Inoue G2, Sekiguchi H2, Takaso M2: Int Arch Orthop Surg 2018/9; DOI: 10.23937/iaos-2017/1710002. (e[Í1, àcŸY2, ¬À«¡2, ì_m2, Œ{rp3, äã@º2, ÖûTV2, »m2: 1åw@ãÃn€È, 2®O, 3a)
'18-110012. [Ž] Electromyographic analysis of infraspinatus and scapular muscles during external shoulder rotation with different weight loads and positions. Sasaki S, Kenmoku T1, Otera A, Miyajima G, Nagura N, Nakawaki M2, Nakazawa T1, Takaso M1, Fukuda M3, Takahira N3: J Orthop Sci 2019/1; 24 (1): 75-80. (©ÚqI1, e[Í2, àVrV1, »m1, cÏç3, œ®L3: 1®O, 2åw@ãÃn€È, 3ãÃq¶w)
'18-110013. [Ž] Surgical outcomes of spinal fusion for osteoporotic thoracolumbar vertebral fractures in patients with Parkinson's disease: what is the impact of Parkinson's disease on surgical outcome? Watanabe K, Katsumi K, Ohashi M, Shibuya Y, Izumi T, Hirano T, Endo N, Kaito T, Yamashita T, Fujiwara H, Nagamoto Y, Matsuoka Y, Suzuki H, Nishimura H, Terai H, Tamai K, Tagami A, Yamada S, Adachi S, Yoshii T, Ushio S, Harimaya K, Kawaguchi K, Yokoyama N, Oishi H, Doi T, Kimura A, Inoue H, Inoue G1, Miyagi M1, Saito W1, Nakano A, Sakai D, Nukaga T, Ikegami S, Shimizu M, Futatsugi T, Ohtori S, Furuya T, Orita S, Imagama S, Ando K, Kobayashi K, Kiyasu K, Murakami H, Yoshioka K, Seki S, Hongo M, Kakutani K, Yurube T, Aoki Y, Oshima M, Takahata M, Iwata A, Endo H, Abe T, Tsukanishi T, Nakanishi K, Watanabe K, Hikata T, Suzuki S, Isogai N, Okada E, Funao H, Ueda S, Shiono Y, Nojiri K, Hosogane N, Ishii K: BMC Musculoskelet Disord 2019/3; 20 (1): 103. (äã@º1, {é³s1, âV¡@j1: 1®O)
'18-110014. [Ž] Surgical Treatment of Osteoporotic Vertebral Fracture with Neurological Deficit-A Nationwide Multicenter Study in Japan. Hosogane N, Nojiri K, Suzuki S, Funao H, Okada E, Isogai N, Ueda S, Hikata T, Shiono Y, Watanabe K, Watanabe K, Kaito T, Yamashita T, Fujiwara H, Nagamoto Y, Terai H, Tamai K, Matsuoka Y, Suzuki H, Nishimura H, Tagami A, Yamada S, Adachi S, Ohtori S, Orita S, Furuya T, Yoshii T, Ushio S, Inoue G1, Miyagi M1, Saito W1, Imagama S, Ando K, Sakai D, Nukaga T, Kiyasu K, Kimura A, Inoue H, Nakano A, Harimaya K, Kawaguchi K, Yokoyama N, Oishi H, Doi T, Ikegami S, Shimizu M, Futatsugi T, Kakutani K, Yurube T, Oshima M, Uei H, Aoki Y, Takahata M, Iwata A, Seki S, Murakami H, Yoshioka K, Endo H, Hongo M, Nakanishi K, Abe T, Tsukanishi T, Ishii K: Spine Surg Relat Res 2019/3; 3 (4): 3617. (äã@º1, {é³s1, âV¡@j1: 1®O)
'18-110015. [Ž] Increase in mast cell marker expression in the synovium of obese patients with osteoarthritis of the knee. Uchida K1, Takano S1, Inoue G1, Iwase D1, Aikawa J1, Takata K2, Tazawa R2, Kawakubo A2, Sekiguchi H1, Takaso M1: Diabetes Metab Syndr Obes 2019/3; 12: 377-82. (àcŸY1, 잟Y1, äã@º1, â£@å1, ì@~1, c@€2, càV@È2, ìvÛà2, ÖûTV1, »m1: 1®O, 2åw@ãÃn€È)
'18-110016. [Ž] Surgical Treatment of Osteoporotic Vertebral Fracture with Neurological Deficit-A Nationwide Multicenter Study in Japan. Hosogane N, Nojiri K, Suzuki S, Funao H, Okada E, Isogai N, Ueda S, Hikata T1,2, Shiono Y, Watanabe K, Watanabe K, Kaito T, Yamashita T, Fujiwara H, Nagamoto Y, Terai H, Tamai K, Matsuoka Y, Suzuki H, Nishimura H, Tagami A, Yamada S, Adachi S, Ohtori S, Orita S, Furuya T, Yoshii T, Ushio S, Inoue G2, Miyagi M2, Saito W2, Imagama S, Ando K, Sakai D, Nukaga T, Kiyasu K, Kimura A, Inoue H, Nakano A, Harimaya K, Kawaguchi K, Yokoyama N, Oishi H, Doi T, Ikegami S, Shimizu M, Futatsugi T, Kakutani K, Yurube T, Oshima M, Uei H, Aoki Y, Takahata M, Iwata A, Seki S, Murakami H, Yoshioka K, Endo H, Hongo M, Nakanishi K, Abe T, Tsukanishi T, Ishii K: Spine Surg Relat Res 2019/3; 3 (4): 361-7. (úûqG1,2, äã@º2, {é³s2, âV¡@j2: 1k¢åwk¢€a@, 2®O)
'18-120002. [Ž] XeCh«eé dzÒÌÉÆØ÷ÊÌÁ¥. cGêY1, {é³s1, ºcKC2, äã@ãÄ1, ¬Rqv2, ìvÛà2, ARÉ1, Ö¡L÷1, y®^ä, OºIC1, ¡ÖYi2, Äc¹O1, ¡ªõq, àcŸY1, îÑêG, 幞i, äã@º1, »m1 (1®O, 2åw@ãÃn€È): _Þì®`ÐQOÈ€ïG 2018/; 31 (4): 103-6.
'18-522007. [uÀ]yÁW: lHšÖßu·pupdatezGrammont^RSA (reverse shoulder arthroplasty) Ì: B¬Å«œ±Æ, Å«È©Áœ±Æ. ©ÚqI (®O): Monthly Book Orthopaedics 2019/3; 32 (3): 1-6.
[wïE€ï]
H29-733001. [wï (nûïE€ï)] (êÊu) LÉ«eðºÁœŒ€«ôeÊîîÌ1á. ÚLób1, ì_m1, ¬À«¡1, å|IÆ1, cW`2, cGêY1, ¡ÖYi2, ©ÚqI1, œ®L3, »m1 (1®O, 2åw@ãÃn€È, 3ãÃq¶w): æ58ñÖ®`ÐQOÈwï (2018/3/16), .
'18-723017. [wï (S)] (êÊu) Že«Þ¿Á«ðp¢œèªÇÌP3³LÀvffì¬ÌÝ. ì_m1, ŒYCî, ªcìv, ¬À«¡1, »m1, Kai-Nan An (1®O): æ91ñú{®`OÈwïwpï (2018/5/24), _Ë.
'18-723018. [wï (S)] (êÊu) ¯íŒÂÚAãÌÖßSkÉεĊ¯I_ÉæèÇDÈROMlŸÉÁœÇá. ÚqN, KŽcŸ, è@1,2 (1k¢åwfBJZ^[, 2®O): æ53ñú{wÃ@wpåï (2018/7/16-12/23).
'18-723019. [wï (S)] (êÊu) lHÒÖßSu·p³ÒÌpOÒ€^ªpãÉEÅ@\É^Šée¿. àVh÷1, äã@º1, {é³s1, âV¡@j1, äºMV1, àVrV1, ¯i^ŸY2, î1, àR¶1, œ®L3, »m1 (1®O, 2åw@ãÃn€È, 3ãÃq¶w): æ9ñú{¬lÒÏ`wï (2019/3/2), .
'18-733005. [wï (S)] (êÊu) lHÒÖßSu·pð{sµœÖßE}`³ÒÉš¯épã14úÈàÌ©îÞ@ÂÛÉe¿ðyÚ·vö. àR¶1, î1, »m1, ¬À«¡1, œ®L2 (1®O, 2ãÃq¶w): æ21ñ_ÞìE}`ÌnEPA€ï (2019/1/25), ¡l.
'18-733006. [wï (S)] (êÊu) œ]µœ¶€ô£ÐðºÁœôèªÖßw€EPÌ1á. å|IÆ1, ì_m1, ¬À«¡1, »m1 (1®O): æ33ñú{èOÈ€ï (2019/2/2), V.
'18-733007. [wï (S)] (êÊu) AQÀnAÛÉæéêwó«îgDŽõÇÌ¡Ão±. å|IÆ1, ì_m1, ¬À«¡1, »m1 (1®O): æ33ñú{èOÈ€ï (2019/2/2), V.
'18-733008. [wï (S)] (êÊu) œ]µœ¶€ô£ÐðºÁœôèªÖßw€EPÜÌ1á. å|IÆ1, ì_m1, ¬À«¡1, ÚLób1, ©ÚqI1, »m1 (1®O): æ59ñÖ®`ÐQOÈwï (2019/3/22), .
`¬OÈEüeOÈw
[wp_¶]
110285. [Ž] An in Vitro Long-Term Study of Cryopreserved Umbilical Cord Blood-Derived Platelet-Rich Plasma Containing Growth factors-PDGF-BB, TGF-À, and VEGF. Baba K1,2, Yamazaki Y2, Sone Y3, Sugimoto Y2, Moriyama K2, Sugimoto T2, Kumazawa K2,4, Shimakura Y2,5, Takeda A2: J Craniomaxillofac Surg 2019/4; 47 (4): 668-75. (nêq1,2, RèÀ°2, ]ªRüq3, {À2, XRaÌ2, {FV2, FàVê2,4, qNl2,5, c@[2: 1k¢åwfBJZ^[, 2`¬EüO, 3aÔEfÃn, 4~œ, 5k¢åwk¢€a@)
110286. [Ž] Long term(10-year) efficacy of finasteride in 523 Japanese men with androgenic alopecia. Yanagisawa M, Fujimaki H, Takeda A1, Nemoto M1, Sugimoto T1, Sato A: Clin Res Trials 2019/10; 5 (5): 1-5. (c@[1, ª{@[1, {FV1: 1`¬EüO)
110287. [Ž] Differences in pluripotency of jawbone- and iliac bone-derived mesenchymal cells. Moriyama K1, Yamazaki Y1, Sugimoto Y1, Sugimoto T1, Kumazawa K1, Baba K1,2, Sone Y3, Takeda A1: Kitasato Med J 2020/3; 50 (1) :18-26. (XRaÌ1, RèÀ°1, {À1, {FV1, nêq1,2, ]ªRüq3, c@[1: 1`¬EüO, 2k¢åwfBJZ^[, 3aÔEfÃn)
120020. [Ž] ÈÉš¯éü@ÅÌîáEop53áÌ¢. nç²óq, nêq1 (1`¬EüO): ú{EÆEÐQãwï 2019/6; 67 (3): 217-23.
120021. [Ž] ÈÉš¯éüúI±ó¬¹pÇA³ÂœÃ@ (Negative Pressure Wound Therapy with Instillation and Dwelling: NPWTid) Ì¢. nêq1,2, àqFI2, ØTç2 (1k¢åwfBJZ^[, 2`¬EüO): ú{EÆÐQãwï 2020; 68: 56-62.
310036. [Çáñ] Extensive tenosynovial chondromatosis of the wrist: a case report Shimomura M1, Nemoto M1, Moriyama K1, Kounoike N1, Takeda A1: Kitasato Med J 2020/3; 50 (1): 100-4. (ººÀMq1, ª{@[1, XRaÌ1, rÞÃq1, c@[1: 1`¬EüO)
522074. [uÀ] ÊíÌ¡ÃÅÍï¡Å énÉηéVœÈ¡Ã@|ÇA³ÂœÃ@É¢Ä|. nêq1,2 (1k¢åwfBJZ^[, 2`¬EüO): k«§Sãtïïñ 2019; 306: 19-22.
540045. [»ÌŒ (€ñ)]y¶ÈwÈÈw€ï îÕ€ (C): VœÈO{ûWô¡ÃíªÌJÉü¯œä`ÑEä`ÑÆèp]ègDÉæégDĶ (€úÔ: 2016`2019)z2018NÀ{óµñ. €ã\Ò: nêq1,2, €ªSÒ: RèÀ°2, c@[2, {FV2, FàVê2,3 (1k¢åwfBJZ^[, 2`¬EüO, 3~œ):y¶ÈwÈÈw€ï îÕ€ (C): VœÈO{ûWô¡ÃíªÌJÉü¯œä`ÑEä`ÑÆèp]ègDÉæégDĶz2018NxÀ{óµñ 2019/12; https://kaken.nii.ac.jp/report/KAKENHI-PROJECT-16K11376/16K113762018hokoku/.
[wïE€ï]
722113. [wï (S)] (µÒu) pãx®¬ðÇðÇÌo±|üpúìðÇðÇ\hÎôÌ»ó|. ª{@[1, ØTç1, FàVê2, XRaÌ1, ººÀMq1, â쳚è1, cû¬ü1, c@[1 (1`¬EüO, 2~œ): æ62ñú{`¬OÈwïïEwpWï (2019/5/15), Dy.
723529. [wï (S)] (êÊu) êwœwÇèpÉš¯éæ1wÔ`¬pÌ¢. ª{@[1, FàVê2, ººÀMq1, cû¬ü1, ØTç1, c@[1 (1`¬EüO, 2~œ): æ62ñú{èOÈwïwpWï (2019/4/18), Dy.
723530. [wï (S)] (êÊu) ÈÉš¯é±ó¬¹pÇA³ÂœÃ@ (NPWT with Instillation and Dwelling) Ì¢. nêq1,2, ØTç2, ª{@[2, Χj, c@[2 (1k¢åwfBJZ^[, 2`¬EüO): æ62ñú{`¬OÈwïïEwpWï (2019/5/15-17), Dy.
723531. [wï (S)] (êÊu) MÌoßÉñÂÇ«°ÇÇ𹵜3Çá. ª{@[1, FàVê2, ØTç1, aœ1, H{ô1, c@[1, ÛŽFº2, ЪSê2, ó@õ2 (1`¬EüO, 2~œ): æ45ñú{MwïïwpWï (2019/5/24), kãB.
723532. [wï (S)] (êÊu) \hIÈnre[VvOâ®ìw±ðæèüêœûªñçÙ`¬pã³ÒÌêá. i¡¢Ø, cÀuÛ, Øá, ãcGŸ, xì³ã, øwŽcŸ, nêq1,2 (1k¢åwfBJZ^[, 2`¬EüO): æ4ñú{ªñT|[eBuPAwïwpWï (2019/9/6-7), ÂX.
723533. [wï (S)] (êÊu) @\üPðÚIƵœááÙºèpÇáÌ¢. nêq1,2, àqFI2, ØTç2, c@[2 (1k¢åwfBJZ^[, 2`¬EüO): æ67ñú{EÆEÐQãwïwpåï (2019/11/9-10), .
723534. [wï (S)] (êÊu) AÇâcÇÌagDwI¢. nêq1,2, àqFI2, ºªOç, ª{@[2, Χj, c@[2 (1k¢åwfBJZ^[, 2`¬EüO): æ28ñú{`¬OÈwïîbwpWï (2019/11/14-15), åä.
723535. [wï (S)] (êÊu) ·úÛ¶µœRÔtn×E̪»\EB\Ì¢|20N, 15N, 10N, 5N, 1NÌÛ¶ÌðärµÄ|. {À1, RèÀ°1, XRaÌ1, {FV1, FàVê1,2, nêq1,3, ]ªRüq4, c@[1 (1`¬EüO, 2~œ, 3k¢åwfBJZ^[, 4aÔEfÃn): æ28ñú{`¬OÈwïîbwpWï (2019/11/14-15), åä.
723536. [wï (S)] (êÊu) wëØfÌ»ó©çÝœ¡Ãû@Ì¢. ª{@[1, FàVê2, ØTç1, â쳚è1, aœ1, c@[1, ó@õ2 (1`¬EüO, 2~œ): æ46ñú{}CNT[W[wïwpWï (2019/11/28), Vh.
732041. [wï (nûïE€ï)] (µÒu) `¬OÈãª`Šœ¢nÌšbµ``¬OÈ̲Ðî©çÅßÌgsbNÜÅ`. nêq1,2 (1k¢åwfBJZ^[, 2`¬EüO): ±ìk{ÉÞnæãtïwpuï (2019/10/25), éÊ.
733179. [wï (nûïE€ï)] (êÊu) dÇMÉóás«_ùN𹵜1á. ª{@[1, {{j\1, FàVê2, VüTŸ3, â쳚è1, ØTç1, c@[1 (1`¬EüO, 2~œ, 3ž_): æ27ñVhMtH[ (2019/8/30), Vh.
733180. [wï (nûïE€ï)] (êÊu) îÒÉsÁœAÇâcEoEä``¬pÌ1á. àqFI1, nêq1,2, ª{@[1, c@[1 (1`¬EüO, 2k¢åwfBJZ^[): æ22ñk¢`¬OÈtH[ (2019/10/14), ÍŽ.
733181. [wï (nûïE€ï)] (êÊu) k¢åwfBJZ^[`¬OÈÉš¯éááÙºÇèpÇáÌ¢. åGÊÁ1, nêq1,2 (1`¬EüO, 2k¢åwfBJZ^[): æ31ñk«§Snãtïãwï (2019/10/19), k{.
733182. [wï (nûïE€ï)] (êÊu) t»VRKXÉæéLÍÍMÌ¡Ão±. ª{@[1, FàVê2, aœ1, VüTŸ3, â쳚è1, c@[1 (1`¬EüO, 2~œ, 3ž_): æ28ñú{MwïÖnûï (2020/1/25), .
'18NxÈOª
[wp_¶]
H27-120001. [Ž] ãºááÙÌ@\üPðÚIƵœèp52ÇáÌ¢. nêq1,2, Χj, Âöaç (1k¢åwfBJZ^[, 2`¬EüO): éʧãwïG 2015; 50: 53-60.
H27-120002. [Ž] hÎŽxƬ³Ìàðp¢œ@Ü®pãÇÌHv. nêq1,2, Χj (1k¢åwfBJZ^[, 2`¬EüO): ú{EÆEÐQãwïG 2015; 63 (2): 68-72.
H28-120001. [Ž] AÇâcÇ28áÌ¢. nêq1,2, Χj, Âöaç (1k¢åwfBJZ^[, 2`¬EüO): éʧãwïG 2016; 51: 263-8.
H29-120001. [Ž] ÈÉš¯éÇA³ÂœÃ@; Negative Pressure Wound Therapy (NPWT) 107áÌ¢. nêq1,2, Χj (1k¢åwfBJZ^[, 2`¬EüO): ú{EÆEÐQãwï 2017; 65 (2): 89-95.
H29-540001. [»ÌŒ (€ñ)]y¶ÈwÈÈw€ï îÕ€ (C): VœÈO{ûWô¡ÃíªÌJÉü¯œä`ÑEä`ÑÆèp]ègDÉæégDĶ (€úÔ: 2016`2019)z2016NÀ{óµñ. €ã\Ò: nêq1,2, €ªSÒ: RèÀ°2, c@[2, {FV2, FàVê2,3 (1k¢åwfBJZ^[, 2`¬EüO, 3~œ):y¶ÈwÈÈw€ï îÕ€ (C): VœÈO{ûWô¡ÃíªÌJÉü¯œä`ÑEä`ÑÆèp]ègDÉæégDĶz2016NxÀ{óµñ 2018/1; https://kaken.nii.ac.jp/report/KAKENHI-PROJECT-16K11376/16K113762016hokoku/.
'18-120003. [Ž] ÈÉš¯éü@ÅÌîáEop53áÌ¢. nç²óq, nêq1,2, Χj (1k¢åwfBJZ^[, 2`¬EüO): ú{EÆEÐQãwï 2019; 67 (3): 217-23.
'18-540005. [»ÌŒ (€ñ)]y¶ÈwÈÈw€ï îÕ€ (C): VœÈO{ûWô¡ÃíªÌJÉü¯œä`ÑEä`ÑÆèp]ègDÉæégDĶ (€úÔ: 2016`2019)z2017NÀ{óµñ. €ã\Ò: nêq1,2, €ªSÒ: RèÀ°2, c@[2, {FV2, FàVê2,3 (1k¢åwfBJZ^[, 2`¬EüO, 3~œ):y¶ÈwÈÈw€ï îÕ€ (C): VœÈO{ûWô¡ÃíªÌJÉü¯œä`ÑEä`ÑÆèp]ègDÉæégDĶz2017NxÀ{óµñ 2018/12; https://kaken.nii.ac.jp/report/KAKENHI-PROJECT-16K11376/16K113762017hokoku/.
[wïE€ï]
H26-723001. [wï (S)] (êÊu)t@ìpªÖ^µœîÒBlue toeÇóQÌ1á. nêq1,2, Χj (1k¢åwfBJZ^[, 2`¬EüO): æ57ñú{`¬OÈwïïEwpWï (2014/4/9-11), ·è.
H26-723002. [wï (S)] (êÊu) Û¶ãä`ÑRÔtn×EÌ¢. nêq1,2, FàVê2,3, {FV2, ]ªRüq4, RèÀ°2, c@[2 (1k¢åwfBJZ^[, 2`¬EüO, 3~œ, 4aÔEfÃn): æ14ñú{ĶãÃwïï (2015/3/19-21), ¡l.
H26-733001. [wï (nûïE€ï)] (êÊu) ãºááÙÌ@\üPðÚIƵœèp52ÇáÌ¢. nêq1,2, Χj (1k¢åwfBJZ^[, 2`¬EüO): æ52ñéʧãwïï (2015/2/22), Ya.
H27-723001. [wï (S)] (êÊu) ÜBîåÉæèff³êœIgG4ÖA~NbcaÌ1á. nêq1,2, Χj, Âöaç (1k¢åwfBJZ^[, 2`¬EüO): æ58ñú{`¬OÈwïïEwpWï (2015/4/8-10), s.
H27-723002. [wï (S)] (êÊu) Û¶ãä`ÑRÔtn×EÌÀS«Ì¢. nêq1,2, FàVê2,3, {FV2, ]ªRüq4, RèÀ°2, c@[2 (1k¢åwfBJZ^[, 2`¬EüO, 3~œ, 4aÔEfÃn): æ24ñú{`¬OÈwïîbwpWï (2015/10/8-9), ·ª.
H27-723003. [wï (S)] (êÊu) ÈÉš¯éÇA³ÂœÃ@; Negative Pressure Wound Therapy (NPWT) eífoCXÌgpo±. nêq1,2, Χj (1k¢åwfBJZ^[, 2`¬EüO): æ63ñú{EÆEÐQãwïwpåï(2015/11/22-23), øÌä.
H27-733001. [wï (nûïE€ï)] (êÊu) AÇâcÇ28áÌ¢. nêq1,2, ΧjEÂöaç (1k¢åwfBJZ^[, 2`¬EüO): æ53ñéʧãwïï (2016/2/28), éÊ.
H28-723001. [wï (S)] (êÊu) AÇâcÇ24áÌ¢. nêq1,2, Χj, Âöaç (1k¢åwfBJZ^[, 2`¬EüO): æ59ñú{`¬OÈwïïEwpWï (2016/4/13-15), ª.
H28-723002. [wï (S)] (êÊu) Û¶ãä`ÑRÔtn×EÌ`¬\ÆÀS« (æ2ñ). nêq1,2, RèÀ°2, ]ªRüq3, FàVê2,4, {FV2, Χj, c@[2 (1k¢åwfBJZ^[, 2`¬EüO, 3aÔEfÃn, 4~œ): æ25ñú{`¬OÈwïîbwpWï (2016/9/15-16), åã.
H29-723002. [wï (S)] (êÊu) ÈÉš¯éîáEopü@Çá53áÌ¢. nêq1,2, Χj, Âöaç, çJóq (1k¢åwfBJZ^[, 2`¬EüO): æ60ñú{`¬OÈwïïEwpWï (2017/4/12-14), åã.
H29-723003. [wï (S)] (êÊu) ä`ÑRÔtn×EÌ€|{Éš¯égD`¬. nêq1,2, RèÀ°2, ]ªRüq3, {FV2, FàVê2,4, {À2, XRaÌ2, c@[2 (1k¢åwfBJZ^[, 2`¬EüO, 3aÔEfÃn, 4~œ): æ26ñú{`¬OÈwïîbwpWï (2017/10/19-20), åã.
H29-723004. [wï (S)] (êÊu) ÈÉš¯éîáEopü@Çá96áÌ¢. çJóq, nêq1,2, Χj, Âöaç (1k¢åwfBJZ^[, 2`¬EüO): æ65ñú{EÆEÐQãwïwpåï (2017/11/25-26), ¬q.
'18-732001. [wï (nûïE€ï)] (s¯öJuÀ) `¬OÈð²¶mÅ·©?|`¬OÈÌÜԜ̡Ã|. nêq1,2 (1k¢åwfBJZ^[, 2`¬EüO): k¢åwfBJZ^[s¯uÀ (2018/7/11), éÊ.
çÈw
[wp_¶]
110288. [Ž] A potential significance of circ_0024169 down regulation in angiosarcoma tissue. Nakashima S, Jinnin M, Ide M, Kajihara I, Igata T, Harada M, Masuguchi S, Fukushima S, Masuzawa M, Masuzawa M1, Amoh Y1, Ihn H: Intractable Rare Dis Res. 2019/5; 8 (2): 129?33. (àV^Àq1, VHNV1: 1ç)
110289. [Ž] Hair-follicle-associated pluripotent stem cells derived from cryopreserved intact human hair follicles sustain multilineage differentiation potential. Obara K1, Tohgi N1, Mii S1, Hamada Y2, Arakawa N2, Aki R1, Singh SR, Hoffman R, Amoh Y1: Sci Rep 2019/7; 9: 9326. (¬ŽGÆ1, VßÃq1, Oäá1, lcSq2, rìLq2, ÀåYÇê1, VHNV1: 1ç, 2aÔEfÃn)
110290. [Ž] Expression of anti-aging type-XVII collagen (COL17A1/BP180) in hair follicle-associated pluripotent (HAP) stem cells during differentiation. Shirai K1, Obara K1, Tohgi N1, Yamazaki A, Aki R1, Hamada Y2, Arakawa N, Singh SR, Hoffman RM, Amoh Y1: Tissue Cell. 2019/8; 59: 33-8. (äü1, ¬ŽGÆ1, VßÃq1, ÀåYÇê1, lcSq2, VHNV1: 1ç, 2aÔEfÃn)
110291. [Ž] Invasion of human microvascular endothelial cells by Mycobacterium leprae through Mce1A protein. Idris I, Abdurrahman AH, Fatulrachman, Aftitah VB, Fadlitha VB, Sato N1, Fujimura T1, Takimoto H: J Dermatol 2019/10; 46 (10): 853-8. (²¡ŒÆ1, ¡º¿j1: 1ç)
320028. [Çáñ] ×áð浜³Ff«îê×EàÌ1á. àCF1, ãcªm1, äü1 (1ç): Õ°çÈ 2019/4; 73 (4): 331-5.
320029. [Çáñ] ùNEópß]ÚðºÁœÜ°Ìpigmented epithelioid melanocytoma. VßÃq1, àV^Àq1, rÞÃq1, VHNV1 (1ç): çafà 2019/9; 41 (9): 873-6.
320030. [Çáñ] ãèÍ×á©çffÉÁœggLT[gÖApB«Ÿ³Ì1á. rº}1, àV^Àq1, ºŒ@ 2, ¥@cœ3, VHNV1 (1ç, 2åw@ãÃn€È, 3tà): Skin Cancer 2020/2; 34 (3): 215-8.
320031. [Çáñ] ¡ÌZ_ðàÂCOL1A1-PDGFBZâ`qªo³êœåȲN«çüÛ÷îÌ1á. tØÊ©1, àV^Àq1, lcSq2, Oäá1, â쳚è3, ØTç3, VHNV1 (1ç, 2aÔEfÃn, 3`¬EüO): Skin Cancer 2020/2; 34 (3): 238-42.
540046. [»ÌŒ (wïŽ^)]yú{çÈwïnûïæ883ñáïzAv~Xgªtøµœ£á«ÖßÌ1á. ÀÀD1, àV^Àq1, ÀåYÇê1, VHNV1, ºŒ@ 2, óJë¶ (1ç, 2äPŽaEŽõà): ú{çÈwïG 2019/5; 129 (6): 1355-6.
[wïE€ï]
713117. [wï (Û)] (êÊu) FUnctional recovery of spinal cord injury promoted with hair-follicle-associated pluripotent (HAP) stem cells captured on polyvinylidence fluoride membranes (PFM). Obara K1, Tohgi N1, Shirai K1, Mii S1, Hamada Y2, Arakawa N, Aki R1, Hoffman RM, Amoh Y1: 11th World Congress for Hair Research (WCHR 2019) (2019/4/24-27), Barcelona, Spain. (¬ŽGÆ1, VßÃq1, äü1, Oäá1, lcSq2, ÀåYÇê1, VHNV1: 1ç, 2aÔEfÃn)
713118. [wï (Û)] (êÊu) Lymphangiosarcoma as the distinguishable variant of angiosarcoma. Masuzawa M1, Tohgi N1, Hamada Y2, Mori M, Ishii M, Amoh Y1: 24th World Congress of Dermatology (2019/6/10), milano, Italy. (àV^Àq1, VßÃq1, lcSq2, VHNV1: 1ç, 2aÔEfÃn)
713119. [wï (Û)] (êÊu) Foreign body granuloma and temporal arterial stenosis secondary to gold thread facelift and facial injection of polyacrylamide hydrogel. Tohgi N1, Masuzawa M1, Amoh Y1: 24th World Congress of Dermatology (2019/6/10), milano, Italy. (VßÃq1, àV^Àq1, VHNV1: 1ç)
723537. [wï (S)] (êÊu) Guªtøµœp`¿×E«pî¹ÌNon-AIDS Associated Kaposi÷î. àV^Àq1, Rºaç2, c@i3, xÄSê4, VHNV1 (1ç, 2a, 3úËü (îá), 4tà): æ35ñú{ç««îáwïwpåï (2019/5/24), _Ë, æ35ñú{ç««îáwïwpåïŽ^W 2019/5; p.146.
723538. [wï (S)] (êÊu) ¡ÌZ_ðàÂCOL1A1-PDGFBZâ`qªo³êœåȲN«çüÛ÷îÌ1á. ·JìÊ©1, àV^Àq1, lcSq2, Oäá1, â쳚è3, ØTç3, VHNV1 (1ç, 2aÔEfÃn, 3`¬EüO): æ35ñú{ç««îáwïwpåï (2019/5/25), _Ë.
723539. [wï (S)] (êÊu) ãèÍ×á©çffÉÁœggLT[gÖApB«Ÿ³Ì1á. rº}1, àV^Àq1, ºŒ@ 2, ¥@cœ3, VHNV1 (1ç, 2åw@ãÃn€È, 3tà): æ35ñú{ç««îáwïwpåï (2019/5/25), _Ë.
723540. [wï (S)] (êÊu) œ`øo«gÁÌÕ°ð浜à®AM[ÉæéSg«ÚGçÌ2á. ¬ŽGÆ1, àV^Àq1, ºüÄ, VHNV1 (1ç): æ118ñú{çÈwïï (2019/6/6), ŒÃ®.
723541. [wï (nûïE€ï)] (êÊu) IgG4ÖAŸ³ÌÇÉæsµÄ¶¶œçÊÌgÁÌ1á. ãcªm1, j@F1, Œºê, ÑËRüq2, ²¡YêY, Á¡¶^, ²XØSK, äü1 (1ç, 2a@Åì): æ118ñú{çÈwïï (2019/6/6), ŒÃ®.
723542. [wï (nûïE€ï)] (êÊu) pã8NÅœu]ÚðFßœŽ««ÇüçîÌ1á. à£D÷1, àV^Àq1, åvÛuž©1, äü1, VHNV1, ºººF (1ç): æ118ñú{çÈwïï (2019/6/6), ŒÃ®.
733183. [wï (nûïE€ï)] (êÊu)
áv«ÞVáváÉεÄAU`IvðgpÉĶsÇ«nðµœ1á. ÀÀD1, VìTq1, ªÞßq1, ¬ŽGÆ1, äü1, VHNV1, cÍs2 (1ç, 2tà): æ884ñú{çÈwïnûï (2019/5/8), _Þì.
733184. [wï (nûïE€ï)] (êÊu) ÑÜñ«EÑðºÁœVogt-¬ö-ŽcaÌ1á. àRÜè©1, ²Xز1, àV^Àq1, ÀåYÇê1, VHNV1, Ž³p2 (1ç, 2áÈ): æ885ñú{çÈwïnûï¯Õ°nûï (2019/7/20), .
733185. [wï (nûïE€ï)] (êÊu) ¡ÃÉïaµœ¬ë\RW[}Ì1á. Fìåã1, ¬ŽGÆ1, äü1, VHNV1, ší¶ (1ç): æ886ñú{çÈwïnûï (2019/10/19), _Þì.
733186. [wï (nûïE€ï)] (êÊu) ŸÈÌ@\áQ𶶜T]Xt@sWÉæéòÜ«ßqÇÇóQÌ1á. ÀÀD1, ªÞßq1, äü1, VHNV1, °I2 (1ç, 2Á»íà): æ887ñú{çÈwïnûï (2019/12/14), _Þì.
733187. [wï (nûïE€ï)] (êÊu) ªÇ÷îx]ÚÖÌp]pju^ÉæèdÄȬÂáºð«œµœêá. ¬Rüä1, àV^Àq1, ªÞßq1, äü1, ¥@cœ2, VHNV1 (1ç, 2tà): æ889ñú{çÈwïnûï (2020/2/15), _Þì.
'18NxÈOª
[wp_¶]
'18-110017. [Ž] Hypoxia accelerates the progression of angiosarcoma through the regulation of angiosarcoma cells and tumor microenvironment. Maeda-Otsuka S, Kajihara I, Tasaki Y, Yamada-Kanazawa S, Sakamoto R, Sawamura S, Masuzawa M1, Masuzawa M, Amoh Y1, Hoshina D, Abe R, Komohara Y, Ihn H: J Dermatol Sci 2019/2; 93 (2): 123-32. (àV^Àq1, VHNV1: 1ç)
[wïE€ï]
'18-733009. [wï (nûïE€ï)] (êÊu) ^áv«£áÆÌÓÊðvµœ}«Ä«]«^ávÇÌ1á. Fìåã1, åvÛuž©1, äü1, ÀåYÇê1, VHNV1 (1ç): æ882ñú{çÈwïnûï (2019/1/19), _Þì.
'18-733010. [wï (nûïE€ï)] (êÊu) RfXOC1RÌ, RfXRRÌz«B«VáváÌ1á. rº}1, åvÛuž©1, äü1, Oäá1, VHNV1, I@B, Îä¶l (1ç): æ882ñú{çÈwïnûï (2019/1/19), _Þì.
'18-733011. [wï (nûïE€ï)] (êÊu) çŒÚZæ詵œûàÌ1á. aJºŸ1, Fìåã1, ÄRõq1, äü1, VHNV1, Œ{mj2 (1ç, 2ûBEbóBO): æ883ñú{çÈwïnûï (2019/2/16), _Þì.
'18-733012. [wï (nûïE€ï)] (êÊu) Bowenaɹµ, ¶ã®SÁÞµœMerkel×EàÌ1á. ²Xز1, àV^Àq1, ÀåYÇê1, VHNV1 (1ç): æ883ñú{çÈwïnûï (2019/2/16), _Þì.
'18-733013. [wï (nûïE€ï)] (êÊu) Av~Xgªtøµœ£á«ÖßÌ1á ÀÀD1, àV^Àq1, ÀåYÇê1, VHNV1, ºŒ@ 2, óJë¶ (1ç, 2åw@ãÃn€È): æ883ñú{çÈwïnûï (2019/2/16), _Þì.
'18-733014. [wï (nûïE€ï)] (êÊu) ¬
ávðº€yuY}uÉæéøo«gÁ^ò]Ì1á. à£D÷1, äü1, VìTq1, ¬ŽGÆ1, VHNV1, äüç2 (1ç, 2Äzíà): æ883ñú{çÈwïnûï (2019/2/16), _Þì.
åAíÈw
[wp_¶]
110292. [Ž] Histologic variants associated with biological aggressiveness and poor prognosis in patients treated with radical cystectomy. Koguchi D1,2, Matsumoto K1, Ikeda M1,3, Taoka Y1,2, Hirayama T1, Murakami Y1, Utsunomiya T, Matsuda D, Okuno N, Irie A1,3, Iwamura M1: Jpn J Clin Oncol 2019/4; 49 (4): 373-8. (û@å1,2, Œ{a«1, rcb1,3, cªÀ1,2, œRM1, ºã׎1, ü]@[1,3, ⺳k1: 1åAí, 2k¢åwfBJZ^[, 3k¢åwk¢€a@)
110293. [Ž] Tumor multifocality was associated with poor prognosisi in patients with upper urinary tract urothelial carcinoma after radical nephroureterectomy. Hirayama T1, Nomura M1, Matsumoto K1, Iwamura M1: Kitasato Med J 2019/9; 49 (2): 113-8. (œRM1, ìº@b1, Œ{a«1, ⺳k1: 1åAí)
110294. [Ž] Outcome of third-line sunitinib after sequential therapy with cytokines and sorafenib in metastatic renal cell carcinoma. Fujita T1, Hirayama T1, Nishi M1, Matsumoto K1, Yoshida K1,2, Iwamura M1: Mol Clin Oncol 2019/11; 11 (5): 505-10. (¡cNv1, œRM1, Œ@·G1, Œ{a«1, gcê¬1,2, ⺳k1: 1åAí, 2V¢IãÃEæ[ãÃ)
110295. [Ž] Incidence and survival outcomes in patients with upper urinary tract urothelial carcinoma diagnosed with variant histology and treated with nephroureterectomy. Zamboni S1, Foerster B1, Abufaraj M1, Seisen T1, Roupret M1, Colin P1, la Taille AD1, Bona CD1, Peyronnet B1, Bensalah K1, Herout R1, Wirth MP1, Novotny V1, Soria F1, Chlosta P1, Antonelli A1, Simeone C1, Baumeister P1, Mattei A1, Montorsi F1, Simone G1, Gallucci M1, Matsumoto K1,2, Karakiewicz PI1, Briganti A1, Xylinas E1, Shariat SF1, Marco Moschini M1 (1Upper Tract Urothelial Carcinoma Collaboration Group; European Association of Urology - Young Academic Urologists (EAU-YAU), Urothelial carcinoma working group): BJU Int 2019/11; 124 (5): 738-45. (Œ{a«1,2: 2åAí)
110296. [Ž] Impact of histologic variants on the oncological outcomes of patients with upper urinary tract cancers treated with radical surgery: a multi-institutional retrospective study. Murakami Y1, Matsumoto K1, Ikeda M1, Hirayama T1, Utsunomiya T, Koguchi D1, Matsuda D, Okuno N, Taoka Y1, Irie A1,2, Iwamura M1: Int J Clin Oncol 2019/11; 24 (11): 1412-8. (ºã׎1, Œ{a«1, rcb1, œRM1, û@å1, cªÀ1, ü]@[1,2, ⺳k1: 1åAí, 2k¢åwk¢€a@)
110297. [Ž] Peri-operative efficacy and long-term survival benefit of robotic-assisted radical cystectomy in septuagenarian patients compared with younger patients: a nationwide multi-institutional study in Japan. Iwamoto H, Morizane S, Koie T, Shiroki R, Kawakita M, Gondo T, Matumoto K1, Habuchi T, Sunada H, Endo Y, Noma H, Takenaka A, Kanayama H: Int J Clin Oncol 2019/12; 24 (12): 1588-95. (Œ{a«1: 1åAí)
110298. [Ž] Pembrolizumab for Treatment-Refractory Metastatic Castration-Resistant Prostate Cancer: Multicohort, Open-Label Phase II KEYNOTE-199 Study. Antonarakis ES, Piulats JP, Gross-Goupil M, Goh J, Ojamaa K, Hoimes CJ, Vaishampayan U, Berger R, Sezer A, Alanko T, de Wit R, Li C, Omlin A, Procopio G, Fukasawa S, Tabata K1, Park SH, Feyerabend S, Drake CG, Wu H, Qiu P, Kim J, Poehlein C, Sebastian de Bono JS: J Clin Oncol 2020/2; 38 (5): 395-405. (cšê1: 1åAí)
320032. [Çáñ] çØlÇóð_@Éff³êœAÇàÌ1á. ìº@b1, œRM1, âcTî1, ÈÑ@ãÄ1, VìV2, Œ{a«1, ⺳k1 (1åAí, 2åw@ãÃn€È): åAíÈIv 2019/11; 65 (11): 459-62.
320033. [Çáñ] Human immunodeficiency virus (HIV) Žõ, human papilloma virus (HPV) Žõ𹵜äNã÷àÌêá. ìº@b1, œRM1, âcTî1, töÉF1, ÈÑ@ãÄ1, Œ{a«1, ⺳k1 (1åAí): k¢ãw 2019/12; 49 (2): 99-101.
320034. [Çáñ] oŸºtEpÉÄEµŠœã ¬nï`îÌ1á. œìCœ1, ¡cNv1, ìº@b1, ]Nœ1, Œ@·G1, úGN1, Œ{a«1, gcê¬1,2, ⺳k1 (1åAí, 2V¢IãÃEæ[ãÃ): åAíÈIv 2020/1; 66 (1): 5-8.
510011. [à] Quality of life outcomes after low dose-rate brachytherapy for localized prostate cancer: Current status and future perspectives. Murakami Y1, Satoh T1, Tsumura H1, Tabata K1, Matsumoto K1, Ishiyama H2, Iwamura M1: Int J Urol 2019/12; 26 (12): 1099-105. (ºã׎1, ²¡Ð¶1, úGN1, cšê1, Œ{a«1, ÎR2, ⺳k1: 1åAí, 2úËüÈw (úËüîáw)
520011. [à] tÚAã©ç©œÚAãÃ`[ìè`ÚAãÃxºÌð`. gcê¬1,2 (1V¢IãÃEæ[ãÃ, 2åAí): ú{ÚAEĶãÃÅìwï 2019/6; 14 (1): 2-9.
522075. [uÀ]yÁW: nCXNO§Bàð[@è·é@»ÌÏJÆM0 CRPCÌÅV¡Ãz¡HNPC¡ÃÌ»óÆÛè@HNPCÉηéhZ^LZÉæé¡Ã. cšê (åAí): Õ°åAíÈ 2019/7; 73 (8): 552-5.
522076. [uÀ]yÁW: tÚAÌ»µÆc³êœÛèz[c³êœÛè]@tÚAÉš¯é««îá. gcê¬1,2 (1V¢IãÃEæ[ãÃ, 2åAí): tÆ§Í 2019/7; 87 (1): 103-7.
522077. [uÀ]yÁW2: oŸèp`SÒÉœðÇ€³Šé׫©`z oŸºtEtèpÉš¯éSÒ³ç. ¡cNv1, ⺳k1 (1åAí): Japanese Journal of Endourology 2019/12; 32 (1): 25-7.
530009. [»ÌŒ (Congress abstracts)] Peritoneal dialysis catheter insertion surgery and management. Yoshida K1,2, Ishii D2: The Journal of Vascular Access 2019/5; 20 (1_suppl): 97-9. (gcê¬1,2, Îäåã2: 1V¢IãÃEæ[ãÃ, 2åAí)
530010. [»ÌŒ (Comment)] Editorial Comment to Placement of SpaceOAR hydrogel spacer for prostate cancer patients treated with iodine-125 low-dose-rate brachytherapy. Tsumura H1: Int J Urol 2020/1; 27 (1): 66. (úGN1: 1åAí)
540047. [»ÌŒ (€ïL^)]yæ11ñBCG üÃ@€ïL^zBCGäNã÷àüÃ@̱üÃ@ƱüÛÃ@Ìär¢. Œ{a«1, œRM1, rcb1, úGN1, Îäåã1, ⺳k1 (1åAí): åAíOÈ 2019/4; 32 (4): 390-1.
[@]
620069. [wp (ªS·M)] y §ÍfÃwjz §Í³ÒfÃwj@tÚApwj, p.125-7. gcê¬1,2 (1V¢IãÃEæ[ãÃ, 2åAí), ÄC: ªcê`, Ò: ªcê`, Ž{°¶,
û@, ãwÐ, , 2019/7s.
[wïE€ï]
712024. [wï (Û)] (µÒu) Laparoscopic Salvage Pyeloplasty. Iwamura M1: The 36th KOREA-JAPAN UROLOGICAL CONGRESS 2019 (2019/9/21), Seoul, Korea. (⺳k1: 1åAí)
713120. [wï (Û)] (|X^[) Important factors to prevent vascular access obstruction. Yoshida K1,2, Kuwata H, uemura K, Ishii D2, Asai T, Nakajima S, Motohashi S, Kaneda Y, Takeuchi Y3, Tabata K2, Yoshida A: 11th Congress of the Vascular Access Society 2019 (2019/4/12), Rotterdam, the Netherlands. (gcê¬1,2, Îäåã2, |àNY3, cšê2: 1V¢IãÃEæ[ãÃ, 2åAí, 3tà)
713121. [wï (Û)] (êÊu) Exercise Therapy in the Early Stage After Kidney Transplantation Is Effective for Improving Physical Performance: A Prospective Cohort Study with Historical Control. Yamamoto S, Matsuzawa R, Ishii D1, Noguchi F2, Ichikawa T3, Matsunaga A3, Yoshida K1,4: 56th ERA-EDTA Congress (2019/6/14), Budapest, Hungary. (Îäåã1, ìû¶T2, s잶3, ŒiÄF3, gcê¬1,4: 1åAí, 2Åì, 3ãÃq¶w, 4V¢IãÃEæ[ãÃ)
713122. [wï (Û)] (êÊu) EVALUATION OF JAPANESE-STYLE LOW-VOLUME ON-LINE POST-DILUTION HEMODIAFILTRATION. Sakurai K, Saito T, Hosoya H, Yamauchi F, Kurihara Y, Wakabayashi Y, Ishii D1, Yoshida K1,2, Kokubo K3: 56th ERA-EDTA Congress (2019/6/15), Budapest, Hungary. (Îäåã1, gcê¬1,2, ¬vÛªê3: 1åAí, 2V¢IãÃEæ[ãÃ, 3ãÃq¶w)
713123. [wï (Û)] (êÊu) CLINICAL BENEFITS OF ON-LINE HEMODIAFILTRATION FOR@THE IMPROVEMENT OF THE QUALITY OF LIFE OF DIALYSIS PATIENTS. Sakurai K, Saito T, Yamauchi F, Hosoya H, Suzuki A, Kurihara Y, Kurosawa K, Yoshinaga M, Iwadate Y, Tanibayashi Y, Kokubo K1, Ishii D2, Yoshida K2,3, Hydo T: 56th ERA-EDTA Congress (2019/6/15), Budapest, Hungary. (¬vÛªê1, Îäåã2, gcê¬2,3: 1ãÃq¶w, 2åAí, 3V¢IãÃEæ[ãÃ)
713124. [wï (Û)] (êÊu) KEYNOTE-199: Updated Analysis of Pembrolizumab for Metastatic Castration-Resistant Prostate Cancer (mCRPC) Previously Treated With Docetaxel. Jeffrey C Goh, Emmanuel S Antonarakis, Marine Gross-Goupil, Ulka N Vaishampayan, Josep M Piulats, Ronald de Wit, Tuomo Alanko, Fukasawa S, Tabata K1, Susan Feyerabend, Raanan Berger, Haiyan Wu, Jeri Kim, Christian H Poehlein, Johann S deBono: ANZUP Annual Scientific Meeting 2019 (2019/7/21), Brisbane, Australia. (cšê1: 1åAí)
713125. [wï (Û)] (|X^[) Clinical analysis of patients with PD-introduction after kidney allograft loss. Ishii D1, Shimura S1, Amano N2, Sakata Y1, Watanuki S1, Iwamura M1, Sakakibara M3, Takeuchi Y3, Yoshida K1,4: The 9th Asia Pacific Chapter Meeting of International Society for Peritoneal Dialysis (APCM-ISPD2019) (2019/9/6), Nagoya, Japan. (Îäåã1, uºsêN1, VìV2, âcTî1, ÈÑ@ãÄ1, ⺳k1, åŽFq3, |àNY3, gcê¬1,4: 1åAí, 2åw@ãÃn€È, 3tà, 4V¢IãÃEæ[ãÃ)
713126. [wï (Û)] (êÊu) Compared with treatment results between open surgery and laparoscopic surgery for upper tract urothelial carcinoma. Shimura S1, Matsumoto K1, Ikeda M1, Koguchi D1, Taoka Y1, Hirayama T1, Murakami Y1, Utsunomiya T, Matsuda D1, Okuno N, Irie A, Iwamura M1: The 37th World congress of Endourology (2019/10/31), Abu Dhabi, Uae. (uºsêN1, Œ{a«1, rcb1, û@å1, cªÀ1, œRM1, ºã׎1, Œcåî1, ⺳k1: 1åAí)
713127. [wï (Û)] (êÊu) Impact of membranous urethral length on the urinary continence outcomes of patients after robotic]assisted radical prostatectomy. Murakami Y1, Tabata K1, Tsumura H1, Hirayama T1, Matsumoto K1, Iwamura M1: The 37th World congress of Endourology (2019/10/31), Abu Dhabi, UAE. (ºã׎1, cšê1, úGN1, œRM1, Œ{a«1, ⺳k1: 1åAí)
713128. [wï (Û)] (êÊu) k¢åwa@Éš¯éÛ¯ØñŠÌÈ¢OlOófÌ»ó|ÄRÖWÒÆñÄRÖWÒÆÌär|. rc¬]1, ÖªÇî, Îäåã1, ka÷1, ⺳k1, ìû¶T2, äº[P2, º¡@§, gcê¬1,3 (1åAí, 2Åì, 3V¢IãÃEæ[ãÃ): 4th Annual Meeting of International Society of Clinical Medicine (æ4ñÛÕ°ãwïwpWï) (2019/12/14), Fukuoka, Japan.
721019. [wï (S)] (ÁÊu) o IB@Éæé oŸºtEpÉš¯éZpFèRžÌ|Cg. ⺳k (åAí): æ107ñú{åAíÈwïï (2019/4/19), ŒÃ®.
722114. [wï (S)] (`Z~i[) pãðÏŠéÉÝÌÇ. Jûpì, ¡cNv1 (1åAí): æ107ñú{åAíÈwïï (2019/4/18), ŒÃ®.
722115. [wï (S)] (³çu) tsS¡ÃÉš¯éÝîãÃ. gcê¬1,2 (1V¢IãÃEæ[ãÃ, 2åAí): æ1ñú{ÝîãÃAwïåï (2019/7/14), .
722116. [wï (S)] (³çvO) ñ¡Ãs¬÷áÉηéo I oŸºtá±`¬p. Œ@·G1, ⺳k1 (1åAí): æ33ñú{åAíàŸwïï (2019/11/22), s.
722117. [wï (S)] (ÁÊéæ) lHA¹ñØApÌ»óÆÛè: Tips & Pitfalls SÒÅà¬÷³¹éRcÍ? œRM1, Ž³1, âáÁñ1, úGN1, cšê1, Œ{a«1, ü]@[1,2, ⺳k1 (1åAí, 2k¢åwk¢€a@): æ33ñú{åAíàŸwïï (2019/11/23), s.
722118. [wï (S)] (µÒu) {bgxºtªØpãÉñÂÇ«°Çðǵœ1á. âcTî1, Îäåã1, in@o1, ŽìMO1, ì@T1, ÈÑ@ãÄ1, úGN1, cšê1, ¡cNv1, ⺳k1 (1åAí): æ33ñú{åAíàŸwïï (2019/11/23), s.
722119. [wï (S)] ([NVbv) HoLEPãÌ{bgxª¡IO§BSEÖÌHv. úGN1, ¡¶N, Ýyqç, cšê1, ¡cNv1, Œ{a«1, ⺳k1 (1åAí): æ32ñú{àŸOÈwïï (2019/12/6), ¡l.
722120. [wï (S)] (µÒu) {bgx oŸºäNã÷SEpÆÌOñ°±Ç¢Ýp. Œ{a« (åAí): æ32ñú{àŸOÈwïï (2019/12/6), ¡l.
722121. [wï (S)] (µÒu) Ýît§Í³ÒÉš¯é^®Ã@ÌKv«ÆßçêéÀ{û@É¢Ä. áäzó, ¢ÞÃü, ºm¶, º¡@§, gcê¬1,2 (1V¢IãÃEæ[ãÃ, 2åAí): æ10ñú{tnre[VwïwpWï (2020/2/22), .
723543. [wï (S)] (êÊu) t×EàÉηé oŸºª¡ItEpÉš¯épãáuÉÇû@Ì¢. ¡cNv1, œRM1, Œ@·G1, úGN1, Îäåã1, Œ{a«1, gcê¬1,2, ⺳k1 (1åAí, 2V¢IãÃEæ[ãÃ): æ107ñú{åAíÈwïï (2019/4/18), ŒÃ®.
723544. [wï (S)] (ïÜ|X^[) OligometastasesÉηéO§B৬ü¹Ã@Æ]ÚÆËÌ·ú¡Ã¬ÑÌ¢. úGN1, cšê1, ÎR2, º^]1, ºã׎1, ìã³å2, ¡cNv1, kìëj, ²¡Ð¶, ⺳k1 (1åAí, 2úËü (îá)): æ107ñú{åAíÈwïï (2019/4/18), ŒÃ®.
723545. [wï (S)] (|X^[) äNã÷SEpW{Éš¯éTROY»Ì¢. ìº@b, Œ{a«1, Ž
äèq, ¬ÑŸY, rcb1, VìV2, Œ@^Rq, À@ŸG, ·@º3, ²¡Yê3, ⺳k1 (1åAí, 2åw@ãÃn€È, 3ãÃq¶w): æ107ñú{åAíÈwïï (2019/4/18), ŒÃ®.
723546. [wï (S)] (|X^[) VXv`¹p»wÃ@Éš¯éV[gnCh[V@Ì¢. ìºä1, áczi1, Êp¡, c¡q1, ìIF (1åAí): æ107ñú{åAíÈwïï (2019/4/18), ŒÃ®.
723547. [wï (S)] (|X^[) ª¡IäNã÷SEpãÌÄE]ÚÇáÉηé~Ï»wÃ@Ì¢. rcb1, Œ{a«1, œRM1, û@å1, ºã׎1, Œcåî1, ìIF, ©@pÎ, Fs{ñ¡, cªÀ1, ü]@[1,2, ⺳k1 (1åAí, 2k¢åwk¢€a@): æ107ñú{åAíÈwïï (2019/4/18), ŒÃ®.
723548. [wï (S)] (|X^[) oŸºtá±`¬pã·úoßµÄĵœ2Çá. töÉF1, Œ@·G1, œRM1, ¡cNv1, Œ{a«1, ⺳k1 (1åAí): æ107ñú{åAíÈwïï (2019/4/18), ŒÃ®.
723549. [wï (S)] (êÊu) de novo M1O§BàÌ\ãöq; mCNPC¡ÃÌÅK»ðÚwµÄ. cšê1, úGN1, ºã׎1, œRM1, Îäåã1, ¡cNv1, Œ{a«1, ⺳k1 (1åAí): æ107ñú{åAíÈwïï (2019/4/19), ŒÃ®.
723550. [wï (S)] (êÊu) ñ]Ú«šïR«O§Bà (NM-CRPC) ú{lÇáÉηéAp^~hÌLø«yÑÀS«: Ûœ{Ý€¯ñdÓ_»æV±ÌTuðÍ. ²¡Ð¶, ¡[êY, ìûpv, ¬R@º, úGN1, Vä@w, ãºi (1åAí): æ107ñú{åAíÈwïï (2019/4/19), ŒÃ®.
723551. [wï (S)] (|X^[) {bgx oŸºO§BSEpãAžÖŠ (Urine loss ratio, ULR) Ì¢. œRM1, cšê1, VìV2, uºsêN1, Œ{a«1, ⺳k1 (1åAí, 2åw@ãÃn€È): æ107ñú{åAíÈwïï (2019/4/19), ŒÃ®.
723552. [wï (S)] (|X^[) oŸºO§BSEp©ç{bgx oŸºO§BSEpÌp®ÚsÉš¯éØf[z«ÉÖ·é¢. c¡q1, cšê1, ºã׎1, œRM1, úGN1, Îäåã1, Œ{a«1, ⺳k1 (1åAí): æ107ñú{åAíÈwïï (2019/4/19), ŒÃ®.
723553. [wï (S)] (êÊu) ØwñZ«äNã÷àÉηéBCGäNã÷àüÃ@Ì^û@É¢ÄÌ¢. Œ{a«1, œRM1, rcb1, úGN1, Îäåã1, Œ@·G1, cšê1, ¡cNv1, ⺳k1 (1åAí): æ107ñú{åAíÈwïï (2019/4/19), ŒÃ®.
723554. [wï (S)] (êÊu) tá±EAÇàÉš¯éhistologic variantÆ\ãÉÖ·é¢. ºã׎1, Œ{a«1, rcb1, œRM1, û@å1, Œcåî1, cªÀ1, ü]@[1,2, ⺳k1 (1åAí, 2k¢åwk¢€a@): æ107ñú{åAíÈwïï (2019/4/19), ŒÃ®.
723555. [wï (S)] (|X^[) }«P«äNã÷ÉηéZt@NÉæéú¡ÃÌ¢. û@å1, yŽ³l1, œìCœ1, rcb1, Îä~êY (1åAí): æ107ñú{åAíÈwïï (2019/4/19), ŒÃ®.
723556. [wï (S)] (|X^[) k¢€a@Éš¯érA©§w±ÖÌæègÝ. RºpV1, Ž³1, ¬Ñq1, Íí, ŽTêY, Œº©šé, ü]@[1,2 (1åAí, 2k¢åwk¢€a@): æ107ñú{åAíÈwïï (2019/4/20), ŒÃ®.
723557. [wï (S)] (|X^[) AsÉÀǵ¡ÃÉ궵œóás«^çÇÌ1á. m÷1, §ÔMj1, ìc@@1, cªÀ1, ⺳k1 (1åAí): æ107ñú{åAíÈwïï (2019/4/20), ŒÃ®.
723558. [wï (S)] (êÊu) ñ]Ú«O§BàÉš¯éfmX}u60mgçºÌLø«ÆÀS«Ì¢. º^]1, úGN1, ì@T1, töÉF1, uºsêN1, VìV2, c¡q1, ºã׎1, œRM1, cšê1, ²¡Ð¶, ⺳k1 (1åAí, 2åw@ãÃn€È): æ107ñú{åAíÈwïï (2019/4/20), ŒÃ®.
723559. [wï (S)] (|X^[) ·úzÃ@¹púËü¡ÃÉš¯ébone health; ]h_
aš 5 mg _HÃÌúgpo±. uºsêN1, úGN1, º^]1, âcTî1, ÈÑ@ãÄ1, Œ@·G1, cšê1, Îäåã1, Œ{a«1, ²¡Ð¶, gcê¬1,2, ⺳k1 (1åAí, 2V¢IãÃEæ[ãÃ): æ107ñú{åAíÈwïï (2019/4/20), ŒÃ®.
723560. [wï (S)] (|X^[) tàÆÓʪ¢ïÅ ÁœÇ«tîáÌ2á. œRM1, ¡cNv1, töÉF1, ì@T1, uºsêN1, úGN1, Îäåã1, ⺳k1 (1åAí): æ31ñú{àªåOÈwïï (2019/6/14), , ú{àªåOÈwïG 2019; 36 (§): 156.
723561. [wï (S)] (|X^[) PADú©ÌœßºPAD`FbNÆSPP±ü1NÚÌÊÆ¡ãÌÛè. ¢Þ, Ž_Y, gcê¬1,2, ŽTêY (1V¢IãÃEæ[ãÃ, 2åAí): æ64ñú{§ÍãwïwpWïEï (2019/6/28), ¡l, §Íï 2019; 52 (Suppl 1): 665.
723562. [wï (S)] (|X^[) is«tàÉηéªqWIò¡ÃãɧͱüÆÈÁœ1á. Îäåã1, âcTî1, ÈÑ@ãÄ1, uºsêN1, VìV2, ¡cNv1, ⺳k1, gcê¬1,3 (1åAí, 2åw@ãÃn€È, 3V¢IãÃEæ[ãÃ): æ64ñú{§ÍãwïwpWïEï (2019/6/29), ¡l, §Íï 2019; 52 (Suppl 1): 708.
723563. [wï (S)] (|X^[) ãHwZpÌpÉæéÝît§ÍfÃÌøŠ»ÆÀSÎô. áäzó, ¢ÞÃü, ºOÊ, CVŽd, º¡@§, gcê¬1,2 (1V¢IãÃEæ[ãÃ, 2åAí): æ64ñú{§ÍãwïwpWïEï (2019/6/30), ¡l, §Íï 2019; 52 (Suppl 1): 782.
723564. [wï (S)] (|X^[) §Í{ÝÉš¯éÊ@}ÌÓ`Æâè_É¢Äà€êxlŠé`@ÅÌ10NÔÌo±ðàÆÉ`. áäzó, Žc®}, nç³Fq, R¢À, º¡@§, gcê¬1,2 (1V¢IãÃEæ[ãÃ, 2åAí): æ64ñú{§ÍãwïwpWïEï (2019/6/30), ¡l, §Íï 2019; 52 (Suppl 1): 817.
723565. [wï (S)] (|X^[) J{WA€ñsvmyÉš¯é
¿žyÑÂlpROu±^]É¢ÄÌñ. ÿSî, ¢ÞÃü, CVŽd, áäzó, º¡@§, gcê¬1,2 (1V¢IãÃEæ[ãÃ, 2åAí): æ64ñú{§ÍãwïwpWïEï (2019/6/30), ¡l, §Íï 2019; 52 (Suppl 1): 831.
723566. [wï (S)] (|X^[) J{WA€essÉš¯é
¿žÌÊñ. CVŽd, ÿSî, ¢ÞÃü, áäzó, º¡@§, gcê¬1,2 (1V¢IãÃEæ[ãÃ, 2åAí): æ64ñú{§ÍãwïwpWïEï (2019/6/30), ¡l, §Íï 2019; 52 (Suppl 1): 832.
723567. [wï (S)] (|X^[) J{WAÅÌZ~i[JÃÉæé»náèãÃÒ³çxÆC¹±ÊÌXüªÍ. ¢ÞÃü, áäzó, CVŽd, º¡@§, gcê¬1,2, ìŒG÷ (1V¢IãÃEæ[ãÃ, 2åAí): æ64ñú{§ÍãwïwpWïEï (2019/6/30), ¡l, §Íï 2019; 52 (Suppl 1): 832.
723568. [wï (S)] (|X^[) ¶ÌtÚAãÉÔ¿«xª«µœêá. Îäåã1, äc^¶q2, ¢Nç2, uºsêN1, œRM1, Œ{a«1, ìû¶T3, rc¬]1, ⺳k1, ²XØ¡êY4, gcê¬1,5 (1åAí, 2tà, 3Åì, 4V¢IãÃE¡fIãÃ, 5V¢IãÃEæ[ãÃ): æ55ñú{ÚAwïï (2019/10/11), L, ÚA 2019; 54 (ïÕ): 302.
723569. [wï (S)] (|X^[) uPÓÌñv£tÚAóâÌ«Þñ̪ÍÆ¡ãÌÎô. rc¬]1, Îäåã1, ka÷1, uºsêN1, VìV2, ìû¶T3, äº[P3, ⺳k1, gcê¬1,4 (1åAí, 2åw@ãÃn€È, 3Åì, 4V¢IãÃEæ[ãÃ): æ55ñú{ÚAwïï (2019/10/12), L, ÚA 2019; 54 (ïÕ): 328.
723570. [wï (S)] (|X^[) tAÇSEpɺ€pßsŽÌLø«ÉÖ·éœ{ÝOü«€: ÔðÍ. äãõ, ¢ps, [JKj, Éc³M, Vä@w, @¡, Ocki, Œ{a«1, ¬cLŸY, yJF, ⺳k1, ªc@O, ä²j, HºF¥ (1åAí): æ57ñú{à¡ÃwïwpWï (2019/10/24), ª.
723571. [wï (S)] (|X^[) ª¡IäNã÷SEpãÌÄE]ÚÇáÉηé~Ï»wÃ@̡ìÑ. rcb1, Œ{a«1, œRM1, û@å1, ºã׎1, Œcåî1, ìIF, Fs{ñ¡, cªÀ1, ü]@[1,2, ⺳k1 (1åAí, 2k¢åwk¢€a@): æ57ñú{à¡ÃwïwpWï (2019/10/24), ª.
723572. [wï (S)] (êÊu) šïR«O§BàÇáÉš¯éS¶¶\ªmO. ÄRãùq, ODNG, ÍŽi, ãºi, Á¡^j, ¬êœ, Rc_j, ãœ@C, cšê1, úGN1, O}Sã (1åAí): æ57ñú{à¡ÃwïwpWï (2019/10/25), ª.
723573. [wï (S)] (|X^[) áüÊŠ§¬ü¹Ã@ÌPSAÄÆ]Ú¶Öe¿·éöqÌ¢. úGN1, cšê1, ºã׎1, ìLa, ìã³å2, Öû©ß2, ²¡Ð¶, ÎR2, ⺳k1 (1åAí, 2úËü (îá)): æ57ñú{à¡ÃwïwpWï (2019/10/25), ª.
723574. [wï (S)] (êÊu) ffÉ궵œäNã÷paragangliomaÌ2á. ìºä1, º^]1, áczi1, ìIF (1åAí): æ73ñ§a@ãwï (2019/11/9), ŒÃ®.
723575. [wï (S)] (ïÜ|X^[) àŸ¡ÃãÄÉε, CäNã÷ºäNã÷AÇV«pð{sµœäNã÷AÇt¬ÇÌ3á. ì@T1, Œ@·G1, âcTî1, ÈÑ@ãÄ1, œRM1, Îäåã1, Œ{a«1, ⺳k1 (1åAí): æ33ñú{åAíàŸwïï (2019/11/21), s.
723576. [wï (S)] (êÊu) da Vinci Si, X, Xi 3@íÉæé{bgxºtªØÌÕ°I¢. Îäåã1, ¡cNv1, cmj1, âcTî1, ÈÑ@ãÄ1, uºsêN1, Œ@·G1, œRM1, Œ{a«1, ⺳k1 (1åAí): æ33ñú{åAíàŸwïï (2019/11/22), s.
723577. [wï (S)] (|X^[) oŸºO§BSEp, {bgx oŸºO§BSEpÉš¯éPSAÄÌ¢. cšê1, úGN1, ºã׎1, Îäåã1, uºsêN1, œìCœ1, ¡cNv1, Œ{a«1, gcê¬1,2, ⺳k1 (1åAí, 2V¢IãÃEæ[ãÃ): æ33ñú{åAíàŸwïï (2019/11/22), s.
723578. [wï (S)] (|X^[) {bgx oŸºO§BSEpãA֧ɚ¯éMRIÕêðUwöqÌ¢. ºã׎1, cšê1, úGN1, uºsêY1, VìV2, âcSî1, ÈÑ@ãÄ1, Œ{a«1, ⺳k1 (1åAí, 2åw@ãÃn€È): æ33ñú{åAíàŸwïï (2019/11/22), s.
723579. [wï (S)] (|X^[) tá±EAÇàÉηéJ pÆ oŸºpÉš¯é¡Ã¬ÑÌär¢. uºsêN1, Œ{a«1, rcb1, û@å1, œRM1, ºã׎1, Fs{ñ¡, Œcåî1, ìIF, ⺳k1 (1åAí): æ33ñú{åAíàŸwïï (2019/11/22), s.
723580. [wï (S)] (|X^[) Rðòð~·é±Æ³HoLEPð{sµœÇáÌÕ°¢. åRNœ1, Rû@, 䥺, àì§ê, ¿õ³s, ¢IV, ÎcT¥, aJHF (1åAí): æ33ñú{åAíàŸwïï (2019/11/23), s.
723581. [wï (S)] (|X^[) ¬lƬɚ¯éCäNã÷ºäNã÷AÇV«pÌär¢. töÉF1, Œ@·G1, ¡cNv1, Œ{a«1, ⺳k1 (1åAí): æ33ñú{åAíàŸwïï (2019/11/23), s.
731059. [wï (nûïE€ï)] (ÁÊu) §Í©çtÚA, »µÄ§ÍıüÉš¯é¯Ó_. gcê¬1,2 (1V¢IãÃEæ[ãÃ, 2åAí): §knætsStÚA€ï (2019/4/23), ú§.
731060. [wï (nûïE€ï)] (ÁÊu) @Éš¯étÚAÌæègÝ. Îäåã (åAí): æ21ñ{èAH@\€ï^æ220ñ{è§åAíÈãï`{è§útsSEtÚAðlŠéï` (2019/5/23), {è.
731061. [wï (nûïE€ï)] (ÁÊu) ú{lÉš¯éXNöq©çM1O§BàÌ¡ÃíªðlŠé. cšê (åAí): Prostate Cancer Seminar in z (2019/6/21), ·ª.
731062. [wï (nûïE€ï)] (ÁÊu) mHSPC̱ʩçM1O§BàÌ¡Ãíªðêç€. cšê (åAí): FDPC (2019/6/28), .
731063. [wï (nûïE€ï)] (ÁÊu) åAíÈ oŸèpÌßÆ¢|ãÃÀSÇð©ŠÄ|. ⺳k (åAí): ¡{êsåAíÈãwwpuï (2019/7/1), ¡{ê.
731064. [wï (nûïE€ï)] (ÁÊu) åAí oŸèpÌî{èZ`ZpFèæŸðÚwµÄ`. ⺳k (åAí): æ11ñ§åAíèpèZ€ï (2019/7/13), SR.
731065. [wï (nûïE€ï)] (ÁÊu) O§BàÉš¯éòšÃ@`ÂXÌaÔÉš¯éûâ³àe`. úGN (åAí): Pharmacists study seminar in KITASATO (2019/8/7), ÍŽ.
731066. [wï (nûïE€ï)] (ÁÊu) rAguÉ¢Ä. œRM (åAí): 2019Nµïï (2019/10/17), .
731067. [wï (nûïE€ï)] (ÁÊu) ÝîãÃƵÄÌtsS¡Ã`Ýî§Í, §Í, »µÄtÚA`. gcê¬1,2 (1V¢IãÃEæ[ãÃ, 2åAí): æ61ñ_ÞìãwïïEwpåï ú{ãtï¶U³çuÀ (2019/11/23), ¡l.
731068. [wï (nûïE€ï)] (ÁÊu) O§BªñÌòšÃ@ÆFN}lWg. cšê (åAí): Aomori Urology Cancer Seminar (AUCS) (2020/2/6), ÂX.
732042. [wï (nûïE€ï)] (plfBXJbV) ªñÆuÃ@ðÅåÀɶ©·œßÌ¡ÃíªÆÍ`]Ú«AHãçàÉηéIO drugÌgpÀÑÌØ`. Œ{a« (åAí): SEM for urothelial cancer 2019 (2019/7/9), CVŒ.
732043. [wï (nûïE€ï)] (µÒu) ãAHÄ. Œ@·G1, ⺳k1 (1åAí): æ84ñú{åAíÈwïï (2019/10/4), .
732044. [wï (nûïE€ï)] (fBx[gZbV) Júhi[WpÅyõµœçºCîðº€Cî«tá±tÌêá. uºsêN1, cšê1, œRM1, ¡cNv1, Œ{a«1, gcê¬1,2, ⺳k1 (1åAí, 2V¢IãÃEæ[ãÃ): æ84ñú{åAíÈwïï (2019/10/4), .
732045. [wï (nûïE€ï)] (plfBXJbV) pOãÌt@\ÌÏ», t@\ð·¶·éœßÌHv. Îäåã1, ka÷1, ¡cNv1, ⺳k1 (1åAí): æ84ñú{åAíÈwïï (2019/10/5), .
732046. [wï (nûïE€ï)] (µÒu) ñ¡ÃƵÄÌ»wÃ@. Œ{a«1, ⺳k1 (1åAí): æ84ñú{åAíÈwïï (2019/10/5), .
732047. [wï (nûïE€ï)] (V[gN`[) O§BàÌ¡ÃÌOver view. úGN (åAí): æ2ñÍŽEŒÃGAHNPCuï (2019/10/9), ÍŽ.
732048. [wï (nûïE€ï)] (³çZ~i[) »wÃ@ð©·-ìpÇÅøÊðÅåÉ! cšê (åAí): æ71ñŒú{åAíÈwïï (2019/11/9), Œ].
732049. [wï (nûïE€ï)] (plXg) nmCRPCÌ¡ÃíªÉ¢Ä. cšê (åAí): æ1ñProstate Cancer SAKURA Conference (2019/11/20), .
733188. [wï (nûïE€ï)] (êÊu) ALKz«ñ¬×Exà¡ÃÉ¡G«tÌ€EðFßœ1á. rcb1, ©@pÎ (1åAí): k¢åwåAíȧbï (2019/4/6), ¬c.
733189. [wï (nûïE€ï)] (êÊu) §ÍJe[eÌÇѪÌ1á. m÷1, §ÔMj1, ìc@@1, cªÀ1, ⺳k1 (1åAí): k¢åwåAí§bï (2019/4/6), ¬c.
733190. [wï (nûïE€ï)] (êÊu) ffÉ궵œpKOI[}Ì1á. º^]1, Îäåã1, töÉF1, uºsêN1, VìV2, œRM1, Œ{a«1, ⺳k1 (1åAí, 2åw@ãÃn€È): k¢åwåAí§bï (2019/4/6), ¬c.
733191. [wï (nûïE€ï)] (êÊu) @Éš¯évwÔ¶ÌtÚAÌÕ°I¢. ka÷1, Îäåã1, âcTî1, uºsêN1, VìV2, ¡Y, ⺳k1, rc¬]1, ìû¶T3, äº[P3, gcê¬1,4 (1åAí, 2åw@ãÃn€È, 3Åì, 4V¢IãÃEæ[ãÃ): æ35ñtÚAEÇOÈ€ï (2019/5/17), R.
733192. [wï (nûïE€ï)] (êÊu) R[fBl[^[ƵÄ~}[ÆÌtÚAãÃÉÖ·éîñð¬ÉgíÁœo±. rc¬]1, rì@q2, ¬vÛªê3, Îäåã1, º¡@§, áäzó, ⺳k1, gcê¬1,4 (1åAí, 2Åì, 3ãÃq¶w, 4V¢IãÃEæ[ãÃ): æ35ñtÚAEÇOÈ€ï (2019/5/18), R.
733193. [wï (nûïE€ï)] (êÊu) Pazopanib^Å·ú¬ÑðŸœêá. œìCœ1, ¡cNv1, ì@T1, âcTî1, VìV2, uºsêN1, Îäåã1, Œ{a«1, ⺳k1 (1åAí, 2åw@ãÃn€È): West Kanagawa New Generation RCC seminar (2019/5/24), úØ.
733194. [wï (nûïE€ï)] (êÊu) oŸºtá±`¬pã, J tá±`¬pãs¬÷áÉε, non-dismembered@Éæé oŸºtá±`¬pðsÁœ1á. ì@T1, Œ@·G1, Îäåã1, œRM1, ⺳k1 (1åAí): æ16ñåAíÈÄĶ€ï (2019/6/8), ¡l.
733195. [wï (nûïE€ï)] (êÊu) @ÅsÁÄ¢éÅßÌèpEèZÉ¢Ä|enbloc TUR-BT|. áczi1, º^]1, ìºä1, ìIF (1åAí): æ6ñ³ªÝåAínæAgÌï (2019/6/19), ÍŽ.
733196. [wï (nûïE€ï)] (êÊu) ]ÚÌÇ, Ç€µÄÜ·©? VìV (åw@ãÃn€È): FDPC (2019/6/28), .
733197. [wï (nûïE€ï)] (êÊu) tAÇSEãÉ΀tɶµœíºîÉæè§Í±üÆÈÁœ¶tá±àÌêá. in@o1, ka÷1, cmj1, ŽìMO1, âcTî1, uºsêN1, cšê1, Œ{a«1, ⺳k1 (1åAí): æ96ñ_Þì§åAíÈãï (2019/7/13), ìè.
733198. [wï (nûïE€ï)] (êÊu) {bgx oŸºO§BSEpãA֧ɚ¯éMRIðp¢œÕêðUwöqÌ¢. ºã׎1, cšê1, úGN1, uºsêN1, VìV2, ÈÑ@ãÄ1, Œ{a«1, ⺳k1 (1åAí, 2åw@ãÃn€È): LUTS Seminar in Kanagawa (2019/8/29), ¬c.
733199. [wï (nûïE€ï)] (êÊu) KI-TKIÃ@Éæè·ú¶¶ªŸçêÄ¢émRCCÌêá. uºsêN1, ¡cNv1, VìV2, œìCœ1, Îäåã1, gcê¬1,3, ⺳k1 (1åAí, 2åw@ãÃn€È, 3V¢IãÃEæ[ãÃ): KANAGAWA mRCC skill up seminar (2019/9/3), ¬c.
733200. [wï (nûïE€ï)] (êÊu) ž]ÚðµœO§BàÌ1á. º^]1, ìºä1, áczi1, ìIF (1åAí): æ60ñú{åAíÈwï_Þìnûï (2019/9/5), ¡l.
733201. [wï (nûïE€ï)] (êÊu) LÍÈã pß]ÚÅǵœAÇàÌêá. ŽìMO1, ºã׎1, töÉF1, in@o1, ÈÑ@ãÄ1, Îäåã1, ¡cNv1, Œ{a«1, gcê¬1,2, ⺳k1 (1åAí, 2V¢IãÃEæ[ãÃ): æ60ñú{åAíÈwï_Þìnûï (2019/9/5), ¡l.
733202. [wï (nûïE€ï)] (êÊu) dÇŽõÇ[NAbvÉÝ©ÁœOA¹ÙÌêá. ¬Ñq1, œŽºq, ºØŽqŸ, RèYêY, ãŽj (1åAí): æ60ñú{åAíÈwï_Þìnûï (2019/9/5), ¡l.
733203. [wï (nûïE€ï)] (êÊu) äNã÷àÉš¯éPD-L1»Æ\ãÉÖ·é¢. ºã׎1, Œ{a«1, rcb1, œRM1, ¡cNv1, Îäåã1, ²¡Yê2, ⺳k1 (1åAí, 2ãÃq¶w): æ37ñk¢îátH[ (2019/9/13), ÍŽ.
733204. [wï (nûïE€ï)] (|X^[) ÌOÕgÓÎpãÌtíºîÉεÄoJe[e®¬Çðpð{sµœ1á. ¢IV, Rû@, åRNœ1, ¿õ³s, 䥺, ÎcT¥, ÊØ@x, `èGG, ÎËJrŸ, ªªO, «èMô (1åAí): æ84ñú{åAíÈwïï (2019/10/4), .
733205. [wï (nûïE€ï)] (|X^[) {bgx oŸºtªØ (RAPN) ú90áÉš¯épã³€t@\Ì¢. ka÷1, Îäåã1, âcTî1, ŽìMO1, VìV2, uºsêN1, œRM1, ¡cNv1, Œ{a«1, gcê¬1,3, ⺳k1 (1åAí, 2åw@ãÃn€È, 3V¢IãÃEæ[ãÃ): æ84ñú{åAíÈwïï (2019/10/4), .
733206. [wï (nûïE€ï)] (|X^[) O§BàpãÌ]ÚÉεÄ]ÚúËüÃ@ªøµœêá. cmj1, cšê1, in@o1, ŽìMO1, ì@T1, ÈÑ@ãÄ1, âcTî1, úGN1, Œ{a«1, ⺳k1 (1åAí): æ84ñú{åAíÈwïï (2019/10/4), .
733207. [wï (nûïE€ï)] (êÊu) šïR«O§Bà (CRPC) ÉηéJoW^LZÌ\ãöqÌ¢. ºã׎1, cšê1, âcTî1, úGN1, ²¡Ð¶, Œ{a«1, ]Nœ1, âáÁñ1, Fs{ñ¡, ⺳k1 (1åAí): æ84ñú{åAíÈwïï (2019/10/5), .
733208. [wï (nûïE€ï)] (|X^[) äNã÷SEoã̱uNÇÉÄff³êœAsÄÌêá. âcTî1, Œ{a«1, œRM1, c¡q1, ºã׎1, ka÷1, úGN1, ¡cNv1, Îä~êY, ⺳k1 (1åAí): æ84ñú{åAíÈwïï (2019/10/5), .
733209. [wï (nûïE€ï)] (|X^[) oA¹IèpV~
[^[ (UrotrainerÒ) ÉæéèpèẔ. töÉF1, œRM1, ÈÑ@ãÄ1, œìCœ1, Œ{a«1, ⺳k1 (1åAí): æ84ñú{åAíÈwïï (2019/10/5), .
733210. [wï (nûïE€ï)] (|X^[) ffÉ궵œäNã÷ParagangliomaÌ2á. º^]1, ìIF, ìºä1, áczi1, œRM1, Îäåã1, Œ{a«1, ⺳k1 (1åAí): æ84ñú{åAíÈwïï (2019/10/5), .
733211. [wï (nûïE€ï)] (|X^[) nCXNmHNPCÌêá. ºã׎1, cšê1, úGN1, ⺳k1 (1åAí): æ2ñÍŽEŒÃGAHNPCuï (2019/10/9), ÍŽ.
733212. [wï (nûïE€ï)] (êÊu) @̧¬ü¹Ã@©çÝœCRPCiWXNÌ¢. úGN (åAí): k¢åAíȧeï (2019/10/19), ¡l.
733213. [wï (nûïE€ï)] (êÊu) O§Bªñ: fÌÓ`ÆòšÃ@ÌðEìpÉ¢Ä. úGN (åAí): ÍŽsàÈãïEçåAíÈãï¯wpuï (2019/10/30), ¬c.
733214. [wï (nûïE€ï)] (|X^[) RivaroxabanàÉHoLEPð{sµpãoÅ궵œ1á. ]Nœ1, yŽ³l1, û@å1, âcTî1, ©@pÎ, Îä~êY (1åAí): æ69ñú{åAíÈwïï (2019/10/31), åã.
733215. [wï (nûïE€ï)] (êÊu) @Éš¯éJj`Ìgpo±. c@Ö (åAí): Carnitine Forum in Yokohama`§Í³ÒÌÇóÆ¡ÃðlŠé` (2019/11/5), ¡l.
733216. [wï (nûïE€ï)] (|X^[) O§Bstromal tumor of uncertain malignant potential (STUMP) Ì3á. âcTî1, ]Nœ1, û@å1, yŽ³l1, Îä~êY (1åAí): æ71ñŒú{åAíÈwïï (2019/11/9), ª.
733217. [wï (nûïE€ï)] (êÊu) Éð_@Éǵœ¶ã îá. in@o1, ka÷1, cmj1, ŽìMO1, ÈÑ@ãÄ1, Îäåã1, Œ{a«1, ⺳k1 (1åAí): æ97ñ_Þì§åAíÈãï (2019/11/9), ¡l.
733218. [wï (nûïE€ï)] (êÊu) oŸºO§BSEpãÉp𶶜1á. ì@T1, cªÀ1, §ÔMj1, ìc@@1 (1åAí): æ83ñú{åAíÈwïéÊnûï (2019/11/16), éÊ.
733219. [wï (nûïE€ï)] (êÊu) {bgxº oŸºtªØ (RAPN) Éš¯épã³€t@\Ì¢. ¬Ñq1, Îäåã1, ka÷1, ÈÑ@ãÄ1, uºsêN1, cšê1, ¡cNv1, Œ{a«1, ⺳k1, gcê¬1,2 (1åAí, 2V¢IãÃEæ[ãÃ): æ98ñ_Þìt€ïEæ35ñ_Þ짧Í{ÝAŠc﯀ï (2019/11/17), ¡l.
733220. [wï (nûïE€ï)] (êÊu) M1O§BàÉηéÇ¡Ã. cšê (åAí): _Þ짌urology seminar (2019/12/3), CVŒ.
733221. [wï (nûïE€ï)] (êÊu) de novoL]ÚO§BàÉηéŽÖÌúËü¡ÃÌLø«ÉÖ·é¢; œ{Ý€¯ãëü«€. cšê1, úGN1, ÑË~œ, Ž{±L, ODNG, ãºi, _`O, åìF³, îì»å, ìã@ (1åAí): æ35ñO§BV|WE (2019/12/15), .
733222. [wï (nûïE€ï)] (êÊu) ]Ú«O§BàÉηéÇúËüÆË̶¶úÔ·øÊÆrAÖALQÛ}§øÊÌ¢. cŒ÷, ae®u, Ö¡rO, ¡a@W, öœŒ÷, cšê1, c^È, Ž@Ö, ¹@O, ã¡V, Ž{ÀO, ¡ä«l, غO, ¬G, äãM, {²j, ŒRV, ê{qs (1åAí): æ35ñO§BV|WE (2019/12/15), .
733223. [wï (nûïE€ï)] (|X^[) VK\ã\ªf©ç©œIS^O§BàÌ\ã. Àä«l, ODNG, ÍŽi, ãºi, _`O, åìF³, ÑË~œ, Ž{±L, úGN1, cšê1 (1åAí): æ35ñO§BV|WE (2019/12/15), .
733224. [wï (nûïE€ï)] (êÊu) SHPT¡ÃÌÇüãÉü¯œÝ. ËJ`K, îúm, c@Ö1, Àc@³ (1åAí): CKD-MBDðlŠéï ¡l (2019/12/17), ¡l.
733225. [wï (nûïE€ï)] (êÊu) £tÚAóâÌ«Þñ̪ÍÆÎô. cmj (åAí): æ37ñ_ÞìEtÚAð×·éï (2019/12/21), ¡l.
733226. [wï (nûïE€ï)] (xXgv[e[V) s®Sd¡tá±AÇɯ€¯¶µœtá±àÆt×EàÌ1á. ŽìMO1, rcb1, cmj1, in@o1, ¬Ñq1, töÉF1, ¡cNv1, Œ{a«1, ⺳k1 (1åAí): æ61ñú{åAíÈwï_Þìnûï (2020/2/13), ¡l.
áÈw
[wp_¶]
110299. [Ž] Evaluation of Pupil Fields Using a Newly Developed Perimeter in Glaucoma Patients. Totsuka K1, Asakawa K2, Ishikawa H2, Shoji N1: Curr Eye Res 2019/5; 44 (5): 527-32. (ËËaq1, óì@«2, Îì@Ï2, ¯iMs1: 1áÈ, 2ãÃq¶w)
110300. [Ž] Visual Performance in Eyes Undergoing Femtosecond Laser-Assisted Keratoplasty for Advanced Keratoconus. Kamiya K1, Takahashi M2, Igarashi A2,3, Shoji N2: Sci Rep 2019/4; 9 (1): 6442 (6pages). (_JaF1, Ž³p2, Ü\Íj2,3, ¯iMs2: 1ãÃq¶w, 2áÈ, 3R€a@ACZ^[)
110301. [Ž] Repeatability of the Novel Intraocular Pressure Measurement From Corvis ST. Matsuura M1,2, Murata H1, Fujino Y1, Yanagisawa M1, Nakao Y3, Nakakura S4, Kiuchi Y1, Asaoka R1 (1The University of Tokyo, 3Hiroshima University, 4Saneikai Tsukazaki Hospital): Transl Vis Sci Technol 2019/6; 8 (3): 48 (1-8). (ŒY«l1,2: 2åw@ãÃn€È)
110302. [Ž] Adaptation time, electroretinography, and pupillography in healthy subjects. Asakawa K1, Ito A, Kobayashi H, Iwai A, Ito C, Ishikawa H1: Doc Ophthalmol 2019/8; 139 (1): 33-44. (óì@«1, Îì@Ï1: 1ãÃq¶w)
110303. [Ž] Predictability of the vault after posterior chamber phakic intraocular lens implantation using anterior segment optical coherence tomography. Igarashi A1,2, Shimizu K1,2, Kato S2, Kamiya K3: J Cataract Refract Surg 2019/8; 45 (8): 1099-104. (Ü\Íj1,2, Ž
öç1,2, _JaF3,4: 1R€a@ACZ^[, 2áÈ, 3ãÃq¶w)
110304. [Ž] Challenges to detect glaucomatous visual field loss with pupil perimetry. Asakawa K1, Shoji N2: Clin Ophthalmol 2019/8; 13: 1621-5. (óì@«1, ¯iMs2: 1ãÃq¶w, 2áÈ)
110305. [Ž] Piggyback implantable collamer lens implantation for the correction of residual refractive errors after cataract surgery: a multicenter study. Kamiya K1,2, Shimizu K1,3,4, Kojima T1, Nakamura T1, Ichikawa K1,4,5: (1Japan ICL Study Group): Acta Ophthalmol 2019/9; 97 (6): e946-7. (_JaF1,2, Ž
öç1,3, sìêv1,4,5: 2ãÃq¶w, 3áÈ, 4R€a@ACZ^[, 5áÈ)
110306. [Ž] Keratoconus detection using deep learning of colour-coded maps with anterior segment optical coherence tomography: a diagnostic accuracy study. Kamiya K1, Ayatsuka Y2, Kato Y2, Fujimura F1, Takahashi M3, Shoji N3, Mori Y4, Miyata K4 (2Cresco Ltd, Technology Laboratory, 4Miyata Eye Hospital): BMJ Open 2019/9; 9 (9): e031313 (7pages). (_JaF1, ¡º²q1, Ž³p3, ¯iMs3: 1ãÃq¶w, 3áÈ)
110307. [Ž] Ocular Biometric Changes after Trabectome Surgery. Kono Y1, Kasahara M2, Iida Y2, Tsujisawa T1, Shoji N2: Clinics in Surgery 2019/10; 4: Article 2634 (4pages). (ÍìYº1, }Ž³s2, ÑcÃF2, ÒòCF1, ¯iMs2: 1åw@ãÃn€È, 2áÈ)
110308. [Ž] Epidemiologic and Clinical Characteristics of Optic Neuritis in Japan. Ishikawa H1,2, Kezuka T1, Shikishima K1, Yamagami A1,3, Hiraoka M1, Chuman H1, Nakamura M1, Hoshi K1,4, Goseki T1,5, Mashimo K1,5, Mimura O1, Yoshitomi T1, Tanaka K1 (1Working Group on Diagnostic Criteria for Refractory Optic Neuritis Based on Neuroimmunological Perspective): Ophthalmology 2019/10; 126 (10): 1385-98. (Îì@Ï1,2, RãŸq1,3, ¯@ÀF1,4, ãÖŸ1,5, áÁºIüã1,5: 2ãÃq¶w, 3äãáÈa@, 4q¶, 5áÈ)
110309. [Ž] Effects of 0.4% ripasudil hydrochloride hydrate on morphological changes in rabbit eyes. Limratchatamorn B1, Asakawa K2, Mashimo K1, Uga S1, Ishikawa H2: Int J Ophthalmol 2019/10; 12 (10): 1637-42. (óì@«2, áÁºIüã1, FêÎO1, Îì@Ï2: 1áÈ, 2ãÃq¶w)
110310. [Ž] Compression of the Choroid by Horizontal Duction. Chen JY1, Le A2,3,4, De Andrade LM2,4, Goseki T2,4,5, Demer JL2,3,4,6,7 (1Computational and Systems Biology Interdepartmental Program, University of California, 2Department of Ophthalmology, University of California, 3Bioengineering Interdepartmental Program, University of California, 4Stein Eye Institute, University of California, 6Department of Neurology, University of California, 7David Geffen Medical School, University of California): Invest Ophthalmol Vis Sci 2019/10; 60 (13): 4285-91. (ãÖŸ2,4,5: 5áÈ)
110311. [Ž] Comparison of Humphrey Field Analyzer and imo visual field test results in patients with glaucoma and pseudo-fixation loss. Goukon H1,2, Hirasawa K2,3, Kasahara M2, Matsumura K2, Shoji N2: PLoS One 2019/11; 14 (11): e0224711. (œEßN1,2, œàVê@2,3, }Ž³s2, ŒºêO2, ¯iMs2: 1åw@ãÃn€È, 2áÈ, 3Moorfields Eye Hospital)
110312. [Ž] Investigating the structure-function relationship using Goldmann V standard automated perimetry where glaucomatous damage is advanced. Yanagisawa M1, Murata H1, Matsuura M1, Fujino Y1, Hirasawa K1,2, Asaoka R1 (1The University of Tokyo): Ophthalmic Physiol Opt 2019/11; 39 (6): 441-50. (œàVê@1,2: 2áÈ)
110313. [Ž] Differences in accommodative response and pupillary constriction during the near response among various refractive errors. Onozato N, Hara N, Taguchi A, Matsuda S, Miyazaki K, Yanai R, Yoshino A, Asakawa K1, Mukuno K2,3: ©¥_o 2019/12; 56 (4): 269273. (óì@«1, üìaY2,3: 1ãÃq¶w, 2áÈ, 3_ÞìÈåw®¡lNjbN)
110314. [Ž] Kinetic visual acuity, stereopsis, and ocular deviation with an implantable collamer lens. Kato S1, Shimizu K1,2, Igarashi A1,2, Kawamorita T3: J Cataract Refract Surg 2019/12; 45 (12): 1777-81. (Ž
öç1,2, Ü\Íj1,2, ìçcñu3: 1R€a@ACZ^[, 2áÈ, 3ãÃq¶w)
110315. [Ž] Prevalence of Sagging Eye Syndrome in Adults with Binocular Diplopia. Goseki T1,2, Suh SY2, Robbins L2, Pineles SL2, Velez FG3, Demer JL4 (2UCLA Stein Eye Institute, 3Duke University, 4David Geffen Medical School at University of California): Am J Ophthalmol 2020/1; 209: 55-61. (ãÖŸ1,2: 1áÈ)
110316. [Ž] Predictability of intraocular lens power calculation in eyes after phototherapeutic keratectomy. Yoneyama R1, Kamiya K2, Iijima K1, Takahashi M1, Shoji N1: Jpn J Ophthalmol 2020/1; 64 (1): 62-7. (ÄR@È1, _JaF2, Ñ@h1, Ž³p1, ¯iMs1: 1áÈ, 2ãÃq¶w)
120022. [Ž]ywïŽ: æ72ñú{Õ°áÈwïuW [4] u2-4z^mvXg_áò©ç^mvXg/JeI[_z_áòÖÌÏX. Žcuj1, äã«¡1, ìüØq1, â²^|1,2, R{qbq1, Îc±q3, xci3 (1äãáÈa@, 2áÈ, 3MåwãÃZ^[åŽa@áÈ): Õ°áÈ 2019/6; 73 (6): 729-35.
120023. [Ž]yæ29ñú{Îàáwï Žz^mvXg+JeI[©ç^mvXg/JeI[z_áòÖÌÏXÉæé·ú^. ³äqq1, äã«¡1, ìüØq1, â²^|1,2, Îc±q1, xci3 (1äãáÈa@, 2áÈ, 3MåwãÃZ^[åŽa@áÈ): œçµ¢áÈ 2019/6; 36 (6): 804-9.
120024. [Ž] püÜͪ嫢ÇáÉš¯éáàYxvZÌ\ª«Ì¢. Ñ@h1, ÑcÃF1, Îc@Å1, ]Ft1, ¯iMs1 (1áÈ): IOL&RS 2019/6; 33 (2): 289-93.
120025. [Ž]ywïŽ: æ72ñú{Õ°áÈwïuW [6]záàY}üáÉš¯é©oüÜlÆáÍ̪z. ¡ÖSÀq1, ÑcÃF1, àRrî1, ±ì¢G2, Ñ@h1, ]Ft1, ¯iMs1 (1áÈ, 2ãÃq¶w): Õ°áÈ 2019/8; 73 (8): 1021-6.
120026. [Ž] VDTìÆÌKðÉæéáæJážÌÂ\«. ì@Í1, À¡q³1, óì@«2, åàVªñ1 (1() be, 2ãÃq¶w): ú{ðwïG 2019/11; 29 (2): 58-64.
120027. [Ž] KinectÒZT[ðp¢œìƣ̪è. îèØ1, ±ì¢G1,2, Œcmç2, ¯iMs1 (1áÈ, 2ãÃq¶w): œçµ¢áÈ 2019/7; 36 (7): 962-5.
120028. [Ž] ¯êÇáÉεÄsÁœPrecision Pulse CapsulotomyÆContinuous Curvilinear CapsulorrhexisÌœ{ÝOü«är¢. Ocº¢1, ¬²i2, `œêY3, áÁçmê4, cF÷1, Žä¢G1, ðäKO1, sì@c5, à¡®v1, sìêv1,6 (1áÈ, 2c`måw, 3XJCráÈ, 4ÜÈ×áÈNjbN, 5òÔ\a@, 6áÈ): IOL&RS 2019/9; 33(3): 485-91.
120029. [Ž] á
fðl¶µœVÝváŸYÌÝvû@. äTê1, Á¡êæ1, ìçcñu2 (1É¡õwHÆ, 2ãÃq¶w): áŸwW[i 2019/8; 23 (1): 61-6.
120030. [Ž] 2íÞÌ1úg¢ÌÄߌpR^NgYÌÕ°]¿. gìê1, ©Tq2, FWä°²3,4, Âã¡F5, àc@O6, ²XØIK6 (1gìáÈNjbN, 2tV~áÈNjbN, 3N}m~h[áÈ, 4áÈ, 5áÈTËNjbN, 6ú{AR ()): œçµ¢áÈ 2020/2; 37 (2): 209-16.
120031. [Ž]yæ58ñú{\ž³wï: êÊuz¢nÔÇùÌ3ÎÉš¯épüÜÍ. Ö¡@Ê1, rcNç2,3, Îì@Ï4, ËË@å1, ¯iMs2 (1k¢åwa@, 2áÈ, 3R€a@ACZ^[, 4ãÃq¶w): ú{\PûmŠï 2019/12; 48: 159-64.
220004. [Ž (uv|)] á
fðl¶µœVÝváŸYÌLp«. ìçcñu1, äTê2, Á¡êæ2, _JaF1, Œcmç1, ¢@3, ¯iMs4 (1ãÃq¶w, 2É¡õwHÆ, 3áŸêåwZ, 4áÈ): áŸwW[i 2019/8; 23 (1): 73-6.
220005. [Ž (Õ°€)] ©oª¢ïÈÇáÉš¯éµEìªèÌÝ. óì@«1, ËËaq2, áÁçYŸ3, sç³`Í2,4, Îì@Ï1 (1ãÃq¶w, 2_ÞìÈåw®¡lNjbNáÈ, 3_ÞìÈåw®¡lNjbNFmÇEîÒàÈ, 4áÈ): ú{áÈwïG 2019/10; 123 (10): 977-80.
310037. [Çáñ] Child with congenital cataract living in the Bonin Islands. Ito M1, Shimizu K1,2, Shoji N2: JCRS Online Case Reports 2019/10; 7 (4): 61-4. (Ž
öç1,2, ¯iMs2: 1R€a@ACZ^[, 2áÈ)
320035. [Çáñ] MesalazineÉæéòÜ«_oÇÌêá. RãŸq1,2, áqëo1, äã«¡1, ÎìTl3 (1äãáÈa@, 2áÈ, 3ºÉãÈåwáÈ): _oáÈ 2019/6; 36 (2): 184-90.
320036. [Çáñ] ·úoßÏ@ªÂ\Å ÁœViciÇóQÌêá. àRrî1, rcNç1, ãÖŸ1, Îì@Ï2, óì@«2, ¯iMs1 (1áÈ, 2ãÃq¶w): _oáÈ 2019/9; 36 (3): 330-4.
320037. [Çáñ] ¬ÌÁ«®á_oáãÉš¯éµEE²ßáQðqÏIÉÏ@Å«œêá. ìãu1,2, éØ«¡1,2, Ž@Œl1,2, ¡RRIq1,2, ²¡@i1,2, VäcFT1,2,3 (1ÛãÃåwÛãÃw@\Ã@wÈ, 2ÛãÃåwa@, 3áÈ): _oáÈ 2019/9; 36 (3): 340-5.
320038. [Çáñ] m.4171C>AÏÙð浜[xâ`«_oÇÌêá. ŽJ@Õ1, RãŸq1,2, â²^|1,2, äã«¡1, áqëo1, Œ{@Œ3, À{Žn4, Näc¢4, Îì@Ï5 (1äãáÈa@, 2áÈ, 3MåwãÃZ^[åXa@, 4Õ, 5ãÃq¶w): _oáÈ 2019/12; 36 (4): 421-8.
320039. [Çáñ] O«_oÇÌaÔÉvµÈ¢@\áQðµœ1á. xc§F1, Œ{@Œ1, nÓ€l1, Ä@FŸ1, x@Tê1, Îì@Ï2 (1MåwãÃZ^[åXa@, 2ãÃq¶w): _oáÈ 2020/3; 37 (1): 58-63.
520012. [à] üÜž³èp: ú{Ì»ó, ¢EÆÌär. _JaF (ãÃq¶w): ú{ÌáÈ 2019/4; 90 (4): 420-5.
520013. [à] 2019JSCRS Clinical Survey. ²¡³÷1, _JaF1,2, ¬²i1, ã¡m1, c£mu1, âÞÃq1, Ñ@@€1 (1JSCRSf[^ðÍÏõï, 2ãÃq¶w): IOL&RS 2019/9; 33 (3): 453-73.
520014. [à] Dysphotopsia. ìçcñu (ãÃq¶w): IOL&RS 2019/12; 33 (4): 627-32.
521003. [ðà] áÈãÌèø <940> wpÏõïÒ@L
»ÌáàY. _JaF (ãÃq¶w): ú{ÌáÈ 2019/7; 90 (7): 856-7.
521004. [ðà] àáEüÜèpÌ__: SMILE. _JaF (ãÃq¶w): IOL&RS 2019/9; 33 (3): 505-10.
521005. [ðà] áÈãÌèø <949> wpÏõïÒ@MIGSÌIðÆK. ¯iMs (áÈ): ú{ÌáÈ 2019/12; 90 (12): 1549-50.
521006. [ðà] ±ŸíèÌfÃíï: PVDFD
D
p[vj ASFLEX (MODEL I). ÑcÃF (áÈ): IOL&RS 2019/12; 33 (4): 691-3.
521007. [ðà] RTe[VR[i[@GLXp[gÉ·: ñ3. Ü\Íj1,2 (1R€a@ACZ^[, 2áÈ): IOL&RS 2019/12; 33 (4): 694-9.
522078. [uÀ]yR^NgYZ~i[: R^NgYû³çÈéêà@54z.VpR^NgYÌõwÁ«. ìçcñu (ãÃq¶w): œçµ¢áÈ 2019/4; 36 (4): 503-4.
522079. [uÀ]yÇá©çwÔ@àáèpÌÀHN`[ (pÒ15)zóO[Çá. ÑcÃF (áÈ): Õ°áÈ 2019/4; 73 (4): 415-21.
522080. [uÀ]yÁW: lHm\ (AI) ÆrbOf[^zpEàáªìÉš¯éAIp. _JaF (ãÃq¶w): œçµ¢áÈ 2019/4; 36 (4): 465-70.
522081. [uÀ]yÁW: ±êÅí©é©ÈÆu«áŸ³z©ÈÆu«_o. RãŸq1,2 (1äãáÈa@, 2áÈ): OCULISTA 2019/4; 73: 70-5.
522082. [uÀ]yí©èâ·¢Õ°uÀzã[^L
»ÌáàY. Ü\Íj1,2 (1R€a@ACZ^[, 2áÈ): ú{ÌáÈ 2019/4; 90 (4): 436-40.
522083. [uÀ]yí©èâ·¢Õ°uÀzüÜž³èpãÌàáèp. ÑcÃF (áÈ): ú{ÌáÈ 2019/4; 90 (4): 442-7.
522084. [uÀ] ÁW: á©çlŠéðÊÀS`@\i·ãÉš¯éîÒÌðÊÀS`. ìçcñu (ãÃq¶w): ðÊÀS³ç 2019/5; 54 (5): 6-12.
522085. [uÀ] püÜž³Abvf[g: g|KChpNXLO. Ž³p (áÈ): IOL&RS 2019/6; 33 (2): 241-8.
522086. [uÀ]yR^NgYZ~i[: R^NgYû³çÈéêà@57zõ (g·) Æá. Œcmç (ãÃq¶w): œçµ¢áÈ 2019/7; 36 (7): 905-6.
522087. [uÀ]yÁW2: Negative DysphotopsiazõwÀ±©çlŠéNegative Dysphotopsia. ìçcñu (ãÃq¶w): áÈèp 2019/7; 32 (3): 332-7.
522088. [uÀ]yR^NgYZ~i[: R^NgYû³çÈéêà 58z῵³ÌíÞ. ìçcñu (ãÃq¶w): œçµ¢áÈ 2019/8; 36 (8): 1039-40.
522089. [uÀ]yüÜž³èpZ~i[: XLAbvuÀ 231.zOáOCTðp¢œICLTCYÌè. Ü\Íj1,2 (1R€a@ACZ^[, 2áÈ): œçµ¢áÈ 2019/8; 36 (8): 1043-4.
522090. [uÀ]yÁW: òÜÌìpÆ_oáÈzRªñÜÆ_oáÈ. ØLÆ1,2 (1ꧧêªñZ^[, 2áÈ): _oáÈ 2019/9; 36 (3): 297-303.
522091. [uÀ]yÁW: Rrl[VüÜž³èpzpÏ«Ç PTKpãÌàáèp. ÄR@È1, _JaF2 (1áÈ, 2ãÃq¶w): IOL&RS 2019/9; 33 (3): 407-12.
522092. [uÀ]yÁW: Rrl[VüÜž³èpz@\©ç©œááÙºèp. hVãaF1, œàVê@1,2,3, ãºiq1, Øœñ1,4 (1ŸñÌ€ŠáÈNjbN, 2Moorfields Eye Hospital, 3áÈ, 4MåwãÃZ^[åŽa@): IOL&RS 2019/9; 33 (3): 427-33.
522093. [uÀ]yÕ°Z~i[zàápãžÌRc. ±ì¢G1, ìçcñu1 (1ãÃq¶w): IOL&RS 2019/9; 33 (3): 516-21.
522094. [uÀ]yÁW: ßaÌàáèpzáàYxvZ. ÑcÃF (áÈ): OCULISTA 2019/11; 80: 27-33.
522095. [uÀ]yÁW: µEÌ·ÌmVzµEìªèÌÅVZ@. óì@« (ãÃq¶w): _oáÈ 2019/12; 36 (4): 378-85.
522096. [uÀ]yÁW: ÎàáÌVµ¢fÃ@Æ»Ì]¿|zgÌƱëÍ?z¡VKfÃ@ð]¿·é@ÑlÌõÃÅp|}CNpXÑlÌõÃÅpÌzgÌƱë. ÒòCF1, ¯iMs2 (1åw@åw@ãÃn€È, 2áÈ): Õ°áÈ 2019/12; 73 (13): 1546-50.
522097. [uÀ]yÁW: š³ŠÄš«œ¢Vµ¢OážzpÌqXeVXÆ»Ì]¿. _JaF (ãÃq¶w): OCULISTA 2019/12; 81: 55-60.
522098. [uÀ]yÁW: Vµ¢OùNØJzCCCÌ_ (ÄÆðj). Ž
öç1,2,3 (1R€a@ACZ^[, 2ÛãÃåw, 3áÈ): IOL&RS 2019/12; 33 (4): 604-7.
522099. [uÀ]yÁW: Vµ¢OùNØJzPrecision Pulse Capsulotomy (ZEPTOÒ). Ocº¢1, sìêv1,2, ¬²i3 (1áÈ, 2áÈ, 3cä`måwãwáÈw³ºªº) IOL&RS 2019/12; 33 (4): 613-8.
522100. [uÀ]yÁW: µEÌ·ÌmVz_. óì@«1, OcjÄ2 (1ãÃq¶w, 2VãÃåw): _oáÈ 2019/12; 36 (4): 371.
522101. [uÀ]yÁW1: ûÇóQÉηéèpíªzûÎàáÉηé¬oHÄp. }Ž³s1, ¯iMs1 (1áÈ): áÈèp 2020/1; 33 (1): 24-9.
522102. [uÀ]yÁW: fW^»ªiÞáÈèpz4. àáèpÖÌfW^ZpEAIÌp. _JaF (ãÃq¶w): áÈ 2020/1; 62 (1): 29-34.
522103. [uÀ]yÁW: ááÙáz¹z_. Îì@Ï (ãÃq¶w): áÈ 2020/2; 62 (2): 101-2.
522104. [uÀ]yÁW: ááÙáz¹z1. ááÙáz¹ÆÍ. RãŸq1,2 (1äãáÈa@, 2áÈ): áÈ 2020/2; 62 (2): 103-6.
522105. [uÀ]yÁW: AI (lHm\)zfB[v[jOðp¢œ~pÌffšæÑaúªÞ. _JaF (ãÃq¶w): IOL&RS 2020/3; 34 (1): 36-41.
530011. [»ÌŒ (ù³)] Correction to: Causes, background, and characteristics of binocular diplopia in the elderly. Kawai M1, Goseki T2, Ishikawa H3, Hoshina M, Shoji N2: Jpn J Ophthalmol 2019/7; 63 (4): 352. (Í€À1, ãÖŸ2, Îì@Ï3, ¯iMs2: 1åw@ãÃn€È, 2áÈ, 3ãÃq¶w)
540048. [»ÌŒ (j
[X^[)] ÒWÏõ·ACÉ œÁÄ. _JaF (ãÃq¶w): ú{áõwïj
[X^[2019/4; 2019 (1): 3.
540049. [»ÌŒ (j
[X^[)] VCÌÐî. sìêv1,2 (1áÈ, 2áÈ): ú{áõwïj
[X^[2019/4; 2019 (1): 5.
540050. [»ÌŒ]ywZÛÌÅz_Þì§ÌwZÛÌ»ó. Fé`ê1,2 (1_Þì§áÈãïï·, 2áÈ): ú{ÌáÈ 2019/4; 90 (4): 463-5.
540051. [»ÌŒ]yCOãwîñzßáƳáÉš¯éperipheral blurÉηéneural adaptation. ìçcñu (ãÃq¶w): ú{ÌáÈ 2019/6; 90 (6): 711-2.
540052. [»ÌŒ] ÁWÉ œÁÄ. ºMF1, _JaF2 (1œÈµºáÈ, 2ãÃq¶w): IOL&RS 2019/6; 33 (2): 218.
540053. [»ÌŒ] @l©çÌšmç¹: œ¬©çßaÖ. sìêv1,2 (1áÈ, 2áÈ): IOL&RS 2019/6; 33 (2): 395.
540054. [»ÌŒ (Letter to the editor)] Letter to the editor: 土Fæ¶ÖÌñ. ãÖŸ1, ¶^¢2, sç²`Í1,2, N^2, üìaY1,2 (1áÈ, 2_ÞìÈåw®¡lNjbN): _oáÈ 2019/6; 36 (2): 240-2.
540055. [»ÌŒ] ÁWÉ œÁÄ. räGK1, _JaF2 (1ÝÈÆÝç¢ACNjbN, 2ãÃq¶w): IOL&RS 2019/9; 33 (3): 406.
540056. [»ÌŒ] CLogCT[hXe[Wæ57ñ@}`tH[JCL vs }`tH[JIOL. gìê, _JaF1, cë`, ñ{³äè, ñ{ÓF (1ãÃq¶w): ú{R^NgYwï 2019/9; 61 (3): 77-83.
540057. [»ÌŒ (GL)] ¢EÌãw©çuÎàáÖÌIðI[U[@ÛÑ`¬pïpÎøÊÅòšÃ@Éévðà@ŽJú÷pÎàáâá³Ç³ÒÉSLTðæ1IðÆ·é¢ð. ¯iMs (áÈ): MMJ (The Mainichi Medical Journal) 2019/10; 15 (5): 158.
540058. [»ÌŒ (¡Ì\)]y¡Ì\z¬ûa. iìKê1, îJ@å2 (1áÈ, 2äåw): Õ°áÈ 2019/10; 73 (10): 1251.
540059. [»ÌŒ (lbgL)] [VbNÉ®u[É? áàR^NgYuICLvÌó]ÆÀE. _JaF (ãÃq¶w): DIAMOND online 2019/11; https://diamond.jp/articles/-/220614.
540060. [»ÌŒ (L)] Ïíµ¢õ©çÌðúÖ: çœÈj[YÉ
ÚµœR^NgY. Œcmç1, ŒöüLó2, úRüq2, John Buch2 (1ãÃq¶w, 2W\GhW\ () rWPAJpj[): œçµ¢áÈ 2019/12; 36 (12): SÊL (5pages).
540061. [»ÌŒ (wïóÛL)] óÛL: æ34ñJSCRSwpï. _JaF (ãÃq¶w): IOL&RS 2019/12; 33 (4): 713-4.
540062. [»ÌŒ] @l©çÌšmç¹: AWAÅÌáÈãÊÍ. sìêv1,2,3 (1JSCRS·, 2áÈ, 3áÈ): IOL&RS 2019/12; 33 (4): 717.
540063. [»ÌŒ (¡Ì\)]y¡Ì\zTerdsonÇóQ. Rû@ (áÈ): Õ°áÈ 2020/3; 74 (3): 251.
540064. [»ÌŒ (ãïŸæè)]yãïŸæèz<ú{áÈÐïÛ¯ïcV|WEñ> æ73ñú{Õ°áÈwï@ú{áÈÐïÛ¯ïcV|WEufÃñVüèqAOð¥ÜŠÄv4. ú{Îàáwï©çÌv]. ¯iMs (áÈ): ú{ÌáÈ 2020/2; 91 (2): 87-91.
540065. [»ÌŒ (])] ]: SÃáÈ㪳Šé@»ÌÚÌs²Í]ªŽö. RãŸq1,2 (1äãáÈa@, 2áÈ): _oáÈ 2020/3; 37 (1): 76.
540066. [»ÌŒ (wïŽ^)]yæ55ñ k¢åwE_Þì§áÈãï¯T[`Jt@XzI~flpOC\vs_áòÌZúgp¬Ñ. ØŸY1, }Ž³s1, Ž³p1, ÍìYº2, ÒòCF2, ÄR@È1, ¯iMs1 (1áÈ, 2åw@ãÃn€È): áÈÕ°Iv 2020/3; 13 (3): 218.
540067. [»ÌŒ (wïŽ^)]yæ55ñ k¢åwE_Þì§áÈãï¯T[`Jt@Xz[VbNpãOÉæétbv|]𶶜êá. Näq1, Ž³p1, _JaF2, ¯iMs1 (1áÈ, 2ãÃq¶w): áÈÕ°Iv 2020/3; 13 (3): 218.
540068. [»ÌŒ (wïŽ^)]yæ55ñ k¢åwE_Þì§áÈãï¯T[`Jt@Xz_uj[heNjbNðp¢œtW@ÉæéáàYàÅèpÌèp¬Ñ. FìF1, tØG1, öcqF1, ¯iMs1 (1áÈ): áÈÕ°Iv 2020/3; 13 (3): 218.
540069. [»ÌŒ (wïŽ^)]yæ55ñ k¢åwE_Þì§áÈãï¯T[`Jt@Xzá
^®áQ𹵜RMOGRÌz«_oÌ1á. Žäq1, ÎìåN1, àRrî1, ãÖŸ1, Îì@Ï2, ¯iMs1 (1áÈ, 2ãÃq¶w): áÈÕ°Iv 2020/3; 13 (3): 218.
540070. [»ÌŒ (wïŽ^)]yæ55ñ k¢åwE_Þì§áÈãï¯T[`Jt@XzBarrett Universal II®ÆSRK/T®Ì\ª«Ìär. Ñ@h1, _JaF2, ÑcÃF1, ¯iMs1 (1áÈ, 2ãÃq¶w): áÈÕ°Iv 2020/3; 13 (3): 218-219.
540071. [»ÌŒ (wïŽ^)]yæ55ñ k¢åwE_Þì§áÈãï¯T[`Jt@Xzõ±Âfwv (OCT)©ðSƵœÔÉqÌŸ³. tØG (áÈ): áÈÕ°Iv 2020/3; 13 (3): 219.
[@]
620070. [wp (ªS·M)]y¡ÃEžEuÌV[ÊÉí©é@áÈÌÆÁÄš«·èÅ¢ÁœÆ«ÉJ{ (áÈPA2019NtG§)z3Í Ÿ³Ì¡ÃÅÇ€gíêé? ægp³êéò@(2) ááÙ¯¢êñ, p.62-71. ãÖŸ1 (1áÈ), Ò: ŒV2 (2àÕŠãÈåwáÈ), fBJoÅ, åã, 2019/4s.
620071. [wp (ªS·M)]yÎàá¹ê@ffE¡ÃÌêè²wìzR21 áNPÎàáèp (MIGS), p.205. ¯iMs (áÈ), Ò: ØàÇŸ, ãw@, , 2019/4s.
620072. [wp (ªS·M)]y113|æ113ñãtƱâèðàzA-14 ááٺ̎ö, p.14. A-21 ©Á~EÅ\z³êé©oÇó, p.27-8. C-35 dC«áÖÌÎ, p.234. D-4 ̲ÌèÉKvÈÍ\̪, p.279. D-24 ôEŽ¶Ô£ÉεÄsí꜡Ã, p.303-4. D-59 ÔOÌffÉLpÈž, p.371-2. E-6 áÌÁîÉæé²ßÍáºÉÖ^·éÊ, p.411. E-18 €ÁûªÉº·éúÇó, p.420. F-55 ÂÇ÷pÎàáÖÌÎ, p.521-2. ãÖŸ1, sç²`Í1,2 (1áÈ, 2_ÞìÈåw®¡lNjbN), Ò: ãtƱâèðàÒWÏõï, eR RecÆ{, , 2019/4s.
620073. [wp (ªS·M)]yÔÚHMIÌJ®üÆ©®^], ADASÖÌp|hCoóÔo, oÁÛ, ÀÚ÷, ZL
eBÎô|zæ10Í wbhAbvfBXvCÌ\ŠZpÆF«üã, ÀS«]¿@æ3ß ¶õw̧ê©ç©œwbhAbvfBXvCÌÀS«ÆoSÝv, p.465-73. ìçcñu (ãÃq¶w), ZpîñŠï, , 2019/7s.
620074. [wp (ªS·M)]yáÈÆòÜ (áÈ2019N9Õ§)zæ1 ÅßÌáÈòš¡Ã@VII. ._oáÈŸ³@3. «Ä«Ç«_oÇ (CRION), p.1169-72. RãŸq1,2 (1äãáÈa@, 2áÈ), xci, Øcêj, ã¡@_, ÑcmO, Gêiìç, åVêŸ, Îì@Ï3 (3ãÃq¶w), àŽoÅ, , 2019/9s.
620075. [wp (ªS·M)]yržŸÌ éÂ\«Ì 音Q&A ( œçµ¢áÈ 36 (Õ§))zI ržŸÌ éÂ\«Ì 音ƻ̞/¡Ã@6. _oEH@Q3 Á«_oÆÍÈñÅ·©. Üœ¡ÃÍÇ€µÜ·©, p.215-8. àVS¥1, Îì@Ï2 (1åw, 2ãÃq¶w), ÒWå²: غ@Î, Ò: R{Nç, ÑcmO, Oçb, fBJšoÅ, , 2019/11s.
620076. [wp (ªS·M)]yržŸÌ éÂ\«Ì 音Q&A ( œçµ¢áÈ 36 (Õ§))zI ržŸÌ éÂ\«Ì 音ƻ̞/¡Ã@6 ._oEH@Q4 «_oÇÌffÆ¡ÃÉ¢ijŠÄŸ³¢, p.219-22. â²^|1,2, RãŸq1,2 (1äãáÈa@, 2áÈ), ÒWå²: غ@Î, Ò: R{Nç, ÑcmO, Oçb, fBJšoÅ, , 2019/11s.
620077. [wp (ªS·M)]yCurrent Decision Support/CDS (fW^Å)zÇó (]_oEž_)@¡: šªñdÉ©Šé/Double vision (diplopia), https://www.cds.ai/docs/detail/s01500. ãÖŸ (áÈ), vVW, , 2019/12.
620078. [wp (ªS·M)]yCurrent Decision Support/CDS (fW^Å)zÇó (ªèò)@_oûªî¯ (Optic disc swelling), https://www.cds.ai/docs/detail/s05420. ãÖŸ (áÈ), vVW, , 2019/12.
620079. [wp (ªS·M)]y៳AgXV[Y æ3ª@OáAgXz5. á
^®Ùí@e_@4) ØŽ¶á
^®áQ@(5) Sagging eye syndrome, p.386-7. ãÖŸ1 (1áÈ), ÄC: åNY2 (2}gåw), Ò: ìcÀ3, nÓ²p4 (3cåw, 4s{§ãÈåw), ãwÐ, 2019/10s.
621004. [wp (ÒW)]yáÈÆòÜ (áÈ2019N9Õ§)zÒ: xci, Øcêj, ã¡@_, ÑcmO, Gêiìç, åVêŸ, Îì@Ï1 (1ãÃq¶w), àŽoÅ, , 2019/9s.
[wïE€ï]
712025. [wï (Û)] (V|WE) Epidemiological and Clinical Characteristics of Optic Neuritis in Japan. Ishikawa H1: The 8th Chinese Neuro-Ophthalmological Society Conference (2019/7/19), China. (Îì@Ï1: 1ãÃq¶w)
712026. [wï (Û)] (µÒu) Meet tha Experts Japan: Optical and fluid dynamics simulatin in Hole ICL. Kawamorita T1: STAAR Surgical 16th international EVO Visian ICL Experts Summit (2019/9/13), Paris, France. (ìçcñu1 :1ãÃq¶w)
712027. [wï (Û)] (MasterClasses) Mastering Minimally Invasive Glaucoma Surgery (MIGS)/KDB and Trabectome. Shoji N1: 32nd APACRS KYOTO2019 (2019/10/3), Kyoto, Japan. (¯iMs1: 1áÈ)
712028. [wï (Û)] (V|WE) Presbyopia Treatment for Phakic Eye (L
»ÌáÉš¯éVž³). Igarashi A1,2: 32nd APACRS KYOTO2019 (2019/10/4), Kyoto, Japan. (Ü\Íj1,2: 1R€a@, 2áÈ)
712029. [wï (Û)] (V|WE)yÀ·zSUMO-Wrestling with Challenges in Refractive Surgery (üÜž³èpÉš¯é§íÆÌXO). Shimizu K1,2: 32nd APACRS KYOTO2019 (2019/10/5), Kyoto, Japan. (Ž
öç1,2: 1R€a@, 2áÈ)
712030. [wï (Û)] (V|WE) 10Years Follow Up of KS-AquaPORT ICL KS-AquaPORT (ICLÌ10NoßÏ@). Shimizu K1,2: 32nd APACRS KYOTO2019 (2019/10/5), Kyoto, Japan. (Ž
öç1,2: 1R€a@, 2áÈ)
712031. [wï (Û)] (Young Neuro-Ophthalmologists (YNO) Session) High Prevalence of Sagging Eye Syndrome with Binocular Diplopia. Goseki T1: the 10th Asian Neuro-Ophthalmology Society Congress (2019/12/3), Manila, Philippines. (ãÖŸ1: 1áÈ)
722122. [wï (S)] (V|WE)yI[KiCU[zÅ_[xÌg£ÍV¡ÃÌX^_[hÆÈè€é©? _JaF (ãÃq¶w): æ123ñú{áÈwïï (2019/4/18), .
722123. [wï (S)] (V|WE) µEaÆÅ_[x. ìçcñu (ãÃq¶w): æ123ñú{áÈwïï (2019/4/18), .
722124. [wï (S)] (V|WE)yI[KiCU[zImagingÌiàÆ_oáÈŸ³. Îì@Ï (ãÃq¶w): æ123ñú{áÈwïï (2019/4/18), .
722125. [wï (S)] (V|WE) áâ|àDÏ«ÉæéãV¡. ãÖŸ (áÈ): æ123ñú{áÈwïï (2019/4/18), .
722126. [wï (S)] (International Symposium) Trabectome surgery: effects and limitations ¯iMs (áÈ): æ123ñú{áÈwïï (2019/4/18), .
722127. [wï (S)] (V|WE)yI[KiCU[zÎàááÌ÷püÛÑÉηéAv[`. ¯iMs (áÈ): æ123ñú{áÈwïï (2019/4/20), .
722128. [wï (S)] (³çZ~i[) Vµ¢ã¡Ã|ŒáJúºãPû|. Œcmç (ãÃq¶w): æ123ñú{áÈwïï (2019/4/20), .
722129. [wï (S)] (`Z~i[) @\žÌVœÈvbgtH[|EYENACÆaccu-pad|. Œcmç (ãÃq¶w): æ123ñú{áÈwïï (2019/4/20), .
722130. [wï (S)] (TuXyVeBTf[)yI[KiCU[z±êÅ}X^[, _oŸ³. Îì@Ï (ãÃq¶w): æ123ñú{áÈwïï (2019/4/21), .
722131. [wï (S)] (TuXyVeBTf[) _o. Žäq (áÈ): æ123ñú{áÈwïï (2019/4/21), .
722132. [wï (S)] (TuXyVeBTf[) ³«, â`«, Å«_oÇ. RãŸq1,2 (1äãáÈa@, 2áÈ): æ123ñú{áÈwïï (2019/4/21), .
722133. [wï (S)] (TuXyVeBTf[) áàYxvZ. ÑcÃF (áÈ): æ123ñú{áÈwïï (2019/4/21), .
722134. [wï (S)] (TuXyVeBTf[) ªõ§ßŠÆÕõáŸE
FáàY. _JaF (ãÃq¶w): æ123ñú{áÈwïï (2019/4/21), .
722135. [wï (S)] (uKï) üÜž³èpEàOÌ»óÆ¡ãÌW]. _JaF (ãÃq¶w): æ123ñú{áÈwïï (ú{áÈwïüÜž³èpuKï) (2019/4/21), .
722136. [wï (S)] (|íÜLOu) Causes,background,and characteristics of binocular diplopia in the elderly (îÒ̌᫡𶞎ö, wiyÑÁ¥). Í€À1, ãÖŸ1, Îì@Ï2, ÛÈüó3, ¯iMs1 (1áÈ, 2ãÃq¶w, 3R€a@): æ75ñú{ãÎwïïEæ44ñú{¬áÈwïï ¯wï (2019/6/14), ê.
722137. [wï (S)] (CujOZ~i[) A^{ckXÅf»Ü{gbNXuKEÀZZ~i[uÎvŸ³Ò. ãÖŸ (áÈ): æ75ñú{ãÎwïïEæ44ñú{¬áÈwïï ¯wï (2019/6/14), ê.
722138. [wï (S)] (rfIv[e[V) ICLèp. _JaF (ãÃq¶w): æ34ñJSCRSwpï (2019/6/28), s.
722139. [wï (S)] (ÁÊñ) 2019 JSCRS Clinical Survey. ²¡³÷1, _JaF2 (1TgEáÈ, 2ãÃq¶w): æ34ñJSCRSwpï (2019/6/28), s.
722140. [wï (S)] (V|WE)yÀ·zàáèpãÌüÜž³. _JaF (ãÃq¶w): æ34ñJSCRSwpï (2019/6/28), s.
722141. [wï (S)] (V|WE) àápãÌߌpR^NgYp. Ñ@h1, _JaF2, ÑcÃF1, ¯iMs1 (1áÈ, 2ãÃq¶w): æ34ñJSCRSwpï (2019/6/28), s.
722142. [wï (S)] (³çZ~i[) g[bNáàYèpÌÀÛ. sìêv1,2 (1áÈ, 2áÈ): æ34ñJSCRSwpï (2019/6/28), s.
722143. [wï (S)] (V|WE) fB[v[jOÆOáõ±Âfwvðp¢œ~pÌff. _JaF (ãÃq¶w): æ34ñJSCRSwpï (2019/6/29), s.
722144. [wï (S)] (V|WE) üÜž³èpƵÄÌg|KChpNXLO. Ž³p (áÈ): æ34ñJSCRSwpï (2019/6/29), s.
722145. [wï (S)] (CXgNVR[X)yI[KiCU[Eutz¢EÌÅVghðmë€! What's New in 2019. _JaF (ãÃq¶w): æ34ñJSCRSwpï (2019/6/29), s.
722146. [wï (S)] (P[X|[g)yÀ·zP[X|[g
@. Ü\Íj1,2 (1R€a@, 2áÈ): æ34ñJSCRSwpï (2019/6/29), s.
722147. [wï (S)] (P[X|[g) g|KChpNXLOªt÷µœy[VhpÓÏ«Ìêá. ÒòCF1, _JaF2, Ž³p1, ¯iMs1 (1áÈ, 2ãÃq¶w): æ34ñJSCRSwpï (2019/6/29), s.
722148. [wï (S)] ([jOZ~i[) úíºÌœÅ_ÍERgXgŽxž|accu-pad|. Œcmç (ãÃq¶w): æ34ñJSCRSwpï (2019/6/29), s.
722149. [wï (S)] ([jOZ~i[)yÀ·z[jOZ~i[3@Äl!!V`àá¢ãÌQOL. _JaF (ãÃq¶w): æ34ñJSCRSwpï (2019/6/29), s.
722150. [wï (S)] ([jOZ~i[) Ÿæðgå·éIOLÆCLÌg¢ë¢ëhƻ̲a. ìçcñu (ãÃq¶w): æ34ñJSCRSwpï (2019/6/29), s.
722151. [wï (S)] (`Z~i[)yÀ·z`Z~i[11v~AàáèpÌUª@. _JaF (ãÃq¶w): æ34ñJSCRSwpï (2019/6/29), s.
722152. [wï (S)] (`Z~i[) àápO|Total KeratometryÉæéUª|. ¡º²q (ãÃq¶w): æ34ñJSCRSwpï (2019/6/29), s.
722153. [wï (S)] (V|WE)yÀ·zV|WE7: œÅ_IOL|ÅVÌœÅ_áàYÆ»ÌK³gp|. sìêv1,2 (1áÈ, 2áÈ): æ34ñJSCRSwpï (2019/6/30), s.
722154. [wï (S)] (³çZ~i[) pã¹ÇÖÌÎ. _JaF (ãÃq¶w): æ34ñJSCRSwpï (2019/6/30), s.
722155. [wï (S)] (³çZ~i[) OXØJðì¬ÌÓ_Ƭ껀ÈÌÎ@. ÑcÃF (áÈ): æ34ñJSCRSwpï (2019/6/30), s.
722156. [wï (S)] (³çZ~i[) O[[x\ª©çÌžxAbv. Ü\Íj1,2 (1R€a@, 2áÈ): æ34ñJSCRSwpï (2019/6/30), s.
722157. [wï (S)] (³çZ~i[) PÅ_YÌŸæ. sìêv1,2 (1áÈ, 2áÈ): æ34ñJSCRSwpï (2019/6/30), s.
722158. [wï (S)] (CXgNVR[X)yI[KiCU[z[ORTÉæéORTÌœßÌIC] àáEüÜž³èpOãÉš¯éžÌ¬ê. ìçcñu (ãÃq¶w): æ34ñJSCRSwpï (2019/6/30), s.
722159. [wï (S)] (CXgNVR[X)yutz[ORTÉæéORTÌœßÌIC] àáEüÜž³èpOãÉš¯éžÌ¬ê. ¡º²q (ãÃq¶w): æ34ñJSCRSwpï (2019/6/30), s.
722160. [wï (S)] (CXgNVR[X)yutzpNXLOîb©çÅVÌbèÜÅ. _JaF (ãÃq¶w): æ34ñJSCRSwpï (2019/6/30), s.
722161. [wï (S)] ([jOZ~i[)yÀ·z[jOZ~i[4: ð§·éÒªüÜð§·é|g[bNIOLñ]h~ÌæègÝ|. sìêv1,2 (1áÈ, 2áÈ): æ34ñJSCRSwpï (2019/6/30), s.
722162. [wï (S)] ([jOZ~i[)yÀ·z[jOZ~i[5: Patient OrientedÉi»·éTechnology. sìêv1,2 (1áÈ, 2áÈ): æ34ñJSCRSwpï (2019/6/30), s.
722163. [wï (S)] (`Z~i[) ®Sž³l, »ÌÕ°IÓ``îb©çÅVÌm©ÜÅ`. Œcmç (ãÃq¶w): æ62ñú{R^NgYwïï (2019/7/6), s.
722164. [wï (S)] (V|WE) ÀS«©çÝœKÍÍ. Fé`ê1,2 (1FéáÈã@, 2áÈ): æ62ñú{R^NgYwïï (2019/7/7), s.
722165. [wï (S)] (`Z~i[)gõÌmCYhðžçµÄNAÈEð!`QOVüãðÚwµœõwÁ«ðL·éR^NgYÆÍ`. _JaF1, Œcmç1, ìçcñu1 (1ãÃq¶w): æ62ñú{R^NgYwïï (2019/7/7), s.
722166. [wï (S)] (`Z~i[) æèæ¢@\ðŸé±ÆÌÓ`. ìçcñu (ãÃq¶w): æ58ñú{àáwïïEæ45ñ
»Ì€ï (2019/7/19), aÌR.
722167. [wï (S)] (µÒu) _|\PûmÌœßÌÕ°€XL|. Œcmç (ãÃq¶w): The JOVS (ú{Œáž³€ï) Seminar (2019/8/25), €m.
722168. [wï (S)] (µÒu) Õ°€ÌœßÌîbm¯|Ïv·éßNÌÕ°€|. âc@y (ãÃq¶w): The JOVS (ú{Œáž³€ï) Seminar (2019/8/25), €m.
722169. [wï (S)] (µÒu) \PûmÌœßÌAEgvbgXL. Œcmç (ãÃq¶w): The JOVS (ú{Œáž³€ï) Seminar (2019/8/25), €m.
722170. [wï (S)] (f[^ðÍÏõïÁÊZbV) A multicenter,randomized,trial to test non-inferiority of microhook trabeculotomy vs Trabectome/Trabectome vs Microhook (@ÛÑØJpÌᳺ~øÊÆÀS«Ìœ{Ý€¯_»îüñòšØ±). º@œ1, aãuN2, oü€3, ¯iMs4, Ôع5, ¯iñœ6, ¡R@I7, AcrF8, âV¡YŸ9, J˳÷10 (1_Ëå, 2€Qå, 3àòå, 4áÈ, 5så, 6éÊãå, 7kå, 8ñ{ŒáÈ, 9ºaå, 10ªå): æ30ñú{Îàáwï (2019/9/6), F{.
722171. [wï (S)] (V|WE) Trabectome surgery: probability and limitation/gxNg[èpÌÂ\«ÆÀE. ¯iMs (áÈ): æ30ñú{Îàáwï (2019/9/6), F{.
722172. [wï (S)] (CujOZ~i[) ᳺ~¡Ã`¬oHÄpÆpãÇ`. ¯iMs (áÈ): æ30ñú{Îàáwï (2019/9/7), F{.
722173. [wï (S)] (RfBJvO) How to use the Octopus Perimeter to detect early visual field deterioration/Ÿú©çð§Â! OctopusìvÌ|Cg. ¡º²q (ãÃq¶w): æ30ñú{Îàáwï (2019/9/8), F{.
722174. [wï (S)] (V|WE)yÀ·zV|WE1uoCI}[J[v. Îì@Ï (ãÃq¶w): æ39ñú{áòwï (2019/9/14), ŒÃ®.
722175. [wï (S)] (V|WE) RANA|4RÌÆ_o. Îì@Ï (ãÃq¶w): æ39ñú{áòwï (2019/9/14), ŒÃ®.
722176. [wï (S)] (Global English session) The man with 30 spectacles. ãÖŸ (áÈ): æ57ñú{_oáÈwïï (2019/10/5), Dy.
722177. [wï (S)] (CXgNVR[X) CTEMRIÅàÁÆí©é! ÎÌaÔÆ¡Ã. ªÝMu1, ²¡üÛ2, R\q3, FJŸq2, Œº4, ãÖŸ5, _O ¢6 (1Vå, 2lŒãå, 3àòå, 4¹êlŒa@, 5áÈ, 6IsAáÈa@): æ73ñú{Õ°áÈwï (2019/10/24), s.
722178. [wï (S)] (CXgNVR[X) ÀH©çwÔL
»ÌáàY. Ž
öç1,2, _JaF3, sìêv2,4, ºFº5, kàV¢u6 (1R€a@ACZ^[, 2áÈ, 3ãÃq¶w, 4áÈ, 5ŒÃ®ACNjbN, 6TsA^[ACNjbN): æ73ñú{Õ°áÈwï (2019/10/24), s.
722179. [wï (S)] (`Z~i[)yÀ·zàáèpãÌQOVðlŠé|œÅ_IOL VS PÅ_IOLmrW|. Ž
öç1,2 (1R€a@ACZ^[, 2áÈ): æ73ñú{Õ°áÈwï (2019/10/24), s.
722180. [wï (S)] (`Z~i[) mrW@±üABC. ÑcÃF (áÈ): æ73ñú{Õ°áÈwï (2019/10/24), s.
722181. [wï (S)] (`Z~i[)yÀ·z}V[ÅÏíé±ê©çÌàáèp. _JaF (ãÃq¶w): æ73ñú{Õ°áÈwï (2019/10/25), s.
722182. [wï (S)] (`Z~i[) k¢åwÉš¯éàáèpèZÆWHITESTER SIGNATURE PROÌÕ°o±. ÑcÃF (áÈ): æ73ñú{Õ°áÈwï (2019/10/25), s.
722183. [wï (S)] (CujOZ~i[)yÀ·zThe 25th VISION TIMES SEMINAR [rWPAÌ¢. Ž
öç1,2, ÑcÃF2 (1R€a@ACZ^[, 2áÈ): æ73ñú{Õ°áÈwï (2019/10/25), s.
722184. [wï (S)] (CujOZ~i[) àáèpãÌ}`tH[JCLÌ@\]¿. _JaF (ãÃq¶w): æ73ñú{Õ°áÈwï (2019/10/25), s.
722185. [wï (S)] (V|WE) ú{Îàáwï©çÌv]. ¯iMs (áÈ): æ73ñú{Õ°áÈwï (2019/10/26), s.
722186. [wï (S)] ([jOZ~i[) ïÇáÉηéàá¡Ãíª`AoVB3s[XÌLp«`. ÑcÃF (áÈ): æ73ñú{Õ°áÈwï (2019/10/26), s.
722187. [wï (S)] (`Z~i[) ACUVUEߌpR^NgY (CL) `©ŠédgÝ©çg¢ûÜÅ`. _JaF1, ìçcñu1 (1ãÃq¶w): æ73ñú{Õ°áÈwï (2019/10/26), s.
722188. [wï (S)] (V|WE)yI[KiCU[zV|WE19@Åæ[Ìàáèp. ÑcÃF (áÈ): æ73ñú{Õ°áÈwï (2019/10/27), s.
722189. [wï (S)] (V|WE) ªõ§ßŠ (F) ðÓ¯µœáàYIð. sìêv1,2 (1áÈ, 2áÈ): æ73ñú{Õ°áÈwï (2019/10/27), s.
722190. [wï (S)] (uKï) üÜž³èpEàOÌ»óÆ¡ãÌW]. _JaF (ãÃq¶w): æ73ñú{Õ°áÈwï (ú{áÈwïüÜž³èpuKï) (2019/10/27), s.
722191. [wï (S)] (î²u)yf[^[zAIÅœªÏíé? ±ê©çÌáÈãÃ. _JaF1, ìçcñu1 (1ãÃq¶w): The 23rd IRSJ (2019) /æ19ñáÈÕ°@í€ï (2019/11/9), ¡l.
722192. [wï (S)] (At^k[Z~i[)yÀ·zÎàáfÃÌƵ. ¯iMs (áÈ): The 23rd IRSJ (2019)/æ19ñáÈÕ°@í€ï (2019/11/9), ¡l.
722193. [wï (S)] (µÒu)yÀ·zuI: ÷pæžÌ·ÆÀE. }Ž³s (áÈ): The 23rd IRSJ (2019)/æ19ñáÈÕ°@í€ï (2019/11/9), ¡l.
722194. [wï (S)] (µÒu) CASIA2ÌÕ°p. ÒòCF (áÈ): The 23rd IRSJ (2019)/æ19ñáÈÕ°@í€ï (2019/11/9), ¡l.
722195. [wï (S)] (µÒu)yÀ·zuII: Swept Source OCT Triton. öcqF (áÈ): The 23rd IRSJ (2019)/æ19ñáÈÕ°@í€ï (2019/11/9), ¡l.
722196. [wï (S)] (µÒu) Swept Source OCT TritonÌgpo±. tØG (áÈ): The 23rd IRSJ (2019)/æ19ñáÈÕ°@í€ï (2019/11/9), ¡l.
722197. [wï (S)] (µÒu)yÀ·zuIII: IOL Update. ÑcÃF (áÈ): The 23rd IRSJ (2019)/æ19ñáÈÕ°@í€ï (2019/11/9), ¡l.
722198. [wï (S)] (µÒu) Dysphotopsia. Ü\Íj1,2 (1R€a@ACZ^[, 2áÈ): The 23rd IRSJ (2019)/æ19ñáÈÕ°@í€ï (2019/11/9), ¡l.
722199. [wï (S)] (V|WE) AwfEwZfÆß. ¡º²q (ãÃq¶w): æ60ñú{\ž³wï (2019/11/30), ª.
722200. [wï (S)] (`Z~i[) ÈXy[X©®áVXeðp¢œŒáJúüܞɢÄ. ìçcñu (ãÃq¶w): æ60ñú{\ž³wï (2019/11/30), ª.
722201. [wï (S)] (V|WE) ÔEÂFõÉæéÎõœËðp¢œÔŸ³Ì]¿. óì@« (ãÃq¶w): ú{owï2020N~Gåï (2020/1/11), _Þì.
722202. [wï (S)] (V|WE)yI[KiCU[zV|WE1: áNPÎàáèp (MIGS) ÌøÊÆK. ¯iMs (áÈ): æ43ñú{áÈèpwïwpï (2020/1/24), .
722203. [wï (S)] (³çZ~i[) üÜž³èpÌíÞ. Ü\Íj1,2 (1R€a@ACZ^[, 2áÈ): æ43ñú{áÈèpwïwpï (2020/1/24), .
722204. [wï (S)] (`Z~i[)yÀ·z`Z~i[3: JFC Cutting EdgeZ~i[ Part6. sìêv1,2 (1áÈ, 2áÈ): æ43ñú{áÈèpwïwpï (2020/1/24), .
722205. [wï (S)] (V|WE)yI[KiCU[zV|WE8: lHpÚAÌ»óÆâè_. ìkNç1,2 (1áÈ, 2k¢€a@): æ43ñú{áÈèpwïwpï (2020/1/25), .
722206. [wï (S)] (³çZ~i[)yÀ·z³çZ~i[10: àáèpÌpguÆ»ÌÎ@. sìêv1,2 (1áÈ, 2áÈ): æ43ñú{áÈèpwïwpï (2020/1/25), .
722207. [wï (S)] (³çZ~i[)yÀ·z³çZ~i[14: tFgZJh[U[èp. sìêv1,2 (1áÈ, 2áÈ): æ43ñú{áÈèpwïwpï (2020/1/25), .
722208. [wï (S)] (³çZ~i[) tFgZJh[U[. _JaF (ãÃq¶w): æ43ñú{áÈèpwïwpï (2020/1/25), .
722209. [wï (S)] (ï·éæ) Corneal biomechanicsÆpŸ³. _JaF (ãÃq¶w): æ43ñú{áÈèpwïwpï (2020/1/25), .
722210. [wï (S)] (CujOZ~i[) WFhñ`{¹Åg[N. Ž
öç1,2 (1R€a@ACZ^[, 2áÈ): æ43ñú{áÈèpwïwpï (2020/1/25), .
722211. [wï (S)] (CXgNVR[X)yI[KiCU[EutzCXgNVR[X@CCCðÉßé! sìêv1,2 (1áÈ, 2áÈ): æ43ñú{áÈèpwïwpï (2020/1/25), .
722212. [wï (S)] (`Z~i[)yÀ·z`Z~i[9: ææè! AhoXgàáüÜž³èp. sìêv1,2 (1áÈ, 2áÈ): æ43ñú{áÈèpwïwpï (2020/1/25), .
722213. [wï (S)] (³çZ~i[) pÚAÌî{èZ: \wÚA. ìkNç1,2 (1áÈ, 2k¢€a@): æ43ñú{áÈèpwïwpï (2020/1/26), .
722214. [wï (S)] ([jOZ~i[)yÀ·z[jOZ~i[8: i»·éàáèp, DZÜÅžxðÉßé©! sìêv1,2 (1áÈ, 2áÈ): æ43ñú{áÈèpwïwpï (2020/1/26), .
722215. [wï (S)] (s¯öJuÀ) àáÆŸíêœç. Ž
öç1,2 (1R€a@ACZ^[, 2áÈ): æ43ñú{áÈèpwïwpï (2020/1/26), .
723582. [wï (S)] (êÊu) o±ÌÙÈé3ŒÌpÒÉæétFgZJh[U[àáèpÌpãú¬Ñ. Ocº¢1, ¬²i2, àVØ»q3, sì@c4, à¡®v1, ðäKO1, Á¡Km1, ìãÄå1, Žä¢G1, cF÷1, sìêv1,5 (1áÈ, 2cäå, 3JCHOa@, 4òÔ\a@, 5áÈ): æ123ñú{áÈwïï (2019/4/18), .
723583. [wï (S)] (êÊu) tFgZJh[U[àáÉš¯éV^I/A`bvÌgp¬Ñ. sì@c1, ¬²i2, Á¡Km3, Žä¢G3, Ocº¢3, àVØ»q4, sìæq3, à¡®v3, sìêv3,4,5 (1òÔ\a@, 2cäå, 3áÈ, 4næãÃi@\a@, 5áÈ): æ123ñú{áÈwïï (2019/4/18), .
723584. [wï (S)] (êÊu) }ü³êœáàYÌÊuðpãúÔÌá¢Åär·éVµ¢ðÍ@. n@Ž1, sì@c2, ðäKO3, à¡®v3, Ъ4, éJ®÷4, ºFº4, ÊuŸì4, sìêv3,5,6 (1áÈŸá@, 2òÔ\a@, 3áÈ, 4ŒÃ®ACNjbN, 5JCHOa@, 6áÈ): æ123ñú{áÈwïï (2019/4/18), .
723585. [wï (S)] (êÊu) tbgpáÉηéBarrett®Ì\ª«Ì¢. Ñ@h1, _JaF2, ÑcÃF1, ]Ft1, ¯iMs1 (1áÈ, 2ãÃq¶w): æ123ñú{áÈwïï (2019/4/18), .
723586. [wï (S)] (êÊu) ÚWüÜlÌâ³®ðp¢œáàYD
pÉš¯épãüÜë·. ÑcÃF1, ²¡MV1,2, ¡ÖSÀq1,3, öcqF1, ¯iMs1 (1áÈ, 2k¢åwfBJZ^[, 3åas§a@): æ123ñú{áÈwïï (2019/4/18), .
723587. [wï (S)] (êÊu) [wwKðp¢œ~pÌff\Ì¢ (æ3ñ: v`h®p`óðÍÅÌ¢). _JaF1, »ËSñ2, Á¡Yå2, ¡º²q1, ¯iMs3, X@mÄ4, {caT4 (1ãÃq¶w, 2NXRÐ, 3áÈ, 4{cáÈ): æ123ñú{áÈwïï (2019/4/18), .
723588. [wï (S)] (êÊu) I[gPg[^ðp¢œyx~pÌXN[jO (œ{Ý€¯€). ¬²i1,2,3, Œcmç2, ºFº2, ¯ì²G4, ØEM4, ²¡Tç5, n@Â5, ·Jì¢6, ÊuŸì6, sìêv7,8 (1cäå, 2ŒÃ®ACNjbN, 3òÔ\a@, 4Ñcs§a@, 5²¡TçáÈã@, 6JCHOa@, 7áÈ, 8áÈ): æ123ñú{áÈwïï (2019/4/18), .
723589. [wï (S)] (wpWŠ) SS OCT BiometerÉæépÌ·ZüÜŠÆÀªlÉæépSüÜÍÌär. ÊuŸì1,2, ¬²i3, ŽÜÇŸ1, ·Jì¢1, ÁêBu1, sìêv1,4,5, c@Ž2 (1áÈ, 2MBåw@Hwn€È, 3c`måw, 4áÈ, 5áÈ): æ123ñú{áÈwïï (2019/4/18), .
723590. [wï (S)] (wpWŠ) ^mvXg/`[©ç^mvXg/JeI[ÖÌz_áòÌÏX. p@@Ø1, äã«¡1, â²^|1,2, Îc±q3, xci3 (1äãáÈa@, 2áÈ, 3MåEåŽ): æ123ñú{áÈwïï (2019/4/18), .
723591. [wï (S)] (wpWŠ) Visual Snow SyndromeÌ6áñšæѻ̟³TO. cL1, RãŸq1,2, áqëo1, äã«¡1, Îä«ñ3 (1äãáÈa@, 2áÈ, 3sN·õãÃZ^[€): æ123ñú{áÈwïï (2019/4/18), .
723592. [wï (S)] (êÊu) gxNg[èpãú¬ÑsÇáÌwiöq. ÍìYº1, }Ž³s1, ]Ft1, ¯iMs1 (1áÈ): æ123ñú{áÈwïï (2019/4/19), .
723593. [wï (S)] (êÊu) ¬lŒá«¡ðÎÛƵœsagging eye syndromeÌLaŠ. ãÖŸ1,2, Soh Youn Suh2, Laura Robbins2, Stacy L Pineles2, Federico G Velez2, Joseph L Demer2 (1áÈ, 2Pediatric Ophthalmology and Adult Strabismus division, Stein Eye Institute, David Geffen School of Medicine, UCLA): æ123ñú{áÈwïï (2019/4/19), .
723594. [wï (S)] (êÊu) ¢AwÉš¯éõw®á²·ªèuðp¢œüÜÙíÌožx. ²¡@i1, É¡ü¹G2, ŽRk1, ìãu1, lV{Cn1, ]ËÊè3, VäcFT1,4 (1ÛãÃå, 2R€a@, 3ÛãÃåwa@, 4áÈ): æ123ñú{áÈwïï (2019/4/19), .
723595. [wï (S)] (êÊu) ãàáÉηé[U[ãùNØJpOãÌ1bÍÌLp«. Á¡Ñî1, Ž
öç1,2, Ü\Íj1,2, ìçcñu3 (1R€a@, 2áÈ, 3ãÃq¶w): æ123ñú{áÈwïï (2019/4/19), .
723596. [wï (S)] (êÊu) ðxj^ðgpµœÂNíÒÌ`Ôo@\Ì]¿. éØ«¡1, Ü\¢K1, äoÙÈÝ1, ¯@ª¬1, ŒºÑLÀ1, VäcFT1,2 (1ÛãÃåw, 2áÈ): æ123ñú{áÈwïï (2019/4/19), .
723597. [wï (S)] (êÊu) L
»ÌáàYèpOãÉš¯é÷pJåxÌoÏ». À¡aÌq1, _JaF2, Ž³p1, ÒòCF1, ¯iMs1 (1áÈ, 2ãÃq¶w): æ123ñú{áÈwïï (2019/4/19), .
723598. [wï (S)] (êÊu) L
»ÌáàY}üáÉš¯é÷pJåxªpàç×E§xâá³ÉyÚ·e¿. ÒòCF1, _JaF2, Ž³p1, À¡aÌq1, ¯iMs1 (1áÈ, 2ãÃq¶w): æ123ñú{áÈwïï (2019/4/19), .
723599. [wï (S)] (êÊu) KS®ðp¢œICLpãvaultÌ¢. Ü\Íj1,2, Ž
öç1,2, Á¡Ñî1 (1R€a@ACZ^[, 2áÈ) æ123ñú{áÈwïï (2019/4/19), .
723600. [wï (S)] (êÊu) is«~pÉηég|KChpNXLOÆ]@ÌúÕ°¬ÑÌär. Ž³p1, _JaF2, ÒòCF1, À¡aÌq, Ö¡@Ê, zn¹q, ¯iMs1 (1áÈ, 2ãÃq¶w): æ123ñú{áÈwïï (2019/4/19), .
723601. [wï (S)] (wpWŠ) Aa©ÁÇÌSâ|ºd«ÁÉηéirQ[V[U[ÌøÊ. ²¡TV1,2, cF÷2, sìêv2,3, à¡®v2, ÁêBu4, gc¥F5, ¡R@ãÄ4, X@rj6, Œc×ã4, OcºEl4, Ocº¢2, ²¡Tç1 (1²¡TçáÈã@, 2áÈ, 3áÈ, 4JCHOa@, 5òÔ\a@, 6Ñcs§a@): æ123ñú{áÈwïï (2019/4/19), .
723602. [wï (S)] (wpWŠ) dxÌãÉηéOcclu-padÒðp¢œãPûÌ¢. ËË@å1, Œcmç2, Îì@Ï2, ¯iMs1 (1áÈ, 2ãÃq¶w): æ123ñú{áÈwïï (2019/4/19), .
723603. [wï (S)] (wpWŠ) }§¡ÃIpØp (Hyperopia Correcting-PTK) ÌlÄÆ]PTKÆÌär. ìGP1, _JaF2, Ž³p1, ¯iMs1 (1áÈ, 2ãÃq¶w): æ123ñú{áÈwïï (2019/4/19), .
723604. [wï (S)] (êÊu) Variational Bayesðp¢œìªèASY. ºcj1, ¡ìF¢1, ŒY«l1, c@«2, ¡º²q3, ¯iMs4, ©ª@º1 (1å, 2»a, 3ãÃq¶w, 4áÈ): æ8ñú{ìæwïwpWï (2019/5/18), åã.
723605. [wï (S)] (êÊu) Date augmentationðp¢œìis\ªÌLp«Ì¢. ŒY«l1,2, ºcj1, ¡ìF¢1,2, OØÄç3, J˳÷4, aãuN5, X@aF6, éØÀ9, RºŸ7, Ø«¡8, ¯iMs2, ©ª@º1 (1å, 2áÈ, 3åãå, 4ªå, 5€Qå, 6s{ãå, 7å, 8Rå, 9Rûå): æ8ñú{ìæwïwpWï (2019/5/18), åã.
723606. [wï (S)] (êÊu)yÀ·zêÊuIII. ¯iMs (áÈ): æ8ñú{ìæwïwpWï (2019/5/19), åã.
723607. [wï (S)] (êÊu) üÛÑØãÌpqXeVXÆÎàá«ìisÆÌÖW. ¡ìF¢1,2, ºcj1, ŒY«l1,2, qrS2,3, ¯iMs2, ö`²4, ØàÇŸ1, ©ª@º1 (1å, 2áÈ, 3cJULa@, 4Lå): æ8ñú{ìæwïwpWï (2019/5/19), åã.
723608. [wï (S)] (êÊu) á
fðl¶µœVÝváŸYÌÝvû@. äTê1, Á¡êæ1, ìçcñu2 (1É¡õwHÆ®ïÐ, 2ãÃq¶w): æ23ñú{áŸwïNZ~i[šæÑèï (2019/5/28), ªR.
723609. [wï (S)] (êÊu) á
fðl¶µœVÝváŸYÌLp«. ìçcñu1, äTê2, Á¡êæ2, _JaF1, Œcmç1, ¢@, ¯iMs3 1ãÃq¶w, 2É¡õwHÆ®ïÐ, 3áÈ): æ23ñú{áŸwïNZ~i[šæÑèï (2019/5/28), ªR.
723610. [wï (S)] (êÊû)yÀ·zêÊû@fW^foCXÆÎ. VäcFT1,2 (1ÛãÃåw, 2áÈ): æ75ñú{ãÎwïïEæ44ñú{¬áÈwïï ¯wï (2019/6/14), ê.
723611. [wï (S)] (êÊû) w¶úÉǵœQ[˶ÇƵÄÌ}«ãVàÎ2ÇáÌÕ°IÁ¥. ]ËÊè1, Ž@Œl2, ªì^|2, ËŽRÀ1, ¬ì¢Kq1, A|ó¢1, ÃËCR1, ²|Âq1, VäcFT2,3 (1ÛãÃåa@, 2ÛãÃå, 3áÈ): æ75ñú{ãÎwïïEæ44ñú{¬áÈwïï ¯wï (2019/6/14), ê.
723612. [wï (S)] (êÊû) VRÉæé]@\Eß©œšæÑæJŽÖÌe¿šæÑ»ÌoIÈϻ̢. Ž@Œl1, cײ1, œŽÊÔ1,
º@©1, RèØ1, VäcFT1,2 (1ÛãÃå, 2áÈ): æ75ñú{ãÎwïïEæ44ñú{¬áÈwïï ¯wï (2019/6/14), ê.
723613. [wï (S)] (êÊû) üðÍuÉæéADHDÌÕ®«á
^®Ìövª. lV{Cn1, éØ«¡1, ¬ì|G2, lã±F1, ²¡q1, OXçí1, VäcFT1,3 (1ÛãÃå, 2Ÿ¡å, 3áÈ): æ75ñú{ãÎwïïEæ44ñú{¬áÈwïï ¯wï (2019/6/14), ê.
723614. [wï (S)] (êÊû) WilliamsÇóQÉš¯éáÙí¹px. 厵d1, Žãq1, Îì@Ï1 (1ãÃq¶w): æ75ñú{ãÎwïïEæ44ñú{¬áÈwïï ¯wï (2019/6/14), ê.
723615. [wï (S)] (êÊû)yÀ·zêÊû@ñùÎEŒ. ãÖŸ (áÈ): æ75ñú{ãÎwïïEæ44ñú{¬áÈwïï ¯wï (2019/6/14), ê.
723616. [wï (S)] (wpWŠ) 4`6ÎÉš¯éá
¶ÌvªlÌ1NÔÌoÏ». ²¡@i1, ŽRk1, VäcFT1,2 (1ÛãÃå, 2áÈ): æ75ñú{ãÎwïïEæ44ñú{¬áÈwïï ¯wï (2019/6/14), ê.
723617. [wï (S)] (wpWŠ) ©oI²ßÍÆŒoI²ßÍÌÄ»«ÆªèlÌär. ìãu1, ²¡@i1, ¬Ñ¹b1, ²¡[À1, |àVDq1, R@x1, VäcFT1,2 (1ÛãÃå, 2áÈ): æ75ñú{ãÎwïïEæ44ñú{¬áÈwïï ¯wï (2019/6/14), ê.
723618. [wï (S)] (wpWŠ) ¿âðp¢œÎEãÌqÇàðàÂÛìÒÌXgX²ž. âc@y1, k¢üa2, ãcqî2, [Jxq2, âÞDü2, Îì@Ï1 (1ãÃq¶w, 2åw@ãÃn€È): æ75ñú{ãÎwïïEæ44ñú{¬áÈwïï ¯wï (2019/6/14), ê.
723619. [wï (S)] (wpWŠ) 12NÔúu³êœÎãÌêá. ŽRk1, ²|Âq2, ¡RRIq1, VäcFT1,3 (1ÛãÃå, 2ÛãÃåwa@, 3áÈ): æ75ñú{ãÎwïïEæ44ñú{¬áÈwïï ¯wï (2019/6/14), ê.
723620. [wï (S)] (êÊu) g[bNL
»Ìã[YÌŒÅèÉæépã¬Ñ. Á¡Ñî1, Ž
öç1, Ü\Íj1,2 (1R€a@, 2áÈ): æ34ñJSCRSwpï (2019/6/28), s.
723621. [wï (S)] (êÊu) Vµ¢IOLxvZ®Æù¶®Ì\ªžxÌär. ²¡@i1,2, Ž
öç2, íArŸY2,3, Ü\Íj2,3, Á¡Ñî2, ÛÈüó2, `
@w2,3, lV{Cn1, VäcFT1,3 (1ÛãÃåwEÛãÃw, 2R€a@, 3áÈ): æ34ñJSCRSwpï (2019/6/28), s.
723622. [wï (S)] (êÊu) LASIKOÌžlÍàápãÌüÜë·ðž³¹é©. íArŸY1,2, Ž
öç1,2, Ü\Íj1,2, `
@w1,2, Á¡Ñî1, ÛÈüó1, ²¡@i1,3 (1R€a@, 2áÈ, 3ÛãÃå): æ34ñJSCRSwpï (2019/6/28), s.
723623. [wï (S)] (êÊu) Hole ICLŒÅèÉš¯éKS®ðp¢œpãvaultÌ\ª. Ü\Íj1,2, Ž
öç1,2, Á¡Ñî1 (1R€a@, 2áÈ): æ34ñJSCRSwpï (2019/6/28), s.
723624. [wï (S)] (êÊu) ³
»ÌápøÊ ÊxáàYÌpã·ú¬Ñ. Ž@CÆ1, ¬²i2, sìêv3,4 (1åYïæêa@, 2cäå, 3áÈ, 4áÈ): æ34ñJSCRSwpï (2019/6/28), s.
723625. [wï (S)] (êÊu) ·á²áÉ}ü³êœáàY̪õ§ßÁ«Ìá¢Éæépã·úÌß»XüÌ¢. ²¡TV1, åŒÇ¬2, à¡®v3, Ö¡@T4, å@q5, n\Pv6, ²¡Tç1, sìêv3,7 (1²¡TçáÈã@, 2³ŸÜÂáÈNjbN, 3áÈ, 4Ö¡áÈ, 5åáÈ, 6íœç¢áÈ, 7áÈ): æ34ñJSCRSwpï (2019/6/28), s.
723626. [wï (S)] (êÊu)yÀ·zêÊu4@œÅ_Eg[bN
A. sìêv1,2 (1áÈ, 2áÈ): æ34ñJSCRSwpï (2019/6/28), s.
723627. [wï (S)] (êÊu) œÅ_áàYActive FocusÒÌpãú¬ÑÌ¢. sì@c1, ¬²i2, ìãÄå3, Žä¢G3, Ocº¢3, àVØ»q4, sìæq3, ÊuŸì4, sìêv3,5 (1òÔ\a@, 2cäå, 3áÈ, 4a@, 5áÈ): æ34ñJSCRSwpï (2019/6/28), s.
723628. [wï (S)] (êÊu) ¡ÌpÒÔÌtFgZJh[U[àáèpÌäNÌär. Ocº¢1, ¬²i2, sì@c3, ðäKO1, Á¡Km1, à¡®v1, sìêv1,4 (1áÈ, 2cäå, 3òÔ\a@, 4áÈ): æ34ñJSCRSwpï (2019/6/29), s.
723629. [wï (S)] (êÊu)yÀ·zêÊu7@¶Ìvª. _JaF (ãÃq¶w): æ34ñJSCRSwpï (2019/6/29), s.
723630. [wï (S)] (êÊu)
»ÌÄpOÌÔ¹[xyÑpOãÌO[[xðvª·éVµ¢û@. nŽ@1, sì@c2, ðäKO3, à¡®v3, Ъ4, éJ®P4, ºFº4, ÊuŸì5, sìêv3,6 (1áÈŸá@, 2òÔ\a@, 3áÈ, 4ŒÃ®ACNjbN, 5a@, 6áÈ): æ34ñJSCRSwpï (2019/6/29), s.
723631. [wï (S)] (êÊu) àápO¶Ìvªf[^Ìär€ (æ1ñ: à2{ÝÔÉš¯éär). _JaF1, ¡º²q1, ±ì¢G1, ÑcÃF2, ¯iMs2, X@mÄ3, ìcêY3, {caT3 (1ãÃq¶w, 2áÈ, 3{cáÈa@): æ34ñJSCRSwpï (2019/6/29), s.
723632. [wï (S)] (êÊu) ³íáÉš¯ép·ZüÜÍšæÑSüÜÍÌär. ±ì¢G1, _JaF1, ¡º²q1, Ž³p2, ¯iMs2 (1ãÃq¶w, 2áÈ): æ34ñJSCRSwpï (2019/6/29), s.
723633. [wï (S)] (êÊu) OáOCT CASIA2Éš¯é~páƳíáÌÄ»«Ìär. Ö¡@Ê1, _JaF2, ¡º²q2, ±ì¢G2, Ž³p1, ¯iMs1 (1áÈ, 2ãÃq¶w): æ34ñJSCRSwpï (2019/6/29), s.
723634. [wï (S)] (êÊu) ~páÉš¯é2@íÌp`óðÍu̪èlÌär. ¡º²q1, _JaF1, ±ì¢G1, Ö¡@Ê2, Ž³p2, ¯iMs2 (1ãÃq¶w, 2áÈ): æ34ñJSCRSwpï (2019/6/29), s.
723635. [wï (S)] (êÊu) 2ÂÌSwept Source OCTuÉæépSüÜÍÌär. ŽÜÇŸ1, ÊuŸì1, ¬²i2, ÁêBu1, sìêv3,4 (1a@, 2cäå, 3áÈ, 4áÈ): æ34ñJSCRSwpï (2019/6/29), s.
723636. [wï (S)] (êÊu) àáèpOãÌÜtûwÉÖ·éOü«€. ªºüq1, ¬²i2, Á¡ ©Ë1, Ocº¢3, sìêv3,4 (1òÔ\a@, 2cäå, 3áÈ, 4áÈ): æ34ñJSCRSwpï (2019/6/29), s.
723637. [wï (S)] (wpWŠ) pNXLOÌEpi-off@ÆEpi-on@Ìpãú¬ÑÌär. gczq1, L|Gã1, Œcmç1, Ъ1,
ì×q1, ¬²i1,2, ºFº1, n@Â3, ²¡Tç3, sìêv4,5 (1ŒÃ®ACNjbN, 2cäå, 3²¡TçáÈã@, 4áÈ, 5áÈ): æ34ñJSCRSwpï (2019/6/29), s.
723638. [wï (S)] (wpWŠ) àáèpÌüÜxÝèÉá²·šæÑÎðl¶µœ2Çá. i£xK1, Ü\Íj1,2, íArŸY1,2, É¡ü¹G1, Ž
öç1,2 (1R€a@, 2áÈ): æ34ñJSCRSwpï (2019/6/29), s.
723639. [wï (S)] (êÊu) àáèp{Ý̪z²ž. ¬ìMêY1, Îä@Ž2, sìêv3,4, ¿cF_5 (1ú{ãåE ¬, 2³¢œÜÔ\a@, 3áÈ, 4áÈ, 5äãáÈa@): æ34ñJSCRSwpï (2019/6/30), s.
723640. [wï (S)] (êÊu) NX70CHÌÅèÉš¯é30GjÌVµ¢g¢û. gc¥F1, sìêv2,3 (1òÔ\a@, 2áÈ, 3áÈ): æ34ñJSCRSwpï (2019/6/30), s.
723641. [wï (S)] (êÊu) k¢åwáÈÉš¯éÅß3NÔÅÌ~ppR^NgYpóµ. FWä°²1, zn¹q, Ž³p1, ÒòCF1, À¡aÌq1, Fé`ê1, _JaF2, ¯iMs1 (1áÈ, 2ãÃq¶w): tH[T2019s (æ62ñú{R^NgYwïï) (2019/7/6), s.
723642. [wï (S)] (êÊû) Association between glaucomatous optic disc change and Corvis ST-measured biomechanical property. ÂØCêY1, ¿ÑÔØ2, ¡ìF¢3,4, ŒY«l3,4, ºcj4, qrS5, ©ª@º4, ØàÇŸ2 (1s§Dya@, 2Lå, 3áÈ, 4å, 5cJULa@): æ30ñú{Îàáwï (2019/9/6), F{.
723643. [wï (S)] (êÊû) Effects of the different spectral transmittance of yellow tinted lenses on the retinal sensitivities (ÙÈéªõ§ßŠÈüÌ©F
FYÌÔŽxÖÌe¿). ŽûãÄŸ1, ìçcñu2, ¯iMs3 (1åw@ãÃn€È, 2ãÃq¶w, 3áÈ): æ30ñú{Îàáwï (2019/9/6), F{.
723644. [wï (S)] (êÊû)yÀ·zêÊû17: èpÃ@6. ¯iMs (áÈ): æ30ñú{Îàáwï (2019/9/7), F{.
723645. [wï (S)] (wpWŠ) Effect on the difference in visual acuity of both eyes in the binocular visual field tests (ŒáJúìžÉš¯éÍ̶E·Ìe¿). œEßN1, ¡º²q2, ¯iMs1 (1áÈ, 2ãÃq¶w): æ30ñú{Îàáwï (2019/9/7), F{.
723646. [wï (S)] (êÊû) Short term results of trabeculectomy for elevated intraocular pressure after CYCLO G6 (CYCLO G6{sãÌá³ãžáÉηé@ÛÑØpÌZú¬Ñ). ÒòCF1, ¯iMs1, }Ž³s1, ÍìYº1 (1áÈ): æ30ñú{Îàáwï (2019/9/8), F{.
723647. [wï (S)] (êÊû) Predictability of Cataract Surgery with Trabeculectomy in Eyes using the Barrett Universal 2 formula (àáèp¹p@ÛÑØpÇáÉηéBarrett Universal 2®Ì\ª«Ì¢). Ñ@h1, _JaF2, ÑcÃF1, }Ž³s1, ¯iMs1 (1áÈ, 2ãÃq¶w): æ30ñú{Îàáwï (2019/9/8), F{.
723648. [wï (S)] (êÊû) RMOGRÌz«_oÌÕ°Ì¢. RãŸq1,2, â²^|1,2, äã«¡1, áqëo1, cšq3, ŽK4,5 (1äãáÈa@, 2áÈ, 3Våw]€, 4kåw_oàÈ, 5Äòa@): æ57ñú{_oáÈwïï (2019/10/4), Dy.
723649. [wï (S)] (êÊû) ï¡«_oÉηéåÊÆuOuÃÃ@. Oº@¡1, öYO2, Îì@Ï3, ÑËu4, ~hå5, éت6, º@œ7, nG÷8, äã«¡9, غIq1 (1ºÉãÈåw, 2ßEåw, 3ãÃq¶w, 4ãÈåw, 5bïãÈåw, 6àÕŠãÈåwéÊãÃZ^[, 7_Ëåw, 8{èåw, 9ÏÀ°äãáÈa@): æ57ñú{_oáÈwïï (2019/10/4), Dy.
723650. [wï (S)] (êÊû) ffE¡ÃÉïaµœAXyMXŽõÇÉæé@«_oÇÌ1á. ÎìåN1, Žäq1, Îì@Ï2, ¯iMs1 (1áÈ, 2ãÃq¶w): æ57ñú{_oáÈwïï (2019/10/4), Dy.
723651. [wï (S)] (êÊû) k¢åwa@áÈÉš¯éLeberâ`q_oÇÌÅIÍöxÊ, Õ°IÁ¥. ÀàVEP1, Îì@Ï2, Žäq1, À{Žn3, ¯iMs1 (1áÈ, 2ãÃq¶w, 3Õ): æ57ñú{_oáÈwïï (2019/10/4), Dy.
723652. [wï (S)] (|X^[) áØ^dÇسÍÇÆdouble elevator palsyÆ_oBîÇ2^ÅffðÀ€1á: æ2ñ. xc§F1, Œ{@Œ1, Xìt1, ÷tq1, Á¡jq1, x@Tê1, Îì@Ï2 (1MåwãÃZ^[åXa@, 2ãÃq¶w): æ57ñú{_oáÈwïï (2019/10/4), Dy.
723653. [wï (S)] (êÊû)yÀ·zêÊû5: [xa, _oŸ³. RãŸq1,2 (1äãáÈa@, 2áÈ): æ57ñú{_oáÈwïï (2019/10/5), Dy.
723654. [wï (S)] (êÊû) mt13051C>AÏÙðL·é[xâ`«_oÇÌ1á. â²^|1,2, RãŸq1,2, äã«¡1, áqëo1, À{Žn3, Näc¢3, Îì@Ï4 (1äãáÈa@, 2áÈ, 3Õ, 4ãÃq¶w): æ57ñú{_oáÈwïï (2019/10/5), Dy.
723655. [wï (S)] (êÊû) XeChpX, ÷ð·Ã@ɳœŸÁœ~gRhAâ`qÏÙðL·é_oÌ1á. Žäq1, Îì@Ï2, àRrî1, ÀàVEP1, ¯iMs1 (1áÈ, 2ãÃq¶w): æ57ñú{_oáÈwïï (2019/10/5), Dy.
723656. [wï (S)] (êÊû) @o©çÌgyÉæèìú«dÆ^Û«]^á𹵜ÆlŠçêœáâ|æ[ÇóQÌêá. Žmœ1,2, RãŸq3,4, Rb1, ØSÞsq1 (1TMG ³©ãÃZ^[, 2qãÈåwa@, 3äãáÈa@, 4áÈ): æ57ñú{_oáÈwïï (2019/10/5), Dy.
723657. [wï (S)] (|X^[) µEÙ£Çl©ÉÄǵœFisherÇóQÌêá. Xìt1, Œ{@Œ1, ÷tq1, Á¡jq1, x@Tê1, Îì@Ï2 (1MåwãÃZ^[åXa@, 2ãÃq¶w): æ57ñú{_oáÈwïï (2019/10/5), Dy.
723658. [wï (S)] (êÊu) [wwKðp¢œ~pÌff\Ì¢ (æ4ñ: is\ª). _JaF1, »ËSñ2, Á¡Yå2, ¡º²q1, ¯iMs3, X@mÄ4, {caT4 (1ãÃq¶w, 2NXRÐ, 3áÈ, 4{cáÈa@): æ73ñú{Õ°áÈwï (2019/10/24), s.
723659. [wï (S)] (êÊu) OáOCTÉæéV
ǯèÂÛÊÌgxNg[èp¬Ñ. å|S÷1, }Ž³s1, ÍìYº1, ÒòCF1, Ž³p1, ÄR@È1, ¯iMs1 (1áÈ): æ73ñú{Õ°áÈwï (2019/10/24), s.
723660. [wï (S)] (êÊu) tFgZJh[U[àáèpÌpØJnÌ]¿. sì@c1,2, ¬²i2,3, Á¡Km2, ðäKO2, Ocº¢2, àVØ»q4, sìæq2, sìêv2,5 (1òÔ\a@, 2áÈ, 3cäå, 4JHCOa@, 5áÈ): æ73ñú{Õ°áÈwï (2019/10/24), s.
723661. [wï (S)] (êÊu) ááÙáz¹³ÒÌúí¶Ìs©Rx, ë¯x. Í{Ðëü1, â²^|1,2, RãŸq1,2, äã«¡1, áqëo1 (1äãáÈa@, 2áÈ): æ73ñú{Õ°áÈwï (2019/10/24), s.
723662. [wï (S)] (êÊu) Visual Snow SyndromeÌ15áÌñ. õšÝžÙ1, cL1, â²^|1,2, RãŸq1,2, áqëo1, äã«¡1, éØKv3,4, Îä«ñ4 (1äãáÈa@, 2áÈ, 3JHCOOa@, 4sN·õãÃZ^[€E_oæ€`[): æ73ñú{Õ°áÈwï (2019/10/24), s.
723663. [wï (S)] (wpWŠV[gg[N) J[}bvì¬ÉæéáàYÌXÎûüÆöxÌÏ@. nŽ@1, sì@c2, à¡®v3, ðäKO3, Ъ4, éJ®P4, ºFº4, ÊuŸì5, sìêv3,6 (1áÈŸá@, 2òÔ\a@, 3áÈ, 4ŒÃ®ACNjbN, 5JHCOa@, 6áÈ): æ73ñú{Õ°áÈwï (2019/10/24), s.
723664. [wï (S)] (êÊu) Hill-RBF®Version2Ì\ª«ÆBarrett Universal2®ESRK/T®ÆÌär. Ñ@h1, _JaF2, ÑcÃF1, ÄR@È1, ¯iMs1 (1áÈ, 2ãÃq¶w): æ73ñú{Õ°áÈwï (2019/10/25), s.
723665. [wï (S)] (êÊu) ßLASIKãÌàáèpÉš¯éVµ¢áàYxvZ®Ì\ªžx. íArŸY1,2,3, Ž
öç1,2,3, ²¡@i1,3, Ü\Íj1,2,3, `
@w1,2,3, Á¡Ñî1, ÛÈüó1 (1R€a@ACZ^[, 2áÈ, 3ÛãÃå): æ73ñú{Õ°áÈwï (2019/10/25), s.
723666. [wï (S)] (êÊu) ÙÈéfUCÌIOLÉš¯éVµ¢xvZ®Ì\ªžxÌØ. ²¡@i1,2, Ž
öç1,2,3, íArŸY1,2,3, Ü\Íj1,2,3, Á¡Ñî2, ÛÈüó2, `
@w1,2,3, lV{Cn1, VäcFT1,3 (1ÛãÃå, 2R€a@ACZ^[, 3áÈ): æ73ñú{Õ°áÈwï (2019/10/25), s.
723667. [wï (S)] (êÊu)yÀ·zêÊu26: L
»ÌáàY. Ž
öç1,2 (1R€a@ACZ^[, 2áÈ): æ73ñú{Õ°áÈwï (2019/10/25), s.
723668. [wï (S)] (êÊu) Eoµœã[^L
»ÌáàYICLÌ¢. ºFº1, gczq1,
ì×q1, ¬²i1,2, RNj1, cF÷3, sìêv3,4 (1ŒÃ®ACNjbN, 2cäå, 3áÈ, 4áÈ): æ73ñú{Õ°áÈwï (2019/10/25), s.
723669. [wï (S)] (êÊu) ¯êÂÌÉš¯éÑÊEt«L
»Ìã[YÌÅèÊuÉæépãvaultÌär. Á¡Ñî1, Ž
öç1,2, Ü\Íj1,2 (1R€a@, 2áÈ): æ73ñú{Õ°áÈwï (2019/10/25), s.
723670. [wï (S)] (êÊu) 45ÎÈãÉ{sµœã[^L
»ÌáàY}üpÌpã3N¬Ñ. Ž³p1, _JaF2, å|S÷1, ¯iMs1 (1áÈ, 2ãÃq¶w): æ73ñú{Õ°áÈwï (2019/10/25), s.
723671. [wï (S)] (êÊu) 45ÎÈãÉš¯éÑÊEt«L
»Ìã[YÌœ{ÝÕ°¬ÑÌ¢. Ü\Íj1,2, Ž
öç1,2, _JaF3, Ž³p2, sìêv2,4, ºFº5, ¬²i5, kàV¢u6 (1R€a@ACZ^[, 2áÈ, 3ãÃq¶w, 4áÈo€, 5ŒÃ®ACNjbN, 6TsA^[ACNjbN): æ73ñú{Õ°áÈwï (2019/10/25), s.
723672. [wï (S)] (êÊu) L
»ÌáàYpãVault\ªñA®Ìär. À¡aÌq1, _JaF2, Ž³p1, å|S÷1, ¯iMs1 (1áÈ, 2ãÃq¶w): æ73ñú{Õ°áÈwï (2019/10/25), s.
723673. [wï (S)] (êÊu) @BwKðp¢œã[^L
»ÌáàYÌvault\ª. ¡º²q1, _JaF1, À¡aÌq2, Ž³p2, ¯iMs2, Ràm[3, c£mu3 (1ãÃq¶w, 2áÈ, 3cJULa@): æ73ñú{Õ°áÈwï (2019/10/25), s.
723674. [wï (S)] (êÊu) àá³ÒÉš¯éÎÌLaŠ. rcNç1, É¡ü¹G1, âV¡ÇÞ1, Ü\Íj1,2, Ž
öç1,2 (1R€a@ACZ^[, 2áÈ): æ73ñú{Õ°áÈwï (2019/10/26), s.
723675. [wï (S)] (wpWŠV[gg[N)yÀ·zwpWŠV[gg[N45@Îàá: òš. ¯iMs (áÈ): æ73ñú{Õ°áÈwï (2019/10/26), s.
723676. [wï (S)] (wpWŠV[gg[N) RÎàáòÜÊÌgxNg[èp̬Ñ. ÍìYº1, }Ž³s1, ÒòCF1, ÄR@È1, ØŸY1, ¯iMs1 (1áÈ): æ73ñú{Õ°áÈwï (2019/10/26), s.
723677. [wï (S)] (êÊu) Variational Bayesðp¢œìªèASY. ºcj1, ¡ìF¢1, ŒY«l1,2, c@«3, ©ª@º1 (1å, 2áÈ, 3»a): æ73ñú{Õ°áÈwï (2019/10/27), s.
723678. [wï (S)] (êÊu) êÊFšæÑuõFÉš¯éFRgXgÆF«. ìçcñu1, |@Œ2, Ò@@n3, àäK4, œä5, éØT¶6, Œcmç1, ¯iMs7 (1ãÃq¶w, 2jbZPi¿]¿Z^[, 3JPeXgZ^[, 4MBåw@Ûw, 5MBåwÁC³ö, 6A[AX (), 7áÈ): æ61ñú{YÆEJEðÊáÈwï (2019/11/16), .
723679. [wï (S)] (êÊû) Å_[xg£^3Å_áàYÆáÁüñÜ^2Å_áàYÌpã¬ÑÌär. ìãÄå1, ¬²i2, FÉbq1, ðäKO1, Á¡Km1, Ocº¢1, à¡®v1, ÊuŸì3, sìêv1,4 (1áÈ, 2ccå, 3JCHOa@, 4áÈ): æ60ñú{\ž³wï (2019/11/30), ª.
723680. [wï (S)] (êÊû) õw®¶ÌvªuÆOáOCTÉæég[bNáàYÌž³øÊÌär. ]cçb1, ðäKO1, ¬²i2, ÊuŸì3, Á¡Km1, FÉbq1, ìãÄå1, R{^Ø3, à¡®v1, sìêv1,4 (1áÈ, 2cä`måw, 3JCHOa@, 4áÈ): æ60ñú{\ž³wï (2019/11/30), ª.
723681. [wï (S)] (êÊû) OÎ𺀳ÒÌàápOãÌáÊÏ». ÔÎòq¿1, ±ì¢G2, ÑcÃF1, Îì@Ï2, ¯iMs1 (1áÈ, 2ãÃq¶w): æ60ñú{\ž³wï (2019/11/30), ª.
723682. [wï (S)] (|X^[) pgÊû·ðÍuðp¢œpüÜž³áÉš¯éàápãüÜë·Ìär¢. ììoL1, ðäKO1, ¬²i2, ÊuŸì3, Á¡Km1, éJ®P4, cF÷1, à¡®v1, sìêv1,5 (1áÈ, 2cå, 3JCHOa@, 4ŒÃ®ACNjbN, 5áÈ): æ60ñú{\ž³wï (2019/11/30), ª.
723683. [wï (S)] (|X^[) ¬w4E5N¶Éš¯é¿ÌÉe¿·é@\, moÌ¢. ªì^|1, àì`a1, cºÈå2, âV¡TVî2, VäcFT1,3 (1ÛãÃå, 2ãBÛåwÛÈw@\Ã@wÈ, 3áÈ): æ60ñú{\ž³wï (2019/11/30), ª.
723684. [wï (S)] (|X^[) Õ®«á
^®šæÑ®«Ç]^®ªÃI§ÊÌdS®hÉyÚ·e¿. àì`a1, ªÀT¢1, Ö¡çT1, cä»Þ1, ºªµC1, ªì^|1, VäcFT1,2 (1ÛãÃå, 2áÈ): æ60ñú{\ž³wï (2019/11/30), ª.
723685. [wï (S)] (êÊû) IOLMaster700ÅÌ2ÂÌpüÜÍðp¢œpãüÜë·Ìär. óäDÞ1, ¬²i2, ÊuŸì1, ŽÜÇŸ1, ðäKO3, ÁêBu1, sìêv3,4 (1JCHOa@, 2cå, 3áÈ, 4áÈ): æ60ñú{\ž³wï (2019/12/1), ª.
723686. [wï (S)] (êÊû) [U[XybNt[OtB[Éš¯é_oûª¬ÌÄ»«šæÑêv«. ¬ìä»Þ1, âV¡@Ê1, ]Ft1,2, iìKê1, Rû@1, ¯iMs1 (1áÈ, 2Oc«áÈ): æ60ñú{\ž³wï (2019/12/1), ª.
723687. [wï (S)] (êÊu)yÀ·zêÊu4: pEEupEv. ìkNç1,2 (1k¢€a@, 2áÈ): æ43ñú{áÈèpwïwpï (2020/1/24), .
723688. [wï (S)] (êÊu) ¶ÌÍwÁ«ÆOáOCTðp¢œFFKffÌLp«Ì¢. uê@D1, ¬²i2, Œcmç3, ºFº3, sìêv4,5 (1òÔ\a@, 2cäå, 3ŒÃ®ACNjbN, 4a@, 5áÈ): æ43ñú{áÈèpwïwpï (2020/1/24), .
723689. [wï (S)] (êÊu)yÀ·zêÊu6: ¬EÎu¬EÎv. RãŸq1,2 (1äãáÈa@, 2áÈ): æ43ñú{áÈèpwïwpï (2020/1/24), .
723690. [wï (S)] (êÊu) X}[gtHyɺ€}«àÎÌÚ. ì_Gq1, RãŸq1,2, â²^|1,2, äã«¡1, áqëo1 (1äãáÈa@, 2áÈ): æ43ñú{áÈèpwïwpï (2020/1/24), .
723691. [wï (S)] (êÊu) ©Á~EñÂœáÉηéóCºàŸðgpµœà«E©ÆÚA@. X@rj1, ÁêBu2, gc¥F3, ²¡TV4, Œc×ã2, ¡R@ãÄ2, OcºEl1, sìêv5,6 (1Ñcs§a@, 2JCHOa@, 3òÔ\a@, 4²¡TçáÈ, 5áÈ, 6áÈ): æ43ñú{áÈèpwïwpï (2020/1/24), .
723692. [wï (S)] (êÊu) ÔìªòÂÇÇÌ©ÁîÉηéirQ[V[U[¡ÃÌ·úoß. ²¡TV1, Ocº¢2, sìêv2,3, ÁêBu4, gc¥F5, X@rj6, ¡R@ãÄ4, ²¡Tç1 (1²¡TçáÈ, 2áÈ, 3áÈ, 4JCHOa@, 5òÔ\a@, 6Ñcs§a@): æ43ñú{áÈèpwïwpï (2020/1/24), .
723693. [wï (S)] (êÊu)yÀ·zêÊu18àáuœÅ_áàY1v. Ž
öç (R€a@): æ43ñú{áÈèpwïwpï (2020/1/25), .
723694. [wï (S)] (wpWŠ) ÑÊEt«L
»Ìã[YÌú¡±áÉš¯é·úÕ°¬Ñ. Ü\Íj1,2, Ž
öç1,2, Ž³p2, _JaF3 (1R€a@, 2áÈ, 3ãÃq¶w): æ43ñú{áÈèpwïwpï (2020/1/25), .
723695. [wï (S)] (wpWŠ) ÑÊEt«L
»Ìã[Ypãlow vaultáÉš¯éÕ°¬Ñ. Á¡Ñî1, Ž
öç1,2, Ü\Íj1,2 (1R€a@, 2áÈ): æ43ñú{áÈèpwïwpï (2020/1/25), .
723696. [wï (S)] (êÊu) OdÅ_áàY (PanOptixÒ) Ìpãú¬ÑÌñ. àVØ»q1, ¬²i2, ìãÄå3, éJ®P4, Ocº¢3, sì@c5, ºFº4, sìêv3,6 (1JCHOa@, 2cäå, 3áÈ, 4ŒÃ®ACNjbN, 5ÂRa@, 6áÈ): æ43ñú{áÈèpwïwpï (2020/1/26), .
723697. [wï (S)] (êÊu) œÅ_áàYTorinovaÒÌpãú¬ÑÆüÜë·. sì@c1, ¬²i2,3, ìãÄå2, Á¡ ©Ë4, àVØ»q5, sìæq2, ÊuŸì5, sìêv2,5,6 (1ÂRa@, 2áÈ, 3cäå, 4òÔ\a@, 5JCHOa@, 6áÈ): æ43ñú{áÈèpwïwpï (2020/1/26), .
723698. [wï (S)] (êÊu)yÀ·zêÊu21üÜž³èpuüÜž³èpv. sìêv1,2 (1áÈ, 2áÈ): æ43ñú{áÈèpwïwpï (2020/1/26), .
723699. [wï (S)] (êÊu) is«~pÉηéJX^pNXLOÌú¬Ñ. ¬²i1,2, Œcmç1, Ъ1, gcmq1, ºFº1, sìêv3,4 (1ŒÃ®ACNjbN, 2cäå, 3áÈ, 4áÈ): æ43ñú{áÈèpwïwpï (2020/1/26), .
723700. [wï (S)] (êÊu) ÆŸÝvðÍ\tgðp¢œHole ICLÌÀõðÍ. ìçcñu1, Rè@1, Ž
öç1,2, ¯iMs3 (1ãÃq¶w, 2R€a@, 3áÈ): æ43ñú{áÈèpwïwpï (2020/1/26), .
723701. [wï (S)] (êÊu)yÀ·zêÊu23: àáuFLACS, ¶Ìvªv. sìêv1,2 (1áÈ, 2áÈ): æ43ñú{áÈèpwïwpï (2020/1/26), .
723702. [wï (S)] (êÊu) Hess`[gÌlHm\¯Ê\õI€EO]_oáƳí̯Ê. «§«å1, ¡{_I1, ÎòŒj1, ãÖŸ2, c£mu1,3, Tª^O1, ¬ŒD4, ØàÇŸ4 (1cJULa@, 2áÈ, 3LåDT2M, 4Lå): æ43ñú{áÈèpwïwpï (2020/1/26), .
723703. [wï (S)] (êÊu) 25Q[WàŸ¹poÑlÌGœA[hou}ü̬Ñ. Œc×ã1, ¡R@ãÄ1, ¬²i2, nç³OP3, ÁêBu1, sìêv3,4 (1JCHOa@, 2cäå, 3áÈ, 4áÈ): æ43ñú{áÈèpwïwpï (2020/1/26), .
731069. [wï (nûïE€ï)] (ÁÊu) üÜž³èpw»óÆ¡ãÌW]x. _JaF (ãÃq¶w): OKINAWA Cataract&Corneal Seminar (2019/5/24), «ê.
731070. [wï (nûïE€ï)] (ÁÊu) ±±ÜÅÏíÁœ! ~p¡ÃÌÅOü. _JaF (ãÃq¶w): æ52ñ¹ìáÈWkï (2019/6/1), kC¹.
731071. [wï (nûïE€ï)] (ÁÊu) ÍEüÜžEYÝÌðô. ìçcñu (ãÃq¶w): æ20ñÝâ¬\PûmÌï (2019/6/9), {é.
731072. [wï (nûïE€ï)] (ÁÊu) Îàá³ÒÉš¯éèpÐîÌ^C~O. }Ž³s (áÈ): æ13ñ³ªÝáÈ€ï (2019/6/13), .
731073. [wï (nûïE€ï)] (ÁÊu)yÀ·zÁÊu2. ¯iMs (áÈ): æ13ñ³ªÝáÈ€ï (2019/6/13), .
731074. [wï (nûïE€ï)] (ÁÊu) }CNpX[U[Ìgpo±Æ»ÌÊuï. ¯iMs (áÈ): æ5ñFukuoka Glaucoma Council (2019/6/15), ª.
731075. [wï (nûïE€ï)] (ÁÊu) üÜž³èpAbvf[g2019. _JaF (ãÃq¶w): æ23ñbMZ~i[ (2019/6/23), R.
731076. [wï (nûïE€ï)] (ÁÊu)yÀ·zÁÊu1. ¯iMs (áÈ): æ19ñ_ÞìáÈZ~i[ (2019/7/4), _Þì.
731077. [wï (nûïE€ï)] (ÁÊu) üÜž³èpAbvf[g2019. _JaF (ãÃq¶w): æ42ñàÕŠãÈåwáÈEÈاáÈãï¯uï (2019/7/12), ÈØ.
731078. [wï (nûïE€ï)] (ÁÊu) ®æÅ©¹Ü·àáèp@`èpOãÌûòÉ¢ÄàðàµÜ·`. àVåã1,2 (1CVŒa@ 2áÈ): æ91ñ¬csòÜtïwpuï (2019/7/18), .
731079. [wï (nûïE€ï)] (ÁÊu) í©èâ·¢áõw@oÌ¿ªª©éRgXgŽxž. ìçcñu (ãÃq¶w): æ2ñRfBJXLAbvZ~i[inxR (2019/7/21), xR.
731080. [wï (nûïE€ï)] (ÁÊu) ÎàáÌffÆis»è. ¯iMs (áÈ): æ20ñªÎàáJt@X (2019/7/26), ª.
731081. [wï (nûïE€ï)] (ÁÊu) ±±ÜÅÏíÁœ! ~pÌ¡Ã`CuRV, PiXL©çAI¡ÃÜÅ. _JaF (ãÃq¶w): æ18ñߎ¹! RlAÌSl (2019/8/30), .
731082. [wï (nûïE€ï)] (ÁÊu) áNPÎàáèp. ¯iMs (áÈ): 2019NxâèáÈwpZ~i[ (2019/8/31), âè.
731083. [wï (nûïE€ï)] (ÁÊu) mÁÄéÂàèÌÎõœË. óì@« (ãÃq¶w): æ30ñ¬áÈ (ÎEã) Çá¢ïE×ï (2019/9/12), _Þì.
731084. [wï (nûïE€ï)] (ÁÊu)yÀ·zÁÊu. ãÖŸ (áÈ): ESG`External Surgery Group` (2019/9/13), _Þì.
731085. [wï (nûïE€ï)] (ÁÊu)yÀ·zÁÊuI. _JaF (ãÃq¶w): SENJU Ocular surface Seminar (2019/9/27), _Þì.
731086. [wï (nûïE€ï)] (ÁÊu)yÀ·zÁÊu. ¯iMs (áÈ): æ55ñk¢åwE_Þì§áÈãï¯T[`Jt@X (2019/10/31), _Þì.
731087. [wï (nûïE€ï)] (ÁÊu) ±±ÜÅÏíÁœ! ~pÌÅV¡Ã`CuRV, PiXL©çAIffÜÅ`. _JaF (ãÃq¶w): æ17ñkÖáÈa@€ï (2019/11/7), ÈØ.
731088. [wï (nûïE€ï)] (ÁÊu) pNXLOÌ¢\z}`CuRV, PiXL©çAIis\ªÜÅ`. _JaF (ãÃq¶w): æ230ñÖŒáÈæiãÀï (2019/11/20), åã.
731089. [wï (nûïE€ï)] (ÁÊu) ÅVÌ_oŸ³ÌlŠûEµ¢û`Õ°áðQlÉ. Îì@Ï (ãÃq¶w): æ263ñáÈWkï (2019/11/30), .
731090. [wï (nûïE€ï)] (ÁÊu) MIGSÌøÊÆÀE. ¯iMs (áÈ): æ16ñBay Ophthalmic Surgical Seminar (2019/11/30), _Þì.
731091. [wï (nûïE€ï)] (ÁÊu) îÒÌ¡|Sagging Eye Syndromeðð·é|. ãÖŸ (áÈ): æ107ñHc§áÈWkï (2019/12/15), Hc.
731092. [wï (nûïE€ï)] (ÁÊu)yÀ·zÁÊu. ¯iMs (áÈ): æ17ñk¢áÈafAgï (2020/1/16), _Þì.
731093. [wï (nûïE€ï)] (ÁÊu) ÎàáèpÌKÆpãÇ. }Ž³s (áÈ): æ17ñk¢áÈafAgï (2020/1/16), _Þì.
731094. [wï (nûïE€ï)] (ÁÊu) ©Š¹È¢_oáÈ~}Ÿ³|ÎàáÆÎõœË|. Îì@Ï (ãÃq¶w): æ9ñSUSANOOï (2020/1/19), ª.
731095. [wï (nûïE€ï)] (ÁÊu) Ðî·×«_oáÈŸ³|»Ì^C~OðŠª³È¢œßÉ|. Îì@Ï (ãÃq¶w): æ6ñªáÈtH[ (2020/1/25), m.
731096. [wï (nûïE€ï)] (ÁÊu) k¢åwÉš¯épŸ³¡ÃÌÀÛ`ÐŸ«œ¢Ÿ³Æ»ÌúÉ¢Ä`. _JaF (ãÃq¶w): æ5ñ¡lsÎæáÈãïwpuï (2020/1/31), _Þì.
732050. [wï (nûïE€ï)] (³çuÀ) _oáÈŸ³|wãÉBê音𩊳ȢœßÉ|. Îì@Ï (ãÃq¶w): ú{áÈãïæ76ñ¶U³çuÀ (2019/4/13), €m.
732051. [wï (nûïE€ï)] (~[eBO) ut. ¯iMs (áÈ): æ2ñSENJU Glaucoma Seminar{[h~[eBO (2019/4/23), _Þì.
732052. [wï (nûïE€ï)] (AhoCU[) ACt@K_át0.1%, K`t_át0.3%Ì»ÜÁ¥É¢Ä. }Ž³s (áÈ): çõ»òAhoCU[Dr.éæ (2019/4/25), _Þì.
732053. [wï (nûïE€ï)] (µÒu) ~pÉηéVœÈAv[`. _JaF (ãÃq¶w): æ15ñåãptH[ (2019/5/11), åã.
732054. [wï (nûïE€ï)] (µÒu) MIGSÆÎàá¡ÃòÌAbvf[g. }Ž³s (áÈ): æ18ñOlAï (2019/5/16), _Þì.
732055. [wï (nûïE€ï)] (JïÌ¥A) _ÞìÈåw®¡lNjbNáÈÐî (JïÌ¥A). sç²`Í1,2 (1_ÞìÈåw®¡lNjbN, 2áÈ): æ12ñ_ÞìÈåw¡láÈfXAgÌï (2019/5/31), _Þì.
732056. [wï (nûïE€ï)] (µÒu) ÎàáèpAbvf[g`MIGS`. }Ž³s (áÈ): æ12ñ_ÞìÈåw¡láÈfXAgÌï (2019/5/31), _Þì.
732057. [wï (nûïE€ï)] (ÂïÌ¥A) ÂïÌ¥A. üìaY1,2 (1_ÞìÈåw®¡lNjbN, 2áÈ): æ12ñ_ÞìÈåw¡láÈfXAgÌï (2019/5/31), _Þì.
732058. [wï (nûïE€ï)] (plfBXJbV) ÔŸ³ÌffšæÑ¡ÃIð. sç²`Í1,2, öcqF2 (1_ÞìÈåw®¡lNjbN, 2áÈ): æ14ñ_Þì©Á€ï (2019/6/22), _Þì.
732059. [wï (nûïE€ï)] (î²u)yÀ·zî²u1. ÑcÃF (áÈ): æ2ñk¢åwáÈbï (2019/7/13), .
732060. [wï (nûïE€ï)] (î²u) pNXLOÌ»óÆW]. Ž³p (áÈ): æ2ñk¢åwáÈbï (2019/7/13), .
732061. [wï (nûïE€ï)] (î²u)yÀ·zî²u2. öcqF (áÈ): æ2ñk¢åwáÈbï (2019/7/13), .
732062. [wï (nûïE€ï)] (î²u) ÄÎfÃ-ÅVgsbNXƯwñ-. ãÖŸ (áÈ): æ2ñk¢åwáÈbï (2019/7/13), .
732063. [wï (nûïE€ï)] (³çu)
»ÌÌÁîÏ»Æ@\. ìçcñu (ãÃq¶w): 2019áõw`
[gAZ~i[ (2019/8/3), .
732064. [wï (nûïE€ï)] (Ðà[~) CVŒa@Éš¯éàáèpÉ¢Ä. àVåã1,2 (1CVŒa@, 2áÈ): »a®ïÐ@Ðà[~ (2019/8/22), _Þì.
732065. [wï (nûïE€ï)] (µÒu) }§¡ÃIpØpÌlÄÆ]PTKÆÌär. ìGP1,2 (1ÅÑÔa@, 2áÈ): æ18ñߎ¹! RlAÌSl (2019/8/30), .
732066. [wï (nûïE€ï)] (uKï)yiïzú{_oáÈwïFèuKï. Îì@Ï (ãÃq¶w): æ35ñ^ßZ~i[ (ú{_oáÈwïFèuKï) (2019/9/1), _Þì.
732067. [wï (nûïE€ï)] (uKï) ú{_oáÈwïFèuKï: OáØEáâ|pulley. ãÖŸ (áÈ): æ35ñ^ßZ~i[ (ú{_oáÈwïFèuKï) (2019/9/1), _Þì.
732068. [wï (nûïE€ï)] (Çá¢) _oÆÐî³êœãÌ1á. À¡aÌq (áÈ): æ30ñ¬áÈ (ÎEã) Çá¢ïE×ï (2019/9/12), _Þì.
732069. [wï (nûïE€ï)] (Àkï)yiïzÎàá¡ÃÌ·ÌmV`å¬oHðî·éᳺ~¡ÃÆ»Ìðß`. ¯iMs (áÈ): _Þì§Àkï (»a) (2019/9/25), _Þì.
732070. [wï (nûïE€ï)] (V|WE)yÀ·zTreatment (Medical&Surgical). ¯iMs (áÈ): Asia Glaucoma Academy (AGA) 1st Conference (2019/9/28), .
732071. [wï (nûïE€ï)] (µÒu) Îàá. }Ž³s (áÈ): ÚÌ€ìf[@s¯öJuÀ (2019/9/29), _Þì.
732072. [wï (nûïE€ï)] (µÒu)yÀ·zèp. ¯iMs (áÈ): Keep The Visual Field in Tokyo (2019/10/5), .
732073. [wï (nûïE€ï)] (µÒu) ÎàáèpÌÐî^C~O. }Ž³s (áÈ): æ3ñߪÝÌï (2019/10/6), _Þì.
732074. [wï (nûïE€ï)] (s¯öJuÀ) æí©éÚÌNÌšb`àáEÎàáÌÇóƻ̡Ã`. àVåã1,2 (1CVŒa@, 2áÈ): mÁÄŸ·éNuÀ^CVŒa@ (2019/10/19), _Þì.
732075. [wï (nûïE€ï)] (µÒu) Îàá¡ÃÌAbvf[g. }Ž³s (áÈ): ÃŒáÈuKï (2019/10/19), _Þì.
732076. [wï (nûïE€ï)] (µÒu)yÀ·zgxNg[èp€ï. ¯iMs (áÈ): gxNg[èp€ï2019 in Kyoto (2019/10/26), s.
732077. [wï (nûïE€ï)] (µÒu) ¶õw̧ê©ç©œwbhAbvfBXvCÌÀS«ÆoSÝv. ìçcñu (ãÃq¶w): ZpîñŠïZ~i[ (wbhAbvfBXvCÌÅKîññŠÆoÁ«) (2019/10/29), .
732078. [wï (nûïE€ï)] (³çu)yÀ·z³çu. öcqF (áÈ): æ55ñk¢åwE_Þì§áÈãï¯T[`Jt@X (2019/10/31), _Þì.
732079. [wï (nûïE€ï)] (³çu) õ±Âfwv (OCT) ©ðSƵœÔÉqÌŸ³. tØG (áÈ): æ55ñk¢åwE_Þì§áÈãï¯T[`Jt@X (2019/10/31), _Þì.
732080. [wï (nûïE€ï)] (µÒu) ÎàáÌaúɶœ¡Ã̱ü. ¯iMs (áÈ): æ20ñ³çtH[ (2019/11/2), ª.
732081. [wï (nûïE€ï)] (³öACu) áNPÎàáèp: MIGS. ¯iMs (áÈ): æ45ñk¢ãwïï (2019/11/16), _Þì.
732082. [wï (nûïE€ï)] (µÒu) üÜž³Abvf[g. _JaF (ãÃq¶w): GCGI[EWp@[U[Y~[eBO2019åä (2019/11/24), {é.
732083. [wï (nûïE€ï)] (µÒu)yÀ·zuI. _JaF (ãÃq¶w): OS-GJt@X (2019/11/27), _Þì.
732084. [wï (nûïE€ï)] (µÒu)yÀ·zu1. _JaF (ãÃq¶w): æ61ñÃŒáÈÕ°tH[ (2019/12/12), _Þì.
732085. [wï (nûïE€ï)] (µÒu)yÀ·zu2. ¯iMs (áÈ): æ61ñÃŒáÈÕ°tH[ (2019/12/12), _Þì.
732086. [wï (nûïE€ï)] (µÒu) ÇáæèwÔÅVÌ_oáÈ. Îì@Ï (ãÃq¶w): æ433ñåãáÈWkï (2019/12/14), åã.
732087. [wï (nûïE€ï)] (XyVXgu) »êÌj[Y©çlŠéí©èâ·¢áõw. ìçcñu (ãÃq¶w): æ2ñFuture of Orthoptist (2019/12/14), F{.
732088. [wï (nûïE€ï)] (µÒu) ÎàáÌaúɶœ¡Ã̱ü. ¯iMs (áÈ): Glaucoma Update Seminar GCxX1üNLOuï (2020/1/30), _Þì.
732089. [wï (nûïE€ï)] (µÒu)yÀ·zu1. Îì@Ï (ãÃq¶w): æ7ñ_Þì¬áÈE_oáÈJt@X (2020/2/6), _Þì.
732090. [wï (nûïE€ï)] (µÒu)yÀ·zÁÊu2. _JaF (ãÃq¶w): æ16ñÃìáÈäy (2020/2/13), _Þì.
732091. [wï (nûïE€ï)] (î²u) OáèpÉš¯éŽõÇyÑ»Ì\h. Žäq (áÈ): ESG`External Surgery Group` (2020/2/14), _Þì.
732092. [wï (nûïE€ï)] (Çáñ) ffÉ궵œï¡«ááÙºÌ1á. rcNç (áÈ): æ12ñ_ÞìNXI[o[V|WE (2020/2/15), _Þì.
732093. [wï (nûïE€ï)] (µÒu)yÀ·zµÒu. ¯iMs (áÈ): æ5ño¶wîbZ~i[ (2020/2/16), åã.
732094. [wï (nûïE€ï)] (AhoCU[)yutzACx[^z_átÌv[VÉ¢Ä. ¯iMs (áÈ): AhoCU[Dr.µãÙéæ (2020/2/20), .
733227. [wï (nûïE€ï)] (êÊu)yÀ·zêÊu. ¯iMs (áÈ): æ11ñ_ÞìáÈwï (2019/6/2), _Þì.
733228. [wï (nûïE€ï)] (êÊu) gxNg[èpãÌá³ÄãžáÉηéÇÁÊtbNg~[ÌZú¬Ñ. ÍìYº1, }Ž³s1, ÒòCF1, ÄR@È1, ¯iMs1 (1áÈ): æ11ñ_ÞìáÈwï (2019/6/2), _Þì.
733229. [wï (nûïE€ï)] (êÊu) OÎ𺀳ÒÌàápOãÌáÊÏ». ÔÎòq¿1, ±ì¢G2, ÑcÃF1, Îì@Ï2, ¯iMs1 (1áÈ, 2ãÃq¶w): æ11ñ_ÞìáÈwï (2019/6/2), _Þì.
733230. [wï (nûïE€ï)] (êÊu) à®ÐÉæéJú«áO𫜵œêá. FìF1, Ñ@»1, tØG1, öcqF1, ¯iMs1 (1áÈ): æ11ñ_ÞìáÈwï (2019/6/2), _Þì.
733231. [wï (nûïE€ï)] (êÊu) j{}u·ú^ÉÔÇ€ðǵœ1á. å|SB1, ÄR@È1, ²¡MV1, öcqF1, nç³W¯2, ¯iMs1 (1áÈ, 2Á»íà): æ11ñ_ÞìáÈwï (2019/6/2), _Þì.
733232. [wï (nûïE€ï)] (êÊu) ~gRhAâ`q11778îÎÏÙðL·é¡ÃïR«_oÌ1á. Žäq1, àRrî1, ãÖŸ1, Îì@Ï2, ¯iMs1 (1áÈ, 2ãÃq¶w): æ11ñ_ÞìáÈwï (2019/6/2), _Þì.
733233. [wï (nûïE€ï)] (êÊu) Photorefractive Intrastromal Cross-linking (PiXL) Éæéßž³ð{sµœêá. Ž³p1, _JaF2, ÒòCF1, ¯iMs1 (1áÈ, 2ãÃq¶w): æ11ñ_ÞìáÈwï (2019/6/2), _Þì.
733234. [wï (nûïE€ï)] (êÊu) ¬µEÅÆŸÌN±ÁœáêÊ^Ì~Ï@. iìKê (áÈ): æ31ñáÈÊ^€ï (2019/7/7), .
733235. [wï (nûïE€ï)] (êÊè) vI«AXyMXÇÉæé@«_oÇÌêá. ÎìåN1, àRrî1, Žäq1, ãÖŸ1, Îì@Ï2 (1áÈ, 2ãÃq¶w): æ35ñ^ßZ~i[ (_oáÈh×ï) (2019/8/31), _Þì.
733236. [wï (nûïE€ï)] (êÊè) vI«AXyMXÇÉæéáâ|æ[ÇóQÌêá. Îì@Ï1, ÎìåN2, àRrî2, Žäq2, ãÖŸ2 (1ãÃq¶w, 2áÈ), æ35ñ^ßZ~i[ (_oáÈh×ï) (2019/8/31), _Þì.
733237. [wï (nûïE€ï)] (êÊè) á
^®áQ𹵜RMOGRÌz«_oÌêá. Žäq1, ÎìåN1, àRrî1, ãÖŸ1, Îì@Ï2 (1áÈ, 2ãÃq¶w): æ35ñ^ßZ~i[ (_oáÈh×ï) (2019/8/31), _Þì.
733238. [wï (nûïE€ï)] (êÊè) MRIÅå]¿ÉLÍÈMÌæðFßœm11778_ÏÙz«_oÇÌêá. àRrî1, ÎìåN1, Žäq1, ãÖŸ1, Îì@Ï2 (1áÈ, 2ãÃq¶w): æ35ñ^ßZ~i[ (_oáÈh×ï) (2019/9/1), _Þì.
733239. [wï (nûïE€ï)] (êÊè)yÀ·zêÊè. ãÖŸ (áÈ): æ55ñk¢åwE_Þì§áÈãï¯T[`Jt@X (2019/10/31), _Þì.
733240. [wï (nûïE€ï)] (êÊè) I~flpOC\vs_átÌZúgp¬Ñ. ØŸY1, }Ž³s1, Ž³p1, ÍìYº1, ÒòCF1, ÄR@È1, ¯iMs1 (1áÈ): æ55ñk¢åwE_Þì§áÈãï¯T[`Jt@X (2019/10/31), _Þì.
733241. [wï (nûïE€ï)] (êÊè) [VbNpãOÉæétbv|]𶶜êá. Näq1, Ž³p1, _JaF2, ¯iMs1 (1áÈ, 2ãÃq¶w): æ55ñk¢åwE_Þì§áÈãï¯T[`Jt@X (2019/10/31), _Þì.
733242. [wï (nûïE€ï)] (êÊè) _uj[heNjbNðp¢œtW@ÉæéáàYàÅèpÌèp¬Ñ. FìF1, tØG1, öcqF1, ¯iMs1 (1áÈ): æ55ñk¢åwE_Þì§áÈãï¯T[`Jt@X (2019/10/31), _Þì.
733243. [wï (nûïE€ï)] (êÊè) á
^®áQ𹵜RMOGRÌz«_oÌ1á. Žäq1, ÎìåN1, àRrî1, ãÖŸ1, Îì@Ï2, ¯iMs1 (1áÈ, 2ãÃq¶w): æ55ñk¢åwE_Þì§áÈãï¯T[`Jt@X (2019/10/31), _Þì.
733244. [wï (nûïE€ï)] (êÊè) Barrett Universal II®ÆSRK/T®Ì\ª«Ìär. Ñ@h1, _JaF2, ÑcÃF1, ¯iMs1 (1áÈ, 2ãÃq¶w): æ55ñk¢åwE_Þì§áÈãï¯T[`Jt@X (2019/10/31), _Þì.
733245. [wï (nûïE€ï)] (êÊè) ïÇáàáèpÉš¢ÄmÀÉOùNØJð¬÷³¹éœßÌíªÆHv. ÑcÃF (áÈ): æ16ñ Bay Ophthalmic Surgical Seminar (2019/11/30), _Þì.
733246. [wï (nûïE€ï)] (êÊè) AhoXpNXLO (CuRVEPiXL). _JaF (ãÃq¶w): æ16ñ Bay Ophthalmic Surgical Seminar (2019/11/30), _Þì.
733247. [wï (nûïE€ï)] (êÊè)yÀ·zêÊè. Îì@Ï (ãÃq¶w): æ17ñk¢áÈafAgï (2020/1/16), _Þì.
733248. [wï (nûïE€ï)] (êÊè)yðàzSagging eye syndrome. ãÖŸ (áÈ): æ17ñk¢áÈafAgï (2020/1/16), _Þì.
'18NxÈOª
[wp_¶]
H29-540002. [»ÌŒ (€ñ)]yœ¬27 (2015) Nx`œ¬29 (2017) Nx ú¶JÈw€ïâàuŸaEáQÎô€ªì ï¡«Ÿ³ô€ (ï¡«Ÿ³ô€)vz_oÆuwI_Éæéï¡«_oÌffîì¬. €ã\Ò: Îì@Ï1, €ªSÒ: Oº@¡,gyu, ~hå, œªüI, nG÷, ÑËi, º@œ, ãÖŸ2, cšq, €ŠÍÒ: RãŸq, ¯@ÀF3, ^ºIüã, É¡@õ (1ãÃq¶w, 2áÈ, 3q¶): œ¬27 (2015) Nx`œ¬29 (2017) Nx ú¶JÈw€ïâàuŸaEáQÎô€ªì ï¡«Ÿ³ô€ (ï¡«Ÿ³ô€) v€ñ 2018/3.
š@ôAÈEªèòOÈw
[wp_¶]
110317. [Ž] Investigation of Stress Levels Before the Onset of Idiopathic Sudden Sensorineural Hearing Loss. Watanabe H1, Sano H2, Maki A1, Ino T1, Nakagawa T1, Okamoto M1, Yamashita T1: J Int Adv Otol 2019/4; 15 (1): 51-5. (nÓTV1, ²ì@£2, q@Öq1, @u1, ìMm1, ª{ql1, Rº@ñ1: 1š@ôAEªèòO, 2ãÃq¶w)
110318. [Ž] Classification of Tumors by Imaging Diagnosis and Preoperative Fine-Needle Aspiration Cytology in 120 Patients With Tumors in the Parapharyngeal Space. Matsuki T1, Miura K, Tada Y, Masubuchi T, Fushimi C, Kanno C, Takahashi H, Kamata S, Okamoto I, Miyamoto S1, Yamashita T1: Head Neck 2019/5; 41 (5): 1277-81. (ŒØ@1, {{rã1, Rº@ñ1: 1š@ôAEªèòO)
110319. [Ž] Carboplatin and Docetaxel in Patients With Salivary Gland Carcinoma: A Retrospective Study. Okada T, Saotome T, Nagao T, Masubuchi T, Fushimi C, Matsuki T1, Takahashi H, Miura K, Tsukahara K, Tada Y: In Vivo 2019/5-6; 33 (3): 843-53. (ŒØ@1: 1š@ôAEªèòO)
110320. [Ž] Oncolytic Sendai Virus-Induced Tumor-Specific Immunoresponses Suppress "Simulated Metastasis" of Squamous Cell Carcinoma in an Immunocompetent Mouse Model. Tanaka Y, Araki K, Tanaka S, Miyagawa Y, Suzuki H, Kamide D, Tomifuji M, Uno K, Harada E, Yamashita T1, Ueda Y, Inoue M, Shiotani A: Head Neck 2019/6; 41 (6): 1676-86. (Rº@ñ1: 1š@ôAEªèòO)
110321. [Ž] Sentinel Lymph Node-Targeted Therapy by Oncolytic Sendai Virus Suppresses Micrometastasis of Head and Neck Squamous Cell Carcinoma in an Orthotopic Nude Mouse Model. Tanaka Y, Araki K, Tanaka S, Miyagawa Y, Suzuki H, Kamide D, Tomifuji M, Uno K, Kimura E, Yamashita T1, Ueda Y, Shiotani A: Mol Cancer Ther 2019/8; 18 (8): 1430-8. (Rº@ñ1: 1š@ôAEªèòO)
110322. [Ž] Usefulness of Narrow Band Imaging With Magnifying Endoscopy for the Differential Diagnosis of Cancerous and Noncancerous Laryngeal Lesions. Hosono H1, Katada C2, Okamoto T1, Ichinoe M3, Sakamoto Y4, Matsuba H1, Kano K1, Ishido K2, Tanabe S2,5, Koizumi W2, Yamashita T1: Head Neck 2019/8; 41 (8): 2555-60. (×ì_j1, ce2, ª{·l1, ê˹Ÿ3, â{×4, ŒtGN1, Á[Fê1, Î˪2, cç³@2,5, ¬òaOY2, Rº@ñ1: 1š@ôAEªèòO, 2Á»íà, 3a, 4Õ°€EvWFNg, 5V¢IãÃEæ[ãÃ)
110323. [Ž] Induction of Cell fusion/apoptosis in Anaplastic Thyroid Carcinoma in Orthotopic Mouse Model by Urokinase-Specific Oncolytic Sendai Virus. Miyagawa Y, Araki K, Yamashita T1, Tanaka S, Tanaka Y, Tomifuji M, Ueda Y, Yonemitsu Y, Shimada H, Shiotani A: Head Neck 2019/9; 41 (9): 2873-82. (Rº@ñ1: 1š@ôAEªèòO)
110324. [Ž] Value of Transoral Surgery for Human Papillomavirus-Mediated Oropharyngeal Cancer: Validation of a New Staging System in Japanese Patients. Kimura E, Araki K, Tomifuji M, Tanaka Y, Uno K, Yamashita T1, Shiotani A: J Int Med Res 2019/10; 47 (10): 5048-59. (Rº@ñ1: 1š@ôAEªèòO)
110325. [Ž] Efficacy and Safety of Nivolumab in 100 Patients With Recurrent or Metastatic Head and Neck Cancer - A Retrospective Multicentre Study. Okamoto I, Sato H, Kondo T, Koyama N, Fushimi C, Okada T, Miura K, Matsuki T1, Yamashita T1, Omura G, Tsukahara K: Acta Otolaryngol 2019/110; 139 (10): 918-25. (ŒØ@1, Rº@ñ1: 1š@ôAEªèòO)
110326. [Ž] Clinical Predictors of Descending Necrotizing Mediastinitis After Deep Neck Infections. Kimura A1, Miyamoto S1, Yamashita T1: Laryngoscope 2019/11. doi: 10.1002/lary.28406. Online ahead of print. (غé¢1, {{rã1, Rº@ñ1: 1š@ôAEªèòO)
110327. [Ž] Venous malformation of the parapharyngeal space: Two surgical case reports and a literature review. Matsuki T1, Miura K, Tada Y, Masubuchi T, Fushimi C, Nitta Y, Kamata S, Okamoto I, Miyamoto S1, Yamashita T1: Otolayngology Case Reports 2019/11; 13: 100130. (ŒØ@1, {{rã1, Rº@ñ1: 1š@ôAEªèòO)
110328. [Ž] Addition of S-1 to Radiotherapy for Treatment of T2N0 Glottic Cancer: Results of the Multiple-Center Retrospective Cohort Study in Japan With a Propensity Score Analysis. Sano D, Tanabe T, Kubota A, Miyamoto S1, Tanigaki Y, Okami K, Komatsu M, Ikoma R, Suzuki K, Akazawa Y, Kobayashi S, Yamada Y, Oridate N: Oral Oncol 2019/12; 99: 104454. ({{rã1: 1š@ôAEªèòO)
110329. [Ž] Post-operative Complications Due to Salvage Total Laryngectomy for Recurrent Laryngeal Cancer After Radiotherapy - A Multicentre Retrospective Study. Okamoto I, Matsuki T1, Sato H, Kondo T, Fushimi C, Okada T, Miura K, Yamashita T, Omura G, Tsukahara K: Acta Otolaryngol 2020/2; 140 (2): 170-4. (ŒØ@1: 1š@ôAEªèòO)
120032. [Ž] Jj
[hÉæéCÇ·óÉε쮺åÂœpð{sµœÇá. ŽìRy1, ì^l, ×ì_j1, åŽìÆ1, ÃØÈá1, Rº@ñ1 (1š@ôAEªèòO): ªèòOÈ 2019/4; 28 (3): 301-6.
120033. [Ž] Ênre[VpîÒÌ®o]¿|šàf@, ®Íž, ¿â²žÉæé¢|. éØbq1, ~ŽKb1, äãG1, `@áØ1, Ž
@œ1, ²ì@£2, ìMm1, Rº@ñ1 (1š@ôAEªèòO, 2ãÃq¶w): Audiology Japan 2019/7; 62 (3): 240-7.
310038. [Çáñ] A Case of Gastric Meningeal Carcinomatosis Involving Bilateral Hearing Loss: The Difference Between Clinical Images and Autopsy Findings. Kimura A1, Takahashi Y, Mizutari K, Tsujimoto H, Nakanishi K, Shiotani A: J Int Adv Otol 2019/8; 15 (2): 333-6. (غé¢1: 1š@ôAEªèòO)
320040. [Çáñ] uVÉæéôªO©çcuCî𜵜êá. غé¢1, Rº@ñ1, ç{Ïq (1š@ôAEªèòO): ú{¬š@ôAÈwïG 2019/4; 40 (3): 271-7.
320041. [Çáñ] IgKCºçÙÉæègåAªSEoãÌôªÄðsÁœîºåãàÌ2á. {{rã1, ŽìRy1, ŒØ@1, Á[Fê1, ç@ãÄœ, éØ»q1, àRÛ1, Rº@ñ1 (1š@ôAEªèòO): ªèòOÈ 2020/3; 29 (3): 311-20.
520015. [à] EºôªÌoûI¡Ã@EºôªàÉηéoûI¡Ã|ELPS, TOVSðSÉ|. Rº@ñ1, ª{·l1, Á[Fê1, ce2 (1š@ôAEªèòO, 2Á»íà): ú{š@ôAÈwïïñ 2019/5; 122 (5): 750--6.
520016. [à] X|[cÆš@ôAÈ|@o¶w©ç^®\ÍÌüãðÚw·|. åز¶1,2 (1š@ôAEªèòO, 2k¢åwfBJZ^[): ú{š@ôAÈwïï 2019/11; 122 (11): 1398-404.
521008. [ðà]yÁW: ¹«Eœñ|ÓÊffÌ|CgÆ¡Ãíª|zòÜ«Ô¿«x. {{rã (š@ôAEªèòO): ENTONI 2019/5; 232: 55-61.
521009. [ðà]ypêðàzLemierreÇóQ. Rº@ñ (š@ôAEªèòO): ú{CÇH¹Èwïïñ 2019/12; 70 (6): 398-400.
522106. [uÀ]y³çuIzŽîÐïÉš¯é®oáQÌâè_. ²ì@£ (ãÃq¶w):R~
jP[VáQw 2019/4; 36 (1): 10-3.
522107. [uÀ]yAÚ: OfÃÉš¯éÌuz@Ìu6: @ÌluCU[¡Ã. åز¶1,2 (1š@ôAEªèòO, 2k¢åwfBJZ^[): JOHNS 2019/4; 35 (4); 503-8.
522108. [uÀ]yæ63ñú{®oãwïåèèÁWzŽîÐïÉš¯é®oãwÌÛèÆgœ: Ênre[VpîÒÌâ®í®. éØbq1, äãG1, ~ŽKb1, `@áØ1, Ž
@œ1, ²ì@£2, ìMm1, Rº@ñ1 (1š@ôAEªèòO, 2ãÃq¶w): Audiology Japan Japan 2019/7; 62 (3): 196-204.
522109. [uÀ]yÁW: @ÂÉÜÂíéâèÆ»Ìðôz_: @Äz̶. åز¶1,2 (1š@ôAEªèòO, 2k¢åwfBJZ^[): JOHNS 2019/11; 35 (11): 1542-6.
522110. [uÀ]yV|WE2: AªàÌAª·¶¡Ã|KÆÀEÉ¢Ä|zAªSEop (supracricoid laryngectomy) ÌKÆÀE|ØüÌÏ_©çÝœ¢|. {{rã1, ŽìRy1, ŒØ@1, ª{·l1, Á[Fê1, ç@ãÄœ1, éØ»q1, àRÛ1, Rº@ñ1 (1š@ôAEªèòO): Aª 2019/12; 31 (2): 84-91.
522111. [uÀ]yClinical Academic TopicszXMÔ²RŽãºÆuÃ@Ì·úp±ÇáÉš¯éøÊ. 原Y1,2, åز¶1,2, {º\ê1, gœìlŸ1,2 (1š@ôAEªèòO, 2k¢åwfBJZ^[): AM[ÌÕ° 2019/12; 39 (12): 44-7.
540072. [»ÌŒ (wïL^)]yæ37ñú{š@ôAÈÆuAM[wï@\L^WzXMԲdzÒÉš¯éâÃ@ƵÄÌ£H
ôòÌÓ`. åز¶1,2, éاr1, ì@èñ (1š@ôAEªèòO, 2k¢åwfBJZ^[): š@ôAÈÆuAM[2019/6; 37 (2): 195-6.
540073. [»ÌŒ (€ñ)]y¶ÈwÈ€ï (2018Nx`2019Nxáè€)zACRgGE4ÉæéD_
«@off. Rûmq (š@ôAEªèòO): 2018NxÀ{óµñ 2019/12; https://kaken.nii.ac.jp/report/KAKENHI-PROJECT-18K16855/18K168552018hokoku/.
[@]
620080. [wp (ªS·M)]yí©èIš@ôAÈfÃKChC, èø«E}j
A|Ìp@| (ENTONI 236<å>)z}«@@oÉηéluCU[Ã@Ìèø«2016@1. Tª, p.78-85. åز¶1,2 (1š@ôAEªèòO, 2k¢åwfBJZ^[), Ò: sìâêY, Sú{a@oÅ, , 2019/9s.
[wïE€ï]
713129. [wï (Û)] (êÊu)Long-term course of eosinophilic sinusitis: 3 cases study with urinary leukotriene E4. Yamaguchi T1, Ishii T1: 5th Congress of European ORL-HNS (2019/6/29-7/3), Brussels. (Rûmq1, ÎäLŸ1: 1š@ôAEªèòO)
713130. [wï (Û)] (êÊu) Nasal Irrigation Therapy in patients with allergic patients. Ohki M1,2, Ohashi K1,2, Miyashita K1, Hatano A1,2: 15th Japan-Taiwan Conference on Otolaryngology-Head and Neck Surgery (2019/12/6-7), Fukuoka, Japan. (åز¶1,2, 原Y1,2, {º\ê1, gœìlŸ1,2: 1š@ôAEªèòO, 2k¢åwfBJZ^[)
713131. [wï (Û)] (êÊu) Activity-dependent Synaptopathy and Demyelination of Auditory Neurons following Conductive Hearring in Adult Mice. Kurioka T1, Mogi S2, Tanaka M, Yamashita T1: ARO 2020 43rd Annual MidWinter Meeting (2020/1/25), San Jose, USA. (Iª²b1, Îعçã2, Rº@ñ1: 1š@ôAEªèòO, 2¶ššn)
722216. [wï (S)] (V|WE)uX|[cÆš@ôAÈv@o¶w©ç^®\ÍÌüãðÚw·. åز¶1,2 (1š@ôAEªèòO, 2k¢åwfBJZ^[): æ120ñú{š@ôAÈïEwpuï (2019/5/9), åã.
722217. [wï (S)] (V|WE) AM[«@Éš¯éluCU[Ã@. åز¶1,2 (1š@ôAEªèòO, 2k¢åwfBJZ^[): æ7ñú{š@ôAÈŽõÇEGA]wïïEwpuï (2019/9/5-6), Od.
723704. [wï (S)] (êÊu) ºåãü
ÇÉεÖóãSÙðp¢ÄºåJ媟çêœ1á. ØäGV, y¡ëV, ¢Ë`º, RèŒí, غé¢1, FìõS, rØKm, J²_ (1š@ôAEªèòO): æ120ñú{š@ôAÈwïïEwpuï (2019/5/8), åã.
723705. [wï (S)] (êÊu) [èò^á©ç~º«ó«cuÉéë¯öqÍœ©? غé¢1, {{rã1, Rº@ñ1 (1š@ôAEªèòO): æ120ñú{š@ôAÈïEwpuï (2019/5/9), åã.
723706. [wï (S)] (êÊu) {ºîá©çff³êœSg«IgG4ÖAŸ³Ìêá. ŽìRy1, ¡ìŒç1, gœìlŸ1, Rº@ñ1 (1š@ôAEªèòO): æ120ñú{š@ôAÈïEwpuï (2019/5/9), åã.
723707. [wï (S)] (êÊu) Èï®OÉš¯éyEx﮳ÒÌâ®ípóµÉ¢ÄÌ¢. ¬ŽÖq1, ÃØÈá1, ìMm1, Iª²b1, ¬ìYê, ²ì@£2, Rº@ñ1 (1š@ôAEªèòO, 2ãÃq¶w): æ120ñú{š@ôAÈïEwpuï (2019/5/10), åã.
723708. [wï (S)] (êÊu) ÈÉš¯éâ®ípÒÌtBbeBOÆû^[QbgÌär. ÃØÈá1, ²ì@£2, Iª²b1, ¬ŽÖq1, Rº@ñ1 (1š@ôAEªèòO, 2ãÃq¶w): æ120ñú{š@ôAÈïEwpuï (2019/5/10), åã.
723709. [wï (S)] (êÊu) ÈÅo±µœÙ«bóBÌ5á. àRÛ1, {{rã1, ŽìRy1, ŒØ@1, Á[Fê1, ç@ãÄœ2, éØ»q1, gœìlŸ1, Rº@ñ1 (1š@ôAEªèòO, 2åw@ãÃn€È): æ120ñú{š@ôAÈïEwpuï (2019/5/11), åã.
723710. [wï (S)] (êÊu) Jtt«Xs[`^CvCÇØJ`
[uðgpµºªÂ\ÆÈÁœlHÄzÇØWXgtB[¬á. åŽìÆ1, ¡ìŒç1, gœìlŸ1, ¬ŽÖq1, Rº@ñ1 (1š@ôAEªèòO): æ14ñú{¬š@ôAÈwïïEwpuï (2019/5/23), ª.
723711. [wï (S)] (êÊu) Äz¢ï𶶜V¶ãôªï`îÌêá. ¡ìŒç1, åŽìÆ1, ¬ŽÖq1, gœìlŸ1, Rº@ñ1 (1š@ôAEªèòO): æ14ñú{¬š@ôAÈwïïEwpuï (2019/5/24), ª.
723712. [wï (S)] (êÊu) HPVÖAôªàÆREV7»Ì¢. àRÛ1, {{rã1, ŽìRy1, ŒØ@1, Á[Fê1, ç@ãÄœ2, éØ»q1, Rº@ñ1 (1š@ôAEªèòO, 2åw@ãÃn€È): æ43ñú{ªèòàwï (2019/6/13), àò.
723713. [wï (S)] (êÊu) CÇãAªªØpÉæè@\·¶µœºåºiWÄT4AªàÌ2á. {{rã1, ŽìRy1, ŒØ@1, Á[Fê1, ç@ãÄœ2, éØ»q1, àRÛ1, ŽcYî1, Rº@ñ1 (1š@ôAEªèòO, 2åw@ãÃn€È): æ43ñú{ªèòàwï (2019/6/13), àò.
723714. [wï (S)] (êÊu) ªèòàÉš¯éCD109»Ì¢. ç@ãÄœ1, {{rã2, ŽìRy2, ŒØ@2, Á[Fê2, éØ»q2, àRÛ2, º_F÷3, Rº@ñ2 (1åw@ãÃn€È, 2š@ôAEªèòO, 3a): æ43ñú{ªèòàwï (2019/6/13), àò.
723715. [wï (S)] (êÊu) j{}uð^µœÄ]Úºôªà21áÌLø«ÆÀS«Ì¢|œ{Ý€¯ÉæéãûI€|. ªcñN, ©ç, ª{Éì, ²¡G÷, ŒØ@1, ß¡Mm, ¬º@, ¬RMV, OYOK, Rº@ñ1, ËŽŽ² (1š@ôAEªèòO): æ43ñú{ªèòàwï (2019/6/13), àò.
723716. [wï (S)] (êÊu) Nivolumabð^µœãôªà12áÌLø«ÆÀS«Ì¢|œ{Ý€¯ÉæéãûI€|. ²¡G÷, ª{Éì, ©ç, ªcñN, ŒØ@1, ß¡Mm, ¬RMV, ¬º@, OYOK, Rº@ñ1, ËŽŽ² (1š@ôAEªèòO): æ43ñú{ªèòàwï (2019/6/13), àò.
723717. [wï (S)] (êÊu) Nivolumabð^µœÄE]Úªèòà102áÌLø«ÆÀS«Ì¢|œ{Ý€¯ÉæéãûI€|. ª{Éì, ËŽŽ², ²¡G÷, ß¡Mm, ¬RMV, ©ç, ªcñN, OYOK, ¬º@, ŒØ@1, Rº@ñ1 (1š@ôAEªèòO): æ43ñú{ªèòàwï (2019/6/13), àò.
723718. [wï (S)] (êÊu) Nivolumabð^ãC»wÃ@ð{sµœªèòàÌLø«ÆÀS«|œ{Ý€¯ÉæéãûI€|. ©ç, ª{Éì, ŒØ@1, ²¡G÷, ¬º@, ß¡Mm, Rº@ñ1, ËŽŽ², œcYêY, £Bv, ªcñN, nêåã, OYOK (1š@ôAEªèòO): æ43ñú{ªèòàwï (2019/6/13), àò.
723719. [wï (S)] (êÊu) Nivolumabð^µœÄ]ÚªèòGœãçà88áÉš¯étwI\ã}[J[Ì¢|œ{Ý€¯€|. ŒØ@1, Rº@ñ1, ª{Éì, ²¡G÷, ËŽŽ², ß¡Mm, OYOK, œcYêY, ©ç, ªcñN, ìkåî, àV@Ï, ¬º@ (1š@ôAEªèòO): æ43ñú{ªèòàwï (2019/6/13), àò.
723720. [wï (S)] (êÊu) ôªH¹\ÝàÉηéoûIèpÌÀS«ÆLø«Ì¢. Á[Fê1, ce2, ê˹Ÿ3, Î˪2, {{rã1, ŽìRy1, ŒØ@1, ç@ãÄœ4, éØ»q1, àRÛ1, ŽcYî1, cç³@2,5, Rº@ñ1 (1š@ôAEªèòO, 2Á»íà, 3a, 4åw@ãÃn€È, 5V¢IãÃEæ[ãÃ): æ43ñú{ªèòàwï (2019/6/14), àò.
723721. [wï (S)] (êÊu) ÈÉš¯éªèòBlXEàÌ¢. éØ»q1, {{rã1, ŽìRy1, ª{·l1, ŒØ@1, Á[Fê1, ç@ãÄœ2, àRÛ1, Rº@ñ1 (1š@ôAEªèòO, 2åw@ãÃn€È): æ43ñú{ªèòàwï (2019/6/14), àò.
723722. [wï (S)] (êÊu) ~ÏoûèpãÉdÄÈx«pãoðµœôªàÌ1á. ŽcYî1, {{rã1, ŒØ@1, ŽìRy1, Á[Fê1, àRÛ1, ç@ãÄœ2, éØ»q1, Rº@ñ1 (1š@ôAEªèòO, 2åw@ãÃn€È): æ43ñú{ªèòàwï (2019/6/14), àò.
723723. [wï (S)] (êÊu) ŸêªÙÈèR~
jP[Vª¢ïÅ Áœèò^áÌ1Çá. ºg¬1, åز¶1,2, 原Y1,2, {º\ê1, éاr1, Rº@ñ1 (1š@ôAEªèòO, 2k¢åwfBJZ^[): æ7ñú{š@ôAÈŽõÇEGA]wïïEwpuï (2019/9/5), Od.
723724. [wï (S)] (êÊu) °³ÄzÉεúAèèp{sãôªoÉæè~}ófµœ1á. gœìlŸ1,2, {º\ê1, åز¶1,2, Rº@ñ1 (1š@ôAEªèòO, 2k¢åwfBJZ^[): æ32ñú{ûoEôªÈwïïÈçÑÉwpuï (2019/9/12), åª.
723725. [wï (S)] (êÊu) @Éš¯éIgG4ÖAŸ³³ÒÌ¢. ŽìRy1, gœìlŸ1,2, Rº@ñ1 (1š@ôAEªèòO, 2k¢åwfBJZ^[): æ32ñú{ûoEôªÈwïïÈçÑÉwpuï (2019/9/12), åª.
723726. [wï (S)] (êÊu) @opãÇÉš¯é©®@oôòígpÌÝ. gœìlŸ1,2, åز¶1,2, 原Y1,2, {º\ê1, Rº@ñ1 (1š@ôAEªèòO, 2k¢åwfBJZ^[): æ58ñú{@ÈwïïEwpuï (2019/10/4), .
723727. [wï (S)] (êÊu) ¹¿@ovªžÌú{lîlðôè·éœßÌœ{Ý€¯€|æêñ|. |àTü, ºzS, åز¶1,2, éاr1, Œ (1š@ôAEªèòO, 2k¢åwfBJZ^[): æ58ñú{@ÈwïïEwpuï (2019/10/4), .
723728. [wï (S)] (êÊu) «šÉæéàšÖÌe¿Ì]¿. ÃØÈá1, Iª²b1, ²ì@£2, Rº@ñ1 (1š@ôAEªèòO, 2ãÃq¶w): æ29ñú{šÈwïïEwpuï (2019/10/10), R`.
723729. [wï (S)] (êÊu) ¬ï®Ì`¹¬ªªê¹ŸÄxÉ^Šée¿É¢Ä. Iª²b1, ²ì@£2, ÃØÈá1, ¡ìŒç1, Rº@ñ1 (1š@ôAEªèòO, 2ãÃq¶w): æ29ñú{šÈwïïEwpuï (2019/10/10), R`.
723730. [wï (S)] (êÊu) ÈÉš¯éçÊ_oáÌ\ãKèöqÌ¢. ¡ìŒç1, Iª²b1, ÃØÈá1, ²ì@£2, Rº@ñ1 (1š@ôAEªèòO, 2ãÃq¶w): æ29ñú{šÈwïïEwpuï (2019/10/10), R`.
723731. [wï (S)] (êÊu) Nivolumabð^µœÄE]ÚªèòGœãçà88áÉš¯étwI}[J[Ì€. ŒØ@1, ª{Éì, ©ç, àV@Ï, ìkåî, ²¡G÷, ËŽŽ², ß¡Mm, ªcñN, œcYêY, OYOK, ¬º@, Rº@ñ1 (1š@ôAEªèòO): æ57ñú{à¡ÃwïwpWï (2019/10/24), ª.
723732. [wï (S)] (êÊu) Nivolumabð^µœÄE]Úªèòà100ÌLø«ÆÀS«Ì¢. ª{Éì, ²¡G÷, ß¡Mm, ¬RMV, ©ç, ªcñN, OYOK, ¬º@, ŒØ@1, Rº@ñ1, ËŽŽ² (1š@ôAEªèòO): æ57ñú{à¡ÃwïwpWï (2019/10/24), ª.
723733. [wï (S)] (êÊu) bóB@\áºÇÌ_ošÈwI¢. @Ö1, ìMV1, ·ÀpŸ1,2 (1š@ôAEªèòO, 2V¢IãÃEæ[ãÃ): æ78ñú{ßÜ¢œtãwïïwpuï (2019/10/24), xR.
723734. [wï (S)] (êÊu) jG[aÇᚯéSDS (self-rating depression scale) XRAÌXü. ìMV1, @Ö1, ·ÀpŸ1,2 (1š@ôAEªèòO, 2V¢IãÃEæ[ãÃ): æ78ñú{ßÜ¢œtãwïïEwpuï (2019/10/24), xR.
723735. [wï (S)] (êÊu) @Éš¯éVEMPðp¢œ
`ùN/`ùNÌ@\áºÉæéÇóÌ¢. cº¹ç1, @Ö1, ìMV1, ·ÀpŸ1,2 (1š@ôAEªèòO, 2V¢IãÃEæ[ãÃ): æ78ñú{ßÜ¢œtãwïïEwpuï (2019/10/24), xR.
723736. [wï (S)] (êÊu) â®ítBbeBO\tgÅÌNAL-NL, DSL@ÌúÝèlÌë. ÃØÈá1, ²ì@£2, Iª²b1, äãG, ~ŽKb, Ž@RI2, éØbq2, Rº@ñ1 (1š@ôAEªèòO, 2ãÃq¶w): æ64ñú{®oãwïïEwpuï (2019/11/7), åã.
723737. [wï (S)] (êÊu) næO[v®QÁîÒÌ®o]¿Æâ®í®. éØbq1, äãG, ~ŽKb, `@áØ1, Ž
@œ, ²ì@£1, ìMm2, Rº@ñ2 (1ãÃq¶w, 2š@ôAEªèòO): æ64ñú{®oãwïïEwpuï (2019/11/7), åã.
723738. [wï (S)] (êÊu) æ[]È^d«àŸºÅoûIÉEoµœôªÔìï`. غé¢1, ŽìRy1, Rº@ñ1 (1š@ôAEªèòO): æ71ñú{CÇH¹ÈwïïÈçÑÉwpuï (2019/11/28), ÈØ.
723739. [wï (S)] (êÊu) ãÁ»ÇàŸÉæéºÑaÏÉη鞞̢. ×ì_j1, ce2, غé¢1, ç@ãÄœ3, Á[Fê1, ŽìRy1, Rº@ñ1 (1š@ôAEªèòO, 2Á»íà, 3åw@ãÃn€È): æ71ñú{CÇH¹ÈwïïÈçÑÉwpuï (2019/11/28), ÈØ.
723740. [wï (S)] (êÊu) Aª·¶¡ÃÌžsáÉwÔ: OØJAªªØãÌžsá|AªSEopÌžsáÆ»ÌÎ|. {{rã1, ŽìRy1, ŒØ@1, ª{·l, Á[Fê1, ç@ãÄœ2, éØ»q1, àRÛ1, Rº@ñ1 (1š@ôAEªèòO, 2åw@ãÃn€È): æ71ñú{CÇH¹ÈwïïÈçÑÉwpuï (2019/11/28), ÈØ.
723741. [wï (S)] (êÊu) AªSEopã̺áQÉεÄVºåbüpð{sµœ1á. ŽìRy1, {{rã1, ×ì_j1, غé¢1, ¡ìŒç1, Rº@ñ1 (1š@ôAEªèòO): æ71ñú{CÇH¹ÈwïïÈçÑÉwpuï (2019/11/29), ÈØ.
723742. [wï (S)] (êÊu) Œ€V-YOiSÙÉæèêúIĵœúºûOàÌ2á. {{rã1, ŒØ@1, Á[Fê1, ç@ãÄœ2, ÃØ»q1, àRÛ1, Rº@ñ1 (1š@ôAEªèòO, 2åw@ãÃn€È): æ30ñú{ªèòOÈwïïÈçÑÉwpuï (2020/1/30), «ê.
723743. [wï (S)] (êÊu) Sistrunk@ðsÁœbóãÇàÌ1á. àRÛ1, {{rã1, ŒØ@1, Á[Fê1, ç@ãÄœ2, éØ»q1, Rº@ñ1 (1š@ôAEªèòO, 2åw@ãÃn€È): æ30ñú{ªèòOÈwïïÈçÑÉwpuï (2020/1/31), «ê.
731097. [wï (nûïE€ï)] (ÁÊu) ¶wIÏ_©çÝœš@ôAÈfÃ|@AM[E°áQðSÉ|. åز¶1,2 (1š@ôAEªèòO, 2k¢åwfBJZ^[): œ¬31NxšïïELOuï (2019/4/7), Vh.
731098. [wï (nûïE€ï)] (ÁÊu) ªèòàfÃÌáNP». Rº@ñ (š@ôAEªèòO):¬csš@Èãïwpuï (2019/7/31), .
731099. [wï (nûïE€ï)] (ÁÊu) ªèòàÌæÉš¯éICI·úgpáÆirAEÌo±. {{rã1, ŒØ@1, Á[Fê1, ç@ãÄœ2, éØ»q1, àRÛ1, Rº@ñ1 (1š@ôAEªèòO, 2åw@ãÃn€È): Kitasato Immuno-Oncology Seminar (2019/7/12), ÍŽ.
731100. [wï (nûïE€ï)] (ÁÊu) ªèòàÉηéáNP¡ÃÉ¢Ä. Rº@ñ (š@ôAEªèòO): æ20ñ¿§š@ôAÈŸ³€ï (2020/2/6), ¿.
732095. [wï (nûïE€ï)] (~jN`[) AM[«@Ì¡Ã|k¢åwa@Ìê|. éاr (š@ôAEªèòO): æ18ñìÖš@ôAÈEªèòuKï (2019/5/17), .
732096. [wï (nûïE€ï)] (³çpl)ugßÜ¢hÌgZc (æµ¢àŸ)vk¢åwû®ßÜ¢nre[V. @Ö (š@ôAEªèòO): ú{š@ôAÈwï_Þì§nûïæ187ñš@ôAÈEªèòOÈwpuï (2019/6/29), ¡l.
732097. [wï (nûïE€ï)] (Z~i[) ªèòàÌæÉš¯éICI·úgpáÆirAEÌo±. {{rã1, ŒØ@1, Á[Fê1, ç@ãÄœ2, éØ»q1, àRÛ1, Rº@ñ1 (1š@ôAEªèòO, 2åw@ãÃn€È): Kitasato immuno-oncology Seminar (2019/7/12), Íåì.
732098. [wï (nûïE€ï)] (³çu) °³ÄzÉεúAèèp{sãôªoÉæè~}ófµœÇá. gœìlŸ (š@ôAEªèòO): æ8ñSleep surgery€ï (2019/9/13), åª.
732099. [wï (nûïE€ï)] (³çu) ï¡«ôAªŸ³ÌffÆÎô. {º\ê (š@ôAEªèòO): æ5ñéʧnæš@ôAÈ€ï (2019/10), k{.
732100. [wï (nûïE€ï)] (Z~i[) ï®ÌîbÆÕ°``¹ï®Éæé®oáQÆ»ÌaÔðŸ`. Iª²b (š@ôAEªèòO): _Þìš@ôAÈZ~i[ (2019/11/8), ¡l.
733249. [wï (nûïE€ï)] (êÊu) îìVlÛ{ÝüÒÌâ®í®@æññ|â®íKÌ®ÌÊ|. äãG (š@ôAEªèòO): œ¬31NxšïïELOuï (2019/4/7), Vh.
733250. [wï (nûïE€ï)] (êÊu) ôªÔîá120áÉš¯épOæffÆúhzø×EfÌ¢. ŒØ@ (š@ôAEªèòO): œ¬31NxšïïELOuï (2019/4/7), Vh.
733251. [wï (nûïE€ï)] (êÊu) ªèòàÆH¹à̯«d¡àÉηé¡ÃÉÖ·éãûI¢. ª{·l (š@ôAEªèòO): œ¬31NxšïïELOuï (2019/4/7), Vh.
733252. [wï (nûïE€ï)] (êÊu) ºÑbüãÉŽõðN±µCÇØJ{sµœÇá. ×ì_j1, غé¢1, Rº@ñ1 (1š@ôAEªèòO): æ40ñú{¹ºOÈ€ï (2019/4/13), .
733253. [wï (nûïE€ï)] (êÊu) ôªH¹\ÝàÉηéoûIèpÌÀS«ÆLø«Ì¢. Á[Fê1, ce2, ê˹Ÿ3, Î˪2, {{rã1, ŽìRy1, ç@ãÄœ4, éØ»q1, àRÛ1, ŽcYî1, cç³@2,5, Rº@ñ1 (1š@ôAEªèòO, 2Á»íà, 3a, 4åw@ãÃn€È, 5V¢IãÃEæ[ãÃ): æ20ñªèò\Ýà€ï (2019/5/25), iì.
733254. [wï (nûïE€ï)] (êÊu) AªaÏÌàEñàÌÓÊffÉš¯éNBIgåÏ@ÌLp«. ×ì_j1, ce2, Á[Fê1, Rº@ñ1 (1š@ôAEªèòO, 2Á»íà): æ20ñªèò\Ýà€ï (2019/5/25), .
733255. [wï (nûïE€ï)] (êÊu) °³ÄzÉεúAèèp{sãôªoÉæè~}ófµœ1Çá. gœìlŸ1,2, åز¶1,2, 原Y1,2, {º\ê1 (1š@ôAEªèòO, 2k¢åwfBJZ^[): æ132ñú{š@ôAÈwïéʧnûï (2019/6), Ya.
733256. [wï (nûïE€ï)] (êÊu) _Eº¢ež (VF) Ìgp@ÆÎ@. ŽìRy (š@ôAEªèòO): æ26ñúš@_Þ캀ï (2019/6/8), ¡l.
733257. [wï (nûïE€ï)] (êÊu) ÈÉš¯éºfÃ`Çá©çlŠé`. ŽìRy (š@ôAEªèòO): æ88ñš@È€ï (2019/6/22), úØ.
733258. [wï (nûïE€ï)] (êÊu) ÈÉš¯éâ®ífÃ|Àš}üŸÉæé]¿ðSÉ|. ÃØÈá1, ²ì@£2, Iª²b1, Rº@ñ1 (1š@ôAEªèòO, 2ãÃq¶w): æ88ñš@È€ï (2019/6/22), úØ.
733259. [wï (nûïE€ï)] (êÊu) Œ€ºÉ^GüÍ^áÉεĊ^áGEopðsÁœ1á. R{«á1, ŒØ@1, {æq1, ŽìRy1, Rº@ñ1 (1š@ôAEªèòO): ú{š@ôAÈwï_Þì§nûïæ187ñš@ôAÈEªèòOÈwpuï (2019/6/29), ¡l.
733260. [wï (nûïE€ï)] (êÊu) k¢åwû®ßÜ¢nre[V. @Ö (š@ôAEªèòO): ú{š@ôAÈwï_Þì§nûïæ187ñš@ôAÈEªèòOÈwpuï (2019/6/29), ¡l.
733261. [wï (nûïE€ï)] (êÊu) `¹ï®ªàšÉyÚ·e¿É¢Ä. Iª²b1, Îعçã2, Rº@ñ1 (1š@ôAEªèòO, 2¶ššn): æ37ñš@ôAÈj
[TCGX€ï (2019/8/24), åã.
733262. [wï (nûïE€ï)] (êÊu) ºÉ¢ÄÌšb. iä_€ (š@ôAEªèòO): åass¯uÀ (2019/9/21), åa.
733263. [wï (nûïE€ï)] (êÊu) ÈÉš¯éXMÔ²RŽãºÆuÃ@ÌøÊ. åز¶1,2, 原Y1,2, {º\ê1, gœìlŸ1,2 (1š@ôAEªèòO, 2k¢åwfBJZ^[): æ133ñú{š@ôAÈwïéʧnûï (2019/10/7), Ya.
733264. [wï (nûïE€ï)] (êÊu) ŽîÐïÉš¯éï®ÖÌÎ|vîìîÒÌâ®j[YÆâ®ípøỀ̬ÊðàÆÉ|. éØbq1, äãG, ~ŽKb, `@áØ1, Ž
@œ, ²ì@£1, ìMm2, ª{ql, Rº@ñ2 (1ãÃq¶w, 2š@ôAEªèòO): æ42ñ⮀ï (2019/11/7), åã.
733265. [wï (nûïE€ï)] (êÊu) Çá©ç©œºàŸžÌgp@ÆÎ@. iä_€ (š@ôAEªèòO): æ28ñúš@_Þ캀ï (2019/11/30), ¡l.
733266. [wï (nûïE€ï)] (êÊu) {Öß^áð_@É©³êœÇ«°Ÿ³Ìêá. óÃLIq1, ¡ìŒç1, ÃØÈá1, {{rã1, Rº@ñ1 (1š@ôAEªèòO): ú{š@ôAÈwï_Þì§nûïæ189ñš@ôAÈEªèòOÈwpuï (2019/12/7), ¡l.
733267. [wï (nûïE€ï)] (êÊu) ûOšæÑœèòîáð浜îD_
÷èî (غa) Ì1á. {æq1, ŽìRy1, iä_€1, Rº@ñ1 (1š@ôAEªèòO): æ189ñú{š@ôAÈwï_Þì§nûï (2019/12/7), ¡l.
733268. [wï (nûïE€ï)] (êÊu) ¬jG[aÖÌÜèU^á. @Ö (š@ôAEªèòO): æ37ñ³ªÝ¿û§bï (2019), ¬c.
'18NxÈOª
[wp_¶]
'18-110018. [Ž] Phase II Trial of Trastuzumab and Docetaxel in Patients With Human Epidermal Growth Factor Receptor 2-Positive Salivary Duct Carcinoma. Takahashi H, Tada Y, Saotome T, Akazawa K, Ojiri H, Fushimi C, Masubuchi T, Matsuki T1, Tani K, Osamura RY, Hirai H, Yamada S, Kawakita D, Miura K, Kamata S, Nagao T: J Clin Oncol 2019/1; 37 (2): 125-34. (ŒØ@1: 1š@ôAEªèòO)
'18-120004. [Ž] ¬@@oŸ³Éηé@oôòÃ@É¢Ä. åز¶1,2, éاr2, ì@èñ (1š@ôAEªèòO, 2k¢åwfBJZ^[): ú{š@ôAÈŽõÇEGA]wïï 2019/1; 7 (1): 17-20.
'18-320005. [Çáñ] ŸêªÙÈèR~
jP[Vª¢ïÅ Áœèò^áÌ1Çá. ºg¬1, åز¶1,2, 原Y1,2, {º\ê1, éاr1, Rº@ñ1 (1š@ôAEªèòO, 2k¢åwfBJZ^[): ú{š@ôAÈŽõÇEGA]wïï 2019/1; 7 (1); 42-6.
[wïE€ï]
H29-723005. [wï (S)] (êÊu) °³ÄzdzÒÌ@AM[ÌÖWÆÇXeCh_@òÌLp«. åز¶1, éاr1 (1š@ôAEªèòO): æ36ñú{š@ôAÈÆuAM[wï (2018/2/22-24), ºÖ.
H29-723006. [wï (S)] (êÊu) ôªàÉηéTLO, TOVSã̺@\. ŽìRy (š@ôAEªèòO): æ30ñú{AªÈwïïEwpuï (2018/3/1), m.
'18-723020. [wï (S)] (êÊu) XMԲdzÒÉš¯éâÃ@ƵÄÌ£H
ôòÌÓ`. åز¶1,2, éاr1 (1š@ôAEªèòO, 2k¢åwfBJZ^[): æ37ñú{š@ôAÈÆuAM[wï (2019/2/7-9), åã.
'18-723021. [wï (S)] (êÊu) ôªSºîáÉηéoûIØpãxºáQáÌPûoß|ðx}mg[ÉæéðÍ|. JMê, y¡ëV, غé¢1, ŒìŒ÷, rØKm, Ä{@E, J²_ (1š@ôAEªèòO): æ42ñú{ºãwïïÈçÑÉwpuï (2019/3/9), v¯Ä.
ž_Èw
[wp_¶]
110330. [Ž] Associations between readmission and patient-reported measures in acute psychiatric inpatients: a study protocol for a multicenter prospective longitudinal study (the ePOP-J study). Yamaguchi S, Ojio Y, Koike J, Matsunaga A, Ogawa M, Tachimori H, Kikuchi A, Kimura H, Inagaki A, Watanabe H, Kishi Y, Yoshida K, Hirooka T1, Oishi S1, Matsuda Y, Fujii C: Int J Ment Health Syst 2019/6; 13: 40. (AªFz1, åÎ@q1: 1ž_)
110331. [Ž] Improvement of psychiatrists' clinical knowledge of the treatment guidelines for schizophrenia and major depressive disorders using the 'Effectiveness of Guidelines for Dissemination and Education in Psychiatric Treatment (EGUIDE)' project: A nationwide dissemination, education, and evaluation study. Takaesu Y, Watanabe K, Numata S, Iwata M, Kudo N, Oishi S1, Takizawa T1, Nemoto K, Yasuda Y, Tagata H, Tsuboi T, Tsujino N, Hashimoto N, Matsui Y, Hori H, Yamamori H, Sugiyama N, Suwa T, Kishimoto T, Hishimoto A, Usami M, Furihata R, Iwamoto K, Fujishiro H, Nakamura T, Mizuno K, Inagaki T, Katsumoto E, Tomita H, Ohi K, Muraoka H, Atake K,Iida H, Nagasawa T, Fujita J, Yamamura S, Onitsuka T, Murata A, Takayanagi Y, Noda H, Matsumura Y, Takezawa K, Iga J, Ichihashi K, Ogasawara K, Yamada H, Inada K, Hashimoto R: Psychiatry Clin Neurosci 2019/10; 73 (10): 642-8. (åÎ@q1, êàVBî1: 1ž_)
110332. [Ž] A retrospective study on the diagnosis and treatment of dementia in patients referred to the Sagamihara Municipal Medical Center for Dementia for consultation. Kyou Y1,2, Oishi S2, Takizawa T2, Suzuki R2, Nakamura N3, Arai H2, Miyaoka 2: Psychogeriatrics 2020/5; 20 (3): 247-53. doi: 10.1111/psyg.12491. Epub 2019 Dec 4. (I@PM1,2, åÎ@q2, êàVBî2, éØŽŸY2, ºÞÞ3, Väv«2, {ª@2 (1åw@ãÃn€È, 2ž_, 3a@\[V[Nº)
120034. [Ž] ¬l©ÂXyNgÇffÆP-FX^fBÌWcêvxÌÖA. äãv1, ûcOY1, êàVBî1, {ª@1 (1ž_): k¢ãw 2019/12; 49 (2): 79-85.
120035. [Ž] ~œ~}Z^[Éš¯éhnEÄO©Eé}ü@³ÒÌÕ°IÁ¥. Väv«1, ЪSê2, äãv1, êàVBî1, åÎ@q1, Ô@2, ó@õ2, {ª@1 (1ž_, 2~œ): ž_ãw 2019/12; 61 (12): 1485-92.
120036. [Ž] s¯ðÎÛƵœFmÇ€CÉæéóuÒÌFmÇÖÌð̲žÉ¢Ä|OEãÌ¿â[²ž©ç|. I@PM1,2, åÎ@q2, äãüq1,2, ìüç1,2, ©q¶1,2, êàVBî2, {ª@2 (1åw@ãÃn€È, 2ž_): VNž_ãwG 2019/12; 30 (12): 1387-96.
320042. [Çáñ] \o«ŸêáQÌáQwi: bœÆ¹CF¯šæѶKŸÌÖA©ç. Ä@æq, ¡ŽÁÞ], äãv1, ac^q, åÎhq (1ž_): R~
jP[VáQw 2019/4; 36 (1): 1-9.
520017. [à] vC}PAÅÓµÄÙµ¢ž_ÇóÌfûÆÎ. {ª@ (ž_): m§ã 2020/1; 25 (1): 68-75.
520018. [à] Basic Outcome Master (BOM) version 3.0ÌüùûjÆÓ`. ¬cñY, ͺ@i, äàèã, É¡~ñ, åÎ@q1, ººT©q, ª{×x, ²¡kêY, c@³, ¹`@, ätcçH, Œ÷, g{çß, ácDj, ªõhq, ¬ÈKj, FpM, Œªqü, Xè^ü, xctü, Gv (1ž_): ú{NjJpXwï 2020/3; 22 (1): 3-13.
522112. [uÀ]yÁW: òÜtÈç©ŠµµÖ!@üž_òÌìpÆòÜ«ž_ÇózÁWÉ œÁÄ. {ª@ (ž_): Ôò 2019/5; 61 (6): 15-6.
522113. [uÀ]yÁW: òÜtÈç©ŠµµÖ!@üž_òÌìpÆòÜ«ž_Çózüž_òÃ@Ì»óÆâè_. {ª@ (ž_): Ôò 2019/5; 61 (6): 17-20.
522114. [uÀ]yÁW: òÜtÈç©ŠµµÖ!@üž_òÌìpÆòÜ«ž_Çózӷ׫üž_òÌx, Öõ|ûOÉmF·×«Ûè. AªFz (ž_): Ôò 2019/5; 61 (6): 21-30.
522115. [uÀ]yÁW: òÜtÈç©ŠµµÖ!@üž_òÌìpÆòÜ«ž_ÇózûÌâèðÇ€ãtÉ`Šé©: ž_Èã̧ê©ç. {ª@ (ž_): Ôò 2019/5; 61 (6): 84-6.
522116. [uÀ]yÁW: ë@ÇÆZ·E³ª p[g1z_
A@¶sÒÌo, ¢¶ß, qª©EµœÆ«ÌwZÌë@Î. äãv (ž_): wZ^c 2019/5; 694: 16-9.
522117. [uÀ]yÁÊéæ: s®ÌAfBNV|un}évðlŠéz¥un}évÆ¢€»Û@»à»àun}évÆÍœ©|us®vÅlŠé. ¶Ti (ž_): ±±ëÌÈw 2019/5; 205: 17.
522118. [uÀ]y<æ59ñú{SgãwïïÈçÑÉwpuï>@V|WE: ålÌBáQ: Õ°ÌmÆaÔÅOüzålÌBáQÆž_Ÿ³ÌÓÊƹ|»ÌÓ`|. {ª@1, ¬ìzq (1ž_): Sgãw 2019/7; 59 (5): 416-21.
522119. [uÀ]yÁW: ë@ÇÆZ·E³ª p[g2z_
A@¢¶ßÌî{Ið, \hÆú©EDVÆë̶E¶kÌíQðݯœÆ«. äãv (ž_): wZ^c 2019/8; 697: 16-9.
522120. [uÀ]yÁW: ž_È¡ÃűñȱÆðµÄ¢Ü¹ñ©?|ãõKâgä@xhðÄl|z`FbNXgŸ¯ÅffðmèµÄ¢Ü¹ñ©? VÛpŸ (ž_): ž_È¡Ãw 2019/8; 34 (8): 861-4.
522121. [uÀ]yÁW: _oBÇÌÅVgsbNX|fÃExEÐïz<_oBÇÌLª>@_oBÇQÆp[\ieBáQQ|Ç€lŠ, œðc_µ, œðs€×«©|. äãv (ž_): Õ°ž_ãw 2019/10; 48 (10): 1179-85.
522122. [uÀ]yPsychiatric LecturezffEž@©ÂXyNgÇffÉš¯éæüÏÌ. äãv (ž_): ž_ÈÕ° Legato 2019/11; 5 (3): 28-31.
522123. [uÀ]yÁWII: ¡³çlÉ·¯È¢Äñ©ñfÃÌNGX`zÄñ©ñìã]gª³í»·é±Æª éÌÍ? âV¡³Í (ž_): ž_È (SÃàÈ) 2019/12; 35 (6): 579-83.
522124. [uÀ]yÁW: ž_ÈÕ°Éš¯éGrfXÌLp«Æâè_zComorbidity ÌffÍÕ°ãÇÌæ€ÈÓ¡ª é̟뀩. {ª@ (ž_): ž_È¡Ãw 2020/2; 35 (2): 153-5.
540074. [»ÌŒ (ÒW)]yÁÊéæ: s®ÌAfBNV|un}évðlŠéz¶Ti1, {ª@1 (1ž_): ±±ëÌÈw 2019/5; 205: 17Å.
[wïE€ï]
722218. [wï (S)] (µÒu) ¬l©ÂXyNgÇÕ°Éš¯éSEÌð. äãv (ž_): æ115ñú{ž__owïwpï (2019/6/21), V.
722219. [wï (S)] (V|WE) üž_òÉæé}«òšÅ³ÒÌÎÉÖµÄ~œ~}Æž_ÈãÃ@ÖÅÌAgÌÛè. Väv« (ž_): æ41ñú{ÅwïïEwpWï (2019/7/20-21), ìz.
722220. [wï (S)] (ÁÊéæ ZbV) SgãwðêåÆ·éãtÉmÁÄà碜¢±Æ2@ž_ãw©ç. {ª@1, vZêY, äãKI (1ž_): æ2ñú{SgãwÖAwï¯Wï (2019/11/15), åã.
722221. [wï (S)] (µÒu)yÀ·za@Éš¯éãw¶, áèãtÉη鶞_Èհ̳çðlŠé. äãv (ž_): æ32ñú{a@ž_ãwïï (2019/11/15), q~.
723744. [wï (S)] (êÊu) næa@ÅÌSÃàÈ (ž_È) OÉš¯éVNúž_Ÿ³ÌÕ°IÁ¥. Väv«1, Á¡[q, åvÛz¢, àc@], {ª@1 (1ž_): æ34ñú{VNž_ãwï (2019/6/6-8), åä.
723745. [wï (S)] (êÊu) FmdzÒÌÆ°îìÒÉηéS³çvOÌLø«Ì¢. I@PM1, åÎ@q1, êàVBî1, {ª@1 (1ž_): æ115ñú{ž__owïwpï (2019/6/20), V.
723746. [wï (S)] (êÊu) næÉš¯éa@ÅÌSÃàÈ (ž_È) OÉš¯éÕ°IÁ¥. Väv«1, Á¡[q, åvÛz¢, àc@], {ª@1 (1ž_): æ115ñú{ž__owïwpï (2019/6/20), V.
723747. [wï (S)] (êÊu) dC¯¢êñÃ@Éš¯ég¢ÌÄdÉpbhÌçïRðº°éœßÉgp·éòÜÌîü€. ìüç1, àVRbg1, ÄR@ì2, åÎ@q1, âV¡³Í1, cr2, {ª@1 (1ž_, 2åw@ãÃn€È): æ115ñú{ž__owïwpï (2019/6/21), V.
723748. [wï (S)] (êÊu) åwa@Éš¯énÈáQ³ÒÉηéWcÃ@ÌÁ¥ (k¢åwa@Ìê). ©q¶1 íªrº, æÞ, ûcOY2, ¶Ti1, åÎ@q1, Œ{rF, {ª@1 (1ž_, 2Õ°Sº): æ115ñú{ž__owïwpï (2019/6/21), V.
723749. [wï (S)] (êÊu) eqR~
jP[VxÌœßÌSSTvOÌJyÑøÊ€. äwŒã, Ž@b1, Ž
L, ·
üRI (1ž_): æ19ñú{FmÃ@EFms®Ã@wï (2019/8/30), .
723750. [wï (S)] (êÊu) ž_ÈaÉü@ÆÈÁœ_o«³H~dzÒÌ¡Ã|SgŒÊÖÌÎ|. Väv«1, åÎ@q1, NäG÷1, êàVBî1, äãv1, VÛpŸ1, {ª@1 (1ž_): æ32ñú{a@ž_ãwïï (2019/11/15), q~.
723751. [wï (S)] (êÊu) ž_ÈaÉü@ÆÈÁœdÇ_o«³H~dzÒÌ¡Ã. Väv« (ž_): æ32ñú{a@ž_ãwïï (2019/11/15-16), q~.
723752. [wï (S)] (êÊu) åwa@ (a@) Éš¯éa@àÉš¯é©EÎôÉÖµÄ. Väv« (ž_): æ32ñú{a@ž_ãwïï (2019/11/15-16), q~.
723753. [wï (S)] (|X^[) yÀ·zž__oÈ, ^wX
F. VÛpŸ (ž_): æ2ñú{SgãwÖAwï¯Wï (2019/11/16), åã.
723754. [wï (S)] (êÊu) yÀ·zž_ªÍIAZXgÆûÏ@. äãv (ž_): æ37ñú{ÂNúž_Ã@wïï (2019/11/24), ŒÃ®.
723755. [wï (S)] (êÊu) ëÉæé§ÖÌ°|©çÌdžð«œµœ¬w¶Ì¡Ãoß. äãv1,2, _Jrî2, Nã2, gѶ2, {ª@1 (1ž_, 2n涞_): æ60ñú{¶ÂNž_ãwïï (2019/12/5), «ê.
723756. [wï (S)] (êÊu) Æ°ÆÍb³È¢Á¥IÈãgÙÇóð浜w¶Ìêá. äãv1,2, _Jrî2 Nã2, gѶ2, {ª@1 (1ž_, 2n涞_): æ60ñú{¶ÂNž_ãwïï (2019/12/5), «ê.
723757. [wï (S)] (êÊu) ©çuÌgZcvð쬵œ©ÂXyNgÇZ¶Çá©çÌÕ°³P. äãv1,2, _Jrî2, Nã2, gѶ2, {ª@1 (1ž_, 2n涞_): æ60ñú{¶ÂNž_ãwïï (2019/12/6), «ê.
723758. [wï (S)] (êÊu) ¶ž_ÈãÃƳçÉš¯éAgVXeƵÄÌu¶ž_ÈkÆvÌpÉÖ·éAP[g²ž. _Jrî1, Nã1, äãv1,2, gѶ1, Îc§G2, {ª@2 (1n涞_, 2ž_): æ60ñú{¶ÂNž_ãwïï (2019/12/7), «ê.
731101. [wï (nûïE€ï)] (ÁÊu) Õ°ãÌœßÌž_ÈãÃ`7ÂÌ|Cg`. VÛpŸ (ž_): æ20ñRTCR\}€ï (^®íSgãÀï: LPC) (2019/7/27), ŒÃ®.
731102. [wï (nûïE€ï)] (ÁÊu) ålÆqÇàÌ˶Ç. äãv (ž_): æ21ñú{¬ž_ãw€ï³çZ~i[ (2019/8/23), _Ë.
732101. [wï (nûïE€ï)] (vi[ZbV) x]WA[sRsÀòE°òÌÓÆg¢û. {ª@ (ž_): _ÞìãwïïEwpåï (2019/11/23), ¡l.
733269. [wï (nûïE€ï)] (êÊu) ü@É©Eé}ÉÁœAR[¶oǪ^íêœ1á. Îc§G1, Väv«1, ¢F1, éØŽŸY1, åÎ@q1, àVR@§1, âV¡³Í1, {ª@1 (1ž_): æ116ñž_ãwïwpWï (2019/7/13), .
733270. [wï (nûïE€ï)] (êÊu) \ÍÆ{ÝüÉòܪÖAµœÆlŠçêéîÒÌêá. åÎ@q1, Väv«1, éØŽŸY1, Îc§G1, o
æÞ1, ¬ìzq1, Ž{@÷1, I@PM1, AªFz1, ¯ìrí1, êÂÇŸ1, ²Xعv1, âV¡³Í1, {ª@1 (1ž_): æ49ñ_Þì§SgãwïïEwpWï (2019/9/14), ¡l.
733271. [wï (nûïE€ï)] (êÊu) yÀ·zêÊè. VÛpŸ (ž_): æ49ñ_Þì§SgãwïïEwpWï (2019/9/14), ¡l.
733272. [wï (nûïE€ï)] (êÊu) ¶®ÌœßÉü@ÉÁœï®ðº€îÒÌ1á. ¢F1, Îc§G1, Väv«1, éØŽŸY1, غFF1, ¬ì@1, gѶ2, åÎ@q1, âV¡³Í1, {ª@1 (1ž_, 2n涞_): ž_ãwïæ117ñwpWï (2019/11/30), .
733273. [wï (nûïE€ï)] (êÊu) «IE}§s×ðJèÔµœyxFmáQÌ1á. ¬ì@1, I@PM1, ¢F1, o
æÞ1, NäG÷1, åÎ@q1, âV¡³Í1, {ª@1 (1ž_): ž_ãwïæ117ñwpWï (2019/11/30), .
'18NxÈOª
[wp_¶]
H27-522001. [uÀ] yÁW: câ·éÇóÍDZÜÅñ·é©zž²ÇÌcâÇó. Väv« (ž_): ž_È¡Ãw 2015/6; 30 (6): 727-30.
'18-110019. [Ž] Effects of coaching skills training by occupational health staff on improving managers' communication behavior: a randomized controlled trial. Isojima M, Kimura R, Takahashi M1, Kiyotaki S, Fukuda M, Mizukoshi M, Araki H, Oshima Y, Iida D, Tanaka K2: Kitasato Med J 2018/9; 48 (2): 96-104. (Ž@b1, cr2: 1ž_, 2åw@ãÃn€È)
[wïE€ï]
'18-722003. [wï (S)] (µÒu) YÆ^wXÉp·é}ChtlXÆSST. Ž@b (ž_): æ114ñú{ž__owïwpï (2018/6/21), _Ë.
'18-722004. [wï (S)] (µÒu) SIO³ÒÖÌñÊÚ. Ž@b (ž_): æ114ñú{ž__owïwpï (2018/6/22), _Ë.
'18-722005. [wï (S)] (µÒu) SST (\[VEXLYEg[jO) Ìîbm¯. Ž@b (ž_): æ114ñú{ž__owïwpï (2018/6/23), _Ë.
'18-722006. [wï (S)] (µÒu) ãtEYÆÛX^btÌœßÌSST`SSTüå`. Ž@b1, ì@_ (1ž_): æ24ñSSTSo±ð¬[NVbv in (2018/7/29), .
'18-723022. [wï (S)] (êÊu) ü@µœîÒ{ÝüÒ̹ñÏÍFmÇdÇxªÞÆÖW·é. c@, Ž@b1, ÑJüô2, ¶Eca}, acÞüq (1ž_, 2]_oà): æ60ñú{VNãwïwpWï (2018/6/15), s.
úËüÈw (æffw)
[wp_¶]
110333. [Ž] Effects of the scan range on radiation dose in the computed tomography component of oncology positron emission tomography/computed tomography. Inoue Y1, Nagahara K2, Kudo H2, Itoh H2: Radiat Prot Dosimetry 2019/11; 185 (1): 1-6. (äãDî1, iŽa2, H¡°q2, É¡°×2: 1úËü (æ), 2úËü)
110334. [Ž] Effects of scout radiographic imaging conditions on tube current modulation in chest computed tomography. Inoue Y1, Itoh H2: J Radiol Prot 2020/3; 40 (1): 253-69. (äãDî1, É¡°×2: 1úËü (æ), 2úËü)
110335. [Ž] Basolateral amygdala connectivity with subgenual anterior cingulate cortex represents enhanced fear-related memory encoding in anxious humans. Hakamata Y, Mizukami S, Izawa S, Moriguchi Y, Hori H, Kim Y, Hanakawa T, Inoue Y1, Tagaya H2: Biol Psychiatry Cogn Neurosci Neuroimaging 2020/3; 5 (3): 301-10. (äãDî1, cJ_M2: 1úËü (æ), 2ãÃq¶w)
110336. [Ž] Continuous regional arterial infusion versus intravenous administration of the protease inhibitor nafamostat mesilate for predicted severe acute pancreatitis: a multicenter, randomized, open-label, phase 2 trial. Hirota M, Shimosegawa T, Kitamura K, Takeda K, Takeyama Y, Mayumi T, Ito T, Takenaka M, Iwasaki E, Sawano H, Ishida E, Miura S, Masamune A, Nakai Y, Mitoro A, Maguchi H, Kimura K, Sanuki T, Ito T, Haradome H1, Kozaka K, Gabata T, Kataoka K, Hirota M, Isaji S, Nakamura R, Yamagiwa K, Kayaba C, Ikeda K: J Gastroenterol 2020/3; 55 (3): 342-52. (Ž¯O÷1: 1V¢IãÃEæ[ãÃ)
310039. [Çáñ] Lung perfusion scintigraphy in eisenmenger syndrome due to patent ductus arteriosus. Mitsui K1, Woodhams R1, Ukisu R1, Inoue Y1: Clin Nucl Med 2019/11; 44 (11): 879-80. (OäNœ1, EbhnXæq1, FŽŸY1, äãDî1: 1úËü (æ))
320043. [Çáñ] èòhnÉæéªWOèòúÊ«èò®¬¹ÉεCovered stentðp¢œÇà¡ÃÉæè~œµœ1á. ¡ìTá1, ¡@ŸG1, qc@²2, EbhnXæq3 (1ªËs§s¯a@~œ~}Z^[, 2Âtä]_oOÈEàÈ, 3úËü (æ)): ú{OwïG 2019/5; 33 (2): 45-9.
320044. [Çáñ] PwyX]Éš¯é123I-IMP]¬SPECTŽú. ëmü1, äãDî1, Ž@q«1, OäNœ1 (1úËü (æ): Õ°jãw 2019/7; 52 (4): 50-3.
522125. [uÀ]yÁW: Ì_äXÌæÌæff|Ç««Ÿ³ÌÓÊðSÉ|zÌ×EBîÌMRIff|æ©, ÓÊff, ÅVgsbNX. Ž¯O÷1,2 (1V¢IãÃEæ[ãÃ, 2úËü (æ)): Õ°úËü 2019/4; 64 (5): 649-62.
522126. [uÀ]yÁW1F~}IVRÌÅOüzo«Ÿ³ÉηéC~ylEVX^` (IPM/CS) ÌÇðš¿ÆµÄÌLp«. EbhnXæq (úËü (æ): Rad Fan 2019/4; 17 (5): 49-53.
522127. [uÀ]y¡ÌÕ°: YÈë@IoÌxXg}lWg@mÁĚ׫ÅVÌÎôz¡oÖÌ\h@\hIIVRÌKÆíÞ, ¹Ç. EbhnXæq (úËü (æ)): Õ°wlÈYÈ 2019/9; 73 (9): 831-9.
[@]
620081. [wp (ªS·M)]yªèòÌCTEMRI@æ3ÅzI. ªWê, p.1-30. VII. èòØEèògDÔ, p.361-424. FŽŸY1 (1úËü (æ), Ò: öKç2, ðä@C3 (2bïãÈåwúËüãwuÀ, 3{XgåwãwúËüÈ), fBJETCGXEC^[iVi, , 2019/4s.
620082. [wp (ªS·M)]y~}Ÿ³ÌÓÊffÌ|Cg (æff§ Vol.39 No.11)zæ8Í ÌoàÌt̯@ZxÌ oàt̯ÌÓÊ, p.A160-7. EbhnXæq (úËü (æ)), Ò: DImO. w€fBJGÐ, , 2019/9s.
620083. [wp (ªS·M)]ylÌÌJjY©çwÔ æffZpwz4Í (Á»íCåAíE¶Bí) ÌæffZp@5. ÌE_¹Ÿ³ÌaÔÆæ, p.326-59. 6. äXŸ³ÌaÔÆæ, p.360-71. Ž¯O÷1,2 (1V¢IãÃEæ[ãÃ, 2úËü (æ)), Ò: X@@€, ¬qŸv, WJr
[Ð, , 2020/3s.
[wïE€ï]
712032. [wï (Û)] (µÒu) Çðp. Woodhams R1: CEPIR 2019: Continuous Education Program in Interventional Radiology 2019 (IVR¶U³çZ~i[2019) (2019/10/26), Kanagawa, Japan. (EbhnXæq1: 1úËü (æ))
713132. [wï (Û)] (|X^[) Activati on in the amygdala in a simple and short picture viewing task. Kotani Y1, Ohgami Y1, Yoshida N2, Kunimatsu A2, Kiryu S3, Inoue Y4: 2019 Annual Meeting of the Organization of Human Brain Mapping (2019/6/9-13), Rome, Italy, Abstract Book 2019/6; p.25. (¬J×¥1, åãiü1, gcXŽ2, Œ@2, ˶@Î3, äãDî4: 1HÆåwxA[c€³ç@, 2åwãÈw€, 3ÛãÃåwãw, 4úËü (æ))
713133. [wï (Û)] (|X^[) Connectivity dynamics between the right anterior insula and the anterior cingulate cortex. Ohgami Y1, Kotani Y1, Yoshida N2, Kunimatsu A2, Kiryu S3, Inoue Y4: 2019 Annual Meeting of the Organization of Human Brain Mapping (2019/6/9-13), Rome, Italy, Abstract Book 2019/6; p.42. (åãiü1, ¬J×¥1, gcXŽ2, Œ@2, ˶@Î3, äãDî4: 1HÆåwxA[c€³ç@, 2åwãÈw€, 3ÛãÃåwãw, 4úËü (æ))
713134. [wï (Û)] (|X^[) Connectivity dynamics between the right anterior insula and the anterior cingulate cortex during anticipation of interoceptive response. Ohgami Y1, Kotani Y1, Yoshida N2, Kunimatsu A2, Kiryu S3, Inoue Y4: The 59th Annual Meeting of Society for Psychophysiological Research (2019/9/25-29), Washington DC, USA, Psychophysiology 2019/9; 56 (Suppl 1): p.S40. (åãiü1, ¬J×¥1, gcXŽ2, Œ@2, ˶@Î3, äãDî4: 1HÆåwxA[c€³ç@, 2åwãÈw€, 3ÛãÃåwãw, 4úËü (æ))
713135. [wï (Û)] (|X^[) Activation in the amygdala in a simple and short picture viewing task for clinical application. Kotani Y1, Ohgami Y1, Yoshida N2, Kunimatsu A2, Kiryu S3, Inoue Y4: The 59th Annual Meeting of Society for Psychophysiological Research (2019/9/25-29), Washington DC, USA, Psychophysiology 2019/9; 56 (Suppl 1): p.S49. (¬J×¥1, åãiü1, gcXŽ2, Œ@2, ˶@Î3, äãDî4: 1HÆåwxA[c€³ç@, 2åwãÈw€, 3ÛãÃåwãw, 4úËü (æ))
722222. [wï (S)] (€ÃZ~i[) ãÃúËüíÎÆüÊÇ: ÅßÌ®ü. äãDî (úËü (æ)): æ78ñú{ãwúËüwïï (2019/4/14), ¡l.
722223. [wï (S)] (³çu) ªWêÌ CTEMRI ³íðU: Õ°IÉdvÈ|CgðSÉ (The Normal Anatomy of the Skull Base on CT and MR Imaging: Focusing on Clinical Significance in Patients). FŽŸY (úËü (æ): æ78ñú{ãwúËüwï (2019/4/14), ¡l, ú{ãwúËüwïwpWïŽ^W 2019/2; Page S139.
722224. [wï (S)] (V|WE) «ãtÌï: IVRãÌœßÌÀHIíhì. EbhnXæq (úËü (æ)): æ47ñú{ÇOÈwïwpï (2019/5/24), ŒÃ®, ú{ÇOÈwïG 2019; 28 (Suppl): P. SY13-Keynote Lecture.
722225. [wï (S)] (µÒu) wlÈŸ³ÌffÆIVR, NEXT, ~}. EbhnXæq (úËü (æ)): JCR~bhT}[Z~i[2019 (2019/7/20), _Ë.
722226. [wï (S)] (€ÃZ~i[) ãÃúËüÌÀSÇ: úËüÈãÌœßÌ~j}EGbZX. äãDî (úËü (æ)): æ55ñú{ãwúËüwïHGÕ°åï (2019/10/20),ŒÃ®.
722227. [wï (S)] (µÒu) ØEÔðU©çÇÝðªèòæff. FŽŸY (úËü (æ)): æ33ñJCR~bhEB^[Z~i[ (2020/1/18) ª.
722228. [wï (S)] (V|WE) ªWêaÏ@ªWêaÏÌæff. FŽŸY (úËü (æ)): æ39ñú{æãwïwpWï (2020/2/14), , ú{æãwïGæ39ñú{æãwïŽ^W 2020/1; 38 (1): p.37.
723759. [wï (S)] (|X^[) EOç¿ÆOÑóç¿Éš¯é«ÌÔÏ». åãiü1, ¬J×¥1, gcXŽ2, Œ@2, ˶@Î3, äãDî4 (1HÆåwxA[c€³ç@, 2åwãÈw€, 3ÛãÃåwãw, 4úËü (æ)): æ37ñú{¶Swïåï (2019/5/25-26), éÊ, æ36ñú{¶SwïåïvOE\eW 2019; p.54.
723760. [wï (S)] (|X^[) PÈohæŠÛèÉš¯éGÌÌ. ¬J×¥1, åãiü1, gcXŽ2, Œ@2, ˶@Î3, äãDî4 (1HÆåwxA[c€³ç@, 2åwãÈw€, 3ÛãÃåwãw, 4úËü (æ)): æ37ñú{¶Swïåï(2019/5/25-26), éÊ, æ36ñú{¶SwïåïvOE\eW 2019; p.74.
723761. [wï (S)] (êÊû) YÈoÉη鮬ÇðpãÌDP\ãÉÖ·é¢ (Pregnancy outcome following arterial embolization for obstetric bleeding). EbhnXæq1, ¡ä@]1, Ž@q«1, RªñY1, OäNœ1, âèä»l1, ëmü1, ëìmã1, ÀBÝžÙ1, Œihñ1, gºÃL2, äãDî1 (1úËü (æ), 2YÈ): æ48ñú{IVRwïï (2019/5/31), ª, ú{C^[xViWIW[wïG 2019/5; 34 (Suppl): p.214.
723762. [wï (S)] (êÊû) äX_oàªåîáÆÓʪâèÆÈÁœsolid subtypeÌäX÷t«ùNEîáÌ1á. âZ@@1, Ž¯O÷2, CÃMj3, áÁR@4, äãDî1 (1úËü (æ), 2V¢IãÃEæ[ãÃ, 3êÊE¬EÌ_äXO, 4a): æ33ñú{ úËüwï (2019/6/28), ºÖ.
723763. [wï (S)] (êÊu) jɶµœNvgRbJXÇÌæ©. ëìmã1, FŽŸY1, äãDî1, ŒØ@2, Rº@ñ2, cçüT3, ŽV4 (1úËü (æ), 2š@ôAEªèòO, 3a, 4ãÃq¶w): æ55ñú{ãwúËüwïHGÕ°åï (2019/10/18), ŒÃ®.
723764. [wï (S)] (|X^[) EOB-MRIÌ×EÌLp«ªŠŽ³êœÌgL\JÇÌ1á. âZ@@1, Ž¯O÷1,2, äãDî1 (1úËü (æ), 2V¢IãÃEæ[ãÃ): æ55ñú{ãwúËüwïHGÕ°åï (2019/10/18-20), ŒÃ®, ú{ãwúËüwïHGÕ°åïŽ^W55ñ 2019/9; p.S475.
723765. [wï (S)] (|X^[) 99mTc-HSADpV`OtBÅRoÊð¯èÅ«œV¶pãûâô¹Ì1á. âZ@@1, EbhnXæq1, äãDî1 (1úËü (æ)): æ59ñú{jãwïwpïEæ39ñú{jãwZpwïïwpåï (2019/11/1), €Q, jãw 2019/10; 56 (Suppl): p.S169.
723766. [wï (S)] (|X^[) g[Tu_óü¹ðp¢œPEMuêpQA/QCt@gÌ¢. ª{ü÷1, ŽŸY1, {äC÷2, äãDî3, Dc\ê4, @F5, _Ñ5, gäüä5, ìqV5, ì{ëü5, ·JìqV6 (1åw@ãÃn€È, 2úËü, 3úËü (æ), 4kC¹Èwåw, 5ä€ ¢NjbN, 6ãÃq¶w): æ59ñú{jãwïwpïEæ39ñú{jãwZpwïïwpåï (2019/11/2), €Q, jãwZp 2019/10; 39 (\eW): p.389.
723767. [wï (S)] (êÊû) ANzûÌGe-68/Ga-68^Cvg[Tu_óü¹ðp¢éèÊ«EZ³è]¿@ÌJóµñ. ·JìqV1, ª{ü÷2, ŽŸY2, {äC÷3, er@h3, äãDî4, Dc\ê5, äÈ@d6, acNO7 (1ãÃq¶w, 2åw@ãÃn€È, 3úËü, 4úËü (æ), 5kC¹Èwåw, 6sN·õãÃZ^[€, 7»w€¶œ@\Èw€Z^[): æ59ñú{jãwïwpïEæ39ñú{jãwZpwïïwpåï (2019/11/3), €Q, jãw 2019/10; 56 (Suppl): p.S165.
731103. [wï (nûïE€ï)] (ÁÊu) ãÃúËüÌÀSÇÉ¢Ä. äãDî (úËü (æ)): æ11ñLæff€ï (2020/1/11), L.
732102. [wï (nûïE€ï)] (µÒu) äXîáÌMRIff|BÆffÌ|Cg|. Ž¯O÷1,2 (1V¢IãÃEæ[ãÃ, 2úËü (æ)): æ42ñ_ÞìMRIZp€ï (2019/7/19), ¡l.
732103. [wï (nûïE€ï)] (µÒu) ãÃíÎüÊÇÌ韯: ãÃ@{sK¥ü³ðó¯Ä. äãDî (úËü (æ)): æ15ñImaging Now in Kanagawawpuï (2019/8/3), ¡l.
732104. [wï (nûïE€ï)] (µÒu) ÀHIû[¢eMRIÌÇe. EbhnXæq (úËü (æ)): æ34ñaÌRMRIZ~i[ (2019/9/13), aÌR.
732105. [wï (nûïE€ï)] (µÒu) ãûêÉš¯é@ßü³Éº€ïÌIÈãÃúËüÀSÇ̧ÌÎÆãÃúËüÀSÇÒÌð|k¢åwÌê|. äãDî (úËü (æ)): ßa³Nx@ãÃúËüÀSÇuKï (2019/10/13), , ãÃúËühì 2020/3; 82: 31-2.
732106. [wï (nûïE€ï)] (µÒu) YwlÈ~}Ÿ³Ìæff. EbhnXæq (úËü (æ)): æ7ñ~}æN`[ (2019/11/16), ße.
732107. [wï (nûïE€ï)] (µÒu) ×aÇÇðÉš¯éGalaxy G3 miniÌLp«. EbhnXæq (úËü (æ)): CERENOVUS Knowledge Up Seminar (2019/11/6), .
732108. [wï (nûïE€ï)] (µÒu) VãÌjãw. äãDî (úËü (æ)): _Þìjãw€ïn§50üNLOåï (æ423ñèáï) (2019/11/9), ¡l.
732109. [wï (nûïE€ï)] (µÒu) jãw. äãDî (úËü (æ)): æ60ñRadiology Updatewpuï (2019/11/16), .
732110. [wï (nûïE€ï)] (µÒu) wjÌàŸÆÀ^páÐî. äãDî (úËü (æ)): ú{úËüÈêåãïEãï (JCR) ãÃúËüÀSÇuKï (2020/1/19), ª.
732111. [wï (nûïE€ï)] (µÒu) ãÃúËüÌÀSp: üÊÇÌÀH. äãDî (úËü (æ)): ì§úËüÈãï (2020/1/25), Œ.
732112. [wï (nûïE€ï)] (µÒu) ¡@CTÌüÊÇÉ¢Ä. äãDî (úËü (æ)): 2019Nxæ2ñÖjãw€ïwpuï (2020/2/2), ¡l.
732113. [wï (nûïE€ï)] (V|WE) Ì×EBîÌVªÞÆMRIff. Ž¯O÷1,2 (1V¢IãÃEæ[ãÃ, 2úËü (æ)): æ26ñ̬®ÔE@\C[W€ï (2020/2/9), àò.
732114. [wï (nûïE€ï)] (³çu) ãûêÉš¯é@ßü³Éº€ïÌIÈãÃúËüÀSÇ̧ÌÎÆãÃúËüÀSÇÒÌð|k¢åwÌê|. äãDî (úËü (æ)): ãÃúËühìAŠcï@æ41ñuãÃúËüÌÀSpvtH[ (2020/2/23), .
732115. [wï (nûïE€ï)] (î²u) ãÃúËüÉš¯éúËüÀSÌÅK». äãDî (úËü (æ)): ãÃúËühìAŠcï@æ41ñuãÃúËüÌÀSpvtH[ (2020/2/23), .
733724. [wï (nûïE€ï)] (êÊu) ×SØV`OtBÌÇeè. äãDî (úËü (æ): æ9ñk¢@\æZ~i[ (2019/4/16), ÍŽ.
733725. [wï (nûïE€ï)] (êÊu) _oæÌÇeeNjbN. Ž@q« (úËü (æ)): æ7ñÍŽãpæZ~i[ (2019/6/4), ÍŽ.
733726. [wï (nûïE€ï)] (êÊû) nð_@É©³êESDð{sµœÝœØ÷îÌêá. ºØqY1, {{NY1, XvÛñ1, ŽŽTM1, ŒÑ^1, qcVq1, ²ãWŸY1, ¬Ñ@ñ1,2, ì@ë1, îàŽv1,3, å@œ1, íŒ@ß1, úäI¶1,2 (1k¢€a@, 2åw@ãÃn€È, 3úËü (æ)): æ108ñú{Á»íàŸwïÖxáï (2019/6/8), , Progress of Digestive Endoscopy 2019/6; 95 (Suppl): p.s104.
733727. [wï (nûïE€ï)] (êÊû) îá«aÏÆÌÓÊÉ궵œÙ«ÌóÌ1á. âZ@@1, Ž¯O÷1,2, äãDî1 (1úËü (æ), 2V¢IãÃEæ[ãÃ): æ455ñú{ãwúËüwïÖnûïèúåï (2019/6/15), ìè.
733728. [wï (nûïE€ï)] (êÊû) AªŽÌ_oàªåàÌæ©. ëìmã1, FŽŸY1, äãDî1, ŽìRy2, Rº@ñ2, ê˹Ÿ3, gc@÷3 (1úËü (æ), 2š@ôAEªèòO, 3a): æ48ñªèòE¹æ€ï (2019/6/22),
733729. [wï (nûïE€ï)] (êÊû) PwyX]Éš¯é123I-IMP]¬SPECTŽú. ëmü1, OäNœ1, Ž@q«1, äãDî1 (1úËü (æ)): æ91ñú{jãwïÖbMznûï (2019/6/29), , jãw 2019/9; 56 (1): p. 125.
733730. [wï (nûïE€ï)] (êÊû) jɶµœNvgRbJXÇÌæ©. ëìmã1, FŽŸY1, äãDî1, ŒØ@2, Rº@ñ2, cçüT3, ŽV4 (1úËü (æ), 2š@ôAEªèòO, 3a, 4ãÃq¶w): æ32ñªèòúËü€ï (2019/10/19), ŒÃ®, ú{ãwúËüwïHGÕ°åïŽ^W55ñ 2019/9; p. S559.
733731. [wï (nûïE€ï)] (êÊu) Ûºàîáð浜îÌ1á. ÀBÝžÙ1, FŽŸY1, äãDî1, {{rã2, Rº@ñ2, gc@÷3, HJ¹j3 (1úËü (æ), 2š@ôAEªèòO, 3a): 2019Nx_Þì§úËüãïïEæ60ñáï (2019/10/26), ¡l, _ÞìãwïG 2020/1; 47 (1): 106.
733732. [wï (nûïE€ï)] (êÊû) ÌÁaÉÞµœæ©ðæµC}È]AðœÇÁœÌÇ÷îÌêá. OäNœ1, EbhnXæq1, Ž@q«1, Œihñ1, äãDî1 (1úËü (æ)): æ456ñú{ãwúËüwïÖnûïèúåï (2019/12/14), , æ456ñú{ãwúËüwïÖnûïèúåïvOEŽ^W 2019/12; p. 37.
'18NxÈOª
[wïE€ï]
'18-713007. [wï (Û)] (êÊu) CT and MR imaging findings of Cholangiolocellula Carcinoma of the Liver: correlation with histopathologic features and differential diagnosis. Haradome H1,2, Woo J2, Inoue Y2: The European Society of Gastrointestinal and Abdominal Radiology 2018 (2018/6/12), Dublin, Ireland. (Ž¯O÷1,2, âZ@@2, äãDî2: 1V¢IãÃEæ[ãÃ, 2úËü (æ))
'18-722007. [wï (S)] (µÒu) MR imaging diagnosis of hepatocellular adenoma: imaging features, differential diagnosis, and recent topics. Ž¯O÷1,2 (1V¢IãÃEæ[ãÃ, 2úËü (æ)): æ77ñú{ãwúËüwïï (2018/4/13), ¡l.
úËüÈw (úËüîáw)
[wp_¶]
110337. [Ž] A phase I dose-escalation trial of stereotactic body radiotherapy using 4 fractions for patients with localized prostate cancer. Kainuma T1, Kawakami S1, Tsumura H2, Satoh T2, Tabata K2, Iwamura M2, Hayakawa K1, Ishiyama H1: Radiat Oncol 2019/9; 14 (1): 158. (ÀìN1, ìã³å1, úGN2, ²¡Ð¶2, cšê2, ⺳k2, ìad1, ÎR1: 1úËü (îá), 2åAí)
110338. [Ž] Patient-reported health-related quality of life up to three years after the treatment with permanent brachytherapy: Outcome of the large-scale, prospective longitudinal study in Japanese-Prostate Cancer Outcome Study by Permanent I-125 Seed Implantation (J-POPS) Koga H1, Naito S1, Ishiyama H1,2, Yorozu A1, Saito S1, Kojima S1, Higashide S1, Kikuchi T1, Nakamura K1, Dokiya T1, Fukushima M1 (1J-POPS Study Group): Brachytherapy 2019/11-12; 18 (6): 806-13. (ÎR1,2: 2úËü (îá)
110339. [Ž] Dosimetric factors associated with long-term patient-reported outcomes after definitive radiotherapy of patients with head and neck cancer. Hayakawa T1, Kawakami S1, Soda I1, Kainuma T1, Nozawa M1, Sekiguchi A1, Miyamoto S2, Yamashita T2, Ishiyama H1: Radiat Oncol 2019/12; 14 (1): 221. (ìLa1, ìã³å1, c@i1, ÀìN1, ìàVää»Ô1, Öû©ß1, {{rã2, Rº@ñ2, ÎR1: 1úËü (îá), 2š@ôAEªèòO)
110340. [Ž] Imaging Cherenkov emission for quality assurance of high-dose-rate brachytherapy Yogo K, Matsushita A, Tatsuno Y, Shimo T, Hirota S, Nozawa M1, Ozawa S, Ishiyama H1, Yasuda H, Nagata Y, Hayakawa K1: Sci Rep 2020/2; 10 (1): 3572. (ìàVää»Ô1, ÎR1, ìad1: 1úËü (îá))
110341. [Ž] Potential Mechanisms for Protective Effect of D-Methionine on Plasmid DNA Damage Induced by Therapeutic Carbon Ions Katsunori Yogo K, Murayama C, Fujisawa Y, Maeyama T, Hirayama R, Ogawa Y, Matsumoto K, Nakanishi I, Yasuda H, Ishiyama H1, Hayakawa K1: Radiat Res 2020/3. doi: 10.1667/RR15502.1. Online ahead of print. (ÎR1, ìad1: 1úËü (îá))
210005. [Ž]yUrological NotezRelationship between the dose to the bulbomembranous urethra and stricture after high dose-rate brachytherapy for prostate cancer: Matched-pair analysis. Sekiguchi A1, Tsumura H2, Kawakami S1, Satoh T2, Iwamura M2, Ishiyama H1: Int J Urol 2019/9; 26 (9): 938-9. (Öû©ß1, úGN2, ìã³å1, ²¡Ð¶2, ⺳k2, ÎR1 (1úËü (îá), 2åAí)
522125. [uÀ]yÁW: XNO§BàÌ¡Ãíªz5. üÊŠ¬ü¹¡Ã. ÎR (úËü (îá)): Prostate Journal 2019/10; 6 (2): 183-7.
[wïE€ï]
713136. [wï (Û)] (|X^[) Treatment Outcomes and Risk Factors of Limited-Stage Small Cell Lung Cancer Patients Treated with Chemoradiotherapy. Hayakawa T1, Soda I1, Sekiguchi A1, Kawakami S1, Kubota M2, Mitsufuji H3, Igawa S4, Fukui T4, Naoki K4, Hayakawa K5, Ishiyama H1: IASLC 2019 World conference on lung cancer (2019/9/8), Barcelona, Spain. (ìLa1, c@i1, Öû©ß1, ìã³å1, vÛc2, O¡@v3, äì@4, äüç4, PØF4, ìad5, ÎR1: 1úËü (îá), 2ãÃq¶w, 3Åìw, 4Äzíà, 5ÐQãÃZ^[úËü¡ÃÈ)
713137. [wï (Û)] (êÊû) Usefulness of 3D-scanner in baseline and response evaluation of radiotherapy for scalp angiosarcoma. I Soda1, Masuzawa M2, Mamorita N, Sekiguchi A1, Kawakami S1, Hayakawa T1, Kainuma T1, IshiyamaH1 ESTRO meets ASIA 2019 (2019/12/6), Singapore. (c@i1, àV^Àq2, Öû©ß1, ìã³å1, ìLa1, ÀìN1, ÎR1: 1úËü (îá), 2ç)
722229. [wï (S)] (³çu) ³çu1: O§B. ÎR (úËü (îá)): ú{úËüîáwïæ32ñwpåï (2019/11/21), ŒÃ®.
723768. [wï (S)] (êÊû)yÀ·z¡Ã2: åAí. ÎR (úËü (îá)): æ78ñú{ãwúËüwïï (2019/4/13), ¡l, æ78ñú{ãwúËüwïïŽ^W 2019/4; p.69.
723769. [wï (S)] (êÊû) O§Bàiv}ü§¬ü¹¡ÃãCTæ©çoµœRadiomicsŸ÷ÊÌ\ã\ªöqƵÄÌÂ\«. ìã³å1, Ðqv2, Ž{¬¢2, ·JìqV2, úGN3, cšê3, ÎR1 (1úËü (îá), 2ãÃq¶w, 3åAí): ¬ü¹¡Ãïæ21ñwpåï (2019/5/18), ¿, ¬ü¹¡Ãïæ21ñwpåïŽ^ 2019/5; p.46.
723770. [wï (S)] (êÊu) O§BàV[h¡ÃãCTæ©çoµœWI~NXÁ¥ÊÌ\ã\ªöqƵÄÌÂ\«. Ðqv1, ìã³å2, Öû¹l1, cIê1, Œ{Yo1, Ž{¬¢3, ·JìqV3, ÎR2 (1åw@ãÃn€È, 2úËü (îá), 3ãÃq¶w): æ47ñú{úËüZpwïHGwpåï (2019/10/17), åã, Japanese Journal of Radiological Technology 2019/9; 75 (9): 987-8.
723771. [wï (S)] (êÊû) ÀÇ«O§BàÉηé4ªðp¢œèÊúËü¡ÃÌæI±. ÀìN1, ìã³å1, úGN2, ²¡Ð¶, cšê2, ⺳k2, ìad3, ÎR1 (1úËü (îá), 2åAí, 3ÐQãÃZ^[úËü¡ÃÈ): ú{úËüîáwïæ32ñwpåï (2019/11/21), ŒÃ®, ú{úËüîáwïæ32ñwpåïñ¶W 2019; p.233.
723772. [wï (S)] (|X^[) ªçÇ÷îúËü¡ÃÉš¯é3³XLi[Éæéîá]¿ÌLp«. c@i1, àV^Àq2, çc3, ìã³å1, Öû©ß1, ìLa1, ÀìN1, ÎR1 (1úËü (îá), 2ç, 3ãÃq¶w): ú{úËüîáwïæ32ñwpåï (2019/11/21), ŒÃ®, ú{úËüîáwïæ32ñwpåïñ¶W 2019; p.349.
723773. [wï (S)] (|X^[)yÀ·z¬ü¹¡Ã1. ÎR (úËü (îá)): ú{úËüîáwïæ32ñwpåï (2019/11/22), ŒÃ®.
723774. [wï (S)] (|X^[) O§Bàseed¡ÃãCT©çoµœRadiomicsÁ¥ÊÌ\ã\ªöqÌÂ\«. ìã³å1, Ðqv2, Ž{¬¢3, ·JìqV3, úGN4, cšê4, Öû©ß1, ìLa1, c@i1, ⺳k4, ÎR1 (1úËü (îá), 2åw@ãÃn€È, 3ãÃq¶w, 4åAí): ú{úËüîáwïæ32ñwpåï (2019/11/22), ŒÃ®, ú{úËüîáwïæ32ñwpåïñ¶W 2019; p.375.
723775. [wï (S)] (|X^[) ÀÇ^¬×ExàÌfÃKChCÉîáìÑÆ\ãöq. ìLa1, c@i1, Öû©ß1, ìã³å1, PØF2, ìad3, ÎR1 (1úËü (îá), 2Äzíà, 3ÐQãÃZ^[úËü¡ÃÈ): ú{úËüîáwïæ32ñwpåï (2019/11/22), ŒÃ®, ú{úËüîáwïæ32ñwpåïñ¶W 2019; p.388.
732116. [wï (nûïE€ï) (µÒu) O§BàÉηéWwI¡ÃÆWE223. ÎR (úËü (îá)): æ915ñúËüfÀï (2019/5/27), .
732117. [wï (nûïE€ï) (µÒu) ªèòàgZs[ãÌQOLÏ». ìLa (úËü (îá)): æ8ñTomoTherapyZ~i[2019 (2019/6/15), .
732118. [wï (nûïE€ï) (µÒu) úËü¡ÃÌiWÆx}lWg. c@i (úËü (îá)): Lung Cancer Academy (2019/6/25), _Þì.
732119. [wï (nûïE€ï) (Re[^) ÇáfBXJbV. c@i (úËü (îá)): Lung Cancer Academy (2019/6/25), _Þì.
732120. [wï (nûïE€ï) (µÒu)yCufXg[VzMeet The Experts3.4. ÎR (úËü (îá)): æ21ñEf125V[hü¹iv}üÉæéO§B৬ü¹Ã@ZpuKï (2019/6/29), .
732121. [wï (nûïE€ï) (µÒu)yutzMeet The Experts3. ÎR (úËü (îá)): æ21ñEf125V[hü¹iv}üÉæéO§B৬ü¹Ã@ZpuKï (2019/6/29), .
732122. [wï (nûïE€ï) (ut) úËü¡Ãw. ÎR (úËü (îá)): 2019ãwšm~j}uKï (ãw¶šn) (2019/7/13), .
732123. [wï (nûïE€ï) (µÒu) CRTKiÇá̳µ¢ðÆúËüxÌ}lWg. c@i (úËü (îá)): PACIFIC Regimen Academy in Yokohama (2019/8/27), _Þì.
732124. [wï (nûïE€ï) (µÒu) O§BàÌWwI¡Ã. ÎR (úËü (îá)): æ16ñúËü¡Ã€ï (2019/10/5), ŒÃ®.
732125. [wï (nûïE€ï) (î²u) CRTKiÇá̳µ¢ðÆúËüxÌ}lWg. c@i (úËü (îá)): ¡{êLung Cancer Symposium 2019 (2019/10/30), _Þì.
732126. [wï (nûïE€ï) (plXg) Clinical Question. ìLa (úËü (îá)): Stage III Lung Cancer Symposium (2020/1/23), _Þì.
Èw
[wp_¶]
110342. [Ž] Preoperative sepsis is a predictive factor for 30-day mortality after major lower limb amputation among patients with arteriosclerosis obliterans and diabetes. Otsuka T1, Arai M1,2, Sugimura K1, Sakai M1, Nishizawa Y1, Suzuki Y1, Okamoto H1, Kuroiwa M1: J Orthop Sci 2020/5; 25 (3): 441-5. doi: 10.1016/j.jos.2019.05.017. Epub 2019 Jun 18. (åËqv1, Vä³N1,2, ºº1, ãääLq1, ŒàV`V1, éØDŸY1, ª{_k1, âV1: 1, 2V¢IãÃE¡fIãÃ)
110343. [Ž] The Initial Subjective Sensory Change in the Dermatome During Intrathecal Injection of Plain Bupivacaine Predicts the Spread of Sensory Blockade: A Prospective Multi-Level Modeling Study. Kanai A1,2, Niki Y, Hayashi N2, Maeda S, Horie K, Okamoto H2: Anesth Pain Med 2019/9; 9 (5): e91216. (à亶1,2, Ñ ol2, ª{_k2: 1V¢IãÃE¡fIãÃ, 2)
110064. [Ž] Amelioration of experimental autoimmune myocarditis through activation of invariant natural killer T cells by administration of ¿-galactosylceramide. Yoshino K1, Satoh M2, Iwayama T1, Kobayashi S1, Okamoto H3, Eshima K2, Watarai H, Iwabuchi K2: Kitasato Med J 2020/3; 50 (1): 60-72. (gìav1, ²¡@ë2, âRrk1, ¬ÑGô1, ª{_k3, ]kñ2, âºaç2: 1åw@ãÃn€È, 2Æu, 3)
120037. [Ž] nuÉÉηéuvmtBÌLp«. Ñ@ol1, à亶1,2, ¯RLG1, ͺŒ÷1, ŽCêN1, ª{_k1 (1, 2V¢IãÃE¡fIãÃ): k¢ãw 2019/6; 49 (1): 9-13.
120038. [Ž] YÈaÉš¯éRapid Response SystemN®îÉÖ·éãûI¢. ×ìKó1, Á¡¢G, âV1, ¬rüF2, XÀbÀ3, xrV1, Vä³N1,4 (1, 2nr, 3Åì, 4V¢IãÃE¡fIãÃ): ú{W¡ÃãwïG 2020/1; 27 (1): 11-8.
120039. [Ž] Ñóáv]ÖAÉðL·éîÒÌFm@\. ¯RLG1, à亶1,2, Ñ@ol1, ͺŒ÷1, ŽCêN1, ª{_k1 (1, 2V¢IãÃE¡fIãÃ): ú{yCNjbNwï 2020/2; 27 (1): 21-6.
310040. [Çáñ] Awake fiberoptic intubation with an epidural catheter in a morbidly obese patient. Suzuki Y1, Takenami T1, Fujino S1, Nakazawa A1, Okamoto H1: J Anesth 2020/6; 34 (3): 468-71. doi: 10.1007/s00540-020-02760-4. Epub 2020 Mar 21 (éØDŸY1, |Q¯]1, ¡ìÑM1, àVºT1, ª{_k1: 1)
320045. [Çáñ] áNPSèp (MICS) Éš¯éÐx·CÌSpO2áºxÌŸ³Ê¢. {ch1, À¡õb1, Ëcëç1, ì[ää»q1, àVºT1, ª{_k1 (1): 2020/3; 69 (3): 308-11.
522126. [uÀ]yÁW1. bóBOÈ¡ÃÉηéãÃÀSzRapid Response SystemÍbóBOÈpãèòîÉæéSâ~ñðÉLø©? Vä³N1,2 (1V¢IãÃE¡fIãÃ, 2): ú{àªåEbóBOÈwï 2019; 36 (2): 68-73.
522127. [uÀ]yãŽÇïzSÉÖ·ébè. ºº1, À¡õb1, ŒcOü1, Ëcëç1, âV1, ª{_k1 (1): Õ° 2020/2; 44 (2): 179-84.
522128. [uÀ]yÁW: ãÃ`[Éš¯éÈãÌðzŸÆÜÆß. ª{_k (): 2020/3; 69 (3): 238-9.
522129. [uÀ] @àv¬ÎVXe (rapid response system: RRS) ÆÈã. ŒàV`V1, åËqv1, âV1 (1): 2020/3; 69 (3): 265-70.
540075. [»ÌŒ]yªªŸz©ªªìé«. à亶1,2 (1V¢IãÃE¡fIãÃ, 2):Õ° 2019/7; 43 (7): 923.
540076. [»ÌŒ (V·L)] IsIChÁÉò|ÉÝÌíÞÉæÁÄͳøáà|. à亶1,2 (1V¢IãÃE¡fIãÃ, 2): Medical Tribune 2019; 52 (7): 7.
540077. [»ÌŒ]yMember's SiestaszÈð÷é. à亶1,2 (1V¢IãÃE¡fIãÃ, 2): ú{yCNjbNwïNews Letter 2020/1; æ6.
540078. [»ÌŒ (ªªŸ)] íªÌghÍDZ©çœÌ©, ÇñÈàÌ©, DZÖü©ÁÄsÌ©. xrV (): 2020/3; 69 (3): 237.
[@]
620084. [wp (P)]yÉÝÌ\¢ÅlŠéÁÉòÌIðzà亶1,2, Ñ@ol2, ª{_k2 (1V¢IãÃE¡fIãÃ, 2), ^»ðÕãoÅ, , 2019/7s.
620085. [wp (ªS·M)] yICU¡Ãwj I (~}EW¡Ã 31 (2)zII. ÄzퟳÆÇ@ÄzÇ@oçICÇØJ@, OÈICÇØJ@, ¹oúhE¹ohi[W@, p.476-87. Vä³N1,2 (1V¢IãÃE¡fIãÃ, 2), ÄC: ª³a¶, ãwÐ, , 2019/7s.
[wïE€ï]
712033. [wï (Û)] (µÒu) Introduction and Effectiveness of a Rapid Response System for Patient Safety. Kuroiwa M1: 7Th meeting of East Asia anesthesia (2019/5/30), Kobe, Japan. (âV1: 1)
712034. [wï (Û)] (V|WE) Congenital heart surgery. Okamoto H1: ICCVA-ASCA 2019 (2019/6/6), Korea. (ª{_k1: 1)
713138. [wï (Û)] (êÊu) Retrospective study of perioperative complicaions in noncardiac surgeries for children with congenital heart deseases. Amano A1, Matusa H, Toda M1 Okamoto H1: European Society of Anaesthesiology 2019 (2019/6/2), Vienna, Austria. (VìŸÃ¹1, Ëcëç1, ª{_k1: 1)
713139. [wï (Û)] (êÊu) A case of re-operation at early postoperative period due to severe LV-LA shunt in infant with complete AVSD. Ozaki A1, Okamoto H1: ICCVA-ASCA 2019 (2019/6/8), Korea. (öè@·1, ª{_k1: 1)
713140. [wï (Û)] (êÊu) Does intraocular pressure during prone spinal surgery differ according to the type of head-fixing device used (a horseshoe headrest versus a pinned head-holder) ? Yamashita A1, Takenami T1, Yamamoto S1, Ikeda T, Suzuki T, Okamoto H1: The American Society of Anesthesiologists (ASA 2019) (2019/10/20), Orlando, Florida. (Rº@Ö1, |Q¯]1, R{^ç1, ª{_k1: 1)
722230. [wï (S)] (V|WE) ÉaãÃÉš¯éÉݪàœç·e¿. à亶1,2 (1V¢IãÃE¡fIãÃ, 2): æ30ñú{ãwïï (2019/4/27), ŒÃ®.
722231. [wï (S)] (µÒu) ÈêåãÉKvÈoH¹SGR[@ (TEE) Ìîbm¯. ª{_k (): ú{Èwïæ66ñwpWï (2019/5/30), _Ë.
722232. [wï (S)] (V|WE) ÉÝÌ\¢ÆÏ». à亶1,2 (1V¢IãÃE¡fIãÃ, 2): æ13ñú{ÉaãÃòwïNï (2019/6/1), çt.
722233. [wï (S)] (µÒu) æV«SŸ³³ÒÉηéñSèpÌÌôÇÌ¢. ª{_k (): ú{Õ°wïæ39ñåï (2019/11/7), yäò.
722234. [wï (S)] (µÒu) oJe[ešæÑMICSÉæéASDÂœpÆTEE. ª{_k (): ú{Õ°wïæ39ñåï (2019/11/8), yäò.
722235. [wï (S)] (µÒu) ÎèpÌpãÁÉ: emùNºubNðSÉ. ŒcOü1, ª{_k1 (1): ú{¬wïæ25ñåï (2019/11/16), Äq.
722236. [wï (S)] (µÒu) 3DTEE îb. ª{_k1, Ÿc²k (1): ú{SÇwïæ24ñwpåï (2019/9/21), s.
722237. [wï (S)] (µÒu) Je[eèpÆTEE TAVI (TAVR) Mitral Clipping ASD occluder. ª{_k (): ú{SÇwïæ24ñwpåï (2019/9/22), s.
723776. [wï (S)] (êÊu) ÒàºãÌÄz}§ÉXeChªøµœdÇسÍdzÒÌ1Çá. |~å1, |Q¯]1, Rº@Ö1, ì[ää»q1, x]ÊD1, ª{_k1 (1): ú{ææwïæ6ñwpWï (2019/4/18), m.
723777. [wï (S)] (êÊu) dOÜœÍÒàº_ql^ÍDPÉš¯éôIdúhãªÉÌ\hÉLøÅ é. ¡ìÑM1, úürã1, ¡cßb1, ×ìKó, xrV1 (1): ú{ææwïæ6ñwpWï (2019/4/18-20), m.
723778. [wï (S)] (êÊu) ¬ÌOòƵÄÌoû~_]ÌZxÆÁÃxÌär. |~å1, ŒcOü1, Rº@Ö1, R{^ç1, ª{_k1 (1): ú{Èwïæ66ñwpWï (2019/5/30), _Ë.
723779. [wï (S)] (êÊu) é€ØJpÌî³ÉÍüºÌ³ÍK³È¢. ºŒŸú1, ×ìKó1, ¡ìÑM1, úürã1, xrV1, ª{_k1 (1): ú{Èwïæ66ñwpWï (2019/5/30), _Ë.
723780. [wï (S)] (êÊu) ªáÊÅs€{bgx oºO§BE (RALP) pÌá³ãž. ¬ìçq1, |Q¯]1, r@«q1, ãääLq1, ª{_k1 (1): ú{Èwïæ66ñwpWï (2019/5/30), _Ë.
723781. [wï (S)] (êÊu) x®¬ÙaÏðº€æV«SŸ³ÌÄèpÌXNöqÆ\ãÌ¢. R@õ1, x]ÊD1, öè@·1, ¬ìçq1, Ëcëç1, ª{_k1 (1): ú{Èwïæ66ñwpWï (2019/5/31), _Ë.
723782. [wï (S)] (êÊu) TpúÌIsICh^Éš¯éŽoèl̲ž. éعRü1, Ñ@ol1, r@«q1, à亶1,2, ª{_k1 (1, 2V¢IãÃE¡fIãÃ): ú{Èwïæ66ñwpWï (2019/5/31), _Ë.
723783. [wï (S)] (êÊu) Ó¯º}ÇÉš¯éÁÃxyÑ}ÇL¯ÉÖ·éãëü«¢. xÑFÄ1, É¡@q2, ºŒIØ1, r@«q1, éØDŸY1, ª{_k1 (1, 2åw@ãÃn€È): ú{Èwïæ66ñwpWï (2019/5/31), _Ë.
723024. [wï (S)] (êÊu) Ì¡upÇV¶ð§ä·éóeÌ«²ß`1 (RAMP1) Ìð. 1, É¡`ç2, ×ìÁÞq2, äãqm3, ŒcOü4, åUdçG4, {Ci1, åj¹1, ª{_k4, n³²2 (1åw@ãÃn€È, 2ò, 3Á»íà, 4): æ40ñú{ǥĶãwï (2019/7/16), _Ë.
723784. [wï (S)] (êÊu) xªñÉηéj{}u^³ÒÉš¯éÑóáv]̶ (DGè). r@«q1, à亶1,2, Ñ@ol1, ͺŒ÷1, ª{_k1 (1, 2V¢IãÃE¡fIãÃ): ú{yCNjbNwïæ53ñåï (2019/7/19), F{.
723785. [wï (S)] (êÊu) µ¢J«pãÉÉηéÒhÃ@ÅÉÝÆADLÌøÊɵ𶶜2Çá. Ñ@ol1, à亶1,2, ͺŒ÷1, r@«q1, ª{_k1 (1, 2V¢IãÃE¡fIãÃ): ú{yCNjbNwïæ53ñåï (2019/7/19), F{.
723786. [wï (S)] (êÊu) ¯ó_oßubNÆXeChpXÃ@ÅüPµœ_oÉ«ØÞkÇÌ1á. ͺŒ÷1, à亶1,2, Ñ@ol1, r@«q1, ª{_k1 (1, 2V¢IãÃE¡fIãÃ): ú{yCNjbNwïæ53ñåï (2019/7/19), F{.
723787. [wï (S)] (êÊu) x®¬Je[eÉæéx®¬¹ðµV-VA ECMOðgpµ~œµœ1á. ºº1, ì[ää»q1, À¡õb1, éØk1, Ëcëç1, ª{_k1 (1): ú{SÇwïæ24ñwpåï (2019/9/20), s.
723788. [wï (S)] (êÊu) pOÌ6ªÔàs£ (6MD) ÍoJe[eI宬Ùu·p (TAVI) Éš¯épã¹ñ϶ð\ª·é. Rº@Ö1, À¡õb1, ŒcOü1, ºº1, ª{_k1 (1): ú{SÇwïæ24ñwpåï (2019/9/22), s.
723789. [wï (S)] (êÊu) z³â·CðµÈªçCÇxŸºo@}ÇðsÁœûÌbóãÇùNEÌêá. éعRü1, ŒcOü1, àVºT1, É¡@q2, ¡ìÑM1, ÂŽcq1, ¬ÑçÄ1, ª{_k1 (1, 2åw@ãÃn€È): ú{¬wïæ25ñåï (2019/11/16), Äq.
723105. [wï (S)] (êÊu) Potential role of invariant NKT cells in experimental autoimmune myocarditis in mice. gìav1, ²¡@ë2, Watarai H, âºaç2 (1åw@ãÃn€È, 2Æu): æ48ñú{ÆuwïwpWï (2019/12/12), lŒ.
723029. [wï (S)] (êÊu) Æu×EÌTPVOiÍ Ì¡upÇV¶ð£i·é (TP signaling in immune cells promotes lymphangiogenesis in the diaphragm during peritonitis). 1, É¡`ç2, ŒcOü3, ×ìÁÞq2, ª{_k3, n³²2 (1åw@ãÃn€È, 2ò, 3): æ93ñú{òwïNï (2020/3/16-18), ãJÃ.
731104. [wï (nûïE€ï)] (ÁÊu) «áuÉÖÌœpIAv[`. à亶1,2 (1V¢IãÃE¡fIãÃ, 2): œË«áuÉuï (2019/7/24), œË.
731105. [wï (nûïE€ï)] (ÁÊu) ÉÝÌ\¢ÅlŠéÁÉòÌIð. à亶1,2 (1V¢IãÃE¡fIãÃ, 2): æ7ñ¡lìèÒÅEÖßaZ~i[ (2019/8/27), ¡l.
731106. [wï (nûïE€ï)] (ÁÊu) ªñ³ÒÉηéIsIChÁÉòðÄl·é. à亶1,2 (1V¢IãÃE¡fIãÃ, 2): æ6ñLœªñÉa€ï (2019/10/16), Dy.
731107. [wï (nûïE€ï)] (ÁÊu) ÉÝÌ\¢ÅlŠéÁÉòÌIð. à亶1,2 (1V¢IãÃE¡fIãÃ, 2): 2020Nx€CãZ~i[ (2020/1/18), ÍŽ.
731108. [wï (nûïE€ï)] (ÁÊu) ãÌÉÝÌÎ. à亶1,2 (1V¢IãÃE¡fIãÃ, 2): æ9ñ¡lãèpZ~i[ (2020/1/31), ¡l.
732127. [wï (nûïE€ï)] (V|WE) bóBèpÉš¯éãÃÀS, `[ãÃ: Rapid Response SystemÍbóBpãèòîÉæéSâ~ñðÉLp©? Vä³N1,2 (1V¢IãÃE¡fIãÃ, 2): æ1ñºaåwbóBtH[wpWï (2019/5/18), .
732128. [wï (nûïE€ï)] (µÒu) qhtHð©·. à亶1,2 (1V¢IãÃE¡fIãÃ, 2): æ2ñÍŽÉaãÀï (2019/5/23), Íåì.
732129. [wï (nûïE€ï)] (µÒu) åÈÁÉòÌâè_Æ, »êðâ€uvmtB. à亶1,2 (1V¢IãÃE¡fIãÃ, 2): National Symposium on Pain focus. How to optimize opioid treatment for LBP/OA (2019/5/25), .
732130. [wï (nûïE€ï)] (µÒu) ªñ³ÒÌáuÉÇ. à亶1,2 (1V¢IãÃE¡fIãÃ, 2): ªñáuÉðlŠéï (2019/6/10), ÍŽ.
732131. [wï (nûïE€ï)] (µÒu) Rapid Response System RRSÆÍœ©? ȺKv©? Vä³N1,2 (1V¢IãÃE¡fIãÃ, 2): ¹æåwãw®a@ ãÃÀSuKï (2019/6/21), Äq.
732132. [wï (nûïE€ï)] (µÒu) Rapid Response System RRSÆÍœ©? ȺKv©? Vä³N1,2 (1V¢IãÃE¡fIãÃ, 2): Våwãwa@ ãÃÀSuKï (2019/6/27), V.
732133. [wï (nûïE€ï)] (µÒu) Rapid Response System RRSÆÍœ©? ȺKv©? Vä³N1,2 (1V¢IãÃE¡fIãÃ, 2): âèãÈåw®a@ ãÃÀSuKï (2019/7/5), ·ª.
732134. [wï (nûïE€ï)] (µÒu) Rapid Response System RRSÆÍœ©? ȺKv©? Vä³N1,2 (1V¢IãÃE¡fIãÃ, 2): éÊãÈåwÛãÃZ^[ ãÃÀSuKï (2019/7/29), ú.
732135. [wï (nûïE€ï)] (µÒu) Äl: uvmtB\tÜÌLp«. à亶1,2 (1V¢IãÃE¡fIãÃ, 2): M3 Webu (2019/8/8), ú{Ž.
732136. [wï (nûïE€ï)] (µÒu) ápÊtF^j\tÜÌp. à亶1,2 (1V¢IãÃE¡fIãÃ, 2): võ»ò®ïÐWebuï (2019/9/26), WEBã.
732137. [wï (nûïE€ï)] (µÒu) Õ°ã̧ê©çIsIChÁÉòðÄl·é. à亶1,2 (1V¢IãÃE¡fIãÃ, 2): Cancer Pain Forum in Kanagawa (2019/10/18), ¡l.
732138. [wï (nûïE€ï)] (µÒu) IsIChÁÉòÌÁ«ðmé. à亶1,2 (1V¢IãÃE¡fIãÃ, 2): æ3ñãÃÀSZ~i[ (2019/10/25), ÍŽ.
732139. [wï (nûïE€ï)] (Webu) qhtHð©·. à亶1,2 (1V¢IãÃE¡fIãÃ, 2): ªñáuÉÉaPAWEBZ~i[ (2019/10/31), ŒÃ®.
732140. [wï (nûïE€ï)] (µÒu) ªñ³ÒÉηéÒàºÁÉ@. à亶1,2 (1V¢IãÃE¡fIãÃ, 2): ÒàºÁÉuï (2019/11/7), úØ.
732141. [wï (nûïE€ï)] (µÒu) ªñ³ÒÉηéÒàºÁÉ@. à亶1,2 (1V¢IãÃE¡fIãÃ, 2): ÒàºÁÉuï (2020/1/9), ª€q.
732142. [wï (nûïE€ï)] (µÒu) IsIChÁÉòÌÁ«ðmé. à亶1,2 (1V¢IãÃE¡fIãÃ, 2): æ1ñnæòÜtAŠcï×ï (2020/1/16), ÍŽ.
732143. [wï (nûïE€ï)] (µÒu) Õ°ã̧ê©çIsIChÁÉòðÄl·é. à亶1,2 (1V¢IãÃE¡fIãÃ, 2): Cancer Pain Forum in Chiba (2020/2/5), çt.
732144. [wï (nûïE€ï)] (µÒu) ªñ³ÒÉηéÒàºÁÉ@. à亶1,2 (1V¢IãÃE¡fIãÃ, 2): ÒàºÁÉuï (2020/2/6), ¡l.
733733. [wï (nûïE€ï)] (êÊu) \ùÌ ébóBîÉæéCÇìáÉεÄSgð{sµœ1á. öè@·1, ÀB@1, âV1, ª{_k1 (1): ÖbM¥xæ56ñ¯wpWï (2019/9/3), .
733734. [wï (nûïE€ï)] (êÊu) ±ü}XN·Cs\É×ÁœTreacher Collins syndromeÌûÉεi-gelgpÉæè·CÆCÇ}Çɬ÷µœÇáÌo±. ·céq1, ŒcOü1, x]ÊD1, ª{_k1 (1): ÖbM¥xæ56ñ¯wpWï (2019/9/3), .
733735. [wï (nûïE€ï)] (êÊu) ÒàºÇºÅåÚ^[jPbgðãÉx¬ð«œµœ1á. ºŒIØ1, ÖcºF1, ¡RF, ²¡F1, ª{_k1, ¬âN°1 (1): ÖbM¥xæ56ñ¯wpWï (2019/9/3), .
733736. [wï (nûïE€ï)] (êÊu) ±üãÌdÇAitBLV[VbNÉε, èp~ÆÈÁœªŒÈÌAgÉæèÄèp𮵊œêá. RHTO1, Rº@Ö1, ãääLq1, ª{_k1 (1): ÖbM¥xæ56ñ¯wpWï (2019/9/3), .
'18NxÈOª
[wp_¶]
H27-110001. [Ž] Neuroprotective effect of nitite-derived NO in brain injury mediated through the NOS-independent but not the GC/COX/xanthine oxidase/PGIS-dependent pathways. Ando H1, Nara Y, Kosaka Y1, Arai M1,2, Okamoto H1: Kitasato Med J 2016/3; 46 (1): 67-72. (À¡õb1, ¬âN°1, Vä³N1,2, ª{_k1: 1, 2V¢IãÃE¡fIãÃ)
H29-522001. [uÀ]yÁW: PICS W¡ÃãÇóQzPart 3 PICS 3vf@[R] PICS-F (family) ÆÍœ©? Vä³N1,2 (1V¢IãÃE¡fIãÃ, 2): INTENSIVIST 2018/1; 10 (1): 98-106.
'18-520001. [à] @à}Ïð¢RÉh®|RRSÌlŠû, ±üEp±ÌACfBA|. Vä³N1,2 (1V¢IãÃE¡fIãÃ, 2): ³ÒÀSiW[i 2018/6; 52: 10-7.
'18-520002. [à] xÆ]ÌíNXg[N. Vä³N1,2 (1V¢IãÃE¡fIãÃ, 2): Õ° 2019/1; 43 (1): 9-15.
[@]
'18-620010. [wp (ªS·M)]yNà±±ÜųŠÄêÈ©Áœ@ÈéÙÇlHÄzÇ (ÄzíPA2018N~G§)z[1Í Äz¶]@(1) C¹ÌðU¶, p.8-18. Vä³N1,2 (1V¢IãÃE¡fIãÃ, 2), ÄC: ÀîêW, fBJoÅ, åã, 2018/12s.
[wïE€ï]
H29-732001. [wï (nûïE€ï)] (µÒu) Rapid Response SystemÆÍœ©? RRSÆÍœ©? ȺKv©? Vä³N1,2 (1V¢IãÃE¡fIãÃ, 2): ãÃÀS³çZ~i[ (ÀHÒ) 2017@æèxÈãÃÀSÖü¯Ä (2017/10/21), .
H29-732002. [wï (nûïE€ï)] (µÒu) Rapid response systemÆÍ? @àSâ~ðh®œßÉÇ€·é©? Vä³N1,2 (1V¢IãÃE¡fIãÃ, 2): OOåwãwt®a@ãÃÀSu (2017/10/13), OO.
H29-732003. [wï (nûïE€ï)] (µÒu) Rapid response systemÆÍ? Vä³N1,2 (1V¢IãÃE¡fIãÃ, 2): ¡ls§åwãw®a@ãÃÀSuKï (2017/9/21), ¡l.
'18-722008. [wï (S)] (V|WE) bóBOÈ¡ÃÉš¯éãÃÀS: bóBpãÌèòîÌú©ÆîüÉRapid Response SystemÍLø©? Rapid Response SystemÌÂ\«Æâè_. Vä³N1,2 (1V¢IãÃE¡fIãÃ, 2): æ51ñú{bóBOÈwïwpWï (2018/10/25), ¡l.
'18-722009. [wï (S)] (plfBXJbV) @à}ÏÎVXe`¢©É±üµÄ¬Êð °é©` Rapid Response System̱ü, è
ÉÖíéíª, @Ì»µ, ±ü, è
ÉÖíéíª. Vä³N1,2, XÀbÀ, ¬rüF, åJ®ç3, âV1, cümb4, y®uÛ4, räLü4, ¹äWO5 (1V¢IãÃE¡fIãÃ, 2, 3Åì, 4ãÃÌ¿EÀSiº, 5ãÃZp³ç): æ13ñú{ãÃÌ¿EÀSwïwpWï (2018/11/24), ŒÃ®.
'18-722010. [wï (S)] (V|WE) RRSÉúÒ³êéãÃÀSÆÌAg\¢ãÉü¯œVµ¢¬ê[@ÅÌuEÁÃÉš¯éRRSN®ÇáÌ¢. ŒàV`V1, âV1, ¬rüF, XÀbÀ, åJ®ç2, ºŒŸú1, éØDŸY1, ãääLq1, åËqv1, Vä³N1,3 (1, 2Åì, 3V¢IãÃE¡fIãÃ): æ46ñú{W¡ÃãwïwpWï (2019/3/2), s.
'18-732002. [wï (nûïE€ï)] (µÒu) uãÃÉð§Â`[Ì èûv ãţê©ç Rapid Response TeamÆÍœ©? Vä³N1,2 (1V¢IãÃE¡fIãÃ, 2): 2018Nx æ1ñ³ÒÀSinætH[ in k¢ (2018/5/19), ÍŽ.
'18-732003. [wï (nûïE€ï)] (µÒu) [NVbN2: @à}ÏÎ@}Ï·éOɩ¯ÄõŠéÆ¢€lŠû`Rapid Response System`. Vä³N1,2 (1V¢IãÃE¡fIãÃ, 2): æ32ñk~}ãwï (2018/6/16), R`.
'18-732004. [wï (nûïE€ï)] (µÒu) Rapid Response SystemÆÍ? RRSÆÍœ©? ȺKv©? Vä³N1,2 (1V¢IãÃE¡fIãÃ, 2): ÇÑåwãwt®a@@ãÃÀSuï (2018/10/29), .
'18-732005. [wï (nûïE€ï)] (µÒu) Rapid Response SystemÆÍ? RRSÆÍœ©? ȺKv©? Vä³N1,2 (1V¢IãÃE¡fIãÃ, 2): R`§§a@@à€Cï (2018/12/2), R`.
'18-732006. [wï (nûïE€ï)] (µÒu) Rapid Response SystemÆÍ? RRSÆÍœ©? ȺKv©? Vä³N1,2 (1V¢IãÃE¡fIãÃ, 2): ®
åwãw®a@€Cï (2019/1/25), ße.
'18-732007. [wï (nûïE€ï)] (µÒu) Rapid Response SystemÆÍ? RRSÆÍœ©? ȺKv©? Vä³N1,2 (1V¢IãÃE¡fIãÃ, 2): ú{ãÃ}lWgwïæ9ñ«ê§xwpWï (2019/1/26), ße.
'18-732008. [wï (nûïE€ï)] (µÒu) Rapid Response SystemÆÍ? RRSÆÍœ©? ȺKv©? Vä³N1,2 (1V¢IãÃE¡fIãÃ, 2): ¶ÑËa@@àuï (2019/2/1), ÑË.
Õ°žffw
[@]
620086. [wp (ªS·M)]yàÈw 5 üèæ9Åz÷`ÌíÞÆ@\, p.489-11. åJp÷, ëìLì1 (1Õw), ÒW: ìw³b, Ò: ººÉêY, RX, , 2019/8s.
'18NxÈOª
[@]
'18-620011. [wp (ªS·M)]yÅV žEæffT 2018-19NÅ@žÌèZEKŸ³EÛ¯¿ª·×Äí©ézAWXJEg, p.299. ëìLì (Õw), Ò: ú{Õ°žãwï, ãwÊMÐ, , 2018/5s.
'18-620012. [wp (ªS·M)]yÅV žEæffT 2018-19NÅ@žÌèZEKŸ³EÛ¯¿ª·×Äí©éz[[^[@, p.299. ëìLì (Õw), Ò: ú{Õ°žãwï, ãwÊMÐ, , 2018/5s.
'18-620013. [wp (ªS·M)]yÅV žEæffT 2018-19NÅ@žÌèZEKŸ³EÛ¯¿ª·×Äí©éztBbV
o[O±, p.299. ëìLì (Õw), Ò: ú{Õ°žãwï, ãwÊMÐ, , 2018/5s.
'18-620014. [wp (ªS·M)]yÅV žEæffT 2018-19NÅ@žÌèZEKŸ³EÛ¯¿ª·×Äí©ézäNã÷A¹t@Co[XRs[, p.316. ëìLì (Õw), Ò: ú{Õ°žãwï, ãwÊMÐ, , 2018/5s.
'18-620015. [wp (ªS·M)]yÅV žEæffT 2018-19NÅ@žÌèZEKŸ³EÛ¯¿ª·×Äí©ézäNã÷A¹Ÿž, p.317. ëìLì (Õw), Ò: ú{Õ°žãwï, ãwÊMÐ, , 2018/5s.
'18-620016. [wp (ªS·M)]yÅV žEæffT 2018-19NÅ@žÌèZEKŸ³EÛ¯¿ª·×Äí©ézAÇJe[e, p.318. ëìLì (Õw), Ò: ú{Õ°žãwï, ãwÊMÐ, , 2018/5s.
'18-620017. [wp (ªS·M)]yÅV žEæffT 2018-19NÅ@žÌèZEKŸ³EÛ¯¿ª·×Äí©éztá±AÇt@Co[XRs[, p.318. ëìLì (Õw), Ò: ú{Õ°žãwï, ãwÊMÐ, , 2018/5s.
AE×EÚAw
[wp_¶]
110344. [Ž] Reduction in adverse transfusion reactions with increased use of washed platelet concentrates in Japan-A retrospective multicenter study. Ikebe E, Matsuoka S, Tanaka A, Yonemura Y, Fujii Y, Ohsaka A, Okazaki H, Kitazawa J, Ohtani S1, Nakayama T, Momose S, Miwa I, Taira R, Toyota K, Kino S, Kato H, Hamaguchi I: Transfus Apher Sci 2019/4; 58 (2): 162-8. (åJTê1: 1AE×EÚA)
110345. [Ž] Characteristics of palliative home care for patients with hematological tumors compared to those of patients with solid tumors. Ishida T1, Ohashi K, Okina C2, Ohashi S, Okina S3, Miyazaki K1, Suzuki T3: Int J Hematol 2019/8; 110 (2): 237-43. (Îc@²1, ¥çq2, ¥@cœ3, {ø_ñ1, éز_3: 1AE×EÚA, 2tà, 3tà)
110346. [Ž] Characteristics of palliative home care for patients with hematological tumors compared to those of patients with solid tumors. Ishida T1, Ohashi K, Okina C2, Ohashi S, Okina S3, Miyazaki K1, Suzuki T3: Int J Hematol 2019/8; 110 (2): 237-43. (Îc@²1, ¥çq2, ¥@cœ3, {ø_ñ1, éز_3: 1AE×EÚA, 2tà, 3tà)
310041. [Çáñ] The clinical outcomes of chronic myeloid leukemia patients harboring alternatively spliced BCR-ABL variants. Ishida T1, Miyazaki K1, Okina S2, Miyata T3, Hayama K3, Higashihara M2, Suzuki T2: Hematology 2019/12; 24 (1): 49-51. (Îc@²1, {ø_ñ1, ¥@cœ2, {Žmü3, HRdÈ3, Ž³Ÿ2, éز_2: 1AE×EÚA, 2tà, 3åw@ãÃn€È)
320046. [Çáñ] Ibrutinib^ÉÜüÍÆ÷è`¬ðJèԵǵR¶Ü¡ÃÅüPµœ«p«a. Îc@²1, {ø_ñ1, HRdÈ2, x]Çê3, éز_4 (1AE×EÚA, 2åw@ãÃn€È, 3ãÃq¶w, 4tà): Õ°t 2019/5; 60 (3): 153.
[@]
620087. [wp (ªS·M)]ytêåãeLXg üùæ3Åz¶Íâè@€Ê^êÊâè 23, p.586, p.588. ¶Íâè@àÈ^êÊâè 7, p.594-6. {ø_ñ (AE×EÚA), Ò: ú{twï, ì]°, , 2019/10s.
620088. [wp (ªS·M)]yfÃÍðã°é! ÇáâèW (àÈ2019N4å)z<æ9Í t> Çáâè@Á«¬Âž«ÁaÛÃ@ÌDP, p.963-4. {ø_ñ (AE×EÚA), ì]°, , 2019/s.
620089. [wp (ªS·M)]yfÃÍðã°é! ÇáâèW (àÈ2019N4å)z<æ9Í t> Çáâè@ËRÌoXü, p.965-6. {ø_ñ (AE×EÚA), ì]°, , 2019/s.
620090. [wp (ªS·M)]yÕ°HwuÀ Õ°ãw_ æ2Åzæ10Í taw@4. o«fö, p.257-62. {ø_ñ (AE×EÚA), ÄC: ú{Õ°HwZm³ç{ÝŠcï, Ò: ÂŽêF, ¬J@§, ãòoÅ, , 2020/3s.
[wïE€ï]
722238. [wï (S)] (µÒu) a@îñVXe6NÔÌàÝ. åJTê (AE×EÚA): æ67ñú{AE×E¡Ãwïwpï (2019/5/24), F{.
723790. [wï (S)] (êÊu) {MÉš¯é¢íŸ³³ÒÉηéÔ
AÌwOrèlÌ»ó. ¡à_ÍF, Rü÷, ãc±T, É¡^, ¡ŽTêY, ·äê_, rìm, qcëT, {ø_ñ1, rcaF, IìCê, c©u, ·JìYê, ¡ìšO, qìÎ`, Œ{^|, |ºŸT, ºäêj (1AE×EÚA): æ67ñú{AE×E¡Ãwïwpï (2019/5/23), F{.
723791. [wï (S)] (êÊu) ÌŸ³Éº€ñ«Æu«¬ÂžÇÉš¯éaÔ`¬@ÌðÍ. ²¡²i1, ëû¹l, °I2, ú@2, vÛ@œ1, {ø_ñ3, x]Çê1 (1ãÃq¶w, 2Á»íà, 3AE×EÚA): æ81ñú{twïwpWï (2019/10/13), .
723792. [wï (S)] (êÊu) 2nd-lineÌĶsÇ«nðÎÛƵœ~vX`Ìæ2/3Õ°±ÌªWcðÍ. ·¡Gi, Jun Ho Jang, Jong Wook Lee, yRÀº, {ø_ñ1, PnS, LF, ¡èqŸ, ¬_j, Œº@, ²XØõ, Øè¹O, àV@³j, ú¹O, ¬ÑŒ÷, sì@, ĺYm, |Jõê€, Œc@W, ¬àVhç, OJŠq, öáÁñ (1AE×EÚA): æ81ñú{twïwpWï (2019/10/11), .
~œ~}ãw
[wp_¶]
110347. [Ž] The prevalence and antibiotic susceptibility of Haemophilus influenzae in the Emergency Intensive Care Unit of Kitasato University Hospital. Yamaya T1, Nihonyanagi S2, Takayama Y2.3, Hanaki H4, Nakatani K1, Kataoka Y1, Asari Y1: Kitasato Med J 2019/9; 49 (2): 106-12. (RJ§å1, ñ{öL2, Rzq2.3, ÔØGŸ4, J€l1, ЪSê1, ó@õ1: 1~œ, 2ŽõǺ, 3V¢IãÃE¡fIãÃ, 4åºqLO€)
110348. [Ž] Efficacy of transcatheter arterial embolization for spontaneous extraperitoneal hemorrhage. Maruhashi T1,2, Kashimi F1, Kurihara Y1, Oi M1, Tamura S1, Osada M1, Nishimaki H2, Asari Y1: Kitasato Med J 2019/9; 49 (2): 119-24. (ÛŽFº1,2, ~©¶}1, IŽSŸN1, åä^Þ1, cº@q1, ·c^Rq1, Œª@2, ó@õ1: 1~œ, 2¹}AiãÈåw)
[@]
620091. [wp (ªS·M)]y¡úÌ¡Ãwj 2020NÅ@ͱ€¡ÃµÄ¢éz1. ~}ãÃ@x¹, p.55-6. ЪSê (~œ), ÒW: äî, Ø@œ, ¬ºê¬, ãw@, , 2020/1s.
[wïE€ï]
722239. [wï (S)] (µÒu) ddzÒÉηéØ÷Êðp¢œVœÈGlM[ÁïÊ\ª®. ЪSê1, cº@q1 (1~œ): æ35ñú{Õ°h{ãÓwïwpWï (2020/2/28), s.
723793. [wï (S)] (êÊu) dÇ~}³ÒÉηéh{ÇÌdv«. ЪSê1, cº@q1, ©Gõ²1, aJh²1, Ô@1, J€l1, ó@õ1 (1~œ): æ22ñú{Õ°~}ãwïïEwpWï (2019/6/1), aÌR.
723794. [wï (S)] (êÊu) ÄÕèïêÉš¯éKX{xɺ€œaÒ¶ÄÖÌÎ. ЪSê1, ©Gõ²1 (1~œ): æ22ñú{Õ°~}ãwïïEwpWï (2019/6/1), aÌR.
723795. [wï (S)] (êÊû) ÝIt®¬¹ Z^[Éš¯é¡Ão± (Blunt renal arterial injuries: a single center analysis of management strategies and outcomes). ~©¶}1, Œª@2, ÛŽFº11, cº@q1, IŽSŸN1, EbhnXæq3, Œihñ3, ó@õ1 (1~œ, 2¹}AiãÈåw, 3úËü (æ)): æ48ñú{IVRwïï (2019/6/1), ª, ú{C^[xViWIW[wïG 2019/5; 34 (Suppl): p.301.
723796. [wï (S)] (êÊu) [Ý«äX¹Éηé¡Ã@Ì¢. ЪSê1, Ô@1, cq¬1, ó@õ1 (1~œ): æ33ñú{OwïïEwpåï (2019/6/6), ªË.
723797. [wï (S)] (êÊu) dÇ~}³ÒÉηéNSTÉæéh{Ç. ЪSê1, ó@õ1 (1~œ): æ47ñú{W¡ÃãwïwpWï (2020/3/6), ŒÃ®.
723798. [wï (S)] (êÊu) O«]àîÉηé_oàŸIîpÌLp«Æâè_. ¬ò°V1,2, R{åã2, ó@õ1, GrG2 (1~œ, 2]O): æ43ñú{]_oOwï (2020/3/7), ª.
733737. [wï (nûïE€ï)] (êÊè) IVRªLpÅ ÁœäB®¬ÖÌúÊðºÁœo«Ý×áÌêá. sç²ÔÞ, á¢À1, ~©¶}1, Rà_j1,2, à@@I1, cº@q1, ÛŽFº1, ЪSê1, ó@õ1 (1~œ, 2Á»íà): æ70ñú{~}ãwïÖnûïwpWï (2020/1/18), OŽ.
733738. [wï (nûïE€ï)] (êÊè) ëùµœ`Éæè}«ÝIâ|Dðǵœ1á. Á¡qV, åä^¢Þ1, J€l1, Rà_j1,2, ÛŽFº1, IŽSŸN1, ЪSê1, ó@õ1 (1~œ, 2Á»íà): æ70ñú{~}ãwïÖnûïwpWï (2020/1/18), OŽ.
fÃãw
[wp_¶]
521010. [ðà] ³E«SsSÌùÌ é³ÒÉ€Á«SsSÌÓÊðÓÁÄ«³¹, S³¹œÆµÄ¹Q
ðßœá. ÂRŒP (fÃ): ãûáðà 2020/2; 84: 66-9.
522130. [uÀ]yZ~i[zªÉEßܢ̿û¡Ã. ÜìRÀ (fÃ): t@}VA 2020/3; 56 (3): 218-22.
[@]
620092. [wp (ªS·M)]y¿ûûnhubNzûÌÀÛ@9. _o@14. ªÉ, p.148-58. ÜìRÀ1 (1fÃ), Ò: ÔÖæF2 (2mãw€), ãw@, , 2019/6s.
620093. [wp (ªS·M)]yzÂínre[VÌ_ÆZp üùæ2ÅzI ðUwÌm¯@ÇÌ\¢Æ@\, p.19-27. III zÂퟳÌaÔÆ¡Ã@œ®¬Ÿ³, p.109-23. ÂRŒP1 (1fÃ), Ò: c@ì2, ŒiÄF2 (2ãÃq¶w), WJr
[Ð, , 2020/3s.
[wïE€ï]
722240. [wï (S)] (µÒu) ¿ûüåZ~i[@ªÉÌ¿û¡Ã. ÜìRÀ (fÃ): æ70ñú{mãwïwpï (2019/6/29), .
722241. [wï (S)] (µÒu) ¿ûòÌìpÉÖ·éV|WE@¿ûòÉæéÌáQ. ÜìRÀ (fÃ): æ70ñú{mãwïwpï (2019/6/30), .
723799. [wï (S)] (êÊu) ¿ûòÌìp. ÜìRÀ (fÃ): æ47ñú{¬mãwïwpWï (2019/9/29), ¡l.
ãw®ãw³ç€JZ^[
ãw³ç€å
[wïE€ï]
713141. [wï (Û)] (êÊu) Identification of Topics Explained by Home Doctors to Family Caregivers with Cancer Patients Died at Home: A Quantitative Text Analysis of Actual Speech in All Visits. Chiba H1, Ogata T, Ito M, Kaneko S: World Cancer Actions 2019 (2019/5/9), Valencia, Spain. (çtGB1, É¡¹Æ, ö`ÏŸ, àq³äè: 1ãw³ç)
733739. [wï (nûïE€ï)] (êÊu)uGhIuCtEPAÒ{¬îbuÀv̳çøÊÉÖ·é]¿€ <Ôñ>. çtGB1, ç®À1, ö`ÏŸ, œçàVMj, XJAc, OàVmœ (1ãw³ç): êÊÐc@lGhIuCEPAŠïݧ4üNV|WE (2019/4/14), .
ãwŽ_€å
[wïE€ï]
722242. [wï (S)] (µÒu) SDMÆÏ. âV¡LIq (ãwŽ_): æ23ñú{ANZX€ïwpWïEï (2019/9/29), ¡l.
ãÃZp³ç€å
ŠutàÈwvðQÆ
wKxی
ãÃÇw€å
ŠuÁ»íàÈwvðQÆ
ãÃîñ³ç€å
[wp_¶]
110349. [Ž] A spatial similarity of stereochemical environments formed by amino acid residues defines a common epitope of two non-homologous proteins. Nakashima K, Iwashita S, Suzuki T, Kato C, Kohno T1, Kamei Y, Sasaki M, Urayama O, Ohno-Iwashita Y, Dohmae N Song S-Y: Sci Rep 2019/10; 9 (1): 14818. (ÍìrV1: 1ãÃîñ³ç)
110350. [Ž] NMR characterization of the interaction between Bcl-xL and the BH3-like motif of hepatitis B virus X protein. Kusunoki H, Tanaka T, Kohno T1, Kimura H, Hosoda K, Wakamatsu K, Hamaguchi I: Biochem Biophys Res Commun 2019/10; 518 (3): 445-50. (ÍìrV1: 1ãÃîñ³ç)
[wïE€ï]
723800. [wï (S)] (êÊu) AhióeÌ×EàæO[vÆGPCRW
[^[spinophilinÆÌÝìpðÍ. ìD, ÑGÞ, Yìqq, èÀóq, ÍìrV1, ×caj, eTê, áŒ@] (1ãÃîñ³ç): æ58ñNMR¢_ï (2019) (2019/11/7), ìè.
723801. [wï (S)] (êÊu) í¥«NMRðp¢œYeast Ubiquitin hydrolase 1 (YUH1) Ì\¢èyÑ_Ci~NXðÍ. §Î@×, rJSº, ªc^R, O³K, üì@±, ªØG¹, ÍìrV1, Øì²¥, É¡@² (1ãÃîñ³ç): æ58ñNMR¢_ï (2019) (2019/11/9), ìè.
mãw³ç€å
[wp_¶]
110351. [Ž] Analgesic Effects of Ephedra Herb Extract, Ephedrine Alkaloids-Free Ephedra Herb Extract, Ephedrine, and Pseudoephedrine on Formalin-Induced Pain. Nakamori S1, Takahashi J, Hyuga S2, Yang J, Takemoto H1, Maruyama T, Oshima N, Uchiyama N, Amakura Y, Hyuga M, Hakamatsuka T, Goda Y, Odaguchi H2,3, Hanawa T2, Kobayashi Y1: Biol Pharm Bull 2019/6; 42 (9): 1538-44. (Xrã1, úü{üq2, |³TŸ1, ¬cû_2,3, ÔÖæF2, ¬Ñ`T1: 1òw, 2mãw€, 3mãw³ç)
110352. [Ž] Quality Evaluation and Characterization of Fractions with Biological Activity from Ephedra Herb Extract and Ephedrine Alkaloids-Free Ephedra Herb Extract. Yoshimura M, Amakura Y, Hyuga S1, Hyuga M, Nakamori S2, Maruyama T, Oshima N, Uchiyama N, Yang J, Oka H, Ito H, Kobayashi Y2, Odaguchi H1,3, Hakamatsuka T, Hanawa T1, Goda Y: Chem Pharm Bull (Tokyo) 2020/2; 68 (2): 140-9. (úü{üq1, Xrã2, ¬Ñ`T2, ¬cû_1,3, ÔÖæF1: 1mãw€, 2òw, 3mãw³ç)
320047. [Çáñ] k¢ã€fÃ^©ç (180): Ë«ï®É¿ûEèI̹p¡Ãªt÷µœ1á. éØMF1, ÎÑBç1, ¬cû_1,2, ÔÖæF1 (1mãw€, 2mãw³ç): ¿ûÌÕ° 2019/4; 66 (4): 418-22.
320048. [Çáñ] k¢ã€fÃ^©ç (181): æÅȪzÌDiÉåÄÓå© (÷¶) ªLpÅ Áœ3Çá. ÎÑBç1, ¬cû_1,2, ÔÖæF1 (1mãw€, 2mãw³ç): ¿ûÌÕ° 2019/5; 66 (5): 511-8.
320049. [Çáñ] k¢ã€fÃ^©ç (182): °áQEªÉÉεޡU¿©ç³JU¿É]ûµt÷µœ1Çá. ¯ììV1, ¬cû_1,2, ÔÖæF1 (1mãw€, 2mãw³ç): ¿ûÌÕ° 2019/6; 66 (6): 597-602.
320050. [Çáñ] k¢ã€fÃ^©ç (183): xÌâŠðx[XɵœâŠÇÉãIªtøµœ1á. ¬cû_1,2, ÔÖæF2 (1mãw³ç, 2mãw€): ¿ûÌÕ° 2019/7; 66 (7): 703-6.
320051. [Çáñ] k¢ã€fÃ^©ç (184): º ÉÉAltÁàä£äζIªtøµœŠálÌ1ÇáÆ, álEµálEŠálÉ¢Ä. É¡@1, ¬cû__1,2, ÔÖæF1 (1mãw€, 2mãw³ç): ¿ûÌÕ° 2019/9; 66 (9): 865-72.
320052. [Çáñ] k¢ã€fÃ^©ç (185): ¿û¡Ã̹pªLpŸÁœï¡sD2Çá. XTIq1, âV¡Gü1, ¬cû_1,2, ÔÖæF1 (1mãw€, 2mãw³ç): ¿ûÌÕ° 2019/10; 66 (10): 954-8.
320053. [Çáñ] k¢ã€fÃ^©ç (187): ž²ÇÉ¿û¡Ã̹pªLøÅ Áœ2Çá. ¡åã1, ¬cû_1,2, ÔÖæF1 (1mãw€, 2mãw³ç): ¿ûÌÕ° 2019/12; 66 (12): 1146]53.
520019. [à] ©ÌìpÆGtFhAJCh©GLX (EFE) ÌÀS«. ¬cû_1,2, úü{üq2, Öªq2, Xrã3, |³TŸ3, ©@áO3, åŒ_, cTî, k@àÜ, VqgÍ, úü¹i, àRÞäq, ¬Ñ`T3, ÑËu, cKL, ÔÖæF2 (1mãw³ç, 2mãw€, 3òw): òwG 2019/11; 139 (11): 1417-25.
522131. [uÀ] ©Ì嬪EGtFhAJChÌìpÆVK¶òGLXEFEÌJ. úü{üq1, ¬cû_1,2, ÔÖæF1 (1mãw€, 2mãw³ç): ÊûBIO Clinica 2019/12; 8 (2): 118-22.
540079. [»ÌŒ (ñe)] WHOŠÍZ^[ñe2: k¢åwmãw€`ú{Ì`ãwu¿ûvðʶœWHOÖÌv£`. áÀóT1, Öªq1, ¬cû_1,2 (1mãw€, 2mãw³ç): ÚÅ©éWHO 2019/10; 70 (2019H): 18-9.
[@]
620094. [wp (ªS·M)]y¿ûûnhubNzûÌÀÛ@2. zÂí@3. ³, p.73-5. 8. n@13. n, 144-7. ¶ò, èI, EBM, ãjw@EBM, p.353-6. ¬cû_1,2 (1mãw³ç, 2mãw€), Ò: ÔÖæF2, ãw@, , 2019/6s.
[wïE€ï]
712035. [wï (Û)] (µÒu) Application of Kampo Medicine (Traditional Japanese Medicine) to high blood pressure. Odaguchi H1,2: 1st Joint Symposium of WHO Collaborating centers for Traditional Medicine in SEARO and WPRO (Faculty of Medicine Siriraj Hospital) (2019/9/13), Thailand. (¬cû_1,2: 1mãw³ç, 2mãw€)
713142. [wï (Û)] (êÊu) Therapeutic and analgesic effects of Ephedrine alkaloids-free Ephedra Herb extract on complete Freud's adjuvant-induced arthritis model mouse. Nakamori S, Miyajima N, Hyuga S, Minami Y, Kazama K, Hiyama M, Endo M, Yang J, Oshima N, Uchiyama N, Amakura Y, Hyuga M, Hakamatsuka T, Goda Y, Odaguchi H1,2, Hanawa T, Kobayashi Y: 67th International Congress and Annual Meeting of the Society for Medicinal Plant and Natural Product Research (2019/9/2), Innsbruck, Austria. (¬cû_1,2: 1mãw³ç, 2mãw€)
713143. [wï (Û)] (êÊu) A Case-series of 10 Patients with Female Hormonal Imbalance (Chi-no-michi syndrome) successfully treated with nyoshinsan. Mori E1, Oikawa T, Odaguchi H1,2, Hanawa T1: 5th International Symposium for Japanese Kampo Medicine (2019/9/7), Germany. (X@lq1, ¬cû_1,2, ÔÖæF1: 1mãw€, 2mãw³ç)
722243. [wï (S)] (V|WE)y¶òV|WE: ¿ûòpÌߢ`ÅßÌ€¬Êð¥ÜŠÄ`zGCPRCTÉæéãtå±Õ°€`EFEÌN¬lÉηéÀS«±`@«Ì¿ûòÌ è©œ, ¿ûÌVœÈãòiJÌ»óâW], ÀSi¿È¶ò. ¬cû_1,2 (1mãw³ç, 2mãw€): æ70ñú{mãwïwpï (2019/6/30), .
722244. [wï (S)] (V|WE)yW»V|WEz¿ûf@@ÌW»É¢Ä. ¬cû_1,2, Vä@M, ÄŽŒ, c@L, ÀزY, ÔÖæF2, Oàk¹, ºŒTê, Öªq2, áÀóT2 (1mãw³ç, 2mãw€): æ70ñú{mãwïwpï (2019/6/30), .
723802. [wï (S)] (êÊu) ãÃAgªLøÉ@\µœÆvíêœÔ«æêsÌêá. ÉG1, É¡@1, ¬cû_1,2 (1mãw€, 2mãw³ç): æ68ñ (öÐ) Sú{èIwïwpåï€måï (2019/5/12), €m
723803. [wï (S)] (êÊu) wûÉxÖAãÐÉæécª ÌÃû€. ¯ììV1, ¬cû_1,2, ÔÖæF1 (1mãw€, 2mãw³ç): æ120ñú{ãjwïïEwpåï (2019/5/18), €m.
723804. [wï (S)] (êÊu) o¡ÃÌy®É¢Ä. ühêœ1, ¬cû_1,2, ÔÖæF1 (1mãw€, 2mãw³ç): æ120ñú{ãjwïïEwpåï (2019/5/18), €m.
723805. [wï (S)] (êÊu) ¶Bâãà (ART) Æ¿û¡Ã̹pªLøŸÁœï¡sD2Çá. XTIq1, ¬cû_1,2, ÔÖæF1 (1mãw€, 2mãw³ç): æ70ñú{mãwïwpï (2019/6/29), .
723806. [wï (S)] (êÊu) Aª÷èîÇÉÄpªLpÅ Áœ1Çá. ÎÑBç1, ¬cû_1,2, ÔÖæF1, OŽ_j (1mãw€, 2mãw³ç): æ70ñú{mãwïwpï (2019/6/29), .
723807. [wï (S)] (êÊu) ãÉÇɵš~ºªLøÅ Áœêá. ìçÉW1, ÔÖæF1, ¬cû_1,2 (1mãw€, 2mãw³ç): æ70ñú{mãwïwpï (2019/6/29), .
723808. [wï (S)] (êÊu) {ÝÉš¯é}€ÂÇóðæ·é³ÒÉηé¿û¡ÃÌ¢. ¡åã1, yìNY, É¡@1, ¬cû_1,2, ÔÖæF1 (1mãw€, 2mãw³ç): æ70ñú{mãwïwpï (2019/6/29), .
723809. [wï (S)] (êÊu) {ÝÉš¯éʱUûáÌ¢. ÛR×M1, yìNY, ¬cû_1,2, ÔÖæF1 (1mãw€, 2mãw³ç): æ70ñú{mãwïwpï (2019/6/29), .
723810. [wï (S)] (êÊu) °áQÉηéèI¡ÃÌãûI²ž. äcl1, ÉG1, É¡@1, ¬cû_1,2, ÔÖæF1 (1mãw€, 2mãw³ç): æ70ñú{mãwïwpï (2019/6/29), .
723811. [wï (S)] (êÊu) CÕÖÌhèIªåÚOÊÌáêÉεÄtøµœêÇá. É¡Yê1, ÉG1, É¡@1, ¬cû_1,2, ÔÖæF1 (1mãw€, 2mãw³ç): æ70ñú{mãwïwpï (2019/6/29), .
723812. [wï (S)] (êÊu) zÅÇ«ØÌpãÌáêÉεÄèI¡ÃªLøŸÁœ1Çá. ß¡Ñ1, ÉG1, É¡@1, ¬cû_1,2, ÔÖæF1 (1mãw€, 2mãw³ç): æ70ñú{mãwïwpï (2019/6/29), .
723813. [wï (S)] (êÊu) @\áºðº€sDÉε¿ûèI¡Ãð¹pµÄDPµœêÇá. âÞXq1, ÉG1, É¡@1, ¬cû_1,2, ÔÖæF1 (1mãw€, 2mãw³ç): æ70ñú{mãwïwpï (2019/6/29), .
723814. [wï (S)] (êÊu) ú{ÅñÅ«éÌNÉ¢ÄÌ¢. OàV@S1, çü1, âcK¡1, ²ŽÀY1, ûçH1, ¬Ñ`T1, ¬cû_1,2, ÔÖæF1 (1mãw€, 2mãw³ç): æ70ñú{mãwïwpï (2019/6/29), .
723815. [wï (S)] (êÊu) Ž¿¶ò̶YóµÉš¯éîñûWyÑÕ°ÖÌpÉ¢Ä. ¬òmŸ1, âcK¡1, ²ŽÀY1, ûçH1, ¬Ñ`T1, ¬cû_1,2, ÔÖæF1 (1mãw€, 2mãw³ç): æ70ñú{mãwïwpï (2019/6/29), .
723816. [wï (S)] (êÊu) €ÌòwÉš¯é¿û³çÌÓ`.
è°Þ1, ²ŽÀY1, âcK¡1, ûçH1, ¬Ñ`T1, ¬cû_1,2, ÔÖæF1 (1mãw€, 2mãw³ç): æ70ñú{mãwïwpï (2019/6/29), .
723817. [wï (S)] (êÊu) òw³çÉš¯éu{¶@ƵÄÌŸÉvw±Ì³çøÊÌ¢. ¬Ñ`T1, ¬cû_1,2 (1mãw€, 2mãw³ç): æ70ñú{mãwïwpï (2019/6/29), .
723818. [wï (S)] (êÊu) {ÝÉš¯éªñ³ÒÉηé¿û¡ÃÌ¢. X@lq1, yìNY, ¬cû_1,2, ÔÖæF1 (1mãw€, 2mãw³ç): æ70ñú{mãwïwpï (2019/6/30), .
723819. [wï (S)] (êÊu) ©ÉÜÜêéGtFhAJChÌSÉηéìpÌðÍ. ©@áO1, úü{üq2, àRÞäq, úü¹i, åŒ_, VqgÍ, ÑËu, ¬cû_2,3, ÔÖæF2, ¬Ñ`T1 (1òw, 2mãw€, 3mãw³ç): æ70ñú{mãwïwpï (2019/6/30), .
723820. [wï (S)] (êÊu) ÃûhÊ{Q©çÌÄ©. ¯ììV1, ¬cû_1,2, ÔÖæF1 (1mãw€, 2mãw³ç): æ70ñú{mãwïwpï (2019/6/30), .
723821. [wï (S)] (êÊu) wèIãwxÉ¢Ä. ühêœ1, ¬cû_1,2, ÔÖæF1 (1mãw€, 2mãw³ç): æ70ñú{mãwïwpï (2019/6/30), .
723822. [wï (S)] (êÊu) SAMP8}EXðpµœ¢a]¿fƵÄÌÂ\«. É¡Œ÷1, |³TŸ2, ·Jì»ß, RçÀ1, ¡c¢Þ, ¬û°ü, iä²V3, ¬Ñ`T2, ŽŽ°Í3, yìNY, ¬cû_1,4 (1mãw€, 2òw, 3åw@Žõ§äÈw{a¿òšw€º, 4mãw³ç): æ34ñV»£if}EX (SAM) wïwpåï (2019/7/13), ì.
723823. [wï (S)] (êÊu) LPSUxÇfÉηéâvCÌìpÌðÍ. ù¶ëq1, oìqj, ÛROq2, iä²V1, ÔÖæF3, ¬cû_3,4, Xè@_, ŽŽ°Í1 (1åw@Žõ§äÈw{a¿òšw€º, 2ãÃq¶w, 3mãw€, 4mãw³ç): æ36ña¿ãòwïwpåï (2019/8/31), xR.
723824. [wï (S)] (êÊu) aÔÅÌxSÆunÉη骡Û÷ÜÌìpÌðÍ. Ý{åu1, iä²V1, É¡@2, ÔÖæF2, ¬cû_2,3, ŽŽ°Í1 (1åw@Žõ§äÈw{ a¿òšw€º, 2mãw€, 3mãw³ç): æ36ña¿ãòwïwpåï (2019/8/31), xR.
723825. [wï (S)] (êÊu) âvCÌT×E˶«SgÇyѬ°SÉηéüPìp|QÜœÍQzÜÌär|. ¡^1, ÌìD, ŽŽ°Í2, yìNY, ¬cû_1,3, ÔÖæF1 (1mãw€, 2åw@Žõ§äÈw{a¿òšw€º, 3mãw³ç): æ36ña¿ãòwïwpåï (2019/9/1), xR.
723826. [wï (S)] (êÊu) ©Éæéc-MetÌ_EM
[VÌJjY. úü{üq1, úü¹i, ÑËu, cKL, ¬cû_1,2, ÔÖæF1 (1mãw€, 2mãw³ç): æ36ña¿ãòwïwpåï (2019/9/1), xR.
723827. [wï (S)] (êÊu) V»£i}EXðp¢œhUÌ¢a§ä. É¡Œ÷1, ·Jì»ß, RçÀ1, iä²V2, ŽŽ°Í2, yìNY, ¬cû_1,3 (1mãw€, 2åw@Žõ§äÈw{a¿òšw€º, 3mãw³ç): æ36ña¿ãòwïwpåï (2019/9/1), xR.
723828. [wï (S)] (êÊu) Ößf}EXÌîgD¹ÉηéGtFhAJCh©GLXÌøÊ. ì@Âb1, Xrã1, úü{üq2, ¡^2, {ŒI, wRüt, ÔT, |à@, k@àÜ, àRÞäq, úü¹i, åŒ_, VqgÍ, ÑËu, cKL, ¬cû_2,3, ÔÖæF2, ¬Ñ`T1 (1òw, 2mãw€, 3mãw³ç): ú{¶òwïæ66ñNï (2019/9/22), .
723829. [wï (S)] (êÊu) nI«EãIwiÉæèÏJ·éû. xcL, ¯ììV, ¬cû_1,2, ÔÖæF2 (1mãw³ç, 2mãw€): æ47ñú{¬mãwïwpWï (2019/9/29), _Þì.
723830. [wï (S)] (êÊu) V\ÞAšÌ1H-NMR^{bNvt@CO. šCí1, œRG1, Ñc³í1, cBj1, yìNY, ÔÖæF2, ¬cû_2,3, ŠËëV, ¬cÀF, vüq, ºìTV, ìŽMv, ¬Ñ`T1 (1òw, 2mãw€, 3mãw³ç): æ8ñHiòwV|WE (2019/10/18), ê.
733740. [wï (nûïE€ï)] (êÊu) ºÉàLøÅ ÁœAäPäÌêá. ÛR×M1, ìçÉW1, ¬cû_1,2, ÔÖæF1 (1mãw€, 2mãw³ç): æ29ñ¿û¡Ã€ï (2019/10/6), åã.
4a@Ag³ç€å
ŠuºÁ»ÇOÈwvðQÆ
ãÃÀSw€å
Õ°ðU³çå
næãÃw³ç€å
ŠuSÇOÈwvðQÆ
ãw®Õ°€Z^[
éæJå
[wp_¶]
110353. [Ž] The Current State and Future Prospects of Population Pharmacokinetic Research in Post-marketing Clinical Studies in Japan. Watanabe-Uchida M, Watanabe T1, Narukawa M: Yakugaku Zasshi 2019/10; 139 (10): 1297-303. (nç³Bç1: 1Õ°€Eéæ)
522132. [uÀ]ytH[z¡±Éš¯éï¯ÓÌ»óÆÛè. °rF, TcLóq, nç³Bç1, Ž@~ (11Õ°€Eéæ): Õ°ò 2019/7; 50 (4): 177-82.
522133. [uÀ]y<æ18ñCRCÆÕ°±Ì èûðlŠéïc 2018 in xR> V|WE5: FèÕ°€RžÏõï`«©çŒNÌSHINKA`zwjÆ@Ì·ÔÉ égÕ°€hÉÖ·ék|frŠé€ÒšæÑÏÏõï©çÌkðSÉ|. nç³Bç (Õ°€Eéæ): òÆ¡Ã 2019/10; 47 (10): 1568-71.
[wïE€ï]
722245. [wï (S)] (µÒu) ãÃòw€ÉæègÞ×ÌîbÆÀH`Õ°€ÉæègÞœßÌ€ÏÌ|CgÆÓ_`. nç³Bç (Õ°€Eéæ): æ29ñú{ãÃòwïNï (2019/11/3), ª.
723831. [wï (S)] (êÊu) ãtðÎÛƵœg€Ï³çhÉÖ·éÓ¯²ž. nç³Bç1, ¬q¢, |œbq, Lcxq (1Õ°€Eéæ): æ40ñú{Õ°òwïwpï (2019/12/6), .
vWFNgÀ{å
[wp_¶]
110354. [Ž] Pharmacokinetics, Pharmacodynamics, and Safety of E6011, a Novel Humanized Antifractalkine (CX3CL1) Monoclonal Antibody: A Randomized, Double-Blind, Placebo-Controlled Single-Ascending-Dose Study. Tabuchi H, Katsurabara T, Mori M, Aoyama M, Obara T, Yasuda N, Kawano T, Imai T, Ieiri I, Kumagai Y1: J Clin Pharmacol 2019/5; 59 (5): 688-701. (FJY¡1: 1Õ°€EvWFNg)
110355. [Ž] No Effect of Digoxin on Rosuvastatin Pharmacokinetics in Healthy Subjects: Utility of Oita Combination for Clinical Drug-Drug Interaction Study. Otani N, Wakuda H, Imai H, Kuranari M, Ishii Y, Ito Y, Okubo A, Ogawa O, Takeda K, Ohyama T, Hasunuma T1, Uemura N: Clin Transl Sci 2019/9; 12 (5): 513-8. (@Àqq1: 1Õ°€EvWFNg)
110356. [Ž] Overall Similarities and a Possible Factor Affecting Plasma Metabolome Profiles Between Venous and Capillary Blood Samples From 20 Healthy Human Males. Saito K, Ueno S, Nakayama A, Nitta S, Arai K, Hasunuma T1, Saito Y: J Pharm Sci 2019/11; 108 (11): 3737-44. (@Àqq1: 1Õ°€EvWFNg)
110357. [Ž] Plasma pentraxin 3 is associated with progression of radiographic joint damage, but not carotid atherosclerosis, in female rheumatoid arthritis patients: 3-year prospective study. Funakubo-Asanuma Y, Aizaki Y, Noma H, Yokota K, Matsuda M, Kozu N, Takebayashi Y, Nakatani H, Hasunuma T1, Kawai S, Mimura T: Mod Rheumatol 2020/11; 30 (6): 959-966. doi: 10.1080/14397595.2019.1681583. Epub 2019 Oct 30. (@Àqq1: 1Õ°€EvWFNg)
110358. [Ž] Safety Profiles, Pharmacokinetics, and Changes in Bone Turnover Markers After Twice-Weekly Subcutaneous Administration of Teriparatide in Healthy Japanese Postmenopausal Women: A Single-Blind Randomized Study. Kumagai Y1, Ose A, Tanaka K, Sugimoto T: Clin Pharmacol Drug Dev 2020/1; 9 (1): 87-96. (FJY¡1: 1Õ°€EvWFNg)
110359. [Ž] Dotinurad: a clinical pharmacokinetic study of a novel, selective urate reabsorption inhibitor in subjects with hepatic impairment. Kumagai Y1, Sakaki M, Furihata K, Ito T, Inoue K, Yoshida T, Matsumoto S, Furuno K, Hagino A: Clin Exp Nephrol 2020/3; 24 (Suppl 1): 25-35. (FJY¡1: 1Õ°€EvWFNg)
110360. [Ž] A drug-drug interaction study of a novel, selective urate reabsorption inhibitor dotinurad and the non-steroidal anti-inflammatory drug oxaprozin in healthy adult males. Furihata K, Nagasawa K, Hagino A, Kumagai Y1: Clin Exp Nephrol 2020/3; 24 (Suppl 1): 36-43. (FJY¡1: 1Õ°€EvWFNg)
[@]
620095. [wp (ªS·M)]y2y[WÅð·é Wòš¡Ãt@C æ3Åz¡tEÆuŸ³@27. ÖßE}`, p.54-5. Ãc׳, ¬ìõq, @Àqq1 (1Õ°€EvWFNg), Ò: ú{AvChEZs
[eBNX (ÀHòš¡Ã) wï, ìR°, , 2019/7s.
[wïE€ï]
713144. [wï (Û)] (êÊu) A PHASE 1, SINGLE AND MULTIPLE ASCENDING DOSE, STUDY OF TAS5315, A NOVEL HIGHLY SELECTIVE INHIBITOR OF BRUTON'S TYROSINE KINASE IN HEALTHY MALE VOLUNTEERS. Kumagai Y1, Tanaka Y, Murata M, Takeuchi T: EULAR 2019 (2019/6/14), Madrid, Spain. (FJY¡1: 1Õ°€EvWFNg)
722246. [wï (S)] (³çu) Õ°±ÌÀS«]¿ÌlŠû|]ÎÊæÌñ|. FJY¡ (Õ°€EvWFNg): æ19ñCRCÆÕ°±Ì èûðlŠéïc 2019 in YOKOHAMA (2019/9/14), ¡l.
722247. [wï (S)] (µÒu) AWAÉš¯é¡±Ì»óÆüãÖÌæègÝ. FJY¡ (Õ°€EvWFNg): DIA Global Oncology Development 2020 (2020/1/31), .
722248. [wï (S)] (µÒu) úÕ°€ÖÌŸªÅ«éêåÆ. FJY¡ (Õ°€EvWFNg): æ40ñú{Õ°òwïwpï (2019/12/5), .
722249. [wï (S)] (µÒu) ÌáQÉš¯éoCI}[J[p. FJY¡ (Õ°€EvWFNg): æ40ñú{Õ°òwïwpï (2019/12/6), .
722250. [wï (S)] (µÒu) AJf~AnòÆÕ°±. FJY¡1, ìüa (1Õ°€EvWFNg): æ40ñú{Õ°òwïwpï (2019/12/6), .
723832. [wï (S)] (êÊu) N¬lðÎÛƵœRªñܯ«±Éš¯é¯Ó柊ƯÓPñŠÌ²ž. âÛüq, XìüRM, gc³q, ŒºMq, @Àqq1 (1Õ°€EvWFNg): æ40ñú{Õ°òwïwpï (2019/12/5), .
723833. [wï (S)] (êÊu) ãtå±€ÌÛAgiÌœßÌ€. FJY¡1, âcc (1Õ°€EvWFNg): æ40ñú{Õ°òwïwpï (2019/12/6), .
723834. [wï (S)] (êÊu) í¬lÉš¯éOt[g@Æ£H
zü@Ìär±. FJY¡1, ìºó, ·cÀj, cpq, â{×, OcÀÔ2, ¶ëq (1Õ°€EvWFNg, 2òÜ): æ40ñú{Õ°òwïwpï (2019/12/6), .
723835. [wï (S)] (êÊu) CRBðœÈ¢ãÃ@ÖÉš¯éÕ°€@É]ÁœÁèÕ°€ÌÀ{ÉWé@à豫̮õÆ¡ãÌÛè. Œe^Àq, ~c^|, à_c©ÈŠ, «I, cR, ãCê, @Àqq1 (1Õ°€EvWFNg): ú{Õ°±wïæ11ñwpWïï (2020/2/14-15), .
732147. [wï (nûïE€ï)] (µÒu) Õ°€ja@Éš¯éx@\|äªÉš¯éAROÌûü«Í?|. FJY¡ (Õ°€EvWFNg): æ13ñú¶ÈwRcïÕ°€ï (2019/6/6), Oc.
oCIGVbNXå
nòV[Y€Jå
ãw®V¢IãÃJZ^[
æ[ãÃÌæJå
(gcê¬)
ŠuåAíÈwvðQÆ
(cç³@)
ŠuÁ»íàÈwvðQÆ
(·ÀpŸ)
Šuš@ôAÈEªèòOÈwvðQÆ
(c@)
ŠuêÊE¬EÌ_äXOÈwvðQÆ
(Ž¯O÷)
ŠuúËüÈwiæffwjvðQÆ
(æèGŸ)
Šu¬ÈwvðQÆ
(ŒGF)
Šu¬ÈwvðQÆ
¡fIãÃÌæJå
(à亶)
ŠuÈwvðQÆ
(Rºpj)
ŠuãÁ»ÇOÈwvðQÆ
(Vä³N)
ŠuÈwvðQÆ
(²XØ¡êY)
ŠuÄzíàÈwvðQÆ
(¬ÑŽT)
ŠuÁ»íàÈwvðQÆ
(Rzq)
Šuk¢åwa@ŽõǺvàQÆ
[wp_¶]
310042. [Çáñ] Characterization of the IncFII-IncFIB(pB171) Plasmid Carrying bla NDM-5 in Escherichia coli ST405 Clinical Isolate in Japan. Takayama Y1,2, Sekizuka T, Matsui H3, Adachi Y2, Eda R4, Nihonyanagi S2, Wada T5, Matsui M, Suzuki S, Takaso M6, Kitasato H7, Kuroda M, Hanaki H3: Infect Drug Resist 2020/2; 13: 561-6. (Rzq1,2, ŒäGm3, ÀB@÷2, ]cÈŸY4, ñ{öL2, acBF5, »m6, k¢pY7, ÔØGŸ3: 1V¢IãÃE¡fIãÃ, 2ŽõǺ, 3k¢åwk¢¶œÈw€, 4åw@ãÃn€È, 5äPŽaEŽõà, 6®O, 7ãÃq¶w)
[@]
620096. [wp (P)]yòÜÏ«@No.5 `VÏ«©FuhE
ÛzRzq (V¢IãÃE¡fIãÃ), T, åã, 2019s.
[wïE€ï]
722251. [wï (S)] (µÒu) üpú\hRÛòÌK³»ÖÌæègÝ. Rzq (V¢IãÃE¡fIãÃ): æ67ñú{»wÃ@wïï (2019/5/9), .
722252. [wï (S)] (µÒu) Úµœ¢ÅßÌ_¶: Ï«Û CREÆ«. Rzq (V¢IãÃE¡fIãÃ): æ35ñú{«ŽõwïïEwpWï (2020/2/14), ¡l.
723836. [wï (S)] (êÊu) @Éš¯éRÛòK³gpÌæègÝÉ¢Ä`Ïõï®ðʵÄ`. Rzq1,2, ñ{öL2,3, acBF2,4 (1V¢IãÃE¡fIãÃ, 2ŽõǺ, 3Õ, 4äPŽaEŽõà): æ31ñú{Õ°÷¶šwïïEwpWï (2020/2/1), àò, ú{Õ°÷¶šwïG 2019; 30 (Suppl 1): 322.
732148. [wï (nûïE€ï)] (µÒu) ÄzíECXŽõÇÌ}l[Wg@`¬láðSÉ` CtGUÆx. Rzq (V¢IãÃE¡fIãÃ): æ68ñú{ŽõÇwïú{nûïwpWïEæ66ñú{»wÃ@wïú{xï ¯wï (2019/10/18), åä.
ãw³çnZpEõ
`Ôn
[wïE€ï]
713001. [wï (Û)] (êÊu) The fine structural approach to clarify the pathophysiological mechanism of orthopedic diseases by analyzing the spinal excurved Medaka mutant, wavy (wy). Nishimaki T1, Uchida K2, Yamada M, Oda S, Oga A, Oota H, Katsumura T3, Takaso M2, Ogawa M3: The 19th Congress of the International Federation of Associations of Anatomists (2019/8/9), London, UK. (Œê rV1, àcŸY2, º[j3, »m2, ¬ì³V3: 1`Ôn, 2®O, 3ðU)
¶ššn
aÔEfÃn
[wïE€ï]
723096. [wï (S)] (êÊu) ¶Ì¿ªÍðsÁœXCZÌëHÉæéHÅ3á. gºvmq1, ÛŽFº2, åä^¢Þ2, IŽSŸY2, ²XØçõq3, î_×l2, ²¡¶q3, ó@õ2 (1aÔEfÃn, 2~œ, 3@ã): æ41ñú{ÅwïïEwpWï (2019/7/21), éÊ.
733017. [wï (nûïE€ï)] (êÊu) agDW{ì»Éš¯éLVãÖipÌæègÝÉ¢Ä. Û®ü1, ã{q1, ºãçq2, ü]@Â2, ²XØçõq2, ·åœ1, ²¡¶q2 (1`Ôn, 2@ã): æ88ñú{@ãwïwpÖnûWï (2019/10/12), (äÌœßãJÃ).
'18NxÈOª
[wp_¶]
'18-320001. [Çáñ] RglycineóeÌRÌz«Ìstiff-limbÇóQÌ1á. Ocá, Ž
F÷, ŽFq, ààVŒü1, ÑË_2 (1aÔEfÃn, 2]_oà): Õ°_ow 2019/2; 59 (2): 98-101.
\hãwn
ªqãÈwE§än
a@€n
gD|{Z^[
DNA˱Z^[
oCIC[WO€Z^[
â`q@\ðÍZ^[
NÇZ^[
[wp_¶]
110361. [Ž] Serial renal biopsies in normo- and microalbuminuric patients with type 2 diabetes demonstrate that loss of renal function is associated with a reduction in glomerular filtration surface secondary to mesangial expansion. Moriya T1, Yamagishi T, Matsubara M1, Ouchi M: J Diabetes Complications 2019/5; 33 (5): 368-73. (ç®Bü1, ŒŽÜÇ©1: 1NÇZ)
110362. [Ž] Vitamin B6 intake and incidence of diabetic retinopathy in Japanese patients with type 2 diabetes: analysis of data from the Japan Diabetes Complications Study (JDCS). Horikawa C1, Aida R1, Kamada C1, Fujihara K1, Tanaka S1, Tanaka S1, Araki A1, Yoshimura Y1, Moriya T1,2, Akanuma Y1, Sone H1 (1Japan Diabetes Complications Study Group): Eur J Nutr 2020/6; 59 (4): 1585-94. doi: 10.1007/s00394-019-02014-4. Epub 2019 May 31. (ç®Bü1,2: 2NÇZ)
120040. [Ž] u±±ëÌN²žv©çí©éSxðv·éÂ\«ª¢w¶ÌSzÌÁ¥. RcTq1, ç®Bü1 (1NÇZ): CAMPUS HEALTH 2019/5; 56 (2): 178-84.
120041. [Ž] w¶kÉš¯é¢ïáÅ éñåÌIkw¶ÖÌJEZ[ÌðÆÎÉÖ·éS²ž. å¬mv1, RcTq1, Î˹Û1, ç®Bü1 (1NÇZ): CAMPUS HEALTH 2019/5; 56 (2): 224-30.
522134. [uÀ]yAÚ: DHÕ°Éð§Â #ÐïÌL[[hz#17 pjbNáQ|ìÌsÀÉÕÜê, úí¶Éxá|. {npY (NÇZ): Èq¶m 2019/8; 43 (8): 64-5.
522135. [uÀ]yÁW: «ÉÖÌAv[`z«ÉÆž_Ÿ³. {npY (NÇZ): ÅVž_ãw 2020/3; 25 (2): 101-6.
540080. [»ÌŒ (Nñ)] 2018NxðUèÔÁÄ. RcTq (NÇZ): k¢åwNÇZ^[Nñ 2019; æ3: 17-9.
540081. [»ÌŒ (Nñ)] \acLpXNXåCðÎÛÉÀ{µœ[NVbv^€C (2019N322ú) ÌÜÆß|JEZ[©çÌbZ[WðYŠÄ|. RcTq1, ºzq1, ç®Bü1 (1NÇZ): 2019.
540082. [»ÌŒ (wïñ)]yæ57ñSåwÛÇ€WïzK10ÚÆ®«ÆÌÖA©çÝœAåwVü¶Ìž_NÌÁ¥: 3NÔÌär©ç. RcTq1, Î˹Û1, å¬mv1, ÍŽvüq, c äÝ, §Ô@X, ¬J^ä, ç®Bü1 (1NÇZ): CAMPUS HEALTH 2020/3; 57 (1): 245.
[@]
620097. [wp (ªS·M)]ymÁÄš«œ¢HÈž_ÇóEÇóQ|Çá©çwÔ| (ž_È¡Ãwæ34ª§)z45. ûoàZlXgp`[, p.142-4. {npY1 (1NÇZ), Ò:už_È¡ÃwvÒWÏõï, ÒWŠÍ: åÎ@q2, ËcTV (2ž_), ¯aX, , 2019/10s.
620098. [wp (ªS·M)]y¡úÌffwj æ8ÅzII. Ÿ³Ò@15. ž_Ÿ³@Ï·ÇEð£ÇQ, p.1461. {npY (NÇZ), ÒW: iäÇO, ãw@, , 2020/3s.
[wïE€ï]
713145. [wï (Û)] (êÊu) Diabetic retinopathy is an additional risk factor for hemodialysis induction and mortality in type 2 diabetic patients. Moriya T1, Matsubara M1, Ouchi M: American Diabetes Association 79th Scientific Sessions (2019/6/7-11), San Francisco, USA. (ç®Bü1, ŒŽÜÇ©1: 1NÇZ)
722253. [wï (S)] (µÒu)ytbV[R[X3zÈãªmÁÄš«œ¢ ž_ÈÌm¯. {npY (NÇZ): æ24ñú{ûoçÊÉwï (2019/9/28), ìè.
723837. [wï (S)] (êÊu) îIÉZµœÆ°©çw¶ª©§µÄ¢vZXÌ¢|w¶ÆÆ°ÌÝìpÌ_©ç|. å¬mv1, RcTq1, ç®Bü1 (1NÇZ): ú{w¶kwïæ37ñåï (2019/5/19), .
723838. [wï (S)] (êÊu) NXåCÌw¶ÎÌ»óÆj[Y̪Í|³EõÌw¶ÎÉð§Â€CvOÌJÉü¯Ä|. RcTq1, ºzq1, ç®Bü1 (1NÇZ): ú{w¶kwïæ37ñåï (2019/5/19), .
723839. [wï (S)] (êÊu) °«Au~AÇOÌú{l2^Aa³ÒÌt@\áºð\ª·égDwIöqÍ?|serial biopsyÉæé¢|. ç®Bü1, ŒŽÜÇ©1, RÝMm, åàîi (1NÇZ): æ62ñú{AawïNwpWï (2019/5/23-25), åä.
723840. [wï (S)] (êÊu) ®ìÃ@ÆWcž_Ã@ÌRoChZs[ðKpµœêá`Îl٣̢jqw¶ª©ÈRg[ŽðçñŸvZX`. Î˹Û1, RcTq1, ç®Bü1 (1NÇZ): ú{Õ°®ìwïæ27ñwpåï (2019/9/14), .
723841. [wï (S)] (êÊu) åw¶NîÌWcðÎÛƵœO[vvOÉַ逮ü̪Í. Î˹Û1, RcTq1, å¬mv1, ç®Bü1 (1NÇZ): æ57ñSåwÛÇ€Wï (2019/10/9), Dy.
723842. [wï (S)] (êÊu) K10ÚÆ®«ÆÌÖA©çÝœAåwVü¶Ìž_NÌÁ¥: 3NÔÌär©ç. RcTq1, Î˹Û1, å¬mv1, ÍŽvüq, c äÝ, §Ô@X, ¬J^ä, ç®Bü1 (1NÇZ): æ57ñSåwÛÇ€Wï (2019/10/9), Dy.
723843. [wï (S)] (êÊu) ìåw¶ÌÌg¬ªèÆ»ÌüPÖÌæègÝ. ŒŽÜÇ©1, gcFI1, {npY1, @E1, ìãüqã1, cçH1,
û@e1, OìÀq1, ç®Bü1 (1NÇZ): æ57ñSåwÛÇ€Wï (2019/10/9), Dy.
732149. [wï (€ïEnûï)] (V|WE)yV|WE2: åw³EõÆÛÇÌL@IÈAgðÚwµÄzJEZ[̧ê©ç³EõÆÌAgÌ\z. RcTq (NÇZ): æ57ñSåwÛÇŠïÖbMznûï€Wï (2019/8/29-30), ÍŽ, æ57ñSåwÛŠïÖbMznûï 2019; p.41-4.
732150. [wï (€ïEnûï)] (V|WE)yV|WE1: LøÈw¶fÌÀ»Éü¯Äzã[uÉÍ, àÁÆÅ«é±Æª é|ÁÉáÌdw¶ÌPAÉ¢Ä|.
û@e (NÇZ): æ57ñSåwÛÇŠïÖbMznûï (2019/8/29-30), ÍŽ.
733741. [wï (nûïE€ï)]yã\zç®Bü (NÇZ): æ57ñSåwÛÇŠïÖbMznûï€Wï (2019/8/29-30), ÍŽ.
733742. [wï (nûïE€ï)] (êÊu) ±Ì³Ò³ñÍñT^IAa«tÇ©? ŒŽÜÇ© (NÇZ): æ57ñú{AawïÖbMznûï (2020/1/18), ¡l.
'18NxÈOª
[wp_¶]
'18-540006. [»ÌŒ (wïñ)]yæ56ñSåwÛÇ€Wïzåw¶Ìâ¹ÉηéNÇZ^[ÌLøÈÈÕîü̧Ì\z. gcFI1, àVRbg1, ŒŽÜÇ©1, Œ (1NÇZ): CAMPUS HEALTH. 2019/3: 56 (1): 119-21.
k¢åwa@
Åì
[wp_¶]
120042. [Ž] Åì·ªF¯·éÅìt·Ììzµœ¬ÊÆÖA·éRseV[. Ê{çb (Åì): ú{ãÃEa@Çwï 2019/4; 56 (2): 71-9.
120043. [Ž] ~}ÅìtÌ^[~iPAÉηéÔxÌÀÔ. Öüq1, ÉRN2, Raü1 (1Åì, 2ºÉ§§åwÅìw): Åì€W^ 2019/7; 26: 31-40.
120044. [Ž] ÅìÇÒÌRseV[ÌTOªÍ. Ê{çb (Åì): ú{ÅìÇwï 2019/12; 23 (1): 160-7.
120045. [Ž] îÒÌÏÉIp㣰𣷜ßÌÅìPAm§Éü¯ÄÌ¢|îå°à³ÒÌp㣰ɚ¯éàsƺØÍÆÌÖA©ç|. HìLœ1, Rh2 (1Åì, 2Åìw): ÅìlÔHwï 2020/3; 1: 31-8.
510012. [à] Narrative review on attitudes toward organ donation of undergraduate nurse students. Tsubaki M1, Tougo S, Kobayashi M, Arakawa S1, Yoshida K2: Jpn J Nurs Sci 2020/1; 17 (1): e12291. (Öüq1, rì@1, gcê¬2: 1Åì, 2åAí)
522136. [uÀ]yAÚ: Margaret NewmanÌNÌ_ɱ©êœÆ«, Ȝ̪ñÅìÀHͳçÉJ©êé`ªñ³ÒEÆ°ÆÌPAOp[gi[Vbvð̱µæ€`(æ5ñ)zNewman_ɱ©êœæègÝðʵÄJŠµœÅì`[̬·`ªñ³ÒEư̶Kµ§ÄŒµðx·éOÅìtÌwKïðÆšµÄ`. ÊüRI1, O^2, çøüoq1 (1Åì, 2 ìåwÅìw): ªñÅì 2019/5; 24 (4): 399-402.
522137. [uÀ]yoC^EABC]¿ðgA[WÅàg¢±È·!? úíféçÐQÜÅÇñÈêÊÅàð§Â, øÊIÈIÊÉ©¹È¢]¿Ìµ©œðgɯæ€!`z~}gA[W: ~}OÉš¯é@àgA[W. Raü (Åì): Wfgm[g 2019/5; 21 (3): 482-7.
522138. [uÀ]yÅì: næÉìðL°œÅìÇ\Íð|a@ÅìÇÒÌ}lWg_[: ú{ÅìŠïÅ|zua@ÅìÇÒÌ}lWg_[ ú{ÅìŠïÅvÌÓ` (Àkï). gìvüq1, Ê{çb2, cü²ã3, cTq4 (1ú{ÅìŠï, 2Åì, 3ÃìãÃåw, 4Ü¿Ìi[XXe[Vªçã): Åì 2019/6; 71 (9): 39-44.
522139. [uÀ]yÁW: Äl!@¬ÅìêåÅìtÌÀHÆðzuÅìOvâuêååvÅô·é¬ÅìêåÅìt@
D¬ÖAaÉš¯évANeBuEhÌ®. åJ®ç (Åì): ¬Åì 2019/6; 42 (6): 669-73.
522140. [uÀ]yÁW3: lHÄzÇÌÌÅì`NICUE¬ÈEdÇÒ{ÝÅÌÀÛ`z¬È (¬ICU) ÅsíêélHÄzÇ`VlX^btÖÌw±ÌHv`. äÏØä (Åì): ±ÇàÆÆ°ÌPA 2019/6; 14 (2): 65-71.
522141. [uÀ]yÁW: «ûüv, ªÁÕèlÂ!zI. ãtÆ""«û""Ì»ó@ÅìȨê©ç; ÅìtÆ""«û""̱ê©ç. Ê{çb (Åì): ~}ãw 2019/8; 43 (9): 1142-7.
522142. [uÀ]yÁW: KâÅìtªîüÅ«éîÒÌ|t@[}V[užçµœ¢vÁÄŸÁÄ¢¢!zuòªœ¢váðÅìtªAZXgµÄ©ŠœÛè (Àkï). ºäIq1, y®uÛ2, ¡R2, Raü2 (1PA[YKâÅìnre[VÍŽì, 2Åì): KâÅìÆîì 2019/9; 24 (9): 644-51.
522143. [uÀ]yAÚ: rWB¬Éü¯Ä!@ê]EêCÅÈ¢gZNVzuÌXyVXghpEç¬Ex (æPñ)zÅìt·ÉæéZNVzu\[X: i[XÖηépEç¬ExÌSÌ. ßq1, ß¡ÜäÝ1, âºqìq1, TÎçq1, RìÓÝ¿q1 (1Åì): i[X}lW[ 2019/9; 21 (7): 42-7.
522144. [uÀ]yAÚ: rWB¬Éü¯Ä!@ê]EêCÅÈ¢gZNVzuÌXyVXghpEç¬Ex (æ2ñ)zrWÆA®µœ\[X: i[XpÌœßÌc[ðp¢œ©©íè. âºqìq1, ß¡ÜäÝ1, TÎçq1, ßq1, RìÓÝ¿q1 (1Åì): i[X}lW[ 2019/10; 21 (8): 63-9.
522145. [uÀ]yÁW: »Ìlçµ¢¶ðxŠé§ÍÅìz5-1. AJ·é§Í³ÒðxŠéPA|³ÒðxŠédgÝÌðà; YÆÛtÌ_©ç. åtP1, ºifê2, Öüq3, ¡ãGã4 (1ÅlE±, 2ºaåwÛãÃw, 3Åì, 4ºaåw¡ªua@): Õ°§Í 2019/10; 35 (11): 1387-94.
522146. [uÀ]yÁW: dÇÈqÇàÌiŠðð·é; ©Š¹È¢ÇóÌ]¿z[dÇÈqÇàÌiŠðð·éœßÌæègÝ]
BPICUÉš¯éÁÉEÁÃÇÌÀÛ; ÅìtÆãtÌŠ. É¡Fq (Åì): ¬Åì 2019/10; 42 (11): 1405-9.
522147. [uÀ]yAÚ: rWB¬Éü¯Ä!@ê]EêCÅÈ¢gZNVzuÌXyVXghpEç¬Ex (æ3ñ)zZNVzuÌêåÅìtEFèÅìtÖÌÅìt·Ì©©íèÉÖ·éá¢`ZNVÌrWôèÉÅ_ðÄÄ`. ß¡ÜäÝ1, TÎçq1, âºqìq1, ßq1, RìÓÝ¿q1 (1Åì): i[X}lW[2019/11; 21 (9): 72-7.
522148. [uÀ]yAÚ: rWB¬Éü¯Ä!@ê]EêCÅÈ¢gZNVzuÌXyVXghpEç¬Ex (ÅIñ)zZNVzuÌêåÅìtEFèÅìtÖÌÅìt·Ì©©íèÉÖ·éá¢`\[Xi[XÌpEç¬Ex`. TÎçq1, ß¡ÜäÝ1, âºqìq1, ßq1, RìÓÝ¿q1 (1Åì): i[X}lW[2019/12; 21 (10): 77-81.
522149. [uÀ]yÁW: ©çwÑ, ¶«éÍðçÞ||[gtHIªÆç·»êŒêÌLAz¡¡ÌÉÂȪé|[gtHI@ú{Ô\HcÅìåwÌLAfUCì¬ÉæègñÅ. OY^I (Åì): Åì³ç 2019/12; 60 (12): 1008-9.
522150. [uÀ]yÁW1: Ÿú©çÅ«éNÅàÅ«é^®íáQðøŠœ³Ò³ñÌ|WVjOEÌÊÏ·z<ÅèpÒ> 04. ÅpãÌ|WVjO`ÀÃ`. ÖªRÀ1, gŽçb1, ì¢CŸ2 (1Åì, 2nr): ®`OÈÅì 2020/2; 25 (2): 114-6.
522151. [uÀ]yÁW1: Ÿú©çÅ«éNÅàÅ«é^®íáQðøŠœ³Ò³ñÌ|WVjOEÌÊÏ·z<ÅèpÒ> 05. ÅpãÌÌÊÏ·`ÂçÊÌ€çÊ`. ÖªRÀ1 gŽçb1, ì¢CŸ2 (1Åì, 2nr): ®`OÈÅì 2020/2; 25 (2): 117-20.
522152. [uÀ]yÁW1: Ÿú©çÅ«éNÅàÅ«é^®íáQðøŠœ³Ò³ñÌ|WVjOEÌÊÏ·z<šÖßèpÒ> 08. šÖßpãÌ|WVjO. ¹Fî1, ¬ÑRG1, oûzØ1 (1Åì): ®`OÈÅì 2020/2; 25 (2): 121-4.
522153. [uÀ]yÁW1: Ÿú©çÅ«éNÅàÅ«é^®íáQðøŠœ³Ò³ñÌ|WVjOEÌÊÏ·z<šÖßèpÒ> 09. šÖßpãÌÌÊÏ·. ¹Fî1, ¬ÑRG1, oûzØ1 (1Åì): ®`OÈÅì 2020/2; 25 (2): 125-7.
522154. [uÀ]yÁW: ICUüº©çÞ@Öü¯ÄÅ«éxz[ddzÒÌÞ@Éü¯œxÌÀÛ] ¬³ÒÉš¯éÞ@Éü¯œxÌ»óÆÛè. åJ®ç (Åì): dÇWPA 2020/2; 18 (6): 49-53.
522155. [uÀ]yæ1ÁW: }«úŸ©ç±»æègÞ׫~}EW¡ÃÌæÉš¯éIúPAzPart3 ÅìtªæègÞ~}EW¡ÃÌæÉš¯éIúPA. ÒŒvüq (Åì): ÅìZp 2020/3; 66 (3): 241-4.
522156. [uÀ]yAÚ: ¡ÃIðÉš¯éÓvèxzu¡ÃÌ~Ep±vðlŠé (æ3ñ): ÓvèÉš¯é@Iâè. ÒŒvüq (Åì): ÅìZp 2020/3; 66 (3):305-8.
[@]
620099. [wp (ªS·M)]y¬ÌüÞ@x (¬Åì2019N7§)zÅìtÌðÆxÌÀÛ@
AOÅs€ü@OÊk©çnÜéüÞ@xÌÀÛ, p.1003-10. غäÝq (Åì), éæE\¬: cõb, Öé·oÅ, , 2019/7s.
620100. [wp (ªS·M)]ygA[Wi[XKChubN2020zV. ÎÛÊÌgA[W@1. ¬. 2. Äz¢ï, p.178-81. ìãåã (Åì), ÄC: êÊÐc@l ú{~}Åìwï, Ò: êÊÐc@lú{~}Åìwï gA[WÏõï, Öé·oÅ, , 2019/10s.
620101. [wp (ªS·M)]yzÂínre[VÌ_ÆZp üùæ2ÅzV nre[V (_)@Snre[V{s̳ÒÇ, p.299-306. âºMü1 (1Åì), Ò: c@ì2, ŒiÄF2 (2ãÃq¶w), WJr
[Ð, , 2020/3s.
[wïE€ï]
721020. [wï (S)] (ÁÊu) FmÇÌ é³ÒÆÌR~
jP[VXL. åŒRÁ¢ (Åì): æ16ñú{zÂíÅìwïwpWï@ (2019/11/2), .
722254. [wï (S)] (V|WE) PAÌ»ÛðÐàÆ_@Newman_ɱ©êœÅìÀH. çøüoq (Åì): æ24ñú{ÉaãÃwïwpåï (2019/6/22), _Þì, Palliative Care Research 2019/6; 14 (Suppl): S172.
722255. [wï (S)] (V|WE) îñð§·éÅìÇÒÍu¬×vð§·é (ú{ãÃîñwïÅìï@WCgéæ). Ê{çb (Åì): æ23ñú{ÅìÇwïwpWï (2019/8/24), V.
722256. [wï (S)] (V|WE)yú{ãÃîñwïÅìïWCgéæzîñð§·éÅìÇÒÍu¬×vð§·é|ÀHá|. Ž
(Åì): æ23ñú{ÅìÇwïwpWï (2019/8/24), V.
722257. [wï (S)] (`Z~i[) ãÃîñÌpÉæéÅìEÌƱøŠ». Ê{çb (Åì): æ23ñú{ÅìÇwïwpWï (2019/8/24), V.
722258. [wï (S)] ([NVbv)yÆ°xêåÅìtªs€Åì®ÌÁ«ðŸç©É·éz¬ªñáðp¢œWFlXgÆXyVXgÌÅìîü©çÌ¢. ©Iq1, äãæq2, Näåã2, éØ@a3, À@»4, ŒâR¢5, ¬òDG6, ¬rÞ6 (1Åì, 2CåwãwÛwÈ, 3Æ°xT[`Z^[, 4F{åw, 5_Þ짧Ûåw, 6Cåwãwt®a@): æ26ñú{Æ°ÅìwïwpWï (2019/9/15), s, æ26ñú{Æ°ÅìwïwpWïvOŽ^ 2019/9; p.113.
722259. [wï (S)] (V|WE) ŒEíÆŠµÄÀH·éSÇOÈèpúÌPA. à¡÷ (Åì): æ16ñú{zÂíÅìwïwpWï (2019/11/2), .
722260. [wï (S)] (V|WE) ãÃÌÒÆÈÁœãtÌêèÌ©çxÉ¢ÄwÔ. ìJOq (ãÃx): æ9ñú{ãÃRtNgE}lWgwïwpåï (2020/1/25), xR, æ9ñú{ãÃRtNgE}lWgwïwpåïvOEŽ^W 2019/12; p.16.
723844. [wï (S)] (êÊû) {ÝàÉš¯éêåÅìtEFèÅìtÌLñ®Ì²žñ. tªbq1, ÂúåGº1, Ž{ür1, ŒŽm}1, à¡÷1, XÀbÀ1, Ë{çbü1, cvÛüçã2, ²¡vq3 (1Åì, 2k¢€a@Åì, 3k¢åwfBJZ^[Åì): æ6ñú{CNSÅìwï (2019/6/1), €m.
723845. [wï (S)] (êÊu) RªñÜ^ÌÇmÛðÅìtªs€œßÉKvÈ\ÍÉÖ·éãëü«€. ÌìD1, éJc1 (1Åì): æ21ñú{ãÃ}lWgwïwpï (2019/7/20), €m, ú{ãÃ}lWgwïG 2019/7; 20 (Suppl): 283.
723846. [wï (S)] (êÊû) ÐQÌðïÉš¯éÅìtšæÑòÜtÌAgÌ èû. Raü1, Tä@2 (1Åì, 2lV€åw): ú{ÐQãÃòÜtwïæ8ñwpåï (2019/7/21), {é.
723847. [wï (S)] (êÊu) ü@OÊk©çnÜéœEíAgÆÞ@ã̶x|}g[ggðó¯œqÇàÌ»ÌÆ°ÖÌxðUèÔÁÄ|. غäÝq (Åì): ú{¬Åìwïæ29ñwpWï (2019/8/3), kC¹, ú{¬Åìwïæ29ñwpWïuW 2019/7; p.168.
723848. [wï (S)] (êÊu) ¬ÌæÌü@xÉš¯éü@OÊkÌð|OÅÌü@OÊkðUèÔÁÄ|. IŽËq1, غäÝq1, É¡ÝžÙ1, ŒàÀq1 (1Åì): ú{¬Åìwïæ29ñwpWï (2019/8/3), kC¹, ú{¬Åìwïæ29ñwpWïuW 2019/7; p.196.
723849. [wï (S)] (êÊû) ¬Åìp±³çvOÉ¢ÄlŠæ€|2NÚÈ~̳çÇ€µÄ¢Ü·©?|. غäÝq (Åì): ú{¬Åìwïæ29ñwpWï (2019/8/4), kC¹, ú{¬Åìwïæ29ñwpWïuW 2019/7; p.100.
723850. [wï (S)] (êÊû) ¬W¡ÃÌæÅãtªšŠœEnd-of-Lifeð}Šé³Æ°ÆÌÝìpÌvZX. Ž@b1, ¬ÐÅq2 (1Åì, 2Åìw): ú{¬Åìwïæ29ñwpWï (2019/8/4), kC¹, ú{¬Åìwïæ29ñwpWïuW 2019/7; p.116.
723851. [wï (S)] (êÊû) LA[e[VÌøÊ|LA`¬xƬÅìÌ¿üãðÚwµÄ|. κç¶1, ŒàÀq1, iª@õ1, ²XØüaq1, ·Jzb1, œÑÞc1, à¡ÎK1, Ããq1, Ò@üq2 (1Åì, 2Åìw): ú{¬Åìwïæ29ñwpWï (2019/8/4), kC¹, ú{¬Åìwïæ29ñwpWïuW 2019/7; p.131.
723852. [wï (S)] (êÊû) ÅìâÒç¬Éü¯œ€CÌæègÝ. R{]gq1, äÍq1, ¹Fî1, Hcì^Rü1, @E1, ¡cçb1, nq1, Ü¡zq1, Jûzq1 (1Åì): æ23ñú{ÅìÇwïwpWï (2019/8/23), V, æ23ñú{ÅìÇwïvOŽ^ (WEB) 2019/8; p.O19-2.
723853. [wï (S)] (êÊû) ÅìtÆÅìâÒÆÌŠÉ¢ÄÌæègÝ`p[gi[Vbvi[VOVXeðpµÄ`. ¡cçb1, ]cêd1, gbq1, M1 (1Åì): æ23ñú{ÅìÇwïwpWï (2019/8/23), V, æ23ñú{ÅìÇwïvOŽ^ (WEB) 2019/8; p.O19-3.
723854. [wï (S)] (êÊû) }«úa@Éš¯éÅìâÒç¬`â²_[ðàÆɵœlÞç¬VXeÌ\z`. Ü¡zq1, äÍq1, Hcì^Rü1, ¹Fî1, @E1, R{]gq1, ì[[G1, ÍcœÁ1, à_cq1, nq1 (1Åì): æ23ñú{ÅìÇwïwpWï (2019/8/23), V, æ23ñú{ÅìÇwïvOŽ^ (WEB) 2019/8; p.O20-2.
723855. [wï (S)] (êÊû) }«úa@Éš¯éÅìâÒç¬`â²_[ì¬ÖÌæègÝ`. äÍq1, Ü¡zq1, ¹Fî1, ì[[G1, ÍcœÁ1, à_cq1, @E1, nq1, Hcì^Rü1 (1Åì): æ23ñú{ÅìÇwïwpWï (2019/8/23), V, æ23ñú{ÅìÇwïvOŽ^ (WEB) 2019/8; p.O20-4.
723856. [wï (S)] (êÊû) W¡ÃºÉz®³êœV²ÅìtÖÌConcept Based Learning ðp¢œ³çIxÌLq. R{À (Åì): æ23ñú{ÅìÇwïwpWï (2019/8/23), V, æ23ñú{ÅìÇwïvOŽ^ (WEB) 2019/8; p.O22-3.
723857. [wï (S)] (êÊû) CtH[VEGNX`FW19@Ï»ðææèµÄs®Å«éa@ÅìÇÒðߎµÄ`ua@ÅìÇÒÌ}lWg_[ ú{ÅìŠïÅvÌp`. gìvüq1, Ê{çb2, â@m3 (1ú{ÅìŠï, 2Åì, 3{èPmïa@): æ23ñú{ÅìÇwïwpWï (2019/8/23), V.
723858. [wï (S)] (êÊû) CtH[VEGNX`FW40@uz«IwKvÌøÊIpû@É¢ÄÌÍõ. O}1, R{À1, ÂöGº1, ŽNî1, ¡cºî1, çØÇÞ1, ]cêd1, {Jº2, éØ«÷2, x@Çé2 (1Åì, 2RjJ~m^): æ23ñú{ÅìÇwïwpWï (2019/8/24), V, æ23ñú{ÅìÇwïvOŽ^ (WEB) 2019/8; p.IE-40.
723859. [wï (S)] (êÊu) rWÆA®µœ\[Xi[XpÌœßÌÊkV[gì¬Æ]¿: ZNVzu\[Xi[XÖÌÅìÇÒÌÖíè. âºqìq1, ßq1, TÎçq1, ß¡ÜäÝ1, RìÓÝ¿q1, Ê{çb1 (1Åì): æ23ñú{ÅìÇwïwpWï (2019/8/24), V, æ23ñú{ÅìÇwïvOŽ^ (WEB) 2019/8; p.P6-22.
723860. [wï (S)] (êÊu) CRCÌƱÉí¹œÔÇÌæègÝ|·oÎð±üµÄ|. 캡úq1, ¬ò@w1, Øhq1, Œöüqq1, ¬{Rå1, Xîq1, üËìaã1, ¡cÄê2, FJY¡3 (1Åì, 2òÜ, 3Õ°€EvWFNg): æ19ñCRCÆÕ°±Ì èûðlŠéïc 2019 in YOKOHAMA (2019/9/14), _Þì, æ19ñCRCÆÕ°±Ì èûðlŠéïc 2019 in YOKOHAMA vOEŽ^W 2019/8; p.139.
723861. [wï (S)] (êÊu) SsS¡ÃãÉêÉ«ðFßéSsS³Ò̶Ý. Rèèü1, ¡cSœ2, 箵C1, çc@2, ¬Ñ@2, ¢ÃÆ2 (1Åì, 2zÂíà): æ23ñú{SsSwïwpWï (2019/10/4), L, æ23ñú{SsSwïwpWïvOEŽ^W 2019/10; p.399.
723862. [wï (S)] (êÊû) O~œ~}Z^[~}OÉš¯éO[tPAtH[}bgÌ^pÉ¢Ä. ¯ì³T1, ]ãç»1, m»À1, ¡açü1 (1Åì): æ21ñú{~}ÅìwïwpWï (2019/10/5), çt, æ21ñú{~}ÅìwïwpWïŽ^ 2019/9; p.O15-2.
723863. [wï (S)] (êÊû) |eVhi[ÉηéÅìtÌÓvoÆîüÌÀÛ`C@àhi[R[fBl[^[̳ç©çÝŠœàÌ`. ãºR1, W{³Æ1, Ž@b1 (1Åì): æ55ñú{ÚAwïï (2019/10/11), L, ÚA 2019/9; 54 (ïÕ): 213.
723864. [wï (S)] (êÊû)gíEgDñÌÓvÉηéAP[ghðgpµœIvVñŠÌøÊ. Öüq1,2, ºifê2, Fò^|3, ¡ãGã2, ·ìFIq1, gcê¬4,5 (1Åì, 2ºaåwåw@ÛãÃw€È, 3ºaåw¡ªua@, 4V¢IãÃEæ[ãÃ, 5åAí): æ55ñú{ÚAwïï (2019/10/11), L, ÚA 2019/9; 54 (ïÕ): 213.
723865. [wï (S)] (êÊu) éÔExúhi[îñÉηéSÅìÇÒÖÌ®ÎÌgå. Ž@b1, rì@q1, ßq1, éØü}q1, ²¡^Iq1, gcê¬2,3 (1Åì, 2V¢IãÃEæ[ãÃ, 3åAí): æ55ñú{ÚAwïï (2019/10/11), L, ÚA 2019/9; 54 (ïÕ): 286.
723866. [wï (S)] (êÊu) œEíÉæé@àhi[R[fBl[^[ÌðöÉü¯³çIæègÝ. Ö@ên1, ãºR1, ¬³]¢Þ1, Ž@b1, rì@q1, ¡a@q1 (1Åì): æ55ñú{ÚAwïï (2019/10/11), L, ÚA 2019/9; 54 (ïÕ): 332.
723867. [wï (S)] (êÊu) FmÇÌlÆÌR~
jP[VXLAbvZ~i[. ¬RKã1, ÐäüØq1, åŒRÁ¢2, sr€3, acÞüq4 (1Åìw, 2Åì, 3a@Åì, 4k¢€a@Åì): æ20ñú{úFmÇwïwpåï (2019/10/20), ò, ú{úFmÇwï 2019/10; 12 (3): 50.
723868. [wï (S)] (êÊû) «úÅìwÀKÉš¯éÕ°³õ§x±üÌ]¿ (æ1ñ)|w³õÆÕ°³õÌöÆßö]¿Ìär|. ]üä1, éº1, çØÇÞ1, {{Gü1, öcŸ1, Jûzq1, ŒŽNü2, É¡Tç2, vÛÜ2 (1Åì, 2Åìw): æ50ñú{Åìwï-ÅìÇ-wpWï (2019/10/23), ŒÃ®, æ50ñú{Åìwï-ÅìÇ-wpWïŽ^W 2019/10; p.134.
723869. [wï (S)] (êÊû) «úÅìwÀKÉš¯éÕ°³õ§x±üÌ]¿ (æ2ñ)|Õ°³õÉæéÀKw±Ì¬ÊÆÛè|. éº1, ]üä1, çØÇÞ1, {{Gü1, öcŸ1, ŒŽNü2, É¡Tç2, vÛÜ2 (1Åì, 2Åìw): æ50ñú{Åìwï-ÅìÇ-wpWï (2019/10/23), ŒÃ®, æ50ñú{Åìwï-ÅìÇ-wpWïŽ^W 2019/10; p.134.
723870. [wï (S)] (êÊû) ü@OIGe[VÌøÊ|æè¶ÒÌ_ÉßïÄ|. ãcüé1, Œºçt1, iäD1, ¹Fî1, àR¶2, î2, »m2, œ®L3 (1Åì, 2®O, 3ãÃq¶w): æ46ñú{ÒÖßwïwpWï (2019/10/26), {è, æ46ñú{ÒÖßwïwpWïvOEŽ^W 2019/10; p.595.
723871. [wï (S)] (êÊû) èwq¶À{ñüãðÚwµœæègÝ|èwq¶iÒƵÄÌi®|. ²¡ºÄ1, nç³@à1, iäD1, ¹Fî1, àR¶2, î2 »m2, œ®L3 (1Åì, 2®O, 3ãÃq¶w): æ46ñú{ÒÖßwïwpWï (2019/10/26), {è, æ46ñú{ÒÖßwïwpWïvOEŽ^W 2019/10; p.603.
723872. [wï (S)] (êÊu) Snre[VÆOÆÌîñð·Éš¯éSsS«\hÌøÊÆÛè. ìÞq1, âºMü1 (1Åì): æ16ñú{zÂíÅìwïwpWï (2019/11/3), .
723873. [wï (S)] (êÊu) ¬€^ÇèpÉš¯épáÌ·Ì¢. ªº^à1, âV¡@j2, äã@º2, {é³s2, äºMV2, àVh÷2, àVrV2, ¬Rqv3, àcŸY2, cü1, iª@ò1, »m2 (1Åì, 2®O, 3åw@ãÃn€È): æ53ñú{€]ÇwïwpWï (2019/11/8-9), Qn.
723874. [wï (S)] (êÊu) hN^[J[o®Éš¯éo®vÔšæÑ»êØÝÔÆÖA·évö. Öüq1, ¡açü1 (1Åì): æ39ñú{ÅìÈwwïwpWï (2019/11/30), Îì, ú{ÅìÈwwïwpWïuW 2019/11; 39 (suppl): 378.
723875. [wï (S)] (êÊu) FèÅìtEêåÅìtªªñ³ÒÌ¡ÃÆAJÌŒ§ÌœßÉmFµÄ¢éàeÉ¢Ä. Rè±q1, ¬ò@2, ªØÚü2, RÝMq1, Ô Íq2 (1éåw, 2Åì): æ39ñú{ÅìÈwwïwpWï (2019/11/30), Îì, ú{ÅìÈwwïwpWïuW 2019/11; 39 (suppl): 756.
723876. [wï (S)] (êÊu) ¬sÒ\h`[Éæé¬sÒéÔxúÎt[Ìì¬. àÜèq1, É¡Fq1, œÑÞc1, åË@µ1 (1Åì): ú{qÇàsÒh~wïæ25ñwpWïÐ倲åï (JaSPCAN HYOGO) (2019/12/22), ºÉ, ú{qÇàsÒh~wïæ25ñwpWïÐ倲åïŽ^W 2019/12; p.288.
723877. [wï (S)] (êÊu) êåÅìtyÑFèÅìtÉæéªñ³ÒÌAJxÌ»ó (æ1ñ). ¬ò@1, ªØÚü1, Ô Íq1, Rè±q2, ²XØ¡êY3 (1Åì, 2éåw, 3V¢IãÃE¡fIãÃ): æ34ñú{ªñÅìwïwpWï (2020/2/23), .
723878. [wï (S)] (êÊu) êåÅìtyÑFèÅìtÉæéªñ³ÒÌAJxÌ»ó (æ3ñ). ªØÚü1, ¬ò@1, Ô Íq1, Rè±q2, ²XØ¡êY3 (1Åì, 2éåw, 3V¢IãÃE¡fIãÃ): æ34ñú{ªñÅìwïwpWï (2020/2/23), .
723879. [wï (S)] (êÊu) dÇ~}³ÒÉš¯éçgu̶Æh{óÔÌ¢. Ÿc]Ô1, Îq@€1, x²lq1, 箢¹2, ¡¬q2, c³a1, cº@q3, ЪSê3 (1Åì, 2h{, 3~œ): æ35ñú{Õ°h{ãÓwïwpWï (2020/2/27), s, WEBŽ^ 2020; p.P-01-7.
723880. [wï (S)] (êÊû) sÇÌoIAZXgfgE-HIGH TECHhÌJ. ÒŒvüq1, rŒTq2 (1Åì, 2ŒÃ®åwåw@ãwn€È): æ47ñú{W¡ÃãwïwpWï (2020/3/6), ŒÃ®, WEBŽ^ 2020; p.OR1-16-13-2.
723881. [wï (S)] (|X^[) ICUÉš¯éœEíJt@XpÉæéIú~}³ÒÆ°PAÖÌe¿ÆÛè. ²ìü¢1, ò@¶Ø1, J@Kê1, Ž@b1, ЪSê2 (1Åì, 2~œ): æ47ñú{W¡ÃãwïwpWï (2020/3/7), ŒÃ®, WEBŽ^ 2020; p.P2-3-9-2.
723882. [wï (S)] (|X^[) ICUÉš¯é}ÏÎÉηéæègÝ. ·Jì¢Áq1, ·àmê1, ÐR@€1, à¡÷1, ¡a@q1 (1Åì): æ47ñú{W¡ÃãwïwpWï (2020/3/8), ŒÃ®, WEBŽ^ 2020; p.P3-1-4-6.
731109. [wï (nûïE€ï)] (ÁÊu) äXªñ³ÒÌACPÆ`[ãÃ. ªöçt (Åì): àòªñT|[eBuPAZ~i[2019 (2019/8/29), Îì.
731110. [wï (nûïE€ï)] (ÁÊu) CKD³ÒÌtÚAÉtsSÅìÍÇ€Öíêé©. ìû¶T (Åì): ·ì§§ÍÅìtïwpuï (2019/12/15), ·ì.
731111. [wï (nûïE€ï)] (ÁÊu) Æ°xêåÅìtÌnæAg. ©Iq (Åì): æ10ñTHPNWï (2020/3/1), ŒÃ®.
732151. [wï (nûïE€ï)] (plfBXJbV)yÛ¶úE§ÍEÚAãÃÌR{zïItÚAãÃ̬÷Éü¯Ä. ìû¶T (Åì): Ã@Iðx×ï (2019/4/27), _Þì.
732152. [wï (nûïE€ï)] (V|WE) RTCÌ`x[VÛÉÂÈ°éû@. ìû¶T (Åì): æ35ñtÚAEÇOÈ€ï (2019/5/17), ò, æ35ñtÚAEÇOÈ€ïvOEŽ^W 2019/5; p.73.
732153. [wï (nûïE€ï)] (plfBXJbV)yslÌ`ChvT|[gÆ: sD¡ÃÆdÌŒ§iV|WEzsD¡ÃÌTvEéÆÌægáÐî. V²_q (Åì): sYÆJÇ (2019/6/26), .
732154. [wï (nûïE€ï)] (plfBXJbV)y~}ãÃÆfBG[V: »ÌÂ\«ÆÛèz~}³ÒÆ°ÖÌÓvèxÆfBG[V. Ž@b (Åì): JAHMæ12ñNåï (2019/7/14), .
732155. [wï (nûïE€ï)] (µÒu) ÅßÌtÚAîÆRTCª©©íéÃ@Iðx. ìû¶T (Åì): æ19ñPD OASIS (2019/11/29), _Þì.
732156. [wï (nûïE€ï)] (V|WE)yð¬Wï
A@J±Â«üPÉÖ·éæègÝ|JÔ©çlŠéÅìÇÆÍ|zÅìâÒÌNLxÉæŸÌæègÝ`a𱊜α\ì¬`. ÍcœÁ (Åì): æ19ñk¢Åì€ï (2019/12/21), _Þì æ19ñk¢Åì€ïvOEŽ^ 2019/11; p.40.
733743. [wï (nûïE€ï)] (êÊû) íñÌãÓvèðxŠég{lÆÆ°Ìbµ¢ÌL³hÉÖ·é»ó. Öüq1,2, ºifê2, ¡ãGã2, ·ìFIq1, gcê¬3,4 (1Åì, 2ºaåwåw@ÛãÃw€È, 3V¢IãÃEæ[ãÃ, 4åAí): æ30ñ_ÞìÚAãwï (2019/6/8), _Þì, _ÞìãwïG 2019/7; 46 (2): 252-3.
733744. [wï (nûïE€ï)] (êÊû) ¬W¡ÃºÉš¯éGhEIuECtEPAÌæègÝ|ÔIP\ÌÙÈéIúðß²µœP[XðUèÔé|. É¡Fq1, ¬³]¢Þ1, äÏØä1, ŽKb1 (1Åì): ú{W¡Ããwïæ3ñÖbMzxwpWï (2019/7/27), R, ú{W¡Ããwïæ3ñÖbMzxwpWïvOEŽ^W 2019/6; p.O4-1.
733745. [wï (nûïE€ï)] (êÊû) ¬W¡ÃºÉš¯éCÇ`
[uÅèÇÌÀÛÆÛè|o@Åèû@ÌÏXã1NÌAP[g²žðàÆÉ|. åvÛtü1, É¡Fq1 (1Åì): ú{W¡Ããwïæ3ñÖbMzxwpWï (2019/7/27), R, ú{W¡Ããwïæ3ñÖbMzxwpWïvOEŽ^W 2019/6; p.O9-2.
733746. [wï (nûïE€ï)] (êÊû) PICUÉš¯éSÇpã³ÒÌüºV~
[VwKÌæègÝ. ÂCSõ1, É¡Fq1, àÜèq1, åvÛtü1 (1Åì): ú{W¡Ããwïæ3ñÖbMzxwpWï (2019/7/27), R, ú{W¡Ããwïæ3ñÖbMzxwpWïvOEŽ^W 2019/6; p.O9-3.
733747. [wï (nûïE€ï)] (êÊû) LøÈw¶fÌÀ»Éü¯Ä@ã[uÉÍ, àÁÆÅ«é±Æª é|ÁÉáÌdw¶ÌPAÉ¢Ä|.
û@e (Åì): æ57ñSåwÛÇŠïÖbMznûï€Wï (2019/8/30), _Þì, æ57ñSåwÛÇŠïÖbMznûï€WïvOŽ^ 2019/8; p.26.
733748. [wï (nûïE€ï)] (êÊû) ©ÓÌOª¢M³ÒÌÆ°ÉεÄÌÆ°Åì`AM
Ìâèð^@í_ðp¢œÆ°îü`. âjyßÞ1, Ë{çbü1, ²ìü¢1, c³a1 (1Åì): MtH[ (2019/8/31), .
733749. [wï (nûïE€ï)] (êÊû) ÐQÖÌæègÝ. ªìÝž«1, acÑçÁ1, ì[[G1 (1Åì): _ÞìPWG (2019/9/18), _Þì.
733750. [wï (nûïE€ï)] (|X^[) ¬, ddzÒÀÌo±Æ»ÌÛè|ECMO
³ÒóHÀõÉDMATªÖ^·é±ÆÌÓ`|. ìãåã1, Ãs¥õ1 (1Åì): æ27ñ¬W¡Ã[NVbv (2019/10/19), åã.
733851. [wï (nûïE€ï)] (êÊû) ®æ³Þðp¢œXg[}nre[VÌøÊ. nÓ¹D (Åì): æ42ñ_ÞìXg[}€ï (2019/11/30), _Þì, æ42ñ_ÞìXg[}€ïvOŽ^W 2019/11; p.9.
733752. [wï (nûïE€ï)] (êÊû) OÉš¯éRRTR[Ì»ó`ORRTv¿€LV[gðpµÄ`. ÀcÁÞq1, ì^Rü1, ìºqü1, KŒõü1,
ã¢ÃÝ1 (1Åì): æ19ñk¢Åì€ï (2019/12/21), _Þì, æ19ñk¢Åì€ïvOEŽ^ 2019/11; p.42.
733753. [wï (nûïE€ï)] (êÊû) @àÉš¯é笶»Ìø¬»ðÚwµÄ`Vl³çSÒÌCúÉÅ_ð ÄÄ`. x]çbq1, Ô Íq1, R{]gq1, ïŽü1, iäD1, éØ@1, çØÇÞ1, Jûzq1 (1Åì): æ19ñk¢Åì€ï (2019/12/21), _Þì, æ19ñk¢Åì€ïvOEŽ^ 2019/11; p.45.
733754. [wï (nûïE€ï)] (êÊû) LA[e[VÌøÊ`LA`¬xƬÅìÌ¿üãðÚwµÄ`. iª@õ1, ²XØüaq1, κç¶1, ì³â©1, ·Jzb1, Ò@üq2, œÑÞc1, à¡ÎK1, ²¡@1, Ããq1, ŒàÀq1 (1Åì, 2Åìw): æ19ñk¢Åì€ï (2019/12/21), _Þì, æ19ñk¢Åì€ïvOEŽ^ 2019/11; p.47.
733755. [wï (nûïE€ï)] (êÊû) tò»Z^[Éš¯éƱüPÉæéÔOαÌíž`ŒEŒEíÆÌŠ`. @E1, É¡Šèq1, ·ª@~1 (1Åì): æ19ñk¢Åì€ï (2019/12/21), _Þì, æ19ñk¢Åì€ïvOEŽ^ 2019/11; p.48.
733756. [wï (nûïE€ï)] (êÊû) DonabedianÌu\¢vußövÉÅ_ð Äœåñá\hÌæègÝ. Ž{ür1, ²¡Çq1 (1Åì): æ19ñk¢Åì€ï (2019/12/21), _Þì, æ19ñk¢Åì€ïvOEŽ^ 2019/11; p.50.
733757. [wï (nûïE€ï)] (êÊû) Îàá³ÒÌüÞ@xÉÖ·éæègÝ. Rüq (Åì): æ19ñk¢Åì€ï (2019/12/21), _Þì, æ19ñk¢Åì€ïvOEŽ^ 2019/11; p.51.
733758. [wï (nûïE€ï)] (êÊû) §ÍÅìÌ¿üãðÚwµœ³çEƱüP`tò»Z^[Éš¯éPDOÌæègÝ`. @E1, É¡Šèq1, ·ª@~1, ²XØŒü1, ¬qÚü1 (1Åì): æ19ñk¢Åì€ï (2019/12/21), _Þì, æ19ñk¢Åì€ïvOEŽ^ 2019/11; p.52.
733759. [wï (nûïE€ï)] (|X^[) ñú̳ÒÆÌÖíè`}«ÇÌŸ³ÉæèAR~
jP[Váª¢Ì é³ÒÖÌîü`. Ô_1, ìãåã1, ¡açü1 (1Åì): æ19ñk¢Åì€ï (2019/12/21), _Þì, æ19ñk¢Åì€ïvOEŽ^ 2019/11; p.57.
733760. [wï (nûïE€ï)] (êÊû) uz«IwKvÌøÊIpû@É¢ÄÌÍõ`ú{ÅìÇwïwpWïCtH[VEGNX`FWJÃñ`. R{À1, ÂúåGº1, ]cêd1, ŽNî1, çØÇÞ1, ¡cºî1, O}2, {Jº3, éØ«÷3, x@Çé3 (1Åì, 2³Åì, 3RjJ~m^): æ19ñk¢Åì€ï (2019/12/21), _Þì, æ19ñk¢Åì€ïvOEŽ^ 2019/11; p.61.
733761. [wï (nûïE€ï)] (êÊû) }«úa@Éš¯éÅìâÒç¬`â²_[ì¬ÖÌæègÝ`. Hcì^Rü1, äÍq1, ì[[G1, ÍcœÁ1, à_cq1, ¹Fî1, @E1, nq1, Ü¡zq1 (1Åì): æ19ñk¢Åì€ï (2019/12/21), _Þì, æ19ñk¢Åì€ïvOEŽ^ 2019/11; p.62.
733762. [wï (nûïE€ï)] (êÊû) }«úa@Éš¯éÅìâÒç¬`â²_[ðàÆɵœlÞç¬VXeÌ\z`. Ü¡zq1, äÍq1, Hcì^Rü1, ¹Fî1, @E1, R{]gq1, ì[[G1, ÍcœÁ1, à_cq1, nq1 (1Åì): æ19ñk¢Åì€ï (2019/12/21), _Þì, æ19ñk¢Åì€ïvOEŽ^ 2019/11; p.63.
733763. [wï (nûïE€ï)] (êÊû) ÅìâÒç¬Éü¯œ€CÌæègÝ. R{]gq1, Jûzq1, Ü¡zq1, Hcì^Rü1, ¹Fî1, @E1, nq1, ¡cçb1, äÍq1 (1Åì): æ19ñk¢Åì€ï (2019/12/21), _Þì, æ19ñk¢Åì€ïvOEŽ^ 2019/11; p.64.
733764. [wï (nûïE€ï)] (êÊû) ªñ³ÒðeÉàÂqÇàÌO[tPAðÀHµÄ¢éãÃÒÌnæAgÅø¢ïŽ. ©Iq1, ûJaq2, Ò²bq3, ¬ÐÅq3, ÑüÞq4 (1Åì, 2a@Åì, 3Åìw, 4³ÚåwÅìw): æ19ñk¢Åì€ï (2019/12/21), _Þì, æ19ñk¢Åì€ïvOEŽ^ 2019/11; p.65.
733765. [wï (nûïE€ï)] (êÊû) ªñ³ÒðeÉàÂqÇàÌO[tPAðÀHµÄ¢éãÃÒÌnæAgÌÀÛ. ©Iq1, ûJaq2, Ò²bq3, ¬ÐÅq3, ÑüÞq4 (1Åì, 2a@Åì, 3Åìw, 4³ÚåwÅìw): æ19ñk¢Åì€ï (2019/12/21), _Þì, æ19ñk¢Åì€ïvOEŽ^ 2019/11; p.66.
733766. [wï (nûïE€ï)] (êÊû) NICUÉš¯éCÇà}dzÒÌøÁ±Ìo±. AcÊsq1, RÝüÛ1, ŒàÀq1 (1Åì): æ19ñk¢Åì€ï (2019/12/21), _Þì, æ19ñk¢Åì€ïvOEŽ^ 2019/11; p.67.
733767. [wï (nûïE€ï)] (êÊû) ¬W¡ÃºÉš¯éÞ@xJt@XÌ»óÆÛèÉÖ·é¢. ÊØ1, É¡Fq1 (1Åì): æ19ñk¢Åì€ï (2019/12/21), _Þì, æ19ñk¢Åì€ïvOEŽ^ 2019/11; p.68.
733768. [wï (nûïE€ï)] (êÊû) àŸ¡ÃOKâÌæègÝ`aÅìtÆÌAgðʵÄ`. ~ìqØq1, ¡cüq1 (1Åì): æ19ñk¢Åì€ï (2019/12/21), _Þì, æ19ñk¢Åì€ïvOEŽ^ 2019/11; p.72.
733769. [wï (nûïE€ï)] (êÊû) MÖWÌ\zª³ÒÉàœç·Ï»`gxr[ulÔÎlÔÌÅìv_ðp¢ÄUèÔé`. sìçó1, âV¡@b1, ìtü1 (1Åì): æ19ñk¢Åì€ï (2019/12/21), _Þì, æ19ñk¢Åì€ïvOEŽ^ 2019/11; p.75.
733770. [wï (nûïE€ï)] (êÊû) ãtQÁÉæéCVfg|[ggA[WVXeÌVœÈÝ. y®uÛ1,2, räLü1,2, cümb1,2 (1Åì, 2ãÃÌ¿EÀSiº): æ19ñk¢Åì€ï (2019/12/21), _Þì, æ19ñk¢Åì€ïvOEŽ^ 2019/11; p.78.
733771. [wï (nûïE€ï)] (êÊû) R[fBl[^[Éæéå¡ãÌT|[g. Ž@b (Åì): ¡cãÈåwÚAZ~i[ (2020/1/14), ŒÃ®.
733772. [wï (nûïE€ï)] (êÊû) VlÅìtÖð·m[gðp¢œtNVøÊÌ¢. ÄRÄÀ1, ÒŒvüq1, Öüq1, ¡açü1 (1Åì): æ70ñú{~}ãwïÖnûïwpWï (2020/1/18), Qn, ú{~}ãwïÖnûïG 2020/1; 41 (1): 141.
733773. [wï (nûïE€ï)] (êÊû) ªñ³ÒðeÉàÂqÇàÌO[tPAðÀHµÄ¢éãÃÒÌnæAgÌÀÛ. ©Iq1, ûJaq2, ¬ÐÅq3, Ò²bq3, ÑüÞq4 (1Åì, 2a@Åì, 3Åìw, 4³ÚåwÅìw): ßa³Nx_Þì§ÅìŠïÍŽxÅì€\ï (2020/1/18), _Þì, ßa³Nx_Þì§ÅìŠïÍŽxÅì€\ïW^W 2020/1; p.4.
733774. [wï (nûïE€ï)] (|X^[) Aa@OÉš¯éRRT®ÌæègÝ`ORRT€LV[g±üÉæéÅìtÌÓ¯ÌÏ»`. ÀcÁÞq1,
ã¢ÃÝ1, ì^Rü1, ìºqü1 (1Åì): ßa³Nx_Þì§ÅìŠïÍŽxÅì€\ï (2020/1/18), _Þì, ßa³Nx_Þì§ÅìŠïÍŽxÅì€\ïW^W 2020/1; p.44-7.
733775. [wï (nûïE€ï)] (êÊû) SEEDðó¯éü@³ÒÉηéêÉXN[jOÌæègÝ|¡ÃOãÉmF·éøÊÉ¢Ä|. ¡ä@ç1, ¯ì@1, ìtü1 (1Åì): æ16ñO§B৬ü¹iv}ü¡Ã€ï (2020/1/19), , æ16ñO§B৬ü¹iv}üÃ@€ï-Ž^EL[XChW- 2020/1; p.44.
733776. [wï (nûïE€ï)] (êÊû) OlÇÌÇáÉš¯é¡Ã«ÌIðÆÛ]@ÌÀÛ. ßq1, °I2, cç³üÞ2, ú@2 (1Åì, 2Á»íà): æ19ñÌÚAãÃtH[ (2020/2/15), .
733777. [wï (nûïE€ï)] (êÊû) Ò¹DwÌoYÜÅÌÇ`»Ìl絳𩵜PA`. OY^I1, ì[[G1 (1Åì): æ33ñ_Þìê«q¶wïwpWï (2020/3/7), _Þì.
733778. [wï (nûïE€ï)] (êÊû) ÙŸ³ðL·éDwÖÌüYú`[ƵÄÌÖíè. CVàVlq1, à¹m1, ÎŽ¹D1, ¬Fq1, ¬ììüq1, œÑÞc1 (1Åì): æ33ñ_Þìê«q¶wïwpWï (2020/3/7), _Þì.
Õ°ž
[wp_¶]
120046. [Ž] ACMIA@Éæé^NXZxªèÉEDTAZxªyÚ·e¿|üÇLOTòÆ]LOTòÌär|. yMq»1, äããYØ1, üg1, ÂŽºŸ1, àcêO1, ûLê1, ëìLì1,2 (1Õ, 2Õw): ãwž 2019/7; 68 (3): 514-8.
120047. [Ž] ]gžÉš¯éVXet@XU±ÌîbÆp. ¬ìàVTç1, éØ~q1, ûLê1, ëìLì1,2 (1Õ, 2Õw): ãwž 2019/8; 68 (4): 800-5.
522157. [uÀ]yÁW: úŒÉ\ú¹Ê¶»wEÆužf[^ÆoÁœç|Ä·é©, ñ·é©, êåZtÉA·é©|z2Í \ú¹Êf[^ÆoÁœÌÎ@1. ¶»wžÅ\ú¹Êf[^ªŸçêœç EigE, JE, N[. ¡ºPs (Õ): Medical Technology 2019/5; 47 (5): 409-12.
522158. [uÀ]yAÚ: Õ°žQAzxì¬üg`Ìvªû@Í? ê cìV (Õ): Medical Tecnology 2019/7; 47 (7): 736-9.
540083. [»ÌŒ (wïŽ^)]y_ÞìŽõÇãwïæ84ñãwïzèò^á³Ò©çoµœActinomyces orisÌ1á. ÀB@÷1, èMF1, ¬Ñq¢1, àØ@y1, ñ{öL1,2, acBF2,3, Rzq2,4 (1Õ, 2ŽõǺ, 3äPŽaEŽõà, 4V¢IãÃE¡fIãÃ): _ÞìãwïG 2019/7; 46 (2): 271.
540084. [»ÌŒ (wïŽ^)]y_ÞìŽõÇãwïæ86ñãwïz¿ÊªÍ@Æ16SrRNAâ`qzñðÍðp¢œSalmonella®ÛÌÛí¯èÌ]¿. }äÇq1, ñ{öL1,2, À{Žn1, ÀB@÷1, èMF1, Näc¢1, acBF2,3, Rzq2,4, ûLê1, ëìLì5 (1Õ, 2ŽõǺ, 3äPŽaEŽõà, 4V¢IãÃE¡fIãÃ, 5Õw): _ÞìãwïG 2020/1; 47 (1): 114.
[@]
620102. [wp (ªS·M)]yÛEp±ÜÅ©ŠœISO15189æŸT|[gubN (Õ°ž2019N10§)z¡Part.3 5Í ZpIv@¶ž©çÝœu5.85.9 ÊÌñv, p.1258-62. F¡ŽP1, àcêO1, ûLê1 (1Õ), Ò: œÎŒÈ, ãw@, , 2019/10s.
[wïE€ï]
722261. [wï (S)] (V|WE) ú{dqBM8040GÌTuªÍððpµœLu[VÌär¢. ©R@D1, ¡ºPs1, ¬Rhq1, ªcRI1, ú±Lq1, àcêO1, ûLê1, ëìLì1,2 (1Õ, 2Õw): ú{Õ°ž©®»wïæ51ñåï (2019/10/4), ¡l, ú{Õ°ž©®»wïï 2019/8; 44 (4): 471.
722262. [wï (S)] (V|WE) k¢åwa@Õ°žÉš¯éÕnÀKÌ»ó. ûLê (Õ): æ66ñú{Õ°žãwïwpWï (2019/11/24), ªR, æ66ñú{Õ°žãwïwpWïvO 2019/10; p.102.
723883. [wï (S) (êÊu) o¶ãÉo±µœæV«¡uwjAÌ3á. éØq1, ŒvK1, öŽüqq1, ¡ä@ 1, F¡ŽP1, ê cìV1, c@2,3, ûLê1, ëìLì1,4 (1Õ, 2V¢IãÃEæ[ãÃ, 3êÊE¬EÌ_äXO, 4Õw): æ44ñú{Ž¹gžwïwpWï (2019/4/28), ¡l, Ž¹gžZp 2019/4; 44 (Ž^): S202.
723884. [wï (S) (êÊu) pOffª¢ïÅ ÁœÌÌ1á. öŽüqq1, F¡ŽP1, ê cìV1, éØq1, ŒvK1, ¡ä@ 1, ûLê1, HJ¹j2, CÃMj3, ëìLì1,4 (1Õ, 2aw, 3êÊE¬EÌ_äXO, 4Õw): æ44ñú{Ž¹gžwïwpWï (2019/4/28), ¡l, Ž¹gžZp 2019/4; 44 (Ž^): S205.
723885. [wï (S) (êÊu) S[u¹ÇÌoßÏ@ÉSGR[ÉÄ©µœH¹àÌ1á. H¡ßÇ1, ê cìV1, ¡¯üq1, öŽüqq1, Jß1, F¡ŽP1, ûLê1, ëìLì1,2 (1Õ, 2Õw): æ44ñú{Ž¹gžwïwpWï (2019/4/29), ¡l, Ž¹gžZp 2019/4; 44 (Ž^): S170.
723886. [wï (S) (êÊu) ffÉ궵œå®¬Ùu·pã«úÌSùNt¯Ì1á. OR©šè1, ¡ä±ã1, ŒàVéq1, àäËçt1, åŽ^Iq1, ê cìV2, ìûŸ1 (1k¢åwfBJZ^[, 2Õ): æ44ñú{Ž¹gžwïwpWï (2019/4/29), ¡l, Ž¹gžZp 2019/4; 44 (Ž^): S172.
723887. [wï (S) (êÊu) factitious hypoglycemiaÌÓÊÉÙÈéCXªèLbgªLpÅ Áœ1Çá. yMq»1, ÂŽºŸ1, èLq1, àcêO1, ûLê1, ¡ä¢]2, ¬ì°j2, ëìLì1,3 (1Õ, 2àªåãÓà, 3Õw): æ68ñú{ãwžwï (2019/5/18-19), Rû, ú{ãwžwïŽ^W 2019/5; 68: 84.
723888. [wï (S) (êÊu) nßöÉš¯éHbÆASTELDHEKÌno®ÔÉ¢Ä. LnaÞ1, yMq»1, ¡ºPs1, ¢L1, èLq1, àcêO1, ûLê1, ëìLì1,2 (1Õ, 2Õw): æ68ñú{ãwžwï (2019/5/18-19), Rû, ú{ãwžwïŽ^W 2019/5; 68: 172.
723889. [wï (S) (êÊu) žOvZXÉš¯éìtKXÌÌÀè«É¢Ä. _cmq1, yMq»1, Á¡x1, ÂŽºŸ1, èLq1, àcêO1, ûLê1, ëìLì1,2 (1Õ, 2Õw): æ68ñú{ãwžwï (2019/5/18-19), Rû, ú{ãwžwïŽ^W 2019/5; 68: 188.
723890. [wï (S) (êÊu) t³ÒÌ©AyÑAÉš¯éAöÌär¢. Ñ˶1, yMq»1, É¡í1, ê caä1, OYFT1, àcêO1, ûLê1, ëìLì1,2 (1Õ, 2Õw): æ68ñú{ãwžwï (2019/5/18-19), Rû, ú{ãwžwïŽ^W 2019/5; 68: 387.
723891. [wï (S) (êÊu) CXAiO»ÜÉηéCXªèLbgÌœ«ärÉ¢Ä. yMq»1, ÂŽºŸ1, OYFT1, àcêO1, ÎäŒm2, ÐË^l2, ëìLì1,3 (1Õ, 2ãÃq¶w, 3Õw): æ59ñú{Õ°»wïNwpWï (2019/9/27-29), åä, Õ°»w 2019/9; 48 (suppl 1): 266.
723892. [wï (S) (êÊu) tÇÇOúAabgÌtç¿Éš¯é~gRhAÌZEªôÆ}Cgt@W[É¢Ä. ÎäŒm1, ä{Ÿü1, èËj1, riG÷2, yMq»3, ¬Š@i3, éØpŸ4, ¡ê³T1, s잶1, |Pv5, ÐË^l1 (1ãÃq¶w, 2ritàÈNjbN, 3Õ, 4k¢Ûq¶êåw@, 5ÛãÃåwR€a@tàÈ): æ59ñú{Õ°»wïNwpWï (2019/9/27-29), åä, Õ°»w 2019/9; 48 (suppl 1): 288.
723893. [wï (S) (êÊu) dY_ZxªèÉš¯éyf@ªèòÌîbI«\]¿šæÑÌÀè«É¢Ä. ÂŽºŸ1, yMq»1, ¡ºPs1, èLq1, àcêO1, ûLê1, ëìLì1,2 (1Õ, 2Õw): ú{Õ°ž©®»wïæ51ñåï (2019/10/3-5), ¡l, ú{Õ°ž©®»wïï 2019/10; 44 (4): 518.
723894. [wï (S) (êÊu) AL`¬ªªÍuUSCANNER (E) Ì«\]¿Æ^pøÊÉ¢Ä. yMq»1, Ñ˶1, É¡í1, ê caä1, OYFT1, àcêO1, ûLê1, ëìLì1,2 (1Õ, 2Õw): ú{Õ°ž©®»wïæ51ñåï (2019/10/3-5), ¡l, ú{Õ°ž©®»wïï 2019/10; 44 (4): 538.
723895. [wï (S)] HIVz«³ÒæèoµœHistoplasma capsulatumÌêá. ÀB@÷1, ñ{öL1,2, acBF2,3, àØ@y1, }äÇq1, ¬Ñq¢1, èMF1, Näc¢1, ûLê1, Rzq2,4, ëìLì5, vÄ@õ, TäF (1Õ, 2ŽõǺ, 3äPŽaEŽõà, 4V¢IãÃE¡fIãÃ, 5Õw): æ31ñú{Õ°÷¶šwïïEwpWï (2020/1/31-2/2), àò, ú{Õ°÷¶šwïG 2019; 30 (Suppl 1): 221.
733779. [wï (nûïE€ï)] (êÊu) Ž¹gžªffÉLpÅ ÁœbÒáÌ1á. ŒvK1, H¡ßÇ1, ê cìV1, F¡ŽP1, ëìLì1,2 (1Õ, 2Õw): JSSÖbMz æ41ñnûïwpWï (2019/10/14), , Ž¹gžZp 2020/2; 45 (1): 85.
733780. [wï (nûïE€ï)] (êÊu) @Åo±µœcisA2B3^ÌÇá. c¢Þ1, LnaÞ1, ³ØÇÞ1, cTñ1, âضq1, RÓ°ü1, ¬{üÞ1, àcêO2 (1A, 2Õ): 2019NxúÕZñsxEÖbMxãwžwï (æ56ñ) (2019/10/26), HtŽ.
733781. [wï (nûïE€ï)] (êÊu) W{yILV_[[õFz«×EÉš¯éõF«ÌoIϻɢÄ. äããYØ1, éØI1, ãŽRÀ1, Œ@O1, ¢L1, àcêO1, ûLê1, ëìLì1,2 (1Õ, 2Õw): æ68ñ_Þì§ãwžwï (2019/11/3), ¬cŽ, «ûÆžxÛØ`Vµ¢ã@ßaÉlŠé`vOŽ^W 2019/10; p.32.
'18NxÈOª
[wp_¶]
'18-120005. [Ž] xz³€És[NðŠµœeBpmOÌÕ°IwiÉÖ·é¢. ¬Š@i1, â|S1, Y1, ²Žvüq1, ûLê1, ÎäŒm2, ëìLì1,3 (1Õ, 2ãÃq¶w, 3Õw): ãwž 2018/6; 67 (5): 791-6.
úËü
[wp_¶]
110363. [Ž] Evaluation of a novel reconstruction method based on the compressed sensing technique: Application to cervical spine MR imaging. Takato Y1, Hata H1, Inoue Y2, Matsunaga K2, Hara T2, Komi S1, Nakajima A1: Clinical Imaging 2019/7-8; 56: 140-5. (¡DP1, `@¶1, äãDî2, Œihñ2, Ž@q«2, ¬©³ŸY1, @1: 1úËü, 2úËü (æ))
110364. [Ž] Cortisol-related hippocampal-extrastriate functional connectivity explains the adverse effect of cortisol on visuospatial retrieval. Hakamata Y, Komi S1, Sato E, Izawa S, Mizukami S, Moriguchi Y, Motomura Y, Matsui M, Kim Y, Hanakawa T, Inoue Y2, Tagaya H3: Psychoneuroendocrinology 2019/11; 109: 104310. (¬©³ŸY1, äãDî2, cJ_M3: 1úËü, 2úËü (æ), 3ãÃq¶w)
[wïE€ï]
723263. [wï (S)] (|X^[) 3D ASL CBF æÉš¯éÓMA[`t@NgÉe¿·éöqÌt@gÉæé¢. cõl1, `@¶1, rcNM1, äãDî2 (1úËü, 2úËü (æ)): æ75ñú{úËüZpwïïwpåï (2019/4/13), ¡l, ú{úËüZpwïæ75ñwpåï\eW 2019; p.341.
723264. [wï (S)] (|X^[) 3D ASL CBFæÉš¯éÓ¬A[`t@NgÉηéb}§@ÌøÊÌt@gÉæé¢. cõl1, `@¶1, äãDî2 (1úËü, 2úËü (æ)): æ47ñú{¥C€Âãwïåï (2019/9/21), F{, ú{¥C€ÂãwïG 2019; 39 (Suppl): 290.
733782. [wï (nûïE€ï)] (êÊû) Localize TGÌîbI¢. Ž{Nç1, ¬©³ŸY1, `@¶1 (1úËü): ú{úËüZpwï@æ66ñÖx€\åï (2019/11/16), çt, Öx€\åï2019Ž^W 2019; p.65.
733783. [wï (nûïE€ï)] (êÊû) PROPELLER Multi BladeV[PXÉš¯éT1RgXgÌîbI¢. @1, `@¶1, ¬©³ŸY1 (1úËü): ú{úËüZpwï@æ66ñÖx€\åï (2019/11/17), çt, Öx€\åï2019Ž^W 2019; p.104.
733784. [wï (nûïE€ï)] (êÊu) ãÃ@{sK¥ü³Éº€jãwfÃÉš¯é{ÝÌæègÝ. ŽcŸ1, nç³Äj1, ¢@L1, _{iöñ1, er@h1, äãDî2 (1úËü, 2úËü (æ)): æ92ñú{jãwïÖbMznûï (2020/1/25), , jãw 2020; 57 (1): 37.
òÜ
[wp_¶]
110365. [Ž] Investigating the risk of bone fractures in elderly patients with type 2 diabetes mellitus: a retrospective study. Horii T1, Iwasawa M1, Kabeya Y, Shimizu J, Atsuda K1,2: BMC Endocr Disord 2019/7; 19 (1): 81. (xäj1, âàV^Iq1, úcKêY1,2: 1òw, 2òÜ)
110366. [Ž] Effect of resistance of the exercise band on the peak femoral vein velocity during active ankle flexion. Tsuda K1, Takahira N1,2, Ejiri M, Sakai K1, Sakamoto M, Akamine A1,3: Phlebology 2020/4; 35 (3): 176-183. doi: 10.1177/0268355519865164. Epub 2019 Jul 31. (ÃcWi1, œ®L1,2, âäŸ1, ÔäF1,3: 1åw@ãÃn€È, 2ãÃq¶w, 3òÜ)
110367. [Ž] Polypharmacy and oral antidiabetic treatment for type 2 diabetes characterised by drug class and patient characteristics: A Japanese database analysis. Horii T1, Iwasawa M1, Kabeya Y, Atsuda K1,2: Sci Rep 2019/9; 9 (1): 12992. (xäj1, âàV^Iq1, úcKêY1,2: 1òw, 2òÜ)
110368. [Ž] Determination of factors affecting medication adherence in type 2 diabetes mellitus patients using a nationwide claim-based database in Japan. Horii T1, Momo K, Yasu T, Kabeya Y, Atsuda K1,2: PLoS One 2019/10; 14 (10): e0223431. (xäj1, úcKêY1,2: 1òw, 2òÜ)
110369. [Ž] Comparing treatment intensification and clinical outcomes of metformin and dipeptidyl peptidase-4 inhibitors in treatment-na?ve patients with type 2 diabetes in Japan. Horii T1, Iwasawa M1, Shimizu J, Atsuda K1,2: J Diabetes Investig 2020/1; 11 (1): 96-100. (xäj1, âàV^Iq1, úcKêY1,2: 1òw, 2òÜ)
110370. [Ž] Effects of pharmacist intervention on polypharmacy in patients with type 2 diabetes in Japan. Horii T1, Atsuda K1,2: BMC Res Notes 2020/3; 13 (1): 183. (xäj1, úcKêY1,2: 1òw, 2òÜ)
110371. [Ž] The Population Pharmacokinetics of Rifampicin in Japanese Pulmonary Tuberculosis Patients. Nishimura T, Kohno H, Nagai H, Maruoka D, Koike Y, Kobayashi M1,2, Atsuda K1,2: Drug Res (Stuttg) 2020/5; 70 (5): 199-205. doi: 10.1055/a-1122-8129. Epub 2020 Mar 19. (¬Ñ¹G1,2, úcKêY1,2: 1òÜ, 2òw)
120048. [Ž] ¡ÌãÃ`[ŊǵœHIVŽõÒÌtÚA. îì@°1, ¬Ñ¹G1,2, ¹Áœ1, Îäåã3, gcê¬3,4, acBF5, úcKêY1,2 (1òÜ, 2òw, 3åAí, 4V¢IãÃEæ[ãÃ, 5äPŽaEŽõà): ú{Õ°tÚAwïG 2019/5; 7 (2): 230-6.
120149. [Ž] ov_igEðpµÄ¢éAa³ÒÉš¯éAaÔÇÇÉÖ·éÀÔ²ž. ÑËŒl1, É`Rq1, âV¡\å1, ììçq1,2, RGü1, túäöü1, ¹Omj1, äã@x1, œRi1,2, µ¢áÁ`3, Ž@w1, úcKêY1,4, Rê1,2 (1òw, 2a@òÜ, 3àªåãÓà, 4òÜ): ·èÆAa 2019/6; 8 (1): 138-46.
120050. [Ž] WSLVÌú^ÝvmOÌLp«ÉÖ·é¢. ¬Œq²1,2, ¬òéT1, F³3, ¢ÃÆ3, úcKêY1,4 (1òÜ, 2ŽõǺ, 3zÂíà, 4òw): ú{a@òÜtïG 2019/8; 55 (8): 980-4.
120051. [Ž] ¿û÷tšæÑ¿ûGLX»Ü̬ªªÍ|IESz¿ûòÌoCJšæÑoCJCÊ|. Å@@1,2, cŸœ1, Ð{Tq1, OªË_1 (1òÈåwòw, 2òÜ): ú{VNãwïG 2020/1; 57 (1): 72-80.
521011. [ðà] |t@[}V[ÆòšÝìp. OcÀÔ1, FJY¡2 (1òÜ, 2Õ°€EvWFNg): VNàÈ 2020/2; 1 (2): 261-70.
522159. [uÀ]yÁW: Aa³ÒÌtH[Abv@p±IÈòwIÇƳÒxÌÀHz¡¹Ç/¹¶Ÿ³ðL·éAa³ÒÌp±IÈtH[Abv@Eªñ. îì@° (òÜ): òÇ 2019/7; 70 (8): 94-9.
522160. [uÀ]yÁW3: ZpÒ: Æ°ðª«Þ!@î§Í³ÒÌúí¶ðxŠéPAz1. òÇ. îì@° (òÜ): §ÍPA 2019/10; 25 (10): 926-8.
540085. [»ÌŒ (R)] R: òÜt©çÌVµ¢òšEÅîñ. ß¡¯üq (òÜ): LiSA 2020/2; 27 (2): 204-6.
[@]
620103. [wp (ªS·M)]y_oŸ³ÌÉaPAzPart 1 Çó²ÆÌÉa@1 lE̲@\áQɺ€Çó@B. ÅkE³®Éæé@\áº@òÜtÌ_, p.33. C. áz«Éæé@\áº@òÜtÌ_, p.41. 3 ÄzØáQɺ€Çó@A. ÄzØØÍáº@òÜtÌ_, p.81. B. ÄzíŽõÇ@òÜtÌ_, p.90. 4 ©¥_onáQɺ€Çó@òÜtÌ_, p.118. 5 eáQÉæÁĶ¶éêÉÇó@A. áuÉ, ŽoáQ@òÜtÌ_, p.127. B. ÄzêEÄz¢ïŽ@òÜtÌ_, p.137. E. rÖAgu@òÜtÌ_, p.155. G.¹ñÏ@òÜtÌ_, p.171. H. ž_IêÉ òÜtÌ_, p.177. Œªzq1, Rê2 (1òÜ, 2a@òÜ), Ò: ¬ìübq, ¬ÑNq, ³Mq, RDG, ¬cLá, ìcÁq3, ¢q, ÔäIq (3a@Åì), ìR°, , 2019/7s.
620104. [wp (ªS·M)]y2y[WÅð·éWòš¡Ãt@C@æ3Åz¡_oEž_Ÿ³@30 p[L\a, p.60-1. àäIm, Œªzq1, R¡@, ]Ž³_, |àsî (1òÜ), Ò: ú{AvChEZs
[eBNX (ÀHòš¡Ã) wï, ìR°, , 2019/7s.
620105. [wp (ªS·M)]y2y[WÅð·éWòš¡Ãt@C@æ3Åz¡««îá@63 ««pî, p.126-7. ìžs, {¥q1, xcŒl (1òÜ), Ò: ú{AvChEZs
[eBNX (ÀHòš¡Ã) wï, ìR°, , 2019/7s.
620106. [wp (ªS·M)]y2y[WÅð·éWòš¡Ãt@C@æ3Åz¡««îá@64 œ«î, p.128-9. ìžs, {¥q1, xcŒl (1òÜ), Ò: ú{AvChEZs
[eBNX (ÀHòš¡Ã) wï, ìR°, , 2019/7s.
620107. [wp (ªS·M)]y2y[WÅð·éWòš¡Ãt@C@æ3Åz¡««îá@65 M«D
žÇ, p.130-1. ìžs, {¥q1, ÍV (1òÜ), Ò: ú{AvChEZs
[eBNX (ÀHòš¡Ã) wï, ìR°, , 2019/7s.
620108. [wp (ªS·M)]y2y[WÅð·éWòš¡Ãt@C@æ3Åz¡««îá@66 RªñòÉæé«SEqf, p.132-3. ¬Ñœê, {¥q1, {{Nh, p@¬a (1òÜ), Ò: ú{AvChEZs
[eBNX (ÀHòš¡Ã) wï, ìR°, , 2019/7s.
620109. [wp (ªS·M)]yAaÃ{O[m[gz1. AaÃ{w±mÌXX@4. òÜt©ç@CXËÌÃ{w± (ÍáQ, _oáQ, ØÍáºðº€³ÒÖÌw±) (»CXÃ@ÆBOTÃ@Ìw±), p.289-95. îì@°1, úcKêY1,2 (1òÜ, 2òw), Ò: àNv, ì@, OãwÐ, , 2019/9s.
620110. [wp (ªS·M)]yzÂínre[VÌ_ÆZp üùæ2ÅzV nre[V (_)@Ÿ³ÇÌœß̳çEw±û@@
BòÇw±Ì_ÆÀÛ, p.285-92. ß¡¯üq1 (1òÜ), Ò: c@ì2, ŒiÄF2 (2ãÃq¶w), WJr
[Ð, , 2020/3s.
620111. [wp (ªS·M)]yaCÆ·è2020@îbÆÀH Expert's Guide (òÇ2020N§)z2. ž_E_onÌaCÆ·è@Es°, s°Ç, p.85-95. Ôä¿©]1, úcKêY1,2 (1òÜ, 2òw), ìR°, , 2020/3s.
[wïE€ï]
713146. [wï (Û)] (|X^[) Adaptation of alanine aminotransferase elevations with therapeutic doses of acetaminophen: an exploratory study in healthy subjects. Maeda M1,2, Tanaka R3, Aso M, Sakamoto Y3, Song I3, Ochiai M1, Saito Y, Maekawa K, Arakawa N, Ohno Y, Kumagai Y3,4: EACPT 2019 (14th Congress of the European Association for Clinical Pharmacology and Therapeutics/æ14ñ¢BÕ°ò¡Ãwïc) (2019/7/1), Stockholm, Sweden, æ14ñ¢BÕ°òwïv| 2019; dqŽ^. (OcÀÔ1,2, cpq3, â{×3, v@êå3, H1, FJY¡3,4: 1åw@ãÃn€È, 2òÜ, 3Õ°€Z^[, 4Õ°€EvWFNg)
713147. [wï (Û)] (|X^[) Comparing clinical characteristics and outcomes of dipeptidyl peptidase-4 inhibitors and metformin in treatment of na?ve type 2 diabetes in an academic teaching hospital in Japan. Iwasawa M1, Horii T1, Kashiwagi S1, Atsuda K1,2: ASHP~bhC[~[eBO2019N (2019/12/9), Las Vegas, USA, ASHP~bhC[~[eBO2019Nv| 2019/12; dqŽ^. (âàV^Iq1, xäj1, ØÊØ1, úcKêY1,2: 1òw, 2òÜ)
723896. [wï (S)] (êÊu) l]hÌZxj^Oðs¢¡Ãªt÷µœ2ÇáÉ¢Ä. ¬Œq²1,2, ñ{öL2, acBF2,3, Rzq2,4, úc KêY1 (1òÜ, 2ŽõǺ, 3äPŽaEŽõà, 4V¢IãÃE¡fIãÃ): æ67ñú{»wÃ@wïï (2019/5/11), , ú{»wÃ@wïG 2019; 67: 1340-7007.
723897. [wï (S)] (êÊu) ILVRhúùÉæéIsIChU«Öé (OIC) ÉηéifWÇÁ^@ÆtF^j\tÜÖÌXCb`O@ÌLp«ÉÖ·é¢ (Ï@€). œRi1, ¹Áœ1, Rèàà2, éØ@š2, {Ôëm1, Ÿcq1, œËöÈ1, Ñ@ol3, à亶3,4, úcKêY1,2 (1òÜ, 2òw, 3, 4V¢IãÃE¡fIãÃ): æ24ñú{ÉaãÃwïwpåï (2019/6/22), ¡l.
723898. [wï (S)] (êÊû) Prospective study to investigate the clinical efficacy of G-CSF for Docetaxel + Cisplatin + 5-Fluorouracil (DCF) chemotherapy in patients with esophageal squamous cell carcinoma (ESCC). Ž[L1, ce2, nç³W¯2, Sakamoto Y, Hara H, Fujii H, Nakajima T, Ando T, Kojima T, Ishijima H, Hosokawa A, Hamamoto Y, Muto M, Tahara M, ¬òaOY2 (1òÜ, 2Á»íà): æ17ñú{Õ°îáwïwpWï (2019/7/19), s, æ17ñú{Õ°îáwïv| 2019; dqŽ^.
723899. [wï (S)] (êÊu) IsIChU«ÖéÉηéifWÆtF^jÖÌXCb`OÌLp«ÉÖ·éÏ@€. œRi1, ¹Áœ1, éØ@š2, œËöÈ1, Ÿcq1, {Ôëm1, Ñ@ol3, à亶3,4, úcKêY1,2 (1òÜ, 2òw, 3, 4V¢IãÃE¡fIãÃ): ú{yCNjbNwïæ53ñåï (2019/7/20), F{.
723900. [wï (S)] (êÊû) AaêåEFèòÜt{¬uKïÌLp«. îì@°1, àVŸ2, yäHq3, 캱q4, œRåO5, îä³F6, úcKêY1,7 (1òÜ, 2Íäa@òÜ, 3¡{ê€Ïa@òÜÈ, 4úØs§a@òÜÈ, 5H.E.CTCGXNjbNòÜÛ, 6¡òs¯a@òÇ, 7òw): æ8ñú{·èÆAawïwpWï (2019/9/8), Dy, æ8ñú{·èÆAawïwpWïvOEŽ^W 2019; Êû: 143.
723901. [wï (S)] (|X^[) ¬1^Aa³ÌÃ{«üãÉηéæègÝ`³Eõü¯Z~i[ÌJÃÆQÁÒÖÌAP[g²ž`. {â@O1, kcêP2, â{~q3, |àDq3, úcKêY1,4 (1òÜ, 2¬, 3Åì, 4òw): æ8ñú{·èÆAawïwpWï (2019/9/7-8), Dy, æ8ñú{·èÆAawïwpWïvOEŽ^W 2019; Êû: 190.
723902. [wï (S)] (|X^[) CRCƱÌS`[§Éš¯éÛèÉü¯œæègÝ. ³ºDq1, 캡úq2, ¬ò@w2, ìûbq2, íc€q1, R{Ÿq1, Öªqü1, ¡cÄê1, FJY¡2 (1òÜ, 2Åì, 3Õ°€EvWFNg): æ19ñCRCÆÕ°±Ì èûðlŠéïc2019 in YOKOHAMA (2019/9/14-15), ¡l, æ19ñCRCÆÕ°±Ì èûðlŠéïc2019 in YOKOHAMAvOEŽ^W 2019; p.162.
723903. [wï (S)] (|X^[) æV«TCgKECXŽõÇë³Éš¢ÄoKVNr÷tàÉæè¡ÃðsÁœ1á. ¬ì²O1, cTå1, yàV@~1, ß¡¯üq1, çÝ@w2, úcKêY1,3 (1òÜ, 2¬, 3òw): æ46ñú{¬Õ°òwïwpWï (2019/9/28-29), Dy, æ46ñú{¬Õ°òwïwpWïvOEŽ^W 2019; p.108.
723904. [wï (S)] (|X^[) Hematological Toxicity of Bendamustine in Patients with Renal Dysfunction. {¥q1, c_«2, éز_2, úcKêY1,3 (1òÜ, 2tà, 3òw): æ81ñú{twïwpWï (2019/10/11-13), , æ81ñú{twïwpWïv| 2019; dqŽ^.
723905. [wï (S)] (êÊû) ìðÇðÇ\hÀ{\ðgpµœº®`OÈpã³ÒÉš¯éð¶XNöqÌJbgItlÌZo. ÔäF1,2, œ®L2,3, àR¶4, î4, ÃcWi3, ŽÀô3 (1òÜ, 2åw@ãÃn€È, 3ãÃq¶w, 4®O): æ46ñú{ÒÖßwïwpWï (2019/10/25), {è, æ46ñú{ÒÖßwïwpWï (DVD) 2019; dqŽ^.
723906. [wï (S)] (êÊû) PembrolizumabPÜÃ@ª{s³êœñ¬×Exà³ÒÉš¯éúSXNöqÌ¢. µöJ[1, X@ÊÄ1, {âDl1, îì@°1, Ž[L1, úcKêY1,2, Œ¬cÙq3, íŽêY3, |ì¢óq3, úgNO3, }^u3, äüç3, äì@3, ¡ê³T4, O¡@v5, vÛc4, ÐË^l4, PØF3 (1òÜ, 2òw, 3Äzíà, 4ãÃq¶w, 5Åìw): æ29ñú{ãÃòwïNï (2019/11/3), ª, æ29ñú{ãÃòwïNïv| 2019; dqŽ^.
723907. [wï (S)] (êÊû) ªñ»wÃ@²»ºÆªñ»wÃ@Z^[ÌƱÊÉÖ·éÀÔ²ž. îì@°1, X³\m2, ²XØõq1, ·àVm¿3, Pä_Ÿ3, gc@³3, nêG2, AŽ³X2, ÂŽY3, úcKêY1,4 (1òÜ, 2ºaòÈåwÕ°òw³ç€Z^[, 3ÇÑåwãwt®a@òÜ, 4òw): æ29ñú{ãÃòwïNï (2019/11/4), ª, æ29ñú{ãÃòwïNïv| 2019; dqŽ^.
723908. [wï (S)] (|X^[) Û¯òÇÉš¯éqEnbgÌvööqÌTõ. ²XØPM1, HcŸ_2, œRi1,3, úcKêY1,3 (1òÜ, 2ÛãÃåwãÃåw€ÈãÃocǪì, 3òw): æ29ñú{ãÃòwïNï (2019/11/4), ª, æ29ñú{ãÃòwïNïv| 2019; dqŽ^.
723909. [wï (S)] (|X^[) xàiupN^LZ{J{v`Ã@Éš¯éD
žÌ»óµÆXNöqÌ¢. ÄRåu1, ª{üä2, ²XØõq1, Ž[L1, ²XØèêY3,4, PØF4, úcKêY1,2 (1òÜ, 2òw, 3V¢IãÃE¡fIãÃ, 4Äzíà): æ29ñú{ãÃòwïNï (2019/11/4), ª, æ29ñú{ãÃòwïNïv| 2019; dqŽ^.
723910. [wï (S)] (êÊû) Û¶ú«ta³ÒÉš¯éY_JVEÌgpªŽJVElÉ^Šée¿. R{I÷1, eDÁ1, úcKêY1,2 (1òÜ, 2òw): æ13ñú{taòšÃ@wïwpWïEï2019 (2019/11/16), F{, ú{taòšÃ@wï 2019; 8 (ÁÊ): S143.
723911. [wï (S)] (êÊû) ݪñ³ÒÉηéRamucirumab + PaclitaxelÃ@ÆRamucirumab + nab-PaclitaxelÃ@Éš¯é`A»Ìär. {âDl1, MŸN1, Yuq1, úcKêY1,2 (1òÜ, 2òw): æ13ñú{taòšÃ@wïwpWïEï2019 (2019/11/16), F{, ú{taòšÃ@wï 2019; 8 (ÁÊ): S147.
723912. [wï (S)] (êÊû) HIVz«O³ÒÉ©©è¯òǪp³êÈ¢vöÌ¢|³ÒAP[g²žÌvÊeLXgªÍ|. ¹Áœ1, yàV@~1, Á¡@Î2, crç1, eBç1, ¬ì²O1, túäöü3, acBF4, úcKêY1,3 (1òÜ, 2Åì, 3òw, 4äPŽaEŽõà): æ33ñú{GCYwïwpWïEï (2019/11/27-29), F{, æ33ñ (2019) ú{GCYwïwpWïEïŽ^W 2019/11; 21 (4): 410.
723913. [wï (S)] (|X^[) Rªñܲ»ºÌ»wÃ@WĞɚ¯éÀÔ²ž. AcäG1, îì@°1, ²XØõq1, cºah1, úcKêY1,2 (1òÜ, 2òw): ú{Õ°îáòwïwpåï2020 (2020/3/21), ãJÃ, æ17ñú{Õ°îáwïv| 2019; dqŽ^.
723914. [wï (S)] (|X^[) k¢åwa@Éš¯éªñòšÃ@T|[g`[Ì®ñ. ²XØõq1,2, ªöçt2,3, Ž©šé2,3, cºah1,2, îì@°1,2, ·c^Rü2,3, úcKêY1,4, ²XØ¡êY2,5 (1òÜ, 2k¢åwa@WwIªñfÃZ^[Ê@¡Ãº, 3Åì, 4òw, 5V¢IãÃE¡fIãÃ): ú{Õ°îáòwïwpåï2020 (2020/3/21), ãJÃ, æ17ñú{Õ°îáwïv| 2019; dqŽ^.
723915. [wï (S)] (êÊû) º®`OÈpã³ÒÉš¯éìðÇðÇ\hÀ{\ÌXNöqÆpãìðÇðÇÌÖA«. ÔäF1,2, œ®L2,3, yàV@~1, ÃcWi2, ŽÀô2, âV4, úcKêY1,5 (1òÜ, 2åw@ãÃn€È, 3ãÃq¶w, 4, 5òw): ú{òwïæ140Nï (2020/3/25-28), s (WebJÃ).
nre[V
[wp_¶]
110372. [Ž] Acute Effects of Whole-Body Vibration Training on Endothelial Function and Cardiovascular Response in Elderly Patients with Cardiovascular Disease. Aoyama A1, Yamaoka-Tojo M2, Obara S3, Shimizu E3, Fujiyoshi K4, Noda C4, Matsunaga A2, Ako J4: Int Heart J 2019/7; 60 (4): 854-61. (ÂRWå1, üÞq2, Ž^ê3, Ž
G¢3, ¡ga4, ìcçt4, ŒiÄF2, ¢ÃÆ4: 1åw@ãÃn€È, 2ãÃq¶w, 3nr, 4zÂíà)
110373. [Ž] Short-Term Change in Gait Speed and Clinical Outcomes in Older Patients With Acute Heart Failure. Tanaka S1, Kamiya K2, Hamazaki N3, Matsuzawa R3, Nozaki K3, Nakamura T4, Yamashita M4, Maekawa E5, Noda C5, Yamaoka-Tojo M2, Matsunaga A2, Masuda T2, Ako J5: Circ J 2019/8; 83 (9): 1860-7. (cLí1, _JŸY2, à_èLŸ3, ŒòÇŸ3, ìèNœ3, ºxu4, Rº^i4, Oìbü5, ìcçt5, üÞq2, ŒiÄF2, c@ì2, ¢ÃÆ5: 1ŒÃ®åwãw®a@, 2ãÃq¶w, 3nr, 4åw@ãÃn€È, 5zÂíà)
110374. [Ž] Prognostic value of sarcopenic obesity estimated by computed tomography in patients with cardiovascular disease and undergoing surgery. Yamashita M1, Kamiya K2, Matsunaga A2, Kitamura T6, Hamazaki N4, Matsuzawa R4, Nozaki K4, Tanaka S5, Nakamura T1, Maekawa E6, Masuda T2, Ako J6, Miyaji K6: J Cardiol 2019/9; 74 (3): 273-8. (Rº^i1, _JŸY2, ŒiÄF2, kº@¥3, à_èLŸ4, ŒòÇŸ4, ìèNœ4, cLí5, ºxu1, Oìbü6, c@ì2, ¢ÃÆ6, {n@Ó3: 1åw@ãÃn€È, 2ãÃq¶w, 6SÇO, 4nr, 5ŒÃ®åwãw®a@, 6zÂíà)
110375. [Ž] Absolute reliability of measurements of muscle strength and physical performance measures in older people with high functional capacities. Suzuki Y1, Kamide N2, Kitai Y, Ando M, Sato H2, Shiba Y2, Sakamoto M2: Eur Geriatr Med 2019/10; 10 (5): 733-40. (éØÇa1, ãoŒl2, ²¡tF2, Ä@ì2, â{üì2: 1nr, 2ãÃq¶w)
110376. [Ž] Impact of Gait Speed on the Obesity Paradox in Older Patients With Cardiovascular Disease. Nakamura T1, Kamiya K2, Matsunaga A2, Hamazaki N3, Matsuzawa R3, Nozaki K3, Yamashita M1, Maekawa E4, Noda C4, Yamaoka-Tojo M2, Ako J4: Am J Med 2019/12; 132 (12): 1458-65.e1. (ºxu1, _JŸY2, ŒiÄF2, à_èLŸ3, ŒòÇŸ3, ìèNœ3, Rº^i1, Oìbü4, ìcçt4, üÞq2, ¢ÃÆ4: 1åw@ãÃn€È, 2ãÃq¶w, 3nr, 4zÂíà)
110377. [Ž] Rising time from bed in acute phase after hospitalization predicts frailty at hospital discharge in patients with acute heart failure. Nozaki K1, Hamazaki N1, Kamiya K2, Ichikawa T1, Nakamura T3, Yamashita M3, Maekawa E4, Matsunaga A2, Yamaoka-Tojo M2, Ako J4: J Cardiol 2020/6; 75 (6): 587-93. doi: 10.1016/j.jjcc.2019.12.007. Epub 2019 Dec 30. (ìèNœ1, à_èLŸ1, _JŸY2, sìM¶1, ºxu3, Rº^i3, Oìbü4, ŒiÄF2, üÞq2, ¢ÃÆ4: 1nr, 2ãÃq¶w, 3åw@ãÃn€È, 4zÂíà)
110378. [Ž] Prevalence and prognosis of respiratory muscle weakness in heart failure patients with preserved ejection fraction. Hamazaki N1, Kamiya K2, Matsuzawa R1, Nozaki K3, Ichikawa T1, Tanaka S4, Nakamura T5, Yamashita M5, Maekawa E6, Noda C6, Yamaoka-Tojo M2, Matsunaga A2, Masuda T2, Ako J6: Respir Med 2020/1; 161: 105834. (à_èLŸ1, _JŸY2, ŒòÇŸ1, ìèNœ3, sìM¶1, cLí4, ºxu5, Rº^i5, Oìbü6, ìcçt6, üÞq2, ŒiÄF2, c@ì2, ¢ÃÆ6: 1nr, 2ãÃq¶w, 3ºÉãÃåw, 4ŒÃ®åwãw®a@, 5åw@ãÃn€È, 6zÂíà)
110379. [Ž] Association between sarcopenia and atherosclerosis in elderly patients with ischemic heart disease. Uchida S1, Kamiya K2, Hamazaki N3, Matsuzawa R3, Nozaki K3, Ichikawa T3, Suzuki Y1, Nakamura T1, Yamashita M1, Kariya H3, Maekawa E4, Yamaoka-Tojo M2, Matsunaga A2, Ako J4: Heart Vessels 2020/6; 35 (6): 769-75. doi: 10.1007/s00380-020-01554-8. Epub 2020 Jan 22. (àcãÄŸ1, _JŸY2, à_èLŸ3, ŒòÇŸ3, ìèNœ3, sìM¶3, éØTŸ1, ºxu1, Rº^i1, ¡JpI3, Oìbü4, üÞq2, ŒiÄF2, ¢ÃÆ4: 1åw@ãÃn€È, 2ãÃq¶w, 3nr, 4zÂíà)
110380. [Ž] A portable pneumatic compression device to prevent venous thromboembolism in orthopedic patients with the highest risks of both venous thrombosis and bleeding: A case series study. Takahashi Y1, Takahira N2, Shibuya M1,3, Uchiyama K4, Fukushima K4, Iwase D4, Kawamura T4, Miyagi M4, Higashiyama R4, Moriya M4, Sakai K1, Tsuda K1, Sakamoto M2, Akamine A5, Takaso M4: J Orthop Surg (Hong Kong) 2020/1-4; 28 (1): 2309499020905711. doi: 10.1177/2309499020905711. (ŽÀô1, œ®L2, àFJ^1,3, àR¶4, î4, â£@å4, ͺ@Œ4, {é³s4, Rç¡4, XJõr4, âäŸ1, ÃcWi1, â{üì2, ÔäF5, »m4: 1åw@ãÃn€È, 2ãÃq¶w, 3nr, 4®O, 5òÜ)
110381. [Ž] The maximal gait speed is a simple and useful prognostic indicator for functional recovery after total hip arthroplasty. Shibuya M1,2, Nanri Y1, Kamiya K3, Fukushima K4, Uchiyama K4, Takahira N3, Takaso M4, Fukuda M3, Matsunaga A3: BMC Musculoskelet Disord 2020/2; 21 (1): 84. (àFJ^1,2, ì¢CŸ1, _JŸY3, î4, àR¶4, œ®L3, »m4, cÏç3, ŒiÄF3: 1nr, 2åw@ãÃn€È, 3ãÃq¶w, 4®O)
110382. [Ž] Changes in Respiratory Muscle Strength Following Cardiac Rehabilitation for Prognosis in Patients with Heart Failure. Hamazaki N1, Kamiya K2, Yamamoto S3, Nozaki K1, Ichikawa T1, Matsuzawa R1, Tanaka S4, Nakamura T3, Yamashita M3, Maekawa E5, Meguro K5, Noda C5, Yamaoka-Tojo M2, Matsunaga A2, Ako J5: J Clin Med 2020/3; 9 (4): 952. (à_èLŸ1, _JŸY2, R{®œ3, ìèNœ1, sìM¶1, ŒòÇŸ1, cLí4, ºxu3, Rº^i3, Oìbü5, ÚŸY5, ìcçt5, üÞq2, ŒiÄF2, ¢ÃÆ5: 1nr, 2ãÃq¶w, 3åw@ãÃn€È, 4ŒÃ®åwãw®a@, 5zÂíà)
110383. [Ž] Prognostic value of instrumental activity of daily living in initial heart failure hospitalization patients aged 65 years or older. Yamashita M1, Kamiya K2, Hamazaki N3, Matsuzawa R3, Nozaki K3, Ichikawa T3, Nakamura T1, Maekawa E4, Yamaoka-Tojo M2, Matsunaga A2, Ako J4: Heart Vessels 2020/3; 35 (3): 360-6. (Rº^i1, _JŸY2, à_èLŸ3, ŒòÇŸ3, ìèNœ3, sìM¶3, ºxu1, Oìbü4, üÞq2, ŒiÄF2, ¢ÃÆ4: 1åw@ãÃn€È, 2ãÃq¶w, 3nr, 4zÂíà)
120052. [Ž] äFÂfôCppã³ÒÉηéãPû@íƵÄÌ|[^uXvOoT[ÌLp«|\ÊØd}ðp¢œØ®ªÍ|. ²XØGê1, ©ÚqI2, àVrV2, »m2, cÏç3, œ®L3, óä` (1nr, 2®O, 3ãÃq¶w): ú{`ïwï 2019/12; 35 (4): 297-301.
320054. [Çáñ] ãrßÊ[ÜÉηélHªu·pãÃ@É|[^uXvOoT[ðgpµœ1á. ²XØGê1, ©ÚqI2, óä` (1nr, 2®O): _ÞììÆÃ@€ 2020/3; 10 (1): 19-24.
522161. [uÀ]yÁW: SsS³ÒÌiØ1zwÃ@mÉæéiØ]¿Ì|Cg. à_èLŸ (nr): Snre[V 2019/6; 25 (1): 50-4.
[@]
620112. [wp (ªS·M)]yzÂínre[VÌ_ÆZp üùæ2ÅzV nre[V (_)@^®Ã@, p.244-66. Œ{ìç, xcê÷, _JŸY1 (1ãÃq¶w), Ò: c@ì1, ŒiÄF1, WJr
[Ð, , 2020/3s.
620113. [wp (ªS·M)]yzÂínre[VÌ_ÆZp üùæ2ÅzV nre[V (_)@Ÿ³ÇÌœß̳çEw±û@@
@^®w±Ì_ÆÀÛ, p.274-8. ìèNœ1 (1nr), Ò: c@ì2, ŒiÄF2 (2ãÃq¶w), WJr
[Ð, , 2020/3s.
620114. [wp (ªS·M)]yzÂínre[VÌ_ÆZp üùæ2ÅzV nre[V (_)@lHSEy[X[JEAÝ^×®íð
µœ³ÒÉηéSnre[V, p.320-31. à_èLŸ1 (1nr), Ò: c@ì2, ŒiÄF2 (2ãÃq¶w), WJr
[Ð, , 2020/3s.
620115. [wp (ªS·M)]yzÂínre[VÌ_ÆZp üùæ2ÅzV nre[V (_)@t§Íðó¯Ä¢é³ÒÉηéSnre[V, p.332-8. ŒòÇŸ1 (1nr), Ò: c@ì2, ŒiÄF2 (2ãÃq¶w), WJr
[Ð, , 2020/3s.
620116. [wp (ªS·M)]yzÂínre[VÌ_ÆZp üùæ2ÅzV nre[V (_)@TRyjAEtC𹵜³ÒÉηéSnre[V, p.339-46. _JŸY1 (1ãÃq¶w), Ò: c@ì1, ŒiÄF1, WJr
[Ð, , 2020/3s.
620117. [wp (ªS·M)] yzÂínre[VÌ_ÆZp üùæ2ÅzVI nre[V (e_)@«SsS, p.404-22. _JŸY1, ŒiÄF1 (1ãÃq¶w), Ò: c@ì1, ŒiÄF1, WJr
[Ð, , 2020/3s.
[wïE€ï]
713148. [wï (Û)] (êÊu) Change in respiratory muscle strength and adverse clinical events in patients with chronic heart failure (International Session AwardóÜè). Hamazaki N1, Masuda T2, Kamiya K2, Matsuzawa R1, Nozaki K1, Ichikawa T1, Yamashita M3, Maekawa E4, Fukaya H4, Yamaoka-Tojo M2, Matsunaga A2, Ako J4: Asia PRevent 2019 (2019/7/13-14), Osaka, Japan. (à_èLŸ1, c@ì2, _JŸY2, ŒòÇŸ1, ìèNœ1, sìM¶1, Rº^i3, Oìbü4, [Jpœ4, üÞq2, ŒiÄF2, ¢ÃÆ4: 1nr, 2ãÃq¶w, 3åw@ãÃn€È, 4zÂíà)
713149. [wï (Û)] (êÊu) Change in respiratory muscle strength predicts clinical events in patients with chronic heart failure (Nursing and Allied Health Proffesions Investigator Award Runners-Up PrizeóÜè). Hamazaki N1, Masuda T2, Kamiya K2, Matsuzawa R1, Nozaki K1, Ichikawa T1, Tabata M3, Maekawa E4, Noda C4, Yamaoka-Tojo M2, Matsunaga A2, Ako J4: ESC Congress 2019 (2019/8/31-9/4), Paris, France. (à_èLŸ1, c@ì2, _JŸY2, ŒòÇŸ1, ìèNœ1, sìM¶1, cš@«3, Oìbü4, ìcçt4, üÞq2, ŒiÄF2, ¢ÃÆ4: 1nr, 2ãÃq¶w, 3LŽn¢åw, 4zÂíà)
713150. [wï (Û)] (êÊu) Atrial fibrillation is not associated with the responses to exercise training in heart failure patients with preserved ejection fraction. Hamazaki N1, Masuda T2, Kamiya K2, Matsuzawa R1, Nozaki K1, Ichikawa T1, Tabata M3, Maekawa E4, Fukaya H4, Yamaoka-Tojo M2, Matsunaga A2, Ako J4: ESC Congress 2019 (2019/8/31-9/4), Paris, France. (à_èLŸ1, c@ì2, _JŸY2, ŒòÇŸ1, ìèNœ1, sìM¶1, cš@«3, Oìbü4, [Jpœ4, üÞq2, ŒiÄF2, ¢ÃÆ4: 1nr, 2ãÃq¶w, 3LŽn¢åw, 4zÂíà)
713151. [wï (Û)] (êÊu) Pupillary area predicts all-cause mortality in patients with cardiovascular disease. Nozaki K1, Kamiya K2, Hamazaki N1, Ichikawa T1, Nakamura T3, Yamashita M3, Maekawa E4, Matsunaga A2, Yamaoka-Tojo M2, Ako J4: ESC Congress 2019 (2019/8/31-9/4), Paris, France. (ìèNœ1, _JŸY2, à_èLŸ1, sìM¶1, ºxj3, Rº^i3, Oìbü4, ŒiÄF2, üÞq2, ¢ÃÆ4: 1nr, 2ãÃq¶w, 3åw@ãÃn€È, 4zÂíà)
713152. [wï (Û)] (êÊu) Kinematic analysis of trunk movements during reaching in preterm, very low birth weight and full-term infants Nomura Y1, Sato H2, Ooka M3, Kemmochi M3: 2019 American Academy for Cerebral Palsy and Developmental Medicine (2019/9/18-21), Anaheim, CA, USA. (ìºDq1, ²¡tF2, åª3, çÝ@w3: 1nr, 2ãÃq¶w, 3¬)
722265. [wï (S)] (µÒu)yHot topics in CVD 2019zSŸ³³ÒÉš¯éÄz@\]¿ÌÕ°IÓ`. à_èLŸ (nr): æ4ñú{SÇwÃ@wïEæ6ñú{AawÃ@wï¯wpåï (2019/9/14), «ê.
722266. [wï (S)] (µÒu) Xe[WCÌ^®Ã@ÌÀÛ. ìèNœ1, _JŸY2, à_èLŸ1, ºxj3, OìGü4 (1nr, 2ãÃq¶w, 3åw@ãÃn€È, 4zÂíà): æ23ñú{SsSwïwpWï (2019/10/4-6), L.
722267. [wï (S)] (µÒu) SnðtnÉ©·@«SsS³ÒÉηé^®Ã@ÌøÊÉt@\ÌáºÍe¿·é©? à_èLŸ (nr): æ10ñú{tnre[VwïwpWï (2020/2/22), .
722268. [wï (S)] (µÒu) tÚAãú©çs€^®Ã@ÌøÊÆÀS«. ŒòÇŸ1, R{®œ2, sìM¶1, Îäåã3, ìû¶T4, ŒiÄF5, gcê¬3,6 (1nr, 2åw@ãÃn€È, 3åAí, 4Åì, 5ãÃq¶w, 6V¢IãÃEæ[ãÃ): æ10ñú{tnre[VwïwpWï (2020/2/22), .
723916. [wï (S)] (êÊu) êwCMÖßÇÉηék¢®@\IïÌøÊÌØ|³ZTðp¢œèÊIªÍ|. ²XØGê1, ¬À«¡2, ì_m2, å|IÆ2, ©ÚqI2, œ®L3, »m2 (1nr, 2®O, 3ãÃq¶w): æ62ñú{èOÈwïwpWï (2019/4/18-19), Dy.
723917. [wï (S)] (êÊu) «úîSÇŸ³³ÒÉš¯éèiIúí¶®ìƶºg£\ÌoIÏ»ÌÖA (YIADGÜóÜ). ¡JpI1, éüÞq2, Ž^ê1, ìcçt3, Öªbüq4, ŽRü4, ÂRWå5, ŒiÄF2, ¢ÃÆ3 (1a@nr, 2ãÃq¶w, 3zÂíà, 4a@Åì, 5åw@ãÃn€È): æ55ñú{zÂía\hwïwpWï (2019/5/11-12), ª.
723918. [wï (S)] (êÊu) ^®Ã@ïR«Ég̮ʪặéyÇp[L\a³ÒÌñ^®ÇóÌÁ¥. éØÇa1, Œc²q1, ãoŒl2, Ä@ì2, ì[Ç¡1, œêæµÝ1, iä^Mq3, ŒRa3, cÏç1,2 (1a@nr, 2ãÃq¶w, 3]_oà): æ60ñú{_owïwpåï (2019/5/22-25), åã.
723919. [wï (S)] (êÊu) yÇp[L\a³ÒÉš¯éñ^®ÇóÍg̮ʞð\ª·éöqÅ é. Œc²q1, éØÇa1, ãoŒl2, Ä@ì2, ì[Ç¡1, œêæµÝ1, iä^Mq3, ŒRa3, cÏç1,2 (1a@nr, 2ãÃq¶w, 3]_oà): æ60ñú{_owïwpåï (2019/5/22-25), åã.
723920. [wï (S)] (êÊu) ÛúSÇŸ³³ÒÉš¯éOSnre[VÍèiIúí¶®ìðüã³¹é. ¡JpI1, üÞq2, Ž^ê1, ìcçt3, Öªbüq4, ŽRü4, ÂRWå5, ïgí3, SRbq3, ŒiÄF2, ¢ÃÆ3 (1nr, 2ãÃq¶w, 3zÂíà, 4a@Åì, 5åw@ãÃn€È): æ25ñú{Snre[VwïwpWï (2019/7/13), åã.
723921. [wï (S)] (êÊu) îSsS³ÒÉš¯éñ£°Ìxbh©çÌN«ãªèÔÍÞ@ÌtCð\ª·é. ìèNœ1, _JŸY2, à_èLŸ1, ŒòÇŸ1, sìM¶1, ºxj3, Rº^i3, OìGü4, ŒiÄF2, c@ì2, ¢ÃÆ4 (1nr, 2ãÃq¶w, 3åw@ãÃn€È, 4zÂíà): æ25ñú{Snre[VwïwpWï (2019/7/13-14), åã.
723922. [wï (S)] (êÊu) ÛúSÇŸ³³ÒÉš¯éOSnre[VÍèiIúí¶®ìðüã³¹é. ¡JpI1, üÞq2, Ž^ê1, ìcçt3, Öªbüq4, ŽRü4, ÂRWå5, ïgí3, SRbq3, ŒiÄF2, ¢ÃÆ3 (1a@nr, 2ãÃq¶w, 3zÂíà, 4a@Åì, 5åw@ãÃn€È): æ25ñú{Snre[VwïwpWï (2019/7/13-14), åã.
723923. [wï (S)] (êÊu) }«å®¬ð£³ÒÉš¯éÞ@^®@\ÉÖ·é¢: }«¥ÇóQÆÌçp. sìM¶1, _JŸY2, à_œLŸ1, ŒòÇŸ1, ìèNœ1, ºxj3, Rº^i3, ìÞq1, âºMq1, Oìbü4, üÞq2, ìcçt4, ŒiÄF2, c@ì2, ¢ÃÆ4 (1nr, 2ãÃq¶w, 3åw@ãÃn€È, 4zÂíà): æ25ñú{Snre[VwïwpWï (2019/7/13-14), åã.
723924. [wï (S)] (êÊu) eé dzÒÉš¯éÉÉNö·éàsáQÆØ÷ÊÌÖA. ì¢CŸ1, ©äca³1, ŒÛÀ1, àFJ^, OœºŸ1, {é³s2, äã@º2, àVrV2, äºMV2, âV¡@j2, àVh÷2, »m2 (1nr, 2®O): æ27ñú{Éwï (2019/9/13-14), _Ë.
723925. [wï (S)] (êÊu) «SsS³ÒÉš¯éiØÊÌžÍ1Nã̶ºSØdÊÌÁð\ª·é. Á¡mœ1, ÂRWå1, ·cÆ1, MRžÍ1, Ž^ê2, ¡JpI3, _JŸY4, ¢ÃÆ5, ŒiÄF4, üÞq4 (1åw@ãÃn€È, 2a@nr, 3nr, 4ãÃq¶w, 5zÂíà): æ4ñú{SÇwÃ@wïEæ6ñú{AawÃ@wï¯wpåï (2019/9/14), «ê.
723926. [wï (S)] (êÊu) µEÊÏÍSsS³ÒÌ\ãð\ª·éVœÈwWÅ é (YIAÅDGÜóÜ). ìèNœ1, _JŸY2, à_èLŸ1, ºxj3, Rº^i3, OìGü4, ŒiÄF2, üÞq2, ¢ÃÆ4 (1nr, 2ãÃq¶w, 3åw@ãÃn€È, 4zÂíà): æ23ñú{SsSwïwpWï (2019/10/4-6), L.
723927. [wï (S)] (êÊu) î«SŸ³³ÒÉš¯éèiIúí¶®ìÌÀsóµÍ»ÌãÌSsSü@Ée¿·é. ¡JpI1, üÞq2, Ž^ê3, ìèNœ1, ìcçt4, SRbq4, Öªbüq5, ŽRü5, ŒiÄF2, ¢ÃÆ4 (1nr, 2ãÃq¶w, 3a@nr, 4zÂíà, 5a@Åì): æ23ñú{SsSwïwpWï (2019/10/4-6), L.
723928. [wï (S)] (êÊu) lHÒÖßu·pã³ÒÉš¯éÒÖßO]ØÍÌñÉe¿ðyÚ·öqÌ¢. àFJ^1, ì¢CŸ1, î2, àR¶2, œ®L3, »m2 (1nr, 2®O, 3ãÃq¶w): æ46ñú{ÒÖßwïwpWï (2019/10/25-26), {è.
723929. [wï (S)] (êÊu) lHÒÖßSu·p³ÒÉš¢ÄèpOÌh{sÇÍpãúÌàslŸðx³¹é. ì¢CŸ1, àFJ^1, î2, àR¶2, œ®L3, »m2 (1nr, 2®O, 3ãÃq¶w): æ46ñú{ÒÖßwïwpWï (2019/10/25-26), {è.
723930. [wï (S)] (êÊu) yÇp[L\a³ÒÌgÌ@\šæÑQOLÉηé³çIwÃ@vOÌLp«. éØÇa1, Œc²q1, ãoŒl2, Ä@ì2, ì[Ç¡1, œêæµÝ1, iä^Mq3, ŒRa3, cÏç2 (1a@nr, 2ãÃq¶w, 3]_oà): æ3ñú{nre[VãwïHGwpWï (2019/11/15-17), ê.
723931. [wï (S)] (êÊu) Žáo¶ÌdÌBtH[AbvÉš¯éAo[^ûc^®Bž@Ìgp|VÅj®žÌÊÆÌär|. ìºDq1,
ìöã1, à_èLŸ1, N¡1, ÃèSç2, Œì@p2, åª3, @w3, cÏç1,4 (1nr, 2Õ°Sº, 3¬, 4ãÃq¶w): æ6ñú{¬wÃ@wï (2019/11-16-17), ª.
723932. [wï (S)] (êÊu) OyÇp[L\a³ÒÉš¯é^®Ã@OãÌQOLÏ»ÉÍñ^®ÇóªÖA·é. Œc²q1, éØÇa1, ãoŒl2, Ä@ì2, ì[Ç¡1, œêæµÝ1, iä^Mq3, ŒRa3, cÏç2 (1a@nr, 2ãÃq¶w, 3]_oà): æ6ñú{næwÃ@wïwpåï (2019/12/14-15), s.
723933. [wï (S)] (êÊu) æsItÚA³ÒÉš¯éNÖAQOLÆgÌ®ÊÌÚAOãÏ». sìM¶1, ŒòÇŸ2, R{®œ3, ìû¶ì4, äºLP4, Îäåã5, gcê¬5,6 (1nr, 2ºÉãÃåw, 3åw@ãÀÈ, 4Åì, 5åAí, 6V¢IãÃEæ[ãÃ): æ53ñú{Õ°tÚAwï (2020/2/19-21), .
723934. [wï (S)] (êÊu) {MÉš¯étÚAÒ@ÒÌgÌ@\ÆgÌ®ÊÉÖ·éÀÔ²ž|næÝZÒÆÌär|. ²¡»Ô1, R{®œ1, ŒòÇŸ2, sìM¶2, Îäåã3, ìû¶T4, ka÷3, åŽFq5, _JŸY6, ŒiÄF6, gcê¬3,7 (1åw@ãÃn€È, 2nr, 3åAí, 4Åì, 5tà, 6ãÃq¶w, 7V¢IãÃEæ[ãÃ): æ10ñú{tnre[VwïwpWï (2020/2/22), .
723935. [wï (S)] (êÊu) ¶ºâlHSAÝpOÌSsS³ÒÉηé^®Ã@ÌÀS«ÆøÊ. à_èLŸ1, kº@¥2, ¬Ñ@3, ßq4, Oìbü3, ìèNœ1, sìM¶1, Ü\óq4, ìÞq4, R{Ðq4, _JŸY5, ¢ÃÆ3, {n@Ó2 (1nr, 2SÇO, 3zÂíà, 4Åì, 5ãÃq¶w): æ48ñlHSÆâz§bïwpWï (2020/2/28-29), Dy.
732157. [wï (nûïE€ï)] (³çZ~i[) wÃ@mª©ßéÕ°€. à_èLŸ (nr): ú{Snre[Vwïæ4ñÖbMzxnûï (2019/9/21), V.
733785. [wï (nûïE€ï)] (êÊu) tÚAãú©çÌ^®Ã@ÉæégÌ@\ÌüP. R{®œ1, ŒòÇŸ2, Îäåã3, ìû¶T4, uºsêN3, ka÷3, åŽF5, ŒiÄF6, gcê¬3,7 (1åw@ãÃn€È, 2nr, 3åAí, 4Åì, 5tà, 6ãÃq¶w, 7V¢IãÃEæ[ãÃ): æ97ñ_Þìt€ïïE€Wï (2019/6/1), ¡l.
733786. [wï (nûïE€ï)] (êÊu) ñúnaÉš¯éŒEíAg𻵜Transfer PackageÉæèá€ãÌgppxªü㵜1Çá. Îääœ1, ²XØGê1, ºöçØq1, Ocü¹÷1, _Û¥1, cÏç2 (1nr, 2ãÃq¶w): æ17ñ_Þì§ìÆÃ@wï (2019/7/21), ¡l.
733787. [wï (nûïE€ï)] (êÊu) ñúaÉÄáN«][ÇÒÉε, ÝîAÆÐïQÁðÚwµ{lƪÀ赜¶ðlŸµœÇá. Ocü¹÷1, ²XØGê1, ¬Ñ¢1, Îääœ1, ¬ŽRM1, _Û¥1, ³Øàôq2, cÏç3 (1nr, 2k¢åwnre[VÈ, 3ãÃq¶w): æ17ñ_Þì§ìÆÃ@wï (2019/7/21), ¡l.
733788. [wï (nûïE€ï)] (êÊu) ]îápãÌs@\áQÉæèÆÆ窢ïÆÈÁœÇáÉεnæAgÌ»ð}èÀ赜Ýî¶ÉÁœêÇá. cû°M1, ²XØGê1, Œä¹ü1, çtüœ1, _Û¥1 (1nr): æ17ñ_Þì§ìÆÃ@wï (2019/7/21), ¡l.
733789. [wï (nûïE€ï)] (êÊu) TissueExpanderðpµœêû[ÄpãÌnre[VÉš¯éÁ¥. |à°l1, _Û¥1, c@ç1, R{Ÿü1, Žãq2, cÏç2 (1nr, 2ãÃq¶w): æ17ñ_Þì§ìÆÃ@wï (2019/7/21), ¡l.
733790. [wï (nûïE€ï)] (êÊu) äFÂåELÍÍfôÒÌpã3`6ÌOùØÍÌÚÆÕ°ÇóÌÖA«. ²XØGê1, ©ÚqI2, |à°l1, _Û¥1, ŒqŒd2, e[Í2, cÏç3, œ®L3, »m2 (1nr, 2®O, 3ãÃq¶w): æ16ñšÌ^®@\€ï (2019/10/25-26), ·ì.
733791. [wï (nûïE€ï)] (êÊu) äFÂCpOãÌšÖßüÈEºÝOùØÍäÆáuÉÆÌÖA. |à°l1, ©ÚqI2, ²XØGê1, _Û¥1, àVrV2, »m2, cÏç3 (1nr, 2®O, 3ãÃq¶w): æ16ñšÌ^®@\€ï (2019/10/25-26), ·ì.
733792. [wï (nûïE€ï)] (êÊu) mÁĚ׫³ÒÚZp. _Û¥ (nr): 2019NxÕ°žZtÌœßÌxbhTChÀHuKï (2019/10/5-6) Íåì.
733793. [wï (nûïE€ï)] (êÊu) ú{Æ¢EÌìÆÃ@Ì®ü. _Û¥ (nr): ú{ìÆÃ@mŠï»EÒuKï (2019/11/23), ¡l.
733794. [wï (nûïE€ï)] (êÊu) ú{ìÆÃ@mŠïÕ°ÀKw±ÒuKï. _Û¥ (nr): ú{ìÆÃ@mŠïÕ°ÀKw±ÒuKï (2019/12/7-8), ¬cŽ.
733795. [wï (nûïE€ï)] (êÊu) ú{ìÆÃ@mŠïÕ°ÀKw±ÒuKï. _Û¥ (nr): ú{ìÆÃ@mŠïÕ°ÀKw±ÒuKï (2020/1/25-26), ¬cŽ.
h{
[wp_¶]
120053. [Ž] tÚAVsGgÉš¯éÚAOOGTTÊÆh{wIwWÌ¢. gcüq1, Ñ@NÍ2, Îäåã3, ìû¶T4, ²¡Æq1, µ¢áÁ`2, gcê¬2,5 (1h{, 2àªåãÓà, 3åAí, 4Åì, 5V¢IãÃEæ[ãÃ): ú{aÔh{wïwï 2019/10; 22 (4): 245-51.
522162. [uÀ]yÁW: ¢ÜwÑÈšµœ¢! §Íi[XÉKvÈVNÅìÌm¯ÆZpz<ÁW3> ZpÒ: Æ°ðª«Þ! î§Í³ÒÌúí¶ðxŠéPA@2. HÇ. gcüq (h{): §ÍPA 2019/9; 25 (10): 929-31.
522163. [uÀ]yÁW: Ç€·é!?@DwÌh{ÇEh{w±|DP¹ÇÖÌÎðÜßÄzDPAa³ÒÉηéh{w±Ì|Cg. l©üq (h{): Õ°h{ 2019/11; 135 (6): 789-96.
522164. [uÀ]yÁW1zRrj, X[p[Ìp@. l©üq (h{): §AaCt³©Š 2019/12 59 (12): 5-16.
522165. [uÀ]yAÚzAaÃ{w±mFè@\j
[X [204]. l©üq (h{): §AaCt³©Š 2019/12 59 (12): 55.
[@]
620118. [wp (ªS·M)]yzÂínre[VÌ_ÆZp üùæ2ÅzV nre[V (_)@Ÿ³ÇÌœß̳çEw±û@@
Ah{Çw±Ì_ÆÀÛ, p.279-84. ß¡{q1 (1h{), Ò: c@ì2, ŒiÄF2 (2ãÃq¶w), WJr
[Ð, , 2020/3s.
[wïE€ï]
713153. [wï (Û)] (êÊu) Multidisciplinary Predialysis Team education for patients with Diabetes Nephropathy reduced cost for admission at the induction of hemodialysis and subsequent mortality. Hitomi M1, Sato T1, Moriya T2: American Diabetes Association 79th Scientific Sessions (æ79ñÄAawï) (2019/6/7-11), San Francisco, USA, Diabetes 2019/6; 1: A174. (l©üq1, ²¡Æq1, ç®Bü2: 1h{, 2NÇZ)
722269. [wï (S)] ([NVbv) TRyjAÉηéo`ju±üÌh{Ã@ÌKv«. erÞäq1, °I2, ú@2 (1h{, 2Á»íà): æ26ñú{嬳ŽiÇwïï (2019/9/12-13), ºÖ, æ26ñú{嬳ŽiÇwïïvOŽ^ 2019/8; 25 (3): 117.
722270. [wï (S)] (YtWuÀ)yŸú©çÌãÓÙíDwÌPAɶ©¹éh{w±zãÓÙíDwÌHÃ@ÌÀÛ. l©üq (h{): æ35ñú{AaEDPwïNwpWï (2019/11/22), , AaÆDP 2019/10; 19 (3): 25.
722271. [wï (S)] (V|WE) œEíÅs€tÚAVsGgÌh{Ænre[V. gcüq1, Îäåã2, ìû¶T3, äº[P3, XªDq1, vÛc€ü1, ka÷2, ¢Nç4, |àNY4, gcê¬2,5 (1h{, 2åAí, 3Åì, 4tà, 5V¢IãÃEæ[ãÃ): æ10ñú{tnre[VwïwpWï (2020/2/22), , æ10ñú{tnre[VwïŽ^W (WebfÚ) 2020/1; p.25.
723936. [wï (S)] (êÊè) VKÛt§ÍÌvæ±üÌL³ªh{ÇÉyÚ·e¿Ì¢. gcüq1, ÂRÜ2, XªDq1, ³ØM³2, ࡳg2, ²ì@²2, |àNY2 (1h{, 2tà): æ64ñú{§ÍãwïwpWïEï (2019/6/29), ¡l, æ64ñú{§ÍãwïŽ^W (WebfÚ) 2019/6.
723937. [wï (S)] (v]è) ·úICUݺ~}³ÒÉš¯é`¿^ÊÆgÌ@\É^Šée¿. [ò²bq1, ЪSê2, 箢¹1, ¡¬q1, yì ž³1, {è¹P3, cºqq4, x²lq5, Ÿc¡ã5, ¬ìÇŸ6, ³ØÇÞ6, åìŽT÷7, ²¡Æq1, ó@õ2 (1h{, 2~œ, 3nr, 4ãÃq¶w, 5Åì, 6Õ, 7òÜ): æ35ñú{Õ°h{ãÓwïwpWï (2020/2/28), ÊJÃ, æ35ñú{Õ°h{ãÓwïwpWïvOW 2020/1; 35: 051-4.
733796. [wï (nûïE€ï)] (êÊu) »êŒê̳ðÉü¯œsöëÌx. l©üq (h{): Aa¡ÃXLAbvZ~i[ (2019/7/5), çt.
733797. [wï (nûïE€ï)] (êÊu) œEíîüÍAa«tÇ (tÇ) ³Ò̧ͱüÉÇDÈøÊðàœç·©. l©üq1, ²¡Æq1, ç®Bü2 (1h{, 2NÇZ): Õ°Aaãï (2019/7/27), .
733798. [wï (nûïE€ï)] (êÊu) î×á«å°³ÒÌh{ÇÉ¢Ä. ŸcTq (h{): æ26ñ_ÞìIBD€ï (2019/10/3), ¡l.
733799. [wï (nûïE€ï)] (êÊu) Çá¢ï. l©üq (h{): ³ªÝAaJt@X (2019/10/25), ÍŽ.
733800. [wï (nûïE€ï)] (êÊu) DPAaÌh{Ç. l©üq (h{): ¹æ§a@EAaÃ{w±uKï (2019/12/15), ¹æ.
a@a
[wp_¶]
320055. [Çáñ] pOÌäXEUS-FNAÉæèffµŠœè÷±×EîÌ1á. âû@E1, `ÀAM1, Ÿcœq1, Rºaç1, gc@÷2, O}@M2 (a, 2a): _Þì§Õ°×Ewï 2019/8; 24 (1): 17-20.
[wïE€ï]
723938. [wï (S)] (êÊû) _Þì§Éš¯éHEõFžxDzžW{ÌRGBðÍlðpµœ×EfÌLp«. âû@E1, ¬RcTs2, œcÖj3, acõœ4, à_º®ç5, ¡®£¢6, {è¬S7, cŒ÷3 (1a, 2Cåwa@, 3¹}AiãÈåwa@, 4ÍŽŠ¯a@, 5¡lJÐa@affÈ, 6ìès§ìèa@, 7¬cŽs§a@Õ°ža): æ68ñú{ãwžwï (2019/5/19), ºÖ, ãwž 2019/5; 68 (Êû): 222.
723939. [wï (S)] (êÊû) z}QÅèÌ¢. Rºaç1, ¡R¢³Ý1, âû@E1, vê@÷1, gc@÷2, O}@M2 (1a, 2a): æ68ñú{ãwžwï (2019/5/19), ºÖ, ãwž 2019/5; 68 (Êû): 244.
723940. [wï (S)] (|X^[) úÕZažW»Æ@AP[g²žñ@®ü²ž (1). âªê1, @@w2, Ñ@Ti3 ŒŽ^Þü4, Rºaç5, Îc¬6 (1ꧧ±Çàa@, 2Ùa@Õ°žÈ, 3 êãÈåwãwt®a@, 4ª§§a@žZpÈ, 5a, 6Låwãwt®a@affÈ): æ68ñú{ãwžwï (2019/5/19), ºÖ, ãwž 2019/5; 68 (Êû): 576.
723941. [wï (S)] (|X^[) úÕZažW»Æ@AP[g²žñ@®ü²ž (2). âªê1, @@w2, Ñ@Ti3, ŒŽ^Þü4, Rºaç5, Îc¬6 (1ꧧ±Çàa@, 2Ùa@Õ°žÈ, 3 êãÈåwãwt®a@, 4ª§§a@žZpÈ, 5a, 6Låwãwt®a@affÈ): æ68ñú{ãwžwï (2019/5/19), ºÖ, ãwž 2019/5; 68 (Êû): 577.
723942. [wï (S)] (|X^[) @Éš¯éKChCñl®ÉæéÁtB×EfÌžxÇ. âû@E1, `ÀAM1, ºcä»Ñ1, ÚÑq1, Rºaç1, cçüT2, gc@÷2, O}@M2 (1a, 2a): æ60ñú{Õ°×Ewïï (túåï) (2019/6/7), , ú{Õ°×EwïG 2019/6; 58 (âû1): 223.
723943. [wï (S)] (êÊû) ûªàÆàhE«îáÆÌÓÊðvµœNIFTPÌ1á. âû@E1, ºcä»Ñ1, ¡R¢³Ý1, Rºaç1, cçüT2, gc@÷2, O}@M2 (1a, 2a): æ58ñú{Õ°×EwïHúåï (2019/11/16), ªR, ú{Õ°×EwïG 2019/11; 58 (âû2): 636.
731112. [wï (nûïE€ï)] (ÁÊu) â`qžÌîb (gDÌæèµ¢ðÜßœ). Rºaç (a): œ¬30Nx@FèažZt@wèuKï (2019/7/6), , wèuKïeLXg (ßa³NxÅ) 2019/7.
732158. [wï (nûïE€ï)] (µÒu) xàÆuplÌõFT[xCÊÆW{ì»ÌžxÇðÜÞm¯É¢Ä. Rºaç (a): æ4ñFèažZtéæEaZp€Cï (2019/7/13), ŒÃ®åw, æ4ñFèažZtéæEaZp€CïeLXg 2019.
732159. [wï (nûïE€ï)] (µÒu) ÆugD»wÌžxÇ. Rºaç (a): ú{Õ°q¶žZtïa×Eåx€Cï@æ28ñúÕZÖbMxEñsx@a×Ež€Cï (2020/1/19), éÊ, æ28ñúÕZÖbMxEñsx@a×Ež€CïeLXg 2020/1; p.21-6.
733801. [wï (nûïE€ï)] (êÊû) ]Ú«xîáð^íêœÇ«ØüÛè×EîáÌ1á. éØaÀÞ1, `ÀAM1, ¡R¢³Ý1, âû@E1, Rºaç1, ê˹Ÿ2, cçüT2, gc@÷2, ²¡Vr3, º_F÷2, O}@M2 (1a, 2a, 3ÄzíO): æ38ñ_Þì§Õ°×EwïwpWï (2019/11/23), _Þì, _Þì§Õ°×Ewï 2019/11; 24 (2): 26.
ME
[wp_¶]
522166. [uÀ]yÁW: Õ°HwZmVl³çÌ[ÀðÚwµÄ|tbV[ðÇÌæ€ÉçÄé©|zeƱÅÌVl³çÌÀÛÆw±Ì|Cg: èpºÖAƱ. §ì@ (ME): Clinical Engineering 2019/7; 30 (7): 645-51.
522167. [uÀ]yÁW: Õ°HwZmVl³çÌ[ÀðÚwµÄ|tbV[ðÇÌæ€ÉçÄé©|zvZv^[Vbv̱üÌøÊ. \ê1, âìü¹I (1ME): Clinical Engineering 2019/7; 30 (7): 658-63.
522168. [uÀ]yCVSAPV|WE: ÌOzÂÖÌÙ}conversion|ÎÆ»ÌõŠÉ¢ÄlŠé|zÙ}ÌOzÂÉηéÌOzÂZmÌðÉÖ·é¢. \ê1, Àì@œ, éØê, ã¡@, O¥, ìcG, {{j, rØNK (1ME): ÌOzÂZp 2020/3; 47 (1): 67-75.
[wïE€ï]
722272. [wï (S)] (µÒu) ãÃ@íÇ̧ɚ¯éÕ°HwZmÌð. \ê1, ¡ä³À1 (1ME): æ94ñú{ãÃ@íwïåï(2019/6/15), åã, ãÃ@íw 2019/4; 89 (2): 131.
722273. [wï (S)] (µÒu)y3wï¯CVSAP V|WEzÌOzÂÖÌÙ}conversion?ÎÆ»ÌõŠÉ¢ÄlŠé? \ê (ME): ú{SÇwïæ24ñwpåï(2019/9/20), s, Cardiovascular Anesthesia 2019/9; 23 (suppl): 115.
722274. [wï (S)] (plfBXJbV)y¬ÌOzÂ[UÊÌ Ì Æ¡|^ÌáNPðßÄz@̬lHSxÉš¯éáNPÖÌæègÝ. åOV1, \ê1, Ãœ@1, cÍ1, CVªqã1, KŽÑß1, {n@Ó2 (1ME, 2SÇO): æ45ñú{ÌOzÂZpãwïåï(2019/10/6), ŒÃ®, ÌOzÂZp 2019/9; 46 (3): 274.
722275. [wï (S)] (wpZbV) ÌOzÂÖÌÙ}conversion|ÎÆ»ÌõŠÉ¢ÄlŠé|. \ê (ME): æ45ñú{ÌOzÂZpãwïåï(2019/10/6), ŒÃ®, ÌOzÂZp 2019/9; 46 (3): 282.
723944. [wï (S)] (êÊu) èpx{bgÉš¯éÕ°HwZmÌÖíè`5NÔÌguàeæè`. §ì@1, \ê1, Ãœ@1, ¡ä³À1, ìÊØ1 (1ME): æ29ñú{Õ°Hwï(2019/5/18), ·ª, ú{Õ°HwZmïï 2019/4; 66: 187.
723945. [wï (S)] (êÊu) @Éš¯éãÃ@íÌŽ|ÉÖ·é¢. \ê1, ¡ä³À1, غtÞ1, cÍ1, §ì@1, åOV1, âìü¹I1, Ãœ@1 (1ME): æ29ñú{Õ°Hwï(2019/5/18), ·ª, ú{Õ°HwZmïï 2019/4; 66: 214.
723946. [wï (S)] (êÊu) èpx{bgÉš¯éÕ°HwZmƱøŠ»ÖÌæègÝ|{bgVXezuÌHv|. §ì@1, \ê1, Ãœ@1, ¡ä³À1, ìÊØ1 (1ME): æ41ñú{èpãwïï(2019/9/27), , ú{èpãwï 2019/7; 40 (suppl): 167.
723947. [wï (S)] (êÊu) ¬lHSxÉš¯é³Âx²®û@Ìá¢ÉæéÕ°f[^[Ìär. åOV1, \ê1, Ãœ@1, cÍ1, CVªqã1, KŽÑß1, {n@Ó2 (1ME, 2SÇO): æ45ñú{ÌOzÂZpãwïåï(2019/10/6), ŒÃ®, ÌOzÂZp 2019/9; 46 (3): 282.
733802. [wï (nûïE€ï)] (êÊu) ECMOñHvC~OCÉÖ·é¢. œö@õ1, \ê1, غtÞ1, cºü¹I1, º±q1 (1ME): æ26ñú{ÌOzÂZpãwïÖbMznûïåï(2019/4/14), b{, ÌOzÂZp 2019/10; 46 (3): 274.
Õ°±Z^[
ãÃÌ¿EÀSiº
[wp_¶]
540086. [»ÌŒ (¶£Ðî)] ãÃ]ÒÌßdJÆãÃÀSÆÌÖAÉ¢Ä. räLü1, äã²b2, ]û@®2, ÂmIq2, äãäq, ç@Ÿ2 (1ãÃÌ¿EÀSiº, 2öOq¶): YÆãwW[i 2019/11; 42 (6): 84-7.
ŽõǺ
[wp_¶]
120050. [Ž] WSLVÌú^ÝvmOÌLp«ÉÖ·é¢. ¬Œq²1,2, ¬òéT2, F³3, ¢ÃÆ3, úcKêY2,4 (1ŽõǺ, 2òÜ, 3zÂíà, 4òw): ú{a@òÜtïG 2019/8; 55 (8): 980-4.
120054. [Ž] BQn«T
ÛÛÛDwÉš¯éä°ŽªzÌNÏ»ÉÖ·é¢. ñ{öL1,2, Rzq1,3, acBF1,4, ÀB@÷2, ¬Œq²1, ²XØ°q1, éRüq1, [xMq1, IêŸ5, ëìLì5 (1ŽõǺ, 2Õ, 3V¢IãÃE¡fIãÃ, 4äPŽaEŽõà, 5Õw): k¢ãw 2019/12; 49 (2): 87-98.
310042. [Çáñ] Characterization of the IncFII-IncFIB(pB171) Plasmid Carrying bla NDM-5 in Escherichia coli ST405 Clinical Isolate in Japan. Takayama Y1,2, Sekizuka T, Matsui H3, Adachi Y2, Eda R4, Nihonyanagi S2, Wada T5, Matsui M, Suzuki S, Takaso M6, Kitasato H7, Kuroda M, Hanaki H3: Infect Drug Resist 2020/2; 13: 561-6. (Rzq1,2, ŒäGm3, ÀB@÷2, ]cÈŸY4, ñ{öL2, acBF5, »m6, k¢pY7, ÔØGŸ3: 1V¢IãÃE¡fIãÃ, 2ŽõǺ, 3k¢åwk¢¶œÈw€, 4åw@ãÃn€È, 5äPŽaEŽõà, 6®O, 7ãÃq¶w)
[wïE€ï]
723896. [wï (S)] (êÊu) l]hÌZxj^Oðs¢¡Ãªt÷µœ2ÇáÉ¢Ä. ¬Œq²1,2, ñ{öL1, acBF1,3, Rzq1,4, úc KêY2 (1ŽõǺ, 2òÜ, 3äPŽaEŽõà, 4V¢IãÃE¡fIãÃ): æ67ñú{»wÃ@wïï (2019/5/11), , ú{»wÃ@wïG 2019; 67: 1340-7007.
732160. [wï (nûïE€ï) (µÒu) œÜÏ«Û©çÝœèwq¶ÌKv«. ñ{öL (ŽõǺ): k¢åwfBJZ^[@åºLOÙ2019Nxæ1ñ@àŽõh~Îô€Cï (2019/9/6), éÊ.
733803. [wï (nûïE€ï) (êÊu) RÛòK³gpÖÌæègÝ|AST®Ì»óð¥ÜŠÄ|. ¬Œq²1,2 (1ŽõǺ, 2òÜ): §t@[}VXg (2019/7/11), .
fÃîñǺ
Õ°Sº
[@]
620119. [wp (ªS·M)]yEOLC for ALL ·×ÄÌlÉGhIuCtPAÌõð@_oïaÌÉaPAzPart 1 Çó²ÆÌÉa@5. eáQÉæÁĶ¶éêÉÇó@H. ž_IêÉ@Õ°SmÌ_, p.179. I. Xs`
AEyC@Õ°SmÌ_, p.186. Part 2 »ÌŒÉaI_ðàÂ׫@7. aŒm@Õ°SmÌ_, p.213. 8. ŠÓuè@Õ°SmÌ_, p.219. ùJüØ1, AŒü¿2 (1Õ°Sº, 2a@Õ°Sº), Ò: ¬ìübq, ¬Ñfq, ³Mq, RDG, ¬cLá, ìcÁq, ¢q, ÔäIq, ìR°, , 2019/7/s.
g[^T|[gZ^[
ÉaPAº
ÚAãÃxº
Õ°€xº
[wïE€ï]
723948. [wï (S)] (|X^[) ãtå±€ÌÛAgiÌœßÌ€. âcc1, FJYñ2 (1Õ°€xº, 2Õ°€EvWFNg): æ40ñú{Õ°òwïwpï (2019/12/4-6), , Õ°ò 2019; 50: S316.
O[oÕ°€xZ^[
[wïE€ï]
713154. [wï (Û)] (êÊu) The prognosis of patients with recurrent or persistent ovarian clear cell carcinoma: Results from a randomized phase III study (JGOG3017/GCIG). Kondo E, Tabata T, Suzuki N, Aoki D, Kato K, Hamano T, Kotera Y1, Tokuyama O, Fujiwara K, Kimura E, Terauchi F, Sumi T, Okamoto A, Yaegashi N, Enomoto T, Sugiyama T: American Society of Clinical Oncology 2019 Annual Meeting (2019/5/31-6/4), Chicago, USA. (¬Çv1: 1O[oÕ°€xZ)
713155. [wï (Û)] (êÊu) Randomized phase III trial comparing pegylated liposomal doxorubicin (PLD) 50 mg/m2 and 40 mg/m2 in patients with platinum-resistant Mullerian carcinoma (JGOG3018). Yabuno A, Tabata T, Michimae H, Oishi T, Nonaka M1, Takano M, Hirata T, Fujiwara K, Sugiyama T: American Society of Clinical Oncology 2019 Annual Meeting (2019/5/31-6/4), Chicago, USA. (ìüa1: 1O[oÕ°€xZ)
722276. [wï (S)] (V|WE) AJf~AnòÆÕ°±. ìüa1, FJY¡2 (1O[oÕ°€xZ, 2Õ°€EvWFNg): æ40ñú{Õ°òwïwpWïï (2019/12/6), , Õ°ò 2019/11; 50: S187.
723949. [wï (S)] (|X^[) i¿}lWgÉÖ·ȩ́®õÌæègÝ (k¢åwa@ÌæègÝ1). ¬Ž@L1, ºãq1, ðäºq1, ìüa1, nÓF1, ¬Çv1 (1O[oÕ°€xZ): æ40ñú{Õ°òwïwpWïï (2019/12/6), , Õ°ò 2019/11; 50: S318.
723950. [wï (S)] (|X^[) DMƱÌøŠ»ÆµÄÌCRFÇt@CÌJE±ü (k¢åwa@ÌæègÝ2). ÎXvüq1, @~~1, ðäºq1, nÓF1, Ü{S¡1, ¬Çv1 (1O[oÕ°€xZ): æ40ñú{Õ°òwïwpWïï (2019/12/6), , Õ°ò 2019/11; 50: S318.
k¢åwa@
a@Åì
[wïE€ï]
723951. [wï (S)] (|X^[) a@©ç©îÉÞ@µœÆîÒ̶̱`Þ@ã1ÔÉÅ_ðÄÄ`. åi¢ü (a@Åì): ú{VNÅìwïæ24ñwpWï (2019/6/7), åä, ú{VNÅìwïæ24ñwpWïŽ^W 2019/6; p.145.
723952. [wï (S)] (êÊu) qÇàÌO[tPAðÀHµÄ¢éãÃÒÌnæAgÅø¢ïŽÉÖ·é€. ¬ÐÅq1, Ò²bq1, ûJaq2, ©Iq3, ÑüÞq4 (1Åìw, 2a@Åì, 3Åì, 4³ÚåwÅìw): æ24ñú{ÉaãÃwïwpåï (2019/6/21), _Þì, Palliative Care Research 2019/6; 14 (Suppl): S343.
723953. [wï (S)] (|X^[) @ÌSnre[VåÉš¯éœEíðÜßœ}ÏV~
[VÌÀHÆâè_. Öªbüq1, ŽRü1, Vámb1, Ž^ê2, ¡JpI2, üÞq3, ìcçt4, ¢ÃÆ4 (1a@Åì, 2a@nr, 3ãÃq¶w, 4zÂíà): æ25ñú{Snre[VwïwpWï (2019/7/13), åã, æ25ñú{Snre[VwïwpWïvOW 2019/7; p.P-213.
723954. [wï (S)] (êÊû) Z^[Éš¯éÅìtÁès×̮̻óÆÛè. É¥ŒáØ (a@Åì): æ45ñú{dÇSgáQwïwpWï (2019/9/20), ªR, ú{dÇSgáQwï 2019/8; 44 (2): 376.
723955. [wï (S)] (|X^[) `S`±üÌÛŒÜgpû@Ìw±ÉæéçÇóÌüP. aÆó1, iä^Mq2, ìcÁq1, ü1, ŽRü1, âV¡^ì1, Vámb1, iärs2, ß¡Tq2, ŒRa2 (1a@Åì, 2]_oà): æ60ñú{_owïwpåï (2019/5/25), åã, Õ°_ow 2019/11; 59 (Suppl): S450.
733804. [wï (nûïE€ï)] (êÊû) FmÉ«©¯Ä^òCVfgíž. ëàVD1, Fâ^Rü1 (1a@Åì): æ19ñk¢Åì€ï (2019/12/21), _Þì, æ19ñk¢Åì€ïvOEŽ^ 2019/11; p.46.
733805. [wï (nûïE€ï)] (êÊû) X^btÌÅìÏÌø¬Éü¯œæègÝ`ÅìÌTO»ÌßöðʵÄ`. {ìçGü1, Vámb1 (1a@Åì): æ19ñk¢Åì€ï (2019/12/21), _Þì, æ19ñk¢Åì€ïvOEŽ^ 2019/11; p.53.
733806. [wï (nûïE€ï)] (êÊû) Æ°Æp[gi[VbvðÑȪçAÆ°@\ðÛÂœßÌÆ°x. âJŠè©1, É¥ŒáØ1, ÑËRüq1 (1a@Åì): æ19ñk¢Åì€ï (2019/12/21), _Þì, æ19ñk¢Åì€ïvOEŽ^ 2019/11; p.55.
733807. [wï (nûïE€ï)] (êÊû) dÇSgáQÌV[gXeCpɺ€Æ°Ì¶ÌÏ»`ãÃÆð¹¹àÂÔ{ÝÉš¢Ä¡ãÌæègÝðlŠé`. cKŸq1, É¥ŒáØ1, ÑËRüq1 (1a@Åì): æ19ñk¢Åì€ï (2019/12/21), _Þì, æ19ñk¢Åì€ïvOEŽ^ 2019/11; p.56.
733808. [wï (nûïE€ï)] (êÊû) ¡ÃïR«ž²Ç³ÒÌnæÚsx`œEíAgÉæéÞ@ã̶𩊜îü`. óûm1, Fâ^Rü1 (1a@Åì): æ19ñk¢Åì€ï (2019/12/21), _Þì, æ19ñk¢Åì€ïvOEŽ^ 2019/11; p.58.
733809. [wï (nûïE€ï)] (êÊû) ž__oÈ¡ÃZ^[Ì_ETCWOÉü¯œæègÝÆ¡ãÌÛè`næïPAÌÀHðÚwµœœEíAg`. Fâ^Rü1, RûŸq1, ŽüÄ1, {ìçGü1 (1a@Åì): æ19ñk¢Åì€ï (2019/12/21), _Þì, æ19ñk¢Åì€ïvOEŽ^ 2019/11; p.59.
733810. [wï (nûïE€ï)] (êÊû) åwa@Éš¯éž_ÈKâÅìÌÓ`ÆÛè. ŽüÄ1, Fâ^Rü1, ûJaq1 (1a@Åì): æ19ñk¢Åì€ï (2019/12/21), _Þì, æ19ñk¢Åì€ïvOEŽ^ 2019/11; p.60.
733811. [wï (nûïE€ï)] (êÊû) _ošÈEßÜ¢Z^[§¿ã°ã3NÔÌü@³ÒÌÀÔñ. ¬äüä1, åi¢ü1, ÑËRüq1 (1a@Åì): æ19ñk¢Åì€ï (2019/12/21), _Þì, æ19ñk¢Åì€ïvOEŽ^ 2019/11; p.69.
733812. [wï (nûïE€ï)] (êÊû) ßÄó¯Âž_Ÿ³Ì³ÒÆÖíéÅø¢œŽîÌÏ»ÆÖW\z`gxr[Ì_ðp¢ÄUèÔé`. AØ·ü1, Fâ^Rü1 (1a@Åì): æ19ñk¢Åì€ï (2019/12/21), _Þì, æ19ñk¢Åì€ïvOEŽ^ 2019/11; p.73.
733813. [wï (nûïE€ï)] (êÊû) ËIÈsÀ©ç©s×ðJèÔ·³ÒÌðÆÅì`gxr[Ì_ðp¢ÄUèÔé`. Jü÷1, Fâ^Rü1 (1a@Åì): æ19ñk¢Åì€ï (2019/12/21), _Þì, æ19ñk¢Åì€ïvOEŽ^ 2019/11; p.74.
733814. [wï (nûïE€ï)] (êÊû) `S`±üÉš¯éÛŒÜgpû@Ìw±ÆçÇóÌüP. aÆó1, ìcÁq1, ü1, âV¡^ì1, ŽRü1, Vámb1, iä^Mq2 (1a@Åì, 2]_oà): æ19ñk¢Åì€ï (2019/12/21), _Þì, æ19ñk¢Åì€ïvOEŽ^ 2019/11; p.77.
733815. [wï (nûïE€ï)] (êÊû) Snre[VåÉš¯éœEíðÜßœ}ÏV~
[VÌÀ{ÆÛè. Öªbüq1, ŽRü1, Vámb1, JpI2, Ž^ê2, üÞq3 (1a@Åì, 2a@nr, 3ãÃq¶w): æ19ñk¢Åì€ï (2019/12/21), _Þì, æ19ñk¢Åì€ïvOEŽ^ 2019/11; p.79.
a@Õ°ž
[wp_¶]
120055. [Ž] _Þì§Õ°žZtﶀǜt®oêåO[vÅÀ{µœAP[g²žÊ©ç©œ®ožÌ»óÆÛè. ¬Š@i1, â|Ô2, {IØ3, éØTq4, ¬Ž³šè4, ŒŽRüq5, JéÇŸ6, rc@E7 (1a@Õ, 2Õ, 3ÉšŽŠ¯a@Õ°žº, 4Cåwãwt®a@fÃZpfÃZpÈ, 5ºaåw]LFa@Õ°až, 6åas§a@Õ°žÈ, 7϶ï¡lsìa@ž): _Þì§Õ°žZtïG 2019/12; 54 i171j: 1-5.
521012. [ðà] ®Íž}XLO@Ìî{IÈlŠûÆ»Ìû@. ¬Š@i (a@Õ): sãwž 2019/6; 47 (2): 137-8.
[wïE€ï]
723956. [wï (S) (êÊu) œ±ÂÚ^SØÇ^¢Å¶ºàððFßœALSÌ1á. RLq1, ØŽq1, œcçL1, {ºÀq1, Fc@v1, ãç»1, ¡@m1, ëìLì1,2 (1a@Õ, 2Õw): æ44ñú{Ž¹gžwïwpWï (2019/4/29), ¡l, Ž¹gžZp 2019/4; 44 (Ž^): S166.
733816. [wï (nûïE€ï)] (êÊu) ³ð_@ÉôR©³êœáN« 宬kóÇÌ1ÇáÉ¢Ä. ¡¯üq1, ŒvK1, ê cìV1, F¡ŽP1, ûLê1, œcõ2, ëìLì1,3 (1a@Õ, 2ÍŽa@, 3
Õw): æ17ñk¢ÇtH[ (2019/6/3), ÍŽ, k¢ÇtH[vOEŽ^W 2019/6; p.3.
a@òÜ
[wp_¶]
220006. [Ž] yÀHñzk¢åwa@Ek¢åwa@Ìüùòw³çfERAJL
À{Oa@À±ÀKÉš¯éã\I8Ÿ³ÌÀ{󵲞. túäöü1, Ñê1, c@å1, RGü1, òc[I1,2, ììçq1,2, ¬Ñ¹G1, œRi1,2, Rê1,2, úcKêY1,3 (1òw, 2a@òÜ, 3òÜ): òw³ç 2020/1; 3: 179-84.
a@Õ°Sº
[wïE€ï]
723957. [wï (S)] (êÊu) MuáQÉš¯édÇxÆ®Så`ÆÌœ³IÈ¢. ûcOY1, àcß2, ©q¶2,3 (1a@Õ°Sº, 2ž_, 3åw@ãÃn€È): ú{FmEs®Ã@wïæ45ñåï (2019/8/30), ŒÃ®.